MED6 NOTES

SURGERY

CHAN CHAK FU MAKSIM
(EDITED FROM JASON'S NOTES)

[Image Description: The image is a close-up shot taken during a surgery, featuring medical instruments such as scalpels, hemostats, and a syringe arranged on a blue surgical drape. The instruments are made of stainless steel and reflect the light, creating a stark contrast against the blue background. A surgical box with small holes is in the left foreground. In the blurred background, two surgeons wearing blue scrubs are visible, one holding a surgical tool, with a focused area on their hands and the instrument they are using, while their faces are out of focus. A bright white circle is superimposed in the middle of the image, containing red text that reads "MED6 NOTES" at the top, "SURGERY" in the center, and "CHAN CHAK FU MAKSIM (EDITED FROM JASON'S NOTES)" at the bottom, each separated by a thin red line.]

# GENERAL SURGERY

1 BASIC SURGICAL PRINCIPLES 4
1.1 Tubes & drains 4
1.2 Surgical instruments 15
1.3 Fluids & electrolytes 18
1.4 Surgical nutrition 19
1.5 Pre-op preparation and peri-operative management 21
1.6 Post-op complications 27
1.7 Endoscopy 33
2 CLINICAL APPROACH 41
2.1 Trauma 41
2.2 Abdominal surgical scars 42
2.3 Common short cases 43
2.4 Acute abdomen 44
2.5 Peritonitis 46
3 UPPER GI SURGERY 47
3.1 Anatomy 47
3.2 Dysphagia 49
3.3 UGIB 51
3.4 Benign diseases of esophagus 54
3.5 CA esophagus 60
3.6 Benign diseases of stomach 64
3.7 CA stomach 68
3.8 Bariatric surgery 74
4 LOWER GI SURGERY 75
4.1 Anatomy 75
4.2 LGIB 77
4.3 Intestinal obstruction 79
4.4 Stoma 83
4.5 Diseases of small bowel 86
4.6 Benign diseases of large bowel 88
4.7 Colorectal carcinoma (CRC) 97
4.8 Diseases of anal canal & anus 108
5 HBP SURGERY 116
5.1 Anatomy and physiology 116
5.2 HBP investigations 119
5.3 Obstructive jaundice 120
5.4 Surgical liver diseases 121
5.5 Gallstone diseases 129
5.6 Diseases of biliary tract 135
5.7 Cancers of gallbladder and biliary tree 138
5.8 Diseases of pancreas 141
5.9 Diseases of spleen 151
6 HERNIA 153
6.1 Anatomy 153
6.2 Overview 155
6.3 Inguinal hernia 156
6.4 Incisional hernia 158
6.5 Umbilical hernia 159
6.6 Femoral hernia 159
7 VASCULAR SURGERY 160
7.1 Aneurysm 160
7.2 Peripheral vascular disease 163
7.3 Chronic venous insufficiency 170
7.4 Lower extremity ulcers 175
7.5 Haemoperitoneum 176
7.6 SMV thrombosis 176

8 BREAST SURGERY.
2
8.1 Anatomy 177
8.2 Common breast complaints 177
8.3 Assessment of breast mass 178
8.4 Breast malignancy 179
8.5 Benign breast disease 181
8.6 Benign breast tumours 187
8.7 Gynaecomastia 188
9 ENDOCRINE SURGERY 188
9.1 Thyroid 189
9.2 Parathyroid 189
9.3 Adrenals 198
9.4 Pancreatic neuroendocrine tumours (pNET) 201
206
ORTHOPAEDICS & TRAUMATOLOGY (ORT) 208
1 BASIC PRINCIPLES 208
1.1 Anatomy of bones & joints 208
1.2 History taking 209
1.3 Management overview 209
1.4 Trauma 210
1.5 Orthopaedic appliances 215
1.6 Summary of special tests 218
2 SPINE 219
2.1 Anatomy 219
2.2 XR spine interpretation 221
2.3 Approach to spine diseases 222
2.4 Cervical myelopathy 223
2.5 Spinal stenosis 223
2.6 Degenerative spine disorders 224
2.7 Spine trauma 226
3 SHOULDER AND ARM 228
3.1 Anatomy 228
3.2 Shoulder trauma 229
3.3 Shoulder pain 233
3.4 Biceps tendinopathy 233
3.5 Rotator cuff syndrome 233
3.6 Frozen shoulder / Adhesive capsulitis 235
4 ELBOW AND FOREARM 236
4.1 Anatomy of elbow 236
4.2 Elbow trauma 236
4.3 Forearm fractures 239
4.4 Epicondylitis 239
5 HAND AND WRIST 240
5.1 Anatomy of hand & wrist 240
5.2 Compression neuropathy 243
5.3 Tendon-related pathology 245
5.4 Hand & wrist trauma 247
6 HIP 249
6.1 Anatomy 249
6.2 Hip trauma 249
6.3 OA hip 253
6.4 AVN of hip 254
7 KNEE 255
7.1 Anatomy 255
7.2 Soft tissue injuries 256
7.3 Bone and joint injuries 258
7.4 OA knee 260

3
8 FOOT AND ANKLE................................................................................................................................................................................................................................................................. 261
8.1 Anatomy ...................................................................................................................................................................................................................................................................................... 261
8.2 F&A deformities............................................................................................................................................................................................................................................................................ 262
8.3 F&A trauma ................................................................................................................................................................................................................................................................................. 264
8.4 Soft tissue injury ........................................................................................................................................................................................................................................................................ 267
8.5 Diabetic foot.................................................................................................................................................................................................................................................................................. 268
9 SYSTEMIC DISEASES........................................................................................................................................................................................................................................................................ 269
9.1 Osteoarthritis................................................................................................................................................................................................................................................................................ 269
9.2 Inflammatory arthritis................................................................................................................................................................................................................................................................... 271
9.3 Infections.......................................................................................................................................................................................................................................................................................... 273
10 MALIGNANCY .................................................................................................................................................................................................................................................................................... 275
10.1 Overview....................................................................................................................................................................................................................................................................................... 275
10.2 Malignant bone tumour ............................................................................................................................................................................................................................................................ 277
10.3 Benign bone tumour.................................................................................................................................................................................................................................................................. 278
11 PAEDIATRIC ORTHOPAEDICS ........................................................................................................................................................................................................................................................ 279
11.1 Developmental dysplasia of hip.............................................................................................................................................................................................................................................. 279
11.2 Scoliosis ......................................................................................................................................................................................................................................................................................... 281
11.3 Hip pain in paediatrics................................................................................................................................................................................................................................................................ 282
SUBSPECIALTY SURGERY................................................................................................................................................................................................................................................................... 283
1 ANAESTHESIA AND INTENSIVE CARE .................................................................................................................................................................................................................................... 283
1.1 Trauma ............................................................................................................................................................................................................................................................................................ 283
1.2 Perioperative issues ................................................................................................................................................................................................................................................................... 284
1.3 Airway management................................................................................................................................................................................................................................................................... 287
1.4 General anaesthesia ................................................................................................................................................................................................................................................................. 290
1.5 Local anaesthesia....................................................................................................................................................................................................................................................................... 294
1.6 Regional & obstetrics anaesthesia........................................................................................................................................................................................................................................... 295
1.7 Postoperative care...................................................................................................................................................................................................................................................................... 298
1.8 Ventilator....................................................................................................................................................................................................................................................................................... 301
1.9 Anaesthetic monitoring ............................................................................................................................................................................................................................................................. 303
1.10 Drugs and fluids in anaesthesia........................................................................................................................................................................................................................................... 304
2 UROLOGY .......................................................................................................................................................................................................................................................................................... 307
2.1 Common urological complaints .......................................................................................................................................................................................................................................... 307
2.2 Urological emergencies ......................................................................................................................................................................................................................................................... 309
2.3 Urinary stones (Urolithiasis).................................................................................................................................................................................................................................................... 312
2.4 LUTS & BPH..................................................................................................................................................................................................................................................................................... 315
2.5 Urological neoplasm................................................................................................................................................................................................................................................................. 318
2.6 Benign scrotal conditions......................................................................................................................................................................................................................................................... 326
3 PAEDIATRIC SURGERY................................................................................................................................................................................................................................................................ 329
3.1 Resuscitation ................................................................................................................................................................................................................................................................................. 329
3.2 Neonatal conditions..................................................................................................................................................................................................................................................................... 330
3.3 Paediatric surgical abdomen ................................................................................................................................................................................................................................................. 335
3.4 Paediatric urology....................................................................................................................................................................................................................................................................... 338
3.5 Paediatric oncology..................................................................................................................................................................................................................................................................... 342
4 PLASTIC, RECONSTRUCTIVE & AESTHETIC SURGERY (PRAS).............................................................................................................................................................................. 343
4.1 Wound healing and reconstruction ...................................................................................................................................................................................................................................... 343
4.2 Burns............................................................................................................................................................................................................................................................................................... 345
4.3 Scars ................................................................................................................................................................................................................................................................................................... 348
4.4 Benign skin conditions................................................................................................................................................................................................................................................................. 348
4.5 Skin cancers ..................................................................................................................................................................................................................................................................................... 350
4.6 Lymphaedema ............................................................................................................................................................................................................................................................................. 351
5 NEUROSURGERY.......................................................................................................................................................................................................................................................................... 352
5.1 Traumatic brain injury (TBI)................................................................................................................................................................................................................................................... 352
5.2 Cerebrovascular disease .......................................................................................................................................................................................................................................................... 356
5.3 Hydrocephalus............................................................................................................................................................................................................................................................................. 358
5.4 Skull base tumours.................................................................................................................................................................................................................................................................... 359
5.5 Brain tumours................................................................................................................................................................................................................................................................................ 360
5.6 Spine diseases................................................................................................................................................................................................................................................................................ 362
5.7 Deep brain stimulation ............................................................................................................................................................................................................................................................... 363
5.8 Radiology of brain ....................................................................................................................................................................................................................................................................... 363
For Cardiothoracic surgery, please refer to CTS Student Handbook.

# GENERAL SURGERY

## 1 Basic surgical principles

### 1.1 Tubes & drains

Definition:

- Mechanical conduit that allows passage of abnormal collection (gas, fluid, pus)
- Foley catheter is NOT a drain: urine is not abnormal collection
  Role
- Evacuation: RD, JP drain, chest drain
- Tissue apposition: chest drain
- Diversion: T tube
- Irrigation
  Materials
- Red rubber, e.g. corrugated drain, Sengstaken tube
- Latex rubber, e.g. T tube (stimulate fibrosis)
- Silicon rubber, e.g. Foley, Hickman (durable)
- Plastic
  Size
- French (Fr): external diameter of a catheter in 1/3mm increment, e.g. 24 Fr = 24/pi = 7.6mm
- Gauge (G): the larger the number, the smaller the external diameter
- Note neither system gives the **internal diameter** of catheter which determines the flow
  Monitoring
- Inspection daily for:
  - Drain output: volume, colour
  - Drain problem: loss of suction, drain dislodgement, etc
  - Appearance of wound: erythema, discharge, etc
- Ensure good flow: remove visible clots by gentle massage, ensure adequate suction
  Removal: timing
- Drain for peri-op bleeding: after 24-48h
- Drain for serous collection: after 3-5d
- Drain for intestinal anastomosis: after 5-7d
- Drain for infected materials: until drainage minimal + clinical condition improved
- Drain with suction: after switching suction + drain monitored for 24h
- T tube: **10 days** (to allow tract formation to prevent subsequent biliary leak)
  Complications
- Immediate: pain, bleeding, perforation
- Early: leak, occlusion, dislodgement, inadequate drainage
- Late: erosion, infection, pressure necrosis of bowel/ vessels, fistula formation, retained FB during removal

[Image Description: A page from a medical textbook focusing on surgical principles related to tubes and drains. The text is structured with headings and bullet points, covering definitions, roles, materials, sizing, monitoring, removal timing, and complications associated with surgical drains.]

5
Classification

- Active vs passive
  - Active: used in enclosed space (to min risk of seroma/ haematoma)
  - Passive: used in bowel surgery (to min risk of pressure necrosis of bowel and occlusion of side holes by omentum)
- Open vs closed
  - Open: used in deep abscess; larger skin incision required (to avoid early closure of skin wound)
  - Closed: lower risk of infection and allow measurement of output

|        | Active        | Passive          |
| :----- | :------------ | :--------------- |
| Open   | N/A           | Corrugated drain |
|        |               | Penrose drain    |
|        |               | Yeates drain     |
| Closed | JP drain      | Robinson drain   |
|        | Hemovac drain | Sump drain       |
|        | Minivac drain | Salem sump drain |
|        | Blake drain   | Pigtail catheter |
|        | Chest drain   | T tube           |
|        |               | PTBD             |
|        |               | NBD              |

Open passive drain
Keep the wound open: encourage healing from the base and clean cavity

|                      | Features                                               | Indications                                       |
| :------------------- | :----------------------------------------------------- | :------------------------------------------------ |
| (a) Corrugated drain | Waveform appearance: increase surface area of drainage | Subcutaneous / deep seated abscess in limb wounds |
| (b) Penrose drain    | Single tube                                            | Superficial skin wound                            |
| (c) Yeates drain     | Capillary action (drain against gravity)               | Subcutaneous / deep seated abscess in limb wounds |

[Diagram of three different types of open passive drains. Image (a) shows a corrugated drain, a flexible tube with ridges running along its length. Image (b) shows a Penrose drain, a simple, thin, and flexible tube. Image (c) shows a Yeates drain, several smaller tubes grouped together]

Closed active drain
Flat tube with side holes, bulb must be deflated to provide suction (vacuum)
Volume: Hemovac > JP > Minivac

|                     | Features                                                                                                   | Indications                      |                                                                                                                                                                              |
| :------------------ | :--------------------------------------------------------------------------------------------------------- | :------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Jackson-Pratt drain | visual inspection and easy measurement of output easily clotted, not for laparoscopic OT (space too large) | Breast, thyroid, parotid surgery | [Photograph of a Jackson-Pratt drain in situ. The wound, coated with Dermabond, is visible with drain tubing extending from it. A Jackson-Pratt drain bulb is also visible.] |

Hemovac drain Breast, thyroid, parotid
surgery

[Image of a round, clear plastic container with measurements on the side and a tube extending from the bottom.]

Minivac drain No antenna indicating system Vascular surgery (e.g.
femoral-femoral bypass)

[Image of a transparent, accordion-style reservoir with a tube extending from its base.]

Redivac drain Green antenna: indicate O&T surgery
vacuum status
Changed once per week
Remove if <30mL of fluid
drained per day
Removal (3S): stitch removal,
suction discontinuation, slow
and steady pull

[Image of two clear plastic containers with tubes. The container on the left has a green antenna that is not fully extended and is labeled "No suction 'devacced'". The container on the right has a green antenna that is fully extended and is labeled "Vacuum intact".]

Blake drain 4 channels alongside a solid Breast surgery
core less likely to be torn Cardiac surgery
Increase surface area due to
multiple drainage channels

[Image of a white, flexible tube with four channels running along its sides.]

Closed passive drain

|                         | Features                                                                                                                                           | Indications                                          |
| ----------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------- |
| Robinson (simple) drain | **Side holes** Radio-opaque line Usual size: **21 Fr** for adult, 14 Fr for paediatrics (larger if higher risk of blockage e.g. fecal peritonitis) | Major abdominal surgery (inserted intra-operatively) |

[Image of a clear silicone tube with several small holes along its length.]

| Sump drain                | Concentric double lumen - Inner large lumen: suction - Outer small lumen: air-vent - (Some have 3rd lumen: for irrigation) | Large secretions, e.g. haemorrhagic pancreatitis                           | [Image of a sump drain, it is a transparent tube with a blue line running through it. The blue line spirals along the inside of the transparent tube.] |
| ------------------------- | -------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Salem sump drain          | Blue: venting port (prevent plugging of tube holes by gastric mucosa → suction necrosis)                                   |
| Transparent: suction port | Post-op gastric decompression (when NG tube not feasible)                                                                  | [Image of a Salem Sump Nasogastric Tube. The transparent tube is looping.] |
| Pigtail catheter          | Pigtail curve with side holes to avoid tissue trauma                                                                       | Deep-seated abscess, e.g. liver abscess Percutaneous nephrostomy (PCN)     | [Image of a pigtail catheter, it is a blue and white technical drawing of the tube, showing multiple drainage holes.]                                  |
| T tube                    | Left for **10 days** to allow formation of tract → prevent biliary leakage                                                 |

Latex: stimulate fibrosis
Before removal:

- _T tube cholangiogram_ (TTC) to ensure free bile flow
- _Clamp 24h_ to rule out bile leak | 1. Surgical biliary decompression (exploration of CBD)

2. Facilitate post-op cholangiogram | [Image of three T-tubes. The tubes are made of a yellow material and are shaped like the letter T.]
   | | | Normal size: 14, 16, 18
   Nasobiliary drain | Pink in colour
   Obsolete now: easily pulled out by patient | Endoscopic biliary decompression |

7

Methods of biliary drainage

Percutaneous
(Clinically
difficult to tell
between PTC
and PTBD)

PTC

- Transhepatic:
  - Easier to anchor because liver does not move
  - More vascular, injury to other bile ducts
- Transperitoneal:
  - Less vascular, suitable if bleeding tendency
  - Easier to dislodge if GB reduces inflammation, higher risk of biliary leakage
- PTBD: use a pigtail drain
- External PTBD: when unable to cross obstruction
  - Indications: biliary drainage prior to definitive surgery for hilar cholangioCA, palliation for cholangioCA
- Internal-external PTBD: side holes ABOVE and BELOW level of obstruction, cross the ampulla with tip into the duodenum
  - nutrition improved, eliminates metabolic imbalance,
  - no bag once external component capped → facilitates internalization
  - Cholangiogram is usually done if internalized

Endoscopic
Transpapillary = ERCP + stenting:

- Plastic:
  - Straight or pigtail (can hook onto mucosa and avoid dislodging e.g. large sphincteroplasty)
- Metal: **more durable and wider caliber**, straight
  - Fully covered: With mesh, might dislodge
  - Uncovered: wider patency, tissues may grow in to anchor the stent, but might have tumor in-growth
  - Partially covered: both ends uncovered, but middle covered
- Transmural = EUS-guided drainage (needle / lumen-apposing metal stent LAMS)
  - Endoscopic gallbladder drainage (EGBD): create an artificial cholecysto-duodenal fistula
  - Hepaticogastrostomy (HGS): between stomach and left IHBD
  - Choledochoduodenostomy (CDS): between D1 and CBD

[Image of the human gallbladder and CBD with a metallic stent inserted, with two different views of the gallbladder and ducts and the metallic stent.]

[Image of three t-tubes lined up next to each other, with their t-shaped part laying flat.]

Surgical
Exploration of CBD +/- T-tube insertion

- Latex: stimulate fibrosis
- Normal size: 14, 16, 18Fr

Before removing T-tube:

- Cholangiogram at post-op Day 10: to ensure free bile flow and rule out distal obstruction
- Wait 6 weeks and repeat cholangiogram (KC Ng)
- Spigot 24h to rule out bile leak

[X-ray image showing the biliary tree and the placement of the T-tube.]

[X-ray image showing the biliary tree and the placement of the T-tube, the radiologist has drawn lines and labelled the following items in the image: Hilum CA, L PTBD, R PTBD, HGS, EGBD, Bilat SEMG.]
8

Feeding tube
C/I of Ryles or Entriflex: **base of skull fracture**, obstructing mass in esophagus, maxillofacial abnormalities

| Features                                                                                                                                                                            | Indications                                                                                                                                                                                                                                                                                                                         |
| ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------- |
| Nasogastric tube (Ryles tube)                                                                                                                                                       | Length estimation: 5cm below xiphisternum → ear → nostril Confirm position: 1. Inject air and auscultate for gurgling sound at epigastrium 2. Aspirate content for litmus paper (pH) 3. CXR: midline, tip below diaphragm, 10cm beyond OGJ                                                                                          | 1. **Decompression** e.g. IO, toxins (wide bore) 2. **Feeding** / Medication (fine bore) 3. Aspiration prevention 4. Lavage |
| [Image of a Ryles tube, it is a translucent plastic tube curled in a circle. It is about half an inch in diameter, and there is a green stripe down the middle.]                    |                                                                                                                                                                                                                                                                                                                                     |
| Entriflex tube                                                                                                                                                                      | Smaller calibre Metallic weight at the tip **Central guidewire** to facilitate insertion Silicon: minimize tissue reaction and discomfort                                                                                                                                                                                           | NG tube for **longer** use (< 4 weeks) Cannot be used for suction due to **narrow lumen**                                   |
| [Image of an Entriflex tube, it is a translucent plastic tube, about 1/4 inch in diameter. It has a purple and blue clamp on the end.]                                              |                                                                                                                                                                                                                                                                                                                                     |
| Percutaneous endoscopic gastrostomy tube (PEG)                                                                                                                                      | 3 lumens: balloon, flush, feed Advantage: lower risk of aspiration and dislodging compared to NG tube Changed every few months Placement of PEG tube - Endoscopic: pull method / push method - Operative: if Hx of upper abdominal surgery Cx: perforation, bleeding, infection, leakage of gastric content, blockage, dislodgement | **Prolonged enteral nutrition** (> 4 weeks): e.g. swallowing issues but functional gut                                      |
| [Image of a percutaneous endoscopic gastrostomy tube (PEG). The tube is transparent, about 1/2 inch in diameter. It extends from a circular disk with a raised balloon at the end.] |                                                                                                                                                                                                                                                                                                                                     |
| Jejunostomy tube                                                                                                                                                                    | Placed intraoperatively distal to site of anastomosis (e.g. **esophagectomy**) Can be temporary or permanent                                                                                                                                                                                                                        | Early post-op resumption of feeding                                                                                         |

9

Catheters

|                              | Features                                                                                                                                                                                                                                                            | Indications                                                                                     |                                                                                                                                                                                                         |
| :--------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :---------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Foley                        | Balloon inflation port (thickened): 10mL **sterile water** (saline may crystallise tube)                                                                                                                                                                            | Diagnostic: monitor urine output Therapeutic: urinary retention                                 | [A photograph shows a Foley catheter. The catheter is made of clear plastic tubing. It has two separate outlets. One is connected to a yellow ballon that is inflated. The other is a drainage outlet.] |
|                              | Urine drainage lumen (Some have 3rd lumen for **bladder irrigation** in haematuria)                                                                                                                                                                                 | C/I: urethra trauma                                                                             | Size: Male: 14Fr/12Fr for young male, 20Fr for BPH Female: 12Fr/10Fr Paed: 6-10Fr 3-way: 20-24Fr                                                                                                        |
|                              | Materials: - Latex (yellow): short term - Silicon (transparent): long term, change Q4 week - 3-way Foley: for gross haematuria                                                                                                                                      |                                                                                                 | [A photograph shows a clear plastic bag called the Hourly urine output drainage bag] Hourly urine output drainage bag                                                                                   |
|                              | Difficult catheterisation: - Lignocaine LA - LARGER catheter (to avoid kinking as the catheter passes through prostatic urethra) - Tiemann catheter (curved tip upward - designed for BPH, higher risk of penetration) - Suprapubic catheter (inserted with trocar) |                                                                                                 | [A photograph shows a Tiemann catheter. The catheter is made of clear plastic tubing. The tip of the tube is angled upwards.] Tiemann catheter                                                          |
| JJ stent/ureteric stent      | Insertion: - Retrograde: by cystoscope - Anterograde: percutaneous with imaging guidance                                                                                                                                                                            | Ureteric obstruction                                                                            | [A photograph shows a JJ stent/ ureteric stent. The stent is made of blue plastic tubing. It is curled at both ends.]                                                                                   |
| Flatus tube                  | Shorter than NGT, no length markings Insert by rigid sigmoidoscopy (bedside) or flexible sigmoidoscopy                                                                                                                                                              | 1. Sigmoid volvulus 2. Pseudo-obstruction (Decompression can be done by flexible sigmoidoscopy) | [A photograph shows a flatus tube. The tube is made of orange plastic tubing.]                                                                                                                          |
| Fogarty embolectomy catheter | Inflatable balloon at the tip                                                                                                                                                                                                                                       | Embolectomy in acute limb ischaemia                                                             | [A photograph shows a Fogarty embolectomy catheter. The catheter is made of pink plastic tubing. There is a small balloon at the tip of the catheter.]                                                  |

Chest drainage tube
More rigid than flatus tube
With **length markings**
Size: **24 Fr** for air, **28-32 Fr** for
blood/pus
Pneumothorax
Haemothorax
Pleural effusion

Pulmonary artery catheter
(Swan Ganz)
Inflatable balloon at the tip (to
wedge in small pulmonary
vessels)
Volume status in shock
Diagnosis of PAH

Sengstaken-Blakemore (1-3)
Minnesota (1-4)
Red in colour

Ports:

1. **Gastric balloon**: inject 200-300cc of contrast and water, confirm position by CXR (displacement to oesophagus can kill)

2. **Oesophageal balloon**: inflate with gas to 20-40mmHg

3. **Gastric aspiration**

4. **Oesophageal aspiration**

Usually together with **ET intubation**
Emergency tamponade of gastro-oesophageal variceal bleeding
unresponsive to medical and endoscopic treatment

C/I: large hiatal hernia, unconfirmed variceal bleeding (Mallory-Weiss tear), esophageal stricture, recent eso surgery

Complications:

- Pressure necrosis (deflate after 12h and re-inflate if ongoing bleed)
- **Oesophageal perforation**
- Bleeding, pain
  [Diagram of a Sengstaken-Blakemore tube. The tube is red and has two balloons, a gastric balloon and an esophageal balloon. Labels indicate: gastric balloon port, gastric aspiration port, esophageal aspiration port, esophageal balloon port, length marks, esophageal aspiration opening, gastric aspiration openings, and gastric balloon.]

Malecot
Need guidewire to insert /
remove
Urogenital:
nephrostomy, suprapubic bladder
GI: temporary gastrostomy (to develop
tract)
[Image of a Malecot catheter. It's white and has a unique cloverleaf design at its distal end.]

IVC filter
Place through right IJV / femoral vein
Cx:

- Migration
- Fractured filter
- Infection
  VTE with contraindications/
  complications/refractory
  to anticoagulants
  [Image of an IVC filter. It's a cone-shaped metal device with several prongs or arms extending outwards, designed to trap blood clots.]

11

Vascular access
| | Features | Indications | |
| :---------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| IV catheter/ | Gauge: the larger the gauge, the smaller the external diameter | | [Image of intravenous cannulae. By convention, 16 G cannulae are grey, 18 G are green, 20 G are pink, 22 G are blue and 24 G are yellow. 14 G cannulae are orange. Each of these has a needle with a transparent plastic cannula over it. 14 G is larger than 24 G. A variety of cannula lengths are also available but typically narrower gauge cannulae are shorter in length (2.5 cm for a 24 G, increasing to 4.5 cm for a 14 G).] |
| Angiocath | | | |
| Central venous | By Seldinger technique +/- Trendelenburg position (to prevent air embolism) | IV access: drug administration (e.g. chemotherapy, antibiotics), TPN, conc. IVF | [Image of a central venous catheter in situ. The catheter is inserted into the internal jugular vein and runs subcutaneously to emerge on the chest wall. The catheter has two ports that can be used for drug administration or blood sampling. Next to it, there is a double lumen PICC line with luer lock connectors.] |
| catheter | | | |
| | Hickman (IJV, subclavian vein, femoral vein): cuffed to keep line in place + prevent infection | Haemodialysis Transvenous pacing CVP monitoring Complications: | Hickman. PICC |
| | PICC (cephalic vein): purple, easier to place, but higher infection risk | - Early: PTX (highest for SCV), arterial puncture, arrhythmia, cardiac tamponade, air embolism - Late: line infection, thrombosis | |
| | Tesio catheter (twin-line single lumen CVC): hemodialysis | | |
| | Order CXR after insertion to confirm tip in SVC | | Tesio catheter |
| CVP manometer | 3-way tap "Zero" at the level of RA (4th ICS in mid-axillary line in supine position) | Assess fluid status IV access: drug, IVF Normal range of CVP: 2-6 mmHg Must require low CVP: major hepatectomy | [Image of a diagram showing the setup for measuring central venous pressure using a manometer. The diagram illustrates the manometer connected to a three-way stopcock, which is connected to both the intravenous solution and the patient. The zero point of the manometer is aligned with the patient's right atrium. A nurse is shown holding the manometer during the procedure.] |

Port-A-Cath Aka “totally
implantable venous
access device”

Can last 2-6 years
Long-term IV therapy (e.g.
chemotherapy, TPN)

[Image of a medical port with a long, clear, flexible tube attached to a white disc. The disc has a raised, circular center, and the tube is coiled loosely on a white surface, creating a loop that emphasizes its length and flexibility.]

Bougie
balloon
Dilation of esophagus in
strictures / post-
fundoplication dysphagia

[Image of a blue bougie balloon, it is elongated and tapers at both ends, resembling a slender, slightly inflated balloon with a soft, hazy blue color.]

IV catheters/angiocaths

[Image of several IV catheters arranged in a row on a wooden surface, showing their different sizes and colors. From left to right, the catheters vary in gauge size, indicated by numbers like "24G," "22G," "20G," "18G," "16G," and "14G." Each catheter has a colored hub, with shades including yellow, light blue, pink, green, gray, and orange-red. The catheters are aligned from smallest to largest gauge size and a penny is placed next to the first catheter to give scale.]

13

Artificial airway [ANAES]

| Features                    | Indications                                                                                                                                                                                            |                                                                                                                                                                                           |
| --------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Oropharyngeal airway        | Rigid plastic Measured length: **angle of mouth to angle of mandible**                                                                                                                                 | Maintain airway in **unconscious** patient Bite block for those with ETT                                                                                                                  | [Image of a set of oropharyngeal airways, also known as guedel airways, in various sizes. They are made of rigid, curved plastic with a flange at one end and a hollow channel down the middle. The airways are arranged from smallest to largest.]                                                                                                                                                                       |
| Nasopharyngeal airway       | Soft plastic C/I: **basal skull fracture** Measured length: **nostril to tragus of ear**                                                                                                               | Maintain airway in **semi-conscious** patient                                                                                                                                             | [Image of a nasopharyngeal airway, which is a flexible, hollow tube made of soft plastic. The airway is curved and has a flared end to prevent it from slipping into the nose.]                                                                                                                                                                                                                                           |
| Endotracheal tube           | Cuffed to prevent aspiration / allow MV Double black line: level of **vocal cord** Inserted with laryngoscope Auscultate 2 lungs to rule out 1-lung ventilation                                        | 1. Ventilation (e.g. resuscitation) 2. Airway protection (e.g. massive hemoptysis) 3. Excessive airway secretions C/I in C-spine injury (→ fiberoptic)                                    | [Image of an endotracheal tube. The tube is clear plastic with a cuff at the end. There is a blue pilot balloon attached to the tube. The tube has a double black line indicating the level of the vocal cord.] Can be double lumen for selected one-lung ventilation Pilot balloon (blue): detect whether balloon is inflated                                                                                            |
| Laryngeal mask airway (LMA) | Can be inserted without laryngoscope **NOT** a protected airway: aspiration may still occur                                                                                                            | Maintain airway                                                                                                                                                                           | [Image of a laryngeal mask airway (LMA). The LMA has an inflatable mask that is placed over the larynx. The image has labeled components, including 1) the inflatable cuff, 2) the stalk with a universal connector, and 3) the pilot balloon. There is also a syringe attached to the pilot balloon. The number 4 indicates that the plastic material can be reused less than 40 times.] The LMA (laryngeal mask airway) |
| Tracheostomy tube           | Double tubes: **inner tube** for cleaning and relief of obstruction Cuffed (vs uncuffed): max airway sealing for PPV Fenestrated: allow phonation Materials: PVC (Portex), silicon-coated PVC (Shiley) | 1. Upper airway obstruction (**established** / **anticipated**) 2. Failed intubation 3. Prolonged **intubation** 4. Suctioning of secretions 5. Facilitate weaning of respiratory support | [Image of a tracheostomy tube. The tube is made of clear plastic and has a cuff at the end. There is a blue strap attached to the tube. ] Can be temporary (e.g. during weaning off of intubation) or permanent (laryngectomy)                                                                                                                                                                                            |

[^1]: Footnote text

1.  2 Surgical instruments
    Principles of suturing
    [Detailed image of a suture package, including labels for "US gauge", "Metric gauge", "Needle code", "Needle length", "Needle type", "Manufacturer", "Needle shape", "Brand name of material", "Suture material", "Image of needle", "Suture length", "Lot and expiration date", and "Pick up here with needle driver".]

- Purposes of suturing
  - Hold wound margins together to promote wound healing by primary intention
  - Approximate wound margin to minimize wound contamination
  - Arrest haemorrhage
  - Prevent bone exposure
- Ideal suture
  - Tensile strength: adequate to prevent suture breakdown / typing / knot slippage
  - Tissue biocompatibility and reaction
  - Low capillarity: multifilament soaks up more fluid → medium for infection
  - Good handling and knotting properties
  - Sterilization without deterioration of properties
- Size (from small to large): 3-0, 2-0, 1-0, 0, 1...
- Jenkin's rule: suture length to wound length ratio should be at least 4:1

Classification of sutures (**important!**)

- Material: **natural** (silk, cat gut, collagens) vs **synthetic** (nylon, Vicryl, Prolene, PDS)
- Braidedness: **multifilament** (braided: more tissue resistance, easier to handle, only need 3 knots) vs **monofilament** (minimal tissue trauma, harder to handle due to memory, 6 knots needed, lower infection risk)
- Absorbability: **absorbable** (Vicryl, PDS) vs **non-absorbable** (Ethilon)

|                   | Absorbable                                   | Non-absorbable                                    |
| ----------------- | -------------------------------------------- | ------------------------------------------------- |
| **Monofilament**  | Monocryl [subcuticular]                      | Nylon / Ethilon / Surgilon [skin]                 |
|                   | PDS                                          | Prolene [vessel]                                  |
| **Multifilament** | Vicryl / Vicryl Rapide [bowel]               | Silk [anchor drain]                               |
|                   | (cutting - soft tissue, round body – organs) | (cannot be used too long due to stitch granuloma) |

Needles

- Parts: swaged end (eye), body, point
- Types of needle:
  - Conventional cutting (triangle pointing upward): to penetrate thick tissues - skin
  - Reversed cutting / Taper-point: to penetrate thin tissues **without tearing** - friable tissues
- Shapes: ½ circle, J shape (e.g. lap port sites), straight
- Aim to approximate the tissue: **evert** for skin wounds, **invert** for bowel anastomosis

Suturing patterns / terms:

- Simple interrupted suture
- Simple continuous suture: emergency haemostasis
- Continuous locking suture: better haemostasis (e.g. closing uterus after C-section)
- Vertical mattress suture: wounds with unequal heights
- Subcuticular sutures: cosmetic concern
- Tension suture: suture with plastic tubes to prevent lines from cutting the skin
- Barbed suture (e.g. Stratafix): no need tie knots, just secure by Hem-O-Lok

15

# Surgical instruments

- Veress needle (left fig.): to establish pneumoperitoneum (closed method - blind needle insertion)
- Hasson port (right fig.): to establish pneumoperitoneum (open method - sub-umbilical fascial cut-down to directly visualize peritoneum, reduced risk of organ injury)
- Maryland forceps: laparoscopic forceps

[Image of Veress needle, a long thin needle with a sharp beveled tip, used to create pneumoperitoneum in laparoscopic surgery. Next to it is an image of a Hasson port, a cylindrical device with a blunt tip and a trocar, used for open laparoscopic entry. On the right is an image of Maryland forceps, a grasping instrument with long, slender jaws, used to manipulate tissues during laparoscopic procedures.]

- Energy device:
  - Ultrasound, e.g. Harmonic ace – cut + coagulate
  - Electrical
    - Diathermy: monopolar (require grounding pad at thigh) or bipolar
    - Ligasure (fig.): bipolar, automatic coagulation + cut

[Image of Ligasure, a bipolar vessel sealing device with scissor-like jaws, used for coagulation and cutting of tissues during surgery. The device is mostly white with purple accents on the handles and gray accents on the cutting element.]

- Stapler:
  - Circular: for colorectal anastomosis (left fig.)
  - Linear (right fig.): for both anastomosis & transection
    - EndoGIA stapler: divide and suture bowel simultaneously

[Image of a circular stapler, a surgical instrument with a round head and a handle, used for colorectal anastomosis. Next to it is an image of a linear stapler, a surgical instrument with a straight head, used for both anastomosis and transection. On the right is an image of an EndoGIA stapler, a surgical instrument with a cartridge and a handle, used to divide and suture bowel simultaneously.]

- Surgical wound protector: protect wound from **infection** and **tumor seeding**
- Retractor: Kelly, Langenback, Senn, Volkmann

[Image of a surgical wound protector in situ, showing a circular incision with the wound edges retracted, revealing underlying tissue and blood vessels. Next to it is an image of a Kelly retractor, a surgical instrument with a curved blade and a handle, used to retract tissues during surgery.]

Methods of surgical haemostasis
Mechanical methods

- Direct pressure
- Fabric pads/gauze sponges/sponges
- Sutures/staples/ligating clips

Thermal/energy-based methods

- Electrosurgery
  - Monopolar
  - Bipolar
  - Bipolar vessel sealing device
  - Argon enhanced coagulation
- Ultrasonic device
- Laser

Chemical methods

- Pharmacological agents
  - Epinephrine
  - Vitamin K
  - Protamine
  - Desmopressin
  - Lysine analogues (eg, aminocaproic acid, tranexamic acid)
- Topical hemostatic agents
  - Passive (ie, mechanical) agents
    - Collagen-based products
    - Cellulose
    - Gelatin
    - Polysaccharide spheres
  - Active agents
    - Thrombin products
  - Flowables
  - Sealants
    - Fibrin sealants
    - Polyethylene glycol (PEG) polymers
    - Albumin and glutaraldehyde
    - Cyanoacrylate

17

1.3 **Fluids & electrolytes**
Types of fluid (**important!**)

- Crystalloid: NS, D5, Hartmann's, Plasmalyte, DKI - rapid loss from intravascular space
- Colloid: albumin, gelofusin - risk of anaphylaxis, risk of bleeding due to reduced platelet aggregation

| Osmolality                                                                       | Na/ pint | Features                                                                                  |
| :------------------------------------------------------------------------------- | :------- | :---------------------------------------------------------------------------------------- |
| NS <br>Isotonic: 308 in-vitro, but 286 in- <br>vivo due to incomplete ionisation | 77       | Risk of hyperchloremic metabolic acidosis <br>(NAGMA) → renal vasoconstriction & AKI      |
| Hartmann <br>Hypotonic (254 in-vivo)                                             | 65       | More physiological <br>Risk of free water retention <br>Lactate requires liver metabolism |
| Plasmalyte <br>Isotonic (271)                                                    |          | Can be used in liver patients → commonly used <br>during OT                               |
| D5 <br>Hypotonic                                                                 | 0        | 170 kcal/L <br>Protein-sparing effect                                                     |
| Half-half <br>Hypotonic                                                          | 39       | Minimise glucose fluctuation c.f. 2D1S                                                    |

Indications

- NPO (e.g. IO, ileus, pre-op), vomiting or severe diarrhoea, hypovolemia (e.g. blood loss)
  Clinical assessment
- Symptoms
  - Fluid intake
  - Abnormal fluid loss: vomiting, diarrhoea, polyuria, fever, increased drain output
  - Comorbidities: heart failure, CKD
  - Symptoms of hypovolemia: thirst, dizziness/ syncope, urine output
- Signs: BP/P, CR, JVP, third spaces (ascites, peripheral oedema)
- Severity of dehydration - Mild dehydration (<5%): reduced skin turgor, sunken eyes, dry mucous eyes - Moderate dehydration (5-8%): oliguria, postural hypotension, tachycardia - Severe dehydration (>8%): profound oliguria, hypotension
  Resuscitation
- NS 2L FR until euvolemic & haemodynamically stable → Repeat if still hypovolemic → Consult senior
  Maintenance requirement
- Fluid: 100ml/kg for first 10kg + 50ml/kg for second 10kg + 20ml/kg for remaining
- Electrolytes: - Na: 2mmol/kg/day - K: 1mmol/kg/day
  Replacement of losses
- Insensible loss: skin (increased in fever), respiration (increased in hyperventilation), faeces
- Ongoing loss, e.g. bile 1L/day, SB drainage 1.5L/day
  Prescription
- 1L NS (154mmol Na) would be sufficient for a 70-kg patient → 2S → \_D2S (i.e. \_D_S determined by Na)
- Give sufficient D5 to make up for daily fluid requirement: 2D2S or 3D2S
- Potassium:
  - Not required if NPO is expected to be short:
    - Adding KCl has a risk of inducing cardiac arrhythmia
    - Cell lysis causes potassium release
  - Premixed NS + K now available (usual 10mmol/pint, max 20mmol/pint)
  - 1mmol deficit = 200mmol total body potassium deficit
- Fluid prescription in dehydration
  - Deficit: 0.6 x weight in kg x %loss
  - Maintenance: according to 100-50-20 rule, with Na 2mmol/kg/day
  - Replenishment rate:
    - 50% in first 8h (NS for resuscitation)
    - 50% in subsequent 16h (NS to meet daily Na requirement + D5 to make up to daily fluid
      requirement) + K supplement

[Image Description: A page numbered 18, containing information about fluid and electrolytes. The page includes the following sections: "1.3 Fluids & electrolytes", "Types of fluid (important!)", "Indications", "Clinical assessment", "Resuscitation", "Maintenance requirement", "Replacement of losses", and "Prescription". The page is primarily composed of bullet points, tables and short paragraphs, presented in a structured and organized manner.]

```markdown
1.4 Surgical nutrition
Metabolic changes after trauma / surgery

- Ebb phase (24-48h): temporary shut-down to conserve energy
- Flow phase: catabolic state → anabolic state

Consequences of malnutrition

- Prolonged hospital stay, and thus increased risk of complications, e.g. bedsores, DVT, chest infections
- Increased morbidity: wound failure, sepsis, infection
- Increased mortality

Nutritional assessment

- Screening: **malnutrition screening tool (MST)** in HK
  - Unintentional significant weight loss (>5-10% in a certain time period)
  - History: change in diet intake
  - Some countries use MUST (malnutrition universal screening tool): BMI + weight loss score + acute disease effect score
- History taking: factors that affect intake, e.g. odynophagia, dysphagia
- Physical exam: muscle wasting (temporalis, zygomatic arch, supraclavicular fossa, hand, lower ribs), triceps skin fold, mid-arm circumference
- Biochemical parameters: **LFT** (albumin), **WBC** (total lymphocyte count), cholesterol, transferrin, pre-albumin iron-binding capacity
- Nutritional assessment tool (by dietician): **subjective global assessment (SGA)**, etc

Estimation of nutritional requirement

- Calories: **TEE = BEE x (1+ activity factor + stress factor)**
  - Basal energy expenditure (BEE):
    - **Estimation by IBW x 25** where IBW is when BMI = 22)
    - Harris-Benedict equation
    - Liu's equation
  - Activity factor ~ 0.2
  - Stress factor 0.2 - 0.5, up to 1 in major burns (>50%)
- Volume: 100-50-20 rule
- Additional electrolytes (e.g. Na 2mmol/kg/day, K 1mmol/kg/day, Ca, Mg, PO4)/ vitamins
- Other nutritional requirement
  - Protein 1.5g/kg/day (= nitrogen x 6.25)
  - Carbohydrate 4g/kg/day
  - Lipids 1g/kg/day

Principles of nutritional support

- Pre-op: **7-14 days nutrition** if severe malnourishment
  - Indications: **weight loss >10%** within 6mo, **albumin < 30**, **BMI < 18.5**, SGA Grade C,
- Post-op:
  - Early resumption of oral intake
  - Early enteral feed if oral route not possible
    - Tube feeding if support required < 4 weeks
    - Stoma feeding (PEG / jejunostomy) if support required > 4 weeks

[Image Description: The image shows a line graph depicting the percentage of resting energy expenditure over time after injury. The x-axis represents time after injury, with labels indicating "1 day", "2 days", "3-7 days", and "week to weeks". The y-axis represents the percentage of resting energy expenditure, ranging from 60 to 180. The graph shows three distinct phases: "Ebb phase" (0-2 days) where the energy expenditure drops sharply, "Early flow phase" (3-7 days) where the energy expenditure increases rapidly, and "Late flow phase" (weeks to months) where the energy expenditure plateaus at an elevated level. The "Early flow phase" is highlighted in pink, and the "Late flow phase" is highlighted in yellow.]

[Image Description: The image shows a table with questions to determine a person's MST score. The first question is, "Have you lost weight recently without trying?" with possible answers: "No" (0 points), "Unsure" (2 points), and "If Yes, how much weight (kg) have you lost?" with possible answers: "1-5" (1 point), "6-10" (2 points), "11-15" (3 points), ">15" (4 points), and "Unsure" (2 points). The second question is "Have you been eating poorly because of a decreased appetite?" with possible answers: "No" (0 points) and "Yes" (1 point). Below the questions are boxes for calculating the "Weight Loss Score", "Appetite Score", and "Total MST Score (weight loss + appetite scores)".]
```

- Early parenteral feed if
  - Failed gut (> 7 days): prolonged obstruction/ ileus, anastomotic break down, enterocutaneous fistula, short gut syndrome
  - Failed EN: unable to meet nutritional requirement, severe malnutrition pre-op

Route of administration

|          | Enteral feeding (preferred)                                                                                                                                   | Parenteral feeding                                                                                                                                                                                                                                                                                                                                                                                    |
| :------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------ | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Admin    | Frequency: bolus (PEG/ NG) vs continuous (jejunostomy/ NJ) Volume: 1kcal/ml → remaining fluid requirement can be made up to by water                          | Route: Peripheral: max concentration ~ 800mOsm/kg; 1, larger volume to achieve same energy requirement by central TPN, for use < 7 days Central: concentration > 1000mOsm/kg; for use > 7 days Frequency: round the clock (24h) vs periodic (16h, for deranged LFT or short-gut syndrome) Rate: start with smaller volume, i.e. 40ml/h in first 24h → IV fluid made up to remaining fluid requirement |
| Benefits | More physiological, thus more appropriate hormonal response Maintain gut mucosal barrier (prevent bacterial translocation) Fewer complications Less expensive | Better muscle mass → for malnutrition Not dependent on GI function → for short gut syndrome (no functional SB) or failed enteral feeding (e.g. prolonged ileus > 7d)                                                                                                                                                                                                                                  |
| Risks    | Tube-related: malposition, perforation, bleeding, obstruction GI: aspiration, diarrhoea Metabolic: overfeeding                                                | Catheter-related: infection, thrombosis, extravasation (hyperosmolar) Metabolic: TPN-related cholestasis (CCK), overfeeding                                                                                                                                                                                                                                                                           |

Overfeeding:

- Calories: fatty liver
- Carbohydrates: respiratory failure (due to ↑CO2 production), refeeding syndrome (see note)
- Fat: hyperlipidaemia
- Protein: renal impairment
  Refeeding syndrome
- Patho: metabolic fuel shifts from fat to carbohydrate, causing sudden ↑insulin → ↑cellular uptake of electrolyte
  → shifting of electrolytes & fluid balance → acute HF, electrolyte disturbance
- Electrolyte disturbance: ↓PO4 (1st: used to produce ATP), ↓K, ↓Mg, ↓thiamine
- Monitoring: electrolytes, BW, ECG

ERAS
Enhanced recovery after surgery (ERAS) protocols are multimodal evidence-based perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery

- Fasting: pre-op carbohydrate loading up to 2h before operation
  - Complex carbohydrates with maltodextrins 12.5%, given through NG tube / IV D5
  - Optimise post-op hyperglycaemia control by enhancing insulin sensitivity
- Resume oral intake early:
  - Lower GI surgery: day 0 after flatus test
  - Upper GI surgery: day 1 (except oesophagectomy: require JJ tube feeding)
  - Contrast study (gastrografin swallow study) if uncertain

21

[Illustration of a Venn diagram representing ERAS (Enhanced Recovery After Surgery) protocols. The diagram is divided into three overlapping sections: Preoperative, Intraoperative, and Postoperative. The Preoperative section includes text such as "Preadmission counseling," "Fluid and carbohydrate loading," "No prolonged fasting," and "Antibiotic prophylaxis." The Intraoperative section lists "Short-acting anesthetic agents," "Mid-thoracic epidural anesthesia/analgesia," "No drains," and "Maintenance of normothermia." The Postoperative section contains "Mid-thoracic epidural anesthesia/analgesia," "No nasogastric tubes," "Prevention of nausea and vomiting," "Early removal of catheter," "Early oral nutrition," "Non-opioid oral analgesia/NSAIDs," "Early mobilization," and "Audit of compliance and outcomes."]

1.5 Pre-op preparation and peri-operative management
General considerations

- Duration of operation: risk of hypothermia, fluid and electrolyte loss, drug accumulation, etc.
- Potential blood loss: T&S
- Distention of body cavities with gas: esp. in fragile patients (babies/elderly)
- Post-op respiratory failure: good quality pain relief, closely monitor respi function
- Post-op renal failure: monitor renal function and I/O Q1h

Routine investigations

- CBC, clotting, X-match, LRFT
- Respiratory Ix: CXR +/- lung function test +/- ABG
- Cardiovascular Ix: ECG +/- exercise testing +/- echo

Pre-operative fasting

- Elective OT: **no clear fluid for >2h, no solid food for >6h**
- Emergency OT: apply cricoid pressure, rapid sequence induction
- High-risk situations (e.g. pregnancy, GOO / IO, functional gastroparesis): consider Ng tube decompression, avoid GA if possible

Local anaesthetics
3 types

| Example  | Short acting                         | Long acting     |
| -------- | ------------------------------------ | --------------- |
|          | Lignocaine                           | Levobupivacine  |
| Max dose | 3 mg/kg per day                      | 2 mg/kg per day |
|          | 7mg/kg per day (if adrenaline added) |                 |
| Duration | 1-2 h                                | 4-6 h           |

- Nerve block: deposit LA near main nerve trunk
- Field block: deposit in proximity to larger nerve trunks
- Local infiltration: small terminal nerve endings

Role of adrenaline: **vasoconstriction** to reduce LA systemic absorption

- Prolong block duration
- Reduce systemic toxicity
- C/I for body parts with end arteries (e.g. fingers, toes, penis)

22

Mechanical bowel preparation
Indications

- Any colorectal operations (e.g. urology, gynae, colonic interposition) - aim to reduce risk of SSI
  - Left-sided colonic resection MUST require bowel prep (: colon-colonic anastomosis)
  - Right-sided colonic resection (e.g. R hemi, extended R hemi) may not need bowel prep because SB-TB anastomosis has lower risk of SSI
  - Meta-analysis shows bowel prep does NOT reduce risk of SSI, but bowel prep + oral antibiotics can
- Colonoscopy for better visualization of polyps
- Other imaging: barium enema (no longer done), CT/ virtual colonography (CTC; bowel prep not required, but faecal tagging - label the faeces with oral gastrografin)

Types of laxatives
| Osmotic laxatives | Fleet enema, lactulose 乳果糖, Mg salts |
| --- | --- |
| Stimulant laxatives | Senna 草餅, bisacodyl (Dulcolax), Na picosulphate |
| Bulk-forming agents | Metamucil 橙粉, methylcellulose |
| Stool softener | Docusate, liquid paraffin |

Examples of bowel preparation (**important!**)
[Image of two sachets, side-by-side, in a clear plastic bag, with "Klean-Prep" printed on the bag in white letters. The sachets are white with blue and green writing. Next to the sachets is text that says "*Klean prep = polyethylene glycol".]
[Image of bottle of Fleet enema with white background. The bottle is blue and white and has the "Fleet" logo on it. The bottle is labeled "Fleet enema". Next to the bottle is text that says "Fleet Phospho-soda/ enema".]

| MOA          | Mechanical washing (iso-osmotic by adding balanced electrolyte solution), NOT osmotically active                             | Hyperosmotic solution (sodium phosphate) draws water from intestinal tissue into lumen Significant electrolyte and fluid shift |
| ------------ | ---------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------ |
| Admin        | 4L in 2 divided doses (1-2h) - CLN in morning: 3L the night before, 1L mane - CLN in afternoon: 2L the night before, 2L mane | 45ml in 2 divided doses, 6-12h apart                                                                                           |
| Side effects | N/V, bloating Small risk of fluid overload (10% still absorbed)                                                              | N/V, bloating HypoK, hypoCa, hyperPO4\* Phosphate intoxication: nephropathy (ATN → AKI), arrhythmias                           |
| Remarks      | Preferred in patients with CHF, CKD Cheap, but difficult to tolerate                                                         | Ensure adequate hydration, ginger lemon flavor Avoid in elderly, CHF, CKD (cannot clear PO4!)                                  |

\*Klean prep: PEG itself is osmotically active, but Klean prep is iso-osmotic, so NOT classified as osmotic laxative

Picoprep (sodium picosulphate + Mg citrate) - usually for private patients (orange flavor)

- Dual action: stimulant laxative (picosulphate), osmotic laxative (Mg citrate)
- Much less volume required ~150mL, drink ~2L of other fluids

Bowel preparation in those with stoma

- Loop ileostomy: distal limb washout (by Foley insertion)

Repeated vomiting after bowel prep → must consider IO

- Bowel prep might convert partial IO into genuine IO → risk of perforation

Pre-op prophylaxis
Antibiotic prophylaxis

- Role: to reduce incidence of SSI (surgical site infection)
- Classification of wounds according to risk of infection (%) (**important!**)
  - Principles of deciding the class of wound: surgical vs trauma, timing of trauma, aseptic technique, operative field (whether traverse mucosal surface, any spillage)

| Infection risk     | Types of operation | Prophylactic antibiotics                                                                    |
| ------------------ | ------------------ | ------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Clean              | 1-2%               | Any operation that does not traverse mucosal surface, e.g. breast, thyroid, inguinal hernia | Not required **except FB insertion**, (e.g. mesh repair in inguinal hernia surgery, bone implants for ortho), immunocompromised / mechanical heart valves |
| Clean-contaminated | 5-10%              | Urinary tract, biliary tract, GIT that is well prepared (NPO, bowel prep)                   | Need until end of surgery                                                                                                                                 |
| Contaminated       | 15-20%             | Colon that is inadequately prepared                                                         | Need until end of surgery                                                                                                                                 |
| Dirty              | 40-50%             | Perforated viscera e.g. fecal peritonitis                                                   | Full course: prophylaxis + treatment                                                                                                                      |

- Choice of antibiotics: **Augmentin / cefuroxime + metronidazole**
  - Aim to cover G- rods, enterococci, anaerobes: Augmentin actually has anaerobic coverage
  - PWH: T1/T2 usually uses Augmentin, T3 uses Augmentin + metronidazole
  - Dosages: IV Augmentin 1.2g Q8h, IV metronidazole 500mg Q8h
  - Timing: **at the induction of GA** (to achieve high tissue concentration of antibiotics upon skin incision)
  - No. of doses: usually **1 dose** but consider
    - **Half life**: additional dose if OT > 2x half-life (usually 3h for Augmentin / cefuroxime)
    - **Blood loss**: additional dose if blood loss > 1.5L
    - Cardiac operation
  - If full course is required: IV-to-PO switch is permitted

DVT prophylaxis

- **Virchow's triad**: stasis, endothelial injury, hypercoagulability
- Types:
  - Mechanical:
    - Intra-op massage (**sequential compression device SCD**)
    - Post-op: **early mobilisation** + elastic compression stockings
  - Pharmacological: LMWH
- Current practice in HK
  - **Only** mechanical prophylaxis is routinely given to all patients
  - Indications for pharmacological prophylaxis: **history of VTE** (DVT/ PE), high risk (e.g. congenital thrombophilias), Caucasians (higher risk of thrombosis)
  - Established DVT pre-op: **IVC filter** to prevent PE → remove 2 weeks later

[Image of a patient in a hospital bed wearing sequential compression devices (SCDs) on their legs. The SCDs are inflatable sleeves that wrap around the patient's calves and feet. The sleeves are connected to a machine that inflates and deflates them, providing intermittent pressure to the legs. The patient is lying on their back with their knees slightly bent. The bed is covered in a white sheet and blanket. The machine is sitting on a table next to the bed.]

Peri-operative management of chronic diseases and drugs
Diabetes mellitus (DM)

- Principles
  - Maintain **stable** circulating glucose levels (6-10 mmol/L)
  - Prevent hypoglycemia: moderate hyperglycemia is tolerated
- Management depends on DM severity, magnitude of surgical stress, presence of sepsis, NPO or not - DKI = dextrose/potassium/insulin drip (titrate according to sliding scale) - Alberti regimen: 500mL D10 + 10U short-acting insulin + 10mmol KCl, monitor BG Q2-6h
  | Diet controlled | Monitor BG until eating |
  | ------------------- | --------------------------------------------------------------------------------------------- |
  | Oral hypoglycemics | Omit morning dose of oral hypoglycemic drug |
  | | Monitor BG pre and post-op until eating normally |
  | | Restart oral hypoglycemia drugs when on normal diet |
  | | Switch to DKI if: BG > 10, poorly controlled DM |
  | DM on insulin | Omit morning dose of insulin |
  | | Monitor BG pre and post-op until eating normally |
  | | Restart insulin when on normal diet (+/- bridging with **short-acting** insulin) |
  | | Start DKI if major surgery |
  | | If BG>20 / ketonuria: treat as DKA! |
- SGLT2 inhibitors: risk of peri-operative euglycemic DKA (S/S: n/v, abd pain, fatigue, SOB)
  - Elective surgery:
    - Omit SGLT2i 1 day before minor surgery, 2 days before major surgery
    - Admit 1 day before surgery for BG monitoring +/- DKI drip (if unsatisfactory glucose control / on insulin)
  - Emergency surgery:
    - Stop SGLT2i as soon as possible
    - Check plasma B-OHB, H'stix, ABG
      - B-OHB < 0.6: proceed with surgery
      - B-OHB > 0.6: risk of euDKA, check ABG and treat any DKA, postpone OT
    - Minimize unnecessary fasting and ensure adequate hydration
    - If surgery cannot be postponed, consider post-op ICU care
  - Re-initiation of SGLT2i
    - Resume if clinically well, no surgical complications, well-hydrated
    - Suspend if bariatric surgery

Long-term steroids

- Risk of adrenal insufficiency: watch out for hypotension, hypoNa, hyperK (+/- arrhythmia)
- Give **stress dose steroids** through peri-operative period
  - may need even higher (e.g. 100mg/day hydrocortisone) if post-op complications

Warfarin
Elective cases

- Stop warfarin 5 days before operation if INR 2-3 (or stop 2 days with oral vit K1 2.5 mg x 2 days)
- Check INR the day before OT
  - Aim INR <1.5 for most OT, INR ~1 for neurosur / eye surgery / spinal anesthesia / epidural anesthesia
  - If INR >1.5: give low dose oral vitamin K and recheck INR the next day
- Bridging with LMWH
  - SC LMWH when INR becomes subtherapeutic Discontinue LMWH 12h before OT
  - Indications: high risk of thromboembolism (**important!**)
    - Mechanical heart valve
    - AF: CHA2DS2VASc score ≥ 5
    - Prior VTE / cardioembolism (stroke / TIA) in recent 3 months
    - Previous stroke / TIA with ≥ 3 risk factors (CHF, HT, >75yo, DM)
    - Known hypercoagulability e.g. protein C/S deficiency

Emergency cases

- Stop warfarin or NOAC
- Reverse anticoagulation: idarucizumab (for dabigatran) / PCC / aPCC
- Reserve plasma / platelet concentrates

Post-operative management (Interruption of warfarin doubles risk of stroke in the first week of re-initiation)

- Check adequate hemostasis at wound site, drain fluid amount and status
  - Low bleeding risk: Restart pre-operative dosage at evening of endoscopy / 12-24h after OT
  - High bleeding risk: restart at least 48h after OT
- Take 5-10 days to attain anticoagulant effect (INR > 2): consider post-op low dose LMWH if high risk

Antiplatelets

- On aspirin alone: continue aspirin peri-operatively
- On dual-antiplatelets with intra-coronary stent:
  - Defer elective surgery until switch to aspirin monotherapy (due to high risk of peri-op stent thrombosis) – 1 month for bare-metal stent, 1 year for drug-eluting stent
  - Consult cardiologists if emergency: generally recommend continue DAPT

Pregnancy

- 1st/2nd trimester: consult cardiology for anticoagulation planning
- 3rd trimester: admit 2-3 weeks prior to OT for UFH

Surgical safety
26
Ward Bed:

# 123 SURGICAL

# SAFETY 123

Front Page

1. Consenting process

[Image of a light blue arrow pointing down.]

2. Sending Patient

[Image of a light blue arrow pointing down.]

3. Theatre Reception

[Image of a light blue arrow pointing down.]

1 CONSENTING PROCESS
SURGEON

Surgeon has confirmed the following patient's information
□ Name & HIKID □ Diagnosis □ Procedure / Side
Signed: **\_\_\_\_**
□ Consent has been confirmed with OT list
□ Marking
□ Yes □ N/A
Print: **\_\_\_\_**
□ Type & Screen’ required
□ Yes □ No (Risk of blood loss < 500ml (7ml/kg in children))
Date: **\_\_\_\_**
Availability of essential medical devices confirmed (OT list remark):
□ Yes □ N/A
Time: **\_\_\_\_**

2 SENDING PATIENT
WARD NURSE
Nurse has confirmed the following patient’s information
□ Name & HIKID □ Diagnosis □ Procedure/Side
Signed: **\_\_\_\_**
□ Consent confirmed with OT list
□ Marking
Print: **\_\_\_\_**
□ Confirmed □ N/A
□ Confirm ‘Type & Screen’ available
□ Yes □ Not required
Date: **\_\_\_\_**
□ Medical notes & films (supporting documents) available
Time: **\_\_\_\_**

3 THEATRE RECEPTION
RECEPTION NURSE
Nurse has confirmed the following patient’s information
□ Name & HIKID □ Diagnosis □ Procedure/Side
Signed: **\_\_\_\_**
□ Consent confirmed with OT list
□ Marking
Print: **\_\_\_\_**
□ Confirmed □ N/A
□ Confirm ‘Type & Screen’ available
□ Yes □ Not required
Date: **\_\_\_\_**
□ Medical notes & films (supporting documents) available
Time: **\_\_\_\_**

# 123 SURGICAL

# SAFETY 123

THEATRE, BEFORE ANAESTHESIA
SIGN IN
Anaesthetist (Surgeon in LA) has confirmed the following
patient’s information
□ Name & HIKID □ Diagnosis □ Procedure & Side □ Marking
Anaesthetist (Surgeon in LA) (Circulating nurse) 1

[Image of a number 1 with a box surrounding it, inside a gray box that has the shape of a downward arrow.]

Signed: **\_\_\_\_**
□ Anaesthesia safety check completed (Concentration & dosage of LA) Print: **\_\_\_\_**
□ Known allergy
□ Yes □ No
Date: **\_\_\_\_**
□ Airway assessment
Time: **\_\_\_\_**

Back Page

1. Theatre, before
   anaesthesia

[Image of a light blue arrow pointing down.]

2. Before incision

[Image of a light blue arrow pointing down.]

3. Before leaving theatre

BEFORE INCISION
TIME OUT (Surgeon) 2
□ Time Out
Anaesthetist Signed: Nurse Signed:
[Image of a number 2 with a box surrounding it, inside a gray box that has the shape of a downward arrow.]

□ Name & HIKID
□ Diagnosis Print: **\_\_\_\_** Print: **\_\_\_\_**
□ Procedure & Side

Signed: **\_\_\_\_**
□ Marking
□ Confirmed □ N/A

Print: **\_\_\_\_**
□ Anticipated critical events
□ Prophylactic antibiotics

Date: **\_\_\_\_**
□ Availability of essential medical devices confirmed (OT list remark)
□ Yes □ N/A

Time: **\_\_\_\_**

BEFORE LEAVING THEATRE
SIGN OUT (Circulating nurse) 3

[Image of a number 3 with a box surrounding it, inside a gray box that has the shape of a downward arrow.]

□ Instrument, gauze & needle count correct
□ Name of procedure confirmed
Signed: **\_\_\_\_**
□ Specimen label confirmed and sent
Print: **\_\_\_\_**
□ Equipment problem addressed
□ Key concerns reviewed
Date: **\_\_\_\_**
Time: **\_\_\_\_**

# 1.6 Post-op complications

Overview of post-op management

- Admit to ICU/HDU
- Diet (NPO, when to resume oral intake, IVF)
- Activity (chest physiotherapy)
- Vitals (observation frequency)
- Ix (drain management)
- Drugs (analgesia, prophylaxis/ treatment for complications)

Post-op complications
Definition: any deviation from the normal post-op course

- Pain is NOT a complication but a physiological response to trauma
  Classification
- Anaesthesia related or procedure related
- Timing: immediate vs early vs late
- Systems: respiratory vs CVS vs urogenital vs neurological

General complications
Anaesthesia related:

- LA*: - Neurotoxicity: agitation, convulsion, respiratory depression - Cardiotoxicity: tachycardia - HSR
  *Lignocaine form:
  Lignocaine 1%/2% (max 3mg/kg): VG Na+ channel blocker → inhibit AP propagation
  Lignocaine + adrenaline (max 7mg/kg): vasoconstriction to reduce systemic absorption
- GA: - Common: PONV, sore throat, myalgia - Cardiopulmonary: intra-op/post-op MI, stroke, chest infection - Intra-op awareness
  Procedure related:
- Immediate (<1h post-op)
  - Local: bleeding (primary), damage to neighbouring structures
  - Systemic: shock (blood loss, Ebb phase), respiratory (atelectasis)
  - Laparoscopy-related complications:
    - Abdominal access: organ puncture, vascular injury, nerve injury, port-site hernia
    - Pneumoperitoneum-related: subcutaneous emphysema, pneumothorax, arrhythmia
- Early (within 24-48h post-op)
  - Local: reactionary haemorrhage (within 24h post-op: vasoconstriction during stress masks the bleeding vessel)
  - Systemic: acute confusion (dehydration, sepsis), respiratory (pneumonia), urogenital (AROU, UTI)
- Late (>48h post-op)
  - Local: wound infection, secondary haemorrhage, IO (adhesion), incisional hernia
    - Secondary haemorrhage
      - Patho: pseudoaneurysm due to infection
      - Onset: 7-10 days post-op
      - "Warning bleed": initial bleed before torrential bleed 4-6h later
      - Mx: mesenteric angiogram
  - Systemic: fever, acute confusion, cardiac (arrhythmia, MI)

# Surgical wounds

Wound healing
Phases of wound healing
| 0: Bleeding / Haemostasis | Platelet aggregation, clotting factor activations |
|-----------------------------|---------------------------------------------------|
| 1: Inflammation | Recruitment of inflammatory cells (e.g. neutrophils, macrophages, lymphocytes) |
| 2: Proliferation | Macrophages release chemotactic factors formation of granulation tissue |
| | - Angiogenesis: mobilize EPC from bone marrow |
| | - Epithelialization contraction of wound edge |
| 3: Organization (remodelling) | New collagen deposition → cross-link→ Increase tensile strength of wound |

Wound closure

- **Primary intention:** close wound with minimal gap → heal by epithelial regeneration → **linear scar**
- **Secondary intention:** no closure → heal by contraction and fibrosis (i.e. granulation tissue) → **severe scarring**
- **Tertiary intention** (delayed primary closure): close wound after 3-4 days; used in dirty wounds

# Surgical site infection

Definition: infection occuring at/ near surgical site within 30 days (90 days if implant)
Timing: **3-7 days** post-op, rarely within first 72h (except GAS/ clostridium)
3 types

- Superficial incisional
- Deep incisional (subfascial): increased risk of wound dehiscence
- Organ space

Risk factors

- Patient factors: e.g. old age, malnutrition, poor hygiene, immunocompromised, DM, renal failure, smoking, hypothermia, Hx of RT
- Wound factor: clean vs clean-contaminated vs contaminated
- Operation factor: inadequate skin preparation, foreign bodies, inadequate haemostasis, retained dead tissues

Clinical features

- Swinging fever
- Inflammation: spreading erythema, localised pain, discharge from wound (abdominal pain NOT a feature)
- Wound dehiscence

Investigations

- **Wound swab/ pus** for culture (avoid wound edge: skin flora contamination)
- CT with contrast (for deep/ organ space infection): rim-enhancing collection
- Bloods: CBC, CRP +/- blood culture

Management

- Wash hands and put on sterile gloves
- **Remove clips / sutures:** lay wound open for daily **dressing** (use least toxic materials - to minimise damage to healthy tissues) and heal by secondary intention
- **Drainage:** deep infection may require imaging-guided drainage
- **Empirical antibiotics**
- **Close monitoring:** anastomotic leak, signs of sepsis

Prevention

- Pre-op:
  - Antibiotic prophylaxis
  - Skin preparation: chlorhexidine body wash + intranasal mupirocin
  - Optimise medical comorbidities: DM, CKD, malnutrition
- Intra-op:
  - Hair removal by electronic clippers (not razors) before incision
  - Prepare skin immediately before incision: chlorhexidine or iodine-povidone, alcohol (fire risk, but better) vs aqueous
  - Positive pressure laminar air flow
  - Minimise unnecessary personnel
  - Keep warm: Bair Hugger, fluid warmer
- Post-op
  - Use of see-through dressings

[Image: A diagram illustrating the layers of the skin and subcutaneous tissue. The skin is shown as the outermost layer, followed by the subcutaneous tissue, the deep soft tissue (fascia & muscle), and finally the organ space. The areas marked as "Superficial Incisional SSI" and "Deep Incisional SSI" are indicated in their respective layers. The "Organ Space SSI" is located deep within the organ space layer. The diagram helps visualize the depth of surgical site infections in different layers of tissue.]

Wound dehiscence
Definition: wound ruptures along a surgical incision

- Superficial dehiscence: skin wound alone fails
- Full thickness dehiscence: burst abdomen (evisceration)

Risk factors

- Patient factors: immunocompromised (poor healing power), increasing intra-abdominal pressure (e.g. COPD)
- Wound factors: ischaemia (strangulating sutures), tension, active disease (infection)
- Intra-operative factors: poor surgical closure, prolonged operation, emergency surgery
- Post-operative factors: prolonged ventilation, massive blood transfusion, excessive cough

Possible clinical features

- Early post-op: serosanguinous fluid discharge from wound (amount varies with abdominal pressure, e.g. cough), then subjective feeling of giving-way of wound
- 1 week post-op: burst abdomen with evisceration (skin may be intact)
  - Bulging of wounds, seepage of pink serous/blood-stained fluid
  - Sudden ↑ in wound discharge = deep dehiscence until proven otherwise
- Late: incisional hernia

Management
Superficial dehiscence

- Wound care: irrigate wounds with NS, daily dressing
- Wound closure: keep sutures in situ for longer time, vacuum-assisted closure, re-suture under GA

Burst abdomen

- Call for help!
- Resuscitation: keep patient supine (vasovagal attack) with knees flexed (to relax abdominal muscles), check vitals Q5min
- Remove skin clips / sutures at area of maximal leakage → Physically examine rectus sheath integrity
- Cover eviscerated organs with sterile saline gauze (NOT reinsert organs)
- Broad-spectrum IV antibiotics full course
- Prepare OT: T&S, CBC, clotting, informed consent
- Emergency OT for:
  - Irrigate wounds with NS under GA
  - Redistribute the tension of wound using tension sutures
- Post-op ICU care for ventilatory support and normothermia

Post-op fever
Definitions

- Temp > 38 on 2 consecutive post-op days or >39 on any 1 post-op day
  - Hyperthermia may not be initiated in immunocompromised
  - Hypothermia also indicates severe sepsis
    Aetiology
    [Image Description: A diagram illustrating the Aetiology of Post-op fever. The diagram includes several boxes and arrows, arranged to show the relationships between different causes of fever at different postoperative days. At the top, above the line labelled Aetiology, there are numbers '2', '5', and '7', each with an upward arrow pointing to them. Below these numbers are boxes representing different potential causes. A pink box says 'Non-infectious cause' and below it 'Wind (atelectasis)'. A yellow box saying 'Infectious cause' and below it 'Water (UTI)'. A second yellow box says 'Anastomotic leak' and below it 'Water'. A green box is below the yellow boxes saying 'Infectious & Non-infectious causes'. A light blue box says 'Drug fever' and below it 'DVT/PE'. A second light blue box says 'Wonder drug' and below it 'Walking'. Several other text labels are connected by arrows, indicating potential causes of fever, including 'Wound infection', 'Withdrawal (alcohol)', and 'Wonky glands (adrenal insufficiency & thyrotoxicosis)'.]

| Cause                | Features                                                                                                                                                                                                                                  | Management                                                                                                                                                                                                                                                                                             |
| -------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Wind                 | **Atelectasis** Patho: - ↑Airway secretion post-GA - Ineffective clearance due to wound discomfort, posture & use of narcotics                                                                                                            | Smoking cessation pre-op Early mobilization Good quality pain relief **Incentive spirometry** +/- ICU for post-op ventilation                                                                                                                                                                          |
|                      |                                                                                                                                                                                                                                           | [Image of Incentive spirometer. It is a transparent plastic device with three chambers, each containing a colored ball. A tube connects the device to a mouthpiece. The image shows the device being used, with one ball slightly elevated due to inhalation.] (Different colours = different weights) |
| Nosocomial pneumonia | Risk factors: smoking, pre-existing lung disease (e.g. COPD), prolonged immobilisation                                                                                                                                                    | Mx: **chest physio, IV Abx, mucolytics** Prevention: - Smoking cessation pre-op - Early mobilisation                                                                                                                                                                                                   |
| Water                | UTI Patho: - Catheterisation - Ineffective voiding: post-anaesthesia, wound pain, posture, nerve injury                                                                                                                                   | Resume LUTS medication (e.g. **Xatral**) prior to removal of Foley                                                                                                                                                                                                                                     |
| Anastomotic leak     | See separate section                                                                                                                                                                                                                      |
| Wound                | Surgical site infection                                                                                                                                                                                                                   | See separate section                                                                                                                                                                                                                                                                                   |
| Walking              | DVT/PE Risk factors in post-op: - Surgery (esp. LL & pelvic surgery) - Immobilisation - Existing malignancy First sign: **unexplained tachycardia** - 60-80% clinically silent                                                            | Ix: CXR, ECG, CTPA, V/Q scan, Doppler - D-dimer _not_ useful: elevated in post-op anyway Prevention: - General: **early mobilisation** - Mechanical: compression stockings, SCD - Pharmacological (rare): LMWH                                                                                         |
| Wonder drugs         | Drug fever Hypersensitivity (type IV): 7-10 days for antibody formation – usually ABx Malignant hyperthermia: with FHx, can be delayed up to 24h post-op, common agents include suxamethonium NMS: antiemetic drugs (e.g. metoclopramide) |
| Transfusion reaction | Allergic transfusion reaction: reaction to donor plasma antigens, occur early Febrile transfusion reaction: reaction to donor leukocyte antigens, occur late (30min -2h)                                                                  |
| Wonky glands         | Hyperthyroidism, pheo, Addisonian crisis Easily missed: infected central line, C. diff colitis, acute pancreatitis, acalculous cholecystitis                                                                                              |

# Anastomotic leak

Risk factors

- Wound factors: **ischaemia**, **tension**, active disease (e.g. **infection**)
- Patient factors: nutrition (malnutrition/ obesity), smoking, immunocompromised
- Surgeon factors: handsewn anastomosis

Clinical features

- Suspect if any deviation from normal post-op course (e.g. prolonged ileus)
- Initial features:
  - 50% abdominal, e.g. pain, distension, prolonged ileus
  - 50% systemic, e.g. fever, oliguria, altered MS
- Investigations: **contrast CT abdomen** to locate the collection

[A transverse CT scan image of an abdomen. The image displays a significant amount of fluid or collection in the pelvic region, indicating a possible abscess or leak. The anatomical structures, including the intestines and surrounding tissues, are visible with some distortion due to the abnormal collection.]

Management

Minor leaks (contained leaks without sepsis)

- Defunctioning: **NPO**, decompression (NG/NJ), +/- parenteral nutrition
- Fluid: IV fluid, chart I/O
- Source control: **broad-spectrum IV antibiotics**, percutaneous drainage of abscess (CT-guided)

Major leaks

- Indications:
  - Local: large abscess (not amenable by percutaneous drainage), not improved with conservative treatment, major anastomotic defect (>1/3 of anastomotic circumference)
  - Systemic: multiple separate foci (intraperitoneal leak), sepsis
- Approach: exploratory laparotomy for
  - Lavage
  - **Complete take down of anastomosis** (if major dehiscence / poor blood supply)
  - Proximal diversion stoma

Risk of anastomosis: examples

|                       | Risk    | Comments                                           |
| :-------------------- | :------ | :------------------------------------------------- |
| LAR anastomosis       | Highest | Poor blood supply in colon Tension                 |
| Oesophago-jejunostomy | High    | Blood supply: left gastric artery resected Tension |
| Gastro-jejunostomy    | Lowest  | Relatively low tension                             |

Vascular anastomosis

- 1 layer of suture is always used (1 or 2 in GI anastomosis): to minimise narrowing of vessels
- Everted (instead of inverted): to prevent thrombosis
- Water-tight: to prevent bleeding

Gas bubble in abdomen post-op

- Laparoscopy: should be reabsorbed within 72h
- Leak

Testing for rectal anastomosis

- Intra-op: **air insufflation** (warm saline fluid in pelvis, inflate rectum with air to look for bubbles), **dye test** (iodine/ methylene blue), on-table endoscopy
- Post-op: water-soluble contrast enema, endoscopy (only when highly suspicious, to avoid creating a new anastomosis)

# Post-op oliguria

Definition: urine output <0.5ml/kg/h

Aetiology

- Pre-renal cause:
  - Cause of oliguria until proven otherwise (Ebb phase: hypovolemia during initial 24-48h)
  - Other pre-renal causes:
    - Third spacing: oedema, ascites
    - Internal GI loss: ileus
    - External GI loss: high-output stoma, vomiting, diarrhoea, output from NGT/drains
    - Renal loss: post-obstructive diuresis
    - Bleeding: surgical site bleeding, stress ulcer, anastomotic bleeding
- Intra-renal cause
  - ATN: prolonged hypoperfusion, nephrotoxic insult
  - AIN: allergic reaction to drugs
  - Acute GN
- Post-renal cause: - Outlet obstruction: obstructed urinary catheter, AROU - Ureteric obstruction (ureteric injury, pre-existing stone)
  Management
- Assessment
  - Significant medical/surgery history
  - OT record: blood loss, packed cells given, any bladder injury
  - Hydration status: urine appearance from BSB
  - PR exam (except LAR + TME) – **never PR if newly created low-lying anastomosis!!**
- Resuscitation
  - Fluid challenge (Hartmann's 500ml), then adjust according to hydration status, output and underlying cardiac status
  - Hypovolaemia due to bleeding: 20ml/kg crystalloid if hypotensive, then 3x estimated circulation volume loss
  - Flush Foley with 20-30mL NS to dislodge sediments / clots
- Treat underlying cause
  - Renal cause: chart I/O, remove nephrotoxic drugs, adjust drugs to renal dose

Post-op confusion

[Image Description: This is a flowchart illustrating the causes of post-op confusion. The chart starts with a diamond shape labeled "CONFUSION" in the center. Arrows branch out from this diamond to several yellow rectangular boxes representing different categories of causes.

- One box is labeled "Recent GA/environmental" and lists "Strange environment," "Physical restrain," and "Sunset effect."
- Another box reads "Drugs" and lists "Substance intoxication / withdrawal" and "Centrally acting drugs."
- A third box is labeled "Hypoxia" and includes "Respiratory problems."
- A fourth box is labeled "Pain or other discomfort" and lists "Post-op wound pain," "AROU/faecal impaction," and "Sleep deprivation."
- The confusion diamond also has arrows connecting it to "1° CNS event," which includes "Acute - CVA" and "Chronic - Parkinsonism, dementia."
- Above the confusion diamond is a blue arrow leading to "↓Perfusion," which connects to "Shock state with ↓Cerebral perfusion" and then to a red oval labeled "SEPSIS."
- Another arrow from the confusion diamond leads to "Metabolic / endocrine crisis," listing "Hypoglycemia" and "Electrolyte imbalance."
- A smaller yellow box says "Goal is to identify the cause & keep the patient safe," positioned below the "CONFUSION" diamond, summarizing the overall objective.]

Aetiology (MIND)

- Metabolic: hypoglycaemia, electrolyte imbalance
- Infections
- Neurological: stroke, trauma
- Drugs, e.g. tramadol

  1.7 Endoscopy
  Structure of an endoscope

[Illustration of the proximal end of an endoscope. The endoscope is a long, flexible tube. On the end are three openings, labeled: "Instrument port", "Air", and "Light source". The endoscope body has a ribbed texture.]

[Illustration of the controls of the endoscope, with various parts labeled. The labels are: "air, CO2, water and suction controls", "lens adjustment", "camera mount", "eyepiece", "deflection control", "suction air", "CO2 in water in", "optical fibre", "controllable bending section", "channel for operating instruments", "flexible section", "air/water nozzle", "distal end", "objective lens", "biopsy/suction channel", and "illumination lenses".]

Length & calibre

|             | Length      | Calibre |
| :---------- | :---------- | :------ |
| OGD         | 90cm        | 9mm     |
| ERCP        | 1.5m        | 13.5mm  |
| Colonoscopy | 1.3m / 1.6m | 13mm    |

Management of intra-op desaturation

- DDx:
  - Sedative-related: overdose (MC), allergy
  - Endoscopy-related: perforation, bleeding
- Check pulse oximetry probe to confirm genuine desaturation
- Stop procedure
- ABC: airway, O2
- Antidote: IV naloxone 0.1mg

[Photograph of a distal end of an endoscope. Visible are the "Angulation control knobs" and the descriptions "Up down control" and "Left right control". Also labeled are the "Suction valve", "Air / water valve", and "Biopsy channel".]

33

OGD
Oesophago-gastro-duodenoscopy (OGD)胃鏡/上消化道內窺鏡(100cm)
Indications
Diagnostic: upper GI symptoms with suspicious features (e.g. age > 50, constitutional symptoms)

- Oesophagus: dysphagia, odynophagia, retrosternal pain, abnormal barium swallow
- Stomach & duodenum: epigastric pain, RUQ pain, dyspepsia, epigastric mass, abnormal barium meal, anaemia, LOW/LOA
- UGIB
- Massive LGIB
  Therapeutic:
- UGIB (e.g. varices, ulcer)
- Stricture: stent insertion, dilatation
- Removal of foreign body
- Polypectomy
- Enteral nutrition: percutaneous endoscopic gastrostomy (PEG)
  Contraindication
- Suspected perforation
- (Recent MI is permitted if OGD urgently required)
  Pre-op
  Diet restriction: fast x 6h
  +/- sedation: midazolam for sedative and amnesic, pulse oximetry
  Antibiotic prophylaxis: those with valvular heart diseases
  Intra-op
  Mouthguard + LA (take off any false teeth)
  Reach D2, then retract progressively to examine D1, stomach & oesophagus
  Retching possible
  Duration: 5-20 min
  Post-op
  Discharged immediately in OPD
  Complications Nausea, distension, sore throat
  Dysphagia: due to LA, temporary until LA effect wears off
  Sedation-related: respiratory arrest (rare), cardiac arrhythmia
  Bleeding (thus requiring transfusion): 3 in 10000
  Perforation (thus requiring EOT): < 1 in 10000
  Death: < 1 in 10000
  Alternatives
  Barium study: less sensitive and specific, biopsy cannot be done
  CT: not therapeutic, no biopsy
  Nasoscopic OGD
- Smaller calibre
- Fewer available instruments
- Take the distance between nostril and incisors into account (~5cm)

[Image of Common OGD findings, a collage of six endoscopic images showing various gastrointestinal conditions. The first image shows Oesophageal varices, characterized by swollen, bulging veins in the esophagus. The second shows Gastric antral vascular ectasia, featuring red spots or streaks in the stomach antrum. The third presents a Peptic ulcer, with a visible open sore in the stomach or duodenum lining. The fourth is a close-up of an AVM (Arteriovenous Malformation), a tangle of abnormal blood vessels. The fifth illustrates a Stromal cell tumor, a mass or growth in the gastrointestinal tract. The sixth shows Reflux esophagitis, with signs of inflammation and irritation in the lower esophagus.]

- Common OGD findings
  Gastric antral vascular ectasia
  (GAVE): dilated small vessels in
  antrum, causing chronic GIB and
  IDA; aka watermelon stomach

34

Colonoscopy
Colonoscopy 大腸鏡(150cm)
Advances that improve detection rate

- Magnification scope
- Chromo-endoscopy: use of dyes
- NBI (narrow band imaging): to preliminarily differentiate lesions w/out biopsy (e.g. hyperplasia vs adenoma)

Indications

- Diagnostic:
  - Suspicious **Lower GI symptoms**: PRB, abdominal pain, altered bowel habit, constipation, etc
  - Screening test: FOBT
  - Biopsy
- Therapeutic:
  - Polypectomy
  - Metallic stent insertion
  - Haemostasis (e.g. APC for bleeding angiodysplasia)
  - Endoscopic submucosal dissection (ESD for early cancer)
  - Volvulus (decompression)
- Contraindications
  - Suspected perforation (e.g. toxic megacolon)
  - Acute diverticulitis

Pre-op
3 days before: low-residue diet (低纖食物:白粥、白麵包、白米飯、意粉)
1 day before: fluid diet, bowel prep (Klean prep, Fleet phospho-soda\*) 清瀉藥水
Drugs:
Anticoagulant (e.g. warfarin) 3-4 days before +/- bridging with LMWH (if high risk, e.g. DVT, stop
LMWH 12h before scope), Fe (dark stool) 3 days before
DM (dietary restriction → skip morning dose of OHA/ nocte dose of long-acting insulin to avoid
hypoglycaemia)
Prophylactic antibiotic: for those with high risk of endocarditis or immunocompromised
Intra-op
Lie on left side with knees drawn up towards the abdomen
Premed: IV sedation (midazolam + pethidine)
Lubricated colonoscope reach up to ileocaecal valve 盲瓣/廻 Boston Bowel Preparation Scale (BBPS, 2010)
腸末端
[Image of Boston Bowel Preparation Scale (BBPS, 2010). It shows a scale of endoscopic images of the colon, with labels indicating preparation quality from poor to excellent. The images depict the appearance of the colon lining after different bowel preparation methods, ranging from thick liquid and semisolid stool to a clear and well-visualized colon wall. A table below shows the presence or absence of liquid and solid stool.]

Features to ensure whole colon is reached\*

- Ileocaecal valve
- Appendiceal orifice
- Triradiate folds of caecum (least reliable)
  Duration: 10-45 min

Key performance indicators of colonoscopy (**important!**)

1. Adequate bowel preparation (BBPS ^)
2. Caecal intubation rate\*: around 90-95%
3. Scope withdrawal time (**at least 6 min**) - to minimise miss rates
4. Adenoma detection rate: around 20-30%
   Post-op
   Minor abd pain x 1h
   Minor PR bleed in the first day
   Obs x 1-2h, then d/c

Complications Sedative-related: allergy, respiratory depression, hypotension
Before procedure:
(Complication

- Bowel prep-related: n/v, abd pain, distension, fluid and electrolyte disturbances, aspiration
  rates higher if
  Procedure-related:
  polypectomy
- Incomplete scope (5%)
  is performed)
- Bleeding (requiring transfusion): 2/1000 - usually a/w polypectomy, dilation of strictures,
  ESD
- Perforation (requiring EOT): 1/1000 - mechanical trauma / barotrauma / electrocautery
  injury - Order AXR, CXR for signs of perforation: e.g. free gas under diaphragm,
  subcutaneous emphysema, retroperitoneal gas, pneumomediastinum - Consider CT scan with water-soluble contrast - Mx: clipping, colonic stent, surgery
  After procedure:
- Abd pain, distension: temporary
- Delayed bleeding: 5-7 days post-op due to sloughing of eschar
- Post-polypectomy coagulation syndrome: transmural burn that induces localised
  peritonitis without perforation - S/S: fever, focal abdominal tenderness, leucocytosis 1-5 days post-op - Mx: NPO, IVF, IV antibiotics
  DDx of post-colonoscopy abdominal pain
- Scope-related: perforation, post-polypectomy coagulation syndrome
- Organ injury: splenic rupture, tearing of mesenteric vessels

Alternatives Barium enema
Virtual (CT) Colonoscopy: biopsy cannot be done, no polypectomy, high radiation, may miss
small lesions < 6mm

[A table comparing Colonoscopy and CT Colonography. The table has two columns. The left column is labeled "Colonoscopy" and the right column is labeled "CT Colonography". The first row says "Full bowel preparation" on the left and "faecal tagging only" on the right. The second row says "Invasive" on the left and "Non-invasive" on the right. The third row says "Diagnostic and therapeutic" on the left and "Diagnostic only" on the right.]

36

37
Flexible sigmoidoscopy
乙狀結腸鏡(60cm)
| | |
|-------------|----------------------------------------------------------------------|
| Indications | Diagnostic: fresh PR bleed without alarming symptoms |
| | Therapeutic: polypectomy |
| Pre-op | Low residue diet 3d before, clean fluid diet 1 day before |
| | Bowel preparation: Fleet enema x 2 |
| Intra-op | Lie on left side with knees drawn up towards the abdomen, buttocks overhang the edge of the bed |
| | PR exam |
| | Lubricated sigmoidoscope (finger-thick) reach up to descending colon 降結腸 |
| | Duration: 10 min |
| Post-op | Minor abd pain x 1h |
| | Minor PR bleed in the first day |
| | Obs x 1-2h, then d/c |
| Complications | Incomplete scope: 5% |
| | Bleeding, infection, perforation |
| Alternatives | As above |

Rigid sigmoidoscopy
(25cm)
| | |
|---------------|--------------------------------------------------------------|
| Indications | Diagnostic |
| | - Anorectal pathology, e.g. CRC |
| | - Biopsy (within the reach of the scope) |
| | - CRC: assess the true height, lower resection margin |
| | Therapeutic: Conservative treatment of sigmoid volvulus |
| Pre-op | No sedation required |
| Intra-op | Lie on left side with knees drawn up towards the abdomen, buttocks overhang the edge of the bed |
| | PR exam |
| | Lubricated sigmoidoscope (finger-thick) reach up to sigmoid colon |
| | Visualised by air insufflation and naked eyes |
| | [Image of a rigid sigmoidoscope kit, including the scope, insufflator, and other accessories. The scope is a slender, rigid tube with a handle. The insufflator is a bulb-like device used to inflate the colon with air.] |
| Post-op | Rectal discomfort |
| Complications | Bleeding |
| | Infection |
| Alternatives | As above |

Proctoscopy
(15cm)
| | |
|---------------|------------------------------------------------|
| Indications | Haemorrhoids |
| | Anal fissures |
| Pre-op | No sedation required |
| Intra-op | Lie on left side with knees drawn up towards the abdomen |
| Post-op | Rectal discomfort |
| Complications | Bleeding |
| | Infection |
| Alternatives | As above |

Endoscopic retrograde cholangio-pancreaticography ERCP
膽管鏡(內視鏡逆行胰膽管造影術)
Indications

- Diagnostic: mostly superseded by MRCP, except brush cytology/biopsy
- Therapeutic:
  - Biliary drainage and decompression
  - Stone removal (CBD or pancreatic duct): sphincterotomy\* +/- wire basket/balloon catheter/ mechanical lithotripsy/ stent
  - Dilation of strictures (CBD or pancreatic duct): balloon catheter + **plastic stent** (benign stricture)/ **self-expanding metal stents** (malignant obstruction)
    - To confirm correct stent placement: bile flow after release, aerobilia in AXR
  - Transgastric drainage of pancreatic pseudocysts

* In case where sphincterotomy cannot be performed (e.g. due to coagulopathy): direct placement of stent/ nasobiliary drain
  Contraindications

- Absolute: unstable, contrast allergy
- Relative: altered anatomy (e.g. partial gastrectomy), uncorrected coagulopathy
  Pre-op
  Diet restriction: fast x 6h
  Blood test: LFT, clotting\*, platelet, and correct coagulopathy
  Sedation: benzodiazepines (midazolam)
  Analgesics: opiates (pethidine)
  Antispasmodic: hyoscine (Buscopan)
  **Antibiotics are required**: biliary tract is sterile
  Intra-op
  PRONE position, or left lateral decubitus (LLD) if intolerant
  A flexible **side-view scope** reaches duodenum - short scope (fig.) vs long scope
  Contrast injected at CBD opening (D2)
  **X-ray** of bile and pancreatic ducts
  Duration: 15-60 min

Endoscopic sphincterotomy:

- Indications
  - Pre-requisite for further intra-ductal manipulation
  - Lower biliary tree pressure, e.g. SOD, post-op bile leak (e.g. post-cholecystectomy cystic stump leak)
  - Pancreatic sphincterotomy: pancreatic leak, recurrent pancreatitis

[Image: A medical illustration of a lithotripsy procedure is shown. On the left, a close-up of a sphincterotome is illustrated for sphincterotomy. A cutaway view illustrates a nasobiliary tube positioned in a duct, with a Dormia basket below it used for stone removal. On the right is a balloon for stone removal.]

Post-op
Resume oral feeding 2-4h after
Discharged the next day
Complications
(Overall: 10%)

- Sedation-related
- Ascending infection / Flare-up sepsis (1%): cholangitis, cholecystitis
- Post-sphincterotomy bleeding (2%)
  - Definition: significant blood loss necessitating transfusion or major change in management - intra-op bleeding very common
  - Delayed: hours to 10 days after ERCP
  - Risk factors: intra-op bleeding, coagulopathy, initiation of anticoagulants within 3 days after ES, active cholangitis
  - Management: resuscitation → localisation → haemostasis
    - Modalities: injection therapy (1:10000 epinephrine), clip application, etc; monotherapy is adequate
  - Prevention:
    - Correct coagulopathy
    - Cut along the right axis within the safety zone
    - Combined sphincterotomy + balloon sphincteroplasty

- Post-ERCP perforation (1%)
  - Risk factors:
    - Patient factor: SOD, distal CBD stricture, altered anatomy
    - Procedural factor, e.g. ES
  - S/S: abdominal pain, fever
  - Classification: Stapfer classification

| Type | Location of perforation                                                        | Typical cause       |
| :--- | :----------------------------------------------------------------------------- | :------------------ |
| I    | Gastrointestinal tract wall (classically, the medial or lateral duodenal wall) | Endoscope           |
| II   | Peri-ampullary area (in the immediate vicinity of the papilla of Vater)        | Sphincterotome      |
| III  | Bile ducts                                                                     | Guide-wire / Basket |
| IV   | No proven perforation (retroperitoneal air alone)                              | Compressed air      |

- Ix: AXR (1st in retroperitoneum causing **prominent psoas & kidney shadows**), CXR, CT abdomen
- Initial management: NPO + adequate hydration + empirical IV antibiotics
- Surgical: endoscopic (over-the-scope clip, suturing), surgical repair
  - → Stapfer Type 1 requires laparotomy, Type 2 / 3 requires non-surgical Mx (e.g. TPN, broad spectrum Abx, drainage)
- Post-ERCP pancreatitis (4%)
  - Definition: abdominal pain + increase in **serum amylase >3x ULN** (transient increase very common post-ERCP) + require hospitalisation
  - Pathogenesis: activation of acinar cells by mechanical, chemical or hydrostatic injury
  - Risk factors:
    - Patient factors: young female, suspected sphincter of Oddi dysfunction, Hx of PEP, recurrent pancreatitis
    - Procedural factors, e.g. pre-cut sphincterotomy (i.e. cut sphincter before cannulating CBD), pancreatic duct injection
  - Management: similar to acute pancreatitis
  - Prevention: - Pharmacological (PR NSAID e.g. indomethacin pre-op) - Mechanical: pancreatic duct stent, guidewire cannulation before contrast injection (by avoiding injection into PD)
    Alternatives MRCP: not therapeutic, no biopsy

Reasons for difficult ERCP

- Anatomy: Billroth II reconstruction, duodenal stricture, ampullary stenosis, tortuous biliary tree
- Stone: multiple stones, intrahepatic stones, large stones >15mm

Management of post-ERCP fever and tachycardia

- DDx: persistent cholangitis (e.g. **unsuccessful drainage, migrated/blocked stent**, resistant to antibiotics), ERCP complications (e.g. **flare-up sepsis**, pancreatitis, perforation
- Investigations: AXR (stent migration, blockage)

Management of post-ERCP abdominal pain

- DDx: post-ERCP perforation, post-ERCP pancreatitis
- Investigations: CT abdomen (**retroperitoneal free gas**)
- Mx: antibiotics, surgery

39

40
ASGE guideline for antibiotic prophylaxis before GI endoscopy
NOT required for routine OGD / colonoscopy
Recommended for ERCP (esp if acute cholangitis)
Other indications: EUS-FNA of cystic lesions, PEG/PEJ insertion, colonoscopy in CAPD patients, cirrhosis with GIB
TABLE 3. Antibiotic prophylaxis and/or treatment to prevent local infections

| Patient condition                                                     | Procedure contemplated                                        | Goal of prophylaxis                                                | Periprocedural antibiotic prophylaxis             |
| --------------------------------------------------------------------- | ------------------------------------------------------------- | ------------------------------------------------------------------ | ------------------------------------------------- |
| Bile duct obstruction in absence of cholangitis                       | ERCP with complete drainage                                   | Prevention of cholangitis                                          | Not recommended                                   |
| Bile duct obstruction in absence of cholangitis                       | ERCP with incomplete drainage                                 | Prevention of cholangitis                                          | Recommended; continue antibiotics after procedure |
| Solid lesion in upper Gl tract                                        | EUS-FNA                                                       | Prevention of local infection                                      | Not recommended                                   |
| Solid lesion in lower Gl tract                                        | EUS-FNA                                                       | Prevention of local infection                                      | Not recommended                                   |
| Mediastinal cysts                                                     | EUS-FNA                                                       | Prevention of cyst infection                                       | Suggested                                         |
| Pancreatic cysts                                                      | EUS-FNA                                                       | Prevention of cyst infection                                       | Suggested                                         |
| All patients                                                          | Percutaneous endoscopic feeding tube placement                | Prevention of peristomal infection                                 | Recommended                                       |
| Cirrhosis with acute Gl bleeding                                      | Required for all patients regardless of endoscopic procedures | Prevention of infectious adverse events and reduction of mortality | On admission                                      |
| Synthetic vascular graft and other nonvalvular cardiovascular devices | Any endoscopic procedure                                      | Prevention of graft and device infection                           | Not recommended                                   |
| Prosthetic joints                                                     | Any endoscopic procedure                                      | Prevention of septic arthritis                                     | Not recommended                                   |
| Peritoneal dialysis                                                   | Lower Gl endoscopy                                            | Prevention of peritonitis                                          | Suggested                                         |

EUS-FNA, EUS-guided FNA.

Bronchoscopy
支氣管鏡

Indications | Diagnostic
| - Brushing
| - Bronchoalveolar lavage (BAL)
| - Biopsy: +/- endobronchial US (EBUS)
| Therapeutic
| - FB/ secretions removal
| - Stent insertion
| - Tracheal intubation in patients with difficult airways
|---|---|
Pre-op | Diet restriction: fast x 6h
| Blood test: ABG, clotting
| Denture removed
| Stop aspirin/ warfarin 1w pre-op
|---|---|
Intra-op | Lie supine
| LA sprayed on nostril or throat
| A thin, flexible endoscope passed through nose or mouth (or endotracheal tube in situ) into windpipe and bronchial tree
| Airway irritation causing coughing may occur
| Duration: 10-20 min
| EBUS: 30-40min
|---|---|
Post-op | CXR (if biopsied)
| NPO 2h after as throat still numb
| No driving/ operating machinery for 24h
| FU
|---|---|
Complications | General: S/E from procedure (cough, sore throat), & drugs (arrhythmia, drowsiness)
| Specific: pneumothorax, bleeding, aspiration pneumonia, haemoptysis (if biopsed), lung collapse
|---|---|

2 Clinical approach
2.1 Trauma
Mechanisms of injury

- Blunt injury
- Penetrating injury
- Blast injury
- Iatrogenic (endoscopy, laparoscopy)
  Resuscitation highlights
- Circulation:
  - NS 2L then assess response
  - Stop haemorrhage
    - Direct pressure (external haemorrhage)
    - Pelvic binding, pneumatic anti-shock garment (PASG), external fixation, angiographic embolisation
    - AVOID vessel clamping or tourniquets
    - Intra-op (4P): pressure, packing, positioning (less in abdominal procedure), procedure (suture, ligation)
- Trauma series: CXR (AP), pelvis (AP), C-spine (lateral) - not used now
  Specific management
- Blunt injury: FAST scan laparotomy (unstable) or CT whole body (stable)
  - Arterial phase: for bleeding points & pseudoaneurysm
  - Portovenous phase (most important): visceral injury
  - Delayed phase: for urinary extravasation
  - Lung & bone window
- Penetrating injury: diagnostic laparoscopy → laparotomy
  Focused Assessment with Sonography in Trauma (FAST)
  Standardised approach to detect fluid in abdomen
- Pericardial window: pericardial effusion
- R flank: Morrison's pouch, subphrenic, pleural, right paracolic gutter
- L flank: splenorenal space, subphrenic, pleural, left paracolic gutter
- Pelvis: Pouch of Douglas/ rectovesical space
  [Image: A simple medical illustration of an abdomen with four small incisions labeled A, B, C, and D. A is located just below the sternum in the midline. B and D are positioned on either side of the abdomen, lower than A, and are symmetrically placed. C is placed lower down again in the midline. A short line can be seen under the abdomen, possibly part of an anatomical diagram.]
  Abdominal compartment syndrome (ACS)
- Definition: sustained intra-abdominal pressure > 20mmHg that is associated with new organ dysfunction
- Clinical features
  - Respiratory distress
  - Reduced VR: hypotension, oliguria, LL oedema
  - Splanchnic ischaemia: GIB
- Investigations: urinary manometer (Foley)
- Management
  - NG decompression
  - Ventilatory support until definitive closure
  - Abdominal decompression with delayed wound closure
    Abdominal trauma

1. Spleen - delayed rupture possible
2. Liver
3. Kidney
4. Bowel: most common duodenum
   Chest trauma
5. Pneumothorax
6. Aortic injury/ dissection
7. Flail chest
8. Cardiac tamponade
9. Spinal fracture

2.2 Abdominal surgical scars
Important!

[Detailed illustration showing various abdominal surgical scars on a human torso. The illustration includes labels and lines pointing to different scar locations, such as "Nephrectomy Scar - Right," "Liver Transplant Mercedes Benz," "Laparotomy (3 holes)," "Lanz incision - appendectomy," and "Gridiron - appendectomy." On the right side of the image is a labeled illustration of a human torso with lines indicating various surgical incisions. These include "Rooftop - thoraco-oesophagectomy," "Liver transplant Mercedes Benz," "Right subcostal (Kocher's)," "Right paramedian - hemicolectomy," "Appendicectomy," "Suprapubic (Pfannenstiel) Hysterectomy / cystectomy," and "Left inguinal." Small texts are included in the illustration, such as "Rooftop incision (mercedes benz scar without the top vertical line) - liver transplant / upper GI / pancreas," "Midline scars - laparotomy/AAA repair / bowel resection," and "Loin / lumbar incision - nephrectomy/renal transplant (hockey stick scar)."]

Remember to check for incisional hernia as well - ask
the patient to cough and also to look up from the bed
to tense the abdominal wall muscles

| Scar                                   | Surgery involved                                                                                                               |
| -------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------ |
| Midline laparostomy                    | Exploratory, AAA repair (from xiphoid sternum to pubic symphysis), bowel resection (e.g. hemi-colectomy)                       |
| Right subcostal Kocher's               | Open cholecystectomy, liver resection, biliary surgery (cholecystectomy scar is shorter than liver resection scar)             |
| Reverse Kocher's (i.e. left subcostal) | Open splenectomy                                                                                                               |
| Rooftop scar                           | Liver resection/ transplant                                                                                                    |
| Mercedes                               | Upper Gl surgery (gastrectomy, oesophagectomy) Bilateral adrenalectomy                                                         |
| Left/Right Loin incision               | Renal surgery (i.e..nephrectomy) Appendicectomy/ appendectomy                                                                  |
| Modified Gridiron / Lanz               | - Gridiron/ McBurney: oblique - Lanz/ Modified Gridiron/ Rockey Davis: transverse (cosmetics better)                           |
| Hockey-stick/ Rutherford Morrison      | Kidney transplant (can be quite near the groin, actively look for scar if can feel for mass)                                   |
| Pfannestiel/ suprapubic                | Pelvic surgeries: C-section, hysterectomy, cystectomy, bladder, prostate                                                       |
| Groin incision                         | Hernia repair (inguinal/femoral) Vascular access (AV fistula for haemodialysis)                                                |
| Laparoscopic                           | 4 holes: 3 along right costal margin, 1 at umbilicus-cholecystectomy 3 holes: umbilicus, left flank, suprapubic - appendectomy |

Others: thoraco-abdominal incision (radical nephrectomy / adrenalectomy)

2.3 Common short cases
Lumps and bumps
Approach

- Site, size, shape, surface (smooth/irregular), border (well/poorly defined), consistency (soft/firm/hard)
- Temperature, tenderness
- Pulsatility (expansile / transmitted), transilluminability, compressibility/reducibility, fluctuation
- Fixation to skin / muscle
  Common cases
- Sebaceous cyst: 50% punctum +ve, fixed to skin
- Lipoma: slip sign +ve, not fixed to skin
- Ganglion cyst: movable in one plane, more prominent upon contraction of tendon
  Hepatomegaly
- SPRUE: site (RUQ → RLQ), percussion (dull), respiration (descends), unable to get above, edge (smooth/irregular)
- DDx of hepatomegaly
  - Congestive: right heart failure (TR), Budd-Chiari syndrome
  - Haematological: lymphoma / leukemia, thal major
  - Infection: viral hepatitis, liver abscess, TB, protozoa
  - Alcoholic (AFLD) / Autoimmune
  - Storage: Wilson's disease, hemochromatosis
  - Mass: primary (HCC) / secondary neoplasms, benign masses (e.g. haemangioma, adenoma, FNH)
  - Physiological: Riedel's lobe, hyperexpanded chest
- DDx of hepatic bruit: HCC, alcoholic hepatitis
  Splenomegaly
- SPRUE: site (LUQ → along Gardner's line), percussion (dull), respiration (descends), unable to get above / ballot, edge (splenic notch)
- DDx of splenomegaly
  - Congestive: portal hypertension (e.g. cirrhosis)
  - Haematological: myeloproliferative disorders (e.g. PMF), thalassemia, leukemia (CML), lymphoma
  - Infection: EBV, CMV, HIV, IE, malaria
  - Autoimmune: RA (Felty's syndrome)
  - Storage: Gaucher's disease
  - Mass: primary / secondary neoplasms
- Massive splenomegaly - Primary myelofibrosis - Chronic myeloid leukemia - Malaria - Kala-azar (visceral leishmaniasis)
  Ascites
- Causes of ascites - Exudative: intra-abdominal malignancy, chylous ascites, tuberculosis - Transudative: CLD (cirrhosis), heart failure, nephrotic syndrome
  Scrotum
- Differentiate groin vs scrotal swelling: can you get above it?
- Establish whether testis and epididymis are identifiable
  43

  2.4 Acute abdomen
  Differential diagnosis
  RUQ
  Liver: hepatitis, hepatomegaly,
  liver abscess
  Biliary: cholangitis, cholecystitis,
  cholelithiasis, choledocholithiasis
  Thoracic: pneumonia, pleural
  effusion
  Others: subphrenic abscess
  Epigastric
  Oesophagus: oesophagitis,
  GERD, Boerhaave's syndrome
  Stomach: gastritis, peptic ulcer,
  gastric volvulus, gastric outlet
  obstruction, CA stomach
  Pancreas: pancreatitis, CA
  pancreas
  Thoracic: MI, pericarditis
  (Hepatobiliary)
  Others: rAAA,
  LUQ
  Spleen: rupture, infarct,
  splenomegaly
  Pancreas: pancreatitis
  Thoracic: pneumonia, pleural
  effusion, MI
  R flank
  Kidney: pyelonephritis, renal
  infarct, obstructive uropathy
  (hydronephrosis), renal stone,
  RCC
  (Biliary)
  Para-umbilical
  Small bowels: small bowel
  R flank
  Kidney: pyelonephritis, renal
  obstruction, gastroenteritis, early infarct, obstructive uropathy
  appendicitis, mesenteric
  (hydronephrosis), renal stone,
  ischaemia, IBD
  RCC
  Retroperitoneal: ruptured AAA,
  (Splenic)
  LLQ
  pancreatitis
  RLQ
  Ileum: ileitis (Crohn's disease,
  Yersinia), Meckel's diverticulitis
  Caecum/Rt colon: acute
  appendicitis, diverticulitis, caecal
  ischaemia, colitis (infective, IBD,
  radiation), CA Rt colon/caecum
  O/G: torsion/ruptured of ovarian
  cysts, ectopic pregnancy
  Urological: ureteric colic,
  testicular torsion
  Others: strangulated
  inguinal/femoral hernia,
  mesenteric adenitis
  Hypogastric
  Large bowels: large bowel
  obstruction, colorectal CA
  Urological: AROU, bladder
  stones, cystitis/UTI
  O/G: PID, degenerating fibroid,
  adenomyosis/endometriosis,
  ectopic pregnancy
  Sigmoid colon/Lt colon: colitis
  (infective, IBD, radiation),
  diverticulitis, CA Lt
  colon/sigmoid
  O/G: torsion/rupture of ovarian
  cyst, ectopic pregnancy, PID
  Urological: ureteric colic,
  testicular torsion
  Others: strangulated
  inguinal/femoral hernia
  Diffuse/non-specific abdominal pain
  Bowels: gastroenteritis, constipation, uncomplicated bowel obstruction
  Peritoneum: generalized peritonitis, intra-abdominal haemorrhage, ruptured viscus
  Medical causes: DKA, hypercalcemia, herpes zoster, anaphylaxis, porphyria
  Life-threatening DDx of acute abdomen:

- Perforated viscus e.g. PPU
- Ruptured AAA
- Acute mesenteric ischemia
- Acute IO
- Severe pancreatitis
- Ruptured HCC
- Medical conditions x3: DKA, acute MI, Addisonian crisis
- Obstetric conditions: ruptured ectopic pregnancy, placenta abruptio
  History taking
- Character:
  - Dull, vague, midline (visceral/ referred)
  - Sharp, localised (somatic/ parietal)
  - Radiation: back, jaw, right shoulder, etc
- Exacerbating/relieving factors:
  - Food: GU (exacerbated), DU (relieved)
  - Fatty meal: pancreatitis, biliary colic (exacerbated)
  - Position: GERD, acute pancreatitis, CA pancreas (relieved by leaning forward), PPU (worsened by movement)

[Image Description: The number 44 is present at the top right corner of the document.]

- Associated symptoms:
  - GI: n/v, bowel changes, tarry stool, haematemesis, PRB
  - HBP: jaundice, tea coloured urine, pale stool
  - GU: dysuria, haematuria, frothy urine
  - Gyn: vaginal discharge, PVB, LMP, pregnancy
  - Constitutional symptoms
- Drug history: NSAID, bisphosphonates, steroid
- Red flags:
  - Background: age > 55, FHx of upper GI cancer
  - Constitutional symptoms: significant unintentional weight loss
  - Bleeding: coffee ground/ fresh blood vomiting, tarry stool, PR bleed, anaemic symptoms
  - Obstruction: dysphagia/ early satiety, vomiting, abdominal distension with colicky pain, constipation

Physical examination

- Inspection: distension, visible peristalsis (IO), scars (adhesions), mass, cough impulse (hernia → IO)
- Palpation: tenderness, guarding, rebound tenderness, rigidity, distension, mass, AAA
- Percussion: resonance (IO), dullness, shifting dullness
- Auscultation: bowel sounds (absent = paralytic ileus, hyperactive = mechanical IO), bruits
- PR exam

Investigations

- Bloods
  - CBC, LRFT, amylase, CRP
  - CaPO4 (pancreatitis)
  - Glucose (DKA)
  - ABG, lactate (ischaemic bowel)
  - Urinalysis, urine dipstick urine culture (GU)
  - Pregnancy test
  - ECG, cardiac enzymes (r/o AMI)

| Site of pain | Imaging of choice   |
| ------------ | ------------------- |
| RUQ          | USG                 |
| LUQ          | CT                  |
| RLQ          | CT with IV contrast |
| LLQ          | CT with IV contrast |
| Suprapubic   | USG (TAS or TVS)    |

- Imaging: erect CXR + supine AXR +/- others
- Diagnostic laparoscopy

AVOID endoscopy for acute abdomen: sealed-off perforation may open by gas insufflation during endoscopy

[Image of the number 45 in the top right corner of the page.]

## 2.5 Peritonitis

**Anatomy of peritoneal cavity**

- Morison pouch (hepatorenal recess): a potential space that is
  visualised in USG/CT with minimal amount of fluid collection (e.g.
  ascites, haemoperitoneum)
- Retroperitoneal organs
  - Kidneys, adrenals, ureters
  - Aorta/IVC
  - Duodenum (D2, D3), colon (ascending, descending)
  - Pancreas (except tail)

[Diagram of abdominal cavity showing the right subphrenic space, left subphrenic space, subhepatic space, right paracolic gutter, right infra-mesocolic space, left infra-mesocolic space, left paracolic gutter and pelvis.]

**Peritonitis**
Definition: inflammation of the peritoneum → **surgical emergency!**
Classification

- Etiology: bacterial vs chemical
- Extent: localized vs diffuse / generalized

|           | Definition                                                                                   | Example                                                           |
| :-------- | :------------------------------------------------------------------------------------------- | :---------------------------------------------------------------- |
| Primary   | Ascitic fluid infection **without** surgically treatable intra-abdominal source of infection | SBP, CAPD-associated, TB                                          |
| Secondary | Ascitic fluid infection **with** surgically treatable intra-abdominal source of infection    | Perforation e.g. PPU                                              |
|           |                                                                                              | Ischemic bowel                                                    |
|           |                                                                                              | Infection: cholecystitis, cholangitis, appendicitis, pancreatitis |
| Tertiary  | **Persistent** peritonitis after adequate initial therapy                                    | Incarcerated hernia, anastomotic leak                             |
|           |                                                                                              | Opportunistic infections                                          |

**Clinical features and investigations**

- S/S of peritonitis: burning pain, peritoneal signs (T+G+R+), paralytic ileus, systemic upset (e.g. sepsis)
- Blood tests: CBC, LRFT, amylase, ABG, clotting, T&S
- Imaging: ECG, Erect CXR, erect/supine AXR, USG, CT A+P
- Peritoneal fluid analysis: ↑ amylase / bile-stained / feculent indicates perforated GI tract

Proceed to **exploratory laparotomy** if free gas / florid peritoneal signs

46

# 3 Upper GI surgery

3.1 Anatomy

- Layers of GI tract walls
  - Adventitia (serosa if intra-abdominal)
  - Muscularis propria (outer longitudinal + inner circular ms, myenteric ("Auerbach's") plexus in between)
    - Additional oblique muscle layer in stomach
  - Submucosa (containing Meissner's plexus and interstitial cells of Cajal)
  - Mucosa (stratified squamous non-keratinized epithelium)

Oesophagus

- Parts of oesophagus – C6 to T10
  - Cervical part: from cricopharyngeus (UES) to suprasternal notch
  - Thoracic part: from suprasternal notch to diaphragm
  - Abdominal part: from diaphragm to cardia of stomach

|                 | Upper 1/3               | Middle 1/3                                | Lower 1/3                                  |
| --------------- | ----------------------- | ----------------------------------------- | ------------------------------------------ |
| Muscles         | Skeletal                | Mixed skeletal and smooth                 | Smooth                                     |
| Arterial supply | Inf. thyroid a.         | Esophageal branches of **thoracic aorta** | Esophageal branches of **left gastric a.** |
|                 | (← thyrocervical trunk) |                                           |                                            |
| Venous return   | Brachiocephalic veins   | Azygos veins (→ IVC)                      | **Left gastric v.** (→ PV)                 |
| Lymphatics      | Deep cervical           | Mediastinal                               | Along left gastric / celiac                |

- OGJ vs Z line
  - OGJ: upper limit of gastric folds
  - Z line (squamous-columnar junction): usually where OGJ is located, migrated upwards in Barrett's oesophagus
- Physiology of swallowing
  - Oral phase: voluntary
  - Pharyngeal phase: complex involuntary reflex
  - Oesophageal phase: peristalsis + opening of LES
- Relations:
  - Physiological constrictions where food bolus is most likely to be stuck (ABCD): arch of aorta, bronchus (left main stem), cricoid cartilage, diaphragmatic hiatus
  - Other important structures: thoracic duct, left recurrent laryngeal nerve, vagus nerve

Coeliac trunk

[Image Description: A diagram shows the Coeliac trunk and its branching arteries. The main arteries include the Left Gastric artery, Splenic artery, and Common Hepatic artery. The Common Hepatic artery further branches into the Proper Hepatic artery and the Gastroduodenal artery. The Gastroduodenal artery branches into the Superior Pancreatico-duodenal artery and the Right gastroepiploic artery. The Proper Hepatic artery branches into the Right Hepatic artery and the Left Hepatic artery, with the Right Hepatic artery giving off the Cystic artery. The locations of the abdominal aorta (Ab. Aorta) and the coeliac trunk (CT) are also marked on the diagram. The arteries are red.]

[Image Description: A diagram illustrating endoscopic landmarks in the esophagus, showing distances from the incisor teeth. At 15 cm, there is a cricopharyngeal constriction. At 25 cm, there is an aortic and bronchial constriction. At 40 cm, there is a diaphragmatic and "sphincter" constriction. An inset diagram shows the artery paths, with the right hepatic, right medial sectoral, left hepatic, right gastric, left gastric, and splenic arteries labeled. ]

[Image Description: A grayscale image shows the Coeliac trunk and its branching arteries after being injected with a contrast dye. The arteries appear bright against the darker background of the surrounding tissue. Labels indicate the cystic artery, gastroduodenal artery, common hepatic artery, and right gastroepiploic artery. The background is mostly gray and blurry.]

Stomach

- Arterial supply: 5 arteries (resistant to ischaemia) - **need to know!** - Lesser curve: left gastric artery, right gastric artery (HAP CHA) - Greater curve: right gastroepiploic artery (← GDA CHA), left
  gastroepiploic artery (← splenic a.), short gastric artery (← splenic a.)
- Venous drainage
  - Lesser curve: into portal vein
    - Coronary vein: markedly dilated in portal HT, embolized in TIPSS
  - Greater curve: into splenic vein
- Lymphatic drainage (important for CA stomach) - Lesser curve: gastric, suprapyloric → para-aortic nodes around celiac axis - Greater curve: gastroepiploic, subpyloric superior mesenteric nodes
  around SMA
- Innervation - Sympathetic: T5-T12 (vasoconstriction, inhibit gastric motility, pylorus
  constriction) - Parasympathetic: **ant. vagal trunk** from left vagus n., **post. vagal trunk** from
  right vagus n. (secretomotor, pylorus
  relaxation, afferent fibers for sensation)
  Functional anatomy
- Fundus/body: - Parietal cells (80%): intrinsic factor (bind B12
  for absorption at ileum), HCl - Chief cells: pepsin
- Antrum: - Parietal cells (20%) - Mucus cell - G cell: gastrin - D cell: somatostatin - ECL cell: histamine, serotonin
  [Image of a diagram of the upper gastrointestinal tract, with labels pointing to the hepatic portal vein, the head of the pancreas, the portal triad, the hepatic artery proper, the common bile duct, the right free margin of the lesser omentum, the spleen, the suprarenal gland, the pylorus, the kidney, the transverse mesocolon, and its cut edges, the right colic flexure, the ascending colon, the fundus, the right gastro-omental artery, the corpus, the suprarenal gland, the transverse mesocolon and its cut edges, the splenic flexure, and the duodenum]

Duodenum

- Approximately 25cm long: most is **retroperitoneal**
  (except proximal 2.5cm of D1)
- Shortest, widest and most predictably placed part of
  small bowel (L1-L3)
- 4 parts

[Image of a diagram of the duodenum showing the superior, descending, inferior and ascending parts and the root of mesentery]

| Features       | Important relations                                             |
| -------------- | --------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------- |
| D1: superior   | Most mobile: proximal 2.5cm is **intraperitoneal**              | Posterior: **GDA** (PPU may erode into it), CBD, PV Anterior: quadrate lobe of liver                                                                      |
| D2: descending | Ampulla of Vater at posteromedial wall of D2 (8cm from pylorus) | Anterior: gallbladder, R lobe of liver, **transverse colon** Posterior: hilum of R kidney. R renal vessels, psoas major Medial: **head of pancreas**, CBD |
| D3: horizontal | Clamped between SMA and abdominal aorta                         | Posterior: **IVC, aorta**, R ureter, R psoas major, gonadal vessels                                                                                       |
| D4: ascending  | Suspended by ligament of Treitz                                 | Posterior to DJ flexure: **IMV**                                                                                                                          |

- Arterial supply: gastroduodenal a., superior (D1-2) & inferior (D2-3) pancreaticoduodenal a., jejunal a. branches
  (D4)

# 3.2 Dysphagia

Definitions

- Dysphagia: difficulty in swallowing
- Odynophagia: pain on swallowing
- Globus: sensation of having a lump in the throat without true dysphagia; benign

Classical presentations

- Painless progressive dysphagia (over weeks) is malignancy until proven otherwise
- Painful non-progressive dysphagia points to functional causes

Terminology

- Vomiting: forceful expulsion of contents after reaching stomach
- Reflux: backward flow of contents from stomach
- Regurgitation: backward flow of contents (undigested food) from oesophagus

Differential diagnosis

| Functional                                                             | Structural                                                                                                            |
| ---------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------- |
| Achalasia                                                              | Intraluminal: foreign body                                                                                            |
| Diffuse esophageal spasm                                               | Intramural: CA esophagus, stricture (e.g. GERD, corrosive injury), esophagitis, esophageal rings / webs               |
| Neurological e.g. stroke, MND, Parkinson's disease, MS, MG, myopathies | Extramural (4T): tumour/ LN (e.g. CA lung, lymphoma), thyroid (retrosternal goitre), thymus, thoracic aortic aneurysm |
| Systemic diseases e.g. scleroderma, Sjogren's syndrome                 |                                                                                                                       |

History taking

|                       | Functional                                                                                           | Structural                                                                                           |
| --------------------- | ---------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------- |
| Onset                 | Acute (stroke) or Slowly progressive (achalasia, MS, PD) or Intermittent (diffuse oesophageal spasm) | Rapidly progressive                                                                                  |
| Type of food          | Fluid > solid                                                                                        | Solid > fluid                                                                                        |
| Difficulty initiating | Yes                                                                                                  | No                                                                                                   |
| Hold-up sensation     | Higher: usually oropharyngeal in origin (lower in achalasia)                                         | Lower: usually oesophageal in origin                                                                 |
| Associated symptoms   | Immediate choking, coughing, nasal regurgitation Neuro symptoms (e.g. dysarthria, weakness)          | Regurgitation Chest discomfort Alarm symptoms: HOV (RLN invasion), bleeding, constitutional symptoms |

- Associated symptoms:
  - GI:
    - Odynophagia (oesophagitis)
    - Chest pain (oesophageal motility disorders)
    - Heart burn, acid sensation, acid reflux, choking (GERD → adenoCA)
  - Neurological
    - Tremor (PD)
    - Ptosis, intermittent weakness (MG)
    - Weakness, dysarthria (stroke)
  - Others
    - Neck swelling (goitre)
    - Cough, hemoptysis, HoV (CA lung)
- Severity: weight loss (overlap with constitutional symptoms), malnutrition, aspiration pneumonia
- PMH: GERD / reflux (stricture), any previous OGD / investigations
- FHx: malignancy
- DH: CCB, nitrates (reflux)
- SH: smoking, alcohol, hot tea

Physical exam

- Functional causes likely:
  - CNS: speech, cognition, CN9-12
  - PNS: limb weakness (stroke), Parkinsonism (PD), fatigability (MG)
  - Skin: scleroderma
- Structural causes likely:
  - HEENT: radiation mark
  - Thyroid: goitre, thyroid status
  - Lymph node (Virchow's node)
  - Abdomen: epigastric mass, hepatomegaly
- Complications - Nutritional status - Respiratory exam: signs of aspiration pneumonia
  Investigations
- Suspect structural causes: OGD - diagnostic and therapeutic
- Suspect functional causes:
  - Barium swallow: can visualize obstructive lesions, less invasive
    - **Gastrografin** contrast: safe for suspected perforation, but may cause **chemical pneumonitis** if aspirated
      - If high risk of aspiration: use **Omnipaque** (water-soluble contrast medium: lower osmolarity and thus lower risk of pulmonary oedema c.f. gastrografin)
  - Video-fluoroscopic swallowing study (VFSS)
  - **Manometry** (achalasia)

# 3.3 UGIB

Definitions

- Upper GI bleeding: bleeding from oesophagus to ligament of Treitz (DJ flexure)
- Lower GI bleeding: bleeding from ligament of Treitz to rectum
- GI bleeding of obscured origin: bleeding of unknown origin with negative top & tail; most found in small bowel eventually
  - Obscured overt GI bleeding: with obvious GI bleeding symptoms (UGIB/LGIB)
  - Obscured occult GI bleeding: with IDA and FOBT positive

Differential diagnosis

- Oesophagus: oesophagitis, oesophageal varices, Mallory-Weiss syndrome, malignancy
- Stomach: gastritis, PUD (MC), Dieulafoy's lesion, portal hypertensive gastropathy, gastric varices, malignancy
- Duodenum: duodenitis, ulcer, malignancy, haemobilia (cholangiocarcinoma)
- Aortic-enteric fistula (after aortic repair with grafts)
- Any site: AV malformation

Important questions

- Vomitus: amount, character (hematemesis [fast rate of bleeding], coffee ground [small amount/ slow rate that is altered in stomach], haemoptysis)
- Stool: melena (slow bleeding that is altered through digestion in GIT), haematochezia (fresh PR bleeding that is profuse & fast)
  - Melena: fresh (jet-black tarry stool) vs stale (black-grey dull, mixed with normal stool)
- Severity: for emergency OGD
  - Volume loss: syncope, postural hypotension, palpitation
  - Rate of bleeding: massive haematemesis + fresh PR bleed
  - Anaemic symptoms: UNCOMMON (both plasma & blood cells are lost)
- Associated symptoms:
  - Preceding forceful vomiting (Mallory-Weiss syndrome)
  - Epigastric pain associated with meal (PUD)
  - Jaundice, easy bruising, distended abdomen, peripheral oedema (liver failure)
  - Constitutional symptoms (malignancy), dysphagia (CA oesophagus), persistent epigastric pain (CA stomach)
- Risk factors: drug (antiplatelet/ anticoagulant, NSAID, steroid), H pylori, liver disease

Initial management: resuscitation, localisation of bleeding, haemostasis

- Resuscitation:
  - Airway: cuffed ET tube + NG tube if massive haematemesis / IO
  - Breathing: O2
  - Circulation:
    - Closely monitor pulse, BP, I/O
    - (ATLS classification of haemorrhagic shock - **important!**)
    - NPO, 2 large bore IV cannula
    - IV NS 2L FR to maintain BP/P + urine output
    - Blood transfusion if Hb < 7 or massive\*
    - Withhold anticoagulants and antiplatelets (balance thrombotic risk when considering reversal)

[Image of a table with the following columns: BloodLoss (ml), %, HR, BP, PP, RR, UOP, CNS. The table has four classes (I, II, III, IV) with corresponding values for each parameter.]

- Pre-endoscopy management:
  - Bloods: CBC (baseline Hb), clotting, X-match, LRFT, VBG (acidosis)
  - RFT: elevated urea:Cr ratio (>100:1) because Hb digestion + reduced renal perfusion
  - CXR (pneumoperitoneum caused by PPU, left-sided pleural effusion by Boerhaave's perforation)
  - CT aortogram if Hx aortic graft (aorto-enteric fistula)

52

- Pre-endoscopic PPI (IV esomeprazole 80mg stat → 8mg/h until OGD) (HO handbook: only if early endoscopy cannot be arranged)
- Risk stratification:

| Parameters | Glasgow-Blatchford score (GBS)        | Rockall score                          |
| ---------- | ------------------------------------- | -------------------------------------- |
|            | Clinical                              | ABCDE                                  |
|            | Lab (endoscopic results not required) | - Clinical (Age, BP, Comorbidities)    |
|            |                                       | - Endoscopy (Dx, Evidence of bleeding) |
|            |                                       |                                        |

|     |                 | Score         |                  | Variables | 0                      | 1                      | 2                                                                                 | 3                                           |
| --- | --------------- | ------------- | ---------------- | --------- | ---------------------- | ---------------------- | --------------------------------------------------------------------------------- | ------------------------------------------- | --- | --- |
|     | Blood Urea      | 6.5 to <8     | 2                |           | Age                    | <60                    | 60-79                                                                             | ≥80                                         |     |
|     |                 | 8 to <10      | 3                |           | Blood pressure         | No shock SBP>100 P<100 | Tachycardia SBP>100 P>100                                                         | Hypotension SBP <90                         |     |
|     |                 | 10 to <25     | 4                |           | Co-morbidity           | No                     | CHF, IHD, major diseases                                                          | Renal failure, liver failure, metastatic ca |
|     |                 | >25           | 6                |           | Dx at time of OGD      | Mallory-Weiss, no SRH  | All other Dx except malignancy                                                    | Gl malignancy                               |     |
|     | Нь              | Male 12 to 13 | Female 10 to <12 | 1         |                        | Evidence of bleeding   | No, or dark spot only                                                             | Blood, adherent clot, spurter               |     |     |
|     |                 | 10 to <12     | 2                |           |                        |                        |                                                                                   |                                             |     |
|     |                 | <10           | <10              | 6         |                        | Pre-endoscopy score    | 0-1: Early discharge or non-admission                                             |                                             |     |     |
|     | Systolic BP     | 100-109       | 1                |           | 0-1: Low risk          |                        | Full score (Pre-endoscopic + endoscopic) 0-3: excellent, consider early discharge |
|     |                 | 90-99         | 2                |           | 2-3: Moderate risk     |                        |                                                                                   |
|     |                 | <90           | 3                |           | >4: High risk of death |                        |                                                                                   | >8: high risk of death and rebleeding       |
|     | Pulse           | >100          | 1                |           |                        |                        |                                                                                   |                                             |
|     | Melaena         | Yes           | 1                |           |                        |                        |                                                                                   |                                             |
|     | Syncope         | Yes           | 2                |           |                        |                        |                                                                                   |                                             |
|     | Hepatic disease | Yes           | 2                |           |                        |                        |                                                                                   |                                             |
|     | Cardiac failure | Yes           | 2                |           |                        |                        |                                                                                   |                                             |

| Interpretation | 0: manage outpatient                       |
| -------------- | ------------------------------------------ |
|                | >0: manage inpatient                       |
| Role           | >6: >50% risk requiring intervention       |
|                | Better at predicting need for intervention |

Good prognosis if < 3, high mortality if > 8
Better at predicting rebleeding/ mortality within 30 days

- For cirrhotic patients (suspected esophageal varices): - IV antibiotics (SBP prophylaxis): IV ceftriaxone 1g daily for 7 days / augmentin / levofloxacin - IV vitamin K1 - Vasoactive drug: either one - IV octreotide: somatostatin analogue with increased half-life; inhibit vasodilator hormone (e.g. glucagon) + direct splanchnic vasoconstriction - IV terlipressin: V1 agonist for non-specific arteriole vasoconstriction (caution if CV risk, e.g. IHD, stroke)
  OGD
- Indications
  - Emergency: unstable haemodynamics despite resuscitation, massive haematemesis, suspected variceal bleeding
  - Elective (NPO 6h before OGD): all other cases
  - 2nd look OGD: if GU (6-8 weeks) or large/ complicated DU
- Contraindications: suspected perforation, unstable cardiac/ pulmonary status
- Diagnostic: **Forrest classification** (endoscopic stigmata of recent haemorrhage) - **important!**

|                              | Forrest | Risk of re-bleeding if untreated | Management                    |
| ---------------------------- | ------- | -------------------------------- | ----------------------------- |
| Acute spurter                | Ia      | ~ 100%                           | Endoscopic therapy, then      |
| Acute oozing                 | Ib      | 10-27%                           | IV PPI bolus + infusion x 72h |
| Non-bleeding visible vessel  | IIa     | 50%                              |                               |
| Non-bleeding adherent clot\* | IIb     | 30-35%                           |                               |
| Flat spot                    | IIc     | 5-8%                             | Oral PPI                      |
| Clean base                   | III     | <3%                              |                               |

[Image of Endoscopy of a bleeding ulcer, the ulcer is bleeding actively. A white arrow is pointing towards the bleeding ulcer.]

[Image of Endoscopy of a bleeding ulcer, the ulcer has stopped bleeding. A white arrow is pointing towards the scar of the bleeding ulcer.]

[Image of Endoscopy of a bleeding ulcer, the ulcer is bleeding actively. A white arrow is pointing towards the bleeding ulcer.]

[Image of Endoscopy of a bleeding ulcer, the ulcer has stopped bleeding and is covered by a blood clot. A white arrow is pointing towards the blood clot covering the ulcer.]

[Image of Endoscopy of a bleeding ulcer, the ulcer has stopped bleeding and is showing a clean base. A white arrow is pointing towards the base of the ulcer.]

\*Need to remove by vigorous flushing to reveal underlying vessels

- Therapeutic (**need to know!**)
  - Bleeding ulcer: **dual therapy**, i.e. adrenaline + heater probe or clips (more prolonged action)
    - Injection therapy: **adrenaline 1:10000** (**tamponade** + **vasoconstriction** + **platelet aggregation**)
    - Thermal therapy: **heater probe** (coaptive effect: pressure + heat)
    - Mechanical therapy: **haemospray** "雲南白藥"(mechanical barrier + absorbent), clips (for large area ulcer)
  - Variceal bleeding
    - **Endoscopic band ligation** (EBL): 1st line for _oesophageal_ varices
    - **Histoacryl glue** (sclerosant)
      - 1st line for _gastric_ varices (EBL cannot catch the thick gastric wall)
      - Complications: ulceration, stricture, mediastinitis, obviate use of subsequent EBL
    - Persistent/ recurrent bleeding
      - Sengstaken-Blakemore tube
      - Transjugular intrahepatic portosystemic shunts (TIPSS )
      - Surgical shunts
- Post-OGD PPI infusion: pantoprazole/esomeprazole 80mg stat, then 8mg/h for 72h (higher pH stabilises clot since platelet function depends on normal pH)
  - Indicated for endoscopic treatment for Forrest Class Ia, Ib, IIa, IIb _ulcer bleeding_
  - _NOT_ efficacious for _variceal_ bleeding: only give oral PPI to _reduce post-banding ulcers_
- Principles of antithrombotic management
  - Withhold all stat +/- reversal agents
  - Resume aspirin after OGD, clopidogrel 5-7 days later
- Alternative investigations in inconclusive OGD (refer to LGIB section)

[Image of the number 53 in the top right corner of the page.]

3.4 Benign diseases of esophagus
Achalasia
Definition

- Most common esophageal motility disorder: loss of receptive relaxation of LES
- Characterised by a triad of:

1.  Aperistalsis with uncoordinated contraction
2.  Increased LES tone at rest
3.  Poor LES relaxation in response to swallowing

DDx:

- Pseudo-achalasia (paraneoplastic: CA cardia invades esophageal neural plexus) - differentiate by OGD + EUS
- Other esophageal motility disorders - differentiate by esophageal manometry (normal LES pressure)

Pathophysiology

- Causes: primary, secondary (e.g. Chagas disease: degeneration of myenteric plexus due to Trypanosoma cruzi
  infection)
- Degeneration of inhibitory neurons (NO/VIP) in myenteric (Auerbach's) plexus → unopposed activity of
  excitatory neurons (Ach): Initially presented with uncoordinated peristalsis → aperistalsis

Clinical features

- Age: MC 35-45, but actually any age group
- Progressive dysphagia (solid + liquid)
- Regurgitation after meal → acidic smell (fermentation of food)
- Chest pain (food stasis in lower oesophagus)
- Recurrent aspiration pneumonia, weight loss

Investigations

- High-resolution oesophageal manometry (HRM): for definitive diagnosis (triad of high resting LES pressure,
  failure to relax upon swallowing, abnormal peristalsis) and Chicago classification (based on esophageal
  pressure topography, see fig.)
- Type I: achalasia with minimal oesophageal pressurisation
- Type II: achalasia with oesophageal compression (pan-
  esophageal pressurisation)
- Type III: achalasia with esophageal spasm
- OGD: to assess complications (e.g. oesophagitis, SCC
  oesophagus) & rule out mechanical causes (e.g. malignancy,
  stricture)
- Typical finding: tight cardia and food residue in
  esophagus
- Barium swallow (fig.): usually not done now
- Bird's beak sign (early): hold up of contrast with tapering stricture in distal
  esophagus and proximal dilation
- Sigmoid-like appearance due to massive oesophageal dilatation (late)
- Any shouldering/ heaping should lead to suspicion of pseudo-achalasia (due to
  extramural obstruction, e.g. OGJ tumour)
- Barium vs gastrografin
- Barium: avoid if risk of perforation - barium peritonitis
- Gastrografin: avoid if risk of aspiration - chemical pneumonitis
- CXR: widening of mediastinum, absent gastric bubble, air-fluid level behind heart,
  double right heart border

[Image: Three line graphs labeled as 'A: Type I', 'B: Type II', and 'C: Type III', each representing esophageal pressure over time. The y-axis shows Length along the esophagus (cm) going from 5 to 35, and the x-axis shows Time (s). The graphs display different patterns of pressure, with 'Type III' exhibiting the most pronounced pressure spikes.]

[Image: An x-ray image displaying the esophagus, which appears to be significantly dilated. The lower part of the esophagus shows a tapered stricture, creating a narrow point just before the stomach. The overall appearance suggests a "bird's beak" shape.]

Complications

- Stasis of food: erosions, candida esophagitis
- Lower esophageal diverticula
- Aspiration pneumonia
- Esophageal SCC
  54

Management

- Pharmacotherapy (CCB, nitrates): transient symptomatic relief only
- Endoscopic treatment - to abolish LES
  - Graded pneumatic balloon dilation of LES → disrupt muscles
    - Curative in 65-85% of patients
    - Complications: perforation, GERD
  - Endoscopic injection of Botox (block ACh release from nerve terminals)
  - Per-oral endoscopic myotomy (POEM): creation of a submucosal tunnel at mid-oesophagus, allow long myotomy
    - Complications: reflux (no fundoplication done → PPI), mediastinitis, surgical emphysema
- Surgical treatment: laparoscopic Heller's myotomy
  - Indication: failed endoscopic Tx
  - With partial anterior fundoplication (180°) to prevent post-op GERD (Heller-Dor operation)
  - Successful in ≥ 90% cases
  - Complications: perforation, dysphagia (due to fundoplication)
- Comparison of treatment
  - Myotomy (endoscopic/lap) most effective
  - POEM has fewer hospital stay, but more reflux as no fundoplication done
  - Lap Heller's myotomy has more dysphagia

Other esophageal motility disorders

- Diffuse (Distal) esophageal spasm: uncoordinated simultaneous / premature contractions in distal esophagus
  - S/S: severe retrosternal chest pain + dysphagia / GERD
  - Barium swallow: cockscrew esophagus
- Hypercontractile esophagus (jackhammer / nutcracker esophagus): high pressure but normal coordinated contractions
  - S/S: odynophagia
- Absent esophageal peristalsis due to systemic sclerosis (SSC)
  [Image: Two anatomical illustrations side by side, labeled A and B. Both depict the junction between the esophagus and the stomach. In illustration A, labeled "Trapped food," the esophagus narrows sharply near the stomach, creating a pocket where food is lodged. A small, horizontal cut is shown on the esophagus. Illustration B, labeled "Split muscle," shows a similar junction, but the esophagus is wider, with a surgical cut separating the muscle fibers.]
  [Image: X-ray of the esophagus showing a narrowing in the middle portion, with the shape of the esophagus resembling a corkscrew]

# Gastroesophageal reflux disease (GERD)

(Refer to [MED] for clinical features and medical treatments)
Relationship with hiatus hernia and oesophagitis

- Inter-related, although they can occur independently
- Oesophagitis: can develop into ulcer → stricture → Barrett's oesophagus (10%) → metaplasia → adenoCa (7% of Barrett's)
  Surgical treatment

[Diagram illustrating the relationships between GERD, Hiatus Hernia and Oesophagitis.
GERD is in the center.
A double headed arrow points from GERD to Hiatus Hernia.
A double headed arrow points from GERD to Oesophagitis.]

- Pre-op: esophageal manometry, 24h ambulatory pH monitoring, OGD x biopsy (refer to [MED])
- Indications
  - Young and fit PPI-dependent patients (so as to avoid long term use of PPI)
  - GERD / Complications unresponsive to medical treatment (very rare: consider alternative diagnosis)
- Contraindications: aperistalsis → risk of dysphagia
- Laparoscopic fundoplication
  - Goal:
    - Close the hiatal defect
    - Restore the pressure around LES and angle of His
    - Lengthen the intra-abdominal part of oesophagus
  - Types:
    - Total (Nissen): 360° → more durable, but more dysphagia
    - Partial (e.g. Toupet, Lind, Dor): preferred in Chinese - less dysphagia
      - Toupet: posterior 270°
      - Dor / Watson: anterior 90 or 180°) - in Heller's myotomy
  - Specific complications:
    - Improved anti-reflux mechanism: **gas bloat syndrome** (90%) esp. in Nissen (inability to burp or vomit, flatus; self-limiting in 4 weeks)
    - Too tight: dysphagia (50% in early post-op, 10% long-term)
      - Ix: **Water-soluble contrast swallow**
      - Tx: endoscopic Bougie balloon dilation / revise fundoplication
    - Too loose: recurrence of reflux
    - Surgical emphysema (gas absorbed in mediastinum)
    - Perforation → mediastinitis
    - Slipped Nissen: wrap slides down, GEJ retracts into chest
  - Efficacy: PPI independence rate ~60%
- Endoscopic treatment (emerging treatment option):
  - Target LES: RFA (by inducing LES hypertrophy)
  - Target EGJ: Transoral incisionless fundoplication

[Image depicting three different surgical fundoplication techniques. From left to right they are Nissen, Dor and Toupet.
Nissen shows the Normal Stomach with a blue box around the gastroesophageal junction. Next to it, an illustration shows the sutured fundus wrapped completely around the esophagus.
Dor shows the Normal Stomach with a blue box around the gastroesophageal junction. Next to it, an illustration shows the sutured fundus wrapped partially around the anterior part of the esophagus.
Toupet shows the Normal Stomach with a blue box around the gastroesophageal junction. Next to it, an illustration shows the sutured fundus wrapped partially around the posterior part of the esophagus.]

[Image illustrating Laparoscope cannula sites for laparoscopic fundoplication.
A torso is shown with five red dots representing the laparoscopic cannula sites.]

# Barrett's oesophagus

- Definition: **intestinal metaplasia** of oesophageal stratified squamous epithelium to **columnar epithelium** (with mucus-secreting goblet cells) as an adaptation mechanism to long-term acid reflux
- Clinical features: Long-standing GERD, dysphagia, heartburn, UGIB
  - H. pylori infection is a protective factor due to parietal cell atrophy
- Classification: Classic (≥ 3cm columnar epithelium) vs Short- segment (<3cm columnar epithelium)
  - Prague's classification (fig.): C = circumferential extent, M = maximal extent
- Investigations: OGD with biopsy +/- chromoendoscopy (e.g. NBI, Lugol's iodine) for higher sensitivity
  - "Seattle protocol": biopsy every 1-2cm in 4 quadrants
- Diagnostic:
  - Proximal migration of squamocolumnar junction (Z- line) >1cm
  - Salmon-pink epithelium in distal oesophagus
- Detect complications: Barrett's ulcers, strictures, dysplasia, adenocarcinoma (↑risk 0.5%/year)

[Diagram of the distal esophagus and gastric cardia in Barrett's oesophagus.
The esophagus is shaped like a tube with a narrowing at the bottom. The distal esophagus is orange colored, and the proximal margin of the Barrett's tongue is shown at the top. The gastric cardia at the bottom of the esophagus is red colored, and the proximal margin of the cardiac folds is shown at the bottom.
Arrows point vertically from the Proximal margin of the longest Barrett's tongue to the Proximal margin of the cardiac folds. A bracket on the arrow indicates this length is M (maximal extent).
Shorter Arrows point vertically from the Proximal margin of the circumferential Barrett's segment to the Proximal margin of the cardiac folds. A bracket on the arrow indicates this length is C (circumferential extent).]

57

- Management:
  - Treat underlying GERD: high-dose PPI for life
  - Endoscopic surveillance:
    - No dysplasia: OGD + biopsy Q3y (>3cm) or Q5y (<3cm)
    - Low-grade dysplasia: OGD at 6 months x 2 then Q1y if negative, or endoscopic treatment
    - High-grade dysplasia: intense surveillance (Q3mo), or endoscopic treatment (e.g. EMR) (advised)

[Image Description: A flowchart titled "Summary of updated British Society of Gastroenterology guidelines for surveillance of BO.1" showing pathways for managing Non-dysplastic Barrett's Esophagus (BO), Low-Grade Dysplasia (LGD), and High-Grade Dysplasia (HGD). The Non-dysplastic BO branch splits based on length (<3cm or >=3cm). The LGD branch involves repeat OGD in 6 months. The HGD branch involves MDT referral. Arrows connect these branches with options like "Glandular metaplasia", "Intestinal metaplasia", "Repeat OGD in 3 to 5 years", "OGD every 3 to 5 years", "OGD every 2 to 3 years", "Endoscopic therapy", and "LGD".]

Hiatal hernia
Definitions: protrusion of an organ from abdominal cavity into thorax via oesophageal hiatus of diaphragm
Classification
Sliding (Type 1) vs Para-esophageal (Types 2-4)
| I | Sliding: Herniation of OGJ above diaphragm (MC) |
| II | Rolling: Herniation of fundus, but fixed OGJ |
| III | Mixed: Herniation of both OGJ and fundus |
| IV | Herniation of organs other than stomach |

[Image Description: Four cartoon diagrams depicting different types of hiatal hernia: Type I (Sliding), Type II (Rolling), Type III (Mixed), and Type IV (Herniation of organs other than stomach). Each diagram shows the relative positions of the stomach, esophagus, and diaphragm, illustrating the varying degrees and manners in which the stomach protrudes into the chest cavity.]

Risk factors

- Age: loss of diaphragmatic tone, increased diaphragmatic diameter
- Increased intra-abdominal pressure: pregnancy, obesity, ascites
- Previous surgery around hiatus: anti-reflux surgery, Heller's myotomy, partial gastrectomy
  Clinical features
- Asymptomatic (MC)
- GERD symptoms
  - Anti-reflux eliminated in hiatus hernia: intra-abdominal part of oesophagus, angle of His, mucosal fold
  - Bleeding (oesophageal ulceration)
- Chest pain, hiccups, palpitations (irritation of diaphragm/pericardial sac)
- Dysphagia (oesophageal stricture/ incarceration of hernia)
- Complications: surgical emergency (Mx: NG tube decompression + EOT)
  - Gastric volvulus (only in rolling type)
  - Strangulation
  - Gastric perforation
  - Gangrene
    Investigations
- CXR: gastric bubble in retrocardiac area
- CT thorax with oral contrast: diagnostic
- OGD: upward displacement of Z-line (fig.) – Hill classification

[Image Description: Two X-ray images of a chest, side by side. In the left image, the lungs and heart are visible in grayscale. In the right image, the same anatomy is present, but the esophagus is highlighted in blue and the stomach is highlighted in green, showing their position in relation to the diaphragm.]

[Image Description: Four sets of three images. The first image in each set shows the type of hiatal hernia (Type I to Type IV). The second image is an endoscopic view of the lower esophagus with a hiatal hernia. The third image in each set is a schematic illustration of the hernia.]

Management

- Conservative: indicated if sliding hernia (Type 1)
  - Weight loss, smoking cessation, reduce alcohol intake
  - Treat GERD: PPI
- Surgical (hernia repair + Nissen fundoplication): indicated in
  - Symptomatic despite max medical treatment
  - Rolling type: Increased risk of gastric volvulus

Oesophageal varices
Refer to [MED]

Esophageal perforation
Clinical features

- Cervical: neck pain, surgical emphysema, dysphagia, odynophagia
- Thoracic: retrosternal chest pain, SOB, cyanosis
- Abdominal: acute abdomen
  Causes
- Iatrogenic (MC): therapeutic OGD, transesophageal echocardiogram (TEE), NG tube insertion
- Foreign body (e.g. fish bone, corrosives)
- Boerhaave's syndrome (violent vomiting) → Barotrauma
- Penetrating injuries
  Investigations
- Erect CXR: surgical emphysema
- CT with contrast swallow: localize site of esophageal defect
  Treatment
- Conservative - Cameron's criteria
  - NPO, IV fluids, broad spectrum antibiotics
  - Nutritional support (TPN, feeding jejunostomy, NJ tube)
  - Drainage
- Surgical:
  - Early presentation within 4-6h: direct repair
  - Late presentation: external fistula (T-tube), Endo-vac therapy, esophagectomy +/- delayed reconstruction
    - May require flaps: e.g. intercostal, latissimus dorsi, diaphragm

[Image Description: Illustration depicting surgical management of esophageal perforation. The drawing shows a section of the esophagus with a surgical drain inserted through a perforation, positioned within the mediastinum. Adjacent anatomical structures such as the trachea and surrounding tissues are also visible.]

[Image Description: Coronal CT image showing iatrogenic pharyngeal perforation.]

Cameron's criteria

- Minimal S/S: low-grade fever, leucocytosis, mild pain controllable by opioids
- Absence of shock / sepsis
- Contained leakage within neck / mediastinum with good drainage into esophagus
- Absence of distal obstruction and malignancy

Mallory-Weiss syndrome and Boerhaave's syndrome

|                   | Mallory-Weiss syndrome                                                                                                                                                                                       | Boerhaave's syndrome                                                                                                                                                                                                     |
| :---------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Definition        | Longitudinal mucosal (superficial) tears of distal oesophagus                                                                                                                                                | Full-thickness rupture of oesophagus (MC at left posterolateral aspect of distal esophagus)                                                                                                                              |
| Pathogenesis      | Excessive alcohol intake → severe retching                                                                                                                                                                   | - Failed relaxation of glottis when vomiting → Pressure goes down to lower esophagus - Oesophagus has no serosa → susceptible to perforation                                                                             |
| Risk factors      | Chronic alcoholism, chemotherapy, sudden increase in abdominal pressure                                                                                                                                      |                                                                                                                                                                                                                          |
| Clinical features | UGIB (Haematemesis +/- melena) classically after retching                                                                                                                                                    | - Mackler's triad: vomiting, excruciating chest pain, surgical emphysema - Left pneumothorax, left pleural effusion - Hamman's sign (mediastinal clicking sound synchronous with heartbeat due to mediastinal emphysema) |
| Investigations    | CXR: pneumomediastinum, pleural effusion, hemothorax CT with contrast                                                                                                                                        |                                                                                                                                                                                                                          |
| Management        | 90% bleeding stops spontaneously Resuscitation, NPO, IV fluids Active bleeding: OGD for adrenaline + clipping Failed endoscopic Tx: on-table endoscopy + surgery (longitudinal gastrotomy and locate defect) | Resuscitation, NPO, IV fluids NG decompression IV broad-spectrum antibiotics Urgent OT for decontamination + repair                                                                                                      |

# Zenker's diverticulum

Anatomy: Killian's dehiscence

- At the midline of the posterior wall of pharynx between the 2 parts of inf. constrictor (thyropharyngeus and cricopharyngeus)
  Pathogenesis
- Hypertonic cricopharyngeus
- High intrabolus pressure during swallowing
  Clinical features
- Dysphagia, with gurgling in throat, food regurgitation into mouth
- Foul breath
- Aspiration
- Risk of malignant transformation
  Diagnosis: barium swallow
  Management:
- Observe: if small & asymptomatic
- Surgical: open/ endoscopic cricopharyngeal myotomy + diverticulectomy

[Illustration of Killian's Dehiscence. The illustration shows the anatomy of the throat, specifically the area of Killian's dehiscence, a potential weak spot in the muscular wall where Zenker's diverticulum can develop. Key anatomical structures are labeled, including the thyropharyngeus and cricopharyngeus muscles, which form the inferior constrictor of the pharynx. A triangular area indicating Killian's dehiscence is highlighted between these muscles. Additional labels identify the inner circular fibers and outer longitudinal fibers of the esophagus, providing context to the location of the dehiscence relative to the esophagus.]

# Corrosive esophagitis

Type of agent

- Alkali: more likely to be ingested in large volume, cause liquefaction necrosis (_transmural damage_)
- Acid: cause coagulative necrosis with eschar formation (_limited penetration to deeper layers_), but more damage to stomach due to pooling in antrum due to pylorospasm
  Immediate management
- Drink water to dilute the agent
- OGD under GA
- NPO, IV fluids, antibiotics
- +/- tracheostomy to secure away
- +/- OGD balloon dilation of strictures

60 3. 5 CA esophagus
Epidemiology

- Common in male of 60-70, M:F = 3:1
- SCC most common in HK (90%) c.f. Western countries
- Prognosis poor: > 50% metastasis at presentation, 5-year survival is just 5-10%

| Risk factors                                                                                      | Squamous cell carcinoma (SCC)                                                                  | Adenocarcinoma (ADC)                |
| :------------------------------------------------------------------------------------------------ | :--------------------------------------------------------------------------------------------- | :---------------------------------- |
|                                                                                                   | Lifestyle: **smoking, alcohol, hot drink, nitrosamine**, betel nut, corrosive / caustic injury | GERD                                |
|                                                                                                   | **Oesophageal disorders:** achalasia, Plummer-Vinson syndrome^, long-standing esophagitis      | Barrett oesophagus                  |
|                                                                                                   | Genetics: tylosis^                                                                             |                                     |
| Site                                                                                              | Mostly in upper 2/3                                                                            | Mostly in lower 1/3                 |
| Morphology                                                                                        | Fungating > ulcerative > infiltrative                                                          |                                     |
| Tumor spread                                                                                      | Direct extension (e.g. tracheo-esophageal fistula)                                             |                                     |
|                                                                                                   | Vascular and lymphatics                                                                        |                                     |
| Management                                                                                        | More sensitive to chemoRT                                                                      | Less sensitive to chemoRT → surgery |
| Other possible pathology: neuroendocrine tumor, leiomyoma, GIST, lymphoma                         |                                                                                                |
| ^PVS: triad of post-cricoid dysphagia, IDA, oesophageal web; unknown pathophysiology              |                                                                                                |
| ^Tylosis: AD genetic disorder characterised by hyperkeratosis of palms & soles + oral leukoplakia |                                                                                                |

Clinical features

- **Painless progressive dysphagia (MC)**: ≥75% stenosis
- Odynophagia: usually due to extra-esophageal involvement
- UGIB: haematemesis, coffee ground vomiting, tarry stool, anemic symptoms
- Regurgitation/choking/ aspiration pneumonia: due to esophageal obstruction
- Signs suggestive of locally advanced disease:
  - Stridor / **hoarseness of voice**: vocal cord paralysis (usually left RLN palsy)
  - Horner's syndrome
  - Respiratory symptoms: tracheo-esophageal fistula
  - Hypercalcaemia: HHM - PTHrP (10%)
  - Distant metastasis: Virchow's node, liver (hepatomegaly + ascites), lung (hemoptysis, PE), bone

Investigations

- Diagnosis: **OGD + biopsy**: confirmatory _histological_ diagnosis and pre-op assessment
  - Proximal margin (distance from incisor)
  - Span of tumor
  - % involvement of luminal circumference
  - Whether scope can pass through
- Staging work-up: **EUS + PET-CT (neck + thorax + abdomen)**
  - **Endoscopic ultrasound (EUS)**: best for T & N staging → determine need of neoadjuvant chemoRT
    - T: Assess depth of wall invasion: important to distinguish T1a vs T1b (need open surgery)
    - N: EUS-guided FNAC of suspicious LN (hypoechoic, >1cm, spherical, homogenous)
    - Can also implant metallic markers for delineation of RT
  - **CT whole body with contrast**: for locoregional involvement (T3/4) and distant metastasis (M)
  - **PET-CT**: similar sensitivity as CT for distant metastasis (M)
    - Can also assess the metabolic activity after neoadjuvant chemoRT / detect recurrence
    - May pick up additional signals (e.g. reactive hilar LN due to smoking)
  - - USG neck
  - - Diagnostic laparoscopy: recommended for OGJ tumors (adenoCA) for hepatic / peritoneal seeding
  - - Bronchoscopy: for cervical / upper thoracic tumors to detect **tracheal invasion** → may require stenting before RT to prevent iatrogenic tracheo-esophageal fistula
- Others:
  - CBC, LRFT, clotting
  - Lung function (CXR, ABG, lung function test) for pre-op assessment
  - Laryngoscopy: baseline vocal cord status

Staging of CA esophagus

|      | Primary tumour (T)                                                                                 |
| :--- | :------------------------------------------------------------------------------------------------- |
| TX   | ➡ Primary tumour cannot be assessed                                                                |
| TO   | ➡ No evidence of primary tumour                                                                    |
| Tis  | ➡ High-grade dysplasia                                                                             |
| T1 a | ➡ Tumour invades lamina propria or muscularis mucosae                                              |
| T1 b | ➡ Tumour invades submucosa                                                                         |
| T2   | ➡ Tumour invades muscularis propria                                                                |
| T3   | ➡ Tumour invades adventitia                                                                        |
| T4   | ➡ Resectable tumour invading pleural, pericardium or diaphragm                                     |
|      | ➡ Unresectable tumour invading other adjacent structures such as aorta, trachea and vertebral body |

|     | Regional lymph node (N)                        |
| :-- | :--------------------------------------------- |
| NX  | ➡ Regional lymph node cannot be assessed       |
| NO  | ➡ No regional lymph node metastasis            |
| N1  | ➡ Metastasis in 1-2 regional lymph node        |
| N2  | ➡ Metastasis in 3-6 regional lymph nodes       |
| N3  | ➡ Metastasis in 7 or more regional lymph nodes |
|     | Distant metastasis (M)                         |
| MO  | ➡ No distant metastasis                        |
| M1  | ➡ Distant metastasis                           |
|     | Histological grade (G)                         |
| GX  | ➡ Grade cannot be assessed                     |
| G1  | ➡ Well-differentiated                          |
| G2  | ➡ Moderately differentiated                    |
| G3  | ➡ Poorly differentiated                        |
| G4  | ➡ Undifferentiated                             |

[Diagram illustrating the layers of the esophagus with cancerous growth. Key anatomical features are labeled, including: Epithelium, Basement membrane, Lamina propria, Muscularis mucosae, Submucosa, Muscularis propria, Periesophageal tissue, Aorta, and Pleura. Different stages of cancer invasion (Tis (HGD), T1, T2, T3, T4a, T4b) are shown, along with lymph node involvement (N0, N1 (1 or 2), N2 (3 to 6), N3 (7 or more)).]

61

Management:

- Tumor factor (staging): size and location of tumor, location of anastomosis, regional invasion, LN
  - Resectable: pleura, pericardium, diaphragm
  - Unresectable: aorta, trachea, vertebral body
- Patient factor: age, smoker, comorbidities, lung function (FEV1 > 1.5L), exercise tolerance (> 2 flight of stairs)
- Organ factor: method of reconstructing esophagus

| Stage | TNM staging      | Treatment                                                         |
| :---- | :--------------- | :---------------------------------------------------------------- |
| 0     | Tis, N0, M0      | Tis/T1a (confined to mucosa): EMR / ESD                           |
| 1     | T1, N0, M0       | T1b (invades submucosa): esophagectomy                            |
| 2     | T2-3, N0, M0     | Operable SCC: neoadjuvant chemoRT + esophagectomy                 |
|       | T1-2, N1, M0     | Inoperable SCC: upfront chemoRT +/- esophagectomy (if downstaged) |
| 3     | T3, any N, M0    | Operable ADC: esophagectomy                                       |
|       |                  | Inoperable ADC: chemoRT                                           |
| 4     | any T, any N, M1 | Esophageal balloon dilation +/- stenting                          |
|       |                  | Palliative chemoRT                                                |

Endoscopic therapy: Endoscopic mucosal resection (EMR) / Endoscopic submucosal dissection (ESD)

- Only for T1a cancers (limited to mucosa)
- Preserves esophagus, less invasive, safe and highly effective (90% survival)
  - ESD has higher en-bloc resection rate
- Procedure: using hyaluronic acid + saline to elevate the lesion → snare and remove

[Detailed illustration of EMR (left) and ESD (right) procedures. The left side shows the steps involved in EMR: 1. Careful marking around the tumor using endoscopic marking. 2. Inject saline solution underneath the affected area to raise it. 3. Cut along the markings using an insulated tip knife. 4. Remove the cancerous tissue. The right side illustrates ESD: 5. Snare advanced toward the lesion after submucosal dissection is precisely tuned so that only cancerous tissue is snared. 6. Snare ready to coagulate.]

Esophagectomy

- Ultra-major surgery: 1-3% mortality, 30-40% morbidity
- Only 1/3 tumour resectable at presentation: advanced stage at presentation + comorbidities
- Prerequisites:
  - Good pulmonary function (FEV1 > 1.5L) and good physiological function (ET > 2 FOS)
  - Stage 2 or 3 tumors
  - No invasion to trachea, aorta, RLN
  - No extra-regional LN
  - No distant metastasis
- Principles:
  - Complete resection (R0): Proximal and distal margins of 5cm, adventitial margins, radical
    lymphadenectomy (R1: microscopic residual disease, R2: macroscopic residual disease)
  - For OGJ tumour, partial gastrectomy may be required
  - Maintenance of GIT continuity: stomach transposition + pyloroplasty, colonic interposition, etc.
- Approach:

| Site of tumour |              Two-stage (Ivor-Lewis)              |    Three-stage (McKeown) - preferred for SCC     |
| -------------- | :----------------------------------------------: | :----------------------------------------------: |
| Incisions      |                    Mid/lower                     |             All (including proximal)             |
|                |                   2 incisions                    |                   3 incisions                    |
|                |        - Upper midline abdominal incision        |        - Upper midline abdominal incision        |
|                |     - **Right** thoracotomy (above 5th rib)      |             - **Right** thoracotomy              |
|                | [Image of a human torso with surgical incisions] |            - **Left** neck incisions             |
|                |                                                  | [Image of a human torso with surgical incisions] |

| Anastomosis |                                   Thorax                                    |                                              Neck                                               |
| ----------- | :-------------------------------------------------------------------------: | :---------------------------------------------------------------------------------------------: |
| Stages\*    |            1. **Abdominal**: gastric mobilization + pyloroplasty            |                    1. **Thoracic**: mobilization and dissection of esophagus                    |
|             | 2. **Thoracic**: mobilization and transection of esophagus, O-G anastomosis |                      2. **Abdominal**: gastric mobilization + pyloroplasty                      |
|             |                                                                             |        3. **Cervical**: mobilization and transection of upper esophagus, O-G anastomosis        |
| Pros        |                               Reduced OT time                               |    **Less severe consequence of anastomotic leak →** can control by lay-open cervical wound     |
|             |                       Lower risk of anastomotic leak                        |                                                                                                 |
| Cons        | Severe consequence of anastomotic leak: **mediastinitis → high mortality**  |                                 Higher risk of left RLN injury                                  |
|             |                       Not suitable for higher tumour                        | Higher risk of anastomotic leak (10%): gastric conduit has more tension and poorer blood supply |

- \*Details of procedure:
  - Gastric mobilisation
    - Ligate left-sided blood supply: short gastric a., left gastric a., left gastroepiploic a.
    - Bring gastric conduit up thorax via native tract of esophagus (lowest tension, best blood supply) or other routes if re-operate (e.g. retrosternal, subcutaneous)
  - Pyloroplasty: improve gastric emptying post-op
    - Insert feeding jejunostomy tube
    - Alternative: colonic interposition (e.g. prev. gastrectomy, post-leakage) - need bowel prep & ABx
  - Lymphadenectomy
    - Extent: 10cm proximal and 5cm distal to macroscopic tumor
    - 2-field dissection: Field 1 & 2 for upper 1/3, Field 2 & 3 for lower 1/3
- Other approaches of esophagectomy
  - Transhiatal esophagectomy: unsuitable for SCC, usually for palliation, rarely done now
    - Complete mediastinal lymphadenectomy is difficult → increased risk of recurrence
    - Advantages: reduced risk of pneumonia, suitable for poor lung function
  - Thoraco-abdominal approach: for very distal tumour (approach limited by arch of aorta → only for tumours below)
  - Pharyngo-laryngo-oesophagectomy (PLO): for very proximal tumour, rarely done
    - Require permanent tracheostomy and voice rehab → primary chemoRT is preferred now

Fields of LN dissection:

1. Cervical LN
2. Mediastinal LN
3. Intra-abdominal
   (celiac) LN

#

Neoadjuvant therapy (CROSS 2012 trial)

- Indication: locally advanced SCC-**T2N1, T3N0, T3N1**
- Regimen: 5-fluorouracil + cisplatin + 40 Gy RT
  - 6-8 weeks for 2 courses → wait 4 weeks and repeat PET-CT + OGD → wait 4 weeks for surgery
- S/E: RT-induced fibrosis, worsened dysphagia

Complications of esophagectomy
Early complications

- Post-op pneumonia (20%): due to smoker status, thoracotomy, one-lung ventilation, vocal cord palsy
- Reactional bleeding: transection of azygos vein / aortic branches to esophagus
- Conduit related:
  - Anastomotic leak (10%) – _DDx_: conduit ischemia
    - Risk factors: poor blood supply of oesophagus, tension of conduit, absence of serosa, use of neoadjuvant RT, surgeon technique
    - Management:
      - NPO, IV fluids, TPN, antibiotics, monitor drain output
      - Conservative: lay open for drainage (three-stage only)
      - Endoscopic: stenting, endoscopic vacuum therapy (e.g. EndoSpong)
  - Conduit ischaemia
    - Suspect if sepsis or metabolic acidosis within first 24h
    - Prevention: intra-op ICG
    - Investigations: CT thorax + abdomen with contrast, OGD
    - Management:
      - Conservative if mild (Types 1 / 2)
      - Take down anastomosis if severe (Type 3): cervical esophagostomy + resection of ischemic conduit
- Injury to neighbouring structures - RLN injury (20%) during LN dissection - Vagus nerve injury: delayed gastric emptying → routine pyloroplasty - Thoracic duct injury: chylothorax - Diagnosis: ↑drain output (milky appearance), TG >110 or chylomicrons in pleural fluid - Management - Monitor: clinical (SOB), CXR, drain output - Determine drain output: low volume (<1L/day) vs high volume (>1L/day) - Diet: NPO + ΤΡΝ - Octreotide - Re-operation (Suture ligation of thoracic duct stump) if output >1L/day - Other organs: descending aorta, pulmonary vein, trachea/bronchus, heart - GA complications: e.g. atelectasis – one lung ventilation during surgery
  Late complications
- Anastomotic stricture: require endoscopic dilation
- Post-op GERD: PPI, motility agents
- Biliary reflux
- Delayed gastric emptying

[Image of a black cylindrical sponge-like medical device, attached to a clear plastic tube. This is an EndoSponge. Below, there is a table with two columns and three rows. The first column is labeled "Type" and the second is labeled "Anatomy." The first row depicts a "Simple Anastomotic Leak" with an illustration of a tube inserted into a cavity. The second row shows "Conduit Tip Necrosis" with arrows pointing towards a narrowed part of the tube. The third row illustrates "Complete Conduit Ischaemia" with a completely blocked tube.]

Primary chemoRT

- Indication: inoperable SCC, not fit (e.g. poor lung function)
- Regimen: cisplatin + 5-fluorouracil + >50 Gy RT
  Palliative treatments
- Endoscopic stenting: SEMS with silicon coating to palliate significant dysphagia, unable to go RT after this
- Endoscopic local ablation (e.g. argon plasma coagulation, laser ablation): open esophageal lumen / unblock stent
- Nutritional support: NG tube / PEG tube / open gastrostomy / jejunostomy
- External radiotherapy / brachytherapy (intraluminal RT)

# 3.6 Benign diseases of stomach

Peptic ulcer disease
Refer to [MED-GI] for medical treatments
Modified Johnson's classification for GU
| Type | Location | Acid secretion |
|---|---|---|
| I | Gastric body / Lesser curvature (58%) | N / ↓ |
| II | Simultaneous gastric body + DU (22%) | ↑↑ |
| III | Prepyloric (20%) | ↑↑ |
| IV | High lesser curvature (rare) | ↓↓ |

Surgical management - Rarely required now

- Indications:
  - Uncomplicated ulcers refractory to medical treatment
  - Complicated ulcers - hemorrhage, perforation, GOO
  - Risk of malignancy: non-healing GU > 3months
  - Surgical options

| DU: Jacid   |                                                                                                |
| ----------- | ---------------------------------------------------------------------------------------------- |
|             | - Highly selective vagotomy: nerve of Latarjet preserved, but technically difficult            |
|             | - Truncal vagotomy + drainage (pyloroplasty / gastrojejunostomy): nerve of Latarjet sacrificed |
|             | - Gastrectomy (antrectomy / distal gastrectomy) + reconstruction (Billroth II > Roux-en-Y)     |
| GU: prevent | Type I: distal gastrectomy + Billroth II                                                       |
|             | Type II / III: truncal vagotomy + antrectomy + Billroth II                                     |
| malignancy  | Type IV: subtotal gastrectomy (extending to ulcer) + Billroth I / II / Roux-en-Y               |

PUD complication #1: hemorrhage
Clinical features

- DU: usually posterior wall → GDA involvement → coffee ground vomiting or melena
- Leading cause of death of peptic ulcer
  Management
- Resuscitation
- Endoscopy: adrenaline + heater probe / haemospray / clip
  - Limitation: massive bleeding obscuring view, large bleeding artery (>3.2mm)/ ulcer (>2cm)
- Surgical vs IR: indicated if failed endoscopic haemostasis, rebleeding failing re-scope, ongoing infusion
  - Surgical
    - DU: suture ligation of bleeding vessels → partial gastrectomy
    - GU: partial gastrectomy (risk of malignant ulcer)
  - IR: transcatheter arterial embolisation (TAE) - if unfit for surgery

PUD complication #2: perforation
MC site: anterior wall of D1
S/S:

- Sudden onset severe generalized abdominal pain (able to pinpoint exact onset time)
- +/- RLQ pain (Valentino's sign): GI contents track down right paracolic gutter
- Board-like rigidity with patient lying still
- Shock → fever (chemical peritonitis in first 4-6h → bacterial peritonitis after 6h)
  DDx: perforated appendicitis, acute cholecystitis, acute pancreatitis, MI
  Ix:
- Erect CXR: free gas under diaphragm in 60-70% cases (require sitting upright for 10min)
- CT thorax + abdomen with contrast: rule out other DDx
- CBC (Hb for GIB, WBC), LRFT, T&S, clotting, amylase (↑ due to pancreas irritation, more in acute pancr.)
- Do NOT attempt OGD: may convert sealed-off perforation to real perforation
  Mx:
- Resuscitation: NPO, IVF, NG tube decompression (may have co-existing GOO)
- IV broad-spectrum antibiotics e.g. Augmentin
- IV PPI / H2 blocker (suppress acid production)

[Image: Two diagrams illustrating ulcers associated with relatively high and low acid levels. Diagram A depicts a prepyloric, type III gastric ulcer in relation to the duodenum and gastric body. A duodenal ulcer is also present. Diagram B shows a high lesser curve, type IV gastric ulcer, as well as a gastric body, lesser curve, type I gastric ulcer.]

- Treatment options: HP eradication + surgery + peritoneal lavage (>6L NS) after repair
  - Small DU/GU (<2cm): lap/open (Graham) omental patch repair
    - Alternatives if omentum N/A: falciform lig., jejunal serosal patch
  - Large DU: distal gastrectomy + Billroth II reconstruction +/- controlled duodenostomy (esp. if difficult stump)
    - Billroth II preferred: less anastomoses than Roux-en-Y
    - Controlled duodenostomy: divert bile to consequence of duodenal stump leakage (but does not leakage rate)
  - Large GU: wedge excision / partial gastrectomy + Billroth II reconstruction
- Convert to open if:
  - Hemodynamically unstable: shorter operative time
  - Large defect (e.g. >1cm): difficult laparoscopic suture
  - Gross contamination: limited lap. peritoneal lavage
- Biopsy ulcer edge for ALL gastric ulcers to rule out malignancy

Prognosis: Boey's score (3 points)
Post-op Mx

- NPO until no signs of leakage and return of bowel function
- Complete full course of antibiotics
- Continue PPI until OGD
- FU: OGD 6-8 weeks after surgery for healing + HP status

[A drawing depicts a cross-section of the abdomen, focusing on the stomach and duodenum. The stomach leads into the duodenum, which is partially obscured by the omentum, a fatty tissue layer. A small perforation is indicated on the duodenal wall, where digestive contents leak out. Labels point to the stomach, duodenum, and omentum, highlighting the anatomical context of a perforated duodenal ulcer.]

| Risk factors                                                                      | Points |
| --------------------------------------------------------------------------------- | ------ |
| Time from perforation to admission >24 hours.                                     | 1      |
| Pre-op SBP <100 mmHg.                                                             | 1      |
| Any one or more systemic illness: heart disease, liver disease, renal disease, DM | 1      |
| Mortality : Score 0 = 0%, 1 = 10%, 2 = 45.5%, 3 = 100%                            |        |

Gastric outlet obstruction
Definition: clinical syndrome characterised by epigastric pain & post-prandial vomiting due to mechanical obstruction
Etiology: malignant until proven otherwise
| Benign (20%) | Malignant (80%) |
| --- | --- |
| - PUD-related pyloric stenosis (2nd MC) | - Gastric cancer (MC), lymphoma |
| - Gastric volvulus (e.g. rolling hiatal hernia) | - Extra-luminal compression: CA ampulla, CA head of pancreas, transverse colon / hepatic flexure, locally advanced cholangioCA / CA gallbladder |
| - SMA syndrome | |
| - Intraluminal obstruction: foreign body, bezoar, Bouveret syndrome (big gallstones in duodenum) | |
| - Chronic pancreatitis (inflammatory exudates from pancreas) | |
| - Gastric TB | |
| - Crohn's disease | |

Clinical features

- Waxing-and-waning epigastric pain
- Repeated non-bilious projectile vomiting of undigested food
- Early satiety
- Weight loss
- Signs: succussion splash

Initial work-up

- ABG & electrolytes - less pronounced in malignant GOO
  - HypoCl hypok metabolic alkalosis +/- paradoxical aciduria
    - Repeated vomiting of HCl
    - Paradoxical aciduria due to secondary hyperaldosteronism
    - Transcellular shift of H & K trying to compensate the hypok
  - HypoK: muscle weakness
  - HypoCa: tetany
- Erect AXR: hourglass stomach (enlarged gastric bubble, dilated proximal duodenum, lack of air in SB); calcified mass in RUQ (Bouveret syndrome), pancreatic calcifications (chronic pancreatitis)
- CT abdomen + pelvis with contrast: better for some malignancy (e.g. CA HoP)
- OGD + biopsy: rule out gastric malignancy (after ensuring adequate decompression)

[A flowchart illustrates the process of vomiting and its metabolic consequences. Starting with vomiting, the chart branches into "Loss of Gastric HCl," "Volume depletion," and "Loss of fluid rich in K+." The "Loss of Gastric HCl" branch leads to metabolic alkalosis and then to alkalosis induced hypokalemia. The "Volume depletion" branch leads to increased aldosterone and then to hypokalemia. The "Loss of fluid rich in K+" branch leads directly to hypokalemia. Finally, hypokalemia is linked to hypochloremia. The flowchart suggests a series of interconnected physiological responses and electrolyte imbalances resulting from vomiting.]

- +/- Water-soluble contrast meal
  Management
- Drip and suck: NPO, IV fluid (+K), NG / OG tube decompression
- IV PPI: to reduce gastric secretion
- Biopsy of pylorus to exclude malignancy
- Specific management:
  - Malignant GOO:
    - Curative intent: treat underlying CA
    - Palliative intent: surgical bypass (GJ) or endoscopic
      stent placement (SEMS - self-expandable metal stent)
  - Non-malignant GOO: depend on underlying cause, but in
    general include - Medical therapy e.g. PPI, triple therapy - Endoscopic balloon dilatation +/- duodenal stenting - Surgical: bypass (GJ), pyloroplasty + GD

Dieulafoy's lesion

- Gastric arterio-venous malformation (AVM)
  - Idiopathic dilated aberrant submucosal vessels eroding overlying normal mucosa
  - MC site: gastric fundus
  - Management: endoscopic therapy (e.g. sclerosant, endoscopic clip)

[Image Description: Four different diagrammatic illustrations of a stomach. Each of the illustrations is labeled with the letters a, b, c, and d. The letters a and b are in the upper half, while c and d are on the lower half of the image. Each of the stomach diagrams is in different positions. Black dotted lines are placed over the stomach in each diagram with written texts to clarify what they are illustrating.]

[Image Description: A photograph of a gastric dieulafoy's lesion. The image shows a bright red spot on the surface of the stomach lining, surrounded by slightly raised and irregular tissue.]

Gastric volvulus
Definition: abnormal rotation of stomach >180° → Closed loop obstruction +/- incarceration
or strangulation

- Usually 2º to diaphragmatic / hiatal hernia (rolling-type)
- Types: organo-axial (MC), mesentro-axial, combined

Clinical presentation: Borchardt's triad

- Severe epigastric pain
- Retching without vomiting
- Inability to pass NG tube below diaphragm

Investigations: erect CXR (retrocardiac gastric bubble), CT thorax + abdomen, water-
soluble contrast meal
Management

- NPO, NG decompression
- Diagnostic OGD if no signs of perforation: assess viability of stomach +/- endoscopic decompression /
  derotation (if viable)
- If strangulated / failed reduction:
  - Viable stomach: reduction + gastropexy +/- repair hiatal hernia
  - Ischemic stomach: wedge excision / gastrectomy

[Image Description: X-ray of a human chest. The image shows the rib cage, lungs, heart, and diaphragm. The lungs appear dark and filled with air, while the heart and diaphragm are more opaque.]

Gastroparesis
Definitions: delayed gastric emptying without mechanical obstruction
Aetiology

- DM neuropathy
- Drugs, e.g. CCB, DA agonist, GLP-1 agonist
- Post-op (e.g. gastrectomy, Whipple's)
- Scleroderma
  Clinical features
- N/V
- Abdominal pain
- Early satiety, post-prandial fullness
- Bloating
  66

Investigations

- Exclude mechanical obstruction: CXR/ AXR, CT abdomen, OGD
- Scintigraphic gastric emptying: low fat egg-white meal (fat slows gastric emptying)
- Investigations for underlying cause: HbA1c, ANA, etc

Management

- Dietary modification: low fat diet
- Optimise glycemic control
- Prokinetics, e.g. metoclopramide

Portal hypertensive gastropathy

- Common in liver cirrhosis
- Usually cause minor bleeds (if major bleed, consider variceal bleeding)
- Endoscopic appearance: gastric mucosa with mosaic snakeskin appearance
- Treatment: medical (beta blockers, octreotide, vasopressin) + endoscopic Tx

SMA syndrome
Also known as Wilkie syndrome / "cast syndrome"

- Decreased aorto-mesenteric angle (<20°) compressing on D3,
  due to e.g. - Acute weight loss - Prolonged bedbound - Spinal disease, deformity, trauma (e.g. use of body cast in scoliosis)

Clinical features

- Abdominal distension, early satiety, GOO
- Repeated bile stained vomiting
- Nutcracker syndrome: SMA compressing on left renal vein, causing haematuria & varicocele

[Diagram of the Superior Mesenteric Artery (SMA) and its relationship to the Duodenum and Aorta. Two images are presented, the first showing the relative position of the aorta, stomach, duodenum, ligament of treitz, and jejunum. Labels indicating the 1st portion, 2nd portion, and 3rd portion of duodenum are also shown. An arrow indicates the aorto-mesenteric angle. The second image is a magnified view of the aorto-mesenteric angle, showing the aorta, renal vein, superior mesenteric artery (SMA) and the 3rd portion of duodenum, along with a labelled line indicating the aorto-mesenteric angle.]

Investigations: exclude other causes of D3 obstruction (e.g. tumor, stricture)

- AXR / contrast meal: dilated stomach and duodenum
- OGD: slit-like lumen at D3, exclude intraluminal malignancy
- USG/ CT: decreased aorto-mesenteric angle

Management

- Conservative: NG tube for decompression + NJ tube (Entriflex) for feeding
- Surgery (if failed > 3mo of conservative): enteric bypass - DJ (1st line) or GJ (2nd line)
- “Strong procedure” (obsolete): relieve ligament of Treitz → DJ flexure moves to right and no longer under SMA

67

3.7 CA stomach
Gastric polyps
Approach to gastric polyps

- Polypectomy indicated if: known **neoplastic** polyps / polyps ≥ 1cm in diameter
- Multiple polyps: excise the largest polyp, obtain biopsies from other polyps
- Sample normal-looking mucosa to rule out dysplasia (total 7-12, e.g. 4-quadrant Bx from antrum)

| Pathology                                                                     | Management                                  |
| :---------------------------------------------------------------------------- | :------------------------------------------ |
| **Non-neoplastic** (90%) Hyperplastic polyp (MC): a/w H.pylori                | Resect if >0.5cm                            |
|                                                                               | Treat H. pylori if +ve                      |
|                                                                               | FU OGD at 3-6 months to confirm eradication |
| - Have malignant potential (correlate with size)                              |                                             |
| Fundic gland polyp: a/w PPI use and hypergastrinemia, syndromes e.g. FAP, MAP | Resect if ≥1cm / located in antrum          |
| - 100% benign, may regress after stop PPI                                     | Consider colonoscopy if ≥20 polyps          |
| Inflammatory polyp                                                            |                                             |
| **Neoplastic** (10%) Adenomatous polyp: usually in antrum                     | Resect **ALL** adenomas                     |
| - 4 types: intestinal, foveolar, pyloric gland, oxyntic                       | Examine for synchronous CA                  |
|                                                                               | FU OGD                                      |

Gastric cancer
Epidemiology

- Incidence: ↓ trend (6th incidence, 4th mortality), but ↑ in Asia (Japan: diet-related)
- Cell type: adenocarcinoma (90%) > lymphoma (5%) > GIST, metastasis
- Site: distal stomach (antrum / pylorus) > cardia (↑ trend) > OGJ

Risk factors

- Compensatory epithelial cell proliferation:
  - H. pylori: → chronic atrophic gastritis → intestinal metaplasia → body/distal CA (intestinal type)
  - Chronic gastric reflux (e.g. Barrett's esophagus): proximal CA
  - Hx of gastric resection: bile reflux (e.g. Billroth II)
  - Chronic atrophic gastritis: a/w pernicious anemia and Menetrier's disease
- Environmental factors: smoking, smoked / pickled food, nitrosamines, alcohol
- Host factors: hereditary diffuse gastric carcinoma (HDGC: E-cadherin mutation), HNPCC, FAP, P-J syndrome

Classification of CA stomach

- Histological (Lauren classification)

| Intestinal type - well-differentiated, better Px | Diffuse type - undifferentiated, poorer Px         |
| :----------------------------------------------- | :------------------------------------------------- |
| Risk factors as above, except FHx and HDGC       | Risk factors: HDGC                                 |
| HER2 +ve in 15%                                  | HER2 -ve, signet ring cell +ve                     |
| Hematogenous spread                              | Transmural (linitis plastica) and lymphatic spread |
| Elderly male, distal stomach                     | Young female, proximal stomach                     |

- Endoscopic (Borrmann classification) - _no implication in staging_
  - Type 1: polypoid - uncommon
  - Type 2: fungating
  - Type 3: ulcerated - common - dyspepsia as the MC presentation
  - Type 4: diffuse infiltrative (linitis plastica) - difficult to detect (OGD: difficult to inflate)
- By disease extent:
  - Early gastric cancer (EGC): confined to mucosa or submucosa (i.e. T1) - 5-year OS 95%
    - Further classified into elevated / depressed / combined based on OGD
  - Advanced gastric cancer (AGC): muscularis propria (i.e. ≥ T2) - 5-year OS 50%
  - Siewert's classification of OGJ adenocarcinoma\* (fig.)
    - Type I: distal esophagus (-5 to -1cm) - behave like CA oesophagus
    - Type II: true cardia (-1 to +2cm) - behave like CA oesophagus or CA stomach
    - Type III: subcardial (+2 to +5cm) - behave like CA stomach

[Image Description: A diagram showing the different tumor types in relation to the esophagus and stomach. The image illustrates three distinct regions: Adono-Ca of the distal esophagus, True-Ca cardia, and Subcardial Ca. Each region is labeled with an arrow pointing to the corresponding area on a simplified anatomical sketch of the lower esophagus and upper stomach. The diagram is designed to visually represent the location and extent of different types of tumors in the gastroesophageal junction.]

Clinical features

- Local: dyspepsia, early satiety, bloating, n/v, constitutional symptoms
- Complications: obstruction (dysphagia if proximal, GOO if distal), UGIB, perforation
- 4 routes of metastasis:
  - Local spread: pancreas, transverse colon, liver, duodenum
  - Lymphatic spread: peri-gastric / para-aortic nodes, Virchow's node, Sister Mary Joseph nodule (periumbilical node), Irish node (left axillary node)
  - Haematogenous spread via portal venous circulation: liver (hepatosplenomegaly, jaundice) → lung, bone and brain
  - Transcoelomic spread: ascites, ovaries (Krukenberg's tumors), pouch of Douglas (Blumer's shelf)
- Paraneoplastic for GI adenoCA (e.g. gastric, pancreatic):
  - Trousseau's sign of malignancy (migratory thrombophlebitis)
  - Leser-Trelat sign: seborrheic keratosis
  - Acanthosis nigricans

Staging of CA stomach

- T2: muscularis propria
- T3: subserosal connective tissues (e.g. gastrocolic / gastrohepatic lig., greater or lesser omentum)
- T4: serosa

Investigations

- Diagnostic: OGD + biopsy
  - Obtain tissue diagnosis and evaluate extent of primary tumor
  - Alternative: barium swallow (limited diagnostic value except for linitis plastica)
- Staging (TNM): most important prognostic factor is depth of tumor invasion
  - CT abdomen + pelvis +/- thorax with contrast (thorax if proximal tumor e.g. cardia)
    - Mandatory for M staging but not accurate for T & N
    - Alternative: PET-CT - not too sensitive for CA stomach
  - Endoscopic ultrasound (EUS): NOT mandatory for CA stomach (upfront surgery is advocated)
    - More sensitive in T staging (e.g. differentiating T4a vs T4b) & N staging (e.g. perigastric LN)
    - More operator-dependent and more invasive c.f. CT
  - Staging laparoscopy + peritoneal lavage (routine)
    - More accurate for peritoneal and liver metastasis c.f. CT
    - Direct visualization +/- biopsy of suspicious lesions for frozen section
    - Peritoneal washing for cytology to detect microscopic peritoneal metastasis
- CXR
- Tumor markers: CEA, CA125, CA19-9 - for monitoring recurrence and response to chemotherapy
- Pre-op bloods: CBC, LRFT, clotting

Management
Endoscopic treatment: potentially curative

- Indications: early gastric CA confined to mucosa (T1a) -diagnosed by endoscopic white light picture (not EUS!)
- Options:
  - EMR: only resect lesion < 2cm, by injecting fluid beneath mucosa raising the lesion followed by snare
  - ESD: can resect lesion >2cm, more complications (bleeding, perforation, stricture)
- Histology to determine margin (lateral & deep) - consider curative if clear, salvage gastrectomy if T1b+
- Endoscopic surveillance annually
  [Image of primary tumor (T) table, regional lymph node (N) table, distant metastasis (M) table, and staging system (clinical staging) table. The primary tumor (T) table lists TX as "Primary tumour cannot be assessed", T0 as "No evidence of primary tumour", Tis as "Carcinoma-in-situ: Intraepithelial tumour without invasion of lamina propria, high-grade dysplasia", T1 as "Tumour invades lamina propria, muscularis mucosae or submucosa", T1a as "Tumour invades lamina propria or muscularis mucosae", T1b as "Tumour invades submucosa", T2 as "Tumour invades muscularis propria", T3 as "Tumour penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures", T4 as "Tumour invades the serosa (visceral peritoneum) or adjacent structures", T4a as "Tumour invades the serosa (visceral peritoneum)", and T4b as "Tumour invades adjacent structures or organs". The regional lymph node (N) table lists NX as "Regional lymph node cannot be assessed", N0 as "No regional lymph node metastasis", N1 as "Metastasis in 1 - 2 regional lymph nodes", N2 as "Metastasis in 3 - 6 regional lymph nodes", N3 as "Metastasis in ≥ 7 regional lymph nodes", N3a as "Metastasis in 7 - 15 regional lymph nodes", and N3b as "Metastasis in ≥ 16 regional lymph nodes". The distant metastasis (M) table lists M0 as "No distant metastasis" and M1 as "Distant metastasis". The staging system (clinical staging) table correlates stage, T, N, and M. Stage 0 is Tis, N0, M0. Stage I is T1, N0, M0. Stage II A is T2, N0, M0 or T1, N1/N2/N3, M0. Stage II B is T3, N0, M0 or T2, N1/N2/N3, M0. Stage III is T3, N1/N2/N3, M0 or T4a, N0, M0. Stage IV A is T4a, N1/N2/N3, M0 or T4b, N0, M0 or Any T, Any N, M1. Stage IV B is Any T, Any N, M1.]

Gastrectomy
Refer to later pages for resectability

| Resection margin            | 5cm (proximal margin: may need lower esophagectomy; distal: down to D1/2) |
| --------------------------- | ------------------------------------------------------------------------- | ------------------------------------------------------ | ------------------- | -------------------------------------------------------------------------------- |
| Extent of gastric resection | Type                                                                      | Indications                                            | Transected arteries | Remarks                                                                          |
|                             | Partial                                                                   | Rare                                                   | RGA, RGEA           |                                                                                  |
|                             | Distal subtotal                                                           | Antral/Middle tumor 25cm from OGJ                      | + LGA, LGEA         | Better functional outcome GJ has lower risk of anastomotic leak (eso: no serosa) |
|                             | Total                                                                     | Proximal/Middle tumor <5cm from OGJ Diffuse-type tumor | + short gastric a.  | Better resection margins Roux-en-Y is only option of reconstruction              |

Early stage: lap / robotic
Advanced: open (esp if N+)

| Anastomosis (restore GI continuity) | Type                  | Remarks                                                                                                                                                                             |
| ----------------------------------- | --------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|                                     | Roux-en-Y (preferred) | EJ / GJ + end-to-side JJ + duodenal stump Roux limb should be at least 40cm Prevent bile reflux (GERD, remnant CA) Less dumping, no tension ERCP not possible, Roux stasis syndrome |
|                                     | Billroth I            | End-to-end GD Only possible if low tension (e.g. antrectomy) Seldom used in HK: High risk of bile reflux                                                                            |
|                                     | Billroth II           | End-to-side GJ + duodenal stump Suitable for emergency case: fast, low tension ERCP still possible Afferent loop syndrome                                                           |

[Image: This image shows two different types of subtotal gastrectomy. The first, on the left, is a subtotal gastrectomy with Billroth II anastomosis. The illustration depicts a stomach with a portion surgically removed, and the remaining part connected to the jejunum. The connection point shows a distinct surgical alteration where the stomach and intestine meet. Key anatomical features like the esophagus, stomach, duodenum, jejunum, and pancreas are labeled to provide context to the surgical site.The second, on the right, is a Total gastrectomy with Roux-en-Y. The illustration shows a complete removal of the stomach with the esophagus connected to the jejunum in a Y-shaped configuration. Key anatomical features like the esophagus, duodenum, jejunum, and pancreas are labeled to provide context to the surgical site. ]

| LN clearance (total 16 stations) | Current standard: D2 lymphadenectomy with at least 15 LN for accurate N staging |
| -------------------------------- | ------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------ |
|                                  | Type                                                                            | Nodes                                                                                                  |
|                                  | D1                                                                              | Perigastric (#1-6)                                                                                     |
|                                  | D2                                                                              | + along celiac axis and its branches (L gastric, common hepatic, splenic a.) and splenic hilum (#7-11) |
|                                  | D3                                                                              | + porta hepatis, paraaortic, etc.                                                                      |

[Image: This image shows two illustrations depicting the location and grouping of lymph nodes, crucial for surgical staging in cancer. The left illustration labels lymph node stations 1 to 11 around the stomach and nearby blood vessels. The right illustration labels lymph node stations 12 to 16 along major blood vessels in the abdomen. Each illustration is intended to guide surgeons in identifying and removing these nodes during surgery for accurate staging and treatment planning.]

- Young and fit patients with locally advanced cancer and small peritoneal metastases: consider salvage therapy – radical gastrectomy + peritonectomy + LND + hyperthermic intraperitoneal chemotherapy (HiPEC)

Post-gastrectomy complications

General

- Immediate: bleeding, injury to nearby organs (e.g. pancreas, duodenum)
- Early: wound infection, chest infection, post-op ileus
- Late: recurrence (usually at gastric bed)

Specific

Related to
anastomosis

- Anastomotic leak (OJ > GJ/JJ): Usually on post-op Day 7-10
  - Duodenal stump blowout, chyle leak, pancreatic fistula
  - Mx: NPO, IV fluids, broad-spectrum antibiotics +/- exploration and revision
    - Consider tube duodenostomy if duodenal stump leak
- Obstruction:
  - Intestinal obstruction: Fiber-rich food (冬菇), adhesion
  - Afferent loop syndrome: usually in Billroth II or Roux- en-Y (rare)
    - Emergency: closed loop obstruction → risk of duodenal stump blowout, obstructive jaundice, ascending cholangitis / pancreatitis
    - Acute S/S - severe epigastric pain, non-bilious vomiting, dLFT & amylase
    - Chronic S/S - postprandial pain, intermittent bilious vomiting
    - Usually due to excessive length of afferent loop
    - Dx: CT abdomen (dilated afferent loop)
    - Mx: revise GJ/ convert to Roux-en-Y (left fig.) / Braun's enteroenterostomy (right fig.)

[Image of four anatomical diagrams showing complications after gastric surgery. The first diagram shows kinking and angulation. The second shows an internal herniation behind the efferent limb. The third shows stenosis of the gastrojejunal anastomosis. The fourth shows a redundant twisted afferent limb, also known as volvulus.]

- Efferent loop syndrome: GOO
- Jejuno-gastric intussusception: GOO
- Internal hernia (via Petersen's defect, fig.)

[Image of an anatomical diagram showing adhesions involving both the afferent limb and the efferent limb.]

Related to
motility
("post-
gastrectomy
syndromes")

- Small stomach syndrome: early satiety
- Rapid transit: dumping syndrome (Loss of pylorus → Rapid gastric emptying of hyperosmolar carbohydrates → Draw fluid into intestine lumen and release vasoactive gut hormones)
  - Clinical features
    - Early (15-30min): abdo pain, n/v/d, vasomotor S/S (e.g. sweating, flushing)
    - Late (2-3h): post-prandial hyperinsulinaemic hypoglycaemia (PHH)
    - Management: small frequent meals, avoid simple carbs, octreotide
- Slow transit: Mx with prokinetics (e.g. metoclopramide, erythromycin)
  - Gastric stasis: impaired gastric emptying (post-op atony / vagal denervation)
  - Alkaline reflux gastritis
  - Roux stasis: bloating, n/v, heartburn, delayed regurgitation (ectopic pacemakers in Roux limb → net propulsive activity proximal towards stomach)

Nutritional
deficiency

- B12 deficiency anemia: ↓gastric acid & ↓intrinsic factor, Mx: IM B12 Q3months
- Iron & Ca deficiency: ↓gastric acid required to cleave iron from food and better absorption of Ca - anaemia (iron), osteoporosis (Ca)
- Fat-soluble vitamins (e.g. vit D): loss of duodenal continuity
- Steatorrhea

Non-surgical treatments in CA stomach

- Neoadjuvant chemotherapy: downstage the tumor to improve resectability rate
  - HK: Upfront surgery is preferred - only consider if T3+/ N+
  - Regimen: FLOT (fluorouracil + leucovorin (folinic acid) + oxaliplatin + docetaxel) / Xelox if less fit
- Adjuvant chemotherapy: eradicate micro-metastasis
  - Consider if T3+/ N+
  - Regimen: 5-fluorouracil (or: capecitabine) +/- oxaliplatin (i.e. Xelox) or TS-1

Palliative care

- Tumors considered unresectable if:
  - Distal metastasis (e.g. multiple liver metastasis, peritoneal nodules, pelvic deposits, Virchow's nodes)
  - Extensive nodal involvement (D3)
  - Invasion of major vessel, e.g. aorta, hepatic artery, coeliac axis, proximal splenic artery (not distal)
  - Distal splenic a.: borderline resectable with LUQ exenteration
- Principles: relieve pain, nutrition, bleeding, obstruction, perforation
- Supportive treatments: transfusion, PPI, Fe supplement
- Endoscopic treatments
  - Ethanol injection, adrenaline, clipping: for bleeding
  - Metallic stenting: bypass obstructing tumor, but risk of re-stenosis by tumour ingrowth
- Palliative surgery
  - Palliative resection: relieve bleeding / obstruction
  - Palliative bypass (gastrojejunostomy / gastroenterostomy): more durable than stenting, but possible impaired gastric emptying / bile reflux
- Palliative chemo +/- HER-2 inhibitor (if HER2 +ve) +/- ramucirumab (VEGFR2 antagonist)
- External beam radiotherapy (EBRT) for painful bone metastases

[Image: A drawing depicts the anatomy of the stomach and its connection to the small intestine. The stomach is shown as a large, pink, J-shaped organ. Key anatomical features are labeled, including the small gastric pouch syndrome at the top, followed by the stomach body leading into the duodenum. Pathological conditions are highlighted along the stomach and duodenum, such as a marginal ulcer, afferent loop syndrome, chronic gastroparesis, alkaline reflux gastritis, efferent loop obstruction, early dumping syndrome, duodenal stump leak and postvagotomy diarrhoea. These labels indicate potential sites of complications or disease within the gastrointestinal system.]

Gastric lymphoma

- 5% of gastric cancers
- Usually arise from mucosa-associated lymphoid tissues (MALT)
  - Low-grade: remain in stomach for long time before LN involvement
- Clinical features: similar to gastric adenoCA
- Investigations: OGD + biopsy, CT scan + bone marrow exam for staging
- Treatment:
  - H. pylori eradication: cause regression in 80% of cases
  - Localized disease - surgery
  - Systemic disease - chemotherapy

# Gastrointestinal stromal tumor (GIST)

Pathology: originate from muscularis propria (interstitial cells of
Cajal - GI pacemaker cells)

- Molecular pathogenesis:
  - Activating mutation in c-KIT gene causing
    overproduction of CD117 (95%),
  - PDGFRA mutation
- All GIST should be regarded as **potentially malignant**
- Occur throughout GI tract: 50% in stomach (MC proximal
  stomach) > SB > LB
- Metastasis: liver (MC), peritoneum
- Familial syndrome: Carney's syndrome\*, NF1

Clinical features: usually incidental finding on OGD / CT

- GI bleed (occult/ overt): ulceration of _overlying mucosa_
- Abdominal pain
- Abdominal mass

Types of GIT stromal (soft tissue) tumours

- **GIST (MC)**
  - Lipoma/ liposarcoma
  - Leiomyoma/ leiomyosarcoma
  - Desmoid tumour
  - Schwannoma/ peripheral nerve
    sheath tumour

Differential diagnosis of gastric mass

- Mucosa: adenocarcinoma,
  gastrinoma
- Submucosa: NET, lymphoma
- Muscularis propria: GIST,
  leiomyoma, desmoid tumour
- Adventitia

Investigations

- OGD: mass with smooth margins and normal overlying mucosa (endoscopic Bx typically cannot establish Dx)
- **Endoscopic ultrasound + fine needle aspiration (FNA)**
  - EUS: hypoechoic, homogenous lesions arising from 2nd-4th layer of Gl wall
  - Combined cytologic (histology: _spindle cells_) and IHC (CD117 + c-KIT mutation)
  - Not mandatory - indicated if:
    - Consider use of imatinib for unresectable / metastatic disease
    - Consider neoadjuvant imatinib for large GIST
    - GIST 1-2cm: obtain mitotic index risk stratification
- Percutaneous biopsy is NOT preferred: risk of tumour capsule rupture with peritoneal spread
- Staging: CT with contrast (MRI if at rectum or liver)

Management

- Surgical resection: negative margins are adequate
  - Indications: all GIST ≥ 2cm
  - Approach: segmental resection (regional lymphadenectomy not required - rarely metastasized to LN)
    - Explore abdomen during laparotomy to exclude liver / peritoneal metastases
    - Avoid perforating capsule: chemo may be needed
- **Tyrosine kinase inhibitor** (first line: **imatinib** → acquired resistance: sunitinib)
  - Adjuvant: in all high-risk cases e.g. perforated capsule
  - Neoadjuvant: 3-6 month therapy for locally advanced/ metastatic (liver or peritoneal mets) **potentially**
    resectable tumours (Įsize & vascularity of tumors → forgan preservation)
  - Palliative: first-line treatment for metastatic GIST

Malignant potential of GIST depends
on AFIP prognostic model:

- Location (SB most likely
  malignant)
- Size
- Mitotic index
- Tumor rupture

[Image Description: This is a table showing the risk of progressive disease based on tumor parameters like mitotic index and size. The table is divided into columns for mitotic index (<=5 per 50 hpf and >5 per 50 hpf), size (<=2 cm, >2 and <= 5 cm, >5 and <= 10 cm, > 10 cm), and risk of progressive disease in different locations (gastric, duodenum, small bowel, large bowel). The cells contain descriptors like Very low, Low, Moderate and High for the risk.]

\*Carney triad: GIST, pulmonary chondroma, extra-adrenal paraganglioma

[^1]: \*Carney triad: GIST, pulmonary chondroma, extra-adrenal paraganglioma

# 3.8 Bariatric surgery

Effect on metabolic syndrome: may achieve DM remission due to change in gut hormone levels (GLP-1)

- ABCD score: age, BMI, C-peptide, duration of DM
- Total score = 10; score > 6 predict DM remission after bariatric surgery

Indications for bariatric surgery in Asians: failed medical treatment +

- BMI ≥ 35
- BMI ≥30 with T2DM

C/I: reversible causes (e.g. endocrine), psychiatric disorders, active substance abuse, non-compliance to medical care

| Mechanism                                                                                                | Procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Early complications                                            | Late complications                                                           |
| -------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------- | ---------------------------------------------------------------------------- |
| Restriction: Cause early satiety Overeating → upper abdominal pain                                       | Gastric banding: cuff inflated via injections into port site located in subcutaneous tissues [Diagram illustrating Gastric banding. A band circles the upper stomach. A tube runs from the band to a port implanted under the skin.]                                                                                                                                                                                                                                                                                                    | Access port infection                                          | Band infection Tubing leak Erosion into stomach Weight regain                |
| Restriction +/- ?malabsorption (food enters distal jejunum without exposure to bile / pancreatic content | Roux-en-Y gastric bypass: Roux limb anastomosed to gastric remnant + pouch-jejunostomy (Alternative - mini-gastric bypass: loop GJ) [Diagram illustrating Roux-en-Y gastric bypass and Mini-Gastric Bypass. In Roux-en-Y, the stomach is divided, and the small intestine is connected to the smaller, upper stomach pouch. A loop of intestine is connected to the lower part of the stomach. In Mini-Gastric Bypass, the stomach is stapled to create a smaller pouch, and a loop of the small intestine is connected to this pouch.] | Anastomotic leak Intra-abdominal bleed                         | Internal hernia Malnutrition Anastomotic stricture Weight regain             |
| Malabsorption: alter digestion Overeating → excessive diarrhea and flatulence                            | Sleeve gastrectomy: preserve pyloric antrum [Diagram illustrating Sleeve gastrectomy. The stomach is surgically reduced to a narrow, sleeve-like structure, removing a large portion of the stomach.]                                                                                                                                                                                                                                                                                                                                   | Leak at angle of His (take long to heal) Intra-abdominal bleed | GERD (due to increased intra-gastric pressure & injury to LES) Weight regain |
| Malabsorption                                                                                            | Biliopancreatic diversion (BPD) +/- duodenal switch [Diagram illustrating Biliopancreatic diversion (BPD) and BPD with duodenal switch variant. In BPD, a large portion of the stomach is removed, and the small intestine is connected to the remaining stomach. In BPD with duodenal switch, a sleeve gastrectomy is performed, and the small intestine is rerouted to separate the flow of food and bile/pancreatic juices.]                                                                                                         | Anastomotic leak Intra-abdominal bleed                         | Malnutrition Weight regain                                                   |

Follow-up nutritional monitoring:

- After banding: CBC, RFT, HbA1c, FBG, lipids
- After bypass / sleeve gastrectomy: above + LFT, B12/folate, Fe profile, bone profile (CaPO4, vitD, PTH), Zn, Cu

# 4 Lower GI surgery

## 4.1 Anatomy

### Vasculature

Superior mesenteric artery

- First branch of SMA is inferior pancreatoduodenal artery (inferior PDA)
- Other branches: jejunal and ileal a., ileocolic a., right colic a., middle colic a.

Inferior mesenteric artery

- Main branches: left colic artery, sigmoid arteries, superior rectal artery

[Anatomical drawing comparing the arterial blood supply to the colon. On the left side, there is a representation of the superior mesenteric artery and its branches. Key anatomical features such as the "Middle colic artery," "Right colic artery," "Ileocolic arteries," and "Jejunal and Ileal arteries" are labeled. The right side of the image depicts the inferior mesenteric artery and its branches. Labels include "Left colic artery" and "Sigmoid arteries." These labels indicate the major vascular pathways supplying the colon. ]

Important collaterals between SMA and IMA

- Marginal artery of Drummond: contributed by right, middle and left colic a., supplying colon via vasa recta
- Meandering mesenteric artery of Moskowitz (arc of Riolan): inconstant communication

Large bowel vs small bowel

| Large bowel                                                          | Small bowel                      |
| -------------------------------------------------------------------- | -------------------------------- |
| Shorter (1.5m) & wider calibre                                       | Longer (6m) and narrower calibre |
| More part is fixed, e.g. ascending & descending colon                | More part is mobile              |
| Appendices epiploicae (fat tag, except caecum)                       | Valvulae conniventes             |
| Taenia coli (3 narrow bands of longitudinal muscles)                 | Villi                            |
| Haustra (folds in wall due to shorter taenia coli compared to colon) |                                  |

Important relations of LB - protect at surgery

- Caecum & ascending colon: right ureter, right gonadal vessels, duodenum (posterior)
- Descending colon: left ureter, left gonadal vessels, tail of pancreas (posterior)

The rectum

- Definitions:
  - Anatomical definition:
    - Upper border: at the level of sacral promontory - where taenia coli joins to form a continuous outer longitudinal muscle layer (+ lack of the 2 other features of LB)
    - Lower border: anorectal junction (defined by puborectalis)
  - Endoscopic definition: up to 15cm from anal verge
  - Peritoneal covering:
    - Upper 1/3: mobile, peritoneum covering anteriorly and laterally
    - Middle 1/3: peritoneum covers only anteriorly
    - Lowest 1/3: no peritoneum covering

[A detailed anatomical illustration of the rectum and surrounding structures. The illustration shows a sagittal section, providing a view from the side. Several key features are labeled with measurements indicating distances from the anal verge. "Upper rectum - 15 cm", "Middle rectum - 8 cm", "Distal rectum - 4 cm", and "Anal canal" are clearly marked. Additional labels point out the "Sigmoid colon" connecting to the upper rectum, as well as the "Dentate line" and "Anal verge" at the lower end of the anal canal. The illustration also depicts surrounding musculature and tissues, providing context to the anatomical relationships in this region.]

- AP flexures x2: dorsal bend (concavity of sacrum), ventral bend (puborectalis sling)
- **Lateral curvatures x3:** Upper and lower convex to right, middle convex to left
  - Lumen side: Houston's valves (semi-circular folds) - strongest is the middle one (aka Kohlrausch's valve)

- Fascial layer (**"Holy plane"**): barriers to malignant invasion, part of mesorectal fascia (implicated in TME) (fig.)
  - Denonvilliers' fascia: anterior to lower 1/3 of rectum
  - Waldeyer's fascia: posterior to lower 1/3 of rectum
- Vascular supply:
  - Superior rectal artery (**major** supply, from IMA) → superior rectal vein (to portal venous system)
  - Middle rectal artery (from IIA) → middle rectal vein (to systemic venous system)
  - Inferior rectal artery (from internal pudendal artery, in pudendal canal) → inferior rectal vein (to systemic venous system)
- Lymphatic drainage: Inferior mesenteric node, internal iliac nodes

Anal canal
[Anatomical drawing of the anal canal showcasing different parts like Rectum, Anal column, Anal sinus, Anal valve, Levator ani, Illiococcygeus, Puborectalis, Internal anal sphincter (smooth muscle), Pectinate line, Anocutaneous line ("white line"), Anal pecten, Anal aperture, Deep, Superficial, Subcutaneous, External anal sphincter (skeletal muscle).]

[Diagram showing the deposition of the puborectalis muscle, with a side view of the rectum and anus, showing how it maintains the anorectal angle.]

Extent: from anorectal ring (puborectalis) to anal verge

- Puborectalis: part of levator ani, helps maintain anorectal angle to be ~120°, important in continence
- Anorectal ring: fusion of puborectalis, highest part of IAS & deep EAS - palpable on PR exam
- Internal anal sphincter: formed by thickening of involuntary circular smooth muscle, innervated by autonomic nervous system
- External anal sphincter: innervated by pudendal n. (somatic nervous system)
  - 3 parts: subcutaneous, superficial, deep (blend with puborectalis)

Internal structure
[Image of the internal structure of anal canal. The image depicts the anal valve, anal column and pectinate line.]

- Anal valves: contain anal sinuses that secrete mucus
- Dentate line (pectinate line): divide anal canal into upper 2/3 and lower 1/3

|                      | Above dentate line (Upper 2/3)                                                             | Below dentate line (Lower 1/3)                                                           |
| :------------------- | :----------------------------------------------------------------------------------------- | :--------------------------------------------------------------------------------------- |
| Embryological origin | Endoderm (hindgut)                                                                         | Ectoderm                                                                                 |
| Epithelium           | Columnar epithelium                                                                        | Stratified squamous epithelium                                                           |
| Arterial supply      | Superior rectal artery (← inferior mesenteric) Anastomosing branches from middle rectal a. | Inferior rectal artery (← internal pudendal) Anastomosing branches from middle rectal a. |
| Nerve                | Visceral innervation (inf. hypogastric plexus)                                             | Somatic innervation (inf. rectal n. ← pudendal n.), sensitive to pain                    |
| Lymphatics           | Internal iliac and inf. mesenteric nodes                                                   | Superficial inguinal nodes                                                               |

[An illustration of the blood vessels supplying the rectum. The illustration displays Inferior mesenteric artery, Middle iliac artery, Superior rectal artery, Middle rectal artery, Inferior rectal artery, and Levator ani muscle.]

4.2 LGIB
Definition: bleeding distal to ligament of Treitz

History taking

- Bleeding: nature (PR bleed vs melena), frequency, amount, colour
- Severity: anemic symptoms (SOB, palpitation, tremor, fatigue, dizziness / LOC)
- Relationship of blood with stool
  Ο Melena: UGIT
  Ο Mixed with stool: LGIT proximal to sigmoid colon
  Ο Separate from stool: outlet-type bleeding
  - Immediately after stool: anorectal
  - Blood on its own: diverticular disease, angiodysplasia, IBD, bleeding CA
  - Cyclic manner: GI endometriosis
- Stool: bowel habits, stool calibre, mucus

DDx

|                                         | Features for history taking                                                                                                                                                                                                                                |
| :-------------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Colorectal carcinoma (CRC)**          | Constitutional symptoms, change in bowel habits (e.g. alternating diarrhea and constipation), **change in stool calibre, tenesmus, IO symptoms**, metastatic symptoms (e.g. jaundice, SOB, bone pain), **FHx**, previous colonoscopy / FOBT, diet, smoking |
| **Diverticular disease 憩室病**         | Painless profuse hematochezia                                                                                                                                                                                                                              |
| **Hemorrhoids**                         | Fresh outlet-type bleed, **perianal mass / pain**, constipation, risk factors (e.g. pregnancy)                                                                                                                                                             |
| **IBD**                                 | Joint, liver, eye, skin manifestations                                                                                                                                                                                                                     |
| **Ischemic colitis**                    | CVS risk factors, thromboembolic risk factors (e.g. OCP), previous AMI / stroke / DVT                                                                                                                                                                      |
| **Infective colitis**                   | Fever, night sweats, chills/rigors, recent antibiotic usage (C. diff), TB exposure, TOCC                                                                                                                                                                   |
| **Anal fissure**                        | Hx of constipation, sharp pain a/w start of defaecation                                                                                                                                                                                                    |
| **Angiodysplasia 血管異常增生**         | Usually just anemic symptoms, a/w vascular malformations and aortic stenosis                                                                                                                                                                               |
| **Coagulopathy**                        | FHx, DHx (anticoagulants, antiplatelets)                                                                                                                                                                                                                   |
| **UGIB**\* (e.g. PUD, Dieulafoy lesion) | Melena, coffee ground vomiting, hematemesis                                                                                                                                                                                                                |
| **Procedural-related**                  | Hx of recent anastomosis (esp. stapled), polypectomy, ESD, biopsy, etc.                                                                                                                                                                                    |

Other DDx: Meckel's diverticulum, other neoplasms (e.g. GIST, lymphoma), drug (NSAID enteropathy)
\*10-15% of severe hematochezia is from brisk UGIB.

Acute management of LGIB
[Image of a flowchart titled "Acute lower GI bleed". The flowchart shows a decision-making process for managing lower gastrointestinal bleeding (LGIB). It starts with assessing the patient's hemodynamic stability. If hemodynamically stable, the next step is a colonoscopy, considering sigmoidoscopy if less than 40 years old. This leads to "Source Identified" or "Source Not Identified" options. If the patient is hemodynamically unstable, the flowchart leads to "Concern for upper GI source" and "Upper GI source unlikely". The first leads to Upper Endoscopy, while the second leads to "Angiography, surgery consultation". Both "Source Identified" and "Source Not Identified" can lead to either "Bleeding (overt) persists" or "Bleeding stops". If bleeding persists, treatment is considered. If bleeding stops and a source is identified, treatment is considered. The flowchart includes notes about nuclear scans and angiography detecting bleeding at different rates, and suggests considering EGD or capsule endoscopy.]

- NPO, monitor vitals
- Resuscitate (ABC): Set up 2 large-bore IV access and give 2L IV NS full rate
- Stop all anticoagulants
- Physical examination: GCS, hydration status, abdominal exam (peritoneal signs), PR exam for blood +/- proctoscopy
- Immediate Ix: CBC, clotting, T&S, X-match, LRFT, lactate, ABG

Further investigations

- If outlet type bleeding: proctoscopy + rigid sigmoidoscopy, proceed to colonoscopy if causes not found
- If unstable haemodynamics: early surgery consultation, rule out upper GI bleed by OGD

Role of colonoscopy: Low diagnostic field in massive bleeding (poor visualization)

- Endoscopic hemostasis - Indication: stigmata of recent hemorrhage (active bleeding, non-bleeding vessel, adherent clot) - Options: - Epinephrine injection (1:10000) – not used alone - Thermal energy e.g. argon plasma coagulation (APC) - usually for angiodysplasia - Endoscopic clip / band ligation - usually for diverticular bleeding - Scope clipping device (Ovesco): can even treat GI perforation / leakage / fistula
  Options if inconclusive top & tail
- Active bleeding: mesenteric angiogram / CT angiogram
- Intermittent bleeding: common causes include angiodysplasia, Dieulafoy lesion
  - Double balloon enteroscopy (DBE): scope with 2 inflated balloons, advance into SB from mouth or anus
  - Wireless capsule endoscopy: C/I IO → do CT/ MR enterography beforehand
  - CT/ MR enterography
  - Enteroclysis: intubation of DJ flexure under fluoroscopy → injection of barium, methylcellulose and water (double contrast) → identify small bowel neoplasm
  - Meckel's scan (for young patients)
- Emergency laparotomy may be required for life-threatening bleeding: segmental bowel resection
  - Pre-op localization (e.g. OGD, colonoscopy) preferred
  - If N/A, consider on-table enteroscopy or repeat OGD/colonoscopy

| Approach      | CT angiogram                                                           | Mesenteric angiogram                                                                                                                        | Red cell scan                                                                  |
| ------------- | ---------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------ |
|               | CT abdomen + pelvis with contrast (arterial and portovenous phase)     | Femoral artery puncture → look for contrast extravasation (usually SMA)                                                                     | Technetium-99m labelled RBC remain circulation for 24 hours                    |
| Bleeding rate | 0.3-0.5 ml/min                                                         | 0.5-1 ml/min                                                                                                                                | ≥0.1 ml/min                                                                    |
| Role          | Diagnostic only For active bleed only                                  | Diagnostic + therapeutic: Embolisation - temporary vs permanent\* For active bleed only                                                     | Diagnostic only Suitable for both active and intermittent bleed                |
| Pros          | Widely available, minimally invasive, accurate anatomical localization | Specificity up to 100% with accurate anatomical localization                                                                                | More sensitive than angiogram Repeated scans within 24h for intermittent bleed |
| Cons          | NOT therapeutic Risk of contrast nephropathy                           | False negative: vasoconstriction after bleeding Risk of contrast nephropathy, femoral hematoma/dissection, bowel infarct after embolization | False localisation: overlapping of bowel, forward/backward peristalsis         |

\*Temporary (e.g. absorbable Gelatin sponge): useful in altered anatomy, but higher rebleeding rate
Permanent: coils (most effective, but need patient to form thrombi), particles (bleeding tumor, risk of bowel ischemia), liquid agents e.g. NBCA (good for coagulopathy, but risk of bowel ischemia)

Transfusion and blood products in acute LGIB

- Transfusion threshold: Hb < 7 if clinically stable, Hb <8-9 if massive bleeding or Hx of cardiovascular diseases
- Platelet: top up to 50
- INR: 1.5-2.5 (concomitant reversal agents during endoscopy), >2.5 (reversal agents before endoscopy)
  Management of anti-platelets and anti-coagulants
- Aspirin: stop if primary prophylaxis, continue if secondary prophylaxis (unless severe bleeding)
- DAPT: consult cardiology if recent ACS and coronary stent in-situ
- Warfarin / DOAC: stop +/- reversal

# 4.3 Intestinal obstruction

Description of IO

- Level: small bowel vs large bowel
- Mechanical vs functional
- Simple vs closed-loop
- Underlying cause
  Risk factors: History of hernia, abdominal malignancy, previous IO, previous surgery / RT, medications
  Pathophysiology
- Distal collapse: decompressed as luminal contents are emptied
- Proximal dilation:
  - Initially increased peristalsis overcomes obstruction
  - Soon exacerbated by gas accumulation (swallowed air + bacterial fermentation) + fluid accumulation (risk
    of dehydration and electrolyte imbalance)
- Ischaemia: compromised venous return due to dilated bowel → local mural distension and edema →
  compromised arterial supply → ischaemia, necrosis, perforation
- Dehydration & electrolyte imbalance in IO - Reduced oral intake - Vomiting - Defective intestinal absorption (oedematous wall) - Transudation of fluid into peritoneal cavity
  Aetiology
- Mechanical obstruction
  - Luminal: faecal impaction, gallstone (gallstone ileus), bezoar (trichobezoar, phytobezoar)
  - Intramural: tumour (20%) (lymphoma/GIST/adenoCA), strictures (e.g. diverticular diseases, ischemia,
    Crohn/s disease, post-RT), intussusception
  - Extramural: adhesion (60%) (prior surgery, TB, IBD, post-RT), incarcerated hernia (10%), volvulus,
- Functional obstruction - absence or inadequate peristalsis without mechanical obstruction
  - Paralytic ileus/ post-op ileus (hypoactive bowel sound): mainly SB involvement
  - Pseudo-obstruction: normal bowel sound
- Most common causes according to level:
  - SB (ABC): adhesion, bulge (hernia), cancer
  - LB: cancer, diverticular disease (structuring diverticulitis), volvulus

Cardinal features x4

- **Colicky abdominal pain**: more in SBO, suspect ischaemia if pain becomes constant
- **Vomiting**: profuse in SBO, feculent in late LBO (DDx: gastrocolic fistula)
- **Abdominal distension**: less obvious if high-intestinal obstruction
- **Constipation**: obstipation (+ absence of flatus) OR spurious diarrhoea (increased frequency, small volume)
- SBO vs LBO vs functional
  - Proximal obstruction: more pain & vomiting (bile-stained if high SB, brown if low SB)
  - Distal obstruction: more abdominal distension & constipation; vomiting late (faeculent)
  - Functional obstruction: less colicky pain

Complications

- Local: ischaemia, perforation, closed-loop obstruction
- Systemic: dehydration, electrolyte disturbance, aspiration pneumonia

Physical signs

- Focal tenderness, visible peristalsis, hyperactive bowel sound
- Hydration status: skin turgor, mucous membranes, UO
- Signs of impending strangulation: tachycardia, fever, WCC↑, acidosis, peritoneal signs
- Underlying causes: presence of scars / mass / cough impulse

Initial management

- Resuscitation: ABC
- NPO, O2, IV access, analgesics, anti-emetics
- **Drip and suck:**
  - NG tube / Salem sump tube (suck): free drainage + Q4h aspiration to decompress proximal bowel and reduce n/v
  - IVF rehydration + chart I/O (drip)
- Antibiotics: if suspect bowel perforation; IV ceftriaxone + metronidazole
- Monitor: vitals (temp, BP/P), abdominal tenderness, WBC, ABG

Investigations

- Bloods: CBC (infection), ABG/VBG (acidosis: ischaemia, alkalosis: vomiting), LRFT (↓K due to hypovolaemia and impaired absorption secondary to oedematous bowel wall), amylase, lactate +/- septic work-up
- **Erect CXR:** free gas, aspiration pneumonia, gastric distension, NG tube position
- **Erect and supine AXR**
  - Supine better identify transition point (erect AXR: number of air-fluid levels does not affect Mx)

| Size (3-6-9 rule) | Small bowel                                                                    | Large bowel                                                                             |
| ----------------- | ------------------------------------------------------------------------------ | --------------------------------------------------------------------------------------- |
| Site              | >3cm                                                                           | >6cm (colon), >9cm (caecum)                                                             |
| Appearance        | Central                                                                        | Peripheral                                                                              |
|                   | Valvulae conniventes ("stack of coins") pass across width of bowel, more loops | Haustrae not pass across whole width of bowel, fewer loops, may have feces / rectal gas |

- CT abdomen/pelvis with contrast after adequate fluid resuscitation + RFT:
  - Indications: virgin abdomen with IO, peritoneal signs, unstable vitals, non-resolving despite Tx
  - Compared to AXR: more sensitive
    - Identify transition point and severity of IO (partial / complete)
    - Underlying etiology e.g. apple-core lesion (CRC), target sign (intussusception)
    - Complications e.g. ischemic bowel (intramural gas / PV gas / bowel wall thickening and enhancement)
- SBO that does not improve after 3 days: water-soluble contrast (gastrografin) follow-through
  - Diagnostic: Adhesive IO unlikely to resolve if contrast does not reach colon by 4h → Book EOT!
  - Therapeutic: hyper-osmotic → reduce edema and promote peristalsis → need for surgery
  - Water-soluble enema for LBO: to differentiate mechanical vs functional
- Do NOT order colonoscopy /barium enema in acute settings: risk of perforation and chemical peritonitis

Management principles

- Conservative management: Monitor 72h
  - Signs of resolution: Passage of flatus / stool, decreased abdominal distension, reduced NG tube output, resolved AXR signs
- Urgent laparotomy indicated if:
  - Risk of ischaemia (e.g. closed-loop IO)
  - Risk of perforation (e.g. dilated caecum > 12cm)
  - Failed conservative treatment after 72h
- Surgical principle: Treat underlying cause + resection of non-viable bowels
- Anastomosis: Primary anastomosis (usually SB) or double-barrel ileostomy for observation

Specific management
| Small bowel | Adhesions | Conservative management 80% effective Ix: water-soluble contrast follow-through Adhesiolysis (if failed conservative > 72h): risk of subsequent adhesion |
| --------------- | -------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Strangulated hernia | | Inguinal exploration: look for viability (~6P: cold, pulsation, pallor, peristalsis) → hernia repair (if viable) or resection + stoma (if non-viable) Manual reduction should not be performed: - Recurrence likely |

[Image of a small number 80 in the top right corner of the page.]

- Risk of peritonitis due to ischaemic bowel
- Reduction "en masse" (mass reduced to just below fascia)

Intraluminal
obstruction
(bezoar, gallstone)

MC site: distal ileum / ileocecal valve
Laparotomy for:

- Milking down the object through IC valve into LB
- Enterotomy proximal to obstruction and remove object
- Mx gallstone ileus by cholecystectomy + fistula repair (refer to [HBP])

Large bowel CRC
(emergency if
competent IC
valve!)

Emergency surgery: if signs of ischemia / perforation
Choice depends on risk of anastomotic leak vs morbidity of externalising a
stoma

- 1-stage (only for very good risk patients): resection + primary
  anastomosis with on-table lavage
- 2-stage: most common
  - Resectable tumors: Hartmann's procedure (resection + end
    colostomy + close distal end as rectal stump → reversal of stoma)
  - Unresectable tumours: proximal diversion loop colostomy /
    ileostomy or double barrel stoma (Paul-Mikulicz)
- 3-stage (for rectal tumour, no longer performed): defunctioning loop
  colostomy → resection + anastomosis → reversal of stoma

Endoscopic stenting (SEMS): for left-sided tumour except very large or distal
rectal tumour (risk of tenesmus & pain)

- Must first do CT to r/o closed-loop obstruction (perforation → T4 tumor)
- Bridge to elective surgery: wait 2-4 weeks before surgical resection
  - Avoid EOT (better fluid/nutrition, bowel prep) - higher chance of
    successful anastomosis
  - Allow 1-staged procedure (no stoma)
  - Allow complete oncological staging
- Palliation

Diverticular
disease
Elective: 1-stage
Emergency: 2-stage (Hartmann)

Volvulus
Sigmoid volvulus: conservative decompression preferred

- Flexible sigmoidoscopy de-rotation with cautious insufflation
- Leave rectal tube in-situ x 24h for decompression → serial AXR
- Emergency laparotomy (e.g. Hartmann's operation) if complications
  (ischaemia, perforation) or repeated failed compression
- Elective sigmoidectomy: for young or elderly with recurrent volvulus
  Caecal volvulus: surgery preferred
- Right hemicolectomy
- Colonoscopic de-rotation +/- caecopexy (fixation of caecum to RIF) -
  high recurrence

Closed-loop IO

- Bowel obstructed at both proximal and distal points
- Obstruction inside closed loop → impaired blood flow → risk of necrosis and perforation
- S/S: absolute constipation + no vomiting
- Examples
  - Malignant stricture of colon + competent ileocecal valve (1/3 population)
  - Volvulus
  - Hernia
  - Afferent loop syndrome (post-Billroth II gastrectomy)

[Image of the number 81, likely indicating a page number.]

Paralytic ileus

- Lack of propulsive contractions of small bowel
- Most common cause: **post-operative ileus**
  - Bowel sounds should return to normal within 1-2 days (stomach), hours (SB), 3-5 days (colon)
  - Clinically significant if >72h post-op, no return of bowel sounds, no flatus, abd distension
  - Mx: drip and suck, oral gastrografin (hyperosmotic), other prokinetics (e.g. erythromycin, metoclopramide), pethidine (no effect on gut motility c.f. morphine)
- Other causes:
  - After peritonitis / sepsis
  - Reflex ileus: retroperitoneal irritation after hemorrhage / #spine / #rib
  - Metabolic / drug-induced

Pseudo-obstruction
Definition: S/S of mechanical obstruction (usually colon) in the absence of a mechanical cause
Classification

- Acute colonic pseudo-obstruction (Ogilvie's syndrome): diagnosis of exclusion
- Chronic colonic pseudo-obstruction (e.g. Hirschsprung disease, toxic megacolon)
  Aetiology: autonomic imbalance (↓parasympathetic /↑sympathetic) → aperistalsis
- Metabolic disturbance (DM, hypoK, hypothyroidism, uremia)
- Drugs, e.g. opioids, CCB
- Trauma, e.g. post-op
- Neurological diseases, e.g. Parkinson, MS
  Clinical features
- Features of IO: abdominal distension (but not much pain), n/v, constipation
- Differentiating signs from mechanical obstruction
  - Normal bowel sound
  - Dilated rectum in PR exam (c.f. distal collapse in mechanical IO)
    Investigations
- AXR (repeat daily): presence of gas in rectum
- Bloods: CBC, LRFT, TFT
- CT abdomen (r/o mechanical IO), water-soluble contrast enema, colonoscopy (both Dx and Tx)
  Management
- Supportive: first line up to 72h if no peritonism or extreme colonic dilatation (>12cm)
  - Decompression: drip & suck, rectal tube
  - Ambulation
  - Remove underlying cause: electrolyte disturbance, discontinue causative drugs
- Colonoscopic decompression: bowel prep not required (little propulsion, limit air insufflation to reduce risk of perforation)
- IV Neostigmine: S/E bradycardia (cardiac monitor + atropine), excessive salivation, vomiting
- Surgical decompression: cecostomy

  4.4 Stoma
  Definition: artificial opening in GI tract to divert faeces and flatus outside the abdomen to an external appliance

- Good stoma: good blood supply, no tension, correct site, adequate fascial and skin aperture

Choice of stoma site

- Done with standing, bending, sitting
- Avoid surgical scars, skin creases, bony prominences
- Within rectus abdominis but away from umbilicus: muscle
  support → lower risk of parastomal hernia
- Emergency setting: reverse McBurney's point (2/3 from ASIS to
  umbilicus)

Classification of stoma

- Ileostomy vs colostomy

|          | Ileostomy              | Colostomy         |
| :------- | :--------------------- | :---------------- |
| Site     | Right iliac fossa (MC) | Left iliac fossa  |
| Surface  | Spout                  | Flushed with skin |
| Contents | Watery and fluid       | Faeces            |

- End vs Loop vs Double-barrel
- Permanent vs temporary

General indications of stoma

1. Decompression: ileostomy / colostomy to bypass a distal obstructing
   lesion
2. Diversion / Defunctioning
   a. Ileostomy / colostomy: protect distal bowel anastomosis -
   e.g. low anastomoses (higher tension, poorer blood supply),
   pre-op chemo RT (poor wound healing), intra-op bowel leak
   b. Ileal conduit: urinary diversion after cystectomy
3. Exteriorisation: ileostomy / colostomy when anastomosis cannot be
   performed or permanent stoma (e.g. APR)
4. Feeding: gastrostomy / jejunostomy
5. Lavage: appendicostomy for patients with fecal incontinence

Indications based on type of stoma

|      | Ileostomy                                       | Colostomy                                                                  |
| :--- | :---------------------------------------------- | :------------------------------------------------------------------------- |
| Loop | Temporary:                                      | Temporary                                                                  |
|      | - Fecal diversion after LAR + TME               | - Decompression: IO (e.g. inoperable CA sigmoid / rectum)                  |
|      | - UC with ileal pouch-anal anastomosis (IPAA)   | - Fecal diversion: e.g. LAR + TME, diverticulitis with primary anastomosis |
|      | - Fistulas                                      | - Facilitate surgical treatment of high anal fistula                       |
|      |                                                 | - Rest distal bowel: acute Crohn's disease                                 |
| End  | Permanent:                                      | Permanent:                                                                 |
|      | - Pan-proctocolectomy (e.g. UC pancolitis, FAP) | - Abdominal-perineal resection\*                                           |
|      | - Subtotal colectomy with mucus fistula (e.g.   | Temporary:                                                                 |
|      | toxic megacolon)                                | - Hartmann's operation                                                     |

[Detailed diagram showing different types of stoma locations. The diagram is an irregular hexagon shape with rounded corners. The top left corner shows a circle labeled "Percutaneous endoscopic gastrostomy". To the right of this and slightly lower is a horizontal line with a circle at each end, labeled "Transverse loop colostomy" and "End colostomy". Further down and to the left is a circle labeled "Ileal conduit". To the right of this is a circle labeled "Ileostomy". At the bottom of the shape is a line labeled "Mucous fistula".]

Examination of stoma: Ask to remove stoma bag

- Site
- Content: formed feces / semi-formed liquid / urine / mucus
- No. of lumens: end / loop/ double barrel
- Size and shape
- Relation to skin: spout/ flushed with skin
- Mucosal lining: color, moisture
- Complications
- Cough impulse

Complete: abdominal exam, external genitalia for anus, DRE, digital exam for stoma patency, fluid status

\*End colostomy → Check perineum and scars - APR (absent anus, 4 lap ports) vs Hartmann (present anus, midline laparotomy)

83

84
Other types of stoma

- Double barrel colostomy: divide bowel separately - one opening outputs stool, the other is "mucus fistula"
- Ileal conduit: urinary diversion following cystectomy for CA bladder
  [Man with a medical bag on his stomach. The medical bag is transparent, so you can see the fluids inside the bag.]
  Ileostomy
- Usually in right iliac fossa (DDx: ileal conduit)
- Fashioning:
  - Bring out at least 5cm to form a spout - alkaline SB contents are erosive and can damage local skin
  - Opening on distal limb allows bowel prep before LB investigations and rectal washout for clearance
- Ileostomy output: takes up to 6-8 weeks to stabilize (around 200-700mL/day)
  - Post-op Day 1-3: usually 1.5-1.8L of bilious output before adaptation
  - Post-op Day 3-8: critical period of high-output stoma
    - Do NOT discharge patient if ileostomy output >1500mL/day
    - Classification: Early (<3 weeks post-op) vs Late (≥ 3 weeks post-op)
- Management of high-output stoma (Defined as stoma output >1L/day
  - Strict chart I/O and daily BW
  - NPO
  - Aggressive fluid and electrolyte replacement (e.g. IV NS 2-4L/day) +/- oral Mg
  - Identify and treat underlying cause
    - Medications: prokinetics (e.g. metoclopramide, erythromycin), metformin
    - Bacterial infection esp. _C. difficile_ enteritis / colitis
    - Inadequate absorptive surface e.g. short gut, post-RT, fistula
  - Monitor RFT: aim UO 0.5-1mL/kg/h and urine Na >20
  - Dietary modification: adequate oral fluids and electrolytes (despite high output), small meals at 2-3h intervals, avoid foods that quicken transit time (e.g. hyperosmolar food, lactose, high-fibre diet)
  - Anti-motility agents: e.g. loperamide (preferred - non-sedative & non-addictive), codeine phosphate
  - Anti-secretory drugs: PPI (e.g. omeprazole 40mg BD), somatostatin analogues (e.g. octreotide)
  - Mineralocorticoids: might reduce stoma output by enhancing Na reabsorption in ileum

[This image shows a flow chart for NPO for 48 hours to assess baseline output. Starting at the top with NPO, it then branches to greater than 1200 mL per day where Plan long term IVF or TPN is used, or less than 1200 mL per day where ORS for 48 hours is used. This then branches to greater than 1500 mL per day, where commence liquid feed is used, or less than 1500 mL per day where starts food and monitor output is used. Then there is a separate flowchart for sequential trial. The sequential trial is greater than 1500 mL per day. Sequential trial is PPI 80 mg/day, Loperamide 8 mg, 4-5 x per day, codeine 60 mg 4 x per day, octreotide, stop if its impact is less than 300 ml a day after 72 hours.]

[Image shows the anatomy of the large intestine and rectum. The sigmoid colon has diverticula or pouches. A straight object is shown below the intestines.]

Colostomy

- Creation of loop colostomy:
  - Held in place by stoma rod (fig.) → remove at Day 5-7
  - Usually transverse colostomy (RUQ) or sigmoid colostomy (LLQ) - but loop ileostomy is now preferred
- Closure of temporary colostomy: easier when stoma is mature (≥ 2 months)
  - Contrast study (proctogram) to rule out distal obstruction / anastomotic leakage
  - Closed by circumstomal incision

Complications of stoma
Early

1. Necrosis:

- Causes: blood supply, tension, inadequate fascial aperture
- Management:
  - full-thickness necrosis: revision
  - partial-thickness necrosis: conservative, watch out for stenosis

[Image of a stoma with dark black tissue surrounding the opening, indicating necrosis.]

2. Retraction: Stoma recedes 25mm below skin surface

- Causes: tension, obesity
- Management: revision if significant

[Image of retracted stoma. The stoma is a circular opening with pink tissue visible inside, but it is sunken below the surrounding skin level.]

3. Peristomal abscess
   Intermediate 1. Dermatitis

- Causes: effluent dermatitis (excoriation, usually in ileostomy), contact dermatitis (allergy to stoma appliance)
- Management:
  - Educate stoma care techniques
  - Change appliance
  - Protect skin with barriers (e.g. creams, powders)

[Image of a stoma surrounded by red, irritated skin, showing dermatitis. The stoma itself is pink and slightly raised, but the skin around it is inflamed.]

2. Granuloma

- Causes: repeated trauma at suture site (mucocutaneous junction)
- Management:
  - Rule out tumor recurrence by biopsy
  - Resize stoma bag aperture
  - Apply silver nitrate / surgical excision of granuloma

[Image of a stoma with small, raised bumps or nodules (granulomas) around the opening. The stoma appears red and inflamed, and the nodules are scattered around its perimeter.]

3. Stenosis

- Causes: scarring, inflammation (e.g. Crohn's disease)
- Management:
  - Mild: stool softener, stoma dilator
  - Severe: revision

[Image of a stoma with significant narrowing of the opening, indicating stenosis. The opening is small and constricted, with some surrounding redness or inflammation.]

4. Fistula: usually ileostomy, esp. Crohn's disease
5. High output (ileostomy) - refer above
   Late
6. Parastomal hernia

- Risk factors: end stoma, emergency surgery (esp. IO), multiple surgery, post-op complications
- Problems: faecal leak, difficulty in fitting stoma bag, risk of strangulation / obstruction
- Management:
  - Conservative: weight reduction, abdominal truss
  - Surgical repair: mesh repair (laparoscopic)

[Image of a parastomal hernia showing a bulge or protrusion of tissue around the stoma site. The stoma is visible, but there is a noticeable swelling or lump adjacent to it.]

2. Prolapse

- MC in loop transverse colostomy, swollen stoma is at risk of necrosis
- Management:
  - Conservative: larger stoma bag, baby oil to reduce friction
  - Surgical revision if symptomatic / impending gangrene

[Image of a prolapsed stoma, showing a significant portion of the intestine protruding out through the stoma opening. The prolapsed tissue is swollen and appears moist.]

3. Parastomal varix

- Associated with portal hypertension
- Management: hemostasis (e.g. direct ligation, sclerotherapy)

[Image of parastomal varices, showing prominent, dilated veins around the stoma. The veins appear as bluish or purplish lines close to the stoma opening.]

4. Lateral space herniation
   85

4.5 Diseases of small bowel
Small bowel tumour
Types

- Adenocarcinoma (MC)
- Neuroendocrine tumour (NET)
- Lymphoma
- Leiomyosarcoma
- GIST
- Metastasis
  Small bowel adenocarcinoma
  Genetic associations
  Syndrome Mode of inheritance Mutated/associated Relative Lifetime Polyps/pathway
  gene risk risk for
  (95%CI) SBA
  FAP [7.29] Autosomal dominant APC 330 (132- 3%-5% Adenoma-
  (AD) 681) carcinoma
  HNPCC/LS[13,14.29] AD MMR (MSH2, 291 (71- 1%-4% Adenoma-
  MSH6, MLHI 681) carcinoma
  PMS2)
  PJS[31.36.37] AD STK11 500 (220- 1.7%-13% Hamartoma,

1306. adenoma-Ca
      JPS[38.41] AD BMPRIA, SMAD4 Unknown Unknown Hamartoma,
      adenoma-Ca
      Crohn's disease Unknown (genome wide Unknown 30-60[44- 2.2% Dysplasia-
      studies have associated 49] (15- after/25 ут carcinoma
      140 loci) 609)
      Celiac disease Association with HLA- Unknown 60-80[61- <1% Adenoma-
      DQ2,HLA-DQ8 63] (7- carcinoma
1307.

FAP: Familial adenomatous polyposis; APC: Adenomatous polyposis coli; HNPCC: Hereditary nonpolyposis
colorectal cancer; MMR: Mismatch repair gene; LS: Lynch syndrome; PJS: Peutz-Jeghers syndrome; STK11: Serine
threonine kinase; JPS: Juvenile polyposis syndrome; BMPRIA: Bone morphogenetic protein receptor, type IA;
SMAD4: Mothers against decapentaplegic homolog; HLA: Human leukocyte antigen complex.

Carcinoid tumors

- Origin: APUD cells of neural crest origin (enterochromaffin cells / Kulchitsky cells)
- Presentations: abdominal pain, ileus, acute appendicitis, ischaemic bowel, carcinoid syndrome
- Site: GIT (3/4), lung (1/4)

| Site    | Carcinoid syndrome                | Metastasis      | Secretion     |
| ------- | --------------------------------- | --------------- | ------------- | ------------------------------------- |
| Foregut | Pancreas, stomach Bronchus / lung | Occur, atypical | Rare          | 5-hydroxytryptophan (5-HTP) Histamine |
| Midgut  | Jejunum, ileum (MC), appendix     | Frequent (70%)  | Almost always | Serotonin                             |
| Hindgut | Colon, rectum                     | Rare            | Rare          | Neither serotonin nor 5-HTP           |

Pathology

- Staging: TNM staging
- Grading: according to mitotic rate and Ki-67 index
- Functionality: most are non-functional (functional, e.g. gastrinoma)
  Investigations:
- Markers: chromogranin A, 5-HIAA
- Localisation: endoscopy, CT enteroclysis, whole body somatostatin receptor scintigraphy (SSRS)
  Management
- Gastric NET: endoscopic resection if type 1-2, gastrectomy with LN clearance if type 3
- SB NET: resect all extra-hepatic lesions + LN clearance, Tx hepatic lesions by chemo-embolization
- Appendiceal NET: appendectomy if < 2cm, appendectomy + right colectomy if >2cm
- Colonic NET (worst prognosis): partial colectomy + LN clearance

Carcinoid syndrome

- Most common in SB (jejunum & ileum)
- Pathophysiology:
  - Altered metabolism of tryptophan (--> serotonin --> 5-HIAA)
  - Other secretory products include histamine, kallikrein, etc
  - Mostly metabolised into inactive forms by liver, unless **liver metastasis** or tumour invasion into IVC bypassing portal circulation --> carcinoid syndrome
- Clinical features:
  - Episodic flushing, hypotension (histamine, substance P)
  - Diarrhoea (serotonin)
  - Bronchospasm (histamine)
  - Secondary restrictive cardiomyopathy (serotonin-induced fibrosis of right heart only due to lung as a filter; cause TIPS: Tricuspid Insufficiency, Pulmonary Stenosis)
- Investigations:
  - 24h urine 5-HIAA: only in those symptomatic; reflect tumour load
- Management: - **IV octreotide** (both symptomatic + improve survival) - Ondansetron (5-HT3 antagonist for diarrhoea)

  4.6 Benign diseases of large bowel
  Constipation
  DDx: IBS, drugs (e.g. CCB), hypothyroidism, hyperCa, hypoK, cord compression, IO

Acute appendicitis
Anatomy

- Base of appendix: McBurney's point (1/3 distance from ASIS to umbilicus)
- Constant position of base of appendix: confluence of 3 taeniae coli of caecum
  → appendix traced by gentle traction on taeniae coli during OT
- Position of appendix: MC is retrocecal but intraperitoneal (74%)
  - Affected by malrotation /non-rotation of cecum (e.g. in RUQ)
- In colonoscopy: posteromedial wall of cecum, around 2cm below IC valve
- Mesoappendix contains appendicular artery (← ileocolic a. SMA) and vein - "End-artery" - thrombosis causes necrosis of appendix (gangrenous appendicitis)
  [A drawing that shows the position of the appendix. It is a small, finger-like projection that extends from the cecum, which is the beginning of the large intestine. The appendix is located in the lower right abdomen. Labeled parts are: Prelleal 1%, Retrocecal 74%, Paracaecal 2%, Postleal 0.5%, Pelvic 21%, Subcaecal 1.5%]
  Overview
- Definition: inflammation of appendix, 2/3 due to occlusion of lumen, 1/3 non-occlusive
  - Obstruction of lumen → venous congestion → ischemia → gangrene / perforation → phlegmon / abscess / peritonitis
- Aetiology:
  - Faecolith: a hard-stony mass of faeces
  - Lymphoid hyperplasia in mesoappendix
  - Rare: tumour (CA caecum), intestinal parasite, foreign bodies
- Complications: transmural inflammation → localized area of sepsis
- Gangrenous appendicitis - Perforation - Walled off: form appendiceal abscess → obstruction - Not walled off: generalized peritonitis
  Clinical features
- Age group: MC 5-12y
- Classical course:
  - Periumbilical pain: crampy, intermittent, poorly localized, aggravated by moving/coughing
  - Low grade fever, vomiting, anorexia (c.f. n/v followed by pain in GE)
  - Pain migrating to RLQ after 12-24h: constant sharp well-localized pain
- Signs (need to know!)
  - Pointing sign: max tenderness at McBurney's point
  - Rovsing's sign (RLQ pain upon rebound pressure of LLQ)
  - Psoas sign (increased pain upon extending hip against resistance) - usually in retrocecal appendix
  - Obturator sign (increased pain upon internal rotation of hip with hip & knee flexed) - usually in pelvic appendix
- Signs of complications: high fever, RLQ mass, imaging shows abscess/ phlegmon (inflammatory mass)
  [An image of the abdomen. It depicts the psoas sign test. The patient is lying on their side, and the examiner is extending the patient's hip. This maneuver will cause pain in the right lower quadrant if the patient has appendicitis.]
  [An image of the abdomen. It depicts the obturator sign test. The patient is lying on their back, and the examiner is flexing the patient's hip and knee. The examiner is then internally rotating the hip, which will cause pain in the right lower quadrant if the patient has appendicitis.]
  [An image of the abdomen that illustrates the Rovsing's sign test. The examiner palpates in the left lower quadrant (LLQ) which elicits pain in the right lower quadrant (RLQ). The text "Pain elicited in RLQ suggestive of acute appendicitis" is below the picture.]

Differential diagnosis

- Caecum: diverticulitis, mesenteric adenitis, cecal /appendiceal tumors (e.g. lymphoma)
- Terminal ileum: Crohn's disease, Meckel's diverticulitis, TB, Yersinia ileitis
- PPU: epigastric pain → RLQ (Valentino's sign)
- Acute pancreatitis
- Urologic: testicular torsion, UTI, ureteric colic
- Gynaecological: "Mittelschmerz" pain (ovulation), ovarian cyst complications, PID, ruptured ectopic pregnancy

Investigations

- Bloods: CBC (leucocytosis) - ↑↑↑ may indicate gangrenous / perforated appendix, normal cannot r/o
- CRP, urine PT for women
- AXR: faecoliths (only 5% radio-opaque)
- Risk stratification: Alvarado score (fig.)
  | 7-10 | Strongly suggestive: consider surgery / further imaging |
  | --- | --- |
  | 5-6 | Equivocal: consider USG / contrast CT abdomen |
  | 0-4 | Not likely: consider other DDx |
- Imaging: - USG: low sensitivity, for pregnant women / children - CT abdomen + contrast: highest diagnostic accuracy - Findings: appendiceal diameter > 6mm, appendiceal wall thickening and hyperenhancement, periappendiceal fat stranding, appendicolith
  Management
- Resuscitation, NPO, IV fluids, analgesics
- **Prophylactic IV antibiotics**
  - Anaerobic coverage, e.g. IV ceftriaxone + metronidazole
  - Non-complicated: continue until 24h post-op
  - Complicated (e.g. abscess, phlegmon): continue 3-7d post-op
- **Laparoscopic appendicectomy (first line!)**
  | | Immediate surgery | Interval surgery (Oschner-Sherren regimen) |
  | :------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
  | Indications | - Present **within 72h** and fit for surgery | Present **>72h and stable** (walled-off appendix → resolve or become abscess → immediate OT is difficult due to adhesions) |
  | | - Complicated and **unstable** (consider open surgery) | |
  | Approach | - **Laparoscopic** is preferred: ↓infection risk, ↓post-op pain, ↓hospital stay | **IV antibiotics** (~90% success rate) +/- image-guided drainage of abscess Lap appendicetomy 6-8 weeks later **Colonoscopy if >40yo:** exclude CA |
  | | - **Open**: indicated if gross sepsis | |
- Positioning: supine +/- Trendelenburg and right side up (allow SB fall away from operative field)
- Incisions in open surgery:
  - Lanz (more popular): transverse incision 2cm below umbilicus, centred on mid-clavicular line
    - ☺ continues with Langer's line - more cosmetically pleasing with reduced scarring
  - Gridiron: perpendicular to line joining ASIS to umbilicus, at McBurney's point
  - Rutherford-Morrison: extend Gridiron obliquely upwards and laterally (for paracecal appendix)
- Risks (**need to know for consent!**)
  - Immediate: convert to open, normal appendix (still removed to avoid diagnostic confusion), malignancy requiring R hemicolectomy ± stoma, injury to surrounding organs, bleeding
  - Early: Wound infection (5-10%), intra-abdominal / pelvic abscess (spiking fever), post-op ileus
  - Late: Incisional hernia, adhesions, recurrent/ stump appendicitis

- **Conservative management** can be considered if uncomplicated (no perforation / abscess) and not fit for surgery
  - Bowel rest, IV ceftriaxone + metronidazole
  - Compared to surgery: shorter duration of disability, but risk of complications and recurrence
  - Recurrence rate: 30% in 3 months, 40% in 1 year, 50% in 3 years

Studies supportive conservative Mx of appendicitis:

- CODA (2020): 10-day antibiotics non-inferior to appendectomy, 30% chance of appendectomy in 90 days, increased risk if appendicoliths +ve
- APPAC I / II / III
- APPIC

[Image Description: A table titled "TABLE 72.2 The Alvarado (MANTRELS) score." The table has two columns: "Symptoms" and "Score." The symptoms listed and their corresponding scores are as follows: Migratory RIF pain (1), Anorexia (1), Nausea and vomiting (1), Tenderness (RIF) (2), Rebound tenderness (1), Elevated temperature (1), Leucocytosis (2), Shift to left (1). The total score at the bottom of the table is 10.]

[Image Description: Two illustrations depict incisions on a human abdomen. The image on the left shows a dashed line, labeled "Gridiron incision," extending horizontally from the right side of the body towards the center of the abdomen. Several small circles or dots are marked along the area to indicate the incision path. The image on the right shows a curved incision, labeled "Lanz incision", situated lower down on the abdomen, also on the right side, with similar dots indicating the incision path. These dots are distributed diagonally from the patient's left to right.]

90
Appendix specimen sent to pathology for assessment of neoplasms (1% chance)

- Carcinoids: appendicectomy if ≤2cm, R hemicolectomy if >2cm or involve cecum / LN
- Epithelial: classified into mucinous or non-mucinous
  Ο
  - Mucinous tumors have risk of perforation and seeding → **pseudomyxoma peritonei (PMP)**
    - Low risk: colonoscopy to exclude associated lesions + surveillance (e.g. CT A+P, tumor markers)
    - High risk: treat as PMP → cytoreductive surgery + heated intraperitoneal chemotherapy (HIPEC)
  - Adenocarcinoma: highly malignant, treated by R hemicolectomy +/- adjuvant chemo

**Volvulus**
Definition: twisting of bowel around its mesentery
Location

- Sigmoid volvulus (70%): elongated mesentery → more mobile
- Caecal volvulus (25%): caecum mostly retroperitoneal, but some intraperitoneal with mesentery
- Transverse colon (3%)
- Splenic flexure (2%)
  Risk factors
- Non-modifiable: aging (stretching of bowel), congenital (hypermobile caecum)
- Modifiable: - Bedbound - High-fibre diet (bulky stool), chronic constipation, laxative abuse - Pregnancy
  Contributed by
- Closed-loop IO: colicky abdominal pain, abdominal distension, vomiting
- Intestinal ischaemia: colicky pain becomes constant
  Investigations
- AXR: sigmoid vs caecal volvulus
  | Sigmoid | Caecal |
  | ----------- | ----------- |
  | Arise in pelvis/ LLQ | Arise in RLQ |
  | Ahaustral | Haustral |
  | 3 lines of sigmoid wall converging to site of obstruction | |
  | Dilated LB with **coffee bean sign** | Dilated SB |
  | Absent rectal gas | Absent rectal gas |

- Barium/ gastrografin enema: bird's beak sign (sigmoid)
- Endoscopy: sigmoidoscopy (sigmoid), colonoscopy (caecal)
- CT (only if AXR/ enema inconclusive): whirl sign (sigmoid, fig.)
  Management
- Initial: NPO, drip & suck, IV antibiotics
- Sigmoid volvulus
  - Endoscopic decompression +/- stenting
    - Flexible sigmoidoscopy de-rotation with cautious insufflation (_first line!_)
      - Successful reduction: sudden expulsion of gas and stool
      - Leave rectal tube in-situ for 24h for decompression → serial AXR to monitor
    - Urgent laparotomy for untwisting +/- sigmoidectomy if non-viable
      - Indication: failed endoscopic treatment, signs of _ischemic bowel_ (e.g. acidosis, T+G+R+), necrotic bowel noted at endoscopy
      - Sigmoidectomy → primary anastomosis + on-table lavage
      - **Emergency Hartmann's operation**: rectal stump + colostomy
      - Paul Mikulicz procedure: removal of volvulus + double barrel colostomy for future anastomosis
  - Elective sigmoidectomy: for young patients or elderly with **recurrent** volvulus (not in every elderly: high mortality) due to high risk of recurrence after endoscopic Tx
- Caecal volvulus: surgery is indicated - usually ischemic
  - Surgery: _right hemicolectomy_
  - Colonoscopic derotation +/- caecopexy (fixation of caecum to RIF) - high recurrence

[Image Description: A coronal view CT scan of an abdomen is displayed. The abdomen is largely distended with air. The descending colon and rectum appear decompressed.]

Ischemic bowel disease
Definition

- Ischaemic bowel/ **mesenteric ischemia:** vascular compromise of the bowel due to occlusion of mesenteric circulation (usually SMA) - further divided into **acute & chronic**
- Ischaemic colitis: vascular compromise of **large bowel** (usually IMA)

Aetiology of mesenteric ischemia

|         |                                           |                                                                                                                                                               |
| :------ | :---------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Acute   | Occlusive mesenteric ischaemia            | **Embolism (50%):** cardiac causes (e.g. _AF_, post-MI mural thrombus), abdominal/ thoracic aneurysm/dissection Lodged at more distal segment, less extensive |
|         |                                           | **Arterial thrombosis (15-25%)** e.g. abdominal trauma, mesenteric aneurysm/dissection Obstruct more proximal segment, more extensive                         |
|         |                                           | **Venous thrombosis (5%):** hypercoagulability, malignancy                                                                                                    |
|         | Non-occlusive mesenteric ischaemia (NOMI) | Generalized hypoperfusion / shock: mesenteric vasoconstriction to preserve supply to vital organs Causes: severe CVS disease, drugs (e.g. digoxin, diuretics) |
| Chronic |                                           | Atherosclerosis                                                                                                                                               |

Extrinsic causes of ischemic bowel: strangulating hernia, volvulus

Pathogenesis:

- Hypoxic injury phase: little damage
- Reperfusion injury phase: ↑ROS (↑O2 supply) + ↑inflammation (↑influx of leukocytes and complements)
- Watershed zones prone to damage: end of arterial supplies
  - Splenic flexure (**Griffith's point**): SMA & IMA
  - Rectosigmoid junction (**Sudeck's point**): sigmoid a. and superior rectal a.

Clinical features: Acute abdomen + metabolic acidosis = ischaemic bowel until proven otherwise

- Hyperactive phase: **generalised abdominal pain out of proportion to physical findings** (can be non-tender), **PR bleed / bloody diarrhea**, vomiting
  - Acute embolus: **severe sudden periumbilical pain** in old patient with _AF_
  - Acute thrombosis: patient with strong cardiovascular risk factors (e.g. HT/HL/DM) and PVD
  - Chronic ischemia: **postprandial pain (mesenteric angina) → fear of eating** (sitophobia), weight loss
- Paralytic phase: absent bowel sound
- Shock phase (fluid leaks through damaged bowel): hypotension, shock

Investigations

- Bloods: CBC (leucocytosis: non-specific), **lactate**, **ABG** (HAGMA), clotting (if suspect hypercoagulability), amylase, RFT
- AXR: can be normal
  - Dilated bowel loops (paralytic ileus)
  - **Thumbprinting sign** (submucosal oedema)
  - **Pneumatosis intestinalis / portal venous gas** (necrosis)
  - Bowel wall thickening
  - Pneumoperitoneum, Rigler's double wall sign (perforation)
- CT abdomen with contrast: sensitive for ischemic bowel and SMA occlusion, exclude other DDx
- CT angiogram (gold standard): sensitive for mesenteric ischemia and allow endovascular interventions
  - Arterial occlusion: lack of enhancement of arterial vasculature with timed IV contrast
  - Venous thrombosis: filling defects / absent flow during venous phase

[Radiographic images showing findings related to ischemic bowel disease. The left image demonstrates thumbprinting sign, which is a radiological sign characterized by the appearance of thickened bowel folds resembling thumbprints due to submucosal edema. The right image shows pneumatosis intestinalis, a condition where gas is present within the bowel wall, indicating necrosis.]

91

Management
Acute ischaemia

- Initial: resuscitation + analgesia + IV broad-spectrum antibiotics
- Systemic **anticoagulation**
- Unstable (with peritoneal signs): **urgent midline laparotomy (within 6h)** / diagnostic laparoscopy
  - Mesenteric revascularization: Palpate SMA to differentiate embolism vs thrombosis
    - Present proximal SMA pulse (embolism): open **surgical embolectomy** → surgical revascularization if unsuccessful
    - Absent SMA pulse (thrombosis): surgical revascularization (e.g. thromboendarterectomy, mesenteric bypass, retrograde stenting)
  - Resect non-viable bowels + stoma (do not attempt anastomosis)
  - High risk of short gut syndrome: diarrhoea, steatorrhea → dehydration, malabsorption, weight loss
- Stable (no peritoneal signs): **CT scan / angiography → thrombolysis** (if no C/I)
  - SMA occlusion: surgical / percutaneous revascularization
  - SMV thrombosis: anticoagulation + catheter-directed thrombolysis
  - NOMI: consider transarterial vasodilator infusion
- Post-op management:
  - ICU support
  - Nutrition: TPN
  - Second look laparotomy 24-48h after (if extent of bowel viability uncertain)
  - Stoma care: reverse if stable
  - Investigate and treat underlying cause, e.g. echocardiogram, anticoagulation

Assess viability of bowels:

- **pink serosa**
- **visible peristalsis**
- **mesenteric pulsation**
- **bleeding from marginal arteries**
- intra-op doppler USG
- fluorescein injection → Wood's lamp

[A black and white X-ray image. The image shows a section of the abdomen with several markings. A yellow arrow points to an area within the abdomen, and red arrows indicate other areas. Purple arrows point to the upper section of the abdomen. In the lower right corner, there's a smaller image labeled "Double wall sign". The image appears to be a medical scan, possibly for diagnostic purposes, highlighting key areas of interest.]

Chronic ischaemia

- Risk factor modification: smoking cessation, antihypertensive, statin, etc
- Endovascular: mesenteric angioplasty with stenting
- Surgical: endarterectomy, bypass

# Inflammatory bowel disease

See [MED] for clinical features, investigations and medical management
Indications of surgical management

- Emergency:
  - Fulminant colitis
  - Toxic megacolon: non-obstructive colonic dilatation with systemic toxicity
  - Impending perforation: thumb-printing sign (fig.)
  - Life-threatening haemorrhage
- Elective: - Luminal complications: SBO, abscess, enterocutaneous fistula - Perianal diseases: abscess, fistula, anorectal stricture - Malignancy: treatment (e.g. biopsy-proven adenoCA) or prophylaxis (e.g. dysplasia on surveillance Bx) - Refractory to medical treatment / complications (e.g. osteoporosis) - Debilitating EIM, except EIM independent of colitis activity - sacroiliitis, hepatobiliary complications
  Surgical principle: preservation of bowel length (should document residual SB length)

# Surgical procedures for UC

Emergency surgery: usually indicated in fulminant colitis / toxic megacolon to prevent perforation

- Total colectomy + temporary end ileostomy
- Rectum left in situ temporarily as Hartmann's pouch / brought out as mucous fistula
- Followed by completion proctectomy + ileo-pouch-anal anastomosis (IPAA) 6mo later
  Elective surgery:
- Normal sphincter function: **restorative proctocolectomy + ileo-pouch-anal anastomosis (IPAA)** - IPAA: in form of J pouch (fig., most common), S pouch or W pouch - Temporary loop ileostomy for diversion - Specific complications - Pelvic nerve damage: impotence - Pouch dysfunction: increased faecal frequency (mean = 6), urgency,
  incontinence; Mx observe - Pouchitis: pouch dysfunction + systemic illness; Mx metronidazole
- Poor sphincter function: **total proctocolectomy + permanent end ileostomy / Koch's continent ileostomy (K-pouch)**
  - Cons: permanent stoma
- Female who wants to maintain fertility: total colectomy + ileorectal anastomosis (IRA)
  - Pros: to avoid pelvic adhesions and thus infertility
  - Cons: risk of rectal disease

# Surgical procedures for CD

- Not curative
- Management strategy according to behaviour of disease: - Inflammatory disease (30%): medical, surgical resection - Fibrostenotic disease (50%): endoscopic dilatation, surgical
  (stricturoplasty or resection for SB, resection for LB) - Fistulising disease (20%): drainage, medical (combined anti-TNF + azathioprine), surgical resection
- Enterocutaneous fistula: abnormal communications between 2 epithelialised surfaces
  - Causes: FRIEND (Foreign body, radiation, inflammation/ infection, epithelialization, neoplasm, distal obstruction)
  - Management
    - Delineate anatomy of fistula: CT abdomen
    - Replace fluid & electrolytes, chart fistula output
    - Wound care, e.g. negative pressure wound therapy (NPWT) (fig.)
    - Bowel rest → drugs (loperamide, octreotide) → endoscopic/ surgical closure
- Perianal CD: Drain pus, lay open for simple fistula, Seton drain for complex fistula
  - Give biologics after drainage of pus to close fistula tract
  - If failed, consider surgery (defunctioning stoma ± proctectomy)

[Radiograph showing the abdomen and pelvis in the anteroposterior projection. There is evidence of several areas where the colon is dilated, indicating the presence of toxic megacolon. The white arrows are pointing to the transition point of the dilated colon]

[Drawing illustrating the creation of an ileal pouch-anal anastomosis (IPAA). The drawing shows the pouch in the pelvic region.]

[Illustration of a fistula with inflammation. Two separate images are displayed; one showing a stenosis, inflammation and fistula 50%, and the other illustrating inflammation 30%.]

[Close-up of an abdominal wound. It is a circular opening in the abdominal wall, covered with transparent film. ]

93

# Diverticular disease

Definitions

- Diverticulum: sac-like outpouchings of **all layers** from a hollow viscera (c.f. polyps)
- Diverticulosis (coli): presence of multiple **false** diverticula (mucosa and submucosa protrude through muscularis propria)
- Diverticular disease: **symptomatic** diverticulosis (e.g. bleeding, pain)
- Diverticulitis: inflammation of a diverticulum (e.g. infection)

Pathophysiology
[Image of a Diverticula diagram showing the Diverticula with labels such as: Antimesenteric taeniae, Blood vessel penetrating wall, Fecalith, Circular muscle, Mesenteric taenia and Mesocolon.]

- **Bowel weakening with aging + increased intraluminal pressure** (e.g. constipation): sigmoid has narrowest lumen → highest pressure due to Laplace's law
- Outpouching at the weakest point (colon only contains one layer of full thickness muscle → weakest where **vasa recta penetrate circular muscle**)
- Most common sites: **right-sided** in Asia, sigmoid in Western countries
- Rectum is **never** affected: outer smooth muscle encompasses full circumference of rectum
  Risk factors
- Age (rare before 30y)
- Low-fibre diet
- **Intraluminal pressure**, e.g. constipation, obesity
- Drugs: **NSAID**, steroid
- Connective tissue disease, e.g. Marfan's

Clinical features

- Asymptomatic diverticulosis (80%)
- Diverticular bleeding: **Painless** massive PR bleeding (rupture of vasa recta)
- Symptomatic uncomplicated diverticular disease (SUDD): **Colicky pain** relieved by defecation, CIBH
- Complications:
  - Diverticulitis: clinical triad of **lower abdominal pain (RLQ in Asia) + fever + leucocytosis**
    - Obstruction of diverticulum by faecalith → stasis and bacterial overgrowth → inflammation
  - Perforation: acute abdomen, generalised peritonitis
  - Abscess (e.g. peri-colic, psoas, liver): persistent fever / abdo pain despite ABx +/- tender mass on PR
  - Fistula formation: MC colovesical (recurrent dysuria, pneumaturia, faecaluria)
  - Intestinal obstruction: LBO due to fibrosis and stricture, SBO due to adhesion to inflamed bowel

Investigations

- CBC D/C, LRFT, amylase, urinalysis and culture
- AXR: dilated bowel
- CXR: free gas under diaphragm
- **CT abdomen + pelvis with contrast** - Diagnostic: bowel wall thickening - Assess complications: fistula, abscess (5cm as cut-off: likely resolve by antibiotics vs require intervention) - Aid treatment: guide percutaneous drainage of abscess - Prognostic: **Hinchey classification** (note NOT applicable in right-sided disease)
  | Stage | Presentations | Mortality (%) | Treatment |
  | --- | --- | --- | --- |
  | I | Localized pericolic abscess | 0 | IV antibiotics +/- drainage |
  | II | Distant abscess (retroperitoneal/pelvic) | 5 | IV antibiotics + drainage |
  | III | Generalised suppurative peritonitis (abscess ruptured, but bowel intact) | 25 | Hartmann's operation / One-stage resection |
  | IV | Faecal peritonitis (bowel wall perforation) | 50 | Hartmann's operation |

95

- Colonoscopy: only **after** resolution of acute episode (risk of perforation)
  - Definitive diagnosis (localisation) & rule out other DDx (e.g. CRC, IBD)
  - Assess complications: stenosis
  - Therapeutic: endoscopic haemostasis
- CT colonography with water-soluble rectal contrast: especially for colovesical fistula

Management
Diverticular disease

- 50% bleeding stop spontaneously
- Lifestyle modification: high-fibre diet, bulk laxative (e.g. methylcellulose), weight reduction
- Antispasmodics if colicky pain
- Avoid stimulant laxatives and NSAIDs
- Localisation of bleeding: colonoscopy → angiography → on-table lavage and colonoscopy → subtotal colectomy and ileostomy if the bleeding source still cannot be identified

Diverticulitis and complications

- Resuscitation if necessary
- Bowel rest: NPO + IV fluid
- IV broad spectrum antibiotics (cover GN & anaerobes)
- Percutaneous drainage of abscess (CT-guided)
- Surgical treatment:
  - Emergency surgery: indicated in perforation, obstruction, Hinchey stage III-IV diverticulitis, or failed conservative treatment
    - Hartmann's operation with on-table peritoneal lavage
      - One-stage resection (resection + primary anastomosis +/- defunctioning stoma): higher mortality due to excessive contamination/inflammation and high chance of anastomotic leak
      - Note: ensure adequate resection margin
        - Inadequate distal margin is the MC cause of recurrent diverticulitis after resection
  - Elective surgery: indicated in chronic complications (e.g. fistula, Hinchey stage I-II)
    - Colovesical fistula: resection of affected colon + omental pedicle between bowel and bladder to prevent recurrent fistulation + synchronous repair of bladder

Meckel diverticulum

- Definition: **true** congenital diverticulum bulging at the **anti-mesenteric aspect** of small intestine, due to incomplete obliteration of vitelline duct (connect midgut to yolk sac in early weeks of gestation)
- Most common congenital anomaly of GI tract
  Rule of 2s
- 2% of the population, in which 2% becomes symptomatic often by age of 2
- 2:1 male-to-female ratio
- 2 inches in length, found within 2 feet of the ileocaecal valve
- 2 types of ectopic tissue: gastric (60%), pancreatic (6%) or both
  Clinical features
- Haematochezia: **massive painless** maroon-coloured stool (due to acid secretion by the ectopic gastric mucosa)
- Abdominal pain (midgut): due to IO or inflammation (mimic appendicitis)
- Intestinal obstruction: due to
  - Recurrent intussusception: Meckel's diverticulum as the lead point
  - Volvulus
  - Littre's hernia: hernia containing Meckel's diverticulum
    Investigations
- Meckel's scan: Technetium-99m pertechnatate scan
  - Gastric mucosa actively secretes chloride into the intestinal lumen
  - Pertechnatate behaves like chloride ion → actively accumulated in the mucosa → secreted
  - Require pre-med with H2 blockers: inhibit excretion of isotope into bowel lumen
    [A series of six nuclear medicine scans are displayed horizontally, depicting the abdomen with increasing intensity over time. The initial scans show faint, diffuse activity, while the later scans reveal a more concentrated area of uptake in the lower right quadrant, highlighted by a pink arrow. The contrast and brightness are consistent across all images, suggesting a sequential progression of radiotracer accumulation.]
    Acute management if bleeding: Resuscitation, IV fluids, PPI, H2 blocker infusion

Management by laparoscopic-assisted resection

- Asymptomatic:
  - Detected on imaging: **not resect**
  - Detected during OT: depends on age (complications decrease with age)
    - Child: resect
    - Adult < 50y: resect if palpable, length > 2cm & broad base >2cm
    - Adult >50y: not resect
- Symptomatic: resect
  - Narrow base: **simple diverticulectomy** (diverticulum excision and suture at the base)
  - Broad base / ulceration at margin / mesenteric border: **segmental bowel resection** + primary anastomosis

Angiodysplasia
Definitions: abnormal dilated submucosal arterio-venous malformation (AVM)

- Increased with aging, mostly right-sided
  Pathophysiology
- Congenital: Heyde's syndrome (LGIB a/w aortic stenosis due to acquired Type 2A vWD), Rendu-Osler-Weber syndrome (hereditary haemorrhagic telangiectasia)
- Acquired: peristaltic contraction → intermittent obstruction of submucosal veins → loss of pre-capillary sphincter competence → formation of small AVM - Most common sites: right-sided (caecum, ascending colon) - Association: ESRD, vWD
  Clinical features
- Painless haematochezia
- Features of anaemia: fatigue, dizziness, SOB
  Investigations
- Colonoscopy: **cherry red spots**
- Mesenteric angiogram (if CLN inconclusive): **mother-in-law phenomenon** (early filling, delayed emptying)
- Occult GIB: wireless capsule endoscopy or double balloon endoscopy
  Management
- Conservative: bed rest, tranexamic acid
- Endoscopic: **argon plasma coagulation** (APC) or monopolar electrocautery
- IR: mesenteric angiogram for super-selective catheterisation and embolisation
- Surgical: only in selected patients because of high mortality
  - Indications:
    - Failed endoscopic & angiographic treatment
    - Severe acute life-threatening GIB
    - Multiple angiodysplastic lesions that cannot be managed otherwise
  - Approach: resection (right hemicolectomy) with anastomosis

Hartmann's operation
Indications: Often emergency operation

- **Severe complicated diverticulitis** (Hinchey class III or above): fecal contamination → primary anastomosis undesirable
- Left-sided CRC with complications requiring **urgent resection** (e.g. obstruction, perforation, bleeding)
- Sigmoid volvulus with complications (perforation, necrotic bowel) or recurrent failed decompression
- Complicated IBD: life-threatening haemorrhage, toxic megacolon, perforation
  Procedure
- Sigmoid resection
- Formation of **temporary end colostomy** at LIF
- Closure of **rectal stump** (or mucous fistula if high risk of breakdown causing sepsis)
- Re-anastomosis 2-3 months post-op
  Specific complications
- Rectal stump leak, abscess, fistula
- Ureter injury
- Stoma complications

  4.7 Colorectal carcinoma (CRC)
  Familial colon cancer syndrome (**important!**)

- Account for ~10% of CRC (remaining 90% are sporadic)

|                             | Familial adenomatous polyposis (FAP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Lynch syndrome                                                                                                                                                                                                                                                                                                  |
| --------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| % of CRC burden             | <1%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 5-7%                                                                                                                                                                                                                                                                                                            |
| Genetics                    | AD mutation in **APC gene** on chromosome 5q21 (~100% penetrance, 25% sporadic cases) → chromosomal instability (CIN) pathway                                                                                                                                                                                                                                                                                                                                                                                                                                  | AD mutation in **DNA mismatch repair (MMR) genes** (e.g. MLH1, MSH2, MSH6, PMS2) / deletion in EPCAM gene → microsatellite instability (MSI) pathway                                                                                                                                                            |
| Clinical features           | Adenomas > 100 (usually 500-2500) by age 20 100% risk of CRC Predominantly left-sided                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Few polyps (HNPCC as a misnomer) Predominantly right-sided, large flat polyps 80% lifetime risk of CRC                                                                                                                                                                                                          |
| Pathology                   | Moderately differentiated adenoCA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Poorly differentiated, lymphocytic infiltration                                                                                                                                                                                                                                                                 |
| Extracolonic manifestations | Increased risk of: - CA duodenum (D2 - periampullary) - CA thyroid (papillary CA) - CA pancreas / gallbladder / bile duct <br> Benign fundic gland polyps Congenital hypertrophy of retinal pigment epithelium (CHRPE), epidermoid cysts in childhood                                                                                                                                                                                                                                                                                                          | Increased risk of: - CA endometrium - CA small bowel - CA urinary tract: ureter & renal pelvis                                                                                                                                                                                                                  |
| Diagnosis                   | Colonoscopy > 100 adenomatous polyps Genetic testing: APC +/- MUTYH^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Genetic testing: PCR for MSI, IHC for MMR proteins **Amsterdam II criteria\*** - ≥3 relatives with Lynch-associated cancers (at least 1 pair of first-degree relatives) - ≥2 successive generations - ≥1 tumour diagnosed by 50y - FAP excluded - Tumours verified by pathology <br> Revised Bethesda guideline |
| Treatment                   | Prophylactic colectomy: indicated if documented CA, adenoma with high-grade dysplasia, marked increase in polyp number or severely symptomatic, unable to survey colon completely - **Total colectomy with ileorectal anastomosis (IRA)**: avoid temporary stoma, no risk of sexual dysfunction due to proctectomy, lower morbidity & mortality - **Restorative proctocolectomy with IPAA (RPC)**: eliminate risk of rectal cancer (small risk of cancer in rectal mucosa between pouch and anal canal), pouch failure - Total proctocolectomy + end ileostomy | Prophylactic total colectomy + IRA Prophylactic TAHBSO Aspirin to reduce risk of CRC                                                                                                                                                                                                                            |

98

Screening
Flexible sigmoidoscopy Qly from 10y
(proceed to colonoscopy if polyps found) - still
require endoscopy Q1-2y after colectomy to
screen for tumor from anal transition zone /
ileal pouch
OGD Q3-5y from 25y: gastric & duodenal
polyps
Thyroid USG Qly
Colonoscopy Qly from 20y
OGD Q2y from 30y
Urine cytology and USG renal tract Qly from
30y
Pelvic exam, ES, TVS, CA-125 Q1y from 30y

Variants
Attenuated FAP: MYH gene mutation (10%),
oligopolyposis (< 100 polyps), later onset (by
age 40)
Gardner syndrome: FAP + extra-intestinal
manifestation (SOD: sebaceous cysts, osteomas,
desmoid tumour)
Turcot syndrome: FAP + CNS tumours
(medulloblastoma, glioblastoma, etc.)
Muir-Torre syndrome: visceral neoplasm
(colorectal, endometrium, ovary, etc) +
cutaneous neoplasm (keratoacanthoma, etc)

\*Lynch syndrome = genetic diagnosis; HNPCC = fulfill Amsterdam criteria
^MUTYH-associated polyposis (MAP): DDx of FAP with less adenomas, AR inheritance, very high risk of CRC
Other cancer syndromes
| | Peutz-Jeghers syndrome (PJS) | Juvenile polyposis syndrome (JPS) | Cowden's syndrome |
| ----------- | ----------- | ----------- | ----------- |
| Genetics | STK11 (AD) | SMAD4, BMPR1A (AD) | PTEN (AD) |
| S/S | Hamartomatous polyps Associated colorectal adenoma and CRC | HHT CRC (JP syndrome ↑ risk, but JP per se does not) | Multiple hamartomas (e.g. periorbital warty trichilemmomas) Increased risk of CRC |
| Associated CA | Breast, pancreas, stomach, etc | | Breast, thyroid |
| Management | Top & tail Capsule endoscopy | Colonoscopy Q1-2y from 15y | |

# Colorectal polyps

## Definitions

- Colonic polyps: protuberance into the lumen of normally flat colonic mucosa
- Malignant polyps: polyps that penetrate muscularis mucosae into submucosa

Morphology: **sessile (flat)** / **pedunculated** (with a stalk)

Histological classification

- Non-neoplastic
  - Hyperplastic/metaplastic: MC polyps in adults, usually in rectosigmoid and <5mm
  - Inflammatory pseudopolyps: IBD, solitary rectal ulcer
  - Hamartomatous polyps: juvenile polyps (LB), Peutz-Jegher polyps (SB > LB > stomach)
    - Hamartoma = disorganized overgrowth of tissue indigenous to that particular site
    - Low malignant potential per se, but malignant risk due to associated adenoma in LB
    - PJP: "Christmas tree" appearance, a/w mucosal pigmentation of buccal mucosa & lips
- Neoplastic
  - Adenoma: pre-malignant, <5% progress to CA in 7-10 years
    - Malignant potential - **villous** (secrete K-rich mucus) > tubulovillous > tubular (MC)
    - Advanced adenoma defined as any one of: **high-grade dysplasia, size > 1cm, villous**

[Image Description: This is a flow chart describing the categorization of polyps. On the top layer there are two options: Non-Neoplastic and Neoplastic. Under the Non-Neoplastic category are 4 options: Hamartomatous polyps, Juvenile polyps, Peutz-Jeghers polyps, Hyperplastic polyps, and Inflammatory (pseudo)polyps. Under the Neoplastic category there are 3 options: Adenoma (with the subcategories: Tubular, Tubulovillous, Villous), Serrated Polyps (with the subcategories: Sessile serrated adenoma, Traditional serrated adenoma), and Carcinoma. There is also a rectangle around text saying "Increased risk of CA colon: all neoplastic + hamartomatous polyps"]

- Endoscopic features of malignancy: friability, induration, ulceration, firm consistency
- Sessile serrated polyps (SSP) / Traditional serrated polyps
- Associated with serrated polyposis syndrome

Other classifications: Haggitt, Sano, JNET

- Paris classification of early GI cancer:
  - 0-1 (polypoid): 0-Ip (pedunculated) vs 0-Is (sessile)
  - 0-II (nonpolypoid): 0-IIa (flat and elevated), 0-IIb (flat), 0-IIc (superficially depressed)
  - 0-III (excavated)

Table 2. Neoplastic lesions with "superficial" morphology

| Type 0                                                                                                                         |                                                                                                                                                                                                                                                                                                                |                                                    |
| ------------------------------------------------------------------------------------------------------------------------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------- |
| Polypoid                                                                                                                       | Non-Polypoid                                                                                                                                                                                                                                                                                                   |                                                    |
| [Diagram of Polypoid flowing to Slightly Elevated and Non-Polypoid flowing to Flat, Slightly Depressed, and Excavated (ulcer)] | [Diagram of 0-Ip: Protruded, pedunculated]                                                                                                                                                                                                                                                                     | [Diagram of 0-Is: Protruded, sessile]              |
| [Diagram of 0-IIa: Superficial, elevated]                                                                                      | [Diagram of 0-IIb: Flat]                                                                                                                                                                                                                                                                                       | [Diagram of 0-IIc: Superficial shallow, depressed] |
| [Diagram of 0-III: Excavated]                                                                                                  | Diagram 1. Schematic representation of the major variants of type 0 neoplastic lesions of the digestive tract: polypoid (Ip and Is), non-polypoid (lla, llb, and II c), non-polypoid and excavated (III). Terminology as proposed in a consensus macroscopic description of superficial neoplastic lesions. 15 |                                                    |
| 0-1 (Ip, Is)                                                                                                                   | 0-lla                                                                                                                                                                                                                                                                                                          | 0-llb                                              |
| 0-llc                                                                                                                          | 0-III                                                                                                                                                                                                                                                                                                          |                                                    |

Management of colonic polyps

- Investigations: colonoscopy
- En-bloc polypectomy with adequate resection margin by electrocautery snare
- Send polyps for pathology: Require evaluation for radical resection if invasive CA with
  - Poorly differentiated histology
  - Lymphovascular invasion
  - Margin <2mm
  - T2+ lesions

# Colorectal cancer screening

Screening test modalities

| Stool-based tests (Detection of early cancer)                                      | Guaiac-based faecal occult blood test (gFOBT) e.g. Hemoccult SENSA | Princple: identify Hb by peroxidase reaction Require 3 stool specimens Non-invasive, no need bowel prep Cannot detect polyps, false positives, diet/drug restriction (red meat, NSAID/ aspirin/vit C > 250mg) |
| ---------------------------------------------------------------------------------- | ------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| +ve screening test → follow-up colonoscopy                                         | Faecal immunochemical test (FIT)                                   | Only require 1 stool sample Non-invasive, no need bowel prep / dietary restriction, detect human Hb only, more specific to LGIB (globin is digested during transit) Still false positive if massive UGIB      |
|                                                                                    | Faecal DNA test                                                    | More sensitive and specific (esp. early stage) Costly                                                                                                                                                         |
| Direct visualization tests (Prevention: interfere with adenoma-carcinoma sequence) | Colonoscopy (if normal: Q10y)                                      | Gold standard Complete examination, diagnostic and therapeutic Require bowel prep, invasive                                                                                                                   |
|                                                                                    | Flexible sigmoidoscopy (recommend Q5y)                             | Examine up to splenic flexure Less stringent bowel prep, no need sedation, diagnostic and therapeutic Still require colonoscopy if +ve, right-sided cancer missed                                             |
|                                                                                    | Capsule endoscopy                                                  | Two cameras (front & back) with real-time datalogger Non-invasive, accurate and safe Bowel prep required, still require colonoscopy to confirm / remove polyps                                                |
|                                                                                    | CT colonography                                                    | Non-invasive, visualize entire colon Bowel prep required, cannot detect polyps < 10mm & sessile (flat) polyps, still require colonoscopy if +ve                                                               |

CRC screening in Hong Kong:

- Eligibility: HK residents aged 50-75 who are asymptomatic with no increased risk for CRC
  - Advise direct colonoscopy if increased risk: symptomatic, Hx of CRC / CR polyps, hereditary CRC syndrome (FAP, Lynch), strong FHx (2 or moe FDR with CRC), Hx of IBD
  - Not necessary to enrol: previous normal colonoscopy within past 10 years, previous normal FS within past 5 years, previous normal FOBT within past 2 years
- Protocol: 2-tier system

1. FIT Q2y starting from 50y
2. If FIT positive, colonoscopy Q10y or flexible sigmoidoscopy Q5y

[Image of a flow chart titled "Eligible Persons." It starts with "Primary Care Doctor," who provides consultation and fecal occult blood tests. The results lead to "Fecal Occult Blood (FIT) test," which branches into "Positive" and "Negative." A positive result leads to "Referral to colonoscopy specialist for colonoscopy," while a negative result leads to "Re-screen in 2 year."]

[Image of a flow chart titled "Age to Begin CRC Screening." The chart is divided into three branches based on risk factors: Family history of CRC or advanced adenoma, Absence of IBD, and factors contributing to an average or increased risk. The family history branch further divides into positive and negative paths, each with specific age recommendations for screening. The average risk category recommends beginning at age 45, while the increased risk category suggests starting at age 40, or 10 years younger than the youngest affected relative.]

Surveillance intervals (**important!!!**)
Screening interval if positive colonoscopy
| Colonoscopy Findings | Surveillance Interval |
| ----------- | ----------- |
| Normal colonoscopy | 10 years |
| < 20 hyperplastic polyps < 10mm | 3-5 years |
| Hyperplastic polyps ≥ 10mm | 7-10 years |
| 1-2 adenomas < 10mm | 3-5 years |
| 3-4 adenoma < 10mm | |
| 5-10 adenomas | |
| Adenoma | 3 years |
| - ≥ 10mm, or | |
| - With villous component, or | |
| - With high grade dysplasia | |
| > 10 adenomas | 1 year and consider genetic testing based on adenoma burden, age and family history |
| 1-2 sessile serrated polyps (SSPs) < 10mm | 5-10 years |
| 3-4 sessile serrated polyps (SSPs) < 10mm | 3-5 years |
| 5-10 sessile serrated polyps (SSPs) | |
| Sessile serrated polyps ≥ 10mm | 3 years |
| Sessile serrated polyps with dysplasia | |
| Traditional serrated adenoma | |

[Image Description: This is a screenshot of a table that outlines surveillance intervals for colonoscopies based on various findings. The table has two columns: "Colonoscopy Findings" and "Surveillance Interval". The first row indicates that a normal colonoscopy requires a 10-year surveillance interval. Subsequent rows list different types and sizes of polyps and adenomas, each with a corresponding surveillance interval ranging from 3 to 10 years. Special conditions like villous components, high-grade dysplasia, and adenoma burden are also addressed.]

102

# Colorectal cancer

## Definition

- Rectum
  - Endoscopic definition: up to 15cm from anal verge
  - Oncological definition: bowel below peritoneal reflection
- Right-sided tumour: tumour before splenic flexure
- Left-sided tumour: tumour after splenic flexure

## Risk factors

- Non-modifiable: age > 50, gender (male)
- Central obesity, sedentary lifestyle, diet (increased fat & red meat, reduced fibre), smoking
- GI: IBD (UC > CD), polyps
- Endocrine: DM, acromegaly (IGF-1 as growth factors for colonic mucosal cells)
- Family history: 25% have FHx; 10% have familial syndrome (FAP, Lynch syndrome)
- Protected factors: prolonged aspirin/ NSAID use

## Pathology

- Chromosomal instability (CIN) pathway (85%): higher risk in large (>2.5cm), villous, sessile adenomatous polyps
- Microsatellite instability (MSI) pathway (15%):
- Location of tumours: rectum > sigmoid

## Clinical features

- Most commonly asymptomatic → detected by screening
- Different presentations between right-sided and left-sided lesions
  | Right-sided (Proximal): present later | Left-sided (Distal): present earlier |
  | ------------------------------------------------------------------- | ------------------------------------------------------------------- |
  | Tend to bleed (larger calibre, polypoid lesion) | Tend to obstruct (smaller calibre, annular lesion) |
  | **Iron deficiency anemia**, dull vague abdominal pain, right-sided abdominal mass | **Change in bowel habits** (tenesmus, reduced stool calibre, mucoid stool) |
  | Not common to have change in bowel habits (stool is more liquid and colon more space on right side) | Hematochezia, intestinal obstruction |
- Metastasis:
  - Direct spread: radial (implicated in resectability in rectal cancer)
  - Lymphatic spread: Virchow's node (Troisier's sign)
  - Haematogenous spread: liver (MC), lung (distal rectal tumour → IVC → lung)
  - Transcoelomic spread: ovary (Krukenberg tumour), pouch of Douglas

## Investigations

- Bloods: CBC D/C (anemia), Fe profile, LFT (liver met), RFT
- Serum carcinoembryonic antigen (CEA): epithelial marker
  - Cut-off: <4.7
  - Low diagnostic ability: low sensitivity + low specificity for CRC
    - Elevated in ~50% of CRC only: may be first-pass metabolized by liver
    - False positive: pregnancy, smoking, TB, IBD, other carcinomas (e.g. GI tract, pancreas, breast)
    - Post-op: take 4-6 weeks to return to normal
    - Roles: prognostication, treatment monitoring and detection of recurrence (even if pre-op normal: can pick up non-portovenous distant metastases e.g. lung)
- Diagnostic: **colonoscopy with biopsy (gold standard)**
  - Confirm diagnosis with histological evidence
  - Exclude synchronous cancers (3-5%) and synchronous polyps (30-50%)
  - Pre-op localization (esp. if tumor is very small): tattooing (inject ink to stain tumor)
- CT colonoscopy: when caecum cannot be reached by CLN
  - Pros: similar diagnostic accuracy for tumors >1cm, extraluminal info, lower risk of perforation
  - Cons: high radiation dose, not therapeutic (still need CLN to take biopsy)
- Double-contrast barium enema (DCBE): barium + air
  - Superseded by CT colonography: risk of barium peritonitis
  - Classical findings: "apple core" lesion - near-circumferential involvement of bowel walls
- Biomarker: for metastatic disease only
  - KRAS & NRAS (signalling downstream of EGFR): mutated in 45% → no response to anti-EGFR
  - MMR: MMR-deficient/ MSI (microsatellite instability) → PD-1 pathway inhibitors

Staging:

- Objectives
  - Determine resectability
  - Select patients for neoadjuvant therapy / local excision
  - Most important prognostic factor
- Colon cancer:
  - **CT thorax + abdomen + pelvis with contrast:** Most sensitive for T-staging, can also give N and M staging
  - Alternative: PET-CT with contrast: better for detecting distant metastasis, also used for follow-up (localizing site of recurrence if ↑CEA)
  - Other adjuncts: Bone scan, CXR and liver USG, liver MRI with contrast
- Rectal cancer:
  - **MRI pelvis:** important for accurate T-staging for planning of neoadjuvant chemoRT
    - Assess extra-mucosal tumor invasion (EMTI): MRI is superior to CT in delineating mesorectal fat
    - Determine circumferential resection margin (CRM)
  - Alternative: Endorectal ultrasound (EUS): only good for T staging, but operator-dependent and might not admit endoscope for obstructive tumors
- TNM staging:
  - I: T1/2 N0
  - II: T3/4 N0
  - III: N1/N2
  - IV: M1
- Modified Duke's criteria (obsolete):
  - A: touch muscularis propria
  - B: breach muscularis propria
  - C: invade LN
  - D: distant metastasis

[Image of a table with the title Primary tumour (T), showing TX, T0, Tis, T1, T2, T3, T4 and their respective descriptions. The table also contains Regional lymph node (N) section with NX, N0, N1, N2 and their descriptions, and Distant metastasis (M) section with M0, M1 and their descriptions]

Management overview

- Stage I: surgery + analysis of ≥12 LN
- Stage II: surgery +/- adjuvant chemo (consider in high-risk stage II)
- Stage III: surgery + adjuvant chemo (FOLFOX) +/- adjuvant RT (rectal only) +/- neoadjuvant chemoRT (in high risk rectal only\*)
- Stage IV: chemo +/- surgery for isolated liver metastasis

[Image of a table with the title Staging System, showing Stage, T, N, M and Stage 0, Stage I, Stage II, Stage III, Stage IV with their respective descriptions]

Management of colon cancer
Surgery

- Surgical principles (**important!**): En-bloc resection of primary tumor and locoregional nodes (75% cure rate)
  - Adequate resection margins: at least 5cm proximally + distally, actual margin depends on blood supply
  - Resect major vascular pedicles and lymphatic drainage basin
    - Excise colonic mesentery, ligate arterial supply at its origin, and excise all accompanying LN
    - At least 12 nodes for proper N staging: inadequate LN might require adjuvant chemo
  - Restore bowel continuity whenever possible
- Elective surgery: laparoscopic / robotic^ approach is preferred
  - Stoma: Temporary diverting colostomy is preferred for left-sided anastomosis

| Tumour site                                        | Surgical procedures                     | Vessels involved & remarks                                             |
| -------------------------------------------------- | --------------------------------------- | ---------------------------------------------------------------------- |
| Caecum Ascending colon                             | Right hemicolectomy                     | Ileocolic, right colic, R branch of middle colic (SMA)                 |
| Hepatic flexure Transverse colon Splenic flexure\* | Extended right hemicolectomy            | Ileocolic, right colic, middle colic (SMA) Marginal artery of Drummond |
| Splenic flexure\* Descending colon                 | Left hemicolectomy                      | Left colic a. (IMA)                                                    |
| Sigmoid colon                                      | Sigmoidectomy (high anterior resection) | IMA & left colic a.                                                    |

[Image of Colorectal Major Resections, showing a diagram of the colon with labels A through H indicating different resection locations.
A-B: Right Hemicolectomy
A-C: Extended Right Hemicolectomy
B-C: Transverse Colectomy
C-E: Left Hemicolectomy
D-E: Sigmoid Colectomy
D-H: Anterior Resection
G-H: (Ultra) Low Anterior Resection
D-G: Abdominoperineal Resection
A-H: Subtotal Colectomy]

\*For splenic flexure tumors, peritumoral subserosal ICG injection can be done to demonstrate the lymphatic drainage
of tumor.
^Benefits of robotic surgery: high-quality 3D vision, restoration of eye-hand-target axis

- Emergency surgery: indicated if complicated (obstruction, perforation, haemorrhage)
  - Right-sided lesion: right hemicolectomy with primary anastomosis +/- bowel decompression if stable, temporary ostomy if unstable
  - Left-sided lesion: Hartmann's operation

Other therapies

- Adjuvant chemotherapy: aim to eradicate micro-metastasis and reduce risk of recurrence
  - Options
    - FOLFOX for 6 months: folinic acid + 5-fluorouracil + oxaliplatin
    - Xelox for 3 months if lower risk (T1-3, N1):
  - Indications: Stage 3 (N1+), high risk stage 2 (T4 tumor, lymphovascular invasion, poor histology)
- No role for neoadjuvant therapy
- Refer to MED notes for non-surgical treatment (e.g. upfront chemotherapy)

Management of rectal cancer

- Differences from CA colon:
  - Narrow bony pelvis + presence of sphincter: wide excision is difficult → require neoadjuvant therapy
  - Transanal approach available
  - Proximity to urogenital structures: potential urogenital dysfunction (e.g. urinary/fecal incontinence, sexual dysfunction)

# Curative surgery

- Surgical principles (**important!**): Similar to CA colon, but additionally
  - Organ-preserving (e.g. TEMS)
  - Sphincter-sparing (e.g. AR and LAR): made more possible by stapled anastomosis and chemoradiotherapy downstaging of tumour
  - Adequate resection margins:
    - **5cm proximally + 2cm distally** (1cm for distal rectum if really wish to preserve sphincter)
    - **Circumferential resection margin (CRM)** at least **1mm →** concept of TME\*
  - Vascular ligation and LN dissection: at least 12 nodes
- Option 1: Local excision
  - Indication: T1N0 disease with low-risk features (e.g. <3cm, favourable histology), T2N0/T3N0 if unfit
  - Approaches:
    - Transanal endoscopic microsurgery (TEM): rigid platform, more costly and time-consuming
    - Transanal minimally-invasive surgery (TAMIS): lap., easier to learn, less stable pneumorectum
  - Follow-up:
    - Favourable prognostic factors (e.g. well differentiated, no lymphovascular or perineural invasion, negative margin): regular endoscopic surveillance
    - Adverse prognostic factors or ≥pT2 disease: proceed to radical resection / chemoRT (if unfit)
- Option 2: sphincter-preserving surgeries
  - Indicated if: T2-4 + adequate pre-op sphincter function + adequate distal margins

| Anastomosis         | Anterior resection (AR) + TME          | Low anterior resection (LAR) + TME                                   |
| ------------------- | -------------------------------------- | -------------------------------------------------------------------- |
|                     | Above peritoneal reflection            | Below peritoneal reflection ("Ultra-low": Just above anal sphincter) |
| Tumor site          | Rectosigmoid junction Upper 1/3 rectum | Mid 1/3 rectum Low 1/3 rectum with adequate distal margin            |
| TME                 | Only partial: 5cm below cancer         | Total: until anorectal junction                                      |
| Distal margin       | 5cm                                    | 2cm (or 1cm if below distal mesorectal margin)\*                     |
| Defunctioning stoma | Not required                           | **Required:** loop ileostomy / colostomy                             |

# For lesions <1cm from anorectal ring, intersphincteric resection (ISR) may extend the distal margin by removing part/all of IAS (provided that intersphincter groove is not invaded by tumor).

- Ligation of IMA: high tie vs low tie
  - High tie (ligate at origin): allow extra length to facilitate **tension-free anastomosis**, better LN clearance at IMA origin
  - Low tie (ligate below left colic a): prevent left colon ischemia (sole supply from marginal a.)
- Anastomosis by double stapling: Create larger neorectal reservoir
  - Colonic J-pouch / side-to-end / transverse coloplasty (highest leakage rate)
- Defunctioning stoma: protect the anastomosis (↓complication rate) but does not ↓leakage rate - Indications: - Low anastomosis (<5cm) - Intra-op leak tests +ve - Pre-op chemoRT
  [Image of a diagram showing the anatomy of the rectum with labeled sections including the rectosigmoid, upper third, middle third, lower third, anal canal, pelvic floor, and annotations of anastomosis locations above and below the peritoneal reflection. The distances from the rectosigmoid are marked at 15cm, 11cm, and 7cm.]

|     | Intra-operative leak tests                                                                                               |
| --- | ------------------------------------------------------------------------------------------------------------------------ |
|     | Air leak test (laparoscopically infuse water into peritoneum while insufflating air in the bowel → positive if bubbling) |
|     | Blood supply: see if the resected bowel is pink in colour, especially check for marginal artery of Drummond              |
|     | Injection of ICG into vein and view under ICG camera (for blood supply)                                                  |
|     | On table colonoscopy (check if intact, any bleeding, and check perfusion)                                                |

[Image of a diagram showing Colonic J-pouch reservoir procedure with annotations.]

[Image of a diagram showing Side-to-end anastomosis procedure with annotations.]

[Image of a diagram showing Transverse coloplasty reservoir procedure with annotations.]

Total mesorectal resection (TME): precise dissection of
mesorectal envelope (containing tumor, surrounding
mesorectal fat, LN and vessels), preserving pelvic
autonomic nerves

- Plane: "holy plane" - avascular alveolar plane
  between presacral and mesorectal fascia
- Benefits:↓ local recurrence rate and ↓ post-
  operative genitourinary dysfunction
- Approaches: transabdominal (open / lap /
  robotic), transanal (rarely)

Option 3: **Abdominal perineal resection (APR)**

- Indicated if ANY one of: poor pre-op sphincter function / **failure to achieve negative distal margin** /
  locally advanced or recurrent low-lying CA rectum
- Steps:
  - Insert catheter to protect membranous urethra in males
  - Abdominal part (open/lap) similar to AR
  - Perineal dissection via circumanal incision for en-bloc resection of sigmoid, rectum and anus
  - Construction of **permanent end colostomy**

Other therapies

- **Neoadjuvant therapy for CA rectum** [German Rectal Cancer Study Group] - 3 main indications (**need to know!**) - Resectable but locally advanced disease: sterilize tumour bed, ↓ intra-op tumor spillage & ↓ local
  recurrence rate - T3/T4 disease → _only definite indication proven by RCT_ - Nodal disease - Threatened CRM (<2mm) - Borderline resectable disease: downstage the tumor and ↑ resectability rate - Low-lying tumor: downsize the tumor and ↑ sphincter preservation rate - Options

| Regimen       | Long course chemoRT (HK)                                                                                                                                    | Short course high-dose RT                                                                                      |
| ------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------- |
|               | 5-FU based chemotherapy x 2 cycles + concurrent RT (50.4 Gy = 1.8 Gy daily x 28 fractions) → Wait 8-10 weeks before surgery → 4 cycles of chemo as adjuvant | RT 25 Gy = 5 Gy x 5 days → Wait 7-10 days before surgery                                                       |
| Disadvantages | Max dose of RT for lifetime Delay surgery                                                                                                                   | More S/E of high dose RT Can only sterilize local tumor bed, but not enough time to downstage / downsize tumor |

- Remission after neoadjuvant chemoRT - Clinical complete remission (CCR) ~20%: consider “watch and wait” for 3 years with MRI Q3m,
  flexible sigmoidoscopy Q3m, PET-CT / CT Q6m - Pathological complete remission (PCR) ~15%: surgical specimen found to be tumor-free, may not
  require adjuvant chemo (case-by-case)
- Adjuvant chemotherapy: First-line is 5-FU based, other options include oxaliplatin, irinotecan, cetuximab
- Adjuvant radiotherapy: not common

**Palliative management for colorectal cancer**

- Palliative surgery
  - **Endoluminal stenting:** for palliating obstruction / bridging therapy before elective surgery (avoid EOT)
    - **Not** for distal rectal tumour (can cause tenesmus and pain)
  - Palliative colostomy +/- tumor resection (palliative intent)
- Palliative radiotherapy: control local symptoms (e.g. pain, discharge, bleeding, incontinence) and bone pain
- Palliative chemotherapy for disseminated disease: oral capecitabine
  [Image of Male Pelvis in a Side View and Front View. The side view depicts the male reproductive organs including the urinary bladder, rectum, prostate gland, and the path of the urethra. A schematic line indicating the "holy plane" of dissection for total mesorectal excision is shown cutting through the mesorectal fat. The front view provides an abdominal cross section with a tumor location highlighted within the rectum and indicates the circumferential resection margin.]

Post-operative complications

Immediate
Massive bleeding requiring conversion to laparotomy (<10%)
Injury to neighbouring structures:

- **Left ureter and gonadal vessels**
- Iliac artery
- GB, D2 (right hemi)
- Seminal vesicles (LAR)
- Spleen (splenic flexure mobilization in TME)
- **Autonomic nerve injury** (esp. in rectal surgery)*: sympathetic (incontinence, impaired
  ejaculation) vs parasympathetic (urinary retention, erectile dysfunction)
  *High tie vs low tie
- High tie if reducing tension is desired
- Low tie (distal to left colic) avoids damage of **hypogastric nerve**, and thus lower risk of
  autonomic dysfunction

Early Post-op ileus, infection, **anastomotic leak**

Late
Anastomotic stricture: might require finger / endoscopic balloon dilation
**Fistula**: enterocutaneous (conservative Mx), rectovaginal / rectourinary (proximal fecal diversion)
Perineal hernia (APR)
**LAR syndrome**:

- S/S: change in bowel movement (ranging from constipation to faecal urgency, faecal
  incontinence) that persists ≥ 1 month after surgery
- Patho: colonic dysmotility, neorectal reservoir dysfunction and anal sphincter dysfunction
- Prevention: post-op **pelvic floor muscle exercise**, anterograde colonic irrigation via stoma /
  enema, fecal diversion
- Management: antidiarrheal, transanal irrigation, pelvic floor rehab, sacral nerve stimulation

Stoma See separate sections
complications

Follow-up for colorectal cancer

- Aim: detect **recurrence** (40%) and **metachronous tumors** (_new primary CA diagnosed 6mo afterwards_)
- Follow-up interval:
  - First 2 years: Q3m
  - 3rd year: Q6m
  - 4-5th year: yearly
  - > 5 years: considered to be in remission
- Investigations in each follow-up:
  - CEA, rigid sigmoidoscopy, LFT
  - СТ ТАР/ PET-CT Q1y
  - Colonoscopy:
    - Pre-op not full scope: within 6m of surgery (risk of synchronous tumour in CA rectum = 3-5%)
    - Pre-op full scope: 1 year post-op, then at 3 years, 5 years, then Q5y

Management principles of metastases

- Liver / Lung metastases: **resect** if possible (solitary metastasis, no other mets, controlled primary tumor) - Refer to **HBP** for management of colorectal liver mets

  4.8 Diseases of anal canal & anus
  History taking

- Chief complaints:
  - Bleeding
  - Pain (fissure in ano: pain on defecation)
    - Proctalgia fugax: severe spasm of anal pain that last only a few min, often at night; Mx amitriptyline
  - Itchy
    - Pruritus ani: avoid scratching, clean with clear water, dry area
  - Swelling: where, frequency, size change, hard/soft
  - Tenesmus
  - Discharge
- Colour of PRB - rough guide
  - Fresh PRB: distal to splenic flexure
  - Dark PRB: proximal to splenic flexure

PR exam

- Inspection; scar, sinus, lesions (fissures, thrombosed haemorrhoids, condyloma)
- Palpation: pain, induration, lesion, tone (ask to squeeze the finger), prostate/ rectovaginal septum

Haemorrhoids (piles)
Definitions

- Haemorrhoids: abnormal **engorgement and prolapse of the anal vascular cushions**
- Anal vascular cushions - clusters of vascular tissue, smooth muscle and connective tissue
  - Components: branches of superior rectal artery, superior rectal veins, covered by a mucosal layer
  - Function: assist the anal sphincter in maintaining continence
  - Found in 3, 7, 11 o'clock positions (when looked at with the patient in the lithotomy position)
    Pathophysiology
- Degeneration of supporting fibroelastic tissues and smooth muscles → anal cushions displaced caudally → dilation & engorgement of AV plexuses → prolapse
- May acutely **thrombose**: painful large, swollen, irreducible mass with marked anal sphincter contraction
  Risk factors
- Aging
- Sitting on toilet for long period of time
- Intra-abdominal pressure: constipation, chronic cough, ascites, pregnancy
- Genetic predisposition

Types

|                   | External                                                     | Internal                                                                           |
| :---------------- | :----------------------------------------------------------- | :--------------------------------------------------------------------------------- |
| Origin            | Ectoderm (squamous epithelium i.e. skin)                     | Endoderm (columnar epithelium of anal mucosa)                                      |
| Location          | Below dentate line                                           | Above dentate line                                                                 |
| Innervation       | Somatic innervation (inf. rectal n. ← pudendal n.)           | Autonomic nervous system (inf. hypogastric plexus)                                 |
| Clinical features | Pain after defecation → severe perianal pain (if thrombosed) | Painless bright red PRB (outlet-type)Prolapse, anal itching                        |
| Venous drainage   | Perianal swelling / skin tagsInferior rectal vein → IVC      | Acute pain if incarcerated/strangulatedSuperior rectal vein → portal venous system |

Mixed type: both internal & external, usually found in pregnancy; treated as external

Examination

- **Digital rectal examination:** inspect for prolapsed piles, associated skin tags, perianal excoriation; assess anal tone (IAS) and squeeze pressure (EAS)
- **Proctoscopy** +/- rigid sigmoidoscopy: 1st/2nd degree piles may not be palpable
- **Flexible sigmoidoscopy** +/- colonoscopy if risk of malignancy:
  - PRB in age > 45y
  - Change in bowel habit/ tenesmus
  - FHx of CRC

[Image of Rigid sigmoidoscopy]

[Image of Proctoscopy]

Goligher grading for **internal haemorrhoids** (need to know!)
| Description | Management |
| ----------- | ----------- |
| I Palpable, non-prolapsing and bleeding | Lifestyle, medical |
| II Prolapse with straining and defaecation, **spontaneous reduction** | Lifestyle, medical, RBL |
| III Prolapse requiring manual reduction | Lifestyle, medical, RBL + surgery |
| IV Chronic prolapse that is _irreducible_ +/- strangulated | Surgery |

109
Management

- Lifestyle modification:
  - Diet: avoid spicy food, high-fibre diet, increase fluid intake (to reduce straining)
  - Toileting habit: avoid prolonged sitting, avoid prolonged straining
  - Exercise, weight loss
- Medical: stool softeners, bulking agents (e.g. metamucil), topical antiseptic (KMnO4 sitz bath), topical haemostatic (e.g. Faktu), topical astringent (e.g. Anusol), topical analgesics

- Invasive therapy:
  | | | |
  | ----------- | ----------- | ----------- |
  | Office-based procedures | **Rubber band ligation (RBL)**[Illustration of rubber band ligation procedure] | Apply rubber bands to strangulate the pile by Baroon's bander → **Ischaemic necrosis** of piles → slough off within 10 days Efficacy: 70% resolve, 30% recur Administration: up to 3 bandings at ≥**1cm above dentate line** Indication: symptomatic Grade II/III internal hemorrhoid Complications: **pain, bleeding** (7-10d post-banding due to sloughing of ligated haemorrhoids; C/I anticoagulant use, immunocompromised), post-banding sepsis |
  | Sclerotherapy ("Mitchell") | | Administration: 5% phenol in almond oil submucosally Aim to create fibrosis → obliterate vascular channels and fix position **Largely abandoned now:** risk of allergy to nuts & intraprostatic injection |
  | Excision | Haemorrhoidectomy [Illustration of circular stapler for hemorrhoidectomy]Internal hemorrhoids Circular stapler Hemorrhoids inside Stapler [Illustration of PPH-03 Kit with surgical tools] | Indications: - Grade III/ IV internal haemorrhoids - Symptomatic internal/external haemorrhoids **refractory** to other treatments Approach: - Conventional haemorrhoidectomy: for **internal ≥ grade III or external** - 3-leaf clover excision (fig.): avoid circumferential excision - prone to stenosis - Closed (**Ferguson**): close wound by continuous suture; more commonly used - Open (**Milligan-Morgan**): open wound and heal by 2° intention; preferred for acute gangrenous haemorrhoids (prevent further tissue oedema & necrosis) - Stapled haemorrhoidectomy / haemorrhoidopexy: for **internal only**, less favoured now due to poorer long-term outcomes, less painful but higher recurrence rate Efficacy: 95% resolve Pre-op preparation: stool softener, enema Position: prone jackknife / lithotomy Anaesthesia: _perianal_ / SA / GA Complications: - **Pain** (~100% due to IAS spasm) - **Urinary retention** |

110

- Causes: Pain and anal spasm, fluid overload, rectal packing, drugs (narcotics, anticholinergics), pre-existing outflow tract obstruction
- Mx: Leave urinary catheter in situ for 24h
- Injury: **faecal incontinence**, anal fissure, anal stenosis

Haemorrhoidal artery ligation operation (HALO)
May be Doppler-guided (DG-HALO) to identify feeding vessels
Mainly for bleeding symptoms, indicated for **Grade II/III haemorrhoids**
Lowest post-op complications, but highest recurrence rate

Acute painful anal mass
Differential diagnosis

- Thrombosed prolapsed internal haemorrhoids
- Thrombosed external haemorrhoids (a.k.a. perianal haematoma; present as painful bluish mass, form skin tag after 48h)
- Incarcerated rectal prolapse (with circular folds, fig.)

[External thrombosed haemorrhoids. A view of a thrombosed external hemorrhoid]

[Spontaneous resolution of external thrombosed haemorrhoid changing into skin tag. A view of a spontaneous resolution of external thrombosed haemorrhoid changing into skin tag]

Management

- Symptomatic Grade IV internal haemorrhoids: **hyperosmolar solution** (gauze with lignocaine + cold water + dextrose) / **warm water sitz bath** to reduce size of haemorrhoids before surgery
- Thrombosed (external) haemorrhoids:
  - Early (<72h) + painful: **urgent haemorrhoidectomy**
  - Late (>72h) or small thrombosis: conservative (analgesia, ice pack, stool softeners, topical nifedipine to induce IIAS relaxation)
- Incarcerated rectal prolapse: sugar application + manual reduction + surgery
  - Altemier's operation (perineal rectosigmoidectomy)
  - DeLorme procedure: plication (folding) of sutures

[Rectal prolapse (A & B) vs prolapsed haemorrhoid (C). A view of Rectal prolapse and prolapsed haemorrhoid]

Anal fissure
Definitions: tear in mucosal lining **below** dentate line
Pathogenesis

- Local trauma (constipation, vaginal delivery) → pain → **IAS spasm** → impaired healing → vicious cycle
- Most at 6H (**posterior midline**): least perfused
- 10% at 12H: after vaginal delivery
- Always suspect **perianal Crohn's disease** if: non-midline, recurring, multiple, unusually deep or wide, perianal hypertrophic skin tags
- Others: HIV, TB, STD

[An image of an anal fissure.]

Clinical features

- Pain on defaecation (vicious cycle: avoid defaecation → constipation → further trauma)
- Fresh PRB +/- mucus
- Chronic fissure: triad of fissure + **sentinel piles** (failed healing → skin tags) + **hypertrophied anal papillae**
  Investigations
- EUA (DRE too painful to perform - AVOID Lord's four fingers stretch)
- Proctoscopy

Management
Conservative

- Risk factor modification: increase fibre/ fluid intake, stool softener
  / laxatives, Sitz bath
- Topical analgesics (e.g. 5% lignocaine)
- Topical vasodilators: reduce IAS spasm and increase local blood
  flow, but risk of incontinence
  - Topical GTN (S/E: headache)
  - Topical nifedipine
- Second-line medical therapy:
  - Botulinum toxin 50IU
  - Topical 0.5% diltiazem

Surgical management

- Indications: if fail conservative management for 8 weeks
- Endoscopy to rule out Crohn's disease first
- Low risk of incontinence: lateral internal sphincterotomy
  (to divide IAS), Cx: faecal incontinence
- High risk of incontinence (e.g. multiparous women, older patients): fissurectomy + V-Y advancement flap -
  sphincter-sparing

[Image: A detailed illustration of a Lateral Internal Sphincterotomy. First, a zoomed-in view depicts the internal sphincter muscle, showcasing the location where the blade is inserted. The surrounding anatomical structures are also clearly labeled. Below this detailed view, there are three images labeled A, B and C, each showing a different stage of the sphincterotomy procedure on the anal region. Image A shows a chronic fissure with an incision line marked. Image B shows the incision being made to cut the fissure. Image C shows the result after the incision with dashed lines.]

111

# Anal fistula (fistula-in-ano)

Definitions

- Sinus: blind-ending tract joining an epithelial surface to a cavity lined by granulation tissue, e.g. an abscess
- Fistula: abnormal connection between 2 epithelial surfaces
- Anal fistula: abnormal communications (hollow tracts lined with granulation tissue) with internal opening in anal canal & external opening in perianal skin

Risk factors

- **Cryptoglandular hypothesis (90%)**: obstruction of anal gland ducts (connected to crypts of Morgani) → infection and formation of abscess → discharge along path of lowest resistance
- Other causes: malignancy, Crohn's disease, TB, actinomycosis, LGV

Clinical features

- Intermittent perianal discharge + pain (until pus discharges)
- Palpable cord-like tract
- Passage of flatus/feces through external opening (suggest internal opening is at rectum)
- Suspect anal fistula if anorectal abscess persists after 6-12 weeks

Classifications

- Parks classification (fig.): relations to external sphincter
  - Not included: superficial fistula (does not involve sphincter)

|     | Types                   | Description                                                        |
| --- | ----------------------- | ------------------------------------------------------------------ |
| 1   | Inter-sphincteric (45%) | Begin in dentate line, and travel in the plane between IAS and EAS |
| 2   | Trans-sphincteric (30%) | Track through EAS into ischiorectal fossa                          |
| 3   | Supra-sphincteric (20%) | Encompass entire sphincter apparatus                               |
| 4   | Extra-sphincteric (5%)  | Primary opening in rectum                                          |

[A diagram of an axial view of the rectum with the surrounding anatomy. The diagram shows the levator ani muscle and the puborectalis muscle superiorly. Inferiorly are shown the internal anal sphincter, the external anal sphincter and the superficial fascia. Three types of fistulas are drawn with arrows showing their path: Intersphincteric fistula, trans-sphincteric fistula, and extrasphincteric fistula.]

- Simple vs complex: determine choice of OT
  - Simple: superficial, inter-sphincteric (Type 1), low trans-sphincteric (Type 2) involving <30% EAS
  - Complex: high trans-sphincteric (Type 2) involving ≥30% EAS, supra-sphincteric (Type 3), extra-sphincteric (Type 4), horseshoe fistulas, multiple tracts, women with anterior fistulas / rectovaginal fistulas, fistula a/w Crohn's disease / radiation / malignancy
- High vs low: above vs below anal sphincter complex

Identify internal opening by **Goodsall's rule** (higher reliability if external opening **within 3cm** of anal verge)

- Transversal anal line: draw through ischial spines
- Fistula anterior to transverse anal line: open to anus in a straight line
- Fistula posterior to transverse anal line: curved track, opening in the midline posteriorly

[A line drawing of a dog demonstrating Goodsall's rule for anterior and posterior fistulas. The dog's front is labeled "Anterior" and its tail is labeled "Posterior".]

[A diagram of a patient in the prone position with their buttocks spread apart. A transverse line is drawn across the anus. There are two fistulas illustrated anterior to the transverse line, and two fistulas illustrated posterior to the transverse line. The anterior side of the anus is labeled as "Anterior", and the posterior side is labeled as "Posterior".]

Assessment: determine sites of internal and external openings, course of primary track, any secondary extensions

- Anorectal examination: pustule-like lesion, perianal skin excoriation, external opening (do **NOT** probe!)
- +/- proctoscopy / sigmoidoscopy for internal opening
- Imaging: endoanal USG / MRI pelvis +/- instil H2O2 via external opening
- **Examination under anesthesia (EUA)**: required before surgery to trace the fistula tract
- Colonoscopy if suspect Crohn's disease

# 113

Definitive treatment

- Primary fistulotomy:
  - Indications: simple fistula with low risk of incontinence
  - Approach: fistula probe to define tract → divide all overlying structures → laid open to heal by secondary intention +/- marsupialization to speed up healing
  - Complications: sphincter injury
- Loose (draining/non-cutting) Seton for 6 weeks + secondary sphincter-sparing procedure
  - Indications: high risk of incontinence / complex fistula
  - Loose Seton is usually inserted at EUA (material: silastic vessel loop)
  - Establish drainage and eradicate septic focus
  - Preserve sphincter mechanism
  - Various approaches of secondary sphincter-sparing procedure:
    - Fistulotomy by cutting Seton: elastic and tightened regularly → slowly cut through the tract to cause scarring
    - Advancement flap: close internal opening by mucosal flap → allow fistula tract to heal and close
    - Ligation of intersphincteric fistula tract (LIFT)
    - Fibrin sealant / fistula plug
    - Modified Hanley procedure: horseshoe fistulas
- Crohn's disease: medical → surgical only if failed
  - Lay open if simple fistula, Seton drain if complex

[Image Description: A flowchart titled "Choose a sphincter-sparing procedure based on fistula anatomy and surgeon preference" It begins with "High transsphincteric fistula (Parks type 2)" flowing down to a question: "Is internal opening distal to the dentate line or does the patient have preexisting incontinence?" If "Yes," it flows down to "LIFT" on one path and "Advancement flap or LIFT" on the other. If "No," it flows down to "Advancement flap." Separately, "Suprasphincteric fistula (Parks type 3)" flows down to "Advancement flap," while "Extrasphincteric fistula (Parks type 4)" flows down to "Diversion or proctectomy." Finally, "Horseshoe fistula" flows down to "Modified Hanley procedure or advancement flap."]

114

# Anorectal abscess

Definitions: collection of pus in anal/ rectal region
Classified by anatomical location (fig.)
Pathophysiology

- Cryptoglandular theory: anal gland infection
- Parks theory: pus travels along the path of least resistance
- Other causes unrelated to anal glands: post-haemorrhoidal sclerotherapy, trauma, Crohn's disease, malignancy
  Clinical diagnosis
- Intermittent / Constant perianal pain, exacerbated when sitting down
- Erythematous fluctuant tender mass felt on palpation / DRE
  Management
- Antibiotics: if surrounding cellulitis or immunocompromised (e.g. DM)
- Incision & drainage under GA: heal by secondary intention
  - Perianal abscess: skin incision
  - Ischiorectal abscess (or its supralevator extension): buttock skin incision → drain as close to sphincter complex as possible to minimize length of potential fistula tract
  - Intersphincter abscess (or its supralevator extension): rectal incision (internal sphincterotomy) → drain **transanally** to avoid creating extrasphincteric fistula
- Pus for C/ST
  - Culture shows skin flora: no fistula → reassurance
  - Culture shows gut flora: likely with fistula → treat as fistula after acute state

[Image of diagram illustrating the spread of infection from the anal gland to the anorectal spaces, leading to abscess formation. The diagram is labeled with terms like "Pelvirectal abscess," "High intermuscular abscess," "Ischiorectal abscess," "Intersphincteric abscess," and "Perianal abscess" to indicate different locations of abscesses.]

[Image of two side-by-side diagrams, one labeled "Normal" and the other "Inflammed". Both diagrams show the anatomical structures around the anal canal, but the "Inflammed" diagram highlights the changes that occur in the presence of an anorectal abscess. The diagram is labeled with "Supralevator space", "Supralevator abscess", "Levator muscle", "Column of Morgagni", "Internal sphincter", "Deep external sphincter", "Intersphincteric abscess (origin)", "Ischiorectal abscess", "External sphincter", and "Perianal abscess".]

[Image of a close-up view of a perianal abscess. The abscess is a visible, raised, and inflamed area near the anus, and it appears red and swollen. The word "Abscess" is overlaid on the image with a red arrow pointing towards it.]

# Pilonidal sinus

Definition: formation of sinus in the natal cleft
Pathophysiology

- Infection & obstruction of hair follicle in intergluteal cleft
- Foreign body-type reaction leads to formation of a cavity
  Risk factors
- Caucasian male with coarse dark body hair (rare in HK)
- Prolonged sitting (e.g. lorry drivers)
- Increased sweating
  Clinical features
- Intermittent red, painful mass with discharge in sacrococcygeal region
- Does not continue into anal canal (c.f. anal fistula)
  Management
- Conservative: shave affected region, plucking the sinus free of embedded hair, washout of accessible sinuses, antibiotics
- Surgical:
  - Acute: I&D
  - Chronic: removal of sinus tract + heal by secondary intention

[Image of a diagram illustrating a pilonidal sinus tract and a pilonidal cavity with hair.]

Proctalgia fugax

- Benign, occur in young anxious men
- Brief attacks of rectal pain at night, unrelated to defaecation
- Mx: reassurance, analgesics, topical GTN

Anal carcinoma
Pathology

- Squamous cell carcinoma - below dentate line (80%)
  - Anal intraepithelial neoplasia (AIN): pre-malignant lesions
- Adenocarcinoma - above dentate line (10%)
- Others: melanoma
  Risk factors
- HPV infection (90%): esp. HPV-16 & 18
- HIV infection
- Smoking
- Immunocompromised
- Crohn's disease
  Clinical features
- Painful PR bleeding
- Pruritus
- Signs: palpable mass and its distance from anal verge, LN (superficial inguinal LN if tumour below dentate line)
  Investigations
- Proctoscopy
- EUA for biopsy
- Pap smear for CIN (HPV)
- Staging: - USG-guided FNA of palpable inguinal LN - MRI pelvis for T staging - CT TAP for distant metastasis
  Management
- Chemoradiation
  - First line for most stages (except for early T1N0 disease)
  - EBRT + dual chemotherapy
- Surgical excision
  - T1N0 disease: wide local excision
  - Failed ChemoRT: APR

```markdown
116

5.  1 Anatomy and physiology
    Liver
    2 surfaces:

- Diaphragmatic surface: bare area, subphrenic recesses
- Visceral surface: covered with peritoneum except bed of GB and porta hepatis
  Division
- Anatomical division:
  - Right and left lobe divided by **falciform ligament**
  - Caudate lobe: most difficult to resect (related to IVC), anatomically in R liver, but functionally independent (segment I)
  - Quadrate lobe: anatomically in R liver, but functionally related to L liver (segment IVb)
- Functional / Surgical division (Couinaud): 8 segments, each with own branch of portal vein, hepatic artery, bile duct and hepatic vein
  - Divided by 3 portal fissures (sagittal) and transverse fissure (level of porta hepatis)
  - Major portal fissure / Cantlie's line: along middle hepatic vein and gallbladder fossa

| Right liver: Segment 1, 5-8 | Left liver: Segment 2-4 |
| --------------------------- | ----------------------- |
| Right anterior (5, 8)       | Left medial (4a, 4b)    |
| Right posterior (6, 7)      | Left lateral (2, 3)     |

Peritoneal ligaments

- Falciform ligament and ligamentum teres: remnant of umbilical vein
- Coronary ligament → Right and left triangular ligaments
- Lesser omentum (hepatoduodenal lig. + hepatogastric lig.)

Epiploic foramen (of Winslow): Pringle's maneuver

- Anterior: **hepatoduodenal ligament** (free edge of lesser omentum, containing **portal triad** - portal vein, PHA, CBD)
- Posterior: IVC, right crus of diaphragm
- Superior: caudate lobe of liver
- Inferior: D1 duodenum

Vascular supply

- Dual blood supply: receives 1500mL/min blood
  - 75% portal vein
  - 25% hepatic artery (← common hepatic artery ← celiac trunk)
- Anatomical variants:
  - Common hepatic artery: might be absent (direct trifurcation of celiac trunk into RHA, LHA, GDA)
  - Right hepatic artery (major supply to liver): can arise directly from SMA
  - Left hepatic artery: can arise from left gastric artery
- Venous drainage: hepatic veins (left/ mid/ right) → IVC
  - Caudate lobe (segment I) drains directly into IVC via minor hepatic veins

Lymphatics: converge towards portal hepatis → hepatic nodes → celiac nodes → cisterna chyli
5 HBP surgery

[Image of the liver from an anterior view. The liver is reddish-brown and lobed, and several structures are labeled including the falciform ligament, left and right lobes, inferior vena cava, and gall bladder. There is also a diagram showing cross sections of the liver labeled with different sections.]

[Image of the liver and related blood vessels from an anterior view. The liver is at the top and the gall bladder is at the bottom. The blood vessels have labels.]

[Image of a diagram of the blood supply to the liver. The diagram shows several blood vessels branching off from the aorta, including the hepatic artery, splenic artery, and superior pancreatico-duodenal artery.]
```

# Gallbladder

Anatomical landmark: Intersection of right costal margin & MCL
Parts: **fundus, body, neck**

- Hartmann's pouch: out-pouching of GB wall at junction of GB neck and cystic duct
- Muscle fibers in the wall arranged in criss-cross manner

## Vascular supply

- **Cystic artery** (← right hepatic artery): most arise **posterior** to CHD and **superior** to cystic duct (15% in front of CHD)

## Important triangles

- Calot's triangle:
  - Boundary: **inferior surface of liver**, cystic duct, CHD
  - Content: right hepatic a. → cystic a., Lund's node (sentinel lymph node of GB → liver)
  - Significance:
    - Locate **cystic artery** during cholecystectomy → Avoid injury to extrahepatic biliary tree and R hepatic artery
    - Identify variants (e.g. caterpillar turn / Moynihan's hump)

[Image: A labeled illustration of the gallbladder, cystic duct, and surrounding structures. The gallbladder is pear-shaped and connected to the cystic duct, which joins the common hepatic duct to form the common bile duct. Labels point to the cystic duct, neck, body, fundus, Hartmann's pouch, right and left hepatic ducts, common hepatic duct, and common bile duct.]

Another definition:
Calot's triangle: cystic artery, cystic duct, CHD
Hepatocystic triangle: inf. surface of liver, cystic duct, CHD

[Image: A diagram of Calot's triangle in the biliary system. The triangle is formed by the cystic duct, the common hepatic duct, and the inferior surface of the liver. The cystic artery runs within this triangle. The Hepatocystic triangle is formed by the inf. surface of the liver, cystic duct, CHD, and includes labels such as superior, lateral, and medial.]

[Image: Three variations of Calot's triangle anatomy. (a) shows the usual anatomy, (b) shows a tortuous common hepatic artery, and (c) shows a tortuous right hepatic artery with a short cystic artery. The captions state that (b) and (c) are examples of so-called "caterpillar turn" or "Moynihan's hump", which if not recognised can lead to inadvertent arterial injury or bleeding during cholecystectomy.]

[Image: A labeled diagram of the biliary tree. The diagram shows the confluence of the left and right hepatic ducts forming the common hepatic duct, which joins the cystic duct from the gallbladder to form the common bile duct. It also shows the pancreatic duct joining the common bile duct at the ampulla of Vater. Labels point to the cystic duct, supraduodenal, retroduodenal, infraduodenal, common hepatic duct, left hepatic duct, common bile duct and others.]

## Biliary tree

- Intrahepatic ducts drain individual liver segments → Left and right hepatic ducts → Common hepatic duct (2.5cm)
  - Duct of Luschka: accessory branch from Segment V of liver joining the R hepatic duct → risk of injury during cholecystectomy causing bile leakage
- Cystic duct: 3cm long, mucosa with spiral folds (valves of Heister)
  - Must be identified passing into neck of GB ("critical view of safety") and ligated just next to GB
- Common bile duct: 7.5cm long, <7mm wide
  - 3 portions: supraduodenal, retroduodenal, infraduodenal
- Hepatopancreatic ampulla (of Vater)
  - Sphincterotomy may be required to access CBD in ERCP

# Pancreas

[Image Description: A highly detailed and colorful anatomical illustration of the pancreas and surrounding organs. The pancreas is depicted in the center, with labels pointing to its various parts such as head, neck, body, tail, and uncinate process. Nearby organs including the stomach, duodenum, spleen, gallbladder, and liver. Arteries and veins such as the hepatic portal vein, splenic artery, superior mesenteric artery, and pancreaticoduodenal arteries are also highlighted. The illustration includes directional arrows to indicate blood flow and labels to identify different anatomical structures.]

## Anatomy

- Retroperitoneal organ behind lesser sac and stomach (posterior surface of pancreas is devoid of peritoneum)
- Parts: head, neck, body, tail, uncinate process
- Pancreatic ducts:
  - Main pancreatic duct (of Wirsung): tail 1mm → body 2mm → head 3mm
  - Accessory pancreatic duct (of Santorini)
- Embryology: uncinate process from ventral bud, rest of pancreas from dorsal bud

## Vascular supply

- Head: ant. & post. superior pancreaticoduodenal artery (←GDA), inferior pancreaticoduodenal artery (SMA)
- Neck, body, tail: branches of splenic a. (e.g. dorsal pancreatic a., transverse pancreatic a.)

## Relationship

- Neck of pancreas is **anterior** to formation of **portal vein** (from SMV and splenic v.) on **transpyloric plane** (L1)
  - CA pancreas might involve these vessels (unresectable!)
- Uncinate process is **posterior** to SMA and SMV
- Splenic a. has tortuous course just **above** body of pancreas

## Physiology

- 98% exocrine pancreas: acinar cells release trypsinogen, lipase, amylase (stimulated by CCK)
- 2% endocrine pancreas: islet of Langerhans

| a cell  | glucagon               |
| ------- | ---------------------- |
| ẞ cell  | insulin                |
| 8 cell  | somatostatin           |
| PP cell | pancreatic polypeptide |

5.2 HBP investigations
USG

- Transabdominal USG: may be compromised by excessive body fat and intraluminal bowel gas
  - Can be contrast-enhanced (CEUS)
  - Assessment of USG abdomen
- Pancreas
- Biliary system: dilatation, stone
  - Distal CBD often obscured by bowel gas
- GB: distended or contracted
- Liver: IHD, abscess
- CBD limit: 0.1cm for every 10 years old
- Cause of dilated CBD
  - Obstruction
  - Aging
  - Post-cholecystectomy

Endoscopic USG (EUS):

- Useful in choledocholithiasis
- Useful in diagnosing & staging pancreatic and periampullary cancers

CT abdomen

- Useful in staging HBP tumours
- Not useful in detecting gallstones (only 75% gallstones identified)

MRI liver

- Liver-specific contrast (Primovist): superior to CT in detecting small HCC vs regenerative nodules

Cholescintigraphy (HIDA scan)

- HIDA is selectively taken up by retroendothelial cells of liver and excreted into bile
- Acute cholecystitis: non-visualised GB
- Chronic cholecystitis: reduced GB

Magnetic resonance cholangiopancreatography (MRCP)

- **Non-contrast, T2-weighted**
- Non-invasive imaging of biliary system & GB
- Avoid complications associated by ERCP, but NOT therapeutic

Percutaneous transhepatic cholangiography (PTC)

- Diagnostic: visualisation of biliary tree
- Therapeutic: bile drainage by catheter (PTBD) or insertion of indwelling stents
- Preferred to ERCP in:
  - Stricture/ obstruction at or above the level of confluence of hepatic ducts (fig.)
  - Examples: cholangiocarcinoma, PSC, RPC
- Complications: bacteraemia (thus antibiotic prophylaxis required), haemobilia

Endoscopic retrograde cholangiopancreatography (ERCP)

- See [Basic principles]

[X-ray image showing a percutaneous needle inserted into the biliary system. Contrast has been injected and shows dilated intrahepatic bile ducts. There is no contrast passing into the extrahepatic bile ducts due to a Klatskin tumor at the confluence of the left and right hepatic ducts. A stent has been inserted in an attempt to alleviate the obstruction. The percutaneous needle insertion site is indicated by a black arrow, and the stent insertion site is indicated by a white arrow.]

5.3 Obstructive jaundice

Definitions

- Jaundice: yellow pigmentation of skin and eyes as a result of excess bilirubin in the circulation, clinically detectable when bilirubin > 50 mmol/L
- Obstructive jaundice: jaundice resulting from biliary obstruction
- **Painless progressive obstructive jaundice** in elderly is malignant biliary obstruction until proven otherwise

Differential diagnosis of obstructive jaundice

- Intraluminal: gallstone (choledocholithiasis, acute cholangitis), RPC
- Mural: cholangiocarcinoma, PSC
- Extramural: CA head of pancreas, lymphadenopathy, gallstone (Mirizzi's syndrome)

Important questions in history taking

- Differential medical (pre-hepatic/ hepatic) vs surgical (obstructive) causes
  - Medical: normal coloured urine & stool
    - Pre-hepatic (hemolysis, Gilbert's syndrome): Palpitation, dizziness
    - Hepatic (hepatitis, decompensated CLD, drugs): Fever, RUQ pain, n/v
  - Surgical: tea-coloured urine, pale-coloured stool, steatorrhoea (floating, foul-smelling, difficult to rush)
    - Tea-coloured urine: no recent intake of rifampicin/ Pyridium/beetroot
- Differentiate stone vs tumour

|                   | Stone                                                                                             | Tumour                                                                                                 |
| :---------------- | :------------------------------------------------------------------------------------------------ | :----------------------------------------------------------------------------------------------------- |
| Jaundice          | Intermittent (stone may pass out)                                                                 | Progressive For HCC, jaundice only when functional liver reserve drops to 25%                          |
| Pain              | Painful: as stones go through Ampulla of Vater                                                    | Painless (until advanced) Except CA pancreatic head: well innervated, spread to coeliac ganglion early |
| Infection (fever) | More likely: accumulation of bile refluxed from GI tract (normally prevented by ampulla of Vater) | Until late stage, malnourished                                                                         |
| Others            |                                                                                                   | Constitutional Sx: LOW, LOA, night sweats                                                              |

- PMH: gallstone, hepatitis B carrier, IBD (risk factor for PSC)
- SH: smoking, alcohol, IVDA, tattoos

Investigations

[A flowchart titled "Jaundice (↑ serum bilirubin)" is displayed. At the top, there is a box labelled "Fractionate bilirubin". This box has two outgoing arrows. The left arrow points to a box labelled "Primarily unconjugated", while the right arrow points to a box labelled "Primarily conjugated".

The "Primarily unconjugated" branch leads to boxes containing information about Hemolysis and Gilbert's syndrome.

The "Primarily conjugated" branch leads to a box labelled "Hepatobiliary disease Abdominal ultrasound", which is connected to another box labelled "Cholestatic pattern".

Below the "Hepatobiliary disease Abdominal ultrasound" box is a split, with one path leading to "Hepatitic pattern" and the other leading to "Cholestatic pattern".

The "Hepatitic pattern" path includes a box labelled "Bile duct normal" connected to a box labelled "Hepatocellular disease Drugs Alcohol Virus Autoimmune Hemochromatosis Wilson's disease, etc.".

The "Cholestatic pattern" path includes a box labelled "Bile duct dilated", which splits into two paths. The left path leads to "Extrahepatic cholestasis Visualize bile duct" and subsequently to "Endoscopic bile duct decompression not likely to be necessary MRCP". The right path leads to "Intrahepatic cholestasis PBC/PSC Drugs AMA, P-ANCA MRCP Liver biopsy".

Additionally, there is a small box labelled "Bile duct obstruction >8mm" connected to "Extrahepatic cholestasis Visualize bile duct". There is also a box labelled "Endoscopic bile duct decompression likely to be necessary ERCP" connected to "Endoscopic bile duct decompression likely to be necessary MRCP".

Finally, at the bottom left, there is a box labelled "CBC Blood film DCT".]

Note: DDx of post-operative jaundice

- Pre-hepatic: hemolysis (e.g. transfusion)
- Hepatic: use of halogenated anesthetics, sepsis, intra-op / post-op hypotension
- Post-hepatic: biliary injury

# 5.4 Surgical liver diseases

**Benign liver neoplasm**

|                   | Haemangioma (MC benign liver tumor)                                                                                                                                | Focal nodular hyperplasia (FNH)                                                   | Hepatic adenoma                                                                                                                                                         |
| ----------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------ | --------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Pathology         | Congenital vascular malformation                                                                                                                                   | Hyperplastic regenerative nodule                                                  | Benign proliferation of hepatocytes (hepatoma)                                                                                                                          |
| Risk factors      | Female                                                                                                                                                             | Female, OCP                                                                       | Female (25-50yo), OCP                                                                                                                                                   |
| Clinical features | Incidental finding Often multiple +/- Consumptive coagulopathy if giant (child)                                                                                    | Asymptomatic **Usually solitary** and <5cm May regress                            | **Usually solitary** RUQ mass Rupture → hemoperitoneum                                                                                                                  |
| Investigations    | USG: well-demarcated hyperechoic **compressible** mass with high vascularity Triphasic CT: peripheral nodular enhancement with progressive **centripetal fill-in** | USG: solid mass with central fibrous scar Triphasic CT: **central stellate scar** | USG: well-demarcated hyperechoic mass Triphasic CT: homogenous enhancement throughout                                                                                   |
| Management        | Observation Serial USG if >5cm Resection if rapid growth / symptomatic (e.g. pain despite analgesia) / complicated (e.g. GOO)                                      | LFT, AFP +/- MRI, liver biopsy No need follow up (no malignant potential)         | Stop OCP + serial USG Excision (esp. if > 5cm): risk of **malignant transformation** (10% to HCC) and spontaneous rupture Avoid pregnancy: RFA before pregnancy if >2cm |

[Image showing a comparison of haemangioma, FNH and adenoma in arterial (20-30 sec), portal venous (60-80 sec) and delayed (6-10 min) phase. In the arterial phase, haemangioma has high arterial enhancement, FNH has a central scar with arterial enhancement, and adenoma has heterogeneous arterial enhancement. In the portal venous phase, haemangioma retains contrast, FNH is washed out except for the central scar, and adenoma shows washout. In the delayed phase, haemangioma remains enhanced, FNH shows central scar enhancement, and adenoma is washed out.]

[Image showing a large cystic mass in the right hepatic lobe.]

**Liver cysts**

|                          | Description                                                             | S/S                     | Ix  | Mx                                                                                              | Cx                      |
| ------------------------ | ----------------------------------------------------------------------- | ----------------------- | --- | ----------------------------------------------------------------------------------------------- | ----------------------- |
| Simple cysts             | Contain clear fluid that do not communicate with intrahepatic bile duct | Usually asymptomatic    | USG | Not required unless symptomatic (bleeding) Laparoscopic deroofing, with oversewing of cyst wall | Intracystic haemorrhage |
| Polycystic liver disease | Multiple cysts that replace the liver tissue                            | 50% associated with PKD | USG | Partial liver resection Drainage                                                                |                         |

| Hydatid liver disease | Infection with tapeworm _Echinococcus granulosus_ with exposure to dogs/sheep | Usually asymptomatic Hepatomegaly Chronic RUQ pain | USG CT: **floating membrane** within the cyst (fig.) Serology | Albendazole Percutaneous: PAIR (puncture, aspiration, injection of hypertonic saline, re-aspiration) Definitive: open / lap. deroofing and complete excision | IVC compression Rupture: to lung (empyema), biliary tract (cholangitis), anaphylaxis |
| --------------------- | ----------------------------------------------------------------------------- | -------------------------------------------------- | ------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------ |
| Cystadenoma           | Rare cystic tumours in liver or extrahepatic bile ducts                       | Epigastric mass/ pain                              | USG Biopsy                                                    | Complete excision of cysts                                                                                                                                   | Cystadenocarcinoma                                                                   |

Liver abscess
Pathogens

- Pyogenic liver abscess: _Streptococcus milleri, E. coli,_ Klebsiella pneumoniae (common in >60yo + _DM_),
- Amoebic liver abscess: Entamoeba histolytica
  Etiology
- Ascending biliary infection (20-30%): e.g. RPC, cholecystitis, cholangitis, infected tumors
- Spread from portal vein (20%): intra-abdominal infections e.g. acute appendicitis, diverticulitis, Crohn's
- Others: e.g. penetrating injury, systemic bacteremia
  Clinical features
- **Swinging fever,** chills and rigors, septic-looking
- **Tender hepatomegaly** (jaundice not significant: mainly liver abscess affected)
- **Bloody dysentery** for amoebic liver abscess
  Investigations
- CBC D/C (note no eosinophilia in amoebic liver abscess), LFT, CRP (for monitoring Tx)
- **Blood culture**
- +/- Amoebic serology, stool microscopy
- Blood glucose level (DM is risk factor)
- Imaging:
- CXR: right basal collapse / effusion
- USG: multiloculated cystic mass, no vascularity
- **CT abdomen with contrast:** double-target sign (rim-enhancing with central hypodensity), cluster sign
- Image-guided aspiration for C/ST: anchovy paste-like for amoebic liver abscess
- For Klebsiella liver abscess
- Urgent consult **eye** if symptoms of endophthalmitis
- Monitor for meningitis
- Colonoscopy for underlying neoplasm
  Management
- IV antibiotics: Augmentin / ceftriaxone + metronidazole (for amoebic coverage) for at least **4-6 weeks**
- Klebsiella liver abscess: meningitic dose ceftriaxone (2g Q12h)
- Percutaneous drainage: USG/CT-guided, both diagnostic and therapeutic
- Needle aspiration if <5cm, catheter placement if >5cm
- Usually not needed for amoebic abscess (only antimicrobials are enough)
  Complications
- Rupture (esp if large): e.g. subphrenic abscess
- Pleuropulmonary complications: pleurisy, pleural effusion, empyema
- Local compression: Budd-Chiari syndrome
  [Image of a ultrasound. The image shows a dark, circular area with a bright spot inside. A white line is pointing toward the bright spot inside the dark circular area.]
  [Image of a abdominal CT scan showing multiple abscesses in the liver. The liver is filled with multiple, dark, circular lesions, each surrounded by a thin, bright rim. The lesions vary in size, with some being quite large.]

# Hepatocellular carcinoma

Overview

- MC primary liver cancer (80%) (intrahepatic cholangiocarcinoma 15%), 5th MC cancer in HK, 3rd in mortality
- Patterns: solitary / multifocal/diffuse
- Histological subtype: - Non-fibrolamellar: a/w HBV and cirrhosis - Fibrolamellar (FLC): a/w younger patients, not a/w HBV or cirrhosis; good prognosis
  Risk factors
- Any cause of cirrhosis: infection (HBV, HCV), metabolic (ALD, NAFLD, Wilson's disease), immune (PBC, PSC)
  - HBV infection carcinogenic in terms of cirrhosis + DNA damage induced by HBV DNA integration
- Smoking, alcohol (free radical production)
- Obesity, DM (liver involved in glucose metabolism)
- Chemical carcinogens, e.g. aflatoxin
  Clinical features: late presentation + absence of pathognomonic symptoms → difficult diagnosis
- Local:
  - RUQ pain +/- right shoulder pain (2° to Glisson's capsule distension)
  - Hepatomegaly
  - Obstructive jaundice (invasion to biliary tree or compression of intrahepatic duct) - NOT common
  - Constitutional symptoms: LOA, LOW
  - Deranged LFT in cirrhotic patients: e.g. encephalopathy, coagulopathy, portal HT (ascites, edema, UGIB), hepatorenal syndrome
- Paraneoplastic syndromes:
  - Erythrocytosis (EPO secretion from tumour)
  - Hypoglycaemia (high metabolic demands of tumour + IGF-2 secretion)
  - Hypercholesterolemia (autonomous cholesterol synthesis)
  - Hypercalcaemia (PTHrP secretion)
  - Watery diarrhoea (VIP secretion)
  - Cutaneous features: dermatomyositis, Leser-Trelat sign (explosive onset of multiple seborrheic keratoses)
- Ruptured HCC
- Metastasis: intrahepatic (via portal vein / hepatic vein), lung (MC), bone, brain, peritoneum, adrenals

Investigations
Investigations for diagnosis

- Bloods: CBC, clotting, LRFT, albumin
- Viral serology for underlying chronic hepatitis
  - HBV: HBV DNA, HBsAg, HBeAg (↑risk of HCC)
  - HCV: anti-HCV IgG, HCV RNA
- AFP: normal <6 (raised in 80%), level correlates with prognosis (risk of recurrence)
  - False positive AFP: pregnancy, germ cell tumor / teratoma, liver cirrhosis, hepatitis,
- USG HBP: screening for HCC (any nodule that is not clearly hemangioma = HCC until proven otherwise)
  - Mass < 1cm: repeat USG Q6m (rationale: tumor doubling time ~4 months)
  - Mass ≥ 1cm: triphasic CT
- **Triphasic CT scan** (gold standard)

|                   | HCC                                                                    | Liver metastasis |
| :---------------- | :--------------------------------------------------------------------- | :--------------- |
| Key features      | Rich supply by hepatic artery (normal liver parenchyma mainly from PV) | Hypovascular     |
| Arterial phase    | Hyperdense                                                             | Hypodense        |
| Portovenous phase | Washout (hypodense)                                                    | Hypodense        |
| Delayed phase     | Hypodense                                                              | Hypodense        |

- MRI liver with Primovist contrast (hepatospecific contrast) - if CT C/I or equivocal findings
  - Typical features: high intensity on T2-weighted and low intensity on T1-weighted images
- Contrast-enhanced USG

[Image: The image contains two bulleted lists and a table, all related to hepatocellular carcinoma.
The first bulleted list, titled "HCC - 80% tumour", details the characteristics and treatment outcomes of HCC, noting its prevalence, association with HBV and liver cirrhosis, and treatment options.
The table compares HCC to liver metastasis across different phases and features, including key characteristics, arterial phase, portovenous phase, and delayed phase, highlighting the differences in vascularity and intensity between the two conditions.
]

124

- CT hepatic angiography: inject intraarterial contrast (e.g. SMA, hepatic a.)
- Post-lipiodol CT scan: HCC shows up on Day 10 due to lack of Kupffer cells to ingest lipiodol
- Percutaneous liver biopsy: Only done in inconclusive diagnosis and unresectable cases (e.g. differentiate primary from secondary tumors) - Contraindications: bleeding tendency (e.g. INR > 1.2 despite vit K), thrombocytopenia (Plt < 50), high-grade biliary obstruction (risk of bile peritonitis) - Risk of bleeding (hypervascular tumour), organ puncture, needle tract seeding of tumour - IHC can be performed to determine liver metastasis of unknown origin - CK-7 (CA lung), CK-19 (CA breast), CK-20 (CRC), TTF-1 (lung adenoCA / thyroid CA)
  Investigations for staging
- Imaging: triphasic CT, bone scan
- PET-CT: limited sensitivity as HCC does not take up FDG well and liver has high background metabolic activity → require dual-tracer ([11C]-acetate + [18F]-FDG) - taken up by tumour cells at varying degrees
- TNM staging vs BCLC staging (less preferred by HK liver surgeon - KC Ng)
  | TNM staging | BCLC staging |
  |----------------------------------------------------|-------------------------------------------------------------------|
  | Validated in patients treated with liver resection or transplantation | T staging of tumor: **number, size, vascular invasion** (inc. ruptured HCC) |
  | | Underlying liver function (Child-Pugh score) |
  | | Eastern Cooperative Oncology Group Performance status (ECOG PS): **0-4** |

Investigations for complications

- CBC: low Hb, Plt (hypersplenism)
- Child-Pugh score (alternative: Albi score - only takes into account objective factors i.e. albumin & bilirubin)
  | Points | Class | One year survival | Two year survival |
  |--------|-------|-------------------|-------------------|
  | 5-6 | A | 100% | 85% |
  | 7-9 | B | 81% | 57% |
  | 10-15 | C | 45% | 35% |

| Clinical & Laboratory Parameters | Points scored for increasing abnormality |
| -------------------------------- | ---------------------------------------- | --------- | --------- |
|                                  | 1                                        | 2         | 3         |
| Albumin (g/L)                    | >35                                      | 28-35     | <28       |
| Bilirubin (mmol/l)               | <35                                      | 35-50     | 50        |
| Clotting profile (INR)           | <1.7                                     | 1.7-2.3   | >2.3      |
| Distended abdomen (ascites)      | Absent                                   | Slight    | Moderate  |
| Encephalopathy                   | Absent                                   | Grade 1&2 | Grade 3&4 |

Management overview
Curative options: **liver resection, local ablation, liver transplant (diseased donor / living donor)**
Palliative options: TACE, sorafenib
BCLC algorithm - for reference, different from local management approach

[Image Description: A flow chart illustrates the hepatocellular carcinoma treatment algorithm based on the Barcelona Clinic Liver Cancer (BCLC) staging system. The chart begins with five categories: Very early stage (0), Early stage (A), Intermediate stage (B), Advanced stage (C), and Terminal stage (D). Each stage has specific treatments. Very Early Stage (0) with single nodule ≤2 cm, Child-Pugh A, ECOG 0, flows to ablation, resection, and transplantation (DDLT/LDLT). Early Stage (A) with single or ≤3 nodule ≤3 cm, Child-Pugh A-B, ECOG 0, branches to a decision point: Solitary (leads to "Optimal Surgical candidate 1") or 2 to 3 nodules ≤3 cm (leads to "Transplant candidate"). From there, ablation is the next step. Intermediate Stage (B) with multinodular, Child-Pugh A-B, ECOG 0, progresses to chemoembolization. Advanced Stage (C) with portal invasion, N1, M1, Child-Pugh A-B, ECOG 1-2, flows to first-line systemic therapy (Atezolizumab + Bevacizumab), then second-line systemic therapy (Sorafenib, Lenvatinib), and finally third-line systemic therapy (Regorafenib, Cabozantinib, Ramucirumab) or nivolumab and pembrolizumab. Terminal Stage (D) with Child-Pugh C, ECOG >3, progresses to best supportive care. Median overall survival (OS) data is also given, with 10 years for transplantation and >6 years for resection/ablation, >26 to 30 months for chemoembolization, >17 months for first-line systemic therapy, 13 to 15 months for second-line, 8 to 12 months for third-line, and 3 months for best supportive care. ]

Liver resection^

- First-line treatment unless not eligible (80% not eligible)
- High recurrence rate (80% within 5 years): "field change" effect
  - Intrahepatic metastasis (< 2 years) vs De-novo HCC (> 2 years)
- Types of resection: Wedge resection, segmental resection, hepatectomy^
- Pre-requisite: size < 5cm is usual threshold (lower risk of vascular invasion) but tumor number and size itself is NOT a contraindication
- Resectability (_must know!_)

| Liver factor                             | Adequate future liver remnant (FLR)^ ≥30% (non-cirrhotic liver), ≥40% (cirrhotic liver), 50% (chemoRT) Hepatic reserve assessment: CT hepatic volumetry: volume of remnant / ideal liver volume (est. by weight & height) Indocyanine green (ICG) clearance: ICG retention at 15 mins (ICG-15) <15% for major resection, <21% for minor resection Pre-operative liver function: C/I if Child's C or portal hypertension |
| :--------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Tumor factor (Similar to Milan criteria) | Contraindications include: Extrahepatic metastasis (except GB) Tumor involving main vessels e.g. main portal vein*, hepatic artery, IVC Bi-lobar tumors* (_not absolute C/I: can do ALPPS_)                                                                                                                                                                                                                             |
| Patient factor                           | General fitness for GA e.g. DM, RFT                                                                                                                                                                                                                                                                                                                                                                                     |

\*Multiple tumors / intrahepatic vascular invasion (e.g. main hepatic vein, left / right PV) are not considered contraindications for liver resection.

^Liver augmentation: ↑FLR

- Portal vein embolization (PVE): obliterate portal blood flow to selected portion of liver (on tumor side) → elicit physiological hypertrophy of liver remnant
- Portal vein ligation: similar to PVE
- Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): 2-staged procedure for initially unresectable liver

| Stage 1 | Tumor resection from L lateral segment Ligate R portal vein but preserve R hepatic artery, hepatic vein and bile duct: prevent liver failure during interval Parenchymal transection: remove collateral PV → accelerated hypertrophy, but frisk of bile leakage |
| :------ | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Stage 2 | R trisectionectomy after 1-2 weeks                                                                                                                                                                                                                              |

Surgical techniques during hepatectomy

- Head up position and keep CVP low to reduce bleeding
- No-touch technique: separation of hemi-liver and tumor from IVC before mobilization - risk of vessel rupture
- Pringle's maneouver at Foramen of Winslow: intermittent clamping (15 minutes →5 minute rest)
- Intraoperative USG: localize tumor
- Anatomical resection: follow Couinaud segments to remove potential satellite nodules
- Instruments: Ligasure, Cavitron ultrasonic surgical aspirator (CUSA) for parenchyma
  Post-operative care
- Specific complications: mortality < 5%
  - Bile leakage: drain bilirubin concentration ≥ 3x serum bilirubin on or after Post-op Day 3
  - Post-hepatectomy liver failure: Day 5 bilirubin >50 and INR > 1.7 (50-50 rule) = high risk
  - Ischemic damage to liver remnant: prolonged rotation → twisting of inflow and outflow pedicles
- Surveillance: Imaging (USG alternating with CT), AFP - FU Q3m for 2 years, then Q6m until 5 years

^Hepatectomy

- Minor (<3 segments), major (≥4 segments)
- Right = segments 5-8
- Central = segments 4, 5, 8
- Left lateral = segments 2, 3
- Left = segments 2-4
- Extended left = segments 2-5, 8

[Image Description: The image has two columns. The first column shows a flow chart, a list of conditions, and a table. The second column shows a diagram of the liver divided into sections, and below the liver, a long, narrow color photo of a torso showing a scar on the stomach.]

A. Open left lateral sectionectomy
B. Laparoscopic left lateral sectionectomy

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)

[Image Description: This is a diagram of two stages of liver resection with labels indicating the changes at each stage.]

126

Liver transplantation

- Scar: Mercedes-Benz scar
- Indications: ≤65 years with Child C cirrhosis / **unresectable** HCC who meet transplant criteria
- Contraindications: active uncontrolled infection, active alcohol/ substance abuse
  - HBV carriers: antivirals x 2mo before transplant + long-term HBIG after transplant
- **Bridging therapy** (e.g. RFA, TACE) is possible to shrink the disease to fulfil transplant criteria, and to prevent tumor progression whilst waiting for transplant

| Criteria                                 | Details                                                                                                                                       | Role                                                             |
| ---------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------- |
| UCSF criteria                            | Single lesion ≤ 6.5 cm in diameterOR ≤3 lesions, each ≤ 4.5cm, sum ≤ 8.0cm                                                                    | Drop-off criteria: only those fulfilled are included in the list |
| Model for End-stage Liver Disease (MELD) | Cr (hepatorenal Sx), bilirubin, INR+/- Na (vasodilation and fluid retention in cirr.)                                                         | Prioritize the list for liver transplant(benefit if score > 18)  |
| Milan criteria                           | Single lesion ≤ 5cm in diameterOR ≤ 3 lesions, each ≤ 3cm in diameterNo gross vascular invasion (PV thrombosis)No nodal or distant metastasis | Bonus score if fulfilled(>75% 5-year survival)                   |

- Complications:
  - Graft failure
  - Acute & chronic rejection
  - Vascular: hepatic artery or portal vein thrombosis, IVC obstruction
  - Complications due to immunosuppression: HT, DM, hyperlipidaemia, osteoporosis, infection

Local ablation

- Roles: Potentially curative, bridge therapy to transplant, or palliative
- Radiofrequency ablation (RFA)
  - Indications: small single tumour < 2cm (as alternative to resection – _resection is preferred if 2-5cm_), **inoperable** solitary HCC < 5cm, **inoperable** ≤3 nodules ≤3cm where transplant not feasible
  - Contraindications: too close to major vessels / major bile ducts / diaphragm (if percutaneous)
  - Route: percutaneous, open
  - Complications: bile duct injury, thermal injury to surrounding tissues
- Other less commonly used: ethanol, microwave, high-intensity focused ultrasound (HIFU), cryotherapy

Trans-arterial chemoembolization (TACE)-大牌針

- Based on the premise that tumour is mainly supplied by hepatic artery
- Procedure:
  - Selective intra-arterial administration of chemotherapy e.g. cisplatin, doxorubicin (drug-eluting beads)
  - Emulsified with lipiodol: retain longer in HCC (no Kupffer cells to ingest)
  - Partial embolization of major tumor artery with Gelfoam: ↓ clearance of chemo, promote tumor necrosis
- Indication: large (>5cm) + unresectable + Child A/B
- Contraindications: portal vein thrombosis (→ liver ischaemia), Child's C, distant metastasis, AV shunt to hepatic vein (→ risk of PE)
- Complications:
  - Post-embolisation syndrome (within 14 days): liver injury due to tumour lysis or ischaemic damage to normal liver tissue; S/S fever, RUQ pain, anorexia; resolve spontaneously after 1 week
  - Liver failure: due to infarction of normal liver tissues
  - Bile duct injury
  - GI bleeding: cytotoxic reflux into other arterial supply to stomach
  - Alterative: transarterial radioembolization (TARE) with 90Yttrium

Others

- Selective internal radiation therapy (SIRT): high-dose RT (3-6 fractions) to small inoperable HCC
- Sorafenib: multitargeted kinase inhibitor (e.g. Raf, VEGF, PDGF)
  - Prolonged survival by 3 months [SHARP trial]
  - Side effects: hand-foot syndrome (acral erythema)
  - Alternatives: other TKI (e.g. regorafenib / lenvatinib), single-agents (e.g. doxorubicin, cisplatin), bevacizumab

Ruptured HCC
Pathogenesis: tend to occur in large and peripherally located tumors (occur in 5-10% of HCC)

- Increased intra-tumoural pressure with occlusion of hepatic veins by tumour thrombi or invasion
- Rapid tumor growth and necrosis
- Vascular dysfunction --> friable vessel
  Clinical features
- Sudden onset of epigastric pain with abdominal distension
- Hypovolemic shock
- Increased likelihood of peritoneal seeding
- Prognosis poor: mortality 25-100%
  Acute management - Resuscitation and initial investigations
- Admit ICU
- NPO, IV access, fluid resuscitation +/- blood products transfusion, monitor vitals, I/O, CVP
- CBC, LRFT, clotting, X-match, HBsAg (may need entecavir cover)
- CXR, USG
- CT scan when stabilized to rule out portal vein thrombosis
  Definitive treatment
- Transarterial embolisation (TAE) if portal vein patent and reasonable LRFT
  - Cx: liver failure, embolism, arterial dissection
- Emergency laparotomy
  - Perihepatic packing + suture plication (small bleeding site only)
  - Absolute alcohol injection
  - Selective hepatic artery ligation (HAL)
  - Staged liver resection
    [Abdominal CT Scan Image: Two axial views of the abdomen are displayed. The image on the left shows a large mass in the liver, indicated by a red arrow, suggesting a tumor. The image on the right shows another axial view, with a red arrow pointing to what appears to be a mass or abnormality in the pelvic region.]
    HCC Screening
- Targets: HBV carriers > 40y, HBV with cirrhosis, HBV/ HCV co-infected with HIV
- Method: USG + AFP Q6m
- CUHK-HCC score: age, albumin, bilirubin, cirrhosis, HBV DNA
  127

Liver metastasis

- MC liver tumour (20x more common than 1º liver tumour)
- Aetiology: _Some GU Cancers Produce Bumpy Lumps_
  - Stomach
  - GU: kidney, ovary, uterus
  - Colon (MC) - 1/3
  - Pancreas
  - Breast
  - Lung
- S/S: hard nodular hepatomegaly, RUQ tenderness, obstructive jaundice (if met to porta hepatis LN)
- Investigations
  - Tumor markers: CEA, CA19-9, AFP, chromogranin A (neuroendocrine marker)
  - **Triphasic CT scan:** hypodense lesion on all phases
  - Full staging workup: e.g. CXR, CT T+A+P, PET-CT, MRI liver with contrast

[Image: CT scan of the abdomen showing multiple liver metastases. The liver is enlarged and contains numerous round lesions, indicating widespread tumor involvement.]

Management of colorectal liver metastasis - similar to primary HCC

- 5-year survival 40-50%
- Resectability
  - Liver factor: **adequate future liver remnant >25%**
  - Tumor factor: R0 (>1cm resection margin), risk scores (e.g. disease course, CEA, # and size of metastasis)
  - Patient factor: fitness for surgery
- C/I: **unresectable** extrahepatic malignancy
- Approach: **laparotomy**
  - Search for regional LN involvement, peritoneal deposits, etc.
  - Intra-op USG to assess number of lesions and determine resectability
  - Total vascular exclusion: may allow resection with involvement of major vessels
- Perioperative chemotherapy: FOLFOX

[Image: A CT scan of a liver with multiple metastatic lesions, similar to the first image but potentially showing a different view or stage.]

Management of other metastases

- Hepatic resection: may be beneficial for some tumors e.g. carcinoids
- TACE: for hypervascular metastases e.g. RCC, breast

Liver injury
AAST scale of liver injury

[Image: A schematic diagram illustrating the American Association for the Surgery of Trauma (AAST) scale for liver injury, showing different grades of injury based on depth of laceration, surface area involved, and the presence of active bleeding. The diagram depicts liver injuries ranging from Grade I (minor laceration) to Grade V (severe parenchymal disruption and vascular injury). The different grades are visually represented with corresponding depths of injury, surface area percentages, and textual descriptions. Grade I shows a small laceration less than 1 cm in depth affecting less than 10% of the surface area. Grade II shows a laceration of 1-3cm in depth affecting 10-50% of the surface area. Grade III depicts a laceration of more than 3cm in depth affecting more than 50% of the surface area with active bleeding contained with the parenchyma. Grade IV shows parenchymal disruption extending to the peritoneum with active bleeding. Grade V shows parenchymal disruption with juxtahepatic venous injury.]

5.5 Gallstone diseases
Overview
Stone composition and pathophysiology

- Most are mixed stones

| Constituents                                                                                                                             | Features     | Pathophysiology                                                                                                                                                                                                                                                         |
| :--------------------------------------------------------------------------------------------------------------------------------------- | :----------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Cholesterol stone (85%)                                                                                                                  | Radiolucent  | Increased cholesterol secretion in bile / Supersaturation of cholesterol (lithogenic bile) - Oestrogens: **fat, female, forty, fertile** (OCP) Decreased emptying of GB - GB stasis, e.g. DM neuropathy - GB malignancy - Pregnancy: progesterone - Fasting, TPN (JCCK) |
| Pigmented stone Black stone: Ca bilirubinate Cholesterol < 30% Brown stone: Ca bilirubinate with bacterial cell bodies Cholesterol < 30% | Radio-opaque | Chronic haemolysis, e.g. G6PD, thalassemia Chronic liver disease                                                                                                                                                                                                        |
|                                                                                                                                          | Radio-opaque | Bacterial infection (e.g. E. coli / Klebsiella: b- glucuronidase - converts conjugated bilirubin back to unconjugated) RPC e.g. Clonorchis sinensis, Ascaris lumbricoides                                                                                               |

[Image of factors associated with gallstone formation. The image shows the impaired gall-bladder function (Emptying, absorption, excretion) and supersaturated bile and the effect of age, sex, genetics, obesity, and diet on it. There is also a description of cholesterol nucleating factors such as mucus, glycoprotein, and infection and absorption/enterohepatic circulation of bile acids such as deoxycholate, bowel transit time, faecal enteric flora, Ileal resection, and cholestyramine. The image also contains illustration of different parts of the liver, gallbladder, cystic duct, biliary colic, and asymptomatic stone. The common bile duct, choledocholithiasis, acute cholangitis, pancreatic duct, and acute biliary pancreatitis are also illustrated.]

Summary: Possible clinical presentations of gallstones

- Asymptomatic (MC – 80%)
- Symptomatic: fig.
  - Biliary colic
  - Complications:
    - Gallbladder: acute cholecystitis, chronic cholecystitis, CA gallbladder, Mirizzi's syndrome, gallbladder empyema/hydrops, gallbladder perforation, mucocele
    - Biliary tree: choledocholithiasis, acute cholangitis, acute biliary pancreatitis
    - Bowel: cholecystoenteric fistulation (Bouveret's syndrome, gallstone ileus)

Note: Courvoisier's Law

- Definition: in painless jaundice with enlarged gallbladder, the cause is unlikely to be gallstone
- Pathophysiological basis: a gallbladder containing stones is likely subject to repeated episodes of cholecystitis, causing extensive fibrosis of the wall → unable to distend when obstructed → periampullary tumours until proven otherwise
- Exceptions (acute cholecystitis with jaundice) - Double impaction (7%): stone simultaneously occluding the cystic duct and the distal CBD - Mirizzi syndrome - RPC
  Note: Saint's triad = gallstones + hiatal hernia + colonic diverticulosis

130
Asymptomatic gallstones

- Risk of future complications: 1-4%/ year
- Management:
  - Watchful waiting: risk factor modifications
  - Ursodeoxycholic acid (oral bile acid: only useful for cholesterol stone)
  - Prophylactic cholecystectomy in high risk patients [Refer to "Cholecystectomy"]

Symptomatic gallstones - summary of main conditions
| | Biliary colic | Acute cholecystitis | Choledocholithiasis | Acute cholangitis |
| :---------------- | :---------------------------------------------- | :-------------------------------------------------------------- | :--------------------------------------------- | :------------------------------------------------------ |
| Mechanism | Gallstone stuck at Hartmann's pouch or cystic duct | Inflammation of GB due to gallstone or biliary sludge | Migration of gallstones into CBD | Bacterial infection secondary to CBD obstruction |
| Clinical features | RUQ pain < 6h | RUQ pain > 6h Fever Murphy sign | RUQ pain > 6h | Charcot triad Reynold pentad |
| Lab | Normal | ↑WBC, CRP | LFT: cholestatic pattern | ↑WBC, CRP LFT: cholestatic pattern |
| Diagnostic imaging| USG: gallstone with posterior acoustic shadow + gravity dependent | USG: distended GB, GB wall thickening, pericholecystic fluid Inconclusive: HIDA scan or MRCP | USG: dilated CBD with gallstone | USG: dilated CBD with gallstone Inconclusive: MRCP |
| Management approach| Elective LC | Resuscitation IV antibiotics Prevent recurrence by LC | Supportive Biliary decompression Prevent recurrence by LC | Resuscitation IV antibiotics Biliary decompression Prevent recurrence by LC |

Biliary colic

- Definitions: GB contracting against **transient obstruction** in Hartmann's pouch/ cystic duct due to gallstones
- Clinical features:
  - **Steady** (usually not colicky: no peristalsis in GB / cystic duct)
  - RUQ/epigastric pain
  - Radiates to right shoulder / scapula
  - More severe after fatty meal (↑CCK), n/v
  - Suspect acute cholecystitis if pain > 6h
- Investigations
  - USG gallbladder (fig.): **hyperechoic stone with posterior acoustic shadowing**, gravity-dependent (turn lateral → rolling stone sign)
    - readily available, quick
    - operator-dependent, limited by body fat and bowel gas
  - AXR: +/- Mercedes Benz sign, radio-opacity (only 15%), differentiated from renal stone by lateral view
  - CBC D/C, LFT (cholestatic picture), amylase and lipase (r/o pancreatitis)
- Management: NPOEM, analgesics (NSAIDs preferred), **elective laparoscopic cholecystectomy** (↓risk of future complications)

[An ultrasound image shows the liver, the GB wall, and a hyperechoic gallstone with posterior shadowing. The image is labeled "Liver", "GB Wall", "Hyperechoic gallstone with posterior shadowing" and "SAG GB 0.26cm"]

Acute cholecystitis
Definition: inflammation of GB
Aetiology

- Calculous (95%)
- Acalculous (5%): dehydration, shock, TPN

[An x-ray image shows an upper quadrant of the body with a vague mass in the upper right side, and an arrow pointing to it.]

# Acute calculous cholecystitis

Pathogenesis

- Prolonged gallstone impaction at Hartmann's pouch/ cystic duct → Stagnant bile leads to bile **concentration** (mucocele/ hydrops) → **Chemical** inflammation in first 48h → **Secondary bacterial** infection (G- rods e.g. E coli, Klebsiella, Strep faecalis)

Clinical features

- Pain starts as biliary colic, but:
  - More constant (local parietal peritoneal inflammation)
  - Longer > 6h
  - With signs of inflammation (fever, tachycardia)
- Murphy's sign: inspiratory arrest during deep palpation of RUQ
- Complications:
  - Gallbladder empyema: tender RUQ mass + septic-looking
  - Gangrenous cholecystitis (20%)
  - Perforation: necrotic GB wall (less likely as usually wrapped by omentum) → biliary peritonitis
  - Emphysematous cholecystitis: secondary bacterial infection of GB wall with gas-forming organisms (e.g. Clostridium welchii); S/S insidious onset, abdominal crepitus
  - Cholecystoenteric fistula & gallstone ileus

Investigations

- USG: **5 cardinal signs of acute cholecystitis** (fig.) - _important!_
  1. Presence of gallstones
  2. Distended GB (> 4 x 10cm)
  3. GB wall thickening > 3mm
  4. Peri-cholecystic fluid (due to wall oedema) /stranding
  5. Sonographic Murphy sign
- Inconclusive USG:
  - Radio-isotope scan (HIDA scan): non-visualisation of GB
  - MRCP + Morphine augmentation: ↑SoD pressure
- Bloods: CBC D/C, LRFT, amylase, clotting, blood C/ST, X-match, lipid profile (risk factors)
- CT A+P: to rule out complications (e.g. empyema, emphysematous cholecystitis, perforation)

Initial management

- NPO & IVF until inflammation subsides (bowel rest)
- IV antibiotics: Augmentin
- Monitor vitals, I/O, analgesics

[An ultrasound image displaying a gallbladder with a thickened wall, pericholecystic fluid, and gallstones. The gallbladder (GB) is labeled within the image. Arrows point to the thickened wall and the pericholecystic fluid surrounding the gallbladder. Gallstones are visible at the bottom of the gallbladder.]

[A table titled "Table 1. Diagnostic Criteria for Acute Cholecystitis, According to Tokyo Guidelines.". The table has two columns: "Clinical manifestations" and a description of the manifestations. The table lists Local symptoms and signs, including Murphy's sign, Pain or tendemess in the right upper quadrant, Mass in the right upper quadrant. It also lists Systemic signs: Fever, Leukocytosis, Elevated C-reactive protein level. There are also Imaging findings: A confirmatory finding on ultrasonography or hepatobiliary scintigraphy. Finally, it lists Diagnosis: The presence of one local sign or symptom, one systemic sign, and a confirmatory finding on an imaging test.]

Definitive treatment: **early or interval laparoscopic cholecystectomy (LC) +/- PTC** (_need to know!_)

- Emergency laparoscopic cholecystectomy (LC): if **complicated** (gangrene, perforation, emphysematous cholecystitis) or disease progression despite best supportive care
- Elective laparoscopic cholecystectomy: 1st line for most patient

| Early LC: within 3-5 days of symptom onset                                          | Interval LC: delayed presentation → LC after 6-8 weeks                                                     |
| :---------------------------------------------------------------------------------- | :--------------------------------------------------------------------------------------------------------- |
| Initial inflammation: pericholecystic fluid in dissection plane → easier dissection | After 72h: dense adhesions form at Calot's triangle                                                        |
| Shorter hospital stay, single admission                                             | Lower risk, better laparoscopic success                                                                    |
| Higher risk of bleeding and post-op infections, higher risk of converting to open   | Separate admission, fibrosis causes difficulty in mobilizing GB, chance of recurrence while waiting for OT |

- GB drainage: if not fit for surgery / waiting for interval LC + **not responding to antibiotics**
  - Percutaneous transhepatic cholecystostomy (PTC) [Tubes & Drains]
    - Specific complications: catheter migration, bile leakage, bowel injury
  - Endoscopic drainage: if PC not feasible; transpapillary (ERCP) or transmural (EUS-guided needle drainage / LAMS)

Acute acalculous cholecystitis

- Definitions: microvascular occlusion within GB causing ischaemia and infection
- Risk factors: **hospitalized / critically ill** patients with medical comorbidities
  - Dehydration
  - Shock: systemic hypoperfusion
  - TPN: JCCK
- Clinical features: similar to calculous cholecystitis, but higher mortality
- Investigations: CT/USG to differentiate from calculous cholecystitis
- Management: laparoscopic cholecystectomy / gallbladder drainage (if unfit)

Chronic cholecystitis

- Definitions: chronic inflammation of gallbladder (as seen in histology), almost always due to **gallstone (95%)**
  - Recurrent acute cholecystitis / persistent mechanical irritation → fibrosis and thickening of GB
  - Infected by Salmonella typhi→ typhoid carrier
- Clinical features:
  - Repeated attacks of biliary colic
  - Complications:
    - **CA gallbladder**
    - **Porcelain gallbladder**: calcification of GB
      wall due to extensive scarring, - 2-3% risk of malignancy - Subtypes: complete intramural, selective mucosal
- Investigations: USG +/- HIDA scan (**contracted gallbladder** with wall thickening and gallstones)
- Management: laparoscopic cholecystectomy

[Detailed anatomical illustration of a gallbladder affected by Mirizzi Syndrome. The gallbladder is green and swollen, with a large gallstone impacted in Hartmann's pouch, causing obstruction of the common hepatic duct. There is an eroded duct wall, with a small portion of the bile duct exposed. An inset image shows a close-up of the gallstone impaction in Hartmann's pouch.]

Mirizzi syndrome
Definition

- **CHD obstruction** caused by extrinsic compression from an **impacted stone in Hartmann's pouch/ cystic duct**
- Chronic inflammation can lead to erosion of bile duct wall, causing **cholecystobiliary fistula** (cholecystohepatic or cholecystocholedochal)
  Clinical features
- Variable presentation: acute cholangitis (fever, RUQ pain, jaundice), acute cholecystitis (RUQ pain), etc.
- **Jaundice with palpable GB** - exceptions to Courvoisier's Law
- Complications: **CA gallbladder** - recurrent inflammation and biliary stasis
  Classification: Csendes classification
  | Type | Cholecystobiliary fistula | Remarks |
  |------|---------------------------|---------------------------------------------------------------------------------------|
  | 1 | X | |
  | 2 | ✅ | Fistula diameter <1/3 of CBD wall circumference |
  | 3 | ✅ | Fistula diameter 1/3 – 2/3 of CBD wall circumference |
  | 4 | ✅ | Fistula diameter >2/3 of CBD wall circumference (i.e. complete destruction) |
  | 5 | Any type + **cholecystoenteric fistula** | (5A: no gallstone ileus, 5B: gallstone ileus) |

Investigations

- USG: dilated biliary tree above stone impaction, presence of gallstone at GB neck, contracted GB
- MRCP
- ERCP: diagnostic (presence of **cholecystobiliary fistula**) + therapeutic (stenting for obstructive jaundice / removal of stones)
- CT abdomen + contrast: rule out malignant causes (e.g. porta hepatis LN)

132

Management:

- Without fistula (type I): laparoscopic / open cholecystectomy
- With fistula (II - V): **open surgery**
  - GB: Subtotal cholecystectomy (severe inflammation impedes safe dissection of Calot's triangle)
  - CBD: Closure of fistula / choledochoplasty / bilioenteric anastomosis (choledochojejunostomy) depending on size of defect

Gallstone ileus

- Definitions: gallstone erodes through GB into adjacent bowel through a **cholecystoenteric fistula**
  - **Bouveret's syndrome**: stone stuck at duodenum/ stomach, causing GOO
  - Cholecystoduodenal fistula (MC): symptomatic gallstone ileus (mechanical obstruction)
  - Cholecystocolic fistula: asymptomatic
- Associated with Mirizzi's syndrome
- Clinical features
  - Features of distal SBO (terminal ileum **2 feet proximal** to ileocaecal valve as the narrowest portion of SB)
- Investigations
  - AXR: **pneumobilia\*** (40%), radio-opaque stone in bowel (10%), features of SBO
    - **Rigler's triad**: **pneumobilia**, **SBO**, **ectopic gallstone** (usually in RIF: stuck at IC valve)
  - CT abdomen: gallbladder wall thickening, Rigler's triad
- Management
  - **Enterolithotomy** to relieve SBO
    - Exploratory laparotomy → **Proximal** enterotomy (NOT over the stone because of ulceration) → **Milk the stone proximally** for extraction
    - Same-session / Elective cholecystectomy
    - Fistula repair

[Image of diagram A and B showing the removal of the gallbladder and impacted stone during Mirizzi syndrome. Diagram A shows the liver, gallbladder, inflamed gallbladder, impacted stone, common hepatic duct, and jejunum. Diagram B illustrates the liver, gallbladder with stone, common bile duct, and jejunum]

[Image of an X-ray showing areas of pneumobilia, SBO and a radio-opaque stone in the bowel]

\*Other DDx of pneumobilia:

- Emphysematous cholecystitis
- Post-ERCP
- Post-cholecystectomy
- Blunt abdominal trauma
- Sphincter of Oddi incompetence

# Cholecystectomy

Indications

- **Symptomatic gallstones** (with or without complications) – study: OT can ↓ risk of recurrent Cx from 25% to 8%
- **Asymptomatic gallstones:** in high risk patients
  - Increased risk of gallstone complications, e.g. gastric bypass (altered anatomy), haemolytic disorders
  - Increased risk of gallbladder cancer: **GB polyps >1cm, porcelain gallbladder, large gallstones >3cm**
  - Concomitant liver surgery

Approach

- Laparoscopic vs open (Kocher incision):
  - ↓pain & early mobilization, ↓hospital stay, ↓most Cx (e.g. wound, chest, ileus), cosmetic
  - ↑biliary tree injury, ↑Cardiopulmonary compromise by pneumoperitoneum (Cx of laparoscopy)
- Indications for open:
  - Cannot tolerate pneumoperitoneum, e.g. cardiopulmonary comorbidities
  - Refractory coagulopathy
  - Multiple abdominal surgeries
- CA gallbladder (extensive adhesions, risk of rupture and thus tumour seeding)

Operative procedure of lap. cholecystectomy

- Positioning: reversed Trendelenburg position (head up), slightly rotated to left
- Surgeon stands on left of patient
- Establish pneumoperitoneum by Hasson open technique: insert 10mm blunt trocar at central umbilical site and insufflate CO2 till ~15mmHg
- Retract gallbladder fundus and lift Hartmann's pouch to identify Rouveiere's sulcus (R posterior portal pedicle)
- Ensure "critical view of safety" to minimize bile duct injury
- Identify and divide cystic duct & cystic artery near GB
- Remove gallbladder via umbilicus

[Diagram of "Standard techniques" for laparoscopic cholecystectomy, showing the positioning of ports. There are 3 ports on the abdomen, one 10 mm primary operating port, one 10 mm camera port, one 5 mm static retraction port and one 5 mm dynamic retraction port]

Critical View of Safety (CVS):

1. Hepatocystic triangle clearance
2. Cystic plate clearance
3. **Only two structures seen** entering gallbladder: cystic duct & cystic artery

[Two images showing the Critical View of Safety (CVS) during cholecystectomy, specifically the identification and isolation of the cystic duct and cystic artery before division]

Specific complications

Immediate:

- **Conversion to open** surgery (5% in elective, 25% in emergency) - NOT indicate failure
- GA risks, bleeding
- **Damage to neighbouring structures:** bile leakage (biliary tree), bleeding (cystic artery), pneumoperitoneum (duodenum, transverse colon, hepatic flexure)

Early:

- **Biliary leakage** (from cystic duct stump / duct of Luschka): 0.5% (elective ~ emergency)
  - Noted intra-op: repair + T-tube placement
  - Delayed presentation (usually post-op D2-10)
  - S/S: fever, RUQ pain, dLFT
  - Ix: USG/CT abdomen → HIDA scan / MRCP
  - Mx: to re-establish flow by ERCP stent (minor) or laparotomy + lavage + Roux-en-Y hepaticojejunostomy (major)
- **Bleeding:** due to liver (middle hepatic vein close to GB fossa), cystic artery, trocar site
- Post-op jaundice (dropped / missed CBD stones), cholangitis (infected stone)
- Post-op diarrhoea (initial uncoordinated excessive bile salt excretion + fat malabsorption)

[Illustration of the biliary system after Roux-en-Y hepaticojejunostomy, highlighting the connection between the liver, gallbladder remnant, and jejunum. The remnant bile duct is attached to the roux limb]

Late:

- Bile duct stricture: Mx by reconstruction +/- hepatojejunostomy
- Subphrenic abscess: Mx by drainage + antibiotics
- **Post-cholecystectomy syndrome:** persistent symptoms (e.g. biliary colic, diarrhea) after operation
- Post-cholecystectomy choledocholithiasis: bile stasis due to increased CBD calibre (loss of GB storing function)

# 5.6 Diseases of biliary tract

## Choledocholithiasis

Definitions: obstruction of CBD/CHD by gallstone
Clinical features

- RUQ pain
- Obstructive jaundice
- Complications: acute cholangitis (see separate section)
  Investigations
- CBC (infection), LFT (cholestatic pattern), amylase (r/o pancreatitis)
- USG:
  - Gallstone in CBD (visible in 1/3 cases only: obscuring gas in duodenum)
  - Dilated CBD (>8mm)
  - Limited value for distal CBD stone due to bowel gas
- Subsequent investigations depend on risk of complications:
  - Low risk: MRCP or EUS (if C/I to MRCP)
  - High risk: ERCP (diagnostic + therapeutic) - high risk of complications (e.g. perforation, pancreatitis)
    Management
- Stone removal:
  - ERCP: sphincterotomy + CBD stone removal
    - Methods of stone removal:
      - Wire baskets
      - Stone extraction balloon
      - Mechanical lithotripsy
  - Surgical: exploration of CBD
    - Indicated if ERCP is C/I (e.g. altered anatomy)
    - Approaches:
      - Transcystic (1st line): insert catheter via cystic duct → perform
        cholangiogram → extract stones (e.g. balloon)
      - Choledochotomy (2nd line): incise CBD → remove CBD stone
        through defect → choledochoscopy to confirm clearance
      - Percutaneous choledochoscopy
    - Technique of stone removal: wire basket, saline flushing, biliary
      Fogarty balloon
    - Advantage: can be performed as one-stage surgery together with LC
    - After exploration
      - T-tube may be inserted for subsequent cholangiogram and bile
        drainage (fig.), but shown to increase complications e.g.
        infection, bile leak, tube dislodgement
      - Primary closure if existing biliary stent
- Elective laparoscopic cholecystectomy (still ~5% risk of recurrent biliary events e.g.
  residual / dropped stones, primary RPC stones)

[Image Description: A diagram illustrating the process of sphincterotomy and stone removal. Two figures, side by side, depict the sphincter of Oddi being widened with a wire, allowing for the passage of a stone.

A diagram shows the liver, gallbladder, stomach, duodenum, and pancreas connected by a network of ducts. A catheter is inserted through the cystic duct.

A vertical diagram shows the common bile duct and a Y-shaped section of ducts. One branch goes to the liver and the other to the duodenum.]

## Acute cholangitis

Definition: bacterial infection of biliary tract due to CBD obstruction
Classification of cholangitis

- Anatomical: Ascending vs descending
- Pathological: Pyogenic, obstructive, etc.
- Others:
  - Primary sclerosing cholangitis: obliterative fibrosis of biliary tree, associated with IBD, rare in Asia
  - Immune (IgG4-associated cholangitis): infiltration of biliary system with IgG4, mostly elderly male

135

Etiology of acute cholangitis

- Biliary obstruction: bile stasis → infection
  - Choledocholithaisis (CBD stones)
  - Strictures (bile duct injury, PBC/PSC)
  - Malignancy: CA pancreas, cholangioCA, periampullary CA, porta hepatis LN
- Post-ERCP: sphincterotomy disrupts barrier to infection
- Biliary stent in-situ: FB serves as nidus for infection
- Pathogens: GNR (E coli, Klebsiella) > enterococcus, Pseudomonas (if stent present)

Clinical features

- **Charcot's triad** (50-70%): Fever, RUQ pain, jaundice
- **Reynold's pentad** (<10%): above + shock + altered mental state

Urgent investigations

- Bloods: CBC, clotting, LFT(+GGT), RFT, amylase, **blood culture!!**
- Erect CXR, AXR (aerobilia)
- USG abdomen: dilated duct, gallstone; rule out liver abscess (similar presentations)
- **ERCP (1st line):** diagnostic and therapeutic, but invasive
- Alternatives: MRCP, EUS, CT scan (r/o liver abscess or malignant obstruction)

Acute management (RAD) - **must know!!**

- **Resuscitation:** NPO, IV fluids, monitor vitals & I/O Q1h
- **Antibiotics** (broad-spectrum): IV Augmentin (mild) or IV Tazocin (severe) x 7 days
- **Drainage:** Urgent if **Reynold's pentad**, not responding to antibiotics for 24h (obstruction: impair secretion of antibiotics in bile)
- Endoscopic:
  - ERCP (plastic stent with/without sphincterotomy) - mortality < 5%
  - Role: **biliary drainage and decompression** in unstable patients (NOT stone removal)
  - Aspirate bile duct to remove bile & pus to decompress biliary tree and reduce risk of inducing bacteraemia during contrast injection
  - Then inject contrast and place plastic stent (temporary, require scheduled change)
  - Remove stone now or interval ERCP after sepsis resolves [refer to "choledocholithiasis"]
  - Therapeutic EUS (EUS-guided cholangiopancreatography)
- Percutaneous transhepatic biliary drainage (PTBD):
  - Similar efficacy & rate of complications as ERCP
  - Indicated when ERCP unsuccessful / contraindicated (e.g. poor respiratory function)
  - Transhepatic insertion of **intrahepatic** BD (Not CBD)
  - Easy output monitoring (external drainage, but can be internalized later)
  - Risk of fluid and electrolyte loss
- Surgery:
  - Intra-op ERCP (supine position)
  - Exploration of CBD - high mortality 30% [refer to "choledocholithiasis"]

Long-term management

- Gallstone: ERCP for lithotripsy + laparoscopic cholecystectomy (early instead of interval)
  - Ascending cholangitis is still possible after LC: biliary stasis due to
    - ERCP-induced CBD dilatation
    - Aging-related CBD dilatation
- Stricture (benign/ malignant): endoscopic stent placement
- RPC: regular stone clearance, surgical resection (see separate section)

136

Recurrent pyogenic cholangitis (RPC)
Definition: recurrent syndrome of bacterial cholangitis that occurs in association with **intrahepatic pigment stones** and **intrahepatic biliary obstruction (strictures)**
Also known as "Hong Kong disease" / oriental cholangiohepatitis
Pathophysiology: usually start in _left intrahepatic ducts_

- Parasitic infestation (e.g. Clonorchis sinensis in raw freshwater fish 淡水魚): epithelial damage → bacterial translocation → stricture formation → biliary stasis
- Malnutrition: low protein diet in Orientals → relative enzyme deficiency → breakdown of conjugated bilirubin to unconjugated form by bacterial glucuronidase → brown pigment stone formation

Different from other gallstone diseases: stones not formed in GB, mainly pigment stones but not cholesterol stones

Clinical features

- Middle-age onset
- Recurrent episodes of acute cholangitis (1-2 episodes per year)
- Complications: - Cx of acute cholangitis: e.g. biliary sepsis, pancreatitis, abscess, fistula - Cirrhosis (due to chronic biliary obstruction) - Cholangiocarcinoma
  Investigations
- Bloods: CBC, LFT, clotting, ova & parasites
- Imaging:
  - USG abdomen: dilated duct, stone, liver abscess
  - CT: central dilated bile ducts with peripheral tapering, left lobe predilection, liver atrophy
  - Cholangiogram (ERCP/MRCP/ PTBD): anatomy of biliary tree

Management

- Acute complications:
  - Resuscitation
  - Antibiotics
  - Biliary drainage: ERCP difficult to access intrahepatic drainage → PTBD, T-tube drainage, HCJ (hepaticocutaneojejunostomy, fig.)
- Prevention of long-term complications
  - Regular ductal clearance: USG surveillance, ERCP to remove stones / dilate strictures
  - Resection of affected hepatobiliary segment + biliary-enteric anastomosis (e.g. HJ)
    - Indication: atrophic liver segment, failed non-operative Tx, suspected cholangioCA

[An anatomical illustration depicting the liver, gallbladder, stomach, duodenum, pancreas, and biliary tree. The liver is a large, reddish-brown organ located in the upper right abdomen. Connected to the liver is the gallbladder, a small, green sac that stores bile. The biliary tree consists of a network of ducts that transport bile from the liver and gallbladder to the duodenum, the first part of the small intestine. The illustration shows the common bile duct, which is formed by the union of the cystic duct from the gallbladder and the common hepatic duct from the liver. The common bile duct joins the pancreatic duct before entering the duodenum. The stomach is a large, muscular organ located on the left side of the abdomen. The duodenum is a C-shaped tube that curves around the head of the pancreas. The pancreas is a long, slender organ located behind the stomach. The illustration provides a clear and detailed view of the anatomy of these important digestive organs, highlighting the complex network of ducts that make up the biliary tree. The colors are vibrant and the lines are sharp, making it easy to distinguish between the different structures.]

Clonorchis sinensis infection

- Humans as definitive host: adult form in biliary tract, embryonated eggs passed in faeces
- Transmission: poorly cooked freshwater fish
- Clinical presentation: asymptomatic, acute cholangitis, RPC,↑ risk of cholangioCA
- Diagnosis: stool microscopy for eggs, duodenal aspirate for eggs, USG for adult flukes, intra-op choledochoscopy for adult flukes
- Treatment: praziquantel 25mg/kg PO tds x 1 day

138
Choledochal cyst

- Definitions: congenital dilations of intra/ extrahepatic biliary system
- Most diagnosed before 10y (60%)
- Todani classification: most commonly type I

[Image: A black and white diagram illustrates five types of choledochal cysts. Type I shows a solitary extrahepatic cyst. Type II shows an extrahepatic diverticulum. Type III shows a choledochocoel. Type IVA shows extra and intrahepatic cysts. Type IVB shows multiple extrahepatic cysts. Type V shows multiple intrahepatic cysts (Caroli's Disease).]

Clinical features

- RUQ mass + pain, jaundice, fever
- Pancreatitis
- Complications: cholangiocarcinoma
  Investigations
- Diagnostic: USG
- Anatomy: MRCP
- Extent: CT
  Management
- Radical excision of cyst + biliary tract reconstruction using a
  Roux-en-Y loop of jejunum (HJ or choledochojejunostomy) - Prevent development of cholangiocarcinoma - Reduced risk of stricture - Reduced risk of recurrent cholangitis
  5.7 Cancers of gallbladder and biliary tree
  Gallbladder polyps
  Types of benign polyps
- Non-neoplastic: no malignant potential
  - Adenomyomatosis: intramural diverticula (Rokitansky-Aschoff sinuses)
  - Cholesterol polyps (MC)
  - Inflammatory polyps
- Neoplastic - Adenomatous polyps: benign epithelial tumors, risk of malignant transformation (↑ if larger size)
  Management of GB polyps
- Polyps <1cm: regular USG (Q6mo if 6-9mm, Q12mo if ≤5mm)
- Indications of laparoscopic cholecystectomy - Symptomatic (e.g. RUQ pain) - Adenomatous polyps ≥1cm (or 8mm if underlying PSC): >2cm might need extended cholecystectomy
  with LN dissection and partial hepatic resection - Rapidly growing polyps
  Gallbladder carcinoma
  Overview
- Very rare in Hong Kong, more common in women
- Very poor prognosis: most discovered late and are unresectable at diagnosis - 5-year OS < 5%
  Risk factors (4P)
- Polyps: higher risk if polyps ≥1cm
  - To differentiate from gallstone: no gravity dependence, no acoustic shadow
  - Higher risk if sessile polyp
- Porcelain gallbladder / other gallstone diseases (chronic inflammation → dysplasia)
- Primary sclerosing cholangitis
- Pancreatobiliary duct anomalous junction: a/w choledochal cyst
  Pathology
- Mostly adenocarcinoma (90%), others are SCC
  Clinical features: difficult to differentiate from other gallbladder diseases
- Early stage: biliary colic, RUQ pain - due to gallstone instead of CA (gallstone found in 95% patients)
- Late stage: obstructive jaundice, palpable mass, constitutional symptoms
- Metastasis: direct extension into liver (adjacent segments IV & V), seedings into peritoneum

Investigation

- Bloods: LFT (cholestatic picture), CA19-9
- Diagnostic: USG, CT, MRI/MRCP, percutaneous biopsy
- Staging: PET/CT, laparoscopy

Treatment
Curative: **Open cholecystectomy with intra-op frozen section**

- Stage I disease (confined to mucosa, T1N0): no further treatment required
- Higher stage disease (extend to _serosa/ transmural_): **extended cholecystectomy**
  - _En-bloc resection_ of gallbladder with rim of liver ≥2cm adjacent to gallbladder bed
  - Segmental hepatectomy (segments IVb, V)
  - Extrahepatic bile duct resection (if cystic duct involved)
  - Regional lymphadenectomy (porta hepatis LN)

Palliative care

- Stenting: for malignant obstructive jaundice
- Surgical bypass: for duodenal obstruction

Cholangiocarcinoma

[Anatomical illustration of the liver, gallbladder, and bile ducts. The liver is depicted in brown with the gallbladder in green attached to its underside. The common bile duct, also in green, extends from the gallbladder and connects to the duodenum. Labels point to Intrahepatic, Perihilar, and Distal extrahepatic areas of the bile ducts.]

[Diagram illustrating Bismuth-Corlette classification of cholangiocarcinoma. The diagram includes 6 types of classifications: Type I, Type II, Type IIIa, Type IIIb, Type IV, Type IV multicentric. Each type shows a different configuration of tumor location relative to the confluence of the hepatic ducts.]

Definitions: carcinoma of bile duct (>90% adenoCA)
Classification by site

- Intrahepatic (10%): proximal to CHD bifurcation, bulky tumour ~HCC; increasing incidence
- Perihilar (MC, 60%): between CHD bifurcation and cystic duct origin, prone to cholangitis, resection difficult; further classified by Bismuth-Corlette classification (table)
- Distal extrahepatic (20-30%): distal to cystic duct origin, decreasing incidence
- Klatskin's tumor: cholangioCA that involves the common hepatic duct bifurcation (usually perihilar type)

Risk factors

- Systemic conditions: DM, obesity, chronic hepatitis (Hep C)
- Cholestatic disease: PSC (less common in Asia), RPC, cholelithiasis
- Congenital: choledochal cysts, Caroli's disease, Lynch syndrome
- Chemicals: thorium dioxide (Thorotrast)

|           |                                         |
| --------- | --------------------------------------- |
| Type I    | Below CHD bifurcation                   |
| Type II   | Reaching CHD bifurcation                |
| Type IIIa | Involve CHD and RHD                     |
| Type IIIb | Involve CHD and LHD                     |
| Type IV   | Involve CHD, RHD and LHD / Multicentric |

139

Clinical features
140

- Local: painless obstructive jaundice (hilar / distal tumors tend to present earlier), RUQ discomfort, cholangitis, haemobilia (UGIB from biliary tree)
- Constitutional symptoms
- Signs: - Hepatomegaly (intrahepatic cholangiocarcinoma) - Painless jaundice, tea-coloured urine, pale-coloured stool - Palpable GB (Courvoisier's Law - if distal tumor)
  Investigations
- Bloods: LFT (cholestatic pattern), CA19-9 (only raised in 80%), CEA, AFP
- Imaging: USG (dilated duct, mass lesion), CT, MRI/MRCP
- Cholangiography: ERCP for distal tumors, PTC for proximal tumors - define level of obstruction +/- stenting
- Tissue diagnosis (not must): brush cytology/CT-guided biopsy if uncertain
- Staging: MRCP (intrahepatic metastasis), EUS (nodal involvement), staging laparoscopy
  Management
  Surgical resection (1st line, but only 10% operable at presentation)
- Unresectable if:
  - Invasion of major vessels (e.g. main PV, main hepatic a., celiac trunk, SMA, SMV)
  - Extensive involvement of biliary tree (bilaterally > 2° radicles)
  - LN metastasis (retropancreatic, paracoeliac, paraaortic)
  - Distal organ metastasis (lung, peritoneum)
- Approach: - Intrahepatic: partial hepatectomy + portal LN dissection - Perihilar (further depend on Bismuth-Corlette type): extrahepatic bile duct resection + cholecystectomy + portal LN dissection (+/- partial hepatectomy) + reconstruction (Roux-en-y hepaticojejunostomy) (fig.)
  [Diagram illustrating the Roux-en-Y Hepaticojejunostomy procedure. The diagram shows the liver and gallbladder with a portion of the bile duct removed. The remaining bile ducts are connected to the jejunum via a surgical connection known as hepaticojejunostomy. The jejunum is also connected to itself in a procedure called jejunojejunostomy, creating a "Y" shape. The text labels different parts of the anatomy, including "Removed bile duct and gallbladder," "Hepaticojejunostomy (Bile ducts drain into small intestine)," and "Jejuno-jejunostomy." Text below the image states: Roux-en-Y Hepaticojejunostomy Procedure performed for cholangiocarcinoma and biliary injuries.] - If FLR inadequate: portal vein embolisation (PVE) to induce atrophy of affected segment + hypertrophy of unaffected segments - Distal CBD tumour: Whipple's procedure (pancreaticoduodenectomy)
- Pre-operative drainage (ERCP / PTBD) considered if biliary sepsis / poor LFT
  Palliative care: Relieve malignant biliary obstruction by stenting / surgical bypass
- Self-expandable metallic stents (SEMS): for established malignancy (longer patency, but cannot be removed)
- Uncovered stents preferred: lower risk of occluding branches of biliary system
- Approaches
  - Internal drainage: ERCP + stenting
  - External drainage: PTBD
  - Internal-external biliary drainage: PTBD (push pass obstruction → internalized)
- Complications:
  - Stent occlusion (e.g. tumor ingrowth, bile sludge): Mx by sweeping or placing new stent
  - Stent migration

# 5.8 Diseases of pancreas

## Acute pancreatitis

Definition: acute inflammation of pancreas parenchyma
Pathogenesis:

- Duodeno-pancreatic reflux → Release and premature activation of pancreatic enzymes (most importantly trypsinogen) → Autodigestion of pancreas → Release of inflammatory mediators & cytokines (SIRS)

Revised Atlanta classification system:

- 2 broad categories:
  - No necrosis = Interstitial edematous acute pancreatitis
  - Necrosis = Necrotizing acute pancreatitis
- By severity: any organ failure (respiratory/cardiovascular/renal) or local/systemic complications
  - Mild = **NO** organ failure / complications
  - Moderately-severe: transient organ failure <48h or local/systemic complications
  - Severe = **persistent** organ failure >48h

Aetiology (GAME ID)

- Gallstone (MC): suspect if Hx of biliary colic or ↑ALP
- Alcohol: suspect if ↑AST
- Metabolic: hyperTG/hyperCa
- ERCP: reduced by PR NSAID or temporary pancreatic stenting
- Idiopathic (10%)
- Drugs (NSAID, steroid, azathioprine, ACEI, valproate)
- Others: trauma, infections (e.g. mumps), autoimmune (e.g. SLE), pregnancy, scorpion venom, pancreatic divisum (MC congenital anomaly)

Clinical features

- Epigastric pain: severe constant, **radiating to the back**, improve with leaning forward, exacerbated by movement, refractory to analgesics
- N/v, fever (chemical but not infection)
- Tetany: _transient hypocalcaemia_ due to fat saponification (lysis of fat cells → release of fatty acids → precipitate with calcium)
- Signs of retroperitoneal haemorrhage: **Cullen's sign** (periumbilical, fig. A), **Grey Turner's sign** (flank, fig. B), Fox's sign (inguinal ligament, fig. B near groin)
- Pleural effusion (ARDS)

[Image of Cullen's sign, represented in two parts. Part A shows a close-up of a patient's abdomen with a prominent, circular, dark bruise around the umbilicus, indicating periumbilical haemorrhage. Part B presents a broader view of a patient's flank area, exhibiting multiple linear bruises along the side, which indicates Grey Turner's sign.]

Investigation

- CBC, LRFT, CRP, glucose, Ca
- Cardiac markers +/- ECG
- Pancreatic enzymes - cut off is 3x ULN, NOT indicative of severity
  - Serum amylase: rise within 6-12h of onset, normalize in 3-5 days, normal: 30-100 U/L
    - Prolonged elevation indicates complications e.g. pancreatic pseudocyst
    - False positive: PPU, ruptured AAA, DKA, macroamylasemia
    - If equivocal / delayed presentation: urine amylase (rise within 24-48h, persist 1 week)
  - Serum lipase: rise within 4-8h of onset, normalize in 8-14 days (longer t1/2), normal: 10-140 U/L - Preferred for **delayed presentation > 24h** - More specific
    Diagnostic criteria (Revised Atlanta criteria):
    Fulfilment of 2 out of 3
- Clinical: typical epigastric pain
- Lab: serum amylase or lipase > 3x ULN
- Imaging findings (USG/CT/MRI)

- Imaging:
  - CXR: rule out perforation (PPU) or other DDx
  - AXR: **sentinel loop sign** (dilated bowel loop due to ileus), **colonic cut-off sign** (descending colon spasm), **obliteration of psoas outline** (retroperitoneal fluid accumulation)

[Image of abdominal X-rays demonstrating "Sentinel loops" on the left and "Colonic cut-off" on the right. The "Sentinel loops" image shows dilated loops of the small intestine. The "Colonic cut-off" image shows a sharp cut-off in the colon, indicating a possible obstruction.]

[Image of a computed tomography (CT) scan of the abdomen showing "Fat stranding" and "Heterogenous swelling" marked with yellow arrows. The "Fat stranding" refers to increased density in the fat surrounding the pancreas, indicating inflammation. "Heterogenous swelling" suggests uneven swelling of the pancreas due to inflammation and fluid accumulation.]

[Image of a computed tomography (CT) scan of the abdomen demonstrating "Peripancreatic fluid collections" marked with a yellow arrow. "Peripancreatic fluid collections" indicates areas of fluid accumulation around the pancreas, which is a common complication of pancreatitis.] - USG abdomen: signs of pancreatitis (pancreas seen in ~50% of cases: **swollen pancreas**, **peripancreatic fluid collection**), associated gallstone, cholangitis & cholecystitis - CT abdomen with contrast: gold standard, performed if - Characteristics of acute pancreatitis - Focal / Diffuse enlargement of pancreas with **heterogenous** contrast enhancement - Peripancreatic fat stranding - Necrosis - **hypoenhancement** / **gas** on contrast CT - Indications: - Diagnose severity of AP and identify complications (especially **necrosis**) - best done on 72-96h after admission, but can be earlier if organ failure - Uncertain diagnosis (DDx PPU, gangrenous cholecystitis, ischaemic bowel) - ERCP/MRCP: not routinely done as the culprit stone is usually passed, but indicated if: - Suspected biliary pancreatitis (stone found in USG, septic) - Severe (last resort)

- Scoring system to estimate severity
  - **Ranson's score (need to remember!)**: require parameters at **0h** ("GALAW") and **48h** ("CHOBBS")
    - Predicts mortality of acute pancreatitis (severe if score ≥3) - validated for alcoholic / gallstone pancreatitis only

- Ranson's Criteria

|               | 0 hours (admission) | 48 hours               |
| :------------ | :------------------ | :--------------------- | ------------------------------------------ |
| Glucose level | > 11.1 mmol/L       |                        |
| Age           | > 55                |                        |
| LDH           | > 350 U/L           |                        |
| AST           | > 250 U/L           |                        |
| WBC count     | > 16 x 10^9/L       |                        |
|               |                     | Ca^2+ level            | < 2 mmol/L (8 mg/dL)                       |
|               |                     | Hematocrit             | Fall by ≥ 10%                              |
|               |                     | Oxygen (PaO2)          | <8 kPa (60 mmHg)                           |
|               |                     | Base deficits          | > 4 MEq/L                                  |
|               |                     | BUN                    | ↑ by ≥ 1.8 mmol/L (5 mg/dL) despite fluids |
|               |                     | Sequestration of fluid | > 6000 mL                                  |

- Glasgow score: ≥ 3 out of 8 in first 48h indicate severe attack
- APACHE II: originally for critically ill, calculated on admission then daily, ≥8/71 indicate severe attack
- Balthazar CT severity index: grade of pancreatitis (0-4) + percentage of necrosis (0-6)
- CRP > 150 at 48h also predicts severe attack

Management
Mild pancreatitis: conservative

- Monitor vitals, I/O, RFT, Ca, glucose +/- ABG
- DAT / NPO + IV fluids to maintain UO > 0.5mL/kg/h (+/- NG suction if ileus / protracted vomiting)
- Correct electrolyte and glucose disturbances
- Analgesics: _tramadol/pethidine_, avoid NSAID (worsen pancreatitis) or morphine (↑sphincter of Oddi pressure)
- PPI for prophylaxis of acute stress ulcer
- Antibiotics: prophylactic Abx is **NOT** recommended – give only when
  - Concurrent **cholangitis** (e.g. LFT shows cholestatic pattern): IV Augmentin
  - Complications e.g. **necrosis** - use antibiotics that penetrate necrosis, e.g. **imipenem**
  - SIRS
- Nutritional support: **Enteral** route is preferred as long as tolerated
  - Encourage early oral feeding if mild
  - Consider NG / NJ tube: similar efficacy and safety
- Biliary pancreatitis:
  - ERCP **within 24-72h** after admission for sphincterotomy and stone extraction (alternative: PTBD to decompress biliary tract if unfit)
  - Lap **cholecystectomy** within the same hospitalisation

Severe pancreatitis:

- **Surgery** indicated if:
  - Infected pancreatic necrosis
  - Progressive clinical deterioration
- **Consult ICU** for organ support
  - GI: enteral feeding (NJ) → TPN
  - CVS: CVP, inotropes
  - Resp: intubation
  - Renal: HD
  - Measure IAP for abdominal compartment syndrome

Complications of acute pancreatitis
Local complications:

- **Pancreatic fluid collections** [refer below]
  - Acute peripancreatic fluid collection
  - Pancreatic pseudocyst
  - Acute necrotic collection
  - Walled off necrosis
- **Pancreatic pseudo-aneurysm:** erosion into artery (esp. GDA)
- **Splenic vein thrombosis:** erosion into vein
- Pancreatic exocrine insufficiency (steatorrhea & malnutrition)
- Pancreatic ascites
- Diabetes mellitus (endocrine insufficiency)

Systemic complications

- Hemodynamic instability
- Electrolyte imbalance
- Sepsis
- Multiple organ failure: ARDS, AKI, DIC

Revised Atlanta classification for pancreatic fluid collections

|           | Interstitial edematous pancreatitis (Necrosis absent)                                                                                                                                                                                                                                                                                        | Necrotizing pancreatitis (Necrosis present)                                                                                             |
| :-------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------------------------------------------- |
| <4 weeks  | Acute peripancreatic fluid collection                                                                                                                                                                                                                                                                                                        | Acute necrotic collection Definition: area of non-viable pancreatic parenchyma (mix of semisolid & solid)                               |
|           | Mx: observe (resolve within 7-10 days)                                                                                                                                                                                                                                                                                                       | S/S:                                                                                                                                    |
|           |                                                                                                                                                                                                                                                                                                                                              | - Mass effect                                                                                                                           |
|           |                                                                                                                                                                                                                                                                                                                                              | - Infected (usually after 2 weeks): ongoing fever, worsening abdominal pain, organ failure                                              |
|           |                                                                                                                                                                                                                                                                                                                                              | Ix: difficult to tell if its infected                                                                                                   |
|           |                                                                                                                                                                                                                                                                                                                                              | - CT abdomen with contrast (hypodense segment +/- gas if infected, e.g. GNR)                                                            |
|           |                                                                                                                                                                                                                                                                                                                                              | - Imaging-guided FNA x C/ST: rarely done due to risk of infection                                                                       |
|           |                                                                                                                                                                                                                                                                                                                                              | - Procalcitonin                                                                                                                         |
|           |                                                                                                                                                                                                                                                                                                                                              | Mx:                                                                                                                                     |
|           |                                                                                                                                                                                                                                                                                                                                              | - Sterile: supportive                                                                                                                   |
|           |                                                                                                                                                                                                                                                                                                                                              | - Infected: step up approach                                                                                                            |
|           |                                                                                                                                                                                                                                                                                                                                              | - Antibiotics: imipenem / meropenem                                                                                                     |
|           |                                                                                                                                                                                                                                                                                                                                              | - +/- Delayed drainage (4 weeks to allow walling off)                                                                                   |
|           |                                                                                                                                                                                                                                                                                                                                              | - +/- Necrosectomy: debridement (minimally invasive method preferred, i.e. endoscopic/ percutaneous > open)                             |
| ≥ 4 weeks | Pancreatic pseudocyst Definition: collection of pancreatic fluid walled by inflammatory fibrosis (but not epithelium) with NO necrosis Risk factors: chronic pancreatitis > acute pancreatitis S/S: persistent epigastric pain, mass effect (GOO, obstructive jaundice) Ix: amylase (persistently elevated), CT abdomen with contrast (fig.) | Walled off necrosis Definition: encapsulated collection of pancreatic / peri-pancreatic necrotic material within inflammatory wall S/S: |
|           | Mx:                                                                                                                                                                                                                                                                                                                                          | - Mass effect: palpable mass, GOO, obstructive jaundice                                                                                 |
|           | - Watchful waiting for 6 weeks: allow wall to "mature" (thicken), 50% resolve spontaneously                                                                                                                                                                                                                                                  | Ix:                                                                                                                                     |
|           | - Drainage (internal preferred) for symptomatic "mature" pseudocyst with size > 6cm, e.g. EUS-guided cystogastrostomy (CG)/CD/Roux-en-Y CJ                                                                                                                                                                                                   | - CT abdomen with contrast (well-defined wall, can be intra-pancreatic / extra-pancreatic)                                              |
|           |                                                                                                                                                                                                                                                                                                                                              | Mx: based on symptoms, location and size                                                                                                |
|           |                                                                                                                                                                                                                                                                                                                                              | - EUS/ERCP-guided transmural drainage +/- necrosectomy (first-line)                                                                     |
|           |                                                                                                                                                                                                                                                                                                                                              | - Percutaneous drainage: high recurrence rate, risk of pancreatocutaneous fistula                                                       |
|           |                                                                                                                                                                                                                                                                                                                                              | - Surgical debridement (open / lap) with external / internal drainage                                                                   |

[Axial CT image of a pancreatic pseudocyst. The pseudocyst, filled with fluid, is clearly visible as a dark, round mass within the pancreas. The pancreas and other abdominal structures surround the pseudocyst. A label "Pseudocyst" points to the cyst, while "Pancreas" points to the pancreatic tissue. A "L1" marker is also visible, likely indicating a vertebral level.]

Pancreatic pseudocyst

[Axial CT image of an acute necrotic collection in the pancreas. The necrotic area appears heterogeneous and ill-defined. Some fluid is present. The surrounding tissues show inflammatory changes.]

Acute necrotic collection

[Axial CT image of a walled-off pancreatic necrosis. The image shows a well-defined, encapsulated collection with heterogeneous contents, indicating necrosis. The capsule or "wall" is visible as a distinct border around the necrotic material. Surrounding tissues may exhibit inflammatory changes.]

Walled-off necrosis

Chronic pancreatitis
Difficult to distinguish from CA pancreas!
Aetiology

- Alcoholism (60%)
- Idiopathic (30%)
- Autoimmune: autoimmune pancreatitis (IgG4-related disease), SLE
- Obstruction: neoplasm, stricture
  Pathophysiology
- Chronic inflammation / Recurrent acute inflammation → Diffuse scarring of pancreatic duct →
- Pancreatic fluid changes composition and facilitates deposition of CaCO3 stones → diffuse pancreatic
  calcification
- Exocrine insufficiency, then endocrine insufficiency (islet of Langerhans more resistant to injury)
  Clinical features
- Local inflammation: recurrent epigastric pain radiating to back;
  painless in 10% (burnt-out pancreas)
- Exocrine insufficiency (<10% exocrine function when it is clinically
  significant): steatorrhea, malnutrition, clotting dysfunction,
  osteoporosis (fat-soluble vitamin deficiency)
- Endocrine insufficiency: T1DM
- Complications: pancreatic pseudocyst, CBD obstruction, pancreatic
  ascites, splenic v. thrombosis, CA pancreas (2%)
  Investigations
- Bloods: ↑glucose; normal amylase & lipase (burnt-out pancreas)
- Stool: Jelastase, chymotrypsin
- Imaging:
  - AXR: pancreatic calcifications at pyloric plane
  - CT: calcification, dilated pancreatic ducts, pseudocyst
  - ERCP: "chain of lakes" appearance (ductal narrowing &
    dilation); can be combined with IV secretin for better view of
    stricture (stimulate production of bicarbonate-rich fluid)
  - MRCP: emerging modality

Classical triad (only seen in
late stage):

1. Pancreatic calcification
2. Steatorrhoea
3. Diabetes mellitus

Test for pancreatic function (if imaging normal): OGTT & HbA1c, 72h fecal fat, secretin stimulation test (rare)

- CA 19-9 and CEA: rule out CA pancreas

Management: mainly medical

- General: - Total abstinence from alcohol and smoking - Narcotics: pain difficult to control → refer to pain specialist - Pancreatic enzyme replacement + fat restriction: Creon + insulin (note risk of hypoglycaemia due to
  glucagon deficiency)
- ERCP for pancreatic sphincterotomy, stenting, stone retrieval, drainage of pseudocyst
- Surgical: to relieve obstruction and remove mass lesions, preserving pancreatic tissues whenever possible - Longitudinal pancreaticojejunostomy (Puestow
  procedure) - Frey procedure (part of head resected) - Beger procedure (duodenum-preserving
  pancreatic head resection) - Resection of tail/ head/ entire pancreas if dysplasia

[Image Description:
This image shows an X-ray of the pancreatic duct. There are visible white spots indicating calcification in the region. The duct appears to be a white tube structure against a darker background. The surrounding tissue is of varying shades of gray. The overall image is of low contrast and contains several artifacts typical of an X-ray.
]

[Image Description:
The image shows a diagram of the Puestow procedure. It shows the Pancreas and Bile Bladder. The bottom part of the image says After.
]
[Image Description:
The image shows a diagram of the Beger procedure. It shows the head of the pancreas excised with the duodenal cuff. The reconstruction with pancreaticojejunostomy is also shown
]
145

# Pancreatic cyst

Definitions

- Collections of fluid that form within the pancreas
- True cysts (non-inflammatory) or pseudocyst (inflammatory)

Subtypes of true cysts

- High risk of malignancy: mucinous cysts, e.g. intraductal papillary mucinous neoplasm, cystic pancreatic neuroendocrine tumour (associated with MEN1 syndrome)
- Low risk of malignancy: serous cysts, e.g. simple cyst, serous cystic adenoma

| Cystic neoplasms                               | Malignant potential | Management                                                                                                                                                                     |
| ---------------------------------------------- | ------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Intraductal papillary mucinous neoplasm (IPMN) | Yes                 | Pancreatic head in old men. Two types: - **Main duct**: resection - **Branch duct**: observe (e.g. Qly MRCP) unless high risk stigmata (e.g. >4cm, nodules within cystic wall) |
| Mucinous cystic neoplasm (MCN)                 | Yes                 | Pancreatic body/tail in _perimenopausal_ women. Similar to IPMN, but have ovarian-type stroma.                                                                                 |
| Serous cystic neoplasm (SCN)                   | No                  | Found in older women. Resection not required.                                                                                                                                  |
| Solid pseudopapillary tumor                    | Yes                 |                                                                                                                                                                                |

Clinical features

- Mostly asymptomatic
- Epigastric pain radiating to back, obstructive jaundice, fever
- Infected cysts: fever
- Malignant transformation: constitutional symptoms

Investigations

- CA 19-9: for monitoring disease progression
- Imaging: CT abdomen → EUS if equivocal findings/ low risk
  - Low risk features: cyst diameter < 3cm, cystic morphology with central calcification
  - High risk features: cyst diameter >3cm, enhancing solid component, main pancreatic duct dilatation > 10mm, pancreatic tail atrophy, lymphadenopathy
- Diagnostic: resection for pathology or EUS-FNA
  - Fluid for CEA (mucin-secreting cyst) & amylase (pseudocyst)

Management

- Low risk: surveillance Q5y
- High risk: surgical resection, then MRI Q2y for surveillance

# Pancreatic carcinoma

Types

- Ductal adenocarcinoma (90%)
- Cystic tumours, ampullary cell tumours, islet cell tumours: much better prognosis
- Metastasis: from RCC (MC), lung, breast

Sites: head (60%), body (15%), tail (5%), diffuse (20%)

Risk factors

- Smoking (3x risk)
- DM, chronic pancreatitis
- FHx
- Pre-malignant conditions e.g. pancreatic intraepithelial neoplasia (PanIN)
- Hereditary cancer syndromes e.g. Lynch

[Image of the number 146, likely representing a page number]

Clinical features

- **Painless progressive obstructive jaundice** (tumor at head)
- **Severe epigastric pain radiating to the back** (tumor at body/tail: retroperitoneal infiltration)
- Constitutional symptoms
- Symptoms of pancreatic insufficiency: e.g. steatorrhoea, maldigestion, malabsorption, new onset DM
- Acute pancreatitis / GOO
- Signs of metastasis: liver, peritoneum, lung, bone
- Paraneoplastic manifestations
  - Trousseau syndrome: hypercoagulable state → migratory superficial thrombophlebitis
  - Paraneoplastic pemphigoid

Investigations

- Bloods: CBC, clotting, LFT (cholestatic pattern), RFT, glucose, amylase, lipase
- Tumor markers:
  - CA19.9 (raised in 80%): prognostic marker + monitoring after Tx
    - Low diagnostic value: not sensitive, not specific
    - Other causes: HCC, cholangioCA, CA gallbladder, chronic pancreatitis, cholangitis
  - CEA (raised in 30-60%)
- Imaging:
  - USG (dilated bile ducts)
  - CT abdomen with contrast (pancreatic protocol) – thin-sliced triphasic (arterial + pancreatic + portovenous phases)
    - Double duct sign: dilated pancreatic duct + CBD
    - Hypoattentuating mass within pancreas
    - Determine resectability: encasement of **SMA**, hepatic artery, celiac trunk, SMV, PV
  - +/- MRCP: delineate anatomy of biliary tree
- Tissue diagnosis: **NOT** mandatory if potentially resectable - only required if CT failed to demonstrate typical features, before chemotherapy, or suspected 2º mets to pancreas
  - EUS-guided FNAC/biopsy preferred over percutaneous USG/CT-guided biopsy (↑risk of tumor seeding)
  - ERCP brush cytology / biopsy: can also relieve jaundice by placing temporary stent
- Staging:
  - CT T+A+P or PET/CT
  - Intra-op laparoscopy (peritoneal metastasis often missed in imaging)

TNM staging

- Resectable: stage 0 - IIB
- Unresectable: stage III (T4) & IV
  - Stage III: longer survival, more beneficial from systemic therapy
  - Stage IV: shorter survival, less beneficial from systemic therapy

Curative treatment
Principle: Upfront pancreatectomy (+ local lymphadenectomy) + adjuvant chemotherapy (all cases) +/- RT

Resectability: require CT abdomen with pancreas protocol +/- EUS +/- staging laparoscopy

- Absolute contraindications
  - SMA/ celiac trunk encasement >180°
    - Tumor contact <180° relative C/I: may be still borderline resectable
  - Unreconstructible SMV / portal vein due to tumour involvement or thrombus
    - Still borderline resectable if suitable vessel proximal and distal to involved site for interposition graft reconstruction
  - Distant metastasis

[Image Description: This is a transverse section of a computed tomography (CT) scan of the abdomen. The liver is seen as a large, homogenous structure. The gallbladder is a dark, teardrop-shaped structure in the upper right quadrant. The pancreas appears as a lobulated structure. The spleen is seen as a crescent-shaped structure.]

Options of pancreatic resection reviewed below:
Pancreaticoduodenectomy (Whipple's operation)

- Indications: CA head of pancreas (and other periampullary tumours)
- Types:
  - Pylorus-preserving pancreaticoduodenectomy (PPPD): standard - preserve gastric antrum, pylorus and proximal 3-6cm of duodenum
  - Conventional Whipple operation: only when entire duodenum has to be removed (e.g. FAP), or when PPPD would not achieve a clear resection margin (tumour encroaches on D1 or distal stomach)
  - PPPD vs conventional Whipple
    - No difference in survival or recurrence rates
    - Less blood loss and shorter operation time
    - Lower rate of post-op dumping syndrome (UTD: similar rate of delayed gastric emptying)
    - Lower rate of marginal ulcer (mucosal erosion at GJ)
    - Lower rate of bile reflux gastritis (difficult to manage)
- Pre-op preparation
  - Top up nutrition, correct electrolyte abnormalities, T&S
  - Pre-op ERCP x biliary drainage: NOT routine, only if septic / OT cannot be arranged in 1-2 weeks
    - Plastic stent is preferred: c.f. metal stent would induce inflammation → difficult removal in OT
- Surgical procedure: exploration → resection → reconstruction
  - Staging laparoscopy: rule out peritoneal metastasis and liver metastasis (intra-op USG)
  - Kocher maneuver: mobilize duodenum to expose retroperitoneal structures
  - Cholecystectomy + dissection of liver hilum (e.g. hepatic a. proper, GDA, CBD)
  - Mobilize relevant structures (e.g. distal stomach, right colon, SMV)
  - Resection of head of pancreas + duodenum + jejunum for ≥15cm distal to ligament of Treitz
  - Upper margin:
    - Pylorus-preserving (PPPD): up to 2-3cm distal to pylorus
    - Conventional Whipple: truncal vagotomy + antrectomy
  - Local lymphadenectomy: LN around SMA, para-aortic LN - take at least **12 LN** for accurate staging
  - Roux-en-Y reconstruction + **triple anastomoses** (in the following order):
    - Pancreaticojejunostomy (PJ)
    - choledochojejunostomy (CJ)
    - gastrojejunostomy (GJ) / duodenuojejunostomy (DJ)

[Illustration showing two surgical procedures. The first image, labeled "A", depicts a classic pancreaticoduodenectomy (Kausch-Whipple), where a tumor is located in the head of the pancreas near the portal vein. The second image, labeled "B", showcases the surgical outcome after the procedure. Below the illustration are detailed diagrams. One diagram illustrates the resection of the head of the pancreas in a pylorus-preserving pancreatoduodenectomy, highlighting the pancreatic duct, jejunum, body and tail of the pancreas, and the superior mesenteric artery and vein. The other diagram shows reconstruction after a pylorus-preserving pancreatoduodenectomy, detailing the liver, bile duct, choledochojejunostomy, pancreaticojejunostomy, jejunum, pylorus, and duodenum.]

- Specific complications
  - Early: anastomotic leak
    - Risk: PJ (30%, due to digestive enzyme + small and soft duct) > CJ > GJ
    - Severe PJ leak: may require distal pancreatectomy
    - Pancreatic fistula and Cx (e.g. GDA pseudoaneurysm, splenic v. thrombosis) (see below)
    - Somatostatin analogue (e.g. octreotide) does NOT reduce risk
  - Late:
    - Delayed gastric emptying (PPPD) or dumping syndrome (Whipple)
      - Mechanisms of DGE in PPPD: Injury to nerve of Laterjet, disrupted pacemaker cells, reduced
        CCK (high concentration found in duodenum)
    - Pancreatic insufficiency: new-onset DM (16%)
- Distal pancreatectomy + splenectomy
  - Indications: body/ tail disease
  - Procedure: resection of pancreas lateral to SMV + splenectomy + local lymphadenectomy
  - Post-splenectomy: vaccination for encapsulated organisms
  - Complications: higher anastomotic leak c.f. Whipple's
- Total pancreatectomy
  - Indications: multifocal tumor (e.g. main duct IPMN), or when body/ tail of pancreas is too inflamed to achieve a
    safe anastomosis with bowel
- Adjuvant chemotherapy
  - Indications: ALL resected CA pancreas
  - Start within 12 weeks post-op
    - FOLFIRINOX (folinic acid, 5-FU, irinotecan, oxaliplatin)
    - Gemcitabine + capecitabine x 6 months
- Palliative treatment
  - Tumor found unresectable during laparotomy: double bypass surgery
    - Gastric bypass: gastroenterostomy (relieve duodenal obstruction)
    - Biliary bypass: choledochoenterostomy (relieve jaundice)
    - Obtain transduodenal trucut biopsy +/- celiac plexus block
  - Tumor found unresectable on imaging: ERCP stenting (PTBD if unfit) + systemic chemotherapy
    - Stenting (SEMS preferred): biliary stent and/or duodenal stent
    - Chemotherapy: first obtain EUS-guided biopsy for tissue diagnosis (DDx: lymphoma)
      - FOLFIRINOX (folinic acid, 5-FU, irinotecan, oxaliplatin)
  - Symptomatic relief
    - Pain control: analgesics (e.g. opioids), celiac plexus block, short course RT
    - Exocrine insufficiency: enzyme replacement
    - Endocrine insufficiency: OHA / insulin
- Pancreatic fistula
  Definition: Abnormal connection between the pancreas and adjacent structures
- Post-op fistula: drain output of any volume after post-op D3 with a drain amylase level > 3xULN
  Risk factors: high BMI, soft pancreas, narrow duct
  Aetiology
- Iatrogenic: pancreatic resection, percutaneous drainage of pancreatic pseudocyst
- Non-iatrogenic: acute/ chronic pancreatitis
  Classification by International Study Group of Pancreatic Fistula (ISGPF)
- Biochemical leak: drain amylase > 3xULN but asymptomatic
- Grade B: persistent drainage >3 weeks, requiring change in Mx, signs of infection but no organ failure
- Grade C: unstable, require re-operation, risk of organ failure

Pathogenesis & clinical features
Partial disruption of pancreatic duct → leak of pancreatic juice →

- Pseudocyst
- High output fistula: dehydration, malnutrition, metabolic acidosis (as loss of HCO3 in pancreatic juice)
- Artery: GDA pseudoaneurysm → intraabdominal haemorrhage / UGIB
- Vein: portal vein thrombosis, splenic vein thrombosis
- Peritoneal cavity: pancreatic ascites

Investigations: CT abdomen
Management

- Conservative management
  - Biochemical leak:
    - Maintain oral feeding
    - Drain in situ for 3 weeks
  - Symptomatic pancreatic fistula:
    - NPO, NJ feeding
    - Correct fluid & electrolyte disturbance
    - Drain in situ
    - Antibiotic prophylaxis
    - Somatostatin analogue
- Management if persistent leak or symptomatic despite conservative
  - Endoscopic: transpapillary stent placement
  - Surgical repair (if Grade C)
  - Embolization for bleeding

Methods to reduce PJ leakage:
Only proven method: **high volume center** with
high case load
Possible options explored:

- Octreotide
- Prophylactic stenting
- Blumgard technique: duct-to-mucosa
  anastomosis
- Small bowel invagination

Periampullary malignancy
Definitions: tumours that arise within 2cm of ampulla of Vater

- All require Whipple's procedure as curative treatment

| Tumours                          | Important features                                                       |
| -------------------------------- | ------------------------------------------------------------------------ |
| CA head of pancreas              | Dull aching pain radiating to the back                                   |
|                                  | New-onset DM                                                             |
| Cholangiocarcinoma of distal CBD | Elderly                                                                  |
| Periampullary duodenum carcinoma | Rare, except in FAP                                                      |
|                                  | **Thomas' sign:** silver stool due to obstructive jaundice (white stool) |
|                                  | + melena (ulceration of tumour)                                          |
| Ampulla of Vater carcinoma       | Jaundice, fat malabsorption                                              |

5.9 Diseases of spleen
Vascular supply

- Splenic artery (from CT)
- Short gastric artery (from splenic artery)
  Splenic infarct
- Definitions: occlusion of splenic artery or one of its branches
- Aetiology
  - Haematological disorders (e.g. leukaemia): by congestion of splenic circulation by abnormal cells, anaemia & splenomegaly
  - Embolic disorders (e.g. AF)
- Clinical features
  - LUQ pain radiating to shoulder (Kehr's sign)
  - Fever, n/v, pleuritic chest pain
- Investigations - CT abdomen with contrast: segmented wedge of hypoattenuated tissue (fig.)
  [Abdominal CT Scan showing a axial slice on the left and a coronal slice on the right, with an asterisk denoting the spleen on both images.]
- Management - Treat underlying cause - Splenectomy if: - Persisting symptoms - Complications develop: - Splenic rupture - Splenic abscess: if embolus non-sterile (e.g. IE); Dx CT abdomen with contrast - Auto-splenectomy: repeated infarction causes progressive atrophy of spleen
  Splenic rupture
- Aetiology:
  - Abdominal trauma: seat-belt injury, fall onto left side
  - Stretched splenomegaly: haematological disorders, EBV infection
- Clinical features
  - Can present late -delayed rupture
  - Kehr's sign
  - Hypovolemic shock (spleen as extremely vascular organ)
  - Triad of LLL atelectasis, elevated left hemidiaphragm, left pleural effusion
- Management - Haemodynamically unstable: urgent laparotomy - Haemodynamically stable: CT thorax-abdomen-pelvis with contrast for AAST splenic injury scale (grade I - V) - Grade V: urgent laparotomy - Grade I-III: conservative management (strict bed rest, repeat CT scan in 1 week, prophylactic vaccinations)
  [Diagram illustrating different grades of splenic injury based on depth and surface area involvement, with descriptions of lacerations, haematomas, and vascular injuries for each grade, ranging from Grade I (minor) to Grade V (shattered spleen).]

---

Splenectomy
Indications

- Trauma (accident, operative)
- **Oncological**: part of en bloc resection (radical gastrectomy, distal/ total pancreatectomy)
- **Haematological (hypersplenism)**: ITP (+/- Evan's syndrome), PMF, spherocytosis
- Portal hypertension: variceal surgery
  Pre-op preparations
- Antibiotic prophylaxis (clean if elective, dirty if traumatic)
- Optimised clotting profile and platelet
- Vaccination: >2 weeks pre-op if elective, ASAP if urgent
  Specific complications
- Immediate:
  - Bleeding: slipped ligature, haematemesis from gastric mucosal damage
  - Injury to surrounding structures: pleural effusion, left basal atelectasis, stomach, pancreas (abscess, fistula)
- Early:
  - Post-op thrombocytosis: prophylactic aspirin if platelet > 1000
  - Post-splenectomy septicaemia:
    - Risk factors: young, immunocompromised
    - Pathogens: Strep pneumoniae, N meningitidis, H influenzae
- Late: overwhelming post-splenectomy infection (OPSI)
  - Patho: asplenic patients unable to mount immunological response against encapsulated organisms
    - Some Nasty Killers Have Some Capsule Protection
      - _Streptococcus pneumoniae_
      - _Neisseria meningitidis_
      - _Klebsiella pneumoniae_
      - _Haemophilus influenzae_
      - _Salmonella typhi_
      - _Cryptococcus neoformans_
      - _Pseudomonas aeruginosa_
  - Prevention:
    - Vaccination: PCV13 + PPSV23 (repeat Q5y), Hib vaccine, meningococcal ACWY vaccine, Flu
    - Penicillin V prophylaxis: not required in adults

152

6 Hernia
153

6.1 Anatomy
Anterior abdominal wall
Layers: skin, Camper's fascia, Scarpa fascia, EO, IO, TA, extra-
peritoneal fat, parietal peritoneum

Rectus sheath

- Interlaced aponeuroses of ext. oblique, int. oblique &
  transversus abdominis
- Contents:
  - Rectus abdominis & pyramidalis
  - SMA, SMV, IMA, IMV, lymphatics
  - Thoraco-abdominal n. and subcostal n.
- Arcuate line: 1/3 distance from umbilicus to pubic crest
- Above arcuate line (5cm below umbilicus): rectus sheath encloses
  rectus abdominis
- Below arcuate line: rectus sheath covers rectus abdominis anteriorly →
  transversalis fascia is the only layer between rectus abdominis and
  peritoneum

Inguinal canal

- Contents of inguinal canal
  - Spermatic cord (or round ligament in F)
  - Ilioinguinal nerve
- Deep inguinal ring: 1cm above midpoint of
  inguinal ligament (halfway between PT and ASIS),
  lateral to the inferior epigastric vessels
- Superficial inguinal ring: just superolateral to PT
- Mid-pt of inguinal ligament vs mid-inguinal point
  - Midpoint of inguinal ligament (PT-ASIS):
    deep inguinal ring is 1cm above
  - Mid-inguinal point (PS-ASIS): femoral pulse
- Myopectineal orifice of Fruchard: weak point

[Diagram of the abdominal wall showing layers, Above Arcuate Line, Below Arcuate Line, Roof, Anterior wall, Posterior wall, Pubis bone, Floor]

[Table with 4 rows and 2 columns describing each side of the abdominal wall: Anterior, Posterior, Roof, Floor. Each row contains the following:]

[Row 1: Anterior - External oblique aponeurosis]
[Row 2: Posterior - Lateral 1/3: lower fibres of internal oblique, Transversalis fascia, Medially: conjoint tendon (merging pubic attachment of internal oblique and transversus abdominis aponeurosis)]
[Row 3: Roof - Central: conjoint tendon, Lateral: transversallis fascia, Medial: medial crus and inter-crural fibres, Central: superior surface of inguinal ligament]
[Row 4: Floor - Lateral: iliopubic tract, Medial: lacunar ligament]

Spermatic cord
3 layers: TA does not contribute

- External spermatic fascia (from EO)
- Cremasteric fascia and muscle (from IO)
- Internal spermatic fascia (from TF)

3 arteries

- Testicular artery (from aorta)
- Cremasteric artery (from inferior epigastric)
- Artery to vas deferens (from inferior vesicular)

3 nerves

- Ilioinguinal nerve (L1) (enter laterally into inguinal
  canal) - NOT inside spermatic cord
- Genital branch of genitofemoral (L1): for cremasteric
  reflex
- Autonomic nerves (T10)

3 other structures

- Vas deferens
- Lymphatics (drain testis to para-aortic LN)
- Pampiniform plexus of veins (drain right testis into IVC, left
  testis into renal vein)

[Illustration of the inguinal region showing Extraperitoneal tissue, Transversus abdominus muscle, Internal oblique, Aponeurosis of external oblique muscle, External iliac artery, External iliac vein, Parietal peritoneum, Inferior epigastric vessels, Transversalis fascia, Deep (internal) inguinal ring, Rectus abdominis muscle, Conjoint tendon, Superficial (external) inguinal ring, Spermatic cord, External spermatic fascia, Cremasteric muscle and fascia, Internal spermatic fascia]

Layers of scrotum
Some Damn Englishman Calls It The Testis

- Skin
- Dartos muscle
- External spermatic fascia (ext oblique)
- Cremasteric fascia (int oblique)
- Internal spermatic fascia (transversalis fascia)
- Tunica vaginalis
- Tunica albuginea

# Hesselbach triangle

- Landmark for **direct** inguinal hernia
- Boundaries
  - Medial: Lateral border of rectus abdominis
  - Lateral: Inferior epigastric vessels
  - Inferior: Inguinal ligament

# Triangles of doom and pain

Triangle of pain (lateral)

- Boundaries
  - Superolateral: iliopubic tract
  - Inferomedial: **gonadal vessels**
- Contents
  - Lateral femoral cutaneous n. of thigh
  - Femoral n.
  - Femoral branch of genitofemoral n.
- Significance: **damage / entrapment** during lap repair → motor and sensory impairment

Triangle of doom (medial)

- Boundaries
  - Apex: deep ring
  - Medial: **vas deferens**
  - Lateral: **gonadal vessels**
- Contents
  - **External iliac vessels**
  - Deep circumflex iliac vein
  - Genital branch of genitofemoral n.
  - Femoral nerve (hidden by fascia)
- Significance: damage to external iliac vessels during lap repair → **massive bleeding**

[Image of the anatomy of the inguinal region depicting the inguinal ligament, rectus abdominis muscle, inferior epigastric vessels, direct inguinal hernia, inguinal triangle (Hesselbach triangle), femoral artery, and femoral vein.]

[Image of the anatomy of the inguinal region depicting direct and indirect hernias, public tubercle, corona mortis, triangle of doom, triangle of pain, and various blood vessels and nerves.]

[Image of the corona mortis showing the anastomosis between the inferior epigastric artery and the obturator artery.]

# Femoral triangle and femoral canal

Femoral triangle

- Boundaries
  - Medial: adductor longus
  - Lateral: sartorius
  - Superior: inguinal lig.
- Contents: NAVEL
  - Femoral Nerve
  - Femoral Artery
  - Femoral Vein
  - Empty space (femoral canal)
  - Lymph nodes

[Image of the femoral triangle anatomy showing the femoral nerve, femoral canal, femoral sheath, and great saphenous vein.]

Femoral canal

- Boundaries
  - Anterior: inguinal ligament
  - Posterior: pectineal (Cooper's) ligament
  - Medial: lacunar ligament
  - Lateral: femoral vein
- Significance of femoral canal
  - Contain deep inguinal node of Cloquet
  - drain penis/ clitoris
  - Narrow dead space where femoral hernia can occur

[Image of a cross-sectional view of the femoral canal with color-coded labels for the femoral canal, inguinal ligament, pectineus, femoral vein, and lacunar ligament.]

6.2 Overview
Definitions

- **Hernia:** protrusion of an organ (or part of organ) through the wall of its containing cavity
- **Reducible:** ability to return the displaced hernia contents to their usual anatomic site
- **Incarcerated:** no IO - 'imprisoned' - swollen or fixed within the hernia sac so that it cannot be replaced into abdomen
- **Obstructed:** IO - loop of bowel trapped in hernia sac such that its lumen (but not blood supply) is obstructed (closed-loop IO)
- **Strangulated:** IO with ischemia (blood supply also affected), impending gangrene - Incidence: femoral > indirect inguinal > direct inguinal - **Richter's hernia:** incarcerated hernia involving only one sidewall of bowel, causing ischaemia but not obstruction - **Reduction-en-masse:** apparently "reducing" the sac but did not push the contents out of the sac → still strangulated
  Risk factors
- **Male**
- Weakened abdominal muscles: **aging**, **trauma**
- **Increased intra-abdominal pressure:** chronic cough, heavy lifting, chronic constipation, straining urine (BPH), pregnancy, ascites
- Congenital: patent processus vaginalis

Types of hernia: inguinal > incisional > femoral > others

|          |                                         |                                                                                                                                  |
| :------- | :-------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------- |
| Internal | Hiatus hernia                           | Hernia through oesophageal hiatus                                                                                                |
| External | Inguinal (78%)                          | Indirect (80%): lateral to inferior epigastric vessels                                                                           |
|          |                                         | Direct (20%): medial to inferior epigastric vessels at Hasselbach triangle                                                       |
|          |                                         | Pantaloon (concurrent direct + indirect hernia) → straddle inf. epigastric vessels                                               |
|          | Femoral (7%)                            | Femoral canal                                                                                                                    |
|          | Umbilical                               | Umbilical ring                                                                                                                   |
|          | Epigastric                              | Linea alba above umbilicus via aponeurotic intersections (only contain preperitoneal fat) Occur in middle-aged men after lifting |
|          | Divarication of recti (Diastasis recti) | Linea alba stretches laterally due to overweight or pregnancy Exacerbated by looking at toe                                      |
|          | Paraumbilical                           | Linea alba around umbilicus                                                                                                      |
|          | Spigelian                               | Linea semilunaris                                                                                                                |
|          | Superior lumbar (Grynfeltt's)           | Superior lumbar triangle: rib 12, inferior oblique, quadratus lumborum                                                           |
|          | Inferior lumbar (Petit's)               | Inferior lumbar triangle: LD, external oblique, iliac crest                                                                      |

DDx of groin lump (L SHAPE)

- Lymph nodes
- Saphenous varix
- Hernia (inguinal / femoral)
- Aneurysm (femoral a.)
- Psoas abscess
- Ectopic testis
- Lipoma / sebaceous cyst
- Transplanted kidney

[Illustration of Richter's hernia. The image shows a cross-sectional view of the abdominal wall with a hernia sac protruding. The bowel is partially trapped within the sac.]

[The image shows a line drawing of a hernia with arrows indicating points of restriction]

External Abdominal Wall Hernias

[A line drawing of a torso, with points on the torso marked to indicate the location of external abdominal wall hernias. The marked points are labeled "Epigastric", "Umbilical", "Spigelian", "Inguinal", and "Obturator". The text, "External hernias: red = common; white = not unusual; black = rare" is visible on the image]

[A photograph shows a close-up of a bulging hernia on a person's abdomen. The skin appears slightly discolored and stretched over the bulge]

[An illustration shows an anterior view of abdominal muscles. The illustration is focused on the superficial muscles of the abdomen and the surrounding skeletal structures. Notable muscles include the superior lumbar triangle, external oblique, rectus abdominis, and latissimus dorsi. Key skeletal landmarks include the iliac crest and lumbar triangle]

Obturator
Obturator canal
"Little old lady hernia": more common in thin
old female
Howship-Romberg sign: pain along medial
aspect of proximal (IR of hip) thigh due to
nerve compression
Amyand
Hernia sac containing a ruptured appendix
Littre's
Hernia containing Meckel's diverticulum
Gluteal
Greater sciatic foramen
Sciatic
Lesser sciatic foramen
Procedural Incisional (10%)
Incisional site
Parastomal
Adjacent to a stoma

6.3 Inguinal hernia

|                          | Direct                                                          | Indirect                                                                                                                                 |
| ------------------------ | --------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------- |
| Proportion               | 20%, older male                                                 | 80%, younger male                                                                                                                        |
| Site of protrusion       | Medial to inferior epigastric vessels (**Hesselbach triangle**) | Lateral to inferior epigastric vessels                                                                                                   |
| Deep ring occlusion test | Not controlled                                                  | **Controlled**                                                                                                                           |
| Course                   | Traverse medial 1/3 of canal                                    | Traverse entire inguinal canal                                                                                                           |
| Descend into scrotum     | NO (rarely)                                                     | **YES**                                                                                                                                  |
| Aetiology                | Acquired (weakened abdominal wall, e.g. in elderly)             | Congenital (incomplete closure of processus vaginalis, i.e. young) Acquired (peritoneum pushed via deep ring, forming a sac, in elderly) |
| Strangulation            | Less common: broad base                                         | More common (esp. deep ring)                                                                                                             |

Clinical features

- Lump in groin (2/3 on right side): cough impulse + reducibility
  - Differentiate from scrotal mass (palpate lower border)
- Incarcerated hernia: painful, tender, erythematous
- Obstructed hernia: features of IO
- Associated features: examine abdomen, chest (COPD), PR (BPH)
- Content: small bowel (MC), omentum, ascending colon
  Investigations
- Clinical diagnosis
- USG: if diagnosis uncertain (esp. irreducible) / post-op for hematoma

Management
Conservative: _watchful waiting_, indicated if asymptomatic inguinal hernia / not fit
for surgery

- Lifestyle modification: weight reduction, change job nature, quit smoking
- Manage underlying medical conditions
- Abdominal truss (fig.): not effective

[Image of Maydl's hernia is shown. Two adjacent loops of bowel are in the sac. The intervening portion in the abdomen is the first to suffer if the neck of the sac is tight, because it is the centre of the whole loop involved. The strangulated piece is intra-abdominal. This is a rare variety of strangulation.]

[Image of Sliding hernia is shown. If bowel which is normally extra-peritoneal forms one side of the sac, it is thought to have slid down the canal pulling peritoneum with it, hence the name hemi-englasade. The sac can contain other loops of bowel, and the gut forming the wall of the sac can be strangled by the external ring.]

[Image of Abdominal truss is shown. The person is wearing it around their waist with straps going down their groin to hold two padded supports. ]

Surgery: mesh repair

- Indications of hernia repair:
  - Irreducible / Complicated inguinal hernia (IO/incarceration/strangulation)
  - Symptomatic inguinal hernia (e.g. groin pain, ADL impairment, difficulty in reduction)
  - All cases of femoral hernia
- Principles:
  - Reduction of hernia content +/- removal of non-viable tissues and repair bowels
  - Excision and closure of peritoneal sac
  - Re-approximate walls of neck of hernia
  - Reinforce abdominal wall defect with sutures or mesh
- Mesh: Prosthetic material to strengthen hernia repair
  - Lower recurrence rate, reduce post-op groin pain, faster recovery
  - Types:
    - Synthetic: polypropylene, PTFE (polytetrafluoroethylene)
    - Biological: sterilized decellularized connective tissue, eventually broken down
  - Positioning: open allows all, lap only allows sublay
    - On-lay: subcutaneous
    - In-lay: plugged within the defect - risk of migrate and "meshoma"
    - Sub-lay: extraperitoneally
  - May be difficult if complicated hernia (infected / edematous) → use non-mesh repair

| Approach    | Open                                                                                                                                                                                                                                                                                                                                                   | Laparoscopic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| ----------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|             | Tension-free mesh repair (Lichtenstein) [Image of Surgical illustration of a Lichtenstein tension-free mesh repair. The illustration depicts an open surgical field with instruments holding tissue. A patch of mesh is positioned over the inguinal area. The illustration includes anatomical details such as the inguinal nerve and blood vessels.] | Total extra-peritoneal approach (TEP): pre-peritoneal space less adhesions, large mesh possible C/I if prior lower abdominal surgery; technically more challenging (limited working space) Trans-abdominal pre-peritoneal repair (TAPP): enter peritoneal space : larger working space, lower risk to convert open : intraabdominal adhesions, injury to organs [Image of A comparative diagram illustrating laparoscopic operations TEP (Total Extraperitoneal Repair) and TAPP (Transabdominal Preperitoneal Repair). On the left is the TEP operation, where the pre-peritoneal space is accessed without entering the peritoneal cavity. On the right is the TAPP operation, where entry into the peritoneal cavity is necessary before accessing the pre-peritoneal space. Arrows and annotations indicate the surgical steps and anatomical differences between the two procedures. "Pre-peritoneal space" and "Abdomen" are written as annotations in the diagram.] |
|             | Non-mesh techniques: more recurrence, indicated if active infection / bowel perforation Shouldice repair: division and reconstruction of inguinal canal with 4-layer overlap Bassini repair: suture conjoint tendon to inguinal ligament                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Anaesthesia | LA: ilioinguinal & iliohypogastric n. (or SA/GA)                                                                                                                                                                                                                                                                                                       | GA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Indications | 1st occurrence Complicated hernia (emergency) Previous lap repair Previous pelvic / lower abdominal midline surgery (adhesions - not fit for TEP) Ascites Not fit for GA                                                                                                                                                                               | Recurrent or bilateral hernia Recurrent: increased adhesions after 1st open repair Bilateral: single port placement for both hernias, allow exploration of contralateral groin if suspected hernia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

158
Advantages
No need GA
Shorter operating time
Quicker recovery, shorter hospital stay
Fewer complications, better cosmetics
Less chronic pain (performed at a deeper level
away from the 3 nerves: ilioinguinal,
iliohypogastric, genital branch of genitofemoral)
Disadvantage Only 1 side (limited by LA max dose)
Higher risk of recurrence
Terminology

- **Herniotomy:** excision of hernia sac without repair, only used in children
- **Herniorrhaphy:** excision + repair of hernia sac + reinforcement of posterior wall of inguinal canal _without mesh_
- **Hernioplasty:** excision + repair + reinforcement of posterior wall of inguinal canal _with mesh_
  - "Tension free": mesh is used to cover the defect, avoiding muscle fibre distortion that increases tension
  - Mesh used: macroporous polypropylene - large pores allow permeation of new blood vessels and
    inflammatory cells such as fibroblasts - essential for creating strong repair

Specific complications
Immediate

- Damage to _vas deferens_ / _ilioinguinal nerve_
- AROU
- Injury to surrounding organs during pneumoperitoneum: bladder, bowels, vascular
- LA: femoral nerve blockade → unilateral LL weakness (usually resolve ~12h)
  Early
- Wound infection: require empirical antibiotics +/- drainage +/- EOT to debride and remove mesh
- **Mesh complications:** infection, migration, erosion, shrinkage
- Seroma (excessive inflammatory response to mesh/ sutures → fluid collection): resolve later, no
  need to aspirate unless infected
- Hematoma
- Testicular infarction (damage to testicular artery)
  Late
- **Chronic pain >3mo** after surgery: injury to nerves (iliohypogastric / ilioinguinal / genitofemoral /
  lat. cutaneous n. of thigh)
- **Hernia recurrence**
- Sexual dysfunction
- Ischemic orchitis / Testicular atrophy due to pampiniform plexus thrombosis
- Adhesions / Internal herniation through peritoneal defect (lap TAPP)

Post-op recovery

- **Early mobilisation**
- Hygiene: allow bathing immediately post-op, keep area clean
- Resume light activities 1-2 weeks post-op, but avoid heavy lifting or vigorous exercise until **6 weeks** post-op
- Avoid predisposing factors: treat chronic cough, give laxatives for constipation

  6.4 Incisional hernia
  Definition:

- Extrusion of abdominal content through a weak scar or accidental wound on abdominal wall
- Partial wound dehiscence (skin remains intact)
  Physical examination:
- Define **fascial defect** by tilting head up to look at toes
- Percuss for content (dull omentum vs resonant bowel)
  Risk factors
- Patient factors: age, obesity, immunocompromised
- Local factors: infection, haematoma, chemo/ RT
- Surgeon factors: poor surgical technique **(tension)**, placing drains through wounds, emergency/prolonged OT
  Complications:
- Intermittent obstruction, incarceration/strangulation
- Enterocutaneous fistula (skin excoriation)

159

Management
Conservative: lifestyle modification, treat medical conditions, **truss**

- Indicated if: high anaesthetic risk, concurrent medical problems, risk of infection/dehiscence/hematoma
  Surgical repair (open / lap): Indicated if **symptomatic** / **risk of strangulation**
- Dissect hernia sac and surrounding tissues ≥3cm on all sides
- Reduce hernia contents and repair fascial defect
  - Defects <1cm: **Mayo repair** (fascial edge repaired with 2cm overlap, use interrupted + continuous sutures)
  - Defects >1cm: **tension-free mesh repair**
    - Allow 5-8cm adequate overlapping over normal tissues for mesh shrinkage / contraction in ALL directions
  - Approach (fig.): _sublay_ has lowest recurrence rate

|       | Laparoscopic                                                                                          | Open                                                                                                           |
| :---- | :---------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------- |
| Layer | Underlay (intraperitoneal), i.e. dual layer mesh (outer layer induces fibrosis, inner layer does not) | Sublay (preperitoneal): between rectus muscle and posterior rectus sheath                                      |
| Role  | ↓Pain, recovery Smaller wound, infection rate                                                         | Emergency Large hernia > 10cm (possibility of "sister hernia": occurrence of hernia elsewhere in the incision) |

6.5 Umbilical hernia
Definition:

- True umbilical hernia: Defect through _linea alba_ (union of rectus sheath) through umbilical scar
- Para-umbilical hernia: Defect through side of umbilical scar (higher risk of strangulation)
  Management:
- Congenital: repair if **symptomatic**
- Acquired: always consider surgery (small defect: Mayo repair; large defect: _sublay_ extra-peritoneal mesh)

  6.6 Femoral hernia
  Risk factors

- **Obese women**: wider pelvis and thus wider femoral canal
  Content of hernia sac
- Omentum
- Knuckle of small bowel (Richter's hernia)
  Clinical features
- **High risk of strangulation** - _all_ femoral hernia should be treated surgically
- Cough impulse can be absent - tight neck of hernia sac → rapidly irreducible
  Investigations
- Groin USG: to differentiate from inguinal hernia (conservative management may be a treatment option)
  Management
- Open repair:
  - Low approach (Lockwood's): infrainguinal approach
    - Preferred in _elective_ settings under LA if no risk of bowel strangulation
    - Direct incision over hernia → reduce content → close femoral ring by non-absorbable sutures
    - Need to protect femoral vein
  - Inguinal approach (Lotheissen's):
    - Incision into inguinal canal → mobilize spermatic cord (round lig.) → open transversalis fascia (femoral hernia is below this) → reduce hernia and repair the defect
  - High approach (McEvedy's): suprainguinal approach
    - Preferred in _emergency_ under SA/GA - easier access to strangulated small bowel
    - Incision at lower abdomen → expose pre-peritoneal space → close femoral defect
- Laparoscopic repair (usually elective cases): TEP, TAPP

[Image Description: The image displays diagrams and an illustration of a femoral hernia repair approach. On the right side, there are three diagrams. Each diagram shows a cross-sectional view of the abdominal wall with different layers labeled, including "anterior rectus sheath," "rectus abdominis muscle," "posterior rectus sheath," "transversalis fascia/peritoneum," "Onlay," "Sublay," "Underlay," and "Inlay." These diagrams illustrate different mesh placement techniques in hernia repair. Below the diagrams, there is an illustration of the inguinal region, showing various anatomical structures. Labels include "Incision through linea semilunaris," "Inguinal ligament," "(C) High approach of McEvedy," "(B) Transinguinal approach of Lotheissen," "Femoral canal," "Superficial ring," "Spermatic cord," and "Low approach of Lockwood."]

7.1 Aneurysm
Abdominal aortic aneurysm (AAA)
Definitions

- Aneurysm: pathological, localized and permanent dilatation of blood vessels by ≥50% of normal diameter
  - True aneurysm: wall is formed by all 3 layers of vessels (TI, TM, TA)
  - Pseudo-aneurysm: wall is formed by extravascular connective tissue
- AAA: permanent dilatation of (infrarenal) abdominal aorta ≥ 3cm (MC type of true arterial aneurysm)

Risk factors: 95% associated with atherosclerosis

- Age
- Male (9:1)
- Most CV risk factors (e.g. smoking, HT, lipid) except DM (unknown mechanism)
- Connective tissue disease (e.g. Marfan's, EDS)
- Others: mycotic (e.g. non-typhoid Salmonella, Staphylococcus, Syphilis)

Locations: Infrarenal (95%), juxtarenal, pararenal, suprarenal

[Image Description: This image presents a series of diagrams illustrating different types and classifications of aortic aneurysms. The top right shows a simplified cross-section of a normal artery and three types of true aneurysms (Saccular, Fusiform, Dissecting) and one type of false aneurysm. The diagrams emphasize the layers of the arterial wall (Adventitia, Media, Intima) and how they are affected in each type of aneurysm. The middle of the image depicts Crawford aneurysm classifications (I-V) showing the extent of aneurysms in the thoracic and abdominal aorta, followed by a series of abdominal aortic aneurysms classifications, infrarenal, juxtarenal, pararenal, and suprarenal. These diagrams highlight the location of the aneurysm in relation to major arterial branches and anatomical landmarks. The aneurysms are represented as dilated sections of the aorta, with arrows indicating the position of key anatomical structures such as the celiac trunk, renal arteries, and bifurcation. The diagrams are color-coded to distinguish different aneurysm types and classifications, and anatomical structures are labeled for clarity.]

Clinical presentation

- Most asymptomatic (60%): +/- concomitant femoral (80% has AAA) or popliteal aneurysm (50% has AAA)
- Symptomatic (10%): must rule out rupture
  - Abdominal / back / loin / groin pain: due to compression on nerves and organs
  - Limb ischemia (e.g. blue toe syndrome, trash foot): due to distal embolization of mural thrombus
- Rupture (30%): refer to separate section
- Others: aortoenteric fistula (massive GIB), aorto-ureteric fistula (hematuria), aortocaval fistula (high-output HF)

Physical examination: pulsatile and expansile mass (usually in epigastrium)

- Features: Non-tender, immobile, firm in consistency, smooth surface, fusiform/saccular
- Border: can get above = infrarenal, can get below = no iliac involvement
- Measure transverse diameter
- Palpate for other aneurysms, femoral pulse and features of limb ischemia

Investigations

- USG abdomen: confirm diagnosis and surveillance of AAA size (surgery if ≥5.5cm)
  - Hemodynamically unstable patients: FAST scan indicated
- CT abdomen + pelvis with contrast: preoperative assessment of anatomy for suitability for EVAR
- Others: CTA/MRA/DSA (not for size due to intramural thrombus), AXR (calcification of aortic wall)

7 Vascular surgery
Thoracoabdominal Aortic Aneurysm: Crawford classification
Class I: below left subclavian artery (SCA) to above renal a.
Class II: below left SCA to include infrarenal aorta
Class III: from 6th intercostal space (ICS) to bifurcation
Class IV: from 12th ICS to aortic bifurcation
Class V: from 6th ICS to above renal arteries

| Aneurysm size | Annual rupture risk (%/year) |
| ------------- | ---------------------------- |
| <5.5cm        | <1%                          |
| 5.5-5.9cm     | 5-10%                        |
| 6.0-6.9cm     | 10-20%                       |
| 7.0-7.9cm     | 20-30%                       |
| ≥8.0cm        | 30-50%                       |

161
Management
Conservative management

- Indication: AAA <5.5cm (no survival benefit)
- CV risk factor modification: smoking cessation, BP control, statin, aspirin, weight loss, exercise
- USG monitoring: yearly for 3.0-3.9cm, Q6m for 4.0-5.4cm
  Surgical management
- Indications (need to know!)
  - AAA ≥5.5cm (_UK Small Aneurysm Trial_) / 5cm (local consensus)
  - Rapidly expanding AAA (>1cm/year or >0.5cm/6months)
  - Symptomatic AAA e.g. pain, distal embolisation
- Open repair vs endovascular aneurysm repair (EVAR): [trials: EVAR1, DREAM, OVER]
  - EVAR: less 30-day morbidity and mortality, shorter duration of hospitalization, rapid return of QoL
  - Open: lower risk of rupture / re-intervention in the long run
  - No significant difference in long-term morbidity and mortality

| Approach     | Open repair: Aneurysmorrhaphy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | Endovascular aneurysm repair (EVAR)                                                                                                                                                                                                                                      |
| :----------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|              | - Midline / supraumbilical transverse incision\* - Small bowel and peritoneum manipulated - Clamp aorta above and below lesion (~30min) give systemic heparin + induce hypotension - Open sac and clear mural thrombus - Plicate backflow from lumbar a. / IMA - Replace the sac with prosthetic graft (Dacron / PTFE) - suture with Prolene - Release clamps to check for hemostasis: give inotropes to prevent hypotension - Close the aneurysm sac around the prosthesis (to lower risk of aortoenteric fistula) | Bilateral femoral arteriotomy / Percutaneous Placement of covered stent graft (2 parts: main body with ipsilateral limb, contralateral limb) under epidural / LA Post-op: lifelong surveillance (CT at 1m, 6m, 1y then Q1y), aspirin (2º prevention of PVD)              |
| Specific Cx  | - Mortality rate ~5% - Early: mainly related to ischemia - Myocardial infarction - Acute renal failure (esp. suprarenal repair) - Ischemic bowel / Prolonged paralytic ileus (IMA occlusion) - LL ischaemia: trash foot (anastomotic kinking, clamp injury, embolism) - Spinal cord ischemia (artery of Adamkiewicz): sexual dysfunction, weakness, incontinence                                                                                                                                                    | Access site complications - Bleeding, haematoma - Pseudoaneurysm - AV fistula - Thromboembolism Endograft-related complications - Endoleak (30%)^: incomplete seal around the aneurysm causing blood leaking around the graft - Graft infection / thrombosis / migration |
| Late         | - Graft infection / thrombosis - Aortoenteric fistula (mostly D3/4 - can occur years after repair) - Pseudoaneurysm                                                                                                                                                                                                                                                                                                                                                                                                 | Systemic complications (similar to open) - Ischaemic: LL, renal, bowel, pelvic (sexual dysfunction due to pelvic artery injury) - Contrast complications: nephropathy, allergy                                                                                           |
| Preferred if | - Failed anatomic requirement for EVAR# - Do not want lifelong surveillance - High risk for AAA rupture                                                                                                                                                                                                                                                                                                                                                                                                             | First line: lower early morbidity & mortality, but higher rupture rate in long term Poor cardiorespiratory reserve                                                                                                                                                       |

\*Retroperitoneal approach if previous abdominal surgery / obese / COPD
Juxta/suprarenal / thoracoabdominal AA

- Open: retroperitoneal approach (left flank incision) - increased risk of renal impairment
  - Suprarenal aorta clamping (e.g. supraceliac) or balloon occlusion
- EVAR: fenestrated graft (fig.), "Chimney" technique
  [Illustration depicting a "Chimney/snorkel graft" technique used in endovascular aneurysm repair (EVAR). The illustration shows a stylized aortic aneurysm, where a main stent graft is placed within the aneurysm sac to exclude it from blood flow. Additionally, one or more smaller stents (chimneys or snorkels) are deployed from the main graft into the renal arteries, maintaining their patency. The "chimneys" run parallel to the main graft within the aorta. The label "a. Chimney/snorkel graft" is present below the illustration.]

#Prerequisites of EVAR:
162
Anatomic requirement

- Aortic neck length (from lowest renal a. to origin of aneurysm): 215mm - adequate proximal landing zone
- Aortic neck diameter: 18-32mm (endograft diameter is 15-20% larger - undersizing → endoleak; oversizing → infolding and inadequate seal)
- Aortic neck angulation (angle formed by lowest renal a., origin of aneurysm and aortic bifurcation) <60°
- Aortic neck morphology: C/I if reverse-tapered
- Common iliac length 220mm: adequate distal landing zone
- Common iliac diameter 8-22mm
- External iliac diameter 27mm for graft to pass through
- Minimal calcifications and tortuosity

[A diagram shows an abdominal aortic aneurysm with measurements. The aortic neck is labeled as ">10-15 mm" and "18-32 mm". The neck angulation is shown as "<45-60°". The common iliac artery (CIA) is marked as "8-22 mm" and ">20 mm", and the external iliac artery (EIA) is labeled as ">7 mm". The text "Minimal CA++ and tortuosity" is placed near the lower part of the illustration.]

Anatomical limitations might be overcome by

- Extend into proximal landing: fenestrated/branched device, chimneys, snorkels
- Proximal sealing with EndoAnchor
- Preservation of internal iliac a. with iliac bifurcation devices

^Types of endoleak after EVAR: Types I and III has continuous direct flow into AAA → require re-operation!
| Type | Description | Management |
|---|---|---|
| I | Seal failure at proximal / distal end - usually stent migration Subtypes: 1a (proximal end), 1b (distal end), 1c (iliac occluder plug in aorto-uni-iliac device) | Repeat EVAR |
| II | Backflow of blood from side branches (lumbar arteries / IMA) Subtypes: 2a (1 vessel), 2b (2 or more vessels) - Most common type of endoleak, a.k.a. "retroleak" | Close observation for AAA expansion → Lap / Open clipping / IR embolization |
| III | Stent break (fabric tear), modular dehiscence Subtypes: 3a (segment disconnection), 3b (holes in endograft fabric) | Repair defect / Bridge across defect |
| IV | Porosity: Blood goes through small pores of endograft material | Observe |
| V | Flow visualized but source not identified ("endotension") | Observe |

Approach to UGIB with background of AAA repair

- Aortoenteric fistula until proven otherwise
- Classic triad: UGIB, fever, abdominal pain
- Ix: OGD (up to D4), contrast-enhanced CT abdomen
- Mx: graft excision with extra-anatomical bypass

[A colorful diagram illustrates different types of endoleaks in an aortic stent graft. Type Ia is at the proximal end, Type Ib at the distal end, Type II from side branches, Type III through fabric tear, and Type IV through the graft material.]

Ruptured AAA

- Risk of AAA rupture increases exponentially with the diameter of aneurysm
  Clinical features
- 50% Clinical triad: severe abdominal/ back pain, pulsatile mass, hypotension
- 20% rupture anteriorly (massive intraperitoneal free bleeding), 80% rupture posteriorly (retroperitoneal haematoma with tamponade effect)
- Rule: 50% reach hospital alive → 50% can do OT → 50% survive OT
  Differential diagnosis
- Ruptured HCC
- Ruptured ectopic pregnancy
  Investigations
- CT abdomen with contrast (skip if haemodynamically unstable)
- USG cannot diagnose ruptured AAA
  Management

[An axial CT scan image shows an abdominal aortic aneurysm (AAA). The aneurysm is a large, dilated blood vessel in the abdomen, easily visible on the CT scan.]

- Resuscitation: high flow O2, IV access, urgent bloods (CBC, LRFT, clotting, X-match), pain control
- Permissive hypotension (SBP 80-100) to prevent further tear
- Unstable patient: immediate open repair
- Stable patient: CT angiogram to decide suitability of open repair vs EVAR
- Massive transfusion protocol: packed cells : platelet : FFP = 1 : 1 : 1 (e.g. 8 units each)

  7.2 Peripheral vascular disease
  Anatomy of arterial system
  [Diagram of the arterial system: Aorta branches into common iliac arteries, which further divide into external and internal iliac arteries. The external iliac artery transitions into the common femoral artery, then into profunda femoris and superficial femoral arteries. The superficial femoral artery becomes the popliteal artery, which branches into anterior tibial, posterior tibial and peroneal arteries, finally leading to dorsalis pedis.]

- External iliac a. passes through inguinal lig. and becomes femoral a.
- Femoral artery
  - Deep femoral → perforating branches, lateral femoral circumflex, medial femoral circumflex (supply femur neck → risk of AVN if #NOF)
  - Superficial femoral → enter Hunter's canal to become popliteal artery
- Popliteal artery gives off LAMP
  - Lateral - Anterior tibial, peroneal, Posterior tibial - Medial

[Diagram of vessel layers: A cross-sectional diagram shows the layers of a blood vessel, including the tunica intima, tunica media, and tunica adventitia. The tunica intima is the innermost layer, consisting of endothelium and subendothelial connective tissue. The tunica media is the middle layer, composed of smooth muscle and elastic fibers. The tunica adventitia is the outermost layer, containing connective tissue, vasa vasorum, and nerves.]
Layers of vessel wall

- Tunica intima
- Tunica media
- Tunica adventitia

History taking
Symptoms

- Onset, duration, progression
- Site of pain
  - Bilateral thigh / buttock: aortoiliac (30%)
  - Unilateral buttock: iliac
  - Calf: superficial femoral a. (70%), femoropopliteal
- Nature of pain: must be muscular pain
- Associated symptoms: numbness, pallor, cold, motor disturbances
- Rule out differential diagnosis
  - Spinal claudication: variable claudication distance, relieved by bending forward
  - Sciatica: back pain with radiation, not relieved by resting
    Severity
- **Claudication distance** (flat surface/ slope)
- How long they have to take rest (usually ~5min)
- Whether they can then walk the same distance again
- **Rest pain** (wake up due to pain, swing legs out of bed to help relieve) / Nocturnal pain
- **Any tissue loss**: ulcer, gangrene +/- infection
  Risk factors
- CV risk factors: DM, HT, HL, smoking
- Previous AF, IHD/MI, TIA/stroke, FHx
- DHx: aspirin, anticoagulants, statin
  Complications
- Impotence (Leriche's syndrome)
- Hx of stroke, MI
  Management-related
- Contrast allergy
- Saphenous vein condition
  Physical examination
- **Buerger's test**: lift both legs slowly for pallor (Buerger's angle) → swing legs down for reactive hyperemia
- To complete: **bedside Doppler** for pulses, measure ABI on both sides, examine abdomen for AAA / RAS, **cardiovascular examination** for other CV risk factors (e.g. BP/P, AF), urine multistix for glucose
  [Diagram of lower limb arterial anatomy: The diagram shows the arterial blood supply of the lower limb, including the aorta, iliac arteries, femoral artery, profunda femoris artery, superficial femoral artery, popliteal artery, tibioperoneal trunk, anterior tibial artery, posterior tibial artery, peroneal artery, and dorsalis pedis artery. The diagram highlights the inflow and outflow segments.]

- Investigations for PVD
  - **Ankle-brachial pressure index (ABPI):** to confirm diagnosis & quantify severity (but normal values may present with IC)
    Left ABI = ratio of

  Higher of the left ankle systolic pressure (posterior tibial or dorsalis pedis)
  Higher arm systolic pressure (left or right arm)
  Right ABI = ratio of

  Higher of the right ankle systolic pressure (posterior tibial or dorsalis pedis)
  Higher arm systolic pressure (left or right arm)
  - Interpretation:
  - Normal 0.9-1.3
  - Claudication 0.4-0.9
  - Severe < 0.4
  - Calcified vessels > 1.3: additional vascular studies required, e.g. toe-brachial index (small vessels spared from calcification), arterial Doppler USG, transcutaneous oxygen measurements (TcO2)

- **Duplex USG = B-mode USG + Doppler**
  - Locate level of obstruction and quantify severity (normal arterial flow should be **triphasic**)
  - Non-invasive, no radiation. Operator-dependent, poor image for aortoiliac segment
- CT angiography
  - Less invasive alternative of DSA Contrast allergy / nephropathy, radiation dose
- MR angiography (MRA) - rarely done
- **Digital subtraction angiography (DSA): gold standard**
  - Indicated only for patients with planned intervention (angioplasty / stenting)
  - Inject radio-opaque dye into arterial tree (usually via femoral a.) → Imaging and digitalized by computer
  - Can be done **intra-op:** guide endovascular intervention
  - Allergy, contrast nephropathy, arterial injury (e.g. dissection, embolism, pseudoaneurysm)

[Image of the lower leg and arm with blood pressure cuffs, illustrating the ankle-brachial index measurement procedure. The image includes annotations indicating the systolic pressure recorded in the brachial artery, the location of the brachial artery, the ultrasound device amplifying the sound of arterial blood flow in the arm, the blood pressure cuff on the arm, the blood pressure cuff on the ankle, the sound of arterial blood flow located in the ankle, the location of arteries in the ankle where arterial flow is located, and the ultrasound device measuring the sound of arterial blood flow.]

# Chronic limb ischaemia

Definition

- Gradual onset (> 2 weeks) symptomatic limb ischaemia:
  - Progressive narrowing of vessels → time to develop collaterals → multi-level disease (critical limb)
- Subdivided into: - Critical limb ischaemia - Non-critical limb ischaemia
  Risk factors
- Atherosclerosis: **CV risk factors** (especially smoking) → a/w IHD, stroke, AAA
- Vasculitis e.g. Buerger's disease, Behcet's disease
- Others: trauma, popliteal entrapment syndrome

Clinical features

|                                                                                                         | Fontaine classification                                               | Rutherford classification                                            | Description                                                                                                                                                                                                                                               |
| :------------------------------------------------------------------------------------------------------ | :-------------------------------------------------------------------- | :------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Non-critical limb ischaemia**                                                                         | Stage I: Asymptomatic                                                 | 0: Asymptomatic                                                      | Reproducible pain of a defined group of muscles that is induced by exercise & relieved by rest                                                                                                                                                            |
|                                                                                                         | Stage II: Intermittent claudication IIA: walk > 200m IIB: walk < 200m | 1: Mild claudication 2: Moderate claudication 3: Severe claudication |                                                                                                                                                                                                                                                           |
| **Critical limb ischaemia:** rest pain/ ulcer/ gangrene + ankle SBP <50mmHg (DM: toe pressure < 30mmHg) | Stage III: Rest pain / Nocturnal pain                                 | 4: Rest pain                                                         | Severe distal LL pain at rest, exacerbated by lying down / limb elevation, relieved by placing the leg in a dependent position May wake patient from sleep - Limb elevation - Reduced cardiac output Relative skin vasodilation due to warmth of blankets |
|                                                                                                         | Stage IV: Ulcer/ gangrene                                             | 5: Minor tissue loss                                                 | Initial: non-healing minor trauma Dry gangrene: uncomplicated, hard shrunken with clear line of demarcation, may fall off (auto-amputation) Wet gangrene: complicated by infection, require debridement                                                   |
|                                                                                                         |                                                                       | 6: Major tissue loss                                                 |                                                                                                                                                                                                                                                           |

[Image of Dry gangrene, showing a foot with blackened and shriveled toes. The skin appears dry and cracked.]
[Image of Wet gangrene, showing a foot with discolored, swollen skin and blisters. There are signs of infection and pus.]

- Leriche syndrome: gradual occlusion of terminal aorta, causing
  - Absent femoral pulses
  - Intermittent claudication
  - Gluteal pain
  - Impotence

Differential diagnosis

- Acute limb ischaemia: presentation < 2 weeks
- Spinal stenosis (neurogenic claudication)

|                     | Vascular claudication                         | Neurogenic claudication                          |
| :------------------ | :-------------------------------------------- | :----------------------------------------------- |
| Cause               | Chronic limb ischaemia                        | Spinal stenosis                                  |
| Radiation of pain   | From distal to proximal                       | From proximal to distal                          |
| Exacerbating factor | Walking uphill                                | Walking downhill                                 |
| Relieving factor    | Rest "Shop window to shop window"             | Bending over, sitting "Park bench to park bench" |
| Pulse               | Absent                                        | Present                                          |
| Associations        | Atherosclerotic risk factors Atrophic changes | Only 10% SLR +ve Back pain                       |

Management
Conservative: **CV risk factor modification**

- Lifestyle: smoking cessation, weight reduction, _supervised exercise programme_ (to increase O2 extraction, collateral circulation and improve muscle metabolism)
- DM / HT / HL control (**statin** - regardless of lipid level for overall CVS protection)
- Low dose **aspirin** (72-325mg): 2° prevention of coronary heart disease and stroke
- **Cilostazol** (PDE3 inhibitor with antiplatelet & vasodilatory effect, C/I CHF)
  - Alternatives: naftidrofuryl (5-HT2 antagonist: reduce platelet aggregation), pentoxifylline / Trental (PDE inhibitor), prostaglandins

Definitive treatment

- Indications: failed conservative management (6 months), disabling claudication, critical limb ischaemia
- Endovascular treatment: **percutaneous transluminal balloon angioplasty (PTA) +/- stenting**
  - Preferred if TASC Types A and B, aortoiliac diseases, short segment occlusion <10cm long, life expectancy < 2y (better short-term outcome)
  - Angioplasty: balloon inflated for ~30 seconds, dilation confirmed by angiogram
  - Stenting (+/- drug-elution): improve patency and reduce distal embolism, NOT used below knee
  - Post-op: antiplatelet + anticoagulation to prevent stent thrombosis
  - Specific complications:
    - Arterial dissection / rupture
    - Distal embolization
    - Re-stenosis
- Surgical treatment
  - Endarterectomy: open up artery to evacuate atheromatous plaque (uncommon now except at **carotid** and femoral bifurcation - profundoplasty)
  - Bypass surgery
    - Preferred if TASC Types C and D, failed angioplasty, long-segment occlusion, **complete occlusion** (no lumen for angioplasty guidewire to pass through)
    - Method of reconstruction

| Anatomical bypass: preferred                                                                 | Extra-anatomical bypass: when anatomical bypass not possible                                                                                                                                                                                                              |
| -------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| - Aorto-bifemoral bypass - Femoro-popliteal bypass (above/below knee) - Femoro-distal bypass | - Femoro-femoral bypass: for unilateral iliac occlusion + unfit for abdominal surgery, can be performed under LA - Axillo-bifemoral bypass: no need enter thoracic / abdominal cavity, can be performed under LA - Axillo-popliteal bypass: last resort before amputation |

- Type of graft
  - Autogenous: preferred for smaller arteries
    - Vein grafts (GSV, SSV, arm veins)
    - Lined by endothelium: natural antithrombotic
    - More resistant to infection
    - Valvulotome is used to disrupt venous valves
  - Prosthetic: preferred for larger arteries
    [Image of a prosthetic graft with a thin tube and a balloon-like structure at the end, likely a vascular graft]
    - PTFE (polytetrafluoroethylene)
    - Dacron
    - +/- Miller cuff (vein cuff) to improve patency
  - Complications of bypass surgery
    - Graft failure: graft kink (early), neointimal hyperplasia (intermed.), atherosclerosis (late)
    - Palpate for patency, auscultate for bruits, serial USG surveillance
    - Ureter injury
    - Graft infection (esp. prosthetic)
    - Autonomic nerve damage (sexual dysfunction)
    - Aortoenteric fistula
    - Embolic complications: e.g. renal impairment, ischemic bowel, spinal cord ischemia
    - Surveillance: Doppler USG
- Amputation if failed above or gangrene
  \*TASC classification: anatomical distribution, number, length and nature of lesions (stenosis / occlusion)

[Image of diagram titled Fig. 21.7 Balloon angioplasty and stenting. (A) Critical arterial stenosis. (B) A guidewire is used to cross the lesion. (C) The guidewire is used to direct a balloon angioplasty catheter across the lesion. (D) The balloon is inflated. (E) A metal stent may be mounted on a catheter. The stent may be self-expanding or require expansion with a balloon. (F) The first segment of stent is always deployed to ensure a solid and in this circumstance steps C and D may be omitted. (F) Metal stent holding open the stenosis.]

[Image of diagram titled Fig. 21.8 Femoro-femoral bypass. Note: (A) Heat-sensitized dermatome is used to demarcate the operative field. (B) A superficial tunnel is created.]

Acute limb ischaemia
Definitions: sudden decrease in limb perfusion that threatens the viability of limb

- Sudden = <2 weeks duration
  Etiology:
- Acute thrombotic occlusion of a pre-existing stenotic arterial segment (acute-on-chronic PVD): 60% (MC)
- Embolism (30%): usually lodge at branching points - femoral bifurcation (MC), popliteal trifurcation (2nd MC)
- Arterial trauma: e.g. iatrogenic, penetrating, blunt

Acute limb + chest pain:

- MI: mural thrombus /new-onset AF
- Aortic dissection

Distinguish embolism vs thrombosis-in-situ is important because different Ix and Mx
| | Embolus | Thrombosis-in-situ |
| ----------- | ----------- | ----------- |
| Common causes | Cardiac origin (80%) - Atrial fibrillation - MI: LV mural thrombus - Valvular heart diseases / prosthesis AAA (blue toe syndrome / trash foot) | Atherosclerosis: acute plaque rupture in PVD Aortic dissection Hypercoagulability: malignancy, APLS, sepsis Buerger's disease (thromboangiitis obliterans) |
| Severity | Complete ischemia (no collaterals) | Incomplete ischemia (collaterals) |
| Onset | Hyperacute (seconds to minutes) | Acute (hours or days) |
| History and PE | Embolic source identifiable (e.g. AF) Contralateral limb pulses present Absent bruits | Previous claudication PVD in contralateral limb (e.g. absent pulse) Present bruits |
| Management | Embolectomy, anticoagulation | Medical, bypass, thrombolysis |

Clinical features (6P)

- Pain (early: nerves are most sensitive to ischemia)
- Pallor^
- Perishingly cold
- Pulseless: can assess with handheld Doppler
- Paraesthesia
- Paralysis (late: poor prognosis, indicating muscle infarction)

^Limb colour progresses:

- 0-6h: "Marble white" pallor
- 6-12h: Blanchable mottling
- > 12h: Fixed mottling (irreversible: revascularization might cause significant reperfusion injury)

DDx of acute limb ischemia:

- Acute extremity compartment syndrome
- DVT with superficial vein thrombosis (phlegmasia cerulea dolens)

[Image: A photograph shows a human foot, possibly of a deceased person. The foot is pale with areas of blanching mottling, indicating compromised circulation. Additionally, there are patches of fixed mottling, suggesting irreversible tissue damage. The foot is resting on a surface, and there are annotations pointing to areas of skin infection, blanching mottling, and fixed mottling.]

Rutherford classification & corresponding management
| Category | Prognosis | Sensory loss | Motor deficit | Arterial Doppler | Venous Doppler | Ix | Management |
| ----------- | ----------- | ----------- | ----------- | ----------- | ----------- | ----------- | ----------- |
| I (Viable) | No immediate threat | None | None | Audible | Audible | СТА | Revascularisation |
| IIA (marginally threatened) | Salvageable if promptly treated | Minimal (toes) or none | None | Inaudible | Audible | СТА | Revascularisation |
| IIB (immediately threatened) | Salvageable only if immediately revascularised | More than toes Rest pain | Mild/moderate | Inaudible | Audible | СТА | Revascularisation (emergency) |
| III (irreversible) | Inevitable limb loss | Profound | Paralysis | Inaudible | Inaudible | Not required | Amputation |

# Management

Initial management

- NPO, IV fluids, monitor BP/P, SpO2, Foley for I/O
- Anticoagulation (therapeutic dose of heparin, i.e. heparin 5000 IU)
- Improving perfusion: **high-flow O2, keep foot dependent**
- Urgent revascularisation (see below): tissue damage becomes irreversible after 6h

Urgent investigations:

- CBC D/C, clotting, LRFT, T&S, CK (muscle injury)
- ECG and CXR: rule out aortic dissection (especially if chest pain)
- **Urgent CT angiogram** to confirm level of occlusion and determine any run-off (2-3 patent lower leg arteries to the foot / 1 patent artery with intact anterior or posterior foot arch)

Conservative management

- Indications: Rutherford I and IIA
- **Heparin:** IV bolus 3000-5000U + continuous infusion (limit propagation of thrombus and protect collaterals)
  - Monitor APTT (60-80s)
  - Must rule out aortic dissection before giving heparin

Surgical management

- Indications: Rutherford IIB or IIA failing conservative management
- Management according to aetiology and anatomy:

| Embolic cause                                                                                                                                                                                                                                                                                       | Thrombotic cause                                                                                                                                |
| :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------- |
| Above knee: **open embolectomy with Forgaty catheter +/- prophylactic fasciotomy** (if ischemia >6h)                                                                                                                                                                                                | Run-off present: **bypass surgery**                                                                                                             |
| - Usually for femoral emboli and aortic saddle emboli                                                                                                                                                                                                                                               | Run-off absent: **Local thrombolysis (tPA) → angioplasty +/- stenting** after lysis of clot                                                     |
| - Done under LA or GA                                                                                                                                                                                                                                                                               | Thrombolysis: Pre-op angiogram to locate occlusion site → Pass catheter into the clot → Inject tPA → Regular angiogram to check extent of lysis |
| - Post-op: angiogram, continue heparin infusion → bridge with warfarin / NOAC for at least 3 months!                                                                                                                                                                                                | - rtPA (alteplase/reteplase), urokinase, streptokinase                                                                                          |
| [Figure 58.29 - A Fogarty catheter is inserted through an arterial entry in the common femoral artery and fed distally down the superficial femoral artery. The balloon is inflated, and the catheter withdrawn, removing the embolus; the deep femoral artery is protected by an occlusion clamp.] | - Need >6h to lyse clot: non-emergency situation                                                                                                |
|                                                                                                                                                                                                                                                                                                     | - C/I: previous stroke/TIA, recent GI bleed, bleeding tendency, pregnancy                                                                       |
|                                                                                                                                                                                                                                                                                                     | Blue toe syndrome: manage medically e.g. statins                                                                                                |

Below knee: **local thrombolysis / bypass**

- Consider extent of ischemia:
  - Complete ischemia: proceed to LA open embolectomy
  - Incomplete ischemia: obtain pre-op imaging if possible → endovascular treatments
  - Non-viable limb: amputation

Complications:

- Stroke and haemorrhage: after thrombolysis
- Reperfusion injury due to sudden increase in capillary permeability
  - Compartment syndrome: Prolonged ischemia → cell lysis → fluid leak into interstitium
    - Intracompartmental pressure > 30mmHg
    - S/S:
      - Pain out of proportion with clinical signs worsening with time despite analgesia
      - Numbness in distribution of nerves running within the compartment
      - Tense compartment on passive toe dorsiflexion and plantarflexion
      - Pulses can be present (SBP >> intracompartmental pressure)
    - Mx: urgent fasciotomy (medial + lateral incisions
  - Rhabdomyolysis: Release of K+, H+ and myoglobin from damaged muscle cells
    - Post-op: monitor BP/P, UO, APTT, RFT, cardiac monitor
    - S/S arrhythmia, AKI
    - Mx: aggressive hydration, diuresis with mannitol, IV bicarbonate

Amputation
Indications (3D)

- Dead limb: PVD causing gangrene (delay in amputation results in infection & rhabdomyolysis)
- Dangerous: infection (e.g. wet gangrene, necrotising fasciitis), malignancy
- Damn nuisance: un-reconstructable critical limb ischemia, paralysis, contracture, major trauma
  Principles of amputation
- Remove all infected tissue
- Preserve as much length as safely possible
- Adequate blood supply to heal the amputation - revascularisation may be required
  before amputation to ensure good healing
  Level of amputation (fig.)

1. Above-the-Knee Amputation (AKA): if femoral pulse -ve
2. Below-the-Knee Amputation (BKA) (MC): aim to preserve knee joint because much
   easier to walk on below-knee prosthesis, C/I if fixed flexion deformity of knee
3. Syme's amputation: ankle joint
4. Transmetatarsal amputation
5. Toe amputation & ray amputation (not shown; removal of a toe & its metatarsal)
   [Image: A diagram of a leg with dotted lines indicating different levels of amputation. Number labels 1 through 5 point to the thigh, above-knee, below-knee, ankle, mid-foot, and toe amputation levels respectively.]

Specific complications
Early complications

- Wound: hematoma, infection, abscess, dehiscence, gangrene (Mx: higher amputation)
- Surrounding skin: skin necrosis (poor perfusion to stump)
- Nerve: phantom limb pain (Mx: reassurance, amitriptyline, gabapentin)
- Vein: DVT/PE (Mx: prophylactic heparin)
  Late complications
- Joint: fixed flexion deformity
- Bone: osteomyelitis, osteophyte formation
- Surrounding skin: stump ulceration (pressure from prosthesis)
- Nerve: stump neuroma
  Rehab: Usually can bear weight on contralateral limb by 1 week, and fit temporary prosthesis by 3 weeks

Carotid artery disease
Anatomy

- Carotid sheath: Carotid artery, internal jugular vein, vagus nerve, deep cervical LN
  Clinical features
- Asymptomatic: even in unilateral complete occlusion → development of collateral supply
- ΤΙΑ
- Stroke
  Investigations
- Urgent non-contrast CT brain
- CT angiogram: if endovascular therapy is considered
- Carotid Doppler USG
  Management
- Medical therapy: diet, exercise, antiplatelet, antihypertensive (ACEI), statin
- Endovascular therapy: if stenosis > 70% (asymptomatic or symptomatic)
  - Carotid endarterectomy (CEA) → more effective, preferred if tortuous vessels, no need DAPT
  - Carotid angioplasty and stenting (CAS) → preferred if re-stenosis after CEA, unfit for GA, need DAPT 3/12

Subclavian steal syndrome

- Occlusion of proximal subclavian artery, causing retrograde blood flow from vertebral artery
- S/S: UL claudication, syncope, ataxia, diplopia, sensory loss

169

7.3 Chronic venous insufficiency
Anatomy

[Anterior view of the right leg and foot veins. Major veins are labeled, including: Common iliac, External iliac, Internal iliac, Gluteal, Lateral sacral, Internal pudendal, Obturator, Femoral, Femoral circumflex, Great saphenous, Popliteal, Small saphenous, Anterior tibial, Posterior tibial, Fibular, Dorsal venous arch, Digital]

[Posterior view of the right leg and foot veins. Major veins are labeled, including: External iliac, Gluteal, Deep femoral, Great saphenous, Popliteal, Small saphenous, Anterior tibial, Posterior tibial, Fibular, Lateral plantar, Medial plantar, Plantar venous arch]

[A diagram showing the relationship of veins to each other. Veins labeled are External iliac vein, Common femoral vein, Deep femoral vein (Profunda femoris), Femoral vein, Popliteal vein, Anterior tibial vein, Posterior tibial vein, Fibular (Peroneal) vein, Great saphenous vein, Short saphenous vein]

Divided into deep venous system & superficial venous system, separated by the deep fascia

- Deep venous system: veins corresponding to the arterial supply, i.e. popliteal vein, femoral vein
- Superficial venous system: great saphenous vein (GSV) & short saphenous vein (SSV)
- Joined by perforators^
  Course

| GSV 大隱靜脈                                                                   | SSV                                                                  |
| ------------------------------------------------------------------------------ | -------------------------------------------------------------------- |
| Arise from medial aspect of dorsal venous arch                                 | Arise from lateral side of dorsal venous arch                        |
| Anterior to medial malleolus\*, accompanied by saphenous nerve                 | Posterior to lateral malleolus, accompanied by sural nerve           |
| Posterior to medial border of patella                                          | Pierce deep fascia over popliteal fossa to drain into popliteal vein |
| Drain into femoral vein at SFJ (2.5cm inferolateral to pubic tubercle)         |                                                                      |
| \*Constant relationship of GSV with medial malleolus → life-saving cannulation |                                                                      |

[A diagram labeled "^Common LL perforators" shows a leg with veins and labels pointing to horizontal lines representing common perforator locations. The labels are: Hunterian, Dodd, Boyd, and Cockett]

[^1]: Footnote text

# Varicose veins

Physiology of venous return from lower limb

- Decreased intrathoracic pressure during inspiration
- Calf muscle pump (major mechanism)
- One-way valve

Pathophysiology: **venous hypertension** → loss of compliance, thickening, dilation and valvular dysfunction

- Reflux due to pressure gradient dysfunction (90%)
  - Increased abdominal or thoracic pressure: COPD, pregnancy, constipation
  - Decreased calf muscle pump function: prolonged immobility, paralysis
- Venous obstruction
  - Intramural: DVT / trauma
  - Mural: valvular incompetence
  - Extramural: ovarian cysts / fibroids, _May-Thurner syndrome_ (left common iliac vein compressed by right common iliac artery)

Congenital causes of CVI

- Klippel-Trenaunay syndrome: congenital venous malformation causing triad of VV, port wine stains and bony and soft-tissue hypertrophy of limbs; VV may be present over the lateral aspect of thigh
- Parkes-Weber syndrome: multiple AV fistulae with limb hypertrophy, possibly causing high-output HF

Clinical features

- Risk factors: old age, occupation (prolonged standing), posture (cross legs), obesity, chronic cough, constipation, pregnancy, previous Hx of DVT, FHx
- Presentation:
  - Asymptomatic: cosmetic concerns
  - Symptomatic: usually worsen throughout course of day / standing, relieved by lying down / leg elevation
    - Pain, muscle cramps, swelling, dragging sensation, itchiness
    - Complications: hyperpigmentation, eczema, lipodermatosclerosis, ulcers
- Physical examination
  - Inspection: surgical scars, location of varicosities (_GSV / SSV territories_), other signs of chronic venous insufficiency according to CEAP grading
  - Palpate along course of GSV and SSV
  - Check **peripheral pulses** (rule out PVD for planning of OT)
  - +/- Check for saphena varix: painless compressible groin lump with cough impulse
  - +/- Feel inguinal LN if venous ulcers are present
  - +/- Test neuro function (e.g. sural n.) if scars are present
  - Tourniquet test:
    - Ensure all VV are emptied first
    - Apply tourniquet → Stand up and observe filling → Release tourniquet
    - Sites: just below SFJ, mid-thigh, above knee, below knee
  - To complete
    - Examine inguinal region for mass / LN
    - Abdominal + PR examination for masses obstructing IVC
    - ABI to rule out PVD
    - +/- modified Perthes' test to assess deep venous patency (apply tourniquet around SFJ → ask patients to walk → swelling and painful = deep system not patent

[A diagram of incompetent perforator(s) with finding and interpretation. The first image depicts SFJ only. The second image depicts SFJ AND other perforator(s) below SFJ. The third image depicts Perforator(s) below SFJ, but not SFJ. The finding for the first image is VV reappear only above tourniquet. The finding for the second image is Some VV reappear but others do not. The finding for the third image is All VV reappear. The Interpretation for the first image is All VV completely controlled below SFJ. The Interpretation for the second image is VV partially controlled below SFJ. The Interpretation for the third image is None of the VV are controlled below SFJ.]

# CEAP classification

C-Clinical

| Class | Characteristics                           | Comments                                                                                                                                                                                                                                                                                                                       |
| ----- | ----------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| C0    | Asymptomatic                              |                                                                                                                                                                                                                                                                                                                                |
| C1    | Telangiectasia or reticular veins         | Telangiectasia (spider veins) < 1mm Reticular vein: 1-2.9 mm                                                                                                                                                                                                                                                                   |
| C2    | Varicose veins                            | Dilated tortuous vein ≥3mm                                                                                                                                                                                                                                                                                                     |
| C3    | Pitting oedema                            |                                                                                                                                                                                                                                                                                                                                |
| C4    | 4A Pigmentation and/or eczema             | Interstitial accumulation of hemosiderin                                                                                                                                                                                                                                                                                       |
|       | 4B Lipodermatosclerosis, atrophie blanché | Lipodermatosclerosis: progressive fibrosis of the skin and subcutaneous tissues due to fibrin deposits; hyperpigmentation + erythema + induration + tender (palpate!) Atrophic blanche: avascular fibrotic scars, prone to secondary venous ulceration due to poor blood supply; ivory white areas with hyperpigmented borders |
| C5    | Healed ulcers                             | At medial gaiter area: site of medial calf perforators Painless unless infected (usually _S. aureus_) Long-standing ulcer → Marjolin's ulcer (2%)                                                                                                                                                                              |
| C6    | Active ulceration                         | Ulcer: full-thickness skin loss                                                                                                                                                                                                                                                                                                |

E: aetiology (Ec = congenital, Es = secondary, Ep = primary, En = no venous cause identified)
A: anatomy (As = superficial, Ap = perforator, Ad = deep, An = no venous location identified)
P: pathophysiology (Pr = reflux, Po = obstruction, Pro = both, Pn = no venous pathophysiology identified)

[Image of a leg showing the "gaiter" area. The image shows the medial aspect of the lower third of the leg narrowed and hardened by venous lipodermatosclerosis. This is the area in which most venous ulcers develop.]

[Image of a leg showing chronic venous insufficiency causes pigmentation of the skin and dilated intradermal venules. The venules first appear in a triangular area below the medial malleolus, with the apex of the triangle over the first or second lower leg communicating vein. This is known as the ankle-flare or corona phlebectatica.]

[Image of a lower leg with Atrophie blanche, which is the name given to white scars in the skin that appear without the skin ever having broken down or ulcerated.]

[Image of a lower leg with subcutaneous fibrosis, following chronic lipodermatosclerosis, and/or painful ulceration may cause a fixed flexion of the ankle joint.]

[Image of a foot and ankle showing A chronic, recurrent, infected, enlarging venous ulcer. The base contains little healthy granulation tissue and many areas of avascular fibrous tissue.]

[Image of a lower leg with Acute lipodermatosclerosis usually begins on the medial side of the gaiter area and is painful, hot, red and tender. It is often misdiagnosed as cellulitis or acute thrombophlebitis.]

[Image of a lower leg showing the pigmentation of chronic venous disease may cover the whole of the lower limb.]

[Image of a foot and ankle with An acute venous ulcer. The surrounding lipodermatosclerosis is clearly visible. In the acute stages, when tissues are dying and sloughing, venous ulcers can be very painful.]

[Image of a foot and ankle with A healing venous ulcer. The surrounding skin looks healthy, the granulation tissue in the base of the ulcer is clean and pink, and the edges of the ulcer are sloping and made of new epithelium.]

Corona phlebectatica (malleolar flare): fan-shapped telangiectasia on ankle/foot

173
Investigations

- **Duplex USG (B-mode USG + Doppler)**
  - Confirm diagnosis & establish exact distribution and extent:
    - Squeeze calf to elicit reflux
  - Assess function of deep venous system (C/I surgical treatment if concomitant superficial & deep insufficiency)
  - Assess suitability for endovenous treatment: diameter, extent, **tortuosity**, saphena varix
- USG abdomen: if secondary causes suspected

Management
Conservative

- Risk factor modification: avoid prolonged standing, weight loss, increase exercise (promote calf muscle pump)
- **Graduated compression stockings**: improve VV symptoms
  - At least 20mmHg at ankle with decreasing pressure proximally
  - Pre-requisite: ABPI (absolute C/I if ABPI < 0.4)
  - Complications: pressure necrosis, contact dermatitis, fungal infection
- Venotonic drugs (e.g. **Daflon**, micronized disomin): increase venous tone and lymphatic drainage
  - Good for edema (CEAP ≥ C3)

Surgical therapy

- Indications: documented superficial venous reflux (i.e. retrograde flow >0.5sec in duration)
  - Symptomatic: bleeding, recurrent phlebitis
  - Complications: severe disease (C4 or above), thrombosis
- Contraindications:
  - Pregnancy: risk of DVT
  - Combined deep & superficial venous insufficiency (blood has no route back) → conservative treatment
- Treatment option - Endovenous treatment - Approach: under LA, USG-guided - Thermal: use of tumescent^, risk of thermal injury - **Endovenous laser ablation (EVLA)**: preferred due to higher success rate - **Radiofrequency ablation (RFA)**: quicker recovery and less post-operative pain - Non-thermal: tumescent NOT required, but risk of vein hyperpigmentation & ulcer (due to extravasation) - Mechanical occlusion chemically-assisted (MOCA) ablation: both mechanical (rotating wire) + chemical (sclerosant injection) damage - **Cyanoacrylate glue / Venaseal**: adhesive agent to seal off VV, require compression from proximal to distal after injection, post-op stockings NOT required - Foam sclerotherapy (e.g. 1% STS - sodium tetradecyl sulfate): destroy endothelium by detergent or osmotic action, post-op stockings for 2 weeks to appose inflamed vessel walls - Surgical treatment: ligation +/- stripping (above-knee) or stab avulsion (below-knee) - GSV: Trendelenburg's operation\* + stripping +/- below-knee stab avulsion (risk of saphenous nerve damage) - SSV: SPJ ligation + stripping +/- below-knee stab avulsion (risk of sural nerve damage) - Choice between endovenous treatment vs surgical treatment - Endovenous treatment usually as first line - Surgical treatment preferred if: - Superficial varicose veins (<1cm deep): risk of skin burns - Tortuous veins - Chronic/ recurrent phlebitis: formation of adhesions that prevent passage of device
  [Image of "Micky Mouse" transverse B-mode image of the right common femoral vein (CFV) and artery (CFA), great saphenous vein (GSV) and saphenofemoral junction. The image shows a cross-sectional ultrasound view with three circular dark regions. The labels “R CFV” (Right Common Femoral Vein) and “R CFA” (Right Common Femoral Artery) point to the two larger circular regions positioned relatively close to each other on the lower part of the image. A third, smaller circular region labeled “GSV” (Great Saphenous Vein) is positioned above the other two, slightly to the right.]

^Use of tumescent anaesthetics in thermal endovenous treatment
Saline + lignocaine +
epinephrine + NaHCO3 (to
reduce stinging effect)
Roles: increase max dose of
lignocaine, facilitate contact of
vein wall with device, move
vein away from skin to protect
skin, heat sink to protect
surrounding tissues

\*Trendelenburg's operation (SFJ flush ligation): oblique incision in groin → ligate GSV very close to junction with femoral v. to prevent recurrence at remaining GSV stump (may form saphena varix)

# Stripping (pass metal guidewire through GSV with an olive → pull out entire vein) vs Avulsion (piecewise)

Treatment for perforators & deep system

- Perforators: **sub-fascial endoscopic perforator surgery (SEPS)**, perforator mapping and ligation, open sub-fascial ligation
- Deep venous system: **conservative**; valvular reconstruction (limited efficacy)
  Counseling
- Expectations:
  - **Not alter skin changes**
  - May not improve symptoms (e.g. pain)
- Pre-op: antiplatelet/ anticoagulant can be continued
- Specific complications that are common in the treatment options above
  - Pain: analgesia
  - Bruising
  - Vein injury: superficial thrombophlebitis, DVT
  - Nerve injury
    - Saphenous nerve (at mid thigh & mid leg): sensory to medial leg & medial foot
    - Sural nerve (at lateral leg): sensory to posterior leg & lateral foot
  - Recurrence (30%, more common in SSV): neovascularisation, reflux in residual axial vein, new junctional reflux, inadequate initial surgery
- Post-op care - Early ambulation - FU Doppler USG 2-3 days post-op - Compression stockings x 4 weeks - No driving x 1 week - Normal to have pain & pulling tightness of treated vein; consult if excessive pain with swelling (DVT) or numbness/ discolouration of toes (tight stocking)

  7.4 Lower extremity ulcers
  Ulcer: breach in skin or mucosal lining

[Ulcer in the right foot with a circular dark scab surrounded by red and inflamed skin. A ruler is placed next to the ulcer for measurement.]
Arterial ulcer

[Ulcer in the right leg with a bandage around it. The skin is red and inflamed. Multiple small patches of ulcerated skin are visible. The leg is slightly swollen.]
Venous ulcer

[Picture of the bottom of a foot with dry skin and calluses, a bandage is placed on the foot to measure the wound. This is a neuropathic ulcer.]
Neuropathic ulcer

[Ulcer in the left heel, it has broken skin and redness around the wound.]
Pressure ulcer

Location
Pressure areas

- Tips of toes and
  between digits
- Lateral malleolus
- Base of heel
  Gaiter's area (between
  lower calf and medial
  malleolus)
  Plantar aspect of foot
  Tips of toes
  Lateral to 5th MT
  Bony prominences
  Heel
  Associated
  conditions
  DM, HT, PVD
  Varicose veins, DVT,
  recurrent phlebitis
  DM, trauma,
  prolonged pressure
  Immobility
  Characteristics
  Deep
  Punched out edge
  Unhealthy necrotic base
  Shallow
  Gentle sloping edge
  Slough at base with
  granulation tissue
  Shallow / deep
  Punched out edge
  Not too painful
  Deep
  Often macerated
  Condition of
  foot
  Cold thin shiny skin
  Absent or weak pulses
  Delayed capillary refill
  Gangrene
  Hemosiderin-stained
  Eczematous / fibrosis
  Itchy skin
  Limb edema
  Dry cracked, calluses
  Loss of sensation
  Diminished reflexes
  +/- foot deformities
  Skin atrophy
  Muscle atrophy

Management of arterial ulcers
Ix: CBC D/C, CRP/ESR (rule out infection), Duplex USG

- Aggressive wound care + analgesics
- Correct CV risk factors + revascularisation (as above)
  Management of venous ulcers
  Ix: CBC D/C, CRP/ESR (rule out infection), Duplex USG
  Conservative (50-70% heal in 3 months)
- Leg elevation, encourage mobilisation
- Swab for C/ST + antibiotics if signs of infection
- Ulcer care: debridement, wound dressing, barrier cream
- Four-layered graduated compression bandage (AΒΡΙ > 0.4)
  - Orthopaedic wool, cotton crepe, elastic bandage, cohesive bandage
- Treat VV
  Surgical: if failed above
- 4-quadrant biopsy and palpate groin LN to exclude Marjolin ulcer (2%): malignant transformation to SCC or
  rarely BCC
- Fenestrated split-thickness skin graft

# 7.5 Haemoperitoneum

Aetiology

- Abdominal trauma, e.g. splenic rupture
- Aneurysm rupture (e.g. ruptured AAA)
- Neoplasm rupture (e.g. ruptured HCC)
- Pelvic organ rupture (e.g. ruptured ovarian cyst, ruptured ectopic pregnancy)

[Image Description: This is a screenshot of a key concept that visually explains haemoperitoneum and free fluid density. The key concept is enclosed in a blue box with white text at the top that says "Key Concept" and the title is "Haemoperitoneum and free fluid." Below is a scale representing density in Hounsfield Units (HU), ranging from 0 to 80. A blue bar runs along the top of the scale with markers. The scale is segmented into different ranges with labels indicating corresponding substances or conditions: 0 is labeled "water", 0-10 is labeled "free fluid", 30-45 is labeled "acute blood", 45-70 is labeled "clotted blood", and less than 30 is labeled "old blood/anaemia". The scale helps visualize the density ranges associated with various types of fluid or blood in the context of haemoperitoneum.]

# 7.6 SMV thrombosis

Risk factors [MED]

- Hypercoagulable state
- Oral contraception
- History of VTE
- Malignancy

Clinical features: non-specific abdominal pain, insidious onset
Investigations: CT abdomen
Management

- Anticoagulation
- Catheter-directed thrombolysis
- Laparotomy: if failed conservative management or signs of peritonitis

176

# Breast surgery

177

## 8.1 Anatomy

Breast

- Normal boundaries of breast
  - Superior (2nd rib) - inferior (upper rectus sheath /7th-8th rib)
  - Medial (sternum) - lateral (mid-axillary line / edge of LD)
  - Depth: **pre-pectoral fascia**
- Components: - Terminal ductal lobular unit (TDLU): structural unit - lobules (10-100) → lactiferous ducts (15-20) lined by
  myoepithelial cells - **Ligaments of Cooper**: separate the lobules; fibrous tissue attached firmly to superficial fascia → skin
  tethering in CA breast - Areola: contain Montgomery's tubercle (sebaceous glands that lubricate nipple during lactation) and
  involuntary muscles arranged in concentric rings & radially - Nipple: thickened skin, contain orifices of lactiferous ducts - **Axillary tail** (of Spence): between pectoralis muscle and latissimus dorsi, blend with axillary fat

[Image showing a superficial dissection of the pectoral region of the female. The image shows the deltoid muscle, cephalic vein, axillary tail of the breast, latissimus dorsi, areola, serratus anterior, and pectoralis major. Additionally, an image showing a breast lobule with the lactiferous duct and ampulla, areola, and ductule is present, along with the clavicle, rib, pectoralis minor, pectoralis major, and cooper's ligament.]

- Vascular supply:
  - **Internal thoracic artery (ITA)** / internal mammary artery ← Subclavian a.
  - **Lateral thoracic artery (LTA)** / external mammary artery Axillary a.
  - Posterior intercostal a.
- Lymphatics: **axillary LN** (75%), parasternal LN / **internal mammary LN** (run with ITA; not routinely dissected)
  Axilla
- Borders of axilla (fig.)
- Superior border for surgical dissection: **axillary vein**
- 3 levels
  - Level I: **lateral** to pectoralis minor
  - Level II: **deep** to pectoralis minor
  - Level III: **medial** to pectoralis minor
- 5 groups
  - **Anterior**: posterior to pectoralis major
  - **Posterior**: anterior to fold of latissimus dorsi
  - **Medial**: along chest wall
  - **Lateral**: along head of humerus
  - **Apical**: medial to pectoralis minor
  - **Interpectoral (Rotter's)**: between pectoralis minor and pectoralis major
- Drain to supraclavicular LN → subclavian lymph trunk

[Image showing a diagram of the borders of the axilla, including the anterior border (pectoralis major and minor), lateral border (intertubercular sulcus), medial border (serratus anterior and thoracic wall), and posterior border (scapularis, teres major, latissimus dorsi).]

## 8.2 Common breast complaints

**Breast lump**
Differential diagnoses
| | Young (<35) | Old (>35) |
| ----------- | ------------------------------------- | ------------------------------------- |
| Soft | Fibrocystic changes | Fibrocystic changes |
| Firm | Fibroadenoma | Carcinoma |
| | Fat necrosis | Fat necrosis (bruising+) |
| | Lipoma | Lipoma |
| | Breast cyst (tense, fluctuant) | Phyllodes tumour (freely mobile) |

**Mastalgia**
Differential diagnoses

- Cyclical: fibrocystic changes (MC)
- Non-cyclical: acute mastitis, fibroadenoma, inflammatory CA breast
- Management
  - Cyclical or bilateral diffuse pain: no imaging required, reassurance, conservative (NSAID)
  - Ο Noncyclical/ unilateral/ focal pain: USG/ mammogram

**Nipple discharge - DDx**
History taking

- True nipple discharge?
- Unilateral / bilateral
- Colour of discharge
- Recent pregnancy / breastfeeding

Differential diagnoses
| Number | Single | Multiple/bilateral | Pathological |
| ------ | ------------------------------------------ | ------------------------------------- | -------------------------------------------------------------- |
| Colour | Milky | Usually benign | Pregnancy Lactation |
| | Yellow/ green | | Hyperprolactinaemia: e.g. DA agonist, pituitary tumour |
| | | | Infection (**mastitis**, breast abscess) |
| | | | Degenerative (**ductal ectasia**) |
| | Bloody | | Fibrocystic changes **Intraductal papilloma** CA breast/DCIS |

**Investigations**

- Triple assessment
- ± Nipple discharge x cytology
- ± Ductogram / ductoscopy

[Image Description: This is a representation of the page number 178. It is a white rectangle with the number 178 at the top right corner of the page.]

8.3 Assessment of breast mass
Triple assessment: clinical + radiological + pathological assessment
Clinical assessment
Important questions in history taking (_must know!_)

- Mass: Onset & progression, any cyclical changes / mastalgia
- Nipple: discharge / retraction
- Skin: itchiness, erythema, dimpling / Peau d'orange
- Constitutional symptoms: weight loss, bone pain, SOB
- Risk factors of malignancy
  - FHx: BRCA - any CA breast / ovary / prostate / pancreas
  - PMHx: breast disease (e.g. DCIS), breast RT
  - Estrogen exposure: age of menarche, age of menopause, parity, breastfeeding, use of COC/HRT

Physical examination

- Position: 45°
- Inspection:
  - Size, symmetry, surgical scars (e.g. LN biopsy), skin changes (e.g. ulceration, dimpling, Peau d'orange)
  - Nipple changes (5D): deviation, discolouration, dermatitis , depression (retraction), discharge
- Palpation of breast: start from normal side
  - Comment on: site, size, shape, border, surface, consistency, tenderness, mobility (skin & muscle)
  - Include axillary tail of breast
- Palpation of axilla:
  - Groups: anterior, posterior, medial, lateral, apical
  - Comment: number, site, size, consistency, tenderness, fixation

Radiological assessment

- **Mammogram: only for female > 35y** (poor resolution in dense breasts in young female)
  - Low-dose X ray that can be performed even in pregnant female (with shield)
  - 🌝 **Gold standard**, more sensitive for calcifications, less operator- dependent, used for annual screening
  - 😩 Limited localization, difficult to see chest wall & axilla, radiation
  - Presentation of mammogram (_important!_)
    - Breast tissue _appropriate_ for age
    - Views: **craniocaudal (CC) vs mediolateral oblique (MLO)**
    - Location of mass
      - MLO view: upper vs lower half of breast (line perpendicular to pec major)
      - CC view: outer vs inner quadrant of breast
    - Features of malignancy
      - Spiculated opacity with irregular borders
      - Clusters of pleomorphic microcalcifications
      - Architectural distortion e.g. tent sign (fig.)
      - Pectoralis major involvement (only in MLO view )
      - Skin thickening / tethering
      - Nipple involvement

[Radiographic views of the breast Standard views *45° Medio lateral Oblique (MLO view)/Lundgren's view * Craniocaudal view (CC view) A series of black and white mammogram images showing the internal structures of a female breast from different angles, alongside a diagram depicting the Mammogram imaging process. The images highlight the variations in tissue density and are presumably used for diagnostic purposes.]

- **USG breast: for all patients**
  - Roles of USG
    - Improved Sn & Sp combined with mammogram, esp. in young women with dense breast tissue
    - Distinguish cysts from solid lesions
    - Guide FNAC, biopsy and clipping before neoadjuvant chemotherapy
    - Assess axillary LN

180

Ο NOT useful as screening, operator-dependent, cannot pick up most calcifications
Ο Suspicious features on USG: "SHIT CME" - same as thyroid
Ο Suspicious LN: loss of fatty hilum

Breast MRI: not routinely done; unnecessary biopsies may be performed
Ο Possible indications: axillary node +ve but occult primary tumor, Paget's disease but mammogram -ve
Reporting system: Breast Imaging Reporting and Data System (BIRADS)

Final Assessment Categories

| Category                                        | Management                                                    | Likelihood of cancer                                                                                                                                   |
| ----------------------------------------------- | ------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------ |
| 0 Need additional imaging or prior examinations | Recall for additional imaging and/or await prior examinations | n/a                                                                                                                                                    |
| 1 Negative                                      | Routine screening                                             | Essentially o%                                                                                                                                         |
| 2 Benign                                        | Routine screening                                             | Essentially o%                                                                                                                                         |
| 3 Probably Benign                               | Short interval-follow-up (6 month) or continued               | >0 % but ≤ 2%                                                                                                                                          |
| 4 Suspicious                                    | Tissue diagnosis                                              | 4a. low suspicion for malignancy (>2% to ≤ 10%) 4b. moderate suspicion for malignancy (>10% to ≤ 50%) 4c. high suspicion for malignancy (>50% to <95%) |
| 5 Highly suggestive of malignancy               | Tissue diagnosis                                              | ≥95%                                                                                                                                                   |
| 6 Known biopsy- proven                          | Surgical excision when clinical appropriate                   | n/a                                                                                                                                                    |

Pathological assessment

- FNAC: cytological diagnosis
  - Advantage: no need LA, smaller needle (21-23G)
  - Disadvantages: Cannot assess architecture (i.e. carcinoma in situ vs invasive carcinoma)
  - Preferred if low risk (e.g. non-palpable mass, equivocal MMG) or simple cysts
- Core needle biopsy (CNB) - first line: histological diagnosis
  - Performed if BIRADS 4+
  - Advantages: architectural assessment, tumour grading, receptor status (ER/PR/HER2)
  - Disadvantages: require LA, larger needle (9-14G)
  - Non-palpable mass: USG, stereotactic (XR), tomosynthesis (3D mammogram by multiple XR), MRI
  - Increase yield: vacuum-assisted core biopsy

Approach to FNAC:

- Cystic lesion:
  - Lump disappears/ clear fluid: no further Ix
  - Residual thickening/blood-stained fluid: core biopsy
- Solid lesion:
  - Benign: observe or excision
  - Atypical: core needle biopsy
  - Malignant: treat as cancer

- Excisional biopsy:
  - Indicated when core biopsy reveals suspicious lesion by not diagnostic
  - Localizing non-palpable lesions
    - Hook-wire localization (HWL)
      - Problems: extensive normal tissue removal, wire outside skin, risk of broken wire
    - Radioactive seed localization (RSL): 125I-labelled titanium seed inserted 0-5 days prior to surgery
    - Radio-opaque lesion localization (ROLL): 99mTc-labelled albumin-based colloid, injected within 24h of surgery
    - Magseed localization: non-radioactive
    - On-table USG

[Hook Wire Localization and Excision Biopsy. The image depicts a diagram of the process of Hook Wire Localization and Excision Biopsy. The breast is shown in profile with a dark mass inside. A wire with a hook on the end is inserted into the breast, close to the mass. A scalpel is shown cutting around the mass and wire.]

8.  4 Breast malignancy
    Pre-malignant lesions
    Atypical ductal / lobular hyperplasia: 4-5x ↑risk of invasive CA on same side

- If found on core biopsy: excisional biopsy MUST be performed to rule out malignancy
  Carcinoma in-situ: malignancies contained within basement membrane (i.e. no invasion)
- DCIS (20% of all breast CA) >> LCIS (rare)

|                   | Ductal carcinoma in situ (DCIS)                                                                                                                                           | Lobular carcinoma in situ (LCIS)                                                                        |
| :---------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :------------------------------------------------------------------------------------------------------ |
| Pathology         | Malignant cells within TDLU (ductal predominant) without invasion LG: non-comedo (e.g. cribriform) HG: comedo necrosis (with central necrosis → dystrophic calcification) | Malignant cells within TDLU (lobular predominant) without invasion                                      |
|                   |                                                                                                                                                                           | Loss of E-cadherin                                                                                      |
| Clinical features | Asymptomatic, non-palpable Usually unifocal                                                                                                                               | Asymptomatic, non-palpable Usually multifocal + multicentric                                            |
| Investigations    | Mammography: microcalcifications Diagnostic: core biopsy Prognostic: van Nuys prognostic index                                                                            | Mammography: NAD (i.e. incidental findings because of other breast diseases) Diagnostic: core biopsy    |
| CA risk           | Precursor to invasive ductal carcinoma of the same breast 1%/ year                                                                                                        | Precursor and marker of bilateral invasive carcinoma (ductal/ lobular) 1%/ year                         |
| Management        | BCS (2mm margin) + RT (if high risk): first line, if disease limited to one quadrant and cosmetically acceptable tumor-to-breast ratio                                    | Classical LCIS: close observation Non-classical LCIS (pleomorphic): more aggressive → surgical excision |
|                   | Mastectomy + SLNB (altered lymphatic drainage afterwards → impossible to accurately perform SLNB later if IDC is found in mastectomy specimen - 10-20% chance)            |                                                                                                         |
|                   | Adjuvant: tamoxifen/AI if ER/PR+                                                                                                                                          |                                                                                                         |

Breast carcinoma
Epidemiology

- Incidence in female: 1st; mortality: 3rd
- Median age 55 (younger than global data)
- Lifetime risk 1: 16

Classification
Pathology

- Invasive ductal carcinoma (76%): further subclassified into tubular, mucinous (good prognosis), metaplastic, inflammatory (poor prognosis)
- Invasive lobular carcinoma (8%): E-cadherin mutation → loose diffuse pattern → more difficult to detect clinically
- Others: ductal/lobular (7%), colloid (mucinous) (2.4%), tubular (1.5%), medullary (1.2%), papillary (1%)

Male breast carcinoma

- Incidence: M:F = 1:100
- Average age at diagnosis: 65
- Risk factors
  - BRCA2 carriers
  - Increased oestrogen: oestrogen therapy, etc
  - Radiation
  - Klinefelter's syndrome (XXY)
- Management: mastectomy + SLNB/ ALND (if clinically +ve LN)

St Gallen's IHC subtyping

| IHC Subtype     | Definition         | Type of adjuvant therapy                  |
| :-------------- | :----------------- | :---------------------------------------- |
| Luminal A       | HR+/HER2-/Ki67low  | Endocrine therapy alone\*                 |
| Luminal B       | HR+/HER2-/Ki67high | Endocrine therapy ± cytotoxic therapy     |
| Luminal B       | HR+/HER2+          | Cytotoxics + anti-HER2 + hormonal therapy |
| HER2-positive   | HR-/HER2+          | Cytotoxics + anti-HER2 therapy            |
| Triple-negative | HR-/HER2-          | Cytotoxic therapy                         |

\*A few patients require cytotoxics (such as high nodal status or other indicator of risk). Abbreviation: HR, hormone receptor.

Risk factors

- **Unexposed oestrogen**: obesity, early menarche, late menopause, nulliparous, no breastfeeding, COC/HRT
- Lifestyle: smoking, alcohol
- FHx in 1st deg relative (if young)
- Benign breast diseases (refer to table)
  - Epithelial hyperplasia: atypical ductal / lobular hyperplasia (5x risk), sclerosing adenosis
  - Benign tumour: intraductal papilloma, Phyllodes tumour
- Genetics (10%, AD)
  - BRCA1/2: 85% lifetime risk, ↑risk of CA breast (triple negative), ovary (BRCA1), male breast, prostate, pancreas, melanoma (BRCA2); Mx: prophylactic bilateral mastectomy, BSO, PARP1 inhibitor
  - TP53 germline mutation: Li Fraumeni syndrome
  - PTEN mutation: Cowden syndrome/ multiple hamartoma syndrome
  - Peutz-Jeghers syndrome

Clinical features

- Breast mass: hard, irregular, fixed, non-tender, mostly at upper outer quadrant
- Nipple discharge: increased risk if unilateral, single duct, bloody
- Special types:
  - Paget's disease of nipple: invasion of nipple-areolar complex; unilateral nipple eczema + nipple discharge
    - Ix: triple assessment, nipple biopsy x Paget cells
  - Inflammatory breast cancer (T4d): invasion of local lymphatic ducts; painful swollen breast with cutaneous edema involving at least 1/3 of breast (peau d'orange)

[Image Description: The images show two examples of breast abnormalities. On the left is a breast with a dark red, ulcerated lesion on the nipple, representing Paget's disease of the nipple. On the right is a breast exhibiting peau d'orange, characterized by thickened skin with prominent pores, resembling an orange peel.]

- Metastasis: bone, liver, lung, brain

Multifocal vs multicentric disease

- Multifocal: ≥2 foci contained within a limited area, i.e. usually the same quadrant of breast - not C/I to BCT
- Multicentric: ≥2 foci separated by significant disease, i.e. usually involve ≥ 1 quadrant - C/I to BCT

Investigations

- Triple assessment, including bilateral mammogram (for synchronous contralateral breast cancer)
- Bloods: LFT (liver met), CaPO4 (bone met)
- Tumour markers: CA15.3, CEA
- Staging: CXR, PET-CT, bone scan

Breast cancer screening
HK local practice

- All ages: recommend monthly self-examination
- ≥40 year old (earlier if high risk e.g. FHx +ve): annual mammogram + USG

182
TABLE 53.3 Relative risk of invasive breast carcinoma based on pathological examination of benign breast tissue (American College of Pathologists Consensus Statement)."
|No increased risk|Adenosis, sclerosing or florid|
||Apocrine metaplasia|
||Cysts, macro and/or micro|
||Duct ectasia|
||Fibroadenoma|
||Fibrosis|
||Hyperplasia|
||Mastitis (inflammation)|
||Periductal mastitis|
||Squamous metaplasia|
|Slightly increased risk|(1.5-2 times)|Hyperplasia, moderate or florid, solid or papillary|
||Papilloma with a fibrovascular core|
|Moderately increased risk|(5 times)|Atypical hyperplasia (ductal or lobular)|
|Insufficient data to assign a risk|Solitary papilloma of lactiferous sinus|
||Radial scar lesion|

[Image Description: A pie chart divided into four quadrants, representing the relationship of carcinoma of the breast to the quadrants of the breast. The upper left quadrant is marked as 12%, the upper right quadrant is marked as 60%, the lower right is marked as 10%, and the lower left is marked as 6%. A small triangle is positioned outside the upper right quadrant.]

# TNM staging

- Clinical staging: tumour size, chest wall invasion, axillary LN metastasis
- Pathological staging: core biopsy + sentinel LN assessment (see separate section)

Tumour (T)

|                |                                                                                                       |
| :------------- | :---------------------------------------------------------------------------------------------------- |
|                | T0: no evidence of primary tumour                                                                     |
|                | **T1: tumour ≤ 2cm**                                                                                  |
|                | - Tla: tumor ≤ 0.5cm                                                                                  |
|                | - T1b: 0.5cm < tumor ≤ 1cm                                                                            |
|                | - T1c: 1cm < tumor ≤ 2cm                                                                              |
|                | **T2: 2cm < tumor ≤ 5cm**                                                                             |
|                | **T3: tumour > 5cm**                                                                                  |
|                | T4: tumour of any size, with direct extension to                                                      |
|                | - T4a: chest wall (except pectoralis major alone)                                                     |
|                | - T4b: skin (ulceration, edema i.e. Peau d'orange) but not meeting criteria of inflammatory CA breast |
|                | - T4c: both chest wall & skin                                                                         |
|                | - T4d: inflammatory cancer (at least 1/3 of breast)                                                   |
| Node (N)       | N0: no regional LN involvement                                                                        |
| - Clinical     | N1: movable ipsilateral axillary nodes                                                                |
| - Pathological | N2: fixed ipsilateral axillary nodes / internal mammary nodes only                                    |
|                | - N2a: Level I/II axillary LN                                                                         |
|                | - N2b: internal mammary LN without axillary LN                                                        |
|                | N3:                                                                                                   |
|                | - N3a: Level III axillary LN only                                                                     |
|                | - N3b: internal mammary LN + axillary LN                                                              |
|                | - N3c: supraclavicular LN                                                                             |
| Metastasis (M) | M0: no distant metastasis                                                                             |
|                | M1: with distant metastasis                                                                           |

Summary for staging

- T1N0 → Stage Ia
- TxN1 → at least Stage II
- T4Nx → Stage IIIb
- TxN3 → Stage IIIc

Terms

- Early: T1/T2, N0/N1
- Locally advanced: T4 or above

Number of axillary LN metastasis is the strongest prognostic factor

- N0: 5-year survival ~70%
- The more lymph nodes, the worse 5-year survival

Treatment for breast cancer

Breast management
Breast-conserving surgery (BCS)/ wide local excision (WLE)

- Approach:
  - Surgical excision: negative margins defined by "**no ink on tumour**"
    - Wider margin does not reduce recurrence / survival since there will be breast RT
    - Positive margin (ink on tumour): >2x increase in ipsilateral breast tumor recurrence (IBTR)
  - RT to breast
- Contraindications:
  - C/I to BCS (**must know!**): multicentric disease, high tumour-breast ratio >20% (can be downstaged by neoadjuvant chemo), tumor too close to NAC, persistent +ve resection margin, presence of diffuse malignant-appearing calcifications on imaging, inflammatory breast cancer
  - C/I to RT: Hx of RT to affected chest wall / breast, pregnancy, connective tissue disease (e.g. scleroderma, Sjogren's disease - poor skin healing, causing fistula formation)
  - Patient choice, e.g. refuse adjuvant RT (5d/ weeks for 5 weeks)
  - Prophylactic mastectomy (e.g. BRCA carrier)

184
Mastectomy

- Indications: C/I to BCS
- Similar efficacy to BCS
- Approach:
  - Simple mastectomy (indicated if clinically -ve LN): axillary LN not dissected → SLNB
    - Nipple-sparing mastectomy: C/I include IBC, involvement of NAC, nipple retraction
    - Skin-sparing mastectomy: C/I if IBC
  - Modified radical mastectomy (MRM): whole breast + overlying skin + axillary LN (level I + II)
  - Radical mastectomy: not done due to ↑↑morbidity, include pec major
- Drains: Jackson-Pratt drain (closed suction - placed through separate stab wounds inferolateral to main incision) ± 2nd drain at axilla if MRM → remove drains if output <30mL/day x 2 days
- Locally advanced cases:
  - Require removal of part of pectoralis muscle for margin
  - Place clips in anticipation of subsequent RT therapy
  - Positive margin = require adjuvant RT
- Complications:
  - Seroma, hematoma, wound infection
  - Skin flap / NAC necrosis (if reconstruction)
  - Arm morbidities: arm or shoulder pain, numbness, frozen shoulder
  - Phantom breast syndrome: altered chest wall sensation, might persist years after surgery

Axillary management

- Sentinel LN biopsy (SLNB)
  - Indications: clinically -ve LN (for early stage), DCIS with planned mastectomy
  - Sentinel LN: first draining LN group, "gatekeeper" of rest of axillary LN
  - Identified by dual tracer injection to intradermal / subareolar / intratumoral region
    - Technectium99m-labelled albumin: injected on the day before OT, C/I in pregnancy
    - Methylene blue: injected intra-op for direct visualization
  - Techniques:
    - Remove max 3-4 sentinel LN
    - Injection should not be close to axilla (avoid interference), and lateral to previous scars (may block lymphatic drainage)
  - Results

|                                                   |                             |
| ------------------------------------------------- | --------------------------- |
| No metastasis                                     | NO NEED axillary dissection |
| Micrometastasis (cluster of tumors ≤ 2mm)         |                             |
| Macrometastasis (cluster of tumors >2mm) x 1-2 LN | Controversial               |
| Macrometastasis (cluster of tumors >2mm) x ≥ 3 LN | Axillary dissection         |
| Extra-nodal extension                             |                             |
| Sentinel LN not found                             |                             |

- Limitations: false -ve rate 9.8% [NSABP B-32 trial], only 75% lymphatics drain to axilla, skip metastases
- New advancements: ICG, SPIO (supra-paramagnetic iron oxide)
- Axillary LN dissection (ALND):
  - Indications: clinically +ve LN (by palpation/ USG axilla), +ve sentinel LN, inflammatory CA breast (T4d)
  - Routine: Level I (lateral to pec minor) + Level II (deep to pec minor)
    - Level III is NOT indicated unless grossly positive: ↑morbidity without ↑survival
  - Complications: 4 nerves
    - Seroma (lymphatics)
    - Long thoracic nerve injury (winged scapula)
    - Thoracodorsal nerve injury (latissimus dorsi: weak adduction & IR of shoulder)
    - Medial pectoral nerve injury (pec major)
    - Intercostobrachial nerve injury (paraesthesia of axilla, medial arm & lateral chest wall)
    - UL lymphedema: Mx - pneumatic compression device
    - UL lymphangiosarcoma (Stewart-Treves syndrome)

[Image Description: A detailed anatomical illustration of the axillary region, focusing on the nerves and blood vessels. Key structures labeled include the Pectoralis minor and major muscles, the Axillary vein and artery, the Intercostobrachial nerves, the Thoracodorsal nerve bundle (including vein, artery, and nerve), and the Latissimus dorsi muscle. An area infiltrated with local anesthetic is also marked. Labels point to the Medial pectoral nerve, Lateral thoracic vein and artery, and the Long thoracic nerve. The illustration appears to be from a medical textbook, providing a visual reference for surgical or diagnostic procedures in the axilla.]

# Assessment for adjuvant therapy

All patients have to be assessed for adjuvant therapies:

- Patient factors: age, menopausal status, medical co-morbidities (esp. cardiac & renal), family / social
- Tumour factors: size, axillary LN status, ER/PR/HER2 status, tumor histology & grading (Ki67), resection margin, operation done (BCS vs MRM), genomic studies

| Adjuvant therapy | Modality                     | Indications                                                                                                    | Comments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| ---------------- | ---------------------------- | -------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
|                  | RT                           | After BCS (whole breast RT) **Role: locoregional recurrence** **Positive margins**                             | Common S/E: **skin fibrosis**, telangiectasia, cardiac damage, pneumonitis / pulmonary fibrosis, lymphoedema, RT-induced malignancy                                                                                                                                                                                                                                                                                                                                                                    |
|                  |                              | Positive LN (regional nodal RT) High risk cancers: e.g. T4, high grade, PNI/LVI                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                  | Chemo                        | Positive LN High risk cancers: e.g. T2+, high risk scores\*, high grade, PNI/LVI                               | General S/E: n/v, alopecia, mucositis (oral, diarrhoea), BM suppression, infertility, leukemia Specific S/E: Anthracyclines: **cardiotoxicity** (Mx: dexrazoxane) Cyclophosphamide: haemorrhagic cystitis, premature ovarian failure Taxanes: neuropathy, myalgia/ arthralgia                                                                                                                                                                                                                          |
|                  |                              | HER2+ if >1cm TNBC if ≥0.5cm (only option)                                                                     | Example regimen: AC x 4 cycles → T x 4 cycles Each cycle is 3 weeks Add cabecitabine if received neoadjuvant                                                                                                                                                                                                                                                                                                                                                                                           |
|                  | Hormonal therapy             | All ER/PR +ve cases unless C/I                                                                                 | Total treatment for **5-10 years**, choices: SERM (e.g. tamoxifen): S/E weight gain, flushing, ↑risk of CA corpus, VTE Aromatase inhibitor (e.g. letrozole, anastrozole, exemestane): post-menopausal only, S/E fracture More effective than tamoxifen GnRH analogue: pre-menopausal Combine with tamoxifen / exemestane: more effective but more S/E (SOFT, TEXT) Radiation / Oophorectomy (rarely done) NOT given concurrently with chemo: stop breast tissue proliferation → affect uptake of chemo |
|                  | Targeted therapy             | HER2 +ve (strong) 20-25% of CA breast                                                                          | **Trastuzumab (Herceptin):** IV infusion Q1mo x 12 S/E cardiotoxicity (not used concurrently with anthracycline), HSR                                                                                                                                                                                                                                                                                                                                                                                  |
|                  |                              | High risk BRCA carriers High risk ER +ve                                                                       | PARP inhibitors e.g. olaparib CDK4/6 inhibitors e.g. abemaciclib                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Neoadjuvant      | Chemo ± Herceptin (if HER2+) | Locally advanced disease that is inoperable Large operable tumour that may be converted from mastectomy to BCS | Mark the location of tumor with **metal clip / radioactive seed** in case it becomes undetectable after Tx Advantages of neoadjuvant Tx: Tumor shrinkage → **Reduce extent of surgery** Provide **prognostic** information Allow addition of different adjuvant regimens Disadvantages of neoadjuvant Tx: No proven benefit c.f. standard therapy May **upstage** if no response to treatment                                                                                                          |
| Palliative       | Hormonal Bone Tx             | ER/PR +ve Bone metastasis                                                                                      | May be used with targeted therapy (HER2) Bisphosphonates, e.g. pamidronic acid RANKL inhibitor, e.g. denosumab                                                                                                                                                                                                                                                                                                                                                                                         |
|                  | Chemo RT                     | Organ metastasis: liver, lung Brain metastasis, cord compression, SVCO                                         | Can also give steroids for brain met                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

\*Risk scores: Oncotype DX21-gene Recurrence Score (RS), Amsterdam 70-gene profile (MammaPrint), PAM50

Breast reconstruction
Principle of oncoplastic surgery: achieve oncological clearance together with reasonable cosmetic outcome
Timing: immediate vs delayed (if RT required)
Modalities:

|               | Autologous tissue (flaps)                                                                          | Prosthesis / implants                                                                                                                          |
| :------------ | :------------------------------------------------------------------------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------- |
| Options       | Pedicled flap: LD, TRAM Free flap: TRAM, DIEP                                                      | Silicone / Saline bag                                                                                                                          |
|               |                                                                                                    | Tissue expander                                                                                                                                |
| Advantages    | Correct skin defects with better cosmesis No foreign body Suitable for salvage if local recurrence | No donor site morbidity                                                                                                                        |
| Disadvantages | Technically demanding (↑OT time) Infection Flap necrosis                                           | C/I if post-RT or anticipated RT Require 2 stages (tissue expander → implant) Foreign body in-situ Implant-related complications (refer below) |

Comparison for common flaps

|                         |                                                        | Pedicle                                                             | Strengths                                         | Weaknesses                                                                                 |
| :---------------------- | :----------------------------------------------------- | :------------------------------------------------------------------ | :------------------------------------------------ | :----------------------------------------------------------------------------------------- |
| Pedicled flap           | LD (latissimus dorsi)                                  | Thoracodorsal a.                                                    | Low risk of flap loss (reliable blood supply)     | Limited ROM                                                                                |
| Pedicled flap Free flap | TRAM (transverse rectus abdominis myocutaneous) flap   | Superior epigastric a.                                              | Sufficient volume                                 | Hernia Not preferred if Hx of abdominal surgery                                            |
| Free flap               | DIEP (deep inferior epigastric artery perforator) flap | Inferior epigastric vessels anastomosed to internal mammary vessels | Abdominal muscle strength maintained Better shape | Longer OT time: require microsurgery Risk of complete flap loss (failed micro-anastomosis) |

Other possible flaps (seldom): sup. / inf. gluteal artery perforator (SGAP/IGAP), lumbar a. perforator

[TRAM(Transverse Rectus Abdominis Muscle) Pedicle-flap]
[After TRAM pedicle flap surgery]
[Latissimus Dorsi Flap]
[DIEP (Deep Inferior Epigastric Artery Perforator) Flap]
[Images showing before and after breast reconstruction]

Complications of breast implants

| Mechanical Cx                                            | Migration, malposition, exposure, rupture Majority of rupture are often silent Present with changes in breast shape/volume, capsular contracture, palpable lumps (breast or axilla), and pain.                               |
| :------------------------------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Implant infections                                       | Managed by antibiotics +/- explantation and irrigation of the pocket → closure over closed suction drainage                                                                                                                  |
| Capsular contracture                                     | Esp. post-infection, radiation Painful, fibrous capsule around implant → palpable distortion of breast                                                                                                                       |
| Breast implant associated anaplastic large cell lymphoma | ALK -ve, CD 30 +ve Disease confined to the capsule: capsulectomy alone is curative Adjuvant therapies, such as chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone) or anti-CD 30 (brentuximab vedotin) |

8.5 Benign breast disease
"Aberrations of normal development and involution (ANDI)": new term to classify most benign diseases as aberration in one of three stages:

- Development (15-25yo) → Cyclical changes (25-55yo) → Involution (>35-55yo)

Inflammatory breast conditions
| | Definition | Risk factors | Clinical features | Investigations | Management |
|-----------------|------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|
| Mastitis | Infection of breast tissue, mostly due to **S aureus** | **Lactational:** 1st child | Inflammation: tenderness, swelling, erythema Induration Purulent / foul-smelling discharge Complications: **abscess** (fluctuant mass, fever) | **Clinical diagnosis** ± Abscess: USG | Continue **breastfeeding** using the affected breast Analgesics **Antibiotics** (cloxacillin) Abscess: USG-guided aspiration or I&D (if necrotic skin) |
| [Image of ductal ectasia showing a small hole in the center of the areola of a breast.] | **Abnormal dilation** of subareolar ducts with inflammation and fibrosis | Smoking | Nipple discharge (yellow/ green/ black) "Blue breast": cyst with dark fluid under nipple Nipple retraction (fibrosis) Complications: **periductal mastitis**/ abscess | Mammogram: dilated calcified ducts Cytology: plasma cells | Conservative Abscess: as above Microdochectomy if persist |
| Fat necrosis | Ischaemic necrosis of fat lobules | Trauma Iatrogenic, e.g. **breast reconstruction** | Mimic CA clinically, e.g. painless lump with skin dimpling, nipple retraction | Mimic CA radiologically → core biopsy to differentiate | Reassurance Analgesics |
| [Image of Mondor's disease showing a red, raised cord-like structure under the skin of a breast.] | Superficial **sclerosing thrombophlebitis** of breast and anterior chest wall | | Chest pain Palpable **subcutaneous cord** Affected veins: **thoraco-epigastric vein** (MC), lateral thoracic v, sup epigastric v | | Reassurance Analgesics e.g. NSAID Warm compression |

Non-inflammatory breast conditions
| | Definition | Risk factors | Clinical features | Investigations | Management |
|-----------------------|---------------------------------------|--------------|-------------------------------------------------------------|-------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|
| Breast cyst | Epithelial-lined fluid-filled cavity | Young female | Simple/ multiple lumps: soft & fluctuant +/- tender | USG: fluid-filled Cytology only if: blood-stained aspirate, recur, radi suspicious | Reassurance Aspiration Surgery if recur or solid component present |
| Fibrocystic changes/ fibroadenosis (most common) | Multiple small cysts with fibrotic areas, due to exaggeration of cyclical breast changes related to menstrual cycle | Young female | Cyclical painful **mass**/ nodularity Serosanguinous nipple discharge | USG | Avoid caffeine Evening primrose oil Analgesics COC |

# 8.6 Benign breast tumours

|                                    | Definition                                                   | Age              | Clinical features                                                                            | Management                                                                                             |
| :--------------------------------- | :----------------------------------------------------------- | :--------------- | :------------------------------------------------------------------------------------------- | :----------------------------------------------------------------------------------------------------- |
| Fibroadenoma (MC)                  | Proliferation of stromal & epithelial tissue of duct lobules | Reproductive age | Well-defined rubbery mass Highly mobile Can be multiple & bilateral                          | Observation Surgical excision: if symptomatic />2cm                                                    |
| Adenoma                            | Benign glandular tumour                                      | Older age        | Can mimic CA                                                                                 |                                                                                                        |
| Intraductal papilloma              | Benign breast lesion                                         | Perimenopausal   | Nipple discharge (bloody) Multiple papillomas: increased risk of CA                          | Surgical excision (microdochectomy / major duct excision)                                              |
| Phyllodes tumour                   | Fibroepithelial tumour Aka serocystic disease of Brodie      | Older age (>40)  | Smooth painless mass Mobile Can be **malignant** (metastasize via blood - ALND not required) | Wide local excision with **margin of at least 1cm** (mastectomy if adequate margin cannot be achieved) |
| Sclerosing adenosis / Radial scars | Pathological diagnosis: lobular lesions with ↑fibrosis       | Any              | Can mimic CA                                                                                 | Conservative / Excision to rule out CA                                                                 |

# 8.7 Gynaecomastia

Definition: benign enlargement of the male breast resulting from breast glandular proliferation

- Pseudo-gynacomastia (lipomastia 肥仔波): fat deposition without glandular proliferation

Aetiology

- Physiological: newborn, adolescence
- Pathological: change in oestrogen: androgen activity ratio
  - ↑Oestrogen: liver disease, drugs (e.g. spironolactone)
  - Androgen: hypogonadism, **testicular tumour**
  - Defect in AR: androgen insensitivity syndrome

Clinical features

- Rubbery or firm mass extending from nipple
- Suspect CA breast if:
  - Old patients without risk factors
  - Unilateral gynaecomastia
  - Non-tender hard mass within breast tissue
  - Lymphadenopathy

Investigations

- Bloods: LFT, sex hormone profile
- Testis: testicular USG, AFP, βHCG

Management

- Treat underlying cause
- Physiological: reassurance
- Idiopathic: tamoxifen, surgical excision

9 Endocrine surgery
189

9.1 Thyroid
Anatomy
Basic anatomy

- Level: C5-C7
- True capsule vs false capsule (pre-tracheal layer of deep cervical fascia)

Components: 2 lobes → lobule as functional unit → each lobule contains 20-40 follicles → each contains

- Follicular cells (secrete thyroid hormone)
- Colloid (store thyroglobulin)
- C cells (secrete calcitonin)

[Illustration of the Thyroid Gland: The thyroid gland is depicted in an anterior view, situated in the neck region. The trachea is shown as the main airway, leading up to the thyroid cartilage, which is positioned above the lobe of the thyroid gland. The isthmus of the thyroid gland connects the two lobes. The pyramidal lobe, when present, extends upwards. Key anatomical features are labeled including the trachea, thyroid cartilage, lobe of the thyroid gland, isthmus of the thyroid gland, and the pyramidal lobe.]

Arterial supply: anastomosis extensively within gland and on gland surface to provide collateral circulation

- Superior thyroid artery (1st branch of ECA):
  - Divide close to gland to avoid damaging EBSLN
- Inferior thyroid artery (thyrocervical trunk ← subclavian a):
  - Divide away to gland to avoid damaging RLN
  - Arise in vertebral artery triangle (between scalenus anterior and longus colli)
  - Thyroidea ima artery (3-4%, from brachiocephalic trunk/ arch of aorta)

[Illustration of the Arterial Supply of the Thyroid Gland: This diagram showcases the arterial supply to the thyroid gland. It highlights the relationship between the external carotid artery and the superior thyroid artery. The inferior thyroid artery originates from the thyrocervical trunk, which comes off the brachiocephalic artery. The illustration labels key vessels such as the external carotid artery, superior thyroid artery, inferior thyroid artery, thyrocervical trunk, and the brachiocephalic artery.]

Venous drainage - does NOT mirror arterial supply

- Superior thyroid vein (to IJV)
- Middle thyroid veins (to IJV)
- Inferior thyroid vein (to brachiocephalic vein)

[Illustration of the Venous Drainage of the Thyroid Gland: This diagram details the venous drainage of the thyroid gland. It presents the superior thyroid vein draining into the internal jugular vein, the middle thyroid vein also draining into the internal jugular vein, and the inferior thyroid vein draining into the brachiocephalic vein.]

Lymphatics: first to Level VI (central compartment, bounded by CCA)

[Illustration of the Arterial Supply to the Neck, focusing on the Thyroid: The diagram provides a detailed view of the arterial supply to the neck region, focusing specifically on the vessels related to the thyroid gland. The image is labeled with anatomical structures such as the transverse cervical artery, suprascapular artery, vertebral artery, thyrocervical trunk (right), thyrocervical trunk (left), internal thoracic artery, costocervical trunk (right), costocervical trunk (left), dorsal scapular artery, subclavian artery, common carotid artery.]

Important nerves

- External branch of superior laryngeal nerve (motor to cricothyroid which tenses vocal cord):
  - Run close to superior thyroid artery
  - Injury causes loss of high-pitch voice
  - Space of Reeve: avascular space between upper pole of thyroid and cricothyroid muscle
- Recurrent laryngeal nerve (motor to all thyroid muscles except cricothyroid):
  - Run close to inferior thyroid artery
  - Injury causes voice hoarseness or airway obstruction (if bilateral partial injury)
  - Simon's triangle: CCA (lateral), esophagus (medial), ITA (superior)
  - Berry's ligament: attach thyroid gland to cricoid and first 2 rings

[Surgical Image: A surgical field showing the Space of Reeve (SOR) exposed with the upper pole of the thyroid pulled inferiorly and laterally. The area is lit and the anatomical structures are visible.]

[Surgical Image: A surgical site showcasing the recurrent laryngeal nerve. The nerve is highlighted by a yellow arrow, indicating its position in the surgical field. The tissues and surrounding structures are also visible, providing context to the nerve's location.]

Figure 7
Space of Reeve (SOR) exposed with the upper pole of thyroid pulled inferiorly and laterally

Figure 15
Recurrent laryngeal nerve

Approach to thyroid nodules
Differential diagnosis
(Hyperthyroid, euthyroid, hypothyroid) Around 10-15% of nodules are malignant
| | |
| :---------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Solitary nodule | Dominant nodule in MNG Cyst: true simple cyst, colloid nodule Neoplastic: adenoma, **toxic adenoma**, carcinoma |
| Multiple nodules | MNG (Hyperplastic/ adenomatous nodules with varying degree of cystic degeneration), **toxic MNG** Cyst (multiple) Neoplastic: multiple adenoma |
| Diffuse | Graves' disease Physiological (pregnancy, puberty) Hashimoto's thyroiditis De Quervain's/ subacute thyroiditis |

History taking

- Neck lumps:
  - Number
  - Onset & progression
  - Pain (haemorrhagic cyst, thyroiditis, anaplastic carcinoma)
- Compression symptoms: dysphagia, SOB (stridor), HOV
- Thyroid status
- Risk factors for CA:
  - Prior neck irradiation
  - FHx of CA thyroid: MENII, FAP

Physical examination
[Image Description: This is a figure showing thyroid examination. The figure contains a drawing of a person's head and neck with a close-up of the thyroid area, which is a yellow butterfly-shaped gland. Dotted lines indicate the location of the thyroid. Text beside the diagram lists the different aspects of the thyroid examination: Inspection which involves surgical scar, swallowing test, tongue tug test. Voice hoarseness. Palpation (thyroid) which involves the evaluation of: Diffuse vs solitary nodule vs MNG vs dominant nodule in MNG, Size, Consistency, Location, Lower border, Cervical LN, and Trachea. The figure also lists general exam including the evaluations of Eye (Lid retraction, Exophthalmos, Chemosis, Proptosis, Lid lag, Ophalmoplegia), Hands (Tremor, Sweeting, Tachycardia), and Lower limbs (Proximal muscle weakness, Myxedema). ]

Thyroid

Inspection

1. Surgical scar
2. Swallowing test
3. Tongue tug test

Voice hoarseness

Palpation (thyroid)

1. Diffuse vs solitary nodule vs MNG
   vs dominant nodule in MNG
2. Size
3. Consistency
4. Location

5. Lower border
6. Cervical LN
7. Trachea

General exam

1. Eye
   1. Lid retraction
   2. Exophthalmos
   3. Chemosis
   4. Proptosis
   5. Lid lag
   6. Ophalmoplegia
2. Hands
   1. Tremor
   2. Sweeting
   3. Tachycardia
3. Lower limbs
   1. Proximal muscle weakness
   2. Myxedema

Investigations
| | Routine | Selective | |
| :------------------- | :------ | :------------------------------------------------ | :------------------------------------------------------------------ |
| History + Physical exam | √ | | |
| Thyroid function test | √ | | |
| USG thyroid +/- FNAC | √ | | |
| Thyroid scan | X | Only in toxic (elevated TSH) + nodules | |
| CT scan | X | Only when (1) Retrosternal goiter | |
| PET scan | X | (2) Locally advanced thyroid cancer X (no diagnostic role at all) | Retrosternal goitre requires CT because: 1. Cannot be visualised by USG |

Retrosternal goitre requires CT because:

1. Cannot be visualised by USG
2. Surgical planning
3. Retrosternal goitre may be malignant

Locally advanced disease for CT because:

1. Important structures within cervical fascia (for better delineation)

Routine for all patients: TFT, thyroid USG, FNAC
Thyroid function test (TFT): routinely done to identify potentially toxic nodules
Thyroid USG:

- Role:
  - Thyroid gland: assess size of goitre
  - Nodule: number, any suspicious features
  - Cervical LN (esp. deep nodes, e.g. level VI nodes)
  - Assess retrosternal extension
  - Guide FNAC
- Sonographic features suspicious of malignancy: "SHIT CME" - most important are **solid & hypoechoic**

[Image of a Thyroid ultrasound showing different nodules. From left to right, top to bottom, there are images of a hypoechoic nodule, a solid nodule, and an irregular lobulated margin. Below these, there is an image showing taller than wide, microcalcifications, and extrathyroidal extension.]

SHIT CME

- Solid nodule
- Hypoechoic nodule
- Irregular margin
- Taller than wide (AP > TS)
- Chaotic central vascularity
- Microcalcifications
- Extrathyroidal extension

FNAC (under USG guidance)

- Diagnostic and therapeutic for **thyroid cysts**
- Limited assessment on architecture: cannot distinguish follicular adenoma vs carcinoma
- Note: theoretically only for nodule ≥ 1cm based on risk stratification, but all nodules are aspirated in practice
  _Indications for FNAC (UpToDate)_

| Sonographic pattern    | Ultrasound features                                                      | Risk of malignancy | FNA size cut-off       |
| :--------------------- | :----------------------------------------------------------------------- | :----------------- | :--------------------- |
| High suspicion         | Solid hypoechoic nodule + ≥ 1 suspicious features                        | ≥ 70-90%           | FNA if ≥ 1cm           |
| Intermediate suspicion | Hypoechoic solid nodule with smooth margins without other suspicious S/S | 10-20%             | FNA if ≥ 1cm           |
| Low suspicion          | Isoechoic or hyperechoic nodule with no suspicious features              | 5-10%              | FNA if ≥ 1.5cm         |
| Very low suspicion     | Partially cystic nodule                                                  | ≤ 3%               | FNA if ≥ 2cm / observe |
| Benign                 | Purely cystic nodules                                                    | ≤ 1%               | No biopsy              |

- Complications: pain, bleeding, false negative

Thyroid scan (I-123)

- Indicated for clinical or subclinical hyperthyroidism (only ↓TSH)
- Differentiate between toxic nodule (→ hemithyroidectomy) vs toxic MNG / Graves' (→ total thyroidectomy)
- Cold nodules are more likely malignant (3-15% risk)

PET CT has **NO diagnostic role** in thyroid diseases - even malignant nodules can have low uptake

# Bethesda classification for reporting of thyroid cytopathology

| Class | Interpretation                                                                                      | Risk % | Management                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| ----- | --------------------------------------------------------------------------------------------------- | ------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| I     | Quantity insufficient (QI)                                                                          | 5-10   | Repeat FNAC with USG guidance in 4-6 weeks Still QI: observation (low risk) or hemithyroidectomy (high risk\*) \*High risk features: - Suspicious USG features - Clinical risk factors: - Hx: FHx of thyroid CA, prior neck radiation - PE: voice hoarseness, hard/irregular/fixed mass, cervical LN +ve - Growing nodule                                                                                                                                                                                                                                                      |
| II    | Benign (still small risk due to sampling error)                                                     | 0-3    | Management of benign thyroid nodules [Flowchart showing the management options for benign thyroid nodules, starting with Observation, leading to Medical therapy (Thyroxine) - which is crossed out and labeled as Mostly obsoleted (1) Controversial benefits (2) Works in <20% of patients (3) Significant side effects (4) Thyroid gland can regrow after cessation of thyroxine - and Thyroidectomy - which is labeled as Indications 1. Pressure symptoms 2. Growing size 3. Cosmetic concern 4. Patient's worry. Observation is connected to Clinical & USG monitoring.] |
| III   | Atypia of undetermined significance (AUS)\* / Follicular lesion of undetermined significance (FLUS) | 6-18   | Repeat FNAC (low risk) vs hemithyroidectomy (high risk\*) Still Class III: hemithyroidectomy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IV    | Follicular neoplasm / Hurthle cell neoplasm / Oncocytic neoplasm                                    | 10-40  | Hemithyroidectomy^ - FNAC cannot diagnose follicular CA: require evidence of capsular or vascular invasion - After resection, majority is papillary CA (psammoma bodies) - Hurthle cell neoplasm not amendable to RAI → require OT                                                                                                                                                                                                                                                                                                                                             |
| V     | Suspicious of malignancy                                                                            | 45-60  | Refer to later sections for management of thyroid cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| VI    | Malignant                                                                                           | 94-96  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

\*Atypia as a morphological description rather than a premalignant lesion

Approach to multiple nodules

- Malignancy risk much lower
- USG: assess each nodule separately
- FNAC: depend on USG result
  - If no suspicious nodules: FNA the largest nodule
  - Any suspicious nodules: FNA all suspicious nodules

Overview of management

|              | Solitary           | Multinodular        |
| ------------ | ------------------ | ------------------- |
| Euthyroid    | Observe Hemi if 4C | Observe Total if 4C |
| Hyperthyroid | Hemi               | Total               |

Thyroglossal cysts
Definition: failure of thyroglossal tract to obliterate by gestational weeks 7-10 → cystic expansion of remnant

Clinical features:

- Midline upper neck mass, can be slightly lateral
- 60% located at thyrohyoid membrane level
- Tongue tug test +ve
- Association: thyroid ectopia (mostly lingual thyroid) → hypothyroidism
- Complications: abscess (tenderness, fever), fistula formation, malignant transformation to papillary CA (rare)

Investigations:

- CT neck with contrast (USG cannot delineate relations with hyoid)
- USG ± FNAC: confirm presence of normal thyroid gland (otherwise removal of thyroglossal duct might cause
  hypothyroidism)

Management:

- Sistrunk operation: remove cyst + duct + whole tract (including **body of hyoid bone** up to foramen cecum) to prevent recurrence
- Infected cyst: antibiotics → Sistrunk operation

Thyrotoxicosis
Indications
| | Graves' | Toxic MNG (Plummer's) | Toxic nodule |
| :-------------------- | :------- | :------------------------------------------------------------ | :----------- |
| Antithyroid drugs | 1st line | (Ineffective: recur upon discontinuation) Prolonged use if patient does not want RAI or surgery | |
| Radioactive iodine | 2nd line | Preferred if no 4C | |
| Surgery | 2nd line | Preferred if 4C | |

Pre-op preparation in thyrotoxic patients undergoing thyroid surgery

- Maintain **biochemically euthyroid** at operation to prevent thyroid storm
  - High dose carbimazole (30-40mg/day) for 8-12 weeks, then low dose (15mg/day) to maintain euthyroid
  - Propranolol (40mg tds): block beta receptor + reduce T4-T3 conversion
    - More rapid clinical response (days instead of weeks)
    - T4 level still high post-op: continue propranolol until **7 days** post-op
  - Lugol's iodine: ↓iodine uptake + ↓vascularity of thyroid gland (↓intra-op bleeding)
    - Can be given with carbimazole / beta-blocker for 10 days before operation
- Monitor Ca & vit D level and supplement accordingly (post-op hypoPTH/hungry bone syndrome)
- Vocal cord function by laryngoscopy

Extent of resection

- Graves': total thyroidectomy recommended (c.f. subtotal thyroidectomy)
  - Total thyroidectomy vs subtotal thyroidectomy in Graves' disease
    - Immediate return to euthyroid state (vs variable duration)
    - No risk of recurrence
    - Higher risk of
      - Thyroid failure (100%)
      - Parathyroid injury
      - RLN injury
- Toxic MNG: total thyroidectomy
- Toxic adenoma: hemithyroidectomy (if no evidence of nodules in contralateral lobe)

Thyroid cancer
Overview
Primary thyroid cancer
| | Papillary | Follicular | Anaplastic | Medullary |
|---------------|------------------------------|----------------------------|-----------------------------|----------------------------------|
| % of cases | 85% | 10-15% | 1% | 3% |
| Age | Young adult | Middle age (40-60y) | Old > 60y | Sporadic: >50y |
| | | | | Familial: < 30y |
| Cell type | Well differentiated | Well differentiated | Undifferentiated | Para-follicular C cells |
| | follicular cells | follicular cells | follicular cells\* | |
| Pathology | Multifocal, non- | Focal, encapsulated | Small blue round | Deposits of amyloid |
| | capsulated lesions | lesions | cells | (Congo red stain) |
| | Presence of papilla | Capsule or vascular | | 25% genetic |
| | Psammoma bodies | invasion (cf. adenoma) | Very poor | RET oncogene |
| | (microcalcifications) | Hurthle cell tumour: | prognosis: seldom | Familial MTC |
| | Orphan-Annie nuclei | Oxyphil cell, worse | survive >6mo | MEN II syndrome |
| | | prognosis | | 75% sporadic |
| Spread | Lymphatics (to | Haematogenous: to | Lymphatics and | Lymphatics |
| | compartment VI) | bone and lungs | haematogenous | |

\*Can be de novo or de-differentiation from papillary / follicular CA

Other rarer types: lymphoma (require core biopsy), SCC, poorly differentiated CA

Metastatic thyroid cancer

- Renal cell carcinoma (MC)
- Others: colorectal, lung, breast, uterine

Risk factors

- Female
- Family history of thyroid cancer
- Previous H&N irradiation e.g. childhood leukemia
- Familial syndrome, e.g. FAP (papillary), MENII (MTC)
- Hashimoto's thyroiditis (thyroid lymphoma), iodine deficiency (follicular CA)
  Note: Follicular adenoma is NOT a risk factor of follicular CA
  Clinical features
- Palpable neck lumps
- Rapidly enlarging lumps: pain, HOV, stridor
- Multiple enlarged cervical LN

Investigations

- Bloods: TFT (normal), CaPO4 (parathyroid function), thyroid Ab and thyroglobulin (tumor marker)
- Thyroid USG: suspicious features (SHIT CME)
- FNAC: Bethesda system
- CT neck and chest: if locally advanced CA thyroid / bulky LN
- Pre-op workup for MTC - Rule out familial disease (25%): FHx, 24h urine metanephrines, Ca & PTH - Tumour markers: calcitonin (metatstatic if >500), CEA - Workup for metastatic disease if calcitonin > 500: СТ
  T+A+P & bone scan

Staging of thyroid cancer

- Differentiated thyroid cancers: age-dependent
  - Age <55: Stage I if MO, Stage II if M1, never Stage III/IV
  - Age 255: Up to Stage IVB
- Anaplastic thyroid cancers: Stage IV automatically

- T staging:
  - Tla: tumor ≤ 1cm
  - T1b: 1cm < tumor ≤ 2cm
  - T2: 2cm < tumor ≤ 4cm
  - T3: >4cm but limited to thyroid
  - T4: extrathyroidal extension
- N staging: - Nla: Level VI / VII nodes - N1b: Level I-V nodes
  [Image: The number 194 is written in the top right corner of the page.]

Management
Choice of thyroidectomy

1. Differentiated CA thyroid (papillary / follicular)

# Papillary Thyroid Carcinoma

[Image of a flowchart showing the management of Papillary Thyroid Carcinoma. It starts with "Surgery for thyroid gland" and then asks "Any one of the following: 1. Size >4cm (T3) 2. Gross extrathyroidal extension (T4) 3. LN positive (N1) 4. Metastasis positive (M1) 5. Familial disease (high risk) 6. Bilateral or multifocal". If the answer is "NO", it asks "Tumor size?". If the tumor size is >1cm-4cm, then "Total thyroidectomy" is chosen, otherwise, if size ≤1cm "Observation" is chosen. If the answer to the first question is "YES" Total thyroidectomy is chosen. From "Tumor size?" is "Surgery for LN" which leads to "Therapeutic CCD When central LN +ve" and "+ Therapeutic lateral MRND When lateral LN +ve"]

| Total thyroidectomy                                                                  | Hemithyroidectomy                                            |
| ------------------------------------------------------------------------------------ | ------------------------------------------------------------ |
| Total thyroidectomy                                                                  | Hemithyroidectomy                                            |
| - Papillary CA tends to be multifocal                                                | - Morbidities are lower, especially parathyroid & RLN injury |
| - Prevent local recurrence which may progress to undifferentiated CA (anaplastic CA) | - Progression to undifferentiated CA is rare                 |
| - Allow post-op thyroglobulin monitoring                                             | - No evidence to show inferior prognosis                     |
| - Allow adjuvant RAI                                                                 | - Lifelong thyroxine replacement not required                |
|                                                                                      | - RAI is not required in most patients                       |

2. Medullary CA thyroid: total thyroidectomy (require prophylactic total thyroidectomy in high-risk MEN2 cases)
   Choice of neck dissection
   Terms: central compartment dissection (Level VI) vs lateral neck dissection (Level II-V)
1. Papillary CA thyroid:

- Therapeutic CCD/LCD if respective compartment +ve
- No role for prophylactic neck dissection

2. Follicular CA thyroid:

- Usually not required (haematogenous spread)

3. Medullary CA thyroid: often need to dissect one level up

- Prophylactic CCD for all patients
- Ipsilateral central LN +ve: + ipsilateral LCD
- Ipsilateral lateral LN +ve: + ipsilateral LCD (if calcitonin < 200), + bilateral LCD (if calcitonin > 200)
- Contralateral LN +ve: +bilateral LCD

[Image of a diagram of Lymph node levels in the neck, numbered I to VII with corresponding anatomical locations highlighted in different colors. Lymph node levels (I, II, III, IV, V, VI, VII) and associated Lymph node levels]

Post-operative adjuvant treatments

- Remnant ablation: - Residual thyroid tissue actually non-functional (require T4 supp anyway), but it interferes with post- op thyroglobulin monitoring and also cannot r/o residual malignancy!
  | Radioactive iodine ablation (RAI): | External beam irradiation (EBRT) |
  | ----------- | ----------- |
  | Pre-op give rTSH or withdraw T4 to promote ¹³¹I intake<br>Low iodine diet x1 week | |
  | Similar to indication for total thyroidectomy (above): | Indications include: |
  | - T3 / T4 disease | - Positive surgical margins |
  | - N1 / M1 disease | - Incomplete resection (residual tumor left) |
  | - Aggressive histology: tall cell, columnar cell, diffuse sclerosing, poorly differentiated PTC | |

Thyroxine

- Roles: Replacement (prevent hypothyroidism) ± suppression (high TSH stimulates tumour growth)
- Target TSH depends on risk - note that low risk group does NOT require TSH suppression (for reference)
  | Low risk | None of the following features | No TSH suppression (0.5-2.0 mIU/L) |
  | ------------------ | ------------------------------- | ------------------------------------------ |
  | Intermediate risk | - T3, N1 | Low TSH suppression (0.1-0.5 mIU/L) |
  | | - Aggressive histology | |
  | | - Vascular invasion +ve | |
  | High risk | - T4, M1 | High TSH suppression (<0.1 mIU/L) |
  | | - Incomplete resection | |

- Disease monitoring:
  - Neck USG Q6m
  - Bloods: TSH & thyroglobulin (on thyroxine suppression) Q3m - can be performed for both total/hemithyroidectomy
    - Total hemithyroidectomy: Tg < 0.2
    - Hemithyroidectomy: Tg < 30

Thyroidectomy
Indications (4C)

- CA thyroid
- Uncontrolled thyrotoxicosis
- Compression
- Cosmetic concern

Pre-op evaluation

- Maintain biochemically euthyroid (refer to [Thyrotoxicosis])
- Vocal cord function by laryngoscopy
- Monitor Ca & vit D level and supplement accordingly (post-op hypoPTH/hungry bone syndrome)

Terminologies

- Total thyroidectomy: resection of both lobes + isthmus + pyramidal lobe
- Subtotal thyroidectomy: resection of > 1/2 of both lobes + isthmus
- Hemithyroidectomy: resection of one lobe + isthmus
- Lobectomy: resection of one lobe (isthmus preserved)

Alternative surgical approaches (reference)

- Bilateral axillo-breast approach (BABA)
- Transoral vestibular approach
- Retro-auricular trans-hairline approach (RATH)

[Image of a patient's neck post-surgery, displaying significant bruising and swelling. The bruising is most prominent around the surgical incision site in the lower neck area, extending upwards towards the jawline and down towards the upper chest. The skin appears discolored, with shades of purple, blue, and yellow indicating the presence of blood underneath the skin. The swelling causes the neck to appear enlarged and distorted compared to its normal contours. There are visible surgical sutures or staples along the incision line.]

Early complications x3

- Reactionary haemorrhage (fig.) - Patho: reactionary bleeding within first 24h post-op → haematoma
  compresses on venous return → laryngeal oedema → complete closure
  of vocal cord → asphyxiation
- Management:
  - Remove all stitches from skin down to cervical fascia at bedside (first action!)
  - Resuscitation: protect airway, give supplemental oxygen
  - Arrange EOT for haemostasis

- Hoarseness of voice (HOV)
  - Transient HOV: due to vocal cord oedema caused by endotracheal intubation, resolve spontaneously
  - Persistent HOV: RLN injury

|            | Partial injury (irritation)                    | Complete injury                                         |
| :--------- | :--------------------------------------------- | :------------------------------------------------------ |
| Unilateral | Hoarseness                                     | Hoarseness                                              |
| Bilateral  | Airway obstruction (6 adductors > 2 adductors) | Hoarseness: stay in anatomical position (i.e. mid open) |

- Management: cord medialization procedures – e.g. injection thyroplasty, open thyroplasty (Gortex)
- EBSLN injury: loss of high pitch (cricothyroid muscle), poor volume, easy fatigue
- Parathyroid injury
  - Only in total thyroidectomy
  - Most common complication, but usually transient
  - S/S: **perioral numbness**, carpopedal spasm, Chvostek's sign, Trousseau's sign
    - Severe hypoCa can lead to **laryngospasm** requiring emergency intubation / surgical airway
  - Mx: Ca + vit D supplement (acute: IV Ca gluconate)

Late complications x2

- Hypothyroidism (late)
- Wound complications
  - Hypertrophic / Keloid scar
  - Wound infection is NOT a recognized complication (clean surgical field)

Post-op dyspnoea DDx:

- Haemorrhage: hypovolaemic shock, laryngeal oedema
- Bilateral RLN irritation causing airway obstruction
- Laryngeal spasm due to hypocalcaemia
- Injury to trachea/ pneumothorax
- Tracheomalacia (floppy tracheal wall due to chronic compression)

  9.2 Parathyroid
  Basics
  Anatomy
  | | Embryology | Position |
  | :----------------- | :------------------------ | :----------------------------------------------------------------------------------------------------------------- |
  | Superior (x2) | 4th pharyngeal pouch | **More constant** (shorter migration) Most common: intersection of ITA & RLN |
  | Inferior (x2) | 3rd pharyngeal pouch | Less constant (longer migration) Most common: inferior pole of thyroid gland |

- Vascular supply: inferior thyroid artery supplies all four glands

Physiology
| | PTH (active 84-aa peptide) | Calcitonin |
| :-------------------- | :----------------------------------------------------------------------------- | :----------------------- |
| Site | Chief cells of parathyroid glands | C cells of thyroid gland |
| Half life | 4 min | 60min |
| Effect | Kidney: ↑Ca reabsorption Activate vitamin D Bone: act on osteoblast & osteoclast to ↑Ca | Antagonist PTH action |

[Diagram illustrating the physiological effects of PTH and calcitonin on calcium levels. It depicts the parathyroid gland releasing PTH in response to low calcium levels. PTH acts on the kidneys to increase calcium reabsorption and phosphate excretion. It also stimulates the conversion of 25(OH)D to calcitriol, which promotes calcium absorption in the intestine. In bone, PTH stimulates both osteoblasts and osteoclasts, leading to bone resorption and the release of calcium. In contrast, calcitonin, produced by C cells of the thyroid gland, inhibits osteoclastic activity, reducing calcium release from bone.]

Causes of hypercalcemia
| | | |
| :-------------------- | :----------------------------------- | :----------------------- |
| Hyperparathyroidism | Primary hyperparathyroidism | Check PTH |
| Renal failure | Secondary or tertiary hyperparathyroidism | Check history and RFT |
| Malignancy | Paraneoplastic syndromes (PTHrP) | Check history and PE |
| Granulomatous diseases| Sarcoidosis Tuberculosis | Check history and PE |
| Medications | Thiazide diuretics Vitamin A or D intoxication Lithium intoxication | Check history |
| Increased bone turnover | Immobilization Paget's disease Thyrotoxicosis | Check history and PE |

Clinical features of hypercalcaemia

- Renal stone (MC): dehydration
- Painful bone: osteopenia / osteoporosis, "salt-and-pepper" degranulation of skull
- Abdominal groans: due to ileus, PUD (gastrin secretion), pancreatitis
- Psychic moans: fatigue, memory impairment

[X-ray image showing a skull with "salt-and-pepper" degranulation, a characteristic feature of hyperparathyroidism.]

Acute management of hypercalcemia [MED]
| | |
| :------------------------------------- | :---------------------------------------------------- |
| Intravenous saline rehydration | Induce natriuresis and calciuresis |
| Intravenous loop diuretics e.g. furosemide | Induce natriuresis and calciuresis |
| Intravenous bisphosphonate e.g. pamidronate | Inhibit osteoclastic activity and reduce Ca release from bone |
| Calcitonin / Glucocorticoids | Inhibit osteoclastic activity |
| Dialysis | Mechanically remove plasma calcium |

# Primary hyperparathyroidism

Aetiology

- Sporadic: risk factor is previous H&N irradiation
- Familial: MENI/ΙΙΑ

Pathology

- Solitary parathyroid adenoma (80%)
- Multi-gland parathyroid adenoma (5-10%)
- 4-gland hyperplasia (MEN1, MEN2A) (10%)
- Parathyroid carcinoma (<1%)

Investigations

- Biochemical diagnosis: **hyperCa + high/normal PTH**
  - Vit D: rule out vit D deficiency
  - **24h urine Ca (must check!)**: rule out familial hypocalciuric hypercalcemia (FHH)
- Screen for complications of hyperCa
  - Bone scan
  - KUB / USG kidney
  - ALP: ↑ level predict risk of hungry bone syndrome post-op
- **Localisation studies of hyperfunctioning parathyroid: USG + Sestamibi scan**
  (Role: to localise the parathyroid glands to determine whether unilateral
  exploration is needed - 5% present with double adenoma) - USG neck: non-invasive, parathyroid adenomas appear hypoechoic - Sestamibi scan: - Mechanism - **Sestamibi** accumulates in **mitochondria**, and washout rate depends on number of mitochondria in tissues - Parathyroid adenomas are rich in **oxyphilic cells** (lots of mitochondria), so there is **slow washout** compared to thyroid gland - Protocols: Take photo 10 min after injection + after **2h washout time** - Single isotope dual-phase scan - Dual isotope subtraction imaging (**⁹⁹Tc-Sestamibi scan**): subtract thyroid signal
  [Image of two nuclear medicine scans of a patient's neck and upper chest. The images are side-by-side. The left image is labeled "10 mins" and shows a small, bright area in the lower left part of the neck. The right image is labeled "2 hours" and shows that the bright area is still visible, but it has not spread or changed significantly.]

              - Single-photon emission CT scan (SPECT): 3D scan with higher resolution
              - False positive: Hurthle cell adenoma
          - 4D CT scan: multiphase CT imaging, but high radiation dose ®
          - Parathyroid angiography with **selective venous sampling**: invasive, reserved for re-operative cases

Management
Indications of surgical management

- **Symptomatic** PHPT: renal stones, abdominal groans, psychic moans, painful bones
- Asymptomatic PHPT (CASR):
  - Adjusted **Ca ≥ 2.8**
  - Young Age < 50 (longer exposure to PTH → _osteoporosis_)
  - Skeletal (DEXA T score < -2.5 / vertebral fracture on imaging)
  - Renal (CrCl < 60 / 24h urine Ca > 10mmol/L / nephrolithiasis on imaging)

Options

- Focused parathyroidectomy
  - Indication: **adenoma identified** on pre-op localization studies
  - Based on the premise that 80% are due to single adenoma
  - Approach: open with <3cm incision (fig.), video-assisted, imaging-guided
  - Intra-op PTH measurement to confirm removal of hyperfunctioning gland
    - Miami criteria: PTH drop to normal range + <50% of max value at 10min post-resection
    - If -ve: multigland disease possible → convert to BCE
  - Benefits: ↓ post-op hypoCa

[A photograph shows a person's neck and upper chest area. The person has fair skin. A thin white bandage covers a small incision in the lower neck, slightly to the right of the midline. The skin around the bandage is slightly red. A blue surgical drape is visible below the neck. To the right of the neck, the skin appears somewhat mottled and discolored with yellowish tint.]

- Bilateral neck exploration (BCE)
  - Indications: conversion from focused parathyroidectomy, MEN1/2A, uncertain imaging (e.g. USG not consistent with MIBI findings)
  - Approach: Kocher's incision (transverse collar scar)
  - Subtotal parathyroidectomy: "3.5 resection"
    - 3 glands resected
    - Fourth gland: 1/2 gland taken out for **frozen section**(to confirm presence of parathyroid tissue), remaining 1/2 gland left in situ, marked with non-absorbable sutures to aid identification in case of recurrent disease
  - Total parathyroidectomy with autotransplantation (rare)

- ± Cervical thymectomy: indicated if MEN1 to resect supernumerary glands in thymus

Specific complications

- RLN injury
- Reactionary haemorrhage (refer to [Thyroidectomy])
- Hypocalcemia: routinely check Ca level on post-op Day 1
  - Hungry bone syndrome: rapid, profound hypocalcaemia due to sudden drop in PTH, causing a rapid deposition of Ca into demineralised bone; Mx Ca + vit D
  - After focused parathyroidectomy: **transient** suppression of normal glands by adenoma
  - **Permanent hypoparathyroidism**: requiring Ca / vit D supplement **1 year** post-op
- Hyperparathyroidism:
  - Persistent (<6 mo post-op): due to missed pathology → Mx BCE
  - Recurrent (>6 mo post-op): due to missed pathology, parathyromatosis (disseminated parathyroid tissue within the soft tissue of neck and mediastinum due to rupture of parathyroid gland during operation) → Mx MIBI scan, BCE

Medical management

- Indications: surgically unfit
- Options: bisphosphonates, calcimimetics (e.g. cinacalcet), SERM

Tertiary hyperparathyroidism
Definition: persistent autonomous hypercalcaemic hyperparathyroidism after renal replacement therapy
Indications: persistent severe hypercalcaemia, impaired graft
function, progressive symptoms (e.g. osteoporotic fracture)
Procedures

- Total parathyroidectomy: only considered when renal
  transplant is highly unlikely
- Total parathyroidectomy with autotransplantation at
  forearm (brachioradialis) or neck (SCM)
- Subtotal parathyroidectomy (three-and-a-half resection):

[An illustration shows the superficial veins of the left elbow and forearm. The basilic vein runs up the inner arm, the cephalic vein runs up the outer arm, and the median cubital vein connects them in the elbow area. Labels point to each vein. Adjacent to this image is another illustration. It depicts a cross-sectional view of skin. A needle is inserted into the epidermis, past the sebaceous gland, into the subcutaneous fat and deep venous plexus. Labels point to the sweat gland, surface vascular plexus, sebaceous gland, subcutaneous fat, deep venous plexus, and parathyroid graft.]

9.3 Adrenals
Anatomy

[Diagram of the kidneys and adrenal glands. The right and left adrenal glands are located above the right and left kidneys, respectively. Blood vessels surround the kidneys and adrenal glands, including the inferior phrenic artery, the superior suprarenal arteries, the left suprarenal gland, the middle suprarenal artery, the left suprarenal vein, the inferior suprarenal artery, the left kidney, the right suprarenal gland, the right suprarenal vein, the right kidney, the inferior vena cava, and the abdominal aorta.]

- Retroperitoneal organ, situated within Gerota's capsule
- Right adrenal gland
  - Pyramid shaped
  - Relations: diaphragm (posterior), **right lobe of liver** (anterior), IVC (anteromedial)
- Left adrenal gland
  - Crescent shaped
  - Relations: pancreatic tail, spleen, stomach (anterior), diaphragm (posterior)
- Arterial supply
  - Superior suprarenal arteries (6-8) from inferior phrenic a.
  - Middle suprarenal arteries (≥1) from abdominal aorta
  - Inferior suprarenal arteries (≥1) from renal artery
- Venous supply
  - Right adrenal vein → IVC
  - Left adrenal vein → left renal vein
- Physiology
  - Adrenal cortex: zona glomerulosa (aldosterone), fasciculata (cortisol), reticularis (androgen)
  - Adrenal medulla: epinephrine (80%), norepinephrine (20%)
    - **Urine metanephrines:** breakdown product of dopamine metabolism

[Diagram illustrating the pathway of dopamine synthesis and the production of normetanephrine and metanephrine in the adrenal medulla. The pathway starts with L-Tyrosine, which is converted to DOPA by Tyrosine hydroxylase. DOPA is then converted to Dopamine by DOPA decarboxylase. Dopamine is converted to Norepinephrine by Dopamine hydroxylase and then to Epinephrine by PNMT. Norepinephrine is converted to Normetanephrine and Epinephrine is converted to Metanephrine by COMT. A small graphic of the adrenal gland is shown next to "Adrenal Medulla"]

[Diagram of a hexagon with a lightening bolt in the middle of it. It says A cortisol-induced enzyme underneath the hexagon.]

202

Adrenal incidentaloma
Definition

- Adrenal mass > **1cm** in diameter _incidentally found_ in radiological investigation
- Incidence: 0.5-4.5%
- Most important to know: **Functional? Malignant potential?**

Aetiology

- Benign:
  - Non-functional 90%, e.g. **adenoma** (MC), cyst, haemangioma, myelolipoma
  - Functional: subclinical Cushing's syndrome (6%), phaeochromocytoma, Conn's syndrome
- Malignant:
  - Primary: malignant phaeochromocytoma, adrenocortical carcinoma
  - Secondary (more common)

History taking

- History of hypertension (all functional tumors), diabetes (Cushing's)
- S/S of Cushing syndrome: weight gain, striae
- Triad of pheochromocytoma: episodic headache, sweating, palpitations
- FHx / Hx of endocrine tumors (MEN)

Physical examination

- BP, H'stix
- Cushingoid features: moon face, buffalo hump, proximal muscle wasting, central obesity, striae, hirsutism, easy bruising
- Abdominal mass
- Thyroid mass

Investigations

- Screening tests for functional tumors: **ONDST + spot ARR + 24h urine metanephrines**

|                    | Screening                      | Confirmation               |
| :----------------- | :----------------------------- | :------------------------- |
| Cushing's syndrome | 1mg ONDST > 50 nmol/L          | Low dose DST               |
|                    | 24h urine free cortisol        |                            |
|                    | Midnight salivary cortisol     |                            |
| Conn's syndrome    | Aldosterone: renin ratio (ARR) | Salt loading test          |
|                    | RFT for hypoK                  | Saline suppression test    |
| Pheochromocytoma   | 24h urine metanephrines        | Clonidine suppression test |

- CT abdomen (preferably **contrast CT with adrenal protocol**) to evaluate malignant potential
  - Size **>4cm** (25% risk of malignancy)
  - Growing **>0.5cm over 6 months**
  - Morphology: irregular shape, heterogenous, ill-defined border, hypervascularity, central necrosis
  - Hounsfield unit: >10HU (c.f. 70% adenoma has high lipid content -> hypo-attenuated)
  - Contrast wash-out (compare non-enhanced PV phase vs 15-minute delayed phase): **<40% relative washout or <60% absolute washout** (c.f. adenoma usually has more washout)
  - Local invasion
  - Para-aortic lesions
  - Contralateral side involvement
- ± Other investigations
  - MRI adrenal: compare signal intensity with spleen
  - PET-CT: ↑Sn & ↑Sp to differentiate benign vs malignant lesion; compare SUV with liver
  - Fine needle aspiration: only useful in **ruling out metastasis**; must **exclude pheochromocytoma before biopsy** (risk of hemodynamic instability)

Management

- Conservative:
  - Imaging: CT abdomen Q6m for 4 years
  - Biochemical: Q1y for 4 years
- Surgical: if
  - Functional
  - Suspected malignancy (refer above): e.g. >4cm, growing >0.5cm in 6 months

Adrenalectomy
Indications

- Adrenal incidentaloma that meets the resection criteria (see above)
- Adrenal malignancy
- Functional adenoma (phaeochromocytoma, Conn's syndrome, adrenal Cushing's syndrome)
- Cushing disease that is persistent after transsphenoidal resection
  Approach
- Laparoscopic trans-peritoneal approach (lateral decubitus, ipsilateral side up): for mass < 6cm
- Open: preferred if mass > 6cm or malignant
  Pre-op preparation
- Primary aldosteronism: correct electrolyte imbalance, e.g. K
- Cushing's syndrome: peri-op steroid cover, antibiotic prophylaxis (chronic suppressed cortisol)
- Phaeochromocytoma: alpha blockade → beta blockade, fluid replacement
  Complications
- Intra-op:
  - Haemodynamic instability (phaeochromocytoma)
  - Adrenal insufficiency (Conn's, Cushing's): IV hydrocortisone upon removal of adrenal gland
  - Injury to surroundings:
    - Right adrenalectomy: IVC, right lobe of liver
    - Left adrenalectomy: pancreatic tail, spleen
- Early: adrenal insufficiency (PO hydrocortisone post-op)
- Late: hypertension (renal artery injury)

Cushing syndrome
Refer to [MED] for details
Diagnosis
2 out of 3 screening tests ± high pre-test probability by clinical presentation

- 1mg ONDST > 50 nmol/L
- 24h UFC x 3
- LDDST / Late night salivary cortisol x2 / Late night plasma cortisol
- OR: 24h UFC > 3-4x ULN

Management
Definitive treatment depends on underlying cause

- Pituitary: trans-sphenoidal surgery ± pituitary radiotherapy / radiosurgery
- Adrenal: adrenalectomy ± chemotherapy (if CA)
- Ectopic: treat underlying malignancy

Peri-operative cautions:

- Steroid cover: normal HPA axis usually suppressed
- Prophylactic antibiotics ± anticoagulation: high risk of infections / VTE
- Post-op glucocorticoid ± mineralocorticoid supplement until HPA axis recovers ~1y later
- Risk of Nelson's syndrome if bilateral adrenalectomy

204
Conn's syndrome
Refer to [MED] for details
Differential diagnosis
Differentiated by salt-loaded balance study (9am supine + 1pm erect)

- Aldosterone-producing adenoma: paradoxical aldosterone (ACTH-dependent production)
- Bilateral idiopathic adrenal hyperplasia (BIAH): Taldosterone (sensitive to postural change)
  Management
- Adenoma: laparoscopic adrenalectomy (4 week pre-op spironolactone to correct hypoK)
- BIAH: medical treatment e.g. MRA, amiloride (bilateral adrenalectomy would lead to adrenal crisis)
  Phaeochromocytoma
  Definitions
  Pheochromocytoma: catecholamine-secreting tumour derived from chromaffin cells of adrenal medulla
  Paraganglioma: tumour arising from chromaffin cells of sympathetic / parasympathetic nervous system
- Sympathetic paraganglioma: usually catecholamine-secreting (i.e. "extra-adrenal pheochromocytoma"), located
  along sympathetic chain
- Parasympathetic paraganglioma: usually non-functional, located in neck / skull base
  Aetiology
- Sporadic (MC)
- Familial (AD inheritance) - NF1 - MEN2 (RET oncogene) - Von Hippel-Lindau disease - Carney triad (GIST + pulmonary chondroma + paragangliomas): succinate dehydrogenase gene mutation
  Clinical features
- 60% incidentally discovered
- Classic triad: paroxysmal headache, sweating, palpitations
- Other S/S: young-onset paroxysmal HT + postural hypotension (due to
  adrenaline action), anxiety, pallor
- Pressor response during procedures or with certain drugs (e.g. TCA, IV
  contrast) or food (cheese)
- 10% rule: 10% familial, 10% bilateral, 10% extra-adrenal, 10% malignant,
  10% secrete adrenaline/ dopamine (c.f. 90% NA), 10% children, 10% not
  associated with HT, 10% recurrence - Extra-adrenal: para-aortic (75%), urinary bladder (10%), thorax
  (10%), skull base / neck / pelvis (5%), others\*
- Pheochromocytoma crisis: APO, ICH
  [Image of a box containing five P's of Pheochromocytoma. Each P is on a separate line. The P's are: Pressure (HT), Pain (headache, chest pain), Palpitation, Perspiration, Pallor (vasoconstriction)]

\*Organ of Zuckerkandl

- Location: origin of IMA / around aortic bifurcation
- Function: secrete catecholamines during early gestational period
  to regulate BP → regress in late 3rd trimester
  Investigations
  Biopsy is NOT required: high risk of hypertensive crisis and hematoma
- Biochemical:
  screening
- 24h urine catecholamines + fractionated metanephrines (more sensitive: continuous release)
  - Abnormal if >2x elevation
  - False positive: stress, OSA, drugs (e.g. TCA, a agonist, levodopa → stop 1 week)
- Plasma catecholamine / metanephrine (most specific, but need indwelling catheter >30min)
  - Preferred in chronic renal failure because 24h urine sample is difficult to interpret
- Imaging:
  localize tumour
- Anatomical scan: CT with low-osmolar contrast / T2-MRI with gadolinium contrast
  - CT: alpha blockade prior to administration of IV contrast ('.'risk of HT crisis)
  - Low-osmolar contrast: safe even without alpha/beta blockade
- Functional scan: I-123 MIBG scan
  - MIBG (metaiodobenzylguanidine): NE analog, taken up by pheochromocytoma
- PET-CT: 68Gallium-DOTATATE - to detect metastatic disease

205
Dynamic test

- Clonidine suppression test: only if strong clinical suspicion but above tests inconclusive - C/I in pregnancy - Procedure: - Fast overnight → Insert cannula 30 minutes before test → Take bloods for Epi & NE x2 (5 mins apart) - Give PO clonidine 0.3mg with 250mL water - Closely monitor BP/P Q30min for postural hypotension and bradycardia - Take bloods for Epi & NE at 2h and 3h after clonidine
  Management
- Laparoscopic resection (1\* line) - consider open if large tumor / suspected malignancy
- Adequate pre-op preparation: aim to prevent intra-op pheochromocytoma crisis
  - BP and HR control: target BP 130/80 HR 70 (seated)
    - **Alpha blocker** (BP): phenoxybenzamine x 4 weeks (S/E: stuffy nose)
    - **THEN Beta blocker** (HR): propranolol x 2-3 days preoperatively
    - Rationale: ẞ-blocker alone can cause unopposed a-mediated vasoconstriction → HT crisis
    - Postural hypotension indicates adequate alpha blockade
  - Volume expansion: high Na diet on 2nd/3rd day of alpha blockade to reverse catecholamine-induced volume contraction
- Intra-op
  - Meticulous monitoring: risk of unstable haemodynamics → ensure A-line, CVP, Foley
  - Communicate with experienced anesthesist: e.g. possible HT crisis during intubation, inform anesthetist before mobilization / ligation of tumor, medications stand-by (e.g. nitroprusside, adrenaline/NA)
  - Gentle manipulation of lesion
  - Dissect and control adrenal vein first
- Post-operative ICU monitoring for specific complications
  - Cardiac arrhythmia
  - Hypotension: drug effect
  - Hypoglycemia: rebound hyperinsulinemia
- Genetic testing & counselling
- Disease monitoring: lifelong yearly screening for recurrent / metastatic / metachronous tumor - Urine catecholamines, chromogranin A (not useful for diagnosis), imaging
  Malignant pheochromocytoma
- Histologically and biochemically indistinguishable from benign disease, defined by metastasis
- Management: - Surgical excision (tumor debulking) to control catecholamine excess - Symptomatic relief: alpha blockers - Mitotane: adjuvant / palliative treatment
  Adrenocortical carcinoma
- Rare malignancy, highly malignant
- May show biochemical evidence of steroid overproduction
  Investigations
- Contrast CT/MRI: look for vascular and adjacent organ invasion
- FNA biopsy is NOT indicated: cannot differentiate between benign and malignant mass, risk of tumor seeding
  Treatment
- Surgery: open adrenalectomy ± en-bloc resection of kidney / spleen (if invaded)
- Adjuvant mitotane for at least 2 years (disrupt cortisol synthesis)
  - High-dose glucocorticoid replacement: mitotane induces CYP3A4 → rapid activation of glucocorticoids
- Chemotherapy for refractory disease

  9.4 Pancreatic neuroendocrine tumours (pNET)
  Insulinoma
  Clinical features

- Most common pancreatic NET
- Arise from beta-cells of pancreas
- 90% benign, usually solitary (if multiple: consider MEN1 syndrome)
- Whipple's triad: hypoglycemic symptoms + low BG during symptomatic episodes + relief after glucose intake
  Investigations
- Biochemical tests: glucose, insulin, C-peptide, chromogranin A
  - Exclude MEN1: CaPO4, PTH, prolactin, gastrin
- Confirmatory test: prolonged fasting test [MED]
  - Fast for max 72h (± vigorous exercise 20mins if still no hypoglycemia)
  - H'stix Q4h / when symptomatic → Terminate test if BG < 3.0 (Ensure IV D50 40ml & glucagon stand-by)
  - Check BG, insulin & C-peptide Q24h / when symptomatic / H'stix <3.0
  - Results: ↑insulin, ↑C-peptide = insulinoma
- Localization studies: gold standard is intra-operative localization - CT/MRI scan with contrast: 60-70% sensitivity - EUS with biopsy - PET-CT scan with 68Gallium-DOTATATE - Arterial stimulation with hepatic venous sampling: inject 10% Ca gluconate at 4 different arteries (GDA, SMA, splenic a., hepatic a.), and sample R hepatic vein for 30s & 60s insulin for 2-fold increase
  Treatment
- Medical treatment: buy time for surgery / unfit for surgery / metastatic disease
- Diazoxide: ↓insulin release (S/E: edema, hirsutism)
- Octreotide (2nd line)
- Chemotherapy if inoperable: e.g. doxorubicin, everolimus
  Surgical treatment: advised for ALL patients
  Open surgery with extended Kocher maneuver and mobilization of entire pancreas
- → Intraoperative exploration / ultrasound (IOUS) to locate tumour and identify relation to duct
- → Determine surgical extent
- Surgical enucleation for superficial tumours
- Distal pancreatectomy for tumours deep in body/tail of pancreas or ductal involvement
- Whipple's operation for tumours deep in head/neck of pancreas
  Alternative: EUS-guided alcohol ablation

Gastrinoma / Zollinger-Ellison syndrome
Clinical features

- Arise from G cells: gastrin stimulate parietal cells to ↑acid production & ↑parietal cell mass (synergistic effect)
- 60-80% risk of malignancy
- Commonly arise in "gastrinoma triangle" / Passaro's triangle (fig.)
- Classical triad of
  - Multiple PUD in unusual locations e.g. post-D1 duodenum, jejunum, esophagus
  - Gastric acid hypersecretion
  - Gastrinoma: in pancreas (MC), proximal duodenum, etc.
- Other features: chronic diarrhoea, MEN1 (pituitary adenoma, parathyroid hyperplasia)

Investigations

- Fasting serum gastrin >1000 pg/mL (10x ULN)
- Secretin test: distinguish G cell hyperplasia vs gastrinoma
  - G cell hyperplasia: no change in gastrin level (secretin normally inhibits gastrin)
  - Gastrinoma: ↑serum gastrin > 200 pg/mL (aberrant secretin receptor on gastrinoma cells)
- Pre-op localization: OGD with EUS, contrast CT/MRI, 68Gallium-DOTATATE PET-CT, somatostatin receptor scintigraphy (SRS) scan (i.e. octreotide scan)

Management
Medical management

- High-dose PPI
- Octreotide
- Systemic chemotherapy if metastatic

Surgical management: indicated if non-metastatic

- Pancreatic gastrinomas (worse prognosis): enucleation + peripancreatic LN dissection
- Duodenal gastrinomas: enucleation (if small), full-thickness excision (if large)

Non-functioning pNET

- Worse prognosis than functioning pNET
- Most commonly metastasize to liver
- Differentiated from pancreatic adenocarcinoma

|                                          | CA pancreas                    | Non-functioning PET           |
| ---------------------------------------- | ------------------------------ | ----------------------------- |
| Tumour size                              | <5cm                           | ≥5cm                          |
| CT scan                                  | Hypodensity, no calcifications | Hyperdensity ± calcifications |
| Chromogranin A                           | -                              | +                             |
| Somatostatin receptor scintigraphy (SRS) | -                              | +                             |

- Mainstay of treatment: surgery

[Diagram of Passaro's Triangle. A roughly triangular shape is formed by the cystic duct, the neck and body of the pancreas, and the second and third portions of the duodenum. The duodenum is a tan color. The triangle is labeled "Passaro's Triangle".]

# ORTHOPAEDICS & TRAUMATOLOGY (ORT)

## 1.1 Anatomy of bones & joints

### Structure of bone

[Diagram of a growing long bone and a mature long bone with labels. The growing long bone on the left has labels pointing to: Epiphyseal plate (growth plate), Epiphysis, Metaphysis, and Diaphysis. The mature long bone on the right has labels pointing to: Epiphyseal line, Metaphysis, and Epiphysis. Below these two bone diagrams is text: (a) Growing long bone, Femur (thighbone), (b) Mature long bone.]
[Diagram of the Metaphysis, Epiphysis, Physis and Diaphysis of a bone. The Metaphysis (Transitional zone where epiphysis and diaphysis meet) is a region where the epiphysis and diaphysis come together. (Meta- = after, beyond, or transformation of). The diagram also contains the labels: EPIPHYSIS (Epi- = means upon or over), PHYSIS (Growth Plate), and DIAPHYSIS (Shaft or long bone).]

### Classification of joints

|               | Definition                                                 | Examples                                                                                                     |
| :------------ | :--------------------------------------------------------- | :----------------------------------------------------------------------------------------------------------- |
| Fibrous       | Bones connected by fibrous tissue                          | Sutures Syndesmosis (held by intraosseous membrane), e.g. middle radioulnar joint, distal tibiofibular joint |
| Cartilaginous | Bones connected by cartilage                               | Pubic symphysis Joint between vertebral bodies                                                               |
| Synovial      | Articular surface enclosed with fluid-filled joint capsule |                                                                                                              |

### Structure of a synovial joint

[Diagram of a synovial joint. Labels point to: Articular cartilage, Synovial layer (of joint capsule), Fibrous layer (of joint capsule), Joint cavity (with synovial fluid)]

1 Basic principles
208

# 1.2 History taking

Differential diagnosis - tiers

- TIN: trauma, infection, neoplasm
- Inflammatory, metabolic
- Degenerative, vascular, congenital
  Highlights in history taking
- Pain: SOCRATES
- Previous treatment and response
- Complications
  - Physical: sensory, motor, autonomic
  - Psychological
  - Social: occupational, financial, familial
  - Functional: ADL
    - UL: buttoning, combing, chopstick
    - LL: walk flat, upstairs, downstairs
- Background for comparison
  - Physical (pre-morbid functional status)
    - **Hand dominance**
    - Pre-morbid ambulatory status
    - Daily activities requirement
  - Psychosocial: occupation, hobbies
- Expectations

# 1.3 Management overview

Non-trauma management
Non-operative

- Health advice: reassurance, change of daily activities, diet, posture, weight reduction, avoid pain-provoking
- Physiotherapy (early mobilisation): RICE, passive stretching, active muscle strengthening, instrumental (TENS), walking exercises
  - Walking aids: stick → tripod/ quadripod → crutches → walking frame → rollator → wheelchair
- Occupational therapy: UL training, ADL training, vocational training, home visits
- Prosthetics & orthotics: splint, brace, corset, prosthesis
  - Orthosis: to support function
  - Prothesis: to replace function
- Pharmacotherapy: analgesics, steroids, drugs for osteoporosis
- Non-operative intervention: closed reduction, manipulation, etc
  Operative
- Treat underlying cause
- Compression (nerve): decompression, removal
- Deformity: correct and reconstruct
- Joint instability: joint re-alignment, joint replacement, joint fusion

[Image Description: The image shows an illustration of different types of mobility aids for individuals with walking difficulties. From left to right are forearm crutches, a pair of armpit crutches, a walking frame, and a cane.]

Enhanced recovery after surgery (ERAS)

- MSSA screening: de-colonization x 1 week
- Pre-op analgesics
- Dexamethasone on call to OT (16mg IV stat)
- HbA1c control: <8
- Confirm definite discharge plan: 1 month full-time carer after TKA

  1.4 Trauma
  Mechanism of injury

| Mechanism of injury           | Special considerations                                                                                                                          |
| ----------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------- |
| Motor vehicle collision (MVC) | Vehicles: weight, size, speed Location of patient in vehicle Seatbelt use Entrapment Airbag deployment Helmet use (motorcycle)                  |
| Pedestrian-automobile impact  | Vehicle speed Site of impact on car                                                                                                             |
| Falls                         | 1 storey = 3.6m Mortality: 50% at 4 storeys, ~100% at 6 storeys Landing position: vertical (# LL, pelvis, spine) vs horizontal (# UL, ribs, HI) |

210

Fracture healing
Types of healing

- Primary (contact) healing
  - Fragments directly apposed with <0.1mm distance
  - Require anatomical reduction and rigid internal fixation
- Secondary (spontaneous) healing
  - Fracture ends are brought close to each other (instead of "apposed")
  - Stages:
    - Haematoma formation (immediate)
    - Soft callus formation (< 2 weeks): inflammatory cells recruited to haematoma; non-weight bearing
    - Bony callus formation (> 2 weeks): allow controlled weight-bearing
    - Remodelling: formation of lamellar bone
- Favourable factors for remodeling
  - Younger age (periosteum thicker)
  - Fracture in metaphysis (close to growth plate)
  - Minimal angulation/ angulation in the plane of joint movement
- Evaluation of bone healing
  - Clinical
  - XR: visible callus, trabeculae across fracture site
- Disturbed fracture healing
  - Risk factors: - Disease factor: blood supply, severe soft tissue damage, etc - Patient factor: smoking, DM, diet - Treatment factor: previous radiation
    [A table with light green header cells and white content cells. The table displays information about bone healing times in the upper and lower limbs. The columns are "Callus visible", "Union" and "Consolidation", and the rows are "Upper Limb" and "Lower Limb" . Callus Visible Upper Limb values is 2-3 wks. Callus Visible Lower Limb value is 2-3 wks. Union Upper Limb value is 4-6 wks. Union Lower Limb value is 8-12 wks. Consolidation Upper Limb value is 6-8 wks. Consolidation Lower Limb value is 12-16 wks.]
- Delayed union: fracture healing 2x normal time (c.f. Perkin's time frame for
- Non-union: fracture healing does not occur after 6 months
  - Sites: scaphoid, NOF
  - Types: atrophic (no callus: failure of biology), hypertrophic (callus +++: failure of stability)
- Malunion: healing in the wrong position
- Refracturing: cortical atrophy due to prolonged fixation material in situ → removed within 18m after remodelling

Fracture XR
XR interpretation
| Site | Name of injured bone |
| -------------------- | ------------------------------------------------------------------------------------ |
| | **Intra-articular vs extra-articular** (epiphyseal, metaphyseal, diaphyseal) |
| Integrity of skin | **Closed fracture:** fracture with intact overlying skin |
| | **Open fracture:** fracture with direct communication to external environment |
| | - Degree of contamination, extent of soft tissue injury (muscle, vessel) |
| Morphology | Transverse: fracture line perpendicular (<30°) to long axis of bone |
| | Oblique: angular fracture line (30-60°) |
| | Spiral: multi-planar fracture lines as a result of rotational force |
| | Butterfly: triangular fracture fragment (c.f. comminuted) |
| | Comminuted: > 2 fracture fragments |
| | Avulsion: bone fragment pulled off by tendon or ligament |
| | Impacted/ compression: shortened bone, e.g. vertebra |
| Alignment | **Displacement:** non-displaced, displaced, translated (loss of contact) |
| | **Angulation:** varus, valgus |
| | Length: impacted, distracted |
Associated fracture-dislocation (e.g. Monteggia)

[Image of various types of bone fractures. The first row depicts fractures labeled from A to H: A. Transverse fracture, B. Oblique fracture, C. Butterfly fracture, D. Segmental fracture, E. Spiral fracture, F. Comminuted fracture, G. Shifted fracture, H. Angulated fracture. The second row features fractures labeled I to K: I. Rotated fracture, J. Avulsion fracture, K. Impacted fracture. To the right, there are illustrations of a Greenstick Fracture and a Torus Fracture.]

XR interpretation in paediatrics

- Specific morphology: due to more active periosteum
  - Bowing (plastic: due to elasticity)
  - Greenstick: incomplete fracture of one cortex
  - Buckled (impacted cortex)
- Epiphyseal injury: weaker part of bone - susceptible to fracture
  - Salter-Harris classification of epiphyseal injury

| Type                     | Stability | Management                        | Remarks                           |
| ------------------------ | --------- | --------------------------------- | --------------------------------- |
| I (Straight through)     | Stable    | Closed reduction + castSCFE: ORIF |                                   |
| II (Above)               | Stable    | Closed reduction + cast           | **Most common**                   |
| III (Low)                | Unstable  | ORIF                              |                                   |
| IV (Through and through) | Unstable  | ORIF                              |                                   |
| V (Ram)                  | Unstable  | No specific treatment             | **Highest risk of growth arrest** |

[Image of Salter-Harris classification of epiphyseal injuries. The image shows five types of fractures: Type I, Type II, Type III, Type IV, and Type V. Each fracture type is depicted by a diagram illustrating the location and nature of the break in relation to the growth plate.]

Principles of trauma management

Overview (6A)

- ABC (resuscitation)
- Anti-swelling (RICE)
- Analgesics: immobilisation as the best analgesic
- Anaesthesia: prepare for OT
- Anchorage (temporary splint, slab, neck collar, Thomas splint, etc.)
- Anti-sepsis (wound cleansing & dressing, antibiotics in open fracture, tetanus prophylaxis)

Immediate management (SAQ)

- Resuscitation if necessary
- Analgesics
- Trauma series: C-spine (#→ neck collar), CXR (pneumothorax → chest drain), pelvic X-ray (external fixator,
  pelvic binder)
- Extremities stabilisation: splint fracture
- Wound dressing: remove gross debris but not bone fragments; cover wound with sterile dressing
- Anti-sepsis: urgent IV antibiotics (cefuroxime + metronidazole), tetanus prophylaxis
- Urgent consult anaesthesia & O&T
- Prepare for OT: NPO, T&S, consent, ECG, CXR

Management of closed fractures (3R)

- Reduction:
  - Aim: tamponade of bleeding, restore blood supply, reduce traction on traversing nerves (neuropraxia),
    reduce traction on surrounding soft tissue (compartment syndrome)
  - Not indicated if:
    - No/ little displacement
    - Reduction unlikely to succeed, e.g. compression fracture of vertebrae
  - Methods:
    - Closed reduction: apply traction in the long axis of limb (Laplace law) + repositioning of fragments
      by reversing the original direction of trauma
    - Open reduction: indicated in (NO CAST)
      - Failed closed reduction
      - Non-union
      - Open fracture
      - Neurovascular Compromise
      - Intra-Articular fracture (2° OA, misalignment)
      - Salter-Harris 3-5
      - PolyTrauma
  - Post-reduction: check neurovascular supply + XR
- Restraint (immobilization)
  - Cast & splints:
    - Splint: elastic, non-circumferential, used in pre-hospital setting, but ↑ROM at injury site
    - Brace: elastic, circumferential
    - Slab: rigid, non-circumferential, used if significant soft tissue swelling
    - Cast (plaster or fibreglass): rigid, circumferential, higher risk of Cx (e.g. pressure sore)
    - Spica: immobilise limb with trunk, e.g. hip spica
  - External fixation: Bone & soft tissues stabilised at a distance from site of injury with external frame
    - Indications: significant soft tissue injury
    - Risk of infection over site of application
  - Internal fixation
    - Indications: unstable fracture, multiple fractures
    - Ensure anatomical reduction (to avoid early degenerative changes)
    - Affect healing (periosteum stripped)
    - Types: extramedullary (screws, plates, wires), intramedullary (nails)
      - Extramedullary: very stable reconstruction
      - Intramedullary: semi-closed procedure, shorter OT time, direct full weight bearing
        afterwards

Multiple system injuries

1. Unstable pelvic #
2. Long bone #
3. Spine injury

Limb-threatening Cx:

1. Open #
2. Neurovascular
   injury
3. Compartment
   syndrome
   [Image of a vertical line separating the limb-threatening complications and the multiple system injuries from the main text]
   12

Treatment choice based on stability of fracture
| | Stable | Unstable |
|---|---|---|
| Energy of trauma | Low | High |
| Displacement/angulation | Minimal | Yes |
| Fragments | 2 | >2 (comminuted) |
| Risk of displacement upon weight-bearing or normal physical activity | Tend not to displace | Tend to displace |
| Management | Reduction **not required/ closed** Repair: **cast** (slab if significant soft tissue swelling) | Reduction: closed/ **open** Repair: **internal fixation** (external fixation if significant soft tissue injury) |

- **Rehabilitation**: as in non-trauma management (PT, OT, etc)

Management of open fracture

- **Gustilo-Anderson classification**: fracture pattern, degree of contamination, soft tissue injury
  | Grade | Wound length | Description | Antibiotics |
  |---|---|---|---|
  | I | < 1cm | Low energy, minimal contamination & soft tissue injury | 1st generation cephalosporin |
  | II | 1-10cm | Moderate energy, moderate contamination & soft tissue injury | 1st generation cephalosporin + aminoglycoside |
  | III | Usually >10cm | High energy, extensive contamination & soft tissue injury IIIA: adequate soft tissue covers wound IIIB: extensive periosteal stripping requiring soft tissue transfer IIIC: vascular injury requiring vascular repair |

- Urgent wound debridement and lavage
  - To reduce risk of infection if done within 6-8h
  - Wound left open for re-examination in 48h
- **Reduction and external fixation**: primary aim is to facilitate soft tissue healing for wound coverage

Complications of trauma
Classification

- General vs specific
- Early vs late
- Anatomical

Early complications

- Local: **neuro-vascular injury** (be specific!), **compartment syndrome**, wound infection (osteomyelitis)
- Systemic: shock, sepsis, DVT, PE, ARDS (due to fat embolism)

Late complications

- Local: skin (bed sores), muscle (atrophy), tendon/ ligaments (adhesions, joint instability), nerve (paralysis), bone (delayed/mal/non-union, **heterotopic ossification**, AVN, chronic osteomyelitis), CRPS type I (complex regional pain syndrome), Volkmann's contracture
- Systemic: crush syndrome

214
Note on complications
| | |
| :-------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Fracture blisters | Formed by elevation of epidermal layer from dermis - indicate severe soft tissue injury |
| | Puncture not required: may even lead to local infection |
| Heterotopic ossification | Formation of bone in abnormal locations, e.g. muscle (myositis ossifican) |
| Compartment syndrome | Patho: fintra-compartmental pressure due to bleeding, oedema, inflammation → ↓capillary flow → muscle ischaemia More common in legs (4 compartments) than thigh (3 compartments) Diagnosis: Clinical: 6P of ischaemia (paralysis and pulseless late); most sensitive sign = **excessive pain on passive stretching** Intra-compartmental pressure > 30 mmHg (if P/E unreliable) Management: Remove constrictive dressings (e.g. cast), limb elevation at the level of heart Analgesia, O2, IV fluid **Emergency fasciotomy of all compartments** Leave skin incisions open for re-inspection after 48h +/- remove necrotic tissues Post-op: RFT, CK (rhabdomyolysis) |
| [Image of a Stryker compartment pressure monitor held by a hand, with a digital display showing pressure readings] | |
| (Stryker compartment | |
| pressure monitor) | |
| Volkmann's contracture | Commonly found in **supracondylar fracture** in children Vascular compromise with subsequent necrosis of forearm flexors, causing claw-like deformity |
| [Image of a hand showing severe deformity, with the fingers clawed inward, consistent with Volkmann's contracture.] | |
| Crush syndrome | Limb compressed for extended periods → **reperfusion injury** (myonecrosis releases toxic metabolites upon limb is freed) |
| Non-traumatic fracture | |
| Stress fracture | Fracture that occurs in the normal bone, due to **small repetitive stress**: Bending stress: strong & repetitive stress on bone beyond its ability to tolerate, e.g. heavily trained athletes Compression stress: impacted fracture of soft cancellous bone due to frequent repetition Common sites: tibia, fibula, metatarsal |
| Pathological fracture | Fracture that occurs in **diseased bone**, due to **malignant or non-malignant conditions** (e.g. osteoporosis) **Fragility fracture**: a subtype of pathological fracture Fracture resulting from low energy trauma that would not ordinarily result in fracture (defined as forces equivalent to a fall from a standing height or less) Common sites: **hip, distal radius (Colles'), lumbosacral spine** Risk factors: reduced bone density, Hx fragility fracture XR features (osteoporosis): decreased bone density, cortical thinning, loss of trabeculae DDx: bone metastasis (suspect if fracture above T5, constitutional symptoms) |
| | |
| | [Image of a lateral X-ray of the lumbar spine showing vertebral compression fractures and endplate sclerosis] |
| | Lumbar kyphosis, cortical thinning ("picture-framing" appearance), wedge compression of T12, retropulsion of L1 body (arrow) |
| | T11 |

Bisphosphonates for osteoporosis: S/E – GI upset (MC), jaw osteonecrosis, atypical femoral fractures

# 1.5 Orthopaedic appliances

**Casts & splint**
**Casts**
Types

- Cast: complete enclosure
- Slab: incomplete enclosure
  Cast material
- **Plaster of Paris (CaSO4)**: easier to mould, cheaper
- Synthetic resin (e.g. fibreglass - Dynacast): stronger, shorter drying time, different colours available
- Air cast (fig.): easily removable, for milder fracture
  Complications
- Tightness of casts:
  - Too tight: compartment syndrome
    - Also due to insufficient padding & excessive swelling
    - Management: elevation, encourage ROM, use bivalved cast (for frequent inspection)
  - Too loose: failure of fixation
- Skin complications
  - Pressure sores: cast window
  - Abrasions & laceration (esp. when electric saw is used)
  - Foreign body
  - Allergic reaction
- MSK complications: muscle wasting, joint stiffness - Muscle strengthening exercise
  **Splints**
- Devices that immobilise and protect an injured limb/ spine

[Image of a gray orthopedic boot with black straps, leaning against a beige wall and floor. The boot has a rounded toe and a wide opening at the top.]

Cervical braces

[Image of a woman wearing a Philadelphia collar. The collar is beige and has a hole in the front. The woman is wearing a black shirt.]
Philadelphia collar (two-piece)
Neck collar, e.g. Philadelphia collar

[Image of a person wearing a SOMI brace. The brace is white and has a hole in the chest area. The person is standing in a room.]
SOMI brace (sternal-occipital-
mandibular immobiliser)

[Image of a woman wearing a halo body jacket. The jacket is white and has a metal frame around the head. The woman is standing in a room.]
Halo body jacket: most rigid

Lower limb

[Image of a pelvic binder being applied to a mannequin. The binder is white and has Velcro straps. There are multiple health workers around the mannequin.]
Pelvic binder: stabilize pelvic
fracture (e.g. open book)

[Image of a patient lying on a Braun's frame. The patient's leg is elevated and wrapped in a bandage. The bed is in a hospital room.]
Braun's frame: to decrease swelling
post-op

[Image of a patient lying on a Thomas splint. The patient's leg is elevated. The bed is in a hospital room.]
Thomas splint: to elevate LL to decrease
swelling

Braces
216

[Image Description: Photograph of an ankle-foot orthosis (AFO). The AFO is a white plastic brace that extends from just below the knee to the foot. It has adjustable velcro straps. It is on a blue surface.]

Ankle-foot orthosis (AFO)

[Image Description: Photograph of three knee-ankle-foot orthosis (KAFO). The KAFOs are white plastic braces that extend from the upper thigh to the foot. They are standing against a beige colored wall.]
Knee-ankle-foot orthosis
(KAFO)

[Image Description: Photograph of a hip-knee-ankle-foot orthosis (HKAFO). The HKAFO is a white plastic brace that extends from the chest to the foot. It is standing against a white background.]
Hip-knee-ankle-foot
orthosis (HKAFO)

[Image Description: Photograph of a sugar-tong brace. The brace is made of plaster and extends from the upper arm to the fingertips, enclosing the elbow.]
Sugar-tong brace: prevent
forearm rotation
Traction
Definition

- Use of pull to exert force to bones to overcome deformity or restore alignment following trauma
  Types
- Skin traction: apply traction onto skin
- Skeletal traction: apply traction through skeleton via transosseous pin
  Examples

[Image Description: Photograph of a man lying in a hospital bed wearing a halo traction device. The device is attached to his skull and connected to a weight that is suspended from a pulley system. The patient's eyes are closed.]
Halo traction: cervical vertebrae

[Image Description: Photograph of a woman lying in a hospital bed wearing a halter traction device. The device is attached to her head and connected to a weight that is suspended from a pulley system. The patient is looking toward the left.]
Halter traction: cervical spondylosis

[Image Description: Photograph of a man lying in a hospital bed with a pelvic traction device. The device has a belt around the man's pelvis with weights hanging from it via a pulley system over the bed.]
Pelvic traction: lumbar PID

[Image Description: Photograph of a man lying in a hospital bed with Buck's unilateral leg traction device. The device has an extension coming off of the man's right foot and connected to a weight that is suspended from a pulley system.]
Buck's unilateral leg traction:
hip fracture

[Image Description: Photograph of a man lying in a hospital bed with a skeletal traction device. The device is attached to his leg with a pin and connected to a weight that is suspended from a pulley system.]
Skeletal traction: for # acetabulum or #
femoral shaft

Other appliances
Devices after joint replacement

[Image of a person lying in a bed with a knee extension splint on their leg.]
Knee extension splint: to
immobilise knee in extension post-
TKR, preventing knee contracture

[Image of a person lying in a bed with an abduction pillow positioned between their legs.]
Abduction pillow: to keep the hip
from excessive adduction (& thus
dislocation) post-THR

[Image of a Hi-Lo chair with a cutout in the seat.]
Hi-Lo chair: to keep the operated hip
from excessive flexion (& thus
dislocation) post-THR

Equipment for toileting

[Image of a commode with wheels, consisting of a metal frame and a toilet seat]
Commode: toilet seat with wheels, not for post-THR

[Image of a raised toilet seat installed on a toilet.]
Raised seat toilet: for post-THR

Analgesia

[Image of a PCA (patient-controlled analgesia) machine with a screen displaying medical data.]
PCA (patient-controlled analgesia)

[Image of a CEI (continuous epidural infusion) pump with IV tubing and fluid bags attached.]
CEI (continuous epidural infusion):
spinal analgesia

[Image of a Cryocuff ice therapy system, showing a blue cuff connected to a white and blue cooler with tubes.]
Cryocuff: ice therapy to decrease
swelling & pain

217

# 1.6 Summary of special tests

Cervical spine

- Radiculopathy: Spurling's test
- Myelopathy: Lhermitte's test, 10-second test, finger escape test, Hoffmann's test, inverted supinator reflex
  Lumbar spine
- Ankylosing spondylitis (forward flexion): Schober test
- Scoliosis: Adam's forward bending test
- Radiculopathy (sciatica): Straight leg raise (Lasegue test), tension sign, bowstring sign, cross straight-leg-raise, femoral nerve stretch test
  Shoulder
  Degenerative
- Impingement: Neer impingement sign, Hawkin's sign, painful arc
- Biceps tendon: speed test, Yergason test
- AC joint: crossed chest adduction
- Rotator cuff: ext. rotation (IT) → Hornblower's sign (teres minor), empty beer can test (supraspinatus), lift-off test / belly press test (subscapularis)
  Others
- Instability: load and shift test, apprehension test (ant.), sulcus sign (inferior), posterior apprehension test (post.)
- Scapula winging: push against wall
  Elbow
- Collateral ligament laxity: valgus stress test (medial), varus stress test (lateral)
- Ulnar nerve: palpate for subluxation, Tinel's sign
- Tennis elbow: Cozen's test, Mill's test
  Hand and wrist
- De Quervain's tenosynovitis: Finkelstein's test
- CMC arthritis: Grind test

UL nerves

- Screening test: palm down → wrist extension (radial n.) → thumb up (PIN) → palm up (proximal ulnar & median ns.) → thumb opposition (distal median n.) → OK sign (AIN) → finger ab/adduction (distal ulnar n.)
- Median nerve:
  - Carpal tunnel syndrome: Durkin's compression test, Phalen's & reverse Phalen's
  - Pronator teres: resisted pronation at full extension (PT), isolated long finger PIPJ flexion (FDS)
- Ulnar nerve
  - Wrist: Froment's sign, cross finger sign
  - Elbow: Pollock's sign, elbow flexion test + ulnar n. subluxability
- Radial nerve:
  - Supinator: provocative test (extend elbow + flex wrist + pronate arm)
  - Tinel's signs: 9cm proximal to radial styloid (supf. Branch), 2cm distal to lateral epicondyle (PIN)

Hip

- Abductor insufficiency: Trendelenburg's test (lurch? sacral dimple tilting?)
- Fixed flexion deformity: Thomas's test
  Knee
- Effusion: fluid displacement test (minimal), fluid thrill test (moderate), patellar tap test (severe)
- ACL: Lachman test (Endpoint? Excessive laxity?), anterior drawer test, pivot shift test (IR foot + valgus stress)
- PCL: Posterior drawer test, posterior sag test
- Collateral lig.: Valgus/varus stress test at 30° flexion, then at full extension (also test capsular structures)
- Meniscus: McMurray test (turn the foot away from the testing meniscus), Apley's grinding test
  Ankle
- Instability: talar tilt test, anterior drawer test
- Achilles tendon: single leg heel raise, Thompson test

Trendelenburg's gait:

- **Abductor weakness**
  - Polio
  - Sup. gluteal n. palsy
- Decreased lever arm at hip joint
  - #NOF
  - Short neck(coxa vara)
- Painful hip arthropathy
  - Septic hip
  - OA hip

219

2 Spine
2.1 Anatomy
Functions of vertebral column

- Protection of spinal cord (risk of compression/ irritation)
- Support body weight above pelvis (risk of mechanical instability)
- Movement
- Axis
  Structure of vertebra
  [Illustration of a vertebra cross-section viewed from above. The illustration is colored to distinguish the different parts of the vertebra: The spinous process is colored purple, the lamina is orange, the superior articular processes are green, the pedicles are teal, and the transverse processes are pink.]

[Illustration of two cervical vertebrae connected to each other, showing the Facet joint, Cervical vertebra, Cervical disc, and Facet capsule. The vertebrae are light brown in color.]

Features of vertebrae at different levels
| | |
|---|---|
| Cervical | Bifid spinous process except C1 (nil) & C7 (not bifid) Transverse foramina (for vertebral arteries) Triangular vertebral foramen |
| Thoracic | Demi-facets & costal facet for ribs Spinous process oriented inferiorly |
| Lumbar | Largest vertebrae, largest spinal canal Congenital abnormalities: 4 lumbar vertebrae (sacralisation), 6 lumbar vertebrae (lumbarisation) |
| Sacrum & coccyx | Fused vertebrae |

Intervertebral disc

- Fibrocartilaginous cylinder that acts as shock absorbers
- Components:
  - Nucleus pulposus: no nerve endings - asymptomatic even with desiccation
  - Annulus fibrosus: with nerve endings, posterior aspect always convex
    Intervertebral foramen
- Exit of spinal nerves
- Border:
  - Upper & lower: pedicles
  - Anterior: vertebral body & disc
  - Posterior: facet joint & ligamentum flavum
- Any anomaly in any border component causes radiculopathy
  - Short pedicles
  - Intervertebral disc herniation
  - Hypertrophic ligamentum flavum
  - Osteophyte formation at facet joint

Ligaments
[Illustration of the ligaments of the vertebral column. The vertebral column is shown from the side, with the vertebrae stacked one on top of the other. The anterior longitudinal ligament is shown in red, running along the front of the vertebral bodies. The posterior longitudinal ligament is shown in purple, running along the back of the vertebral bodies inside the vertebral canal. The ligamentum flavum is shown in light blue, connecting the laminae of adjacent vertebrae. The interspinal ligament is shown in green, connecting the spinous processes of adjacent vertebrae. The supraspinous ligament is shown in yellow, running along the tips of the spinous processes. A color-coded legend is next to the illustration, each color corresponding to a specific ligament.]

- Posterior longitudinal ligament (PLL)
  - Ossification of PLL (OPLL) very common in Japanese and Chinese - common cause of cervical myelopathy
- Ligamentum flavum (LF)
  - Dynamic compression: osteophytes + buckled LF during extension
  - Ossification of LF (OLF)

220

2.2 XR spine interpretation

[Image showing a lateral X-ray of the cervical spine, with labels indicating anatomical structures. On the left, the bony structures are labeled: Occiput, Dens (Odontoid Process), Clivus, C1, Spinous Process, Articulating Facets, Pedicle, Laminae, C4, C5, C6, C7, Spinous Process Line, Spinolaminal Line, Posterior Vertebral Line, Anterior Vertebral Line, and Vertebral Body. On the right, the soft tissues are labeled: naso-pharyngeal space (blue arrow), retro-pharyngeal space (red arrow), retro-tracheal space (green arrow), Hyoid Bone, Epiglottis, Tracheal Shadow, Pre-Vertebral Soft Tissue, Intervertebral Disk Space.]

Adequacy

- C spine (lateral): from pituitary fossa to C7/T1 junction
  - Odontoid view/ open mouth view: C1 & C2
  - Swimmer's view: cervicothoracic junction
- L spine (lateral): whole L spine including sacral spine

Alignment

- Curvature: cervical/ lumbar lordosis is preserved/ increased/ decreased/ lost/ kyphosis
- Vertebral line (fig.)
  - Ignore the bony spurs
  - Posterior vertebral line easiest to detect

Bone: fracture, bony lesion

Cartilage:

- Joint space: **Pavlov ratio > 0.8** (fig.: the ratio is a/b)
- **Atlantodental interval (ADI)** (fig.):
  - Definition: distance between anterior cortex of dens to posterior cortex of C1 anterior arch at midsagittal plane
  - Abnormal (atlanto-axial subluxation) if ADI ≥ 3mm (adult) or ≥5mm (children)
  - Causes: trauma, Down's (absent transverse ligament), RA (inflammation/ rupture of transverse lig.)

[Image showing a lateral view of a spine, with the vertebral column clearly visible]

[Image showing an open mouth view X-ray of the cervical spine, with clear visualization of the C1 and C2 vertebrae. Labels indicate occiput, lateral masses of C1, dens, C2 body, and spinous processes.]

[Image showing a lateral X-ray of the cervical spine, with the lines indicating the measurement of "a" and "b".]

Soft tissue (only for C spine)

- 3x7=21 rule: C1 ≤ **10mm**, C3≤ 7mm, C7 ≤ 21mm
- 123456 rule: C1-2 less than dens, C3-4 <3-4mm, C5-6 narrower than AP diameter of vertebral body
- Vertebral body rule: mid-cervical level ≤ half of vertebral body thickness, lower cervical level < full vertebral body thickness
  221

  2.3 Approach to spine diseases
  Differential diagnoses of back pain

- Degeneration (**spondylosis**): e.g. OA spine, facet joint arthritis
- Prolapsed intervertebral disc
- Spinal stenosis
- Cauda equina syndrome
- Muscle / ligamentous injury: **muscle strain**
- Fractures / injuries: compression fractures, spondylolysis/spondylolisthesis
- Infection: TB spine, epidural abscess
- Tumor: primary, metastases (e.g. lung, breast, prostate)
- Inflammation: AS, PSA, RA
- Extra-spinal causes / Referred pain: e.g. pancreatitis, AAA, uro/gynae causes, zoster

Manifestation of spinal cord disease
Cervical myelopathy (refer to separate section)

- Definition: compression of cervical spinal cord
- Clinical features
  - Weakness, numbness, clumsiness in arms with UMN signs
  - Neck: Lhermitte's sign, reversed Lhermitte's sign
  - Myelopathic hand signs

Radiculopathy

- Definition: conduction block in axons of a spinal nerve or its roots
- Clinical features
  - Sensory (paraesthesia, numbness)
  - Motor (weakness, hyporeflexia)
  - Radicular pain
  - Red flags:
    - Cauda equina syndrome (most important to r/o!): faecal incontinence, painless urinary retention +/- incontinence, saddle anaesthesia
    - Infection: fever, immunosuppression
    - Fracture: chronic steroid use, osteoporosis / metabolic bone disease

Cauda equina syndrome

- Definition: compression of cauda equina (below **L2**)
- Aetiology:
  - Degenerative: PID (L4/5, L5/S1)
  - Fracture: traumatic, pathological
  - Malignancy (metastasis from paired organ: thyroid, breast, lung, kidney, prostate)
  - Infection: discitis, Pott's disease
  - Inflammatory: AS
  - Iatrogenic: haematoma secondary to spinal anaesthesia
- Clinical features:
  - Motor: LMN signs - weakness, hypotonia, hyporeflexia
  - Sensory: low back pain, bilateral radicular pain, saddle anaesthesia
  - Autonomic: urinary retention with overflow incontinence, faecal incontinence, impotence
- Investigations: whole spine MRI
- Management:
  - High-dose steroid: to reduce localised swelling
  - Surgical decompression < 48h (laminectomy / discectomy)

222

2.4 Cervical myelopathy
Definition: compression of cervical spinal cord
Etiology:

- Degenerative cervical spondylosis (MC): e.g. osteophytes, hypertrophy of ligamentum flavum, degenerative spondylolisthesis
- Congenital spinal stenosis
- Ossification of posterior longitudinal ligament (OPLL)
- Trauma
- Others: tumor, epidural abscess

Clinical features

- Neck pain and stiffness
- UL +/- LL weakness and numbness with UMN signs (e.g. hyperreflexia)
- Neck: Lhermitte's sign, reversed Lhermitte's sign, loss of lordosis
- UL signs: inverted supinator reflex, inverted biceps reflex, finger escape sign, 10-second test, Hoffmann sign, grip and release, pseudoathetosis
- LL signs: gait instability with Romberg test, difficulty in toe-to-heel walk

Classification: Japanese Orthopaedic Association (JOA) classification

Management: surgical decompression and stabilization

- Non-operative: NSAID, lifestyle modification, PT
- Operative: surgical decompression and restoration of lordosis - Laminoplasty / Laminectomy +/- fusion
  2.5 Spinal stenosis
  Definition: abnormal narrowing of spinal canal or IV foramen, MC: lumbar spine > cervical spine
  Aetiology
- Degenerative: prolapsed IV disc (PID), OA spine, facet joint OA, spondylolysis/ spondylolisthesis
- Ossification: ossification of posterior longitudinal ligament (OPLL), ossification of ligamentum flavum (OLF)
- Fracture: traumatic, pathological
- Malignancy
- Infection: Pott's disease, epidural abscess
- Inflammatory: RA (C1/2 subluxation), MS
  Clinical features
- Cervical spine
  - Neck pain
  - Cervical radiculopathy
  - Cervical myelopathy
- Lumbar spine
  - Back pain, radiating to buttock and leg
  - Neurogenic claudication: pain worse with extension, relieved with flexion
  - Bladder disturbance

Investigations
XR spine

- Cervical stenosis: loss of cervical lordosis, Pavlov ratio (ratio of AP diameter of canal to diameter of vertebral body of same level) < 0.8 (fig.)
- Lumbar stenosis: loss of lumbar lordosis, reduced disc height, spondylolysis/ spondylolisthesis, calcification of PLL/ LF
  [Image Description: This is a table titled "TABLE I Japanese Orthopaedic Association Criteria for the Evaluation of Operative Results in Patients with Cervical Myelopathy". The table has four main sections numbered I through IV, with each section further divided into categories. Section I is "Upper extremity function", describing possible movements with chopsticks and spoons with points assigned from 0 to 4. Section II is "Lower extremity function", describing how a person can walk with points assigned from 0 to 4. Section III is "Sensory", further divided into upper extremity, lower extremity and trunk, describing sensory loss with points assigned from 0 to 2. Section IV is "Bladder function" describing bladder disturbances with points from 0 to 3. At the end of the table, it says "Total normal score = 17 points"]

| Cause               | Vascular claudication        | Neurogenic claudication    |
| ------------------- | ---------------------------- | -------------------------- |
| Radiation of pain   | Chronic limb ischaemia       | Spinal stenosis            |
|                     | From distal to proximal      | From proximal to distal    |
| Exacerbating factor | **Walking uphill**           | **Walking downhill**       |
|                     | Exercise                     | Increased lordosis         |
| Relieving factor    | Rest                         | Bending over, sitting      |
|                     | "Shop window to shop window" | "Park bench to park bench" |
| Pulse               | Absent                       | Present                    |

MRI spine

- Disc: intensity signal, disc height (normally L4/5 > L5/S1 > L3/4), PID (note for any high-intensity zone, i.e. oedema)
- Neural tissues: mickey mouse sign (i.e. cauda equina + traversing nerve roots), cord oedema
  Management
- Non-operative
  - PT: flexion exercise, stretching exercise
  - Pharm: NSAID, epidural steroid
- Operative
  - Without spondylolisthesis: decompressive laminectomy / laminoplasty (at every relevant level), interspinous process spacer (MIS)
  - With spondylolisthesis: decompressive laminectomy + spinal fusion

  2.6 Degenerative spine disorders
  Cervical spondylosis

- Definition: degeneration of cervical vertebral column, e.g. OA, PID, OPLL/OLF
- Site: most common at C5/6 (most flexion & extension)

Prolapsed intervertebral disc (PID)
Definition: protrusion of nucleus pulposus (NP) secondary to tear in annulus fibrosis (AF)
Pathogenesis

- Decreased aggrecan content in NP, most commonly at L4/5 and L5/S1
- More fibrous NP unable to evenly distribute compressive forces between the vertebral bodies → transferred to surrounding AF
- Pathology:
  - Bulging
  - Prolapse (AF still containing NP)
  - Extrusion (partial rupture of AF)
  - Sequestration (free movement of NP)
- Herniation and nerve roots affected
  - Level of herniation: L5/S1 > L4/5 > L3/4
  - Direction of herniation: posterolateral > central > lateral
  - Nerve roots affected (L4/5 as example): unilateral L5 (posterolateral) > bilateral L5 (central) > unilateral L4 (lateral)

[Image Description: This image shows Interspinous spacer for stenosis. It illustrates how a spacer device is placed between the vertebrae to alleviate spinal stenosis. The illustration highlights the vertebra, disc, and spacer device.]

[Image Description: This image shows a table comparing Mechanically Stable and Mechanically Unstable conditions in relation to neurology and spinal stabilization. The table has three columns: Neurology, Mechanically Stable and Mechanically Unstable. In Mechanically Stable, the Neurology is Stable with Routine management. In Mechanically Unstable, the Neurology is Unstable. Under Routine management, it mentions Stable with Routine management, which includes early stabilization of spine. Under early stabilization of spine, it mentions 1. Other causes - e.g. epidural haematoma, Incomplete Cord Lesion, Stroke 2. Wrong diagnosis on mechanical stability.]

[Image Description: This image shows two separate illustrations comparing the lumbar and cervical spine anatomy. The lumbar spine illustration shows the L4, L4/5, L5/S1, and S1 vertebral segments, highlighting the L4/5 far lateral disc and L4/5 paracentral disc. The cervical spine illustration shows the C6, C6/7, C7, and T1 vertebral segments with the C6/7 foraminal disc and C6/7 central disc highlighted. Arrows indicate relationships and potential mismatches between lumbar and cervical nerve root locations. In the top right corner it says "Both discs affect same nerve root in cervical spine, different than lumbar spine." One arrow indicates "CB and above Pedicle/ Nerve Root MISMATCH." Another Arrow indicates "Extra CB Nerve Root (without CB pedicle) allows transition from MISMATCH to MATCH. T1 and below Pedicle/ Nerve Root MATCH. At the bottom of the image it states "Lumbar Spine Pedicle/nerve Root MATCH".]

Risk factors

- Patient factor: aging, man, smoking
- Mechanical factor: posture, weak paraspinal muscles
- Occupational factor: heavy lifting

Possible clinical features

- Back pain
- Sciatica: shooting pain in hip radiating down posterior thigh and calf + limited straight leg raise + features of radiculopathy (e.g. diminished sensation over heel, absent ankle jerk, weakness of ankle plantarflexion)

| L4 root | Pain and sensory symptoms in anterior thigh                                                                                                       |
| ------- | ------------------------------------------------------------------------------------------------------------------------------------------------- |
| L5 root | Pain radiates down the posterior thigh, lateral calf, and into the great toe Sensory symptoms affect the lateral calf and great toe               |
| S1 root | Pain radiates down the posterior leg and into the fourth and fifth toes Sensory symptoms affect the lateral calf, foot, and fourth and fifth toes |

- Rule out cauda equina syndrome

Investigations

- XR spine: exclude fracture/ spondylolisthesis
- MRI spine: disc (colour, height, bulging), nerve root compression

Management

- Non-operative: **encourage mobility**, physiotherapy, NSAID, selective nerve root steroid injection
- Operative:
  - Indications: failed non-operative treatment, progressive neurological deficit, cauda equina syndrome
  - Approach: **microdiscectomy** (hemi-laminotomy + partial disc removal)

Spondylolysis & spondylolisthesis
Definition:

- Spondylolysis: defect in pars interarticularis with no movement of vertebral body
- Spondylolisthesis: defect in pars, causing forward slip of one vertebra on another (most commonly **L5/S1**)

Aetiology of spondylolisthesis

- Lytic (50%): spondylolysis
- Degenerative (25%): facet joint/ disc degeneration
- Dysplastic (20%): congenital defect of superior sacral facets (associated with spina bifida occulta)
  XR spine
- Oblique view (or lateral view): broken "Scottie dog", forward shift of vertebral column
- Flexion & extension view: translation of vertebral body
  Management
- Non-operative:
  - Activity restriction, brace
  - PT: stretching & strengthening exercise
- Operative:
  - Indications:
    - Disabling symptoms (ADL)
    - Slip > 50% and **progressing**
    - Significant neurological deficit
  - Approach: decompressive laminectomy + TLIF (transforaminal lumbar interbody fusion)

[Image of human spine, showing L3, L4, L5 and S1 vertebrae. The facet joint, pars interarticularis and sacrum are labeled. The intervertebral disc is also labeled.]

[Image of a single vertebra. The back, body, facet joint, pars interarticularis, transverse process, disc and spinous process are labeled.]

[Image showing Pars Interarticularis, with red arrows showing a stress fracture in the Pars Interarticularis and the text "Spondylolysis (Stress fracture in the Pars Interarticularis)".]

[Image illustrating Spondylolisthesis with a red arrow showing a stress fracture and sliding of vertebra and the text "Spondylolisthesis (Stress fracture and sliding of vertebra)".]

226

## 2.7 Spine trauma

Spinal cord injury

| Mechanism              | Spinal shock                                                        | Neurogenic shock                                                                                                                                    |
| ---------------------- | ------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------- |
|                        | Peripheral neurons become temporarily unresponsive to brain stimuli | Interrupted SNS below level of injury True hypovolemia: blood loss from wound Relative hypovolemia: venous pooling due to skeletal muscle paralysis |
| BP/P                   | Hypotension Bradycardia                                             | Hypotension Bradycardia                                                                                                                             |
| Bulbocavernosus reflex | **Absent**                                                          | **Present**                                                                                                                                         |
| Motor                  | **Flaccid paralysis**                                               | **Normal**                                                                                                                                          |

Investigations in traumatic spine injury

- Minor injury: full C-spine XR (AP + lateral + open mouth view, fig.)

[X-ray image of the cervical spine showing the lateral mass of C1, the dens, and the C2 vertebral body labeled. Red lines indicate the width of the dens. Blue lines indicate the borders of the lateral masses of C1.]

[Diagram illustrating the three columns of the spine: anterior, middle, and posterior. Arrows pointing to each column.]

- All injuries otherwise: CT +/- MRI (if focal neurological deficit)

Three-column theory

- Used in assessing stability of lower C spine and thoracolumbar spine
- Unstable fracture if 2/3 segments disrupted:
  - Anterior column: anterior 2/3 of vertebral body, disc & anterior longitudinal ligament
  - Middle column: posterior 1/3 of vertebral body, disc & posterior longitudinal ligament
  - Posterior column: remaining arch

**ASIA classification for spinal cord injury (IMPORTANT!)**

[Table describing the ASIA Impairment Scale. Column 1 contains the letters A through E. Column 2 contains the descriptions Complete, Incomplete, Incomplete, Incomplete, and Normal, respectively. Column 3 describes the level of impairment for each letter grade. For A, the description reads: No motor, No sensory, No sacral sparing. For B, the description reads: No motor, sensory only. For C, the description reads: 50% of muscles LESS than grade 3 (cant not raise arms or legs off bed). For D, the description reads: 50% of muscles MORE than grade 3 (can raise arms or legs off bed). For E, the description reads: Motor and sensory function are normal.]

AO classification of cervical spine fracture

- Upper cervical fracture

| Region(s) involved                                  | Injury type                   |
| --------------------------------------------------- | ----------------------------- |
| Type 1: occipital condyle, cranio-cervical junction | Type A: bony injury only      |
| Type 2: C1 ring, C1/2 joint                         | Type B: tension band injuries |
| Type 3: C2 and C2/3 joint                           | Type C: translation injuries  |

- Subaxial fracture

| Injury type                  |     |
| ---------------------------- | --- |
| Type A: compression injuries |     |
| Type B: distraction injuries |     |
| Type C: translation injuries |     |
| Type F: facet joint injuries |     |

Upper cervical spine injury

|                         |                                                                           |                                                                                                                       |
| :---------------------- | :------------------------------------------------------------------------ | :-------------------------------------------------------------------------------------------------------------------- |
| Jefferson fracture (C1) | MOI                                                                       | Features                                                                                                              |
|                         | Axial compression/hyperflexion of neck → Occipital condyles drive into C1 | Burst fracture of C1 Unstable fracture although no cord injury (rupture of transverse ligament) Mx: SOMI brace        |
| Hangman's fracture (C2) | Sudden hyperextension and distraction with axial loading                  | Bilateral pedicle fracture of C2 Unstable fracture                                                                    |
| Odontoid peg fracture   | Complete flexion/ extension                                               | Type I: tips of dens, stable Type II (MC): base of dens, unstable Type III: vertebral body, stable Mx: Odontoid screw |

[Image of Jefferson fracture, showing a CT scan with a fracture of the C1 vertebra. The fracture lines are visible on the axial view of the scan. The fractured segment is labeled in red.]

[Image of Hangman's fracture, showing a lateral X-ray of the cervical spine. The fracture is visible in the pedicle of the C2 vertebra. The fractured segment is labeled in red.]

[Image of Odontoid fracture (type II), showing an open-mouth view X-ray of the cervical spine. The fracture line is visible across the base of the dens (odontoid process) of the C2 vertebra. The fracture line is highlighted with arrows.]

[Image of a diagram showing three types of odontoid fractures: Type I, Type II, and Type III. The diagram shows the location of the fracture in each type with respect to the dens and vertebral body.]

Lower cervical spine injury

|                            |                                  |                                                                                                                                                                                                                               |
| :------------------------- | :------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Flexion teardrop fracture  | MOI                              | Features                                                                                                                                                                                                                      |
|                            | Sudden hyperflexion              | Teardrop fragment at anteroinferior aspect of vertebral body Unstable fracture: "teardrop" - associated with severe ligamentous injury & risk of displacement of posterior portion of vertebral body causing cord compression |
| Wedge compression fracture | Compression secondary to flexion | Flattening of vertebral body Stable fracture: single column affected                                                                                                                                                          |
| Burst fracture             | Axial compression                | Unstable fracture: cord damage 2º to retropulsed bony fragment                                                                                                                                                                |

[Image of Teardrop fracture, showing a lateral X-ray of the cervical spine. The teardrop fragment is visible at the anteroinferior aspect of the vertebral body. The image shows a teardrop fragment, anterior dislocation, posterior displacement of vertebral body, and the narrowing of the spinal cord.]

[Image of Wedge compression fracture, showing a lateral X-ray of the thoracic spine. The vertebral body appears wedge-shaped due to compression. The image shows anterior vertebral cortex, site of height loss of vertebral body.]

[Image of Burst fracture, showing a lateral X-ray of the lumbar spine. The vertebral body is fractured with fragments extending into the spinal canal.]

Thoracolumbar spine injury

- Wedge compression fracture
- Burst fracture
- Spondylolisthesis (see above)

Acute management of spinal cord injury

- Assume spinal cord injury and stabilise spine (Philadelphia neck collar) if:
  - Unconscious
  - Significant HI
  - Neck pain
  - Focal neurological deficit
- Resuscitation: ABCD - Delicate spine: - Cervical fracture: halo vest, traction devices, internal fixation (if unstable) - Thoracolumbar spine fracture: bed rest, external brace, internal fixation

  3.1 Anatomy
  Scapula

# 3 Shoulder and arm

[Image of the scapula with labels indicating the acromion, coracoid process, glenoid fossa, and subscapular fossa. The scapula is depicted as a three-dimensional anatomical illustration, showcasing its shape and features.]

- Subacromial space
  - Space **below coracoacromial arch** (acromion + coraco-acromial ligament + coracoid process) and **above humeral head** and greater tuberosity
  - Contents: **rotator cuff tendons** (mainly supraspinatus), **long head of biceps tendon**, subacromial bursa
- Rotator cuff interval
  - Space between supraspinatus and subscapularis
  - Free space that allows direct access to shoulder joint for steroid injection in frozen shoulder
- Proximal humerus
  - Shaft: radial groove (radial nerve, profunda brachii artery)

[Image of the shoulder joint, focusing on the ligaments and tendons, with labels such as Acromion, Bursa, Coracoacromial ligament, Subacromial space, Supraspinatus muscle and tendon, Long head of biceps tendon, Clavicle, Coracoid process and Scapula. The image is a detailed anatomical illustration.]

[Image of the shoulder joint with the supraspinatus muscle and tendon exposed, highlighting the rotator cuff interval and the position of the long head of the biceps tendon. The image provides a clear view of the muscles, tendons, and skeletal structures.]

[Image illustrating the posterior and anterior faces of the proximal humerus. Anatomical features are labeled, including the anatomical neck, humeral head, greater tuberosity, rotator cuff (SIT), surgical neck, axillary nerve, circumflex humeral vessels, intertubercular groove, lesser tuberosity, rotator cuff (subscapularis), and deltoid tuberosity. The images are detailed anatomical illustrations.]

Shoulder joint (glenohumeral joint)

- Joint capsule
- Bursa, e.g. subacromial bursa
- Stabilising mechanism - Rotator cuff (most important) - Joint capsule - Glenoid labrum: to deepen the socket - Biceps tendon long head at superior labrum
  AC joint
- Plane type synovial joint: only allow gliding motion
- Atypical features: - Articular surfaces lined with fibrocartilage (instead of hyaline cartilage) - Joint cavity partially divided by an articular disc (~ meniscus)

  3.2 Shoulder trauma
  Shoulder X-ray

- AP view: also look for associated pneumothorax / rib fractures
- Axillary view / Lawrence view (upper fig.): good for visualizing articular surfaces of glenohumeral joint, and any Hill Sachs lesion
- Y view (lower fig.):
  - Upper arms are acromion & coracoid process
  - Lower arm is scapula

[Image: Radiograph of the axillary view of the shoulder. The humeral head and glenoid are labeled.]

[Image: Radiograph of the Y view of the shoulder.]

[Image: Radiograph of the AP view of the shoulder.]

Axillary view

Y view

AP view

[Image: Radiograph of the normal AP view of the shoulder.]

[Image: Radiograph of the normal AP view of the shoulder with anatomical structures highlighted in color. The legend indicates that blue represents the Humeral head, red represents the Glenoid fossa, green represents the Acromial process, purple represents the Distal clavicle, and yellow represents the Coracoid process.]

[Image: Radiograph of the normal lateral/scapula Y view of the shoulder.]

[Image: Radiograph of the normal lateral/scapula Y view of the shoulder with anatomical structures highlighted in color. The legend indicates that blue represents the Humeral head, red represents the Glenoid fossa, green represents the Acromial process, purple represents the Distal clavicle, and yellow represents the Coracoid process.]
229

Overview of threatened structure
[Image of an arm and shoulder with labels pointing to various possible injuries. The labels include:
Clavicle fracture, with the label "Brachial plexus"
(Anterior) Shoulder dislocation, with labels "Bone: Hill-Sachs, Bony Bankart", "Muscle: rotator cuff", "Nerve: axillary nerve", and "Ligament: glenohumeral ligament"
Proximal humerus fracture, with labels "Nerve: axillary, suprascapular", and "Artery: axillary"
Holstein-Lewis fracture, with the label "Radial nerve"
Mid-humeral shaft spiral fracture, with labels "Radial nerve" and "Brachial artery"
Supracondylar fracture, with labels "AIN" and "Brachial artery (Volkmann's contracture)"
Radial head fracture, with labels "PIN" and "Median, ulnar nerve"
Monteggia fracture, with the label "PIN"]

Shoulder (humeral head) dislocation
S/S: painful shoulder, reduced mobility, instability, reluctancy to move, asymmetry, loss of shoulder contours

|                 | Anterior dislocation (>90%)                                                                                                                                                | Posterior dislocation (5%)                                      |
| :-------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------- |
| ΜΟΙ             | Abducted, externally rotated or extended                                                                                                                                   | 4Es: epileptic seizure, EtOH, electrocution, high Energy trauma |
| XR: trauma      | Blow to posterior shoulder                                                                                                                                                 |                                                                 |
| shoulder series | [Image of an X-ray showing an anterior shoulder dislocation]                                                                                                               | [Image of an X-ray showing a posterior shoulder dislocation]    |
| Axillary view   | Humeral head is anterior                                                                                                                                                   | Humeral head is posterior                                       |
| Y view          | Humeral head anterior to the centre of the "Mercedes-Benz" sign                                                                                                            | Humeral head is posterior to the centre of "Mercedes-Benz" sign |
| AP view         | Sub-coracoid Medial and inferior to glenoid fossa                                                                                                                          | Lightbulb sign (forced IR of humerus) Widened joint space       |
| Associated      | Hill-Sachs lesion at posterior humeral head                                                                                                                                | Reverse Hill-Sachs lesion                                       |
| injuries:       | (Bony) Bankart lesion at anterior inferior glenoid labrum/ (bone)                                                                                                          | Reverse bony Bankart lesion                                     |
| confirmed by    | Rotator cuff injuries Glenohumeral ligament avulsion                                                                                                                       |                                                                 |
| MRI shoulder    | Axillary nerve injury: deltoid wasting, sensory patch over deltoid                                                                                                         |                                                                 |
| Management      |                                                                                                                                                                            |                                                                 |
|                 | Conservative: closed reduction (traction- countertraction) + broad-arm sling (in external rotation) for 3 weeks (fig.), rehabilitation (e.g. PT for rotator cuff exercise) |                                                                 |
|                 | Arthroscopic repair: indicated if ○ Large Hill-Sachs/ bony Bankart lesion (>20%) ○ Joint instability ○ Frequent dislocation                                                |                                                                 |

[Image showing the Bankart lesion and the Hill-Sachs lesion]

[Image showing the arm in a broad-arm sling]

230

231
Inferior shoulder dislocation

- Least common
- MOI: hand outstretched in cycling accident
- Clinical feature: **hold injured arm above head**
  - Highest incidence of axillary n. injury (c.f. ant/post dislocation)
- Radiological features: **luxatio erecta** (humeral head displaced downward, with arm hyper-abducted) (fig.)

Complications of shoulder dislocation

- Recurrence
- Chronic pain / stiffness
- Adhesive capsulitis
- Rotator coff injury
- Nerve damage (especially axillary & suprascapular n.)
- Degenerative joint diseases e.g. secondary OA

Clavicle fracture
Risk groups: adolescents and young adults (MC), elderly with osteoporosis
ΜΟΙ

- Direct: direct blow to shoulder
- Indirect: fall on shoulder, fall on outstretched hand (FOOSH)
  **Allman classification:** by anatomical location
- Type 1: middle 1/3 (80%) - generally stable
- Type 2: lateral 1/3 (15%) - often unstable if displaced
- Type 3: medial 1/3 (5%) - high incidence of pneumothorax / hemothorax
  Clinical features
- Focal tenderness
- Medial fragment displaced _superiorly_ (pull of SCM) and lateral fragment displaced _inferiorly_ (pull of arm)
- **Threatened skin** (tented, tethered, non-blanching skin due to pull of SCM and arm): impending conversion to open injury
- Complications: malunion / delayed union (MC), brachial plexus injury, pneumothorax
  XR: AP, Zanca view (15° cephalic tilt for AC joint)

[Illustration of a clavicle with dotted vertical lines dividing it into thirds labeled as follows: Lateral ⅓ 15%, Middle ⅓ 80%, and Medial ⅓ 5%]

[A man wearing a brace that wraps around his shoulders and upper back to stabilize the clavicle.]

Management: mainly conservative

- Conservative: _sling immobilization_ (e.g. figure-of-eight brace (fig.)), PT (ROM exercise, muscle strengthening)
- Operative:
  - Indications: threatened skin, open fracture, bilateral (to permit weightbearing)
  - Modalities: closed reduction with IM fixation, ORIF (if unable to unite)
- Usually heal within 4-6 weeks

AC joint dislocation

[Radiograph of a shoulder joint labeled to show the acromioclavicular joint dislocation in AP view.]

[Radiograph of a shoulder joint labeled to show the acromioclavicular joint dislocation in AP view, with yellow lines showing clavicle, coracoid, and acromial process; red lines showing misalignment of the clavicle and acromion; and green circles showing increased coracoclavicular distance.]

GEEKYMEDICS.COM

- X-ray features: misalignment of clavicle and acromion, increased coracoclavicular distance (>13mm)

Proximal humerus fracture

- Site: most commonly surgical neck
- Mechanism: low-energy injuries (e.g. FOOSH) in osteoporotic elderly
- Clinical features:
  - Injury to **axillary nerve** (deltoid), **suprascapular nerve** (supraspinatus & infraspinatus)
  - Injury to **axillary artery** (may be masked by extensive collateral circulation preserving distal pulse) → AVN
- **Neer classification** – relationship between 4 main segments (greater tuberosity, lesser tuberosity, articular segment, humeral shaft)
- Investigations: X-ray (AP, Y-view, axillary view) +/- CT scan for pre-operative planning
- Management
  - Non-operative (if no displacement): **sling immobilisation** then rehabilitation
  - Operative (e.g. displaced, open, neurovascular compromise):
    - Closed reduction with **percutaneous pinning**: preferred if surgical neck #
    - ORIF: preferred if head-splitting #
    - Other options (rare): e.g. hemiarthroplasty, reverse shoulder arthroplasty (RSA)
- Complications: AVN of humeral head

Humeral shaft fracture

- Mode of injury
  - Slip and fall (e.g. outstretched hand, fall laterally onto adducted limb)
  - High-energy trauma e.g. RTA
- Pathology
  - Fracture location: proximal, middle or distal third of humeral shaft
  - Fracture pattern: spiral, transverse, comminuted
  - **Holstein-Lewis fracture** (fig.): spiral fracture of _distal third_ of humeral shaft → **entrapment** and neuropraxia of **radial nerve**
- Clinical features
  - Limb shortening and varus
  - **High radial nerve palsy**: wrist drop, finger drop (triceps extension intact), reduced sensation over dorsal 1st webspace
- XR forearm: AP & lateral (fig.)
- Management
  - Non-operative (1st line): coaptation splint with functional bracing (fig.)
    - Suitability: <20° anterior angulation, <30° varus/valgus angulation, <3cm shortening
  - Operative:
    - Indications: open fracture, vascular injury, brachial plexus injury or pathologic fracture
    - ORIF (e.g. plate and screws, intramedullary nail)
  - Usually heal in 8-12 weeks

SLAP tear (superior labrum from anterior to posterior tear)

- MOI: repetitive overhead activity
- Clinical features: vague deep shoulder pain, popping sensation during overhead activity, **O'Brien's active compression test** (fig.)
- Investigations: MRI arthrogram (hyperintense labrum suggests tear)
- Management
  - Conservative: analgesics, stretching
  - Operative (arthroscopic repair): if fail conservative for 3 months

[X-ray of a right humerus showing a Holstein-Lewis fracture. The humerus is broken in the distal third, with the fracture line spiraling around the bone.]

Holstein-Lewis fracture

[Diagram illustrating the application of a sugar-tong splint for humeral shaft fractures. The diagram shows gentle traction being applied (1) as the splint is placed (2) from over the deltoid laterally, under the elbow, and up into the axilla. An elastic wrap holds the splint in place (3). The axilla must be padded (4), and a sling is used (5).]

[Image of a Doctor examining a patient’s shoulder. The patient is shirtless, and the doctor is palpating the patient’s right shoulder. Both doctor and patient are white.]

233

3.3 Shoulder pain
Differential diagnosis

- Rotator cuff syndrome (MC): pain during activity only, passive ROM > active ROM, external rotation spared (infraspinatus + teres minor)
- Frozen shoulder: DM as risk factor (check Hstix), symptoms change over time (pain → pain + stiffness → stiffness → resolution), night pain/ rest pain (inflamed capsule); limited active + passive ROM
- AC joint arthritis: more localised tenderness
- Biceps tendonitis: more localised tenderness
- Cervical radiculopathy: neck pain, radiating pain, weakness

  3.4 Biceps tendinopathy
  Tendinopathy: variety of pathological changes that result in painful, swollen and weakened tendon (↑risk of rupture)
  Clinical features:

- Pain worsened with contracting biceps (e.g. speed test, Yergason test) and relieved with rest
- Localized tenderness
- Disuse atrophy
  Investigations: mainly clinical diagnosis +/- X-ray, USG, MRI (thickened tendons)
  Management:
- Conservative (first line): analgesia, ice therapy, steroid, physiotherapy
- Operative (rare): arthroscopic tenodesis (divide and reattach), tenotomy (divide the tendon)

Biceps tendon rupture
Clinical features:

- Sudden onset pain, weakness with "pop" sound
- Occur at sudden forced extension of flexed elbow
- Popeye sign (fig.): bulging of biceps muscle belly upon contraction
- Elbow flexion and supination intact (due to brachialis & supinator)
  Investigation:
- USG (first-line): localize distal end of biceps tendon
- MRI
  Management
- Conservative: analgesia, physiotherapy
- Operative: form a bone tunnel in radius to re-insert tendon end (single-incision vs dual-incision technique)

[Image of a male arm, flexed with a large bulge on the front of the upper arm. The bulge is the contracted biceps muscle, which has become detached from its tendon and recoiled up the arm. The skin is pale, and the bulge is very prominent and easily visible.]

3.5 Rotator cuff syndrome
Definition: A continuum of disease including

- Subacromial impingement
- Subcoracoid impingement
- Calcific tendonitis
- Rotator cuff tear

Subacromial impingement syndrome (SAIS)
Definition

- Irritation and inflammation of rotator cuff tendons as they pass through the subacromial space
- Range of pathology: rotator cuff tendinosis, subacromial bursitis, calcific tendonitis
  Pathophysiology
- Intrinsic degeneration: repetitive microtrauma, degenerative tendinopathy, rotator cuff muscle weakness
- Extrinsic compression:
  - Humeral head: glenohumeral instability (→ sup. subluxation)
  - Acromion: anatomical variation (curved, hooked)
  - Coracoacromial ligament: hypertrophy
  - ACJ: osteoarthritis

[Image of a diagram of the shoulder joint, showing the bones, ligaments, tendons, and bursae. Key structures are labeled, including the acromion, bursa, clavicle (collarbone), coracoid process, coracoacromial ligament, subacromial space, supraspinatus muscle and tendon, long head of biceps tendon, and scapula.]

Clinical features

- Progressive pain in anterosuperior aspect of shoulder: **exacerbated by abduction**, relieved by rest
- Signs: - Limited ROM in forward flexion - Painful arc (60-120°) - Impingement signs: Neer's impingement sign, Hawkin's sign
  Investigations
- XR shoulder: acromiohumeral distance, acromion morphology, bony spurs, calcification of supraspinatus tendon (chronic)
- MRI shoulder: degree of rotator cuff pathology, bursitis
  Management
- Conservative (first line): analgesia, steroid, physiotherapy (rotator cuff strengthening)
- Operative: - Indications: failed conservative for **6 months** - Approaches: usually arthroscopic - Surgical repair of supraspinatus / long head of biceps tendon → improve ROM - **Subacromial bursectomy**: increase subacromial space - **Acromioplasty** (removal of a section of acromion): increase subacromial space
  Complications
- Rotator cuff degeneration and tear
- Adhesive capsulitis (frozen shoulder)

Rotator cuff tear
Pathophysiology: chronic impingement, degenerative, trauma, iatrogenic (shoulder surgery)
Clinical features

- Pain over lateral aspect of shoulder
- Inability to perform overhead activities
- Signs - Muscle atrophy: supraspinatus & infraspinatus - Loss of active ROM (usually SIT) but **intact passive ROM** - **Drop arm sign**
  Classification
- Acute (<3 months) vs chronic (>3 months)
- Partial thickness vs full thickness - Full thickness: small (<1cm), medium (1-3cm), large (3-5cm), massive (>5cm or multiple tendons)
  Investigations
- XR shoulder: exclude fractures, acromiohumeral distance (proximal migration of humerus), acromion morphology, bony spurs
- **USG shoulder**: dynamic test for tear
- MRI shoulder: gold standard, degree of tear (irreparable if fatty infiltration or muscle tendon atrophy)
  Management
- Considerations:
  - Age & activity of patient
  - Severity of tear (MRI)
  - Shoulder arthropathy status (shoulder not weightbearing thus primary OA uncommon)
- Non-operative (mainstay): analgesics, steroid, PT
- Operative: not a must, indicated if **failed conservative Tx / large and massive tears** / > 2 weeks since injury - Surgical repair (arthroscopic / open) - Tendon transfer: if massive cuff tears - Reverse total shoulder arthroplasty (fig.): if massive cuff tears + glenohumeral arthritis
  Complication: **adhesive capsulitis**, recurrence

[X-ray image of a right shoulder replacement. The image is in grayscale. The humerus is visible in the bottom half of the image and it is connected to the shoulder joint. There is a visible artificial metallic shoulder joint connecting the humerus and the shoulder, with a cup-shaped component on the glenoid side and a stem inserted into the humerus. The bone appears dense, and the soft tissues are less clear. The image is oriented vertically, with the shoulder at the top. There is a marker labeled R in the top left corner]

234

## 3.6 Frozen shoulder / Adhesive capsulitis

Definition

- A shoulder condition where **active and passive** ROM is lost without clear underlying cause
- Adhesive capsulitis: glenohumeral joint capsule becomes contracted and adherent to humeral head
  Pathophysiology
- Primary (idiopathic): associated with **DM**
- Secondary: - Rotator cuff syndrome - Biceps tendinopathy - Post-trauma - Post-surgery: shoulder surgery, axillary LN dissection
  Clinical features
- Disease course
  - Freezing phase (pain): 2-9 mo
  - Frozen phase (pain + stiffness): 4-12 mo
  - Thawing phase (stiffness): 5-24 mo - may not completely resolve spontaneously
- Signs: joint tenderness and stiffness, muscle wasting (e.g. deltoid), ↓ROM (esp. **ER/IR** and flexion)
  Investigations
- HbA1c
- XR shoulder: rule out AC pathology
- MRI shoulder: thickened joint capsule, rule out SAIS
  Management
- Conservative (first line):
  - Analgesics, e.g. intra-articular steroid (at rotator interval): only during **pain** phase
  - PT: after inflammation/ pain subsides
- Operative:
  - Indications: _stiffness_ fails to improve after conservative management for 6 months
  - Modalities:
    - Manipulation under anaesthesia (MUA)
      - Complications: fracture (esp. during ER)
    - Arthroscopic capsular release
      - Complications: residual stiffness (early mobilisation), axillary nerve injury

4 Elbow and forearm

4.1 Anatomy of elbow
Elbow joint & Ligaments

- Carrying angle: 8-12° (male), 10-14° (female)
  Anterior: Posterior:

[Detailed drawing of the anterior and posterior views of the elbow joint.
The anterior view depicts the capitulum, head of radius, and coronoid process.
The posterior view shows the trochlea and olecranon.]

[Detailed drawing of the elbow joint showing ligaments and tendons.
The radial collateral ligament and ulnar collateral ligament are labeled, along with the anular ligament of radius and sacciform recess of synovial membrane.]

Bursa

- Definition: membranous sac filled with synovial fluid, acting as a cushion to reduce friction
- Olecranon bursitis: inflammation (and possible infection) of olecranon bursa
  Cubital fossa
- Content (from lateral to medial): biceps tendon, brachial artery, medial nerve (TAM)
- Median cubital vein (MCV): at the roof of cubital fossa, for venepuncture
  Stability of elbow joint:
- Static: humeroulnar joint, medial and lateral collateral ligaments, radiocapitellar joint, joint capsule
- Dynamic: surrounding muscles e.g. triceps, brachialis

  4.2 Elbow trauma
  Important lines in elbow XR

- Seen in true lateral film (i.e. trochlea overlaps with capitellum)
- Anterior humeral line: should pass through mid-third of capitellum; disruption suggests **supracondylar fracture** (child)
- Proximal radial line (radiocapitellar line): centre of radius should pass through centre of capitellum; disruption suggests capitellar dislocation or radial head dislocation

[Detailed drawing of a sagittal view of the elbow joint, illustrating the anterior humeral line and proximal radial line. The radius, ulna, and humerus are labeled. Key anatomical features and measurement points are also indicated with labels like 'a', 'b', and 'b'.]

[Detailed medical illustration of the cubital fossa with different structures highlighted. The image labels the Superior border (imaginary line between the epicondyles), the Medial border (Lateral border of the pronator teres), and the Lateral border (Medial border of the brachioradialis).]

Elbow fracture
Children:

- Supracondylar (60%)
- Lateral condyle (15%)
- Medial condyle (10%)

Adult:

- Radial head/neck (50%)
- Olecranon (20%)
- Supracondylar (10%)

Supracondylar fracture
MOI: common in children

- 95% extension injury via FOOSH
- 5% flexion injury
  Complications
- Nerve palsy (10%): AIN injury is most common
  - Posterolaterally displaced: **median n.** and brachial artery
  - Posteromedially displaced: radial n
- Malunion: **cubital varus** deformity ("gunstock deformity")
- **Volkmann's contracture** (fig.): brachial artery injury → ischaemic
  necrosis of forearm flexors, causing claw-like deformity
- **Pucker's sign** (fig.): skin tenting, indicate significant soft tissue
  injury (proximal fracture fragment spikes through fascia →
  subcutaneous bruising)
  Radiological features: AP and lateral X-ray elbow
- **Disrupted anterior humeral line**
- **Fat pad sign** (fig.): inflammation around the elbow joint pushes
  the fat pad away
- Displacement: most commonly postero-medial displacement
  (i.e. cubital varus)
  Gartland classification
- Class I: undisplaced
- Class II: displaced, with intact posterior cortex
- Class III: displaced in two or three planes
  Management
- Gartland class I (non-displaced): long-arm cast in < 90° flexion
- Gartland class II-III (displaced) / associated **neurovascular** injury:
  - Closed fracture: CRPP (closed reduction with percutaneous
    K-wire fixation)
  - Open fracture: open reduction with percutaneous pinning +/-
    consult vascular team for vascular exploration
- K-wire insertion:
  - Risk of ulnar n. injury during insertion of medial K-wire
  - Remove in clinic after 3-4 weeks

[Figure 2: Clinical Picture of the Forearm - A photograph illustrates the clinical appearance of a forearm. The image shows a hand with labels pointing to thumb adduction, wrist flexion, MP extension, and IP flexion. The forearm is also labeled with forearm pronation and elbow flexion.]

[Clinical photograph of a child's arm from the side. A bruise is visible on the elbow.]

[An X-ray image of an elbow. Yellow arrows indicate the fracture and displacement.]

[Two x-ray images of an elbow joint after K-wire fixation.]

Radial head fracture
MOI: FOOSH with a carrying angle

- Radial head normally articulates with **capitulum** of humerus
- Indirect trauma → Axial loading pushes radial head against capitulum of humerus

Clinical features

- Elbow effusion
- Limited pronation/ supination
  Complications:
- Essex-Lopresti fracture: radial head # + DRUJ disruption →
  require OT
- **Terrible triad of elbow** (fig.): associated with high risk of
  **instability, stiffness, arthritis** → require OT (see below)
  - Radial head fracture
  - Coronoid fracture
  - Posterior elbow dislocation with LCL injury
- Nerve injury: all 3, but PIN (radial) highest risk

[A medical illustration of a radial head fracture and posterior dislocation of the elbow joint, including labeling of coronoid process fracture.]

Radiological features: AP + lateral X-ray elbow

- **Fat pad sign / Sail sign**: joint effusion (blue arrow)
- Radial head fracture line (red arrow)
- Disrupted radiocapitellar line
- MRI may be required to assess associated ligament injury (LCL)
  **Mason classification & management**
- Type 1 (non-displaced / displaced < 2mm): non-operative (**elbow sling** x 1 week in flexion → early mobilisation)
- Type 2 (displaced >2mm /angulation): **ORIF**
- Type 3 (comminuted fracture):
  - ORIF (+ LCL reconstruction if torn)
  - ORIF not feasible: radial head excision with replacement

[X-ray image of an elbow showing a red arrow pointing to a fracture line and a blue arrow indicating joint effusion.]

**Olecranon fracture**
MOI: FOOSH → sudden pull of triceps muscle

- All olecranon fractures are **intra-articular** (articulate with trochlea of humerus)
  Clinical features
- Elbow effusion
- Inability to **extend** elbow against gravity
  Classifications: Mayo classification, Schatzker classification
  Management:
- Non-operative: if minimally displaced <2mm / not fit
  - Elbow sling x 1 week in flexion → early mobilization
- Operative:
  - Tension band wiring (if # is proximal to coronoid process) (fig.)
  - Olecranon plating (if # is at / distal to coronoid process)

[X-ray image of an elbow with an olecranon fracture.]

[X-ray image of an elbow showing surgical repair with wires.]

**Elbow dislocation**
MOI: FOOSH → usually **posterior** dislocation, 50% associated with bony injury
Clinical features

- Elbow effusion, limited pronation-supination
- Disrupted equilateral triangle of elbow
- Complications: **terrible triad** of elbow, **ulnar nerve injury**, vascular injury
  Radiological features: AP + lateral X-ray elbow
- **Radio-capitellar incongruence** (Disrupted radiocapitellar line)
- **Ulno-trochlear incongruence** (Disrupted anterior humeral line)
  Management
- Simple dislocation (no fracture): **closed reduction** + splinting
  - CR: by in-line traction or manipulation of olecranon
- Complex dislocation (with fracture, e.g. terrible triad): **ORIF** of coronoid process & radial head, LCL/MCL reconstruction

[X-ray image of a dislocated elbow joint.]

4.3 Forearm fractures

|                       |                                            |                                                                   |                                                                          |
| --------------------- | ------------------------------------------ | ----------------------------------------------------------------- | ------------------------------------------------------------------------ | ------------- |
| Radial shaft fracture | Galeazzi fracturedislocation (left fig.)   | Description GRIMUS: distal radius # DRUJ injury (ulnar styloid #) | Radiological features Shortening of distal radius Widening of DRUJ space | Complications |
| Ulnar shaft fracture  | Monteggia fracturedislocation (right fig.) | GRIMUS: proximal ulnar # PRUJ injury (radial head dislocation)    | Disrupted radiocapitellar line                                           | PIN injury    |
|                       | Nightstick fracture                        | Isolated distal ulnar fracture                                    |                                                                          |               |

[Radiograph of forearm showing Galeazzi fracture. The radius is fractured and the distal radioulnar joint is dislocated.]

[Radiograph of wrist showing fracture of radius and ulna fixed with screws and plates.]

Management of forearm fractures:

- Acute: RICE, analgesics, immobilization by slab
- Definitive: **Open reduction internal fixation (ORIF)** is preferred: affect motion (e.g. supination, pronation)

  4.4 Epicondylitis
  Definition: chronic inflammation of forearm tendons at the elbow
  Pathophysiology: repetitive overuse of tendons
  Risk factors: occupations / hobbies that require excessive use of forearm muscles, e.g. tennis, golf
  DDx: cervical radiculopathy, OA elbow, radial carpal tunnel syndrome
  **Lateral epicondylitis (tennis elbow)**: more common

- Anatomy: common extensor tendon attaches superficial extensor muscles to the lateral epicondyle
- Clinical features:
  - Elbow pain radiating down the forearm, worsen over weeks to months
  - Local tenderness on palpation of lateral epicondyle
  - **Cozen's test:** pronate + radially deviate forearm → extend wrist against resistance
  - **Mill's test:** pronate forearm, flex wrist and extend elbow

[Illustration depicting the clinical testing for lateral epicondylitis, also known as tennis elbow, showing the elbow joint. The test involves applying pressure to the affected area while the patient attempts to extend their wrist against resistance.]

[Illustration depicting the Mills Test to evaluate for lateral epicondylitis. The elbow is fully extended, the forearm is pronated, and the wrist is flexed, increasing tension on the wrist extensors.]

- Investigations: clinical diagnosis; USG or MRI to detect any structural abnormalities
- Management:
  - Conservative: activity modification, **PT** (stretching, strengthening exercise, orthoses e.g. **elbow brace**)
  - Pharmacological: analgesics, local steroid injection
  - Surgical: open/arthroscopic debridement of tendinosis, repair of damaged tendon insertions, tendon transfer if >50% damage

**Medial epicondylitis (golfer's elbow)**: less common

- Pronator teres and FCR most commonly affected
- Associated ulnar nerve neuropathy
- Similar management as tennis elbow

5 Hand and wrist

5.1 Anatomy of hand & wrist
Bone of hands

[Anterior view of the bones in the hand and wrist. The bones in the fingers are colored brown, the bones in the palm are colored blue, and the bones in the wrist are colored green.]

Phalanges
Metacarpals
Carpals

[Anterior view of the bones in the wrist and hand. The carpal bones are labeled: Capitate, Trapezoid, Hamate, Pisiform, Trapezium, Scaphoid, Triquetrum, Lunate]

Capitate
Trapezoid
Hamate
Pisiform
Trapezium-
Scaphoid
Triquetrum
Lunate
She Looks Too Pretty
Try To Catch Her

Muscles

- Forearm (Extrinsic muscles)
  - Anterior compartment: all innervated by **median nerve** except FCU & FDP 4/5 (ulnar n.)
    - Superficial: PT, FCU, palmaris longus, FCR, FDS
    - Deep: FDP, FPL, PQ
  - Posterior compartment: all innervated by **radial nerve**
    - Superficial: BR (only muscle in extensor compartment that acts as flexor), ECRL, ECRB, EDC (extensor digitorum communis), EDM, ECU
    - Deep: supinator, APL, EPB, EPL, EIP (extensor indicis proprius)
- Hand (Intrinsic muscles): all innervated by **ulnar nerve** except lateral 2 lumbricals & thenar (median n.)
  - Thenar (APB, OP, FPB): only APB & OP are solely innervated by median nerve, thus tested
  - Hypothenar
  - Lumbricals: account for ulnar claw and hand of benediction
  - Interossei: Palmar ADduct (3), Dorsal ABduct (4)
  - Adductor pollicis

Sensation: two-point discrimination (normal threshold: 4mm), proprioception

Carpal tunnel

[A cross sectional view of the wrist. The median nerve can be seen inside the carpal tunnel. Structures are labeled: Median nerve, Flexor retinaculum, Flexor pollicis longus, Flexor digitorum superficialis, Flexor digitorum profundus]

- Boundary:
  - Flexor retinaculum (transverse carpal lig.)
  - Deep carpal arch: laterally by **scaphoid & trapezium**, medially by **pisiform & hook of hamate**
- Contents:
  - Tendons x 9: FDS (4) & FDP (4) surrounded by a single synovial sheath, FPL by another
  - **Median nerve**: palmar cutaneous branch given off just prior to carpal tunnel

Guyon's canal

[Diagram of the hand and wrist showing the location of Guyon's canal. Structures are labeled: Hook of hamate (Ulnar side), pisiform bone, Palmar carpal ligament (roof), Ulnar nerve]

- Boundary:
  - Floor: Flexor retinaculum
  - Roof: Palmar carpal ligament
  - Radial border: hook of hamate
  - Ulnar border: pisiform bone
- Contents
  - **Ulnar nerve**: dorsal cutaneous branch gives off 5cm proximally
  - Ulnar artery

241

Anatomical snuffbox

- Border: tendon of EPL (ulnar), tendon of EPB & APL (radial), styloid process of radius (proximal)
- Content: radial artery, cephalic vein, superficial branch of radial nerve
- Floor: scaphoid

[Illustration of the anatomical snuffbox on a hand. The Extensor pollicis longus, Anatomical snuff-box, and Extensor pollicis brevis are labeled.]

Immobilisation of hand
Safe position: A position that is designed to

- Prevent joint contractures upon prolonged immobilisation - volar plates are
  maximally stretched in MCPJ flexion + PIPJ/DIPJ extension
- Stabilise joint during trauma (e.g. carpal bone fracture) - collateral ligaments are stretched that does not allow abduction/ adduction

[Drawing of a hand in MCP flexion 60-90° with PIP in full extension and Wrist extension 10-45° and DIP in full extension]

[Drawing of hands, demonstrating "Position of Safety" and "Position of Function"]

Functional position (holding cup): A position that is designed to ensure certain degree of function of hand even if it develops contracture in the future, e.g. in stroke patients

Nerves of UL
Brachial plexus

- Formed by anterior rami of C5-T1
- Supply shoulder & upper limb except trapezius (CN 11)

|                  | Root value | Motor                                                                              | Sensory                   |
| :--------------- | :--------- | :--------------------------------------------------------------------------------- | :------------------------ |
| Musculocutaneous | C5-6       | All arm flexors: BBC                                                               | Lateral forearm           |
| Axillary         | C5-6       | Deltoid                                                                            | Lateral arm\*             |
| Radial           | C5-T1      | All extensors                                                                      | Posterior                 |
| Median           | C5-T1      | Forearm: all flexors except FCU & median 2 FDP Hand: Thenar & lateral 2 lumbricals | Lateral 3.5/5 palmar side |
| Ulnar            | C8, T1     | Forearm: FCU & median 2 FDP Hand: All except thenar & lateral 2 lumbricals         | Medial 1.5/5 hand         |

Other muscles supplied: scapular muscles (C5, 6), pectoralis & lati. dorsi (C6-8)

- Skin over deltoid by C4 instead

Brachial plexus injury
Erb's palsy

- Upper plexus injury (C5-6)
- MOI: stretch during delivery
- Waiter's tip sign: adducted & internally rotated shoulder + extended & pronated forearm
  Klumpke palsy
- Lower plexus injury (C8-T1)
- MOI: UL pulled superiorly, e.g. tree branch
- Automatic 4-finger claw hand: ulnar + median nerve injury

[Illustration of two hands, one with Erb's palsy, Klumpke palsy, and one with normal innervation. The Ulnar, Median, and Radial nerve distributions are highlighted in different colors.]

242

Peripheral nerves of UL

[Diagram of the peripheral nerves of the upper limb, illustrating the paths and branches of the radial, ulnar, and median nerves. The diagram shows the origins of the nerves in the upper arm, their paths around the elbow, and their distribution to the wrist and hand. Key anatomical landmarks such as the triceps, mid-shaft of the humerus, lateral and medial epicondyles, radial head, and carpal tunnel are labeled. Specific muscles innervated by each nerve are also indicated, along with clinical signs associated with nerve damage, such as Pollock's sign and Froment's sign. The radial nerve branches into the superficial branch and the PIN (posterior interosseous nerve), the ulnar nerve goes toward the wrist, showing Lumbricals, ADM, P11/D12, and AdP. The median nerve goes through the carpal tunnel to the thenar area.]

Radial nerve palsy
| Level | Condition | Motor | Sensory | Special tests |
|---|---|---|---|---|
| Elbow | Wartenberg's syndrome (entrapment: ECRL & BR) | Nil | Dorsal aspect of lateral 3 1/2 digits | |
| Upper forearm/ Elbow | Elbow fracture/ dislocation Radial head fracture/ dislocation | Finger drop, hand pronation, thumb adduction, wrist radial deviation (\*.'ECRL) | Nil (superficial branch spared) | Stretch supinator (extend elbow, flex wrist, pronate forearm) |
| Upper arm | PIN compression (supinator) Holstein-Lewis fracture | As above + wrist drop | Dorsal aspect of lateral 3 1/2 digits | |
| Shoulder | Shoulder trauma Saturday night palsy | As above + Weak elbow extension, weak BR | Dorsal aspect of arm, forearm and lateral 3 1/2 digits | |

Ulnar nerve palsy
| Level | Condition | Motor | Sensory | Special tests |
|---|---|---|---|---|
| Wrist | Guyon canal syndrome | Prominent claw hand (lumbricals) Claw thumb Hypothenar, AdP and interossei wasting Longitudinal furrows (lumbricals) Flattened metacarpal arch Weak finger abduction/ adduction | Palmar aspect of medial 1 1/2 digits (dorsal cutaneous branch spared) | Cross finger sign (1st VI / 2nd DI) Froment's sign (AdP weakness → FPL compensation) |
| Elbow | Cubital tunnel syndrome Posterior elbow dislocation | Less prominent claw hand ('.'FDP 4/5) | Palmar + dorsal aspect of medial 1 1/2 digits | Pollock's sign (FDP 4/5) Elbow flexion test |

Median nerve palsy
| Level | Condition | Motor | Sensory | Special tests |
|---|---|---|---|---|
| Carpal tunnel | Carpal tunnel syndrome | Thenar wasting Ape hand deformity Weak thumb abduction and opposition | Palmar aspect of lateral 3 1/2 digits (palmar cutaneous branch spared) | Phalen's test Reverse Phalen's test Durkin's compression test |
| Wrist | Colles' fracture Wrist laceration | As above | Palmar aspect of lateral 3 1/2 digits + thenar area | |
| Elbow | Supracondylar fracture of humerus (→ AIN palsy) AIN compression syndrome Pronator teres syndrome Elbow dislocation | Failed OK sign (FDP 2/3 + FPL) Hand of benediction | No sensory deficit | PT: resisted pronation with elbow extended |
| | | | Palmar aspect of lateral 3 1/2 digits + thenar area | FDS: isolated long finger PIPJ flexion |

5.2 Compression neuropathy
Differential diagnosis of compression neuropathy

- Cervical radiculopathy
- Brachial plexopathy
- Peripheral neuropathy
  Pathophysiology
- Nerve compression impairs epineural blood flow & axonal conduction
- **Double crush syndrome:** peripheral entrapment syndromes often associated with cervical/ lumbar spondylosis
  - Proposed explanation: proximal compression of a peripheral nerve renders it more susceptible to the effects of a second, more distal injury (e.g. cubital tunnel syndrome & Guyon's canal syndrome)

Overview of UL compression neuropathy
| | Syndrome | Compression site | Remarks |
| ----------- | ----------- | ----------- | ----------- |
| Brachial plexus | Thoracic outlet syndrome | 1st rib & clavicle | Causes: cervical rib, fracture clavicle, Pancoast tumour |
| Median nerve | Pronator teres syndrome | 2 heads of pronator teres | |
| | **Carpal tunnel syndrome (MC)** | Carpal tunnel | |
| Ulnar nerve | Cubital tunnel syndrome | Median epicondyle of humerus Olecranon process | Associated with cubital valgus |
| | Guyon canal syndrome | Guyon canal (pisiform & hook of hamate) | Most common cause: ganglion from the triquetrohamate joint |
| Radial nerve | PIN syndrome | Arcade of Frohse | Motor weakness |
| | Wartenberg's syndrome | ECRL & BR | Sensory loss (superficial radial nerve) |

Thoracic outlet syndrome
Anatomy:

- Brachial plexus and subclavian a. pass through scalene triangle
- Subclavian v. passes ant. to scalenus anterior
  Causes:
- Anatomical abnormalities: e.g. **cervical rib**, scalenus hypertrophy, **previous fracture (e.g. clavicle, 1st/2nd rib)**
- **Pancoast tumor**
- Trauma: hyperextension injury, repetitive microtrauma (e.g. athletes), poor posture

[Image of the anatomy of the thoracic outlet with labels indicating the brachial plexus, scalenus medius, scalenus anterior, and subclavian artery.]

Classification, clinical features and management
| Type | Signs | Treatment |
| ----------- | ----------- | ----------- |
| Neurological (nTOS) | **Lower brachial plexus injury** (e.g. paraesthesia / weakness along ulnar distribution) | Physiotherapy +/- Botox injection to relax scalene muscles |
| Venous (VTOS) | Deep vein thrombosis (Paget-Schroetter syndrome) | Thrombolysis, anticoagulation Surgical decompression |
| Arterial (aTOS) | Claudication, acute limb ischemia | Embolectomy Surgical decompression |

Special tests: Adson's maneuver (fig.), Roo's test, Elvey's test
Investigations: bloods, **CXR, Doppler USG**, nerve conduction studies, MRI, CT angiogram

[Image of a doctor performing the Adson's maneuver on a patient.]

Surgical procedures to decompress thoracic outlet: seldom required

- Supraclavicular / Transaxillary excision of 1st rib / cervical rib
- Scalenectomy

244
Cubital tunnel syndrome

- Ulnar nerve entrapment at elbow (DDx: cervical myelopathy, T1 radiculopathy)
- Examine elbow: **cubital valgus** deformity, limited ROM, Tinel sign, ulnar nerve subluxability, elbow flexion test
- Differentiate from distal compression: less prominent claw hand (FDP 4/5), dorsal sensory also affected

Management

- Conservative: **soft elbow extension splint** (fig.), physiotherapy, lifestyle modification
- Pharmacological: local steroid injection, pyridoxine
- Surgical: Decompression in-situ, medial epicondylectomy, **anterior transposition** of ulnar nerve

Carpal tunnel syndrome
Risk factors

- Primary (MC): **aging, female**
- Secondary:
  - Endocrine: **DM, hypothyroid,** acromegaly
  - Inflammatory: **RA**, gout
  - SOL: ganglion
  - Post-traumatic: wrist fracture
  - Physiological: **obesity, pregnancy**

Clinical features

- **Pain & numbness in distribution of median nerve** (first 3 1/2 digits)
  - Thenar area spared: palmar cutaneous branch of median nerve branches proximal to flexor retinaculum
  - Worse at night, relieved by hanging over the side of bed or shaking
- **Thenar muscle wasting** and weakness of thumb abduction

Differential diagnosis

- Cervical spondylosis (esp. C6/7): neck pain + neck movement exacerbates
- Pronator teres syndrome: forearm motor involvement + palmar sensation affected
- Thoracic outlet syndrome
- Peripheral neuropathy

Investigations

- Clinical diagnosis
- Nerve conduction studies (normal conduction does not r/o CTS)

Management

- Conservative: **night-time wrist splint** (fig.), physiotherapy, lifestyle modification
- Pharmacological: local steroid injection to reduce swelling, pyridoxine, diuretics
- Surgical:
  - Indications: CTS **unresponsive to conservative treatment** for 6 weeks, associated **sensory / motor deficit**, axonal loss on NCS
  - **Carpal tunnel release** (division of flexor retinaculum): open vs endoscopic (fig.)
  - Specific complications:
    - Persistent CTS symptoms (inadequate release)
    - Nerve injury: palmar cutaneous branch
    - Vascular injury: superficial palmar arch

[Image of a person wearing a blue elbow brace that immobilizes the elbow joint, keeping the arm straight. The brace is secured with straps around the arm and forearm.]

[Image of a person's hand with an arrow pointing to the thenar eminence, the fleshy area at the base of the thumb. The hand shows signs of aging, with wrinkles and prominent veins.]

[Image of a person wearing a black wrist brace, which extends from the mid-forearm to the mid-palm, immobilizing the wrist joint. The brace has adjustable straps and a rigid support on the palm side.]

[Image of a diagram illustrating the surgical incision points for open carpal tunnel release. The diagram depicts a hand with three marked lines: the "Mini-open" approach, the "Open" approach, and the "Endoscopic" approach. Each line indicates where the incision would be made on the palm.]

[Image showing a surgical field where carpal tunnel release is being performed. The flexor retinaculum is exposed and being cut with surgical instruments.]

[Image showing a surgical procedure with blood visible, indicating the location of superficial palmar arch injury.]

5.3 **Tendon-related pathology**
Definitions

- Tendinosis: age-related degeneration; can be with pain, but no inflammatory signs (e.g. redness)
- Tendinitis: inflammation of tendon
- Tenosynovitis: inflammation of synovial sheath
- Tenovaginitis: inflammation of fibrous sheath, i.e. pulley

[Detailed illustration of a wrist joint with labels. The illustration highlights the tenosynovium, tendon, synovial cavity, mesotendon, marrow, bone, and periosteum. Six extensor compartments are shown: Compartment 1 contains Extensor pollicis brevis and Abductor pollicis longus; Compartment 2 contains Extensor carpi radialis brevis and Extensor carpi radialis longus; Compartment 3 contains Extensor pollicis longus; Compartment 4 contains Extensor digitorum and Extensor indicis; Compartment 5 contains Extensor digiti minimi; and Compartment 6 contains Extensor carpi ulnaris. The ulna and radius are labeled, and the view is marked as Anterior.]

**De Quervain's tenosynovitis (Gamer's thumbs)**

- Anatomy: 6 extensor compartments on dorsal aspect of wrist, separated by fibrous septa
  - De Quervain's disease: stenosing tenovaginitis/ tenosynovitis within the first extensor compartment of wrist (contain APL & EPB)
- Risk factors
  - Female aged 30-50y
  - Pregnancy
  - Occupation that involves repetitive movement of hand & wrist, e.g. housewife
- Clinical features
  - Pain near the base of thumb + swelling
  - Finkelstein's test: acute pain at radial styloid process and along EPB/APL tendons when thumb is grasped and sharply deviated towards the ulnar side
- Differential diagnosis
  - 1st CMCJ osteoarthritis: Grind test+ (forcefully push thumb against CMC joint with rotation)
  - Wartenberg's syndrome (neuritis of superficial radial nerve): common in those wearing tight watch/ jewelry
  - Intersection syndrome: acute tendinopathy of EPB & APL as they cross over the tendons of 2nd extensor compartment (ECRL & ECRB)
- Investigations: clinical diagnosis; plain hand XR to r/o DDx
- Management:
  - Conservative: lifestyle (avoid repetitive actions), wrist splint
  - Pharmacological: local steroid injection
  - Surgical decompression: percutaneous / endoscopic release → widen the tunnel roof for tendons to move

[Illustration of the Finkelstein Test. Step 1 shows a hand making a fist with the thumb tucked inside. Step 2 shows tilting the hand down.]
Pain felt during the Finkelstein Test is a positive indicator of de Quervain's syndrome.

245

# Trigger finger

- Definition: stenosing tenovaginitis of A1 pulley causing finger clicked / **locked** in flexion, preventing a return to extension
  - Most common: ring finger, middle finger, thumb
- Anatomy: Pulley system prevents flexor tendons from bowstringing
  - Palmar aponeurosis
  - Annular ligaments (x5): A1, A3, A5 overlie MCPJ, PIPJ and DIPJ
  - Cruciate ligaments (x3)
- Pathophysiology
  - **Flexor tenosynovitis** causes local nodal formation distal to pulley, most common A1 pulley (overlie MCP joint)
  - Flexion causes node to move proximal to pulley → fail to pass back
- Risk factors
  - Occupation that involves **prolonged gripping**, e.g. golfer
  - Elderly female
  - Inflammation: DM, RA, gout
- Green's classification
  - Grade I: palm pain and tenderness at A1 pulley
  - Grade II: catching of digit, can actively extend
  - Grade III: locking of digit, passively correctable
  - Grade IV: fixed flexion deformities
- Investigations: clinical diagnosis, bloods
- Management
  - Conservative: splint that holds the finger in extension position at night
  - Pharmacological: local steroid injection (into A1 pulley)
  - Surgical: surgical release of A1 pulley

[Illustration of hand with "Trigger finger" condition. The illustration shows the palmar side of the hand with a finger bent at the proximal interphalangeal joint. The A1 pulley is highlighted in red at the base of the finger. The illustration shows how the flexor tendon can get stuck at this point when the finger tries to extend.]

[Illustration of hand with "Trigger finger" condition. The illustration shows the palmar side of the hand with a finger bent at the proximal interphalangeal joint. The A1 pulley is highlighted in red at the base of the finger. The illustration shows how the flexor tendon can get stuck at this point when the finger tries to extend.]

# Ganglion cyst

- Pathogenesis: periarticular mucoid degeneration after repetitive movement → herniation of dense connective tissue → filled with synovial fluid
- MC soft tissue tumor of hands, occur at any age
- Never becomes malignant and may resolve spontaneously
- Risk factors: **female**, **OA**, previous joint / tendon injury
- Clinical features
  - Site: **dorsal wrist (70%)** from radio-lunate ligament
  - Appearance: solitary **spherical painless** smooth cystic lesion
  - Palpation: non-tender, firm, rubbery, attach to joint capsule / tendon sheath, variable mobility
  - **Transilluminable** due to cystic content
  - Neurological deficit if **nerve impingement**
- Differential diagnoses: tenosynovitis, giant cell tumor (solid fixed mass), lipoma, sarcoma
- Diagnosis: clinical +/- USG (well-defined margins, thick wall with acoustic enhancement)
  - X-ray cannot see ganglions: rule out OA / bone malignancy
- Management:
  - Observe with brace / needle aspiration + immobilization (1st line)
  - Complete excision if persistent

[Two-part image labeled "A" and "B". Image A shows a dorsal view of a hand with a ganglion cyst visible on the wrist. The cyst appears as a smooth, rounded bulge under the skin. Image B shows a lateral view of a hand with a ganglion cyst on the wrist. The cyst is seen as a distinct swelling on the dorsal aspect of the wrist.]

# Tendon sheath infections → Kanavel signs

1. Tenderness over flexor sheath
2. Pain on passive extension
3. Flexed posture of digit
4. Fusiform swelling of digit

5.4 Hand & wrist trauma
Distal radius fracture
Very common (1/4 of all fractures), associated with osteoporosis ("fragility fracture")
| | Colles' fracture (MC, >90%) | Smith fracture |
| :----------------- | :------------------------------------------------ | :-------------------------------------------- |
| MOI | FOOSH forwards → landing on palmar wrist | FOOSH backwards → landing on dorsal wrist |
| Clinical features | Extra-articular fracture* | Extra-articular fracture* |
| | Dinner fork deformities | Garden spade deformities |
| | Low median nerve injury: lateral 3 1/2 finger + palm numbness | |
| Radiological features (x6): | Shortened radius | Shortened radius |
| AP + lateral | Ulnar styloid fracture | Ulnar styloid fracture |
| X-ray wrist | Dorsal angulation + displacement | Volar angulation + displacement |
| | Radial angulation + displacement | Radial angulation + displacement |
| Management | Stable extra-articular fracture: Closed reduction + short arm cast immobilisation x 6 weeks (fig.) | |
| | Unstable fracture^: ORIF with plating / K-wire fixation | |
| | Open fracture: external fixation | |

\*Barton's fracture: intra-articular fracture with associated dislocation of radio-carpal joint

[Detailed illustration of Colles' fracture, Smith fracture, and Barton fracture. The images show the fractures in both dorsal and ventral views, highlighting the displacement and angulation of the bone fragments. The different types of fractures are clearly labeled.]

Radiographic criteria
| Measurement | Normal | Unstable fracture: indicated for ORIF |
| :------------------------- | :------- | :------------------------------------------------------------------------------------------- |
| Radial height (AP) | 11mm | >5mm shortening |
| Radial inclination (AP) | 22° | Change >5° |
| Articular stepoff (AP) | Congruous| Intraarticular fracture with >2mm stepoff |
| Volar tilt (Lateral) | 11° | Dorsal angulation >5° or >20° difference with contralateral distal radius |
| Others | | Associated ulnar fracture (NOT ulnar styloid #) |
| | | Comminuted fracture |

Frykman classification of Colles' fracture
| Radius fracture | Ulna fracture: absent | Ulna fracture: present |
| :------------------------------------------------------ | :------------------ | :------------------- |
| Extra-articular | I | II |
| Intra-articular (radiocarpal joint) | III | IV |
| Intra-articular (distal radioulnar joint) | V | VI |
| Intra-articular (radiocarpal joint + distal radioulnar joint) | VII | VIII |

Associated complications

- Nerve: must assess all 3 nerves: lower median nerve injury (~CTS + palm numbness) is most common
- Bone: malunion, radial styloid fracture, scaphoid fracture
- Tendon: EPL tendon rupture
- Soft tissue: TFCC injury (triangular fibrocartilage complex), scapholunate lig. injury, lunotriquetral lig. injury
- Joint: Barton's fracture (radiocarpal joint injury), DRUJ injury, secondary OA

Scaphoid fracture
Mechanism of injury

- FOOSH
- Distribution: waist (70%), distal pole (20%), proximal pole (10%, most likely causing AVN) - Blood supply (dorsal branch of radial a.) enters in distal pole and travels retrograde towards proximal
  Clinical features
- Tenderness over anatomical snuffbox
- Pain on axial loading of thumb / palpating scaphoid tubercle
- Complications - Avascular necrosis (AVN) (30%): higher risk if more proximal fracture - Scaphoid non-union advanced collapse (SNAC): progressive arthritis due to prolonged non-union - Scaphoid relies on primary bone healing (scaphoid is mainly surrounded by articular cartilage, which does not provide blood supply for callus formation and consumes callus) → difficult to achieve absolute immobilisation
  Differential diagnosis
- Distal radius fracture
- Fracture of other carpal bones / base of 1st MC
- Wrist sprain
- De Quervain's tenosynovitis
  Investigations
- XR: AP, lateral, scaphoid view (30° wrist extension, 20° ulnar deviation)
- If high clinical suspicion - Thumb splint + repeat XR in 14 days - MRI wrist
  Management
- Non-operative: indicated if undisplaced fracture, normal XR but high clinical suspicion (as above)
  - Immobilisation: thumb spica cast (fig.)
- Operative: indicated if displaced / proximal fracture
  - Percutaneous screw fixation

[Figure 3-(A) Initial AP radiograph showing a subtle linear lucency within the scaphoid (B) more
pronounced lucency observed in repeat imaging after 12 days]

[Image of a hand with a thumb spica cast]

Kienbock's disease

- Definition: avascular necrosis (AVN) of lunate
- Causes: vascular, trauma
- Clinical features: dorsal wrist pain
- Investigations: XR wrist (sclerosis of lunate), MRI wrist
  Mallet finger
- Definition: injury of extensor tendon of terminal phalanx (Zone 1) when an extended finger is forcibly flexed
- Clinical features: flexed DIPJ that cannot be actively extended (passive ROM intact)
- Management: DIPJ extension splint for 6-8 weeks, require operation if type III
- Complications: swan neck deformity

[Image of Classification of mallet finger: Type I: tendon rupture, Type II: bone avulsion, Type III: joint subluxation (usually fracture involve >50% of articular surface or >2mm articular stepping)]

Dupuytren's contracture

- Causes: alcoholism, cirrhosis, DM, HIV, anti-epileptics (phenobarbitone), systemic fibromatosis
- Management: conservative ROM exercise, resection/fasciectomy (if flexion contracture MCPJ/PIPJ >30%), arthrodesis/amputation

[Image of hand with mallet finger splint]

Other finger deformities

- Jersey finger: closed rupture of FDP; failed DIPJ flexion when hold fist (fig.)
- Skier's thumb: ulnar collateral ligament rupture →↑ ROM of thumb at MCPJ
- Boxer's fracture: fracture of 5th metacarpal neck; due to direct trauma to a clenched fist
- Bennett's fracture: fracture of 1st metacarpal base, due to forced abduction of 1st metacarpal in clenched fist

[Image of Boxer's fracture: fifth metacarpal fracture]

6 Hip
249

6.1 Anatomy
Neurovascular supply of hip joint

- Arterial supply is retrograde:
  - Medial circumflex femoral artery (main) & lateral circumflex femoral artery profunda femoris common femoral a.
  - Ligamentum teres: contain artery to head of femur
  - Nutrient vessels from bone
- Nerve supply: sciatic, femoral, obturator nerves - same innervation to knee joint → hip pain can be referred to knee and vice versa

[Illustration of the hip joint anatomy. The image shows the femoral head, acetabulum, and acetabular labrum. Arrows point to each part with labels. Another illustration depicts the femoral artery and profunda femoris artery, highlighting the adductor hiatus.]

Gluteal muscles

- Superficial muscles: gluteus medius & minimus (abductors; superior gluteal nerve)
- Deep muscles: piriformis (at the exit of sciatic nerve)

Hip muscles
| Muscles | Action | Nerve |
| --- | --- | --- |
| Anterior Quadriceps femoris<br>Sartorius<br>Pectineus<br>Iliopsoas | All except iliopsoas: Femoral<br>knee extension<br>Iliopsoas: hip flexion | Femoral<br>nerve<br>nerve<br>(L2-4) |
| Medial Adductor magnus/<br>longus/ brevis<br>Gracilis<br>Obturator externus | Hip adduction | Obturator<br>nerve<br>(L2-4) |
| Posterior Hamstrings (biceps femoris,<br>semitendinosis,<br>semimembranosus) | Hip extension<br>Knee flexion | Sciatic<br>nerve<br>(L4-S3) |

[Illustration showing the boundaries and contents of the adductor canal. The boundaries are medially (Sartorius), posteriorly (Adductor longus and Adductor magnus), and anterolaterally (Vastus Medialis). The contents are Nerve to vastus medialis, Femoral artery, Femoral vein, and Saphenous nerve]

Hunter's canal (adductor canal)

- Border: vastus medialis (quadriceps), adductor magnus, sartorius
- Femoral artery passes through to form popliteal artery

  6.2 Hip trauma
  Fracture neck of femur (#NOF)
  Definition: fracture between subcapital part of femoral head and 5cm distal to lesser trochanter
  Risk factor: osteoporosis
  Mechanism of injury

- Elderly: slip and fall (low-energy trauma: "fragility fracture")
- Young: road traffic collision (high-energy trauma)

Classification

- Fracture location (fig.)
  - Intracapsular (high AVN risk): head (rare, seen in posterior dislocation of hip), neck (subcapital, transcervical, basicervical)
  - Extracapsular (low AVN risk): intertrochanteric, subtrochanteric (within 5cm of lesser trochanter)

[X-ray image illustrating different types of hip fractures, including Intracapsular fractures (Subcapital, Transcervical, Basicervical) and Extracapsular fractures (Intertrochanteric, Subtrochanteric). The image labels the Capsule and the fracture locations]

Intracapsular #NOF: further classified by [Garden's classification](https://example.com/garden)
| Garden | Description | Prognosis |
| ----------- | ----------- | ----------- |
| Nondisplaced fracture | I | Nondisplaced incomplete fracture | Good → internal fixation |
| | II | Nondisplaced complete fracture | |
| Displaced fracture | III | Incompletely displaced, complete fracture | High risk of AVN (>95%): disruption of blood supply from MCFA |
| | IV | Completely displaced, complete fracture | → ORIF (young), hip replacement (elderly) |

[Image of Garden's classification of femoral neck fractures, showing illustrations and x-ray images of fractures types I-IV. Type I shows a nondisplaced incomplete fracture, Type II shows a nondisplaced complete fracture, Type III shows an incompletely displaced, complete fracture, and Type IV shows a completely displaced, complete fracture.]

Clinical features

- Pain in groin, thigh or referred to knee, exacerbated by **internal rotation** (most sensitive) and axial loading
- **Shortened, abducted and externally rotated** leg (unopposed action of short external rotators, e.g. gluteus medius/ minimus)

Investigation:

- **AP and lateral X-ray hip** +/- CT, MRI or bone scan
- Duplex USG to rule out DVT if delayed presentation
- +/- AP X-ray pelvis and femur (r/o other fractures e.g. pubic ramus, femoral shaft)

Radiological features on X-ray hip

- Externally rotated limb: more prominent lesser trochanter
- Shortened limb: higher lesser trochanter
- **Disrupted Shenton's line** (formed by medial edge of femoral neck and inferior edge of superior pubic ramus) (fig.)
- Displacement & completeness of fracture as in Garden's classification

Management

- Operative management is required for all hip fracture **within 48h** (**young: more urgent**; **old**: optimize medical condition first) to relieve symptoms and restore function
- Factors to consider: Risk of AVN (i.e. intracapsular, displaced fracture), age (<65 vs >65)
- **Surgical options** (need to know!)

|             | Joint replacement                                                           | Open reduction and internal fixation                                      |
| ----------- | --------------------------------------------------------------------------- | ------------------------------------------------------------------------- |
| Indications | **Intracapsular, displaced** fracture (Garden III/IV) **AND elderly >65yo** | Others                                                                    |
| Approaches  | Hemiarthroplasty                                                            | Intracapsular: cannulated hip screws                                      |
|             | Total hip replacement (if OA hip)                                           | Extracapsular: dynamic hip screws / intramedullary nail (e.g. Gamma nail) |

[Image of the anatomy of the hip, labeling structures such as the ischial spine, acetabulum, femoral head, greater trochanter, femoral neck, ischia tuberosity, inferior pubic ramus, superior pubic ramus, lesser trochanter, and femoral shaft. A line is drawn to illustrate a normal Shenton's line.]

More about surgical options:

Joint replacement

ORIF

251

[X-ray of a Hemiarthroplasty of the hip, showing the metallic femoral component inserted into the femur bone. The acetabulum is not replaced.]

Hemiarthroplasty

Cemented (Thompson)
vs uncemented (Austin-Moore)
Unipolar vs bipolar
(additional join
between 2 components)

[X-ray of a Total Hip replacement implant. The acetabulum is replaced and there is a metallic femoral component inserted into the femur bone.]

Total hip
replacement

Hemiarthroplasty

- replacement of
  acetabulum

[X-ray of a Cannulated Hip Screw with three screws inserted through the femoral neck into the head, forming an inverted triangle.]

Cannulated hip
screw

Three parallel screws
in an inverted triangle
formation

[X-ray showing a Gamma Nail implant, which consists of a long intramedullary rod inserted into the femur and secured with screws at the proximal end.]

Gamma nail
(cephalomedullary
nail)

Titanium rod is placed
through the medullary
cavity of the femur for
stabilisation

[X-ray showing a Dynamic Hip Screw implant, consisting of a lag screw inserted into the femoral head and neck, attached to a side plate fixed to the femur shaft.]

Dynamic hip
screw
(sliding hip screw)

Lag screw into the
neck and it can slide
through the sideplate
→ compression and
primary healing of
bone

- Prevent dislocation: do not squat / cross legs / flex hip>90°, **abduction pillow, high-low chair**
- Post-operative complications:
  - Immediate: bleeding, infection, leg length discrepancies, neurovascular injury
  - Long-term: joint dislocation, **prosthesis infection, AVN**
- Management of AVN
  - Joint replacement (hemiarthroplasty / THR)
  - Free vascularized fibular graft (FVFG): for young patients with viable femoral head
- Prevention of recurrence
  - **Fall prevention measures**
  - Treatment of osteoporosis: Improve bone mineral content by bisphosphonates and lifestyle modifications
    **Femoral shaft fracture**

Mechanisms of injury x4

- **High-energy trauma**
- **Pathological fractures** (e.g. metastatic deposits, osteomalacia)
- **Fragility fractures** (low-energy trauma in elderly)
- **Bisphosphonate-related fractures:** classically transverse # of proximal femur
  Clinical features
- Shortened externally rotated leg
- Complications: nerve injury (pudendal, femoral), haemorrhagic shock (can lose
  up to 1.5L of blood), malunion, infection, fat embolism
  Classification: Winquist-Hansen classification (degree of comminution)
  | Type 0 | No comminution |
  | --- | --- |
  | Type 1 | Insignificant comminution |
  | Type 2 | >50% cortical contact |
  | Type 3 | <50% cortical contact |
  | Type 4 | No contact between proximal and distal fragment |
  Investigations
- **AP and lateral X-ray** along entire femur (including hip & knee)
  Management: mainstay is **surgery**
- Immediate reduction & immobilisation: traction splinting e.g. **Kendrick traction device** (fig.)
  - Change to skin traction asap to prevent skin necrosis at groin; C/I in hip / pelvic fracture
- Operative (done within 24-48h): **antegrade intramedullary nail** (with closed or open reduction)
- Non-operative: long leg cast (fig.) if non-displaced fracture with multiple comorbidities

[Image of a traction splinting device]

[Image of a person wearing a long leg cast]

Distal femur fracture
Mechanisms of injury

- High-energy trauma in younger patients
- Low-energy trauma in older patients (pathological fracture)
  Clinical features
- Severe pain in distal thigh, inability to bear weight
- **Knee effusion**: indicate intra-articular extension
  Classification
- Type A: extra-articular
- Type B: partial articular
  - Hoffa fracture (fig.): type B with fracture of posterior femoral condyles in coronal plane (require lateral X-ray to pick up)
- Type C: complete articular
  Investigations: AP and lateral X-ray knee and femur
  Management: mainstay is surgery
- Immediate reduction & immobilisation: skin traction
- Operative: retrograde intramedullary nail (simple) / ORIF (complex) / external fixation (open #)
- Peri-prosthetic fractures may require ORIF or distal femoral replacement

Acetabular fracture
Anatomy

- Acetabulum: cup-like depression on inferolateral aspect of pelvis, articulate with head of femur
  Mechanism
- Usually **high-energy injury** (e.g. road traffic accident, fall from height)
  Clinical features
- Pain and inability to weight bear (similar to #NOF)
- Look for open fracture and assess neurovascular status of both limbs
- Assess skin for Morel-Lavallée lesions (fig.): internal degloving injury where skin and subcutaneous tissues are separated from underlying fascia
  Investigations
- Pelvic X-ray: AP + **Judet view** (tilt the patient 45° laterally in both directions - iliac oblique & obturator oblique)
- +/- CT scan
  Classification: Judet-Letournel classification (elementary fractures vs associated fractures)
  Management
- Pelvic binder is usually not indicated
- Undisplaced fractures: conservative management for 6-8 weeks
- Displaced fractures:
  - Young: ORIF to restore anatomy of joint surface and pelvic stability
  - Old: fracture fixation + total hip replacement

Pelvic fracture
Anatomy: pelvic ring formed by ilium, ischium, pubis and sacrum, and their supporting ligaments
Fracture pattern

- AP compression: **open book injury** (PS diastasis + SIJ diastasis)
- Lateral compression : pubic rami fracture
- Avulsion fractures: ASIS (sartorius), AIIS (rectus femoris), ischial tuberosity (hamstring)
- Vertical shear
  Bleeding source: fracture site, tearing of venous plexus, torn arterioles
  Clinical signs
- Tender bony landmarks
- High-riding prostate
- Estimated blood loss: 3-4L
  Investigation: X-ray pelvis (**AP** + **inlet view** + **outlet view**)

[Radiographs of two knees are shown side by side. Image A shows the anterior view of the knee, highlighting the joint space and bone structure. Image B depicts a lateral view of the same knee, demonstrating the alignment of the femur and tibia.]

[A CT scan shows a cross-sectional view of the pelvis, revealing a disruption in the bone structure on the right side, indicative of a fracture. The surrounding soft tissues appear normal.]

Management

- **Pelvic binder:** at the level of greater trochanters (tamponade effect)
- **External fixators:** pins inserted along iliac crests
- Urgent angiogram

# Hip dislocation

Classification

- Congenital dislocation: DDH [Paed ORT]
- Acquired dislocation: **posterior** (90%), anterior (rare), lateral (rare)
- Posterior dislocation
  - Mechanism of injury: dashboard injury (flexed hip & knee against dashboard in RTA)
  - Clinical features
    - Shortened limb that is **adducted, internally rotated and flexed**
    - Associated injury: fracture (femoral head, NOF), sciatic nerve injury
    - Complications: AVN (fracture-dislocation highest risk)
  - Management
    - XR hip: disrupted Shenton's line
    - Closed reduction
    - Post-reduction CT to assess any fracture

## 6.3 OA hip

See [Systemic diseases] for pathology and aetiology

- Secondary OA hip more common in Chinese population
  Clinical features
- Hip pain radiating to knee, aggravated by weight-bearing and improved with rest
- Morning stiffness
- **Externally rotated** limb on supine position
- Antalgic gait
- Painful passive movement with reduced ROM
- End-stage: fixed flexion deformity with Trendelenburg gait
  DDx: fractures, sciatica, trochanteric bursitis, gluteus medius tendinopathy
  Radiological features
- 4 features of OA (fig.)
- Features of underlying cause
  - DDH: hip dislocation, hip dysplasia (inadequate acetabular coverage)
  - AVN: osteopenia, crescent sign
  - AS: fusion of SI joint
    Management
- Non-operative: pain relief, lifestyle modifications (e.g. weight loss, regular exercise, smoking cessation), physiotherapy
- Operative: hemiarthroplasty / total hip replacement
  - Different surgical approaches defined relative to gluteus medius:

| Approach                          | Advantage                                | Disadvantage                                      |
| :-------------------------------- | :--------------------------------------- | :------------------------------------------------ |
| Posterior - most common           | Preserve abductor mechanism →Rapid rehab | Sciatic nerve injuryRisk of hip joint dislocation |
| Anterolateral (modified Hardinge) | Detach abductor mechanism →Good exposure | Superior gluteal nerve injury                     |
| Anterior (Smith-Petersen) - rare  | For open washout of infected hip         |                                                   |

- Specific complications: thromboembolism, dislocation, infection of prosthesis, leg length discrepancy

[Image of a patient lying on an examination table, showcasing the external rotation of the leg from the hip. The right leg is more noticeably rotated outward compared to the left. The image captures the overall body positioning, including the legs and feet, to illustrate the specific presentation of external rotation at the hip.]

[Image of an X-ray of a hip joint. The X-ray reveals signs of osteoarthritis, including joint space narrowing, osteophyte formation (bone spurs), and subchondral sclerosis (increased bone density). The features suggest degenerative changes within the hip joint.]

254
Follow-up after THR: **Harris Hip Score** (full mark: 100)

- Pain (44)
- Function (47)
  - Gait (33): limp, support (none / cane / crutch), distance walked
  - Activity (14): stairs, wear socks/shoes, sitting time, enter public transportation
- ROM (9)

## 6.4 AVN of hip

Definition: cellular death of bone components due to interruption of blood supply
Aetiology

- Trauma
- Long-term steroid use
- Alcohol (amount similar to cirrhosis)
- Inflammatory: SLE
- Infection: osteomyelitis, septic arthritis
- Decompression sickness (Caisson disease/ bends)

Clinical features

- Insidious onset of hip pain
- Physical exam: limited ROM, esp. **abduction** & **internal rotation**

Investigations

- XR: osteopenia → sclerosis (marrow infarct with calcification) → **crescent sign** (subchondral lucency indicating subchondral collapse) → secondary OA changes
- MRI: more sensitive and specific, detect contralateral AVN (high risk)
  - T2W: **double line sign** (outer dark sclerosis, inner bright granulation tissue) (fig.)

[MRI scan showing a hip joint. The image is in grayscale and shows the detailed anatomy of the hip, including the femur and acetabulum. The scan highlights areas of sclerosis and granulation tissue. There is also a scale included.]

[Conventional radiograph of the right femur in the frog-leg position obtained with the patient's thigh abducted and flexed shows subchondral area of hyperlucency (arrows) in the anterolateral aspect of the proximal femoral head]

- Ficat classification: combine plain XR, MRI, bone scan, clinical features to guide treatment & prognosis

| Stage | Features                                                                                      |
| ----- | --------------------------------------------------------------------------------------------- |
| 0     | Normal radiographs (silent hip)                                                               |
| I     | Inconspicious abnormality orminor osteopenia changes                                          |
| II    | Sclerotic or cystic lesions                                                                   |
| III   | II a. Focal radiological changes                                                              |
|       | II b. Crescent sign without flattening of the femoral head                                    |
| IV    | Flattening of the femoral head or femoral head collapse, joint space normal                   |
|       | Femoral head collapse and osteoarthritis of the hip (joint spacecollapse, acetabular changes) |

Management

- Non-operative: bed rest, walking aids, bisphosphonates (but associated with ONJ)
- Joint-preserving operation:
  - Core decompression (reduce intraosseous pressure to allow ingrowth of blood vessels)
  - Osteotomy
  - Bone graft (free vascularized fibular graft FVFG)
- Total hip replacement (Ficat stage 3&4)

7 Knee
255

7.1 Anatomy
Knee joint

- Arterial supply: genicular anastomoses (genicular
  branches of femoral & popliteal arteries)
- Articular surface - Tibiofemoral: weight-bearing - Patellofemoral: provide fulcrum to increase
  power of knee extensor (quadriceps femoris) +
  stabiliser of knee joint
- Patella: largest sesamoid bone in the body
- Within tendon of quadriceps femoris
- Attach to patellar ligament

Menisci

- C-shaped fibrocartilage
- Functions: **shock absorbers**, increase stability of knee joint (by deepening the articular surface of tibia)
- Significance: - Medial meniscus attached to MCL → MCL damage causes medial meniscal tear - Lateral meniscus not attached to LCL - Mostly avascular (except outer 1/3): no spontaneous repair
  [Diagram of the knee showing the anterior cruciate ligament, posterior cruciate ligament, lateral meniscus, medial meniscus, lateral collateral ligament and medial collateral ligament.]

Bursae

- Small fluid-filled sac lined by synovial membrane
  [Illustration of a knee showing the location of the suprapatella bursa, prepatella bursa, infrapatella bursa, and semimembranosus bursa. The suprapatella bursa is colored blue, the prepatella bursa is colored green, the infrapatella bursa is colored yellow, and the semimembranosus bursa is colored brown.]

Ligaments

- Collateral ligaments (MCL, LCL): prevent excessive medial or lateral movement
- Cruciate ligaments:

|           | ACL                                                  | PCL                                                   |
| :-------- | :--------------------------------------------------- | :---------------------------------------------------- |
| Insertion | Lateral femoral condyle                              | Medial femoral condyle                                |
|           | Medial tibial condyle                                | Lateral tibial condyle                                |
| Function  | Prevent **anterior translation & rotation** of tibia | Prevent **posterior translation & rotation** of tibia |
|           | Prevent hyperextension of knee                       | Prevent hyperflexion of knee                          |

Pes anserinus

- Conjoint tendons of 3 muscles that insert onto anteromedial aspect of tibia
- Say Grace before Tea: sartorius, gracilis, semitendinosus
- Pes anserinus bursitis is a cause of chronic medial knee pain
  Iliotibial band (ITB)
- Shared aponeurosis of tensor fasciae latae & gluteus maximus, inserted onto anterolateral aspect of tibia (Gerdy's tubercle)
- IT band syndrome (due to repetitive flexion & extension of knee) is a cause of chronic lateral knee pain

  7.2 Soft tissue injuries
  Anterior cruciate ligament (ACL) tear
  Mechanism of injury

- Contact mechanism: valgus force to knee when foot is fixated to the ground
- Non-contact mechanism (MC): sudden deceleration & pivoting (change of direction)
- Risk factors: weak hip abductors, genu valgus, flatfoot
- Associated injury: - Unhappy triad: ACL tear, MCL tear, medial meniscus injury - Segond fracture (fig.) - avulsion of lateral tibial plateau, pathognomonic of ACL injury
  Clinical features
- Intensive pain + audible "pop" sound
- Immediate joint swelling (haemoarthrosis due to tear of highly vascularised ligament)
- Knee instability ("give way" sensation) and unable to bear weight
- Special tests: Lachman test (more sensitive), anterior drawer test, pivot shift test

Assess severity: Lachman grading
| Transition grade | Endpoint grading |
| --------------------- | ------------------------------------- |
| Grade 0: <2mm translation | Grade A: firm, sudden endpoint |
| Grade 1: 2-5mm translation | Grade B: absent / ill-defined / softened endpoint |
| Grade 2: 5-10mm translation| |
| Grade 3: >10mm translation| |

DDx: fracture, meniscal tear, collateral ligament tear, quadriceps tendon / patellar ligament tear
Investigations

- XR knee: bony avulsion, joint effusion, lipohaemarthrosis (fat from bone + effusion from ligament)
- MRI knee: gold standard, distinguish partial vs complete tear, assess associated soft tissue injuries (e.g. meniscal tear)

Management
Immediate: RICE
Conservative for inactive patients

- Knee brace (fig.): provide stability, but have no effect of reducing risk of OA
- Physiotherapy: quadriceps strengthening
- Lifestyle modification, e.g. avoid contact sports
- Risk: early OA knee, new cartilage/meniscus injury
  Operative for active patients - Arthroscopic ACL reconstruction (NOT repair)
- Indications
  - Concomitant rupture of collateral ligaments
  - Knee instability
  - ADL & functional demands, e.g. professional sports player (that require pivoting motions)
- Timing: after haemothrosis resolves (risk of arthrofibrosis) and regaining ROM - require PT 'prehab'
- Graft choice:
  - Autograft:
    - Patellar tendon graft (harvest at central 1/3 of patella): early healing (bone-tendon-bone graft), anterior knee pain
    - Hamstring graft (harvest at pes anserinus: gracilis + semitendinosus): high tensile strength if use quadrupled stranded graft, but poor initial healing
    - Quadriceps tendon: avoid injury to infrapatellar branch of saphenous nerve (in patellar tendon graft), highest tensile strength
  - Allograft: risk of infection and immunologic reaction
- Complications: Graft failure, OA knee, arthrofibrosis
- Post-op rehabilitation

[X-ray image of a knee with a red circle highlighting a specific area. The bone structure is visible, showing the femur and tibia, with a joint space in between.]

[An image of a knee brace, made of black fabric and plastic supports, is shown. It covers the knee and part of the upper and lower leg, with adjustable straps and hinges.]

[A photograph shows three legs from the mid-thigh to just below the knee. Each leg has a vertical scar on the front of the knee, indicating different types of tendon grafts: Patellar Tendon, Quad Tendon, and Hamstring Tendon. The skin tones vary slightly, and the scars are in slightly different locations.]

257
Posterior cruciate ligament (PCL) tear
Mechanism of injury: less common than ACL tear

- High-energy trauma: direct blow to proximal tibia
- Low-energy trauma: hyperflexion of knee with plantarflexed foot
  Clinical features
- Posterior knee pain + audible "pop" sound
- Knee instability ("give way" sensation) and unable to bear weight
- Special tests: **posterior sag test**, **posterior drawer test**
  Management
- Immediate: RICE
- Mainly **conservative** (knee brace + PT) → surgery if recurrent instability / associated multi-ligament tears

Medial collateral ligament (MCL) tear
MCL is the most commonly injured ligament of the knee.
Mechanism of injury

- Contact: direct blow to _lateral_ aspect of knee → _valgus_ stress
- Non-contact: valgus stress with external rotation (e.g. skiing)
  Clinical features
- Grade I (no loss of MCL integrity): **medial joint line pain**
- Grade II (incomplete tear of MCL): valgus stress test +ve in 30º flexion
- Grade III (complete tear of MCL + capsule injury): valgus stress test +ve in _both_ 30º flexion and full extension
  Investigations
- XR knee: exclude fracture
- MRI: diagnostic + grading of injury
  Management
- Mild (grade I-II): conservative (RICE, analgesics, strengthening exercise, hinged knee brace)
- Severe (grade III): conservative as above, crutches
  - Ligament repair indicated if **distal avulsion** seen on MRI
- Complications: knee instability, **saphenous nerve** injury (MCL)

Meniscal tear
Causes

- Trauma: **twist** their knee while flexed and weight-bearing
- **Degenerative** in older patients
  Classification
- Location: outer 1/3 (vascularised), inner 1/3 (avascularised), middle 1/3 (intermediate)
- Pattern: - **Vertical / Longitudinal (MC)**: associated with ACL tear, progress to bucket-handle tear - Radial: progress to parrot beak tear - Horizontal (parallel to tibial plateau): more common in degenerative, progress to flap tear
  Clinical features
- Intense sudden onset pain
- Delayed swelling (6-12h): lack of vascular supply
- **Locked knee in flexion**: free body from meniscus (most commonly bucket-handle type)
- Special tests: **McMurray test, Apley's grinding test**
  Investigations
- XR knee: rule out fracture
- MRI knee: diagnostic + grading (fig.)

[Image Description: A diagram illustrating different types of meniscus tears. The diagram consists of six images arranged in two rows. The first row shows a longitudinal or vertical tear, a radial tear, and a horizontal tear, each depicted as a crescent-shaped meniscus with a corresponding tear. The second row shows how each type of tear can progress: the longitudinal tear progresses to a bucket handle tear, the radial tear progresses to a parrot beak tear, and the horizontal tear progresses to a flap tear. Each tear is shown in detail within the meniscus.]

Different Types Of Meniscus Tear

Longitudinal (Vertical) Tear
Radial Tear
Horizontal Tear
May progress to
May progress to
May progress to

Bucket Handle Tear
Parrot Beak Tear
Flap Tear

LOCAL PHYSIO

258
Management
Conservative: preferred for <1cm meniscal tear

- RICE
- Analgesics
- Rehabilitation: encourage ROM, muscle strengthening
  Operative: arthroscopic surgery
- Indications: failed conservative treatment, bucket-handle tear, associated ligament injury, locked knee
- Meniscal repair with suture: indicated if outer 1/3 (.'good vascular supply), vertical tear
- Partial meniscectomy: indicated if inner 1/3 (e.g. radial tear, horizontal tear)
- Either one if middle 1/3
  Complications of knee arthroscopy: damage to saphenous nerve and vein, peroneal nerve, popliteal vessels
  Iliotibial band syndrome
  Anatomy of IT band:
- Shared aponeurosis of tensor fasciae latae and gluteus maximus
- Extend from iliac tubercle to anterolateral tubercle of tibia (Gerdy's tubercle)
- IT band syndrome: inflammation → impingement against lateral femoral condyle
  Risk factors:
- Repetitive flexion and extension of knee: e.g. runners, weightlifters, cyclists
- Genu varum
- Hip abductor weakness
  Clinical features:
- Most common cause of lateral knee pain, exacerbated by exercise
- Special tests demonstrate pain over lateral femoral condyle at 30° flexion: Nobles
  test, Renne test
  Investigations: clinical diagnosis, X-ray / MRI to exclude other pathology
  Management:
- Conservative: lifestyle modifications, analgesics, local steroid injections, physiotherapy
- Operative: indicated if failed conservative treatment for 6 months
  - Percutaneous / Open release of iliotibial band

[Illustration of the iliotibial band on the right leg, showing the Tensor fascia lata and the Iliotibial tract.]

7.3 Bone and joint injuries
Patella fracture
Mechanism of injury

- Direct: fall on knee
- Indirect: sudden flexion of knee against contracted quadriceps
  Clinical features
- Inability to extend knee (unable to straight leg raise)
- Immediate swelling + pain
- Visible and palpable patellar defect
  DDx: other fractures (e.g. tibial plateau, distal femur), cruciate / collateral
  ligament injury, quadriceps tendon rupture
  X-ray features (AP, lateral, skyline view - may not be possible due to pain
  inhibiting knee flexion to 30°)
- Fracture type: transverse, polar, comminuted
- Alignment: displaced, undisplaced
- Not to be confused with bipartite patella (congenital condition in 2-
  3% of population)
  Management
- Non-displaced: straight leg immobilisation by hinged knee brace to
  allow early weight bearing in extension, quadriceps strengthening
- Significantly displaced / Disrupted extensor mechanism: ORIF with tension band wiring (fig.) - convert tensile
  force of extensor mechanism into compression force to assist fracture healing
- Comminuted: partial/total patellectomy
  Complication: loss of ROM, patellofemoral joint OA

[An X-ray image of a fractured patella with an arrow pointing to the fracture site.]

[Two X-ray images showing the patella repaired with tension band wiring technique. These images are oriented in the anteroposterior and lateral views.]

259
Patella dislocation
Mechanism of injury

- Sudden contraction of quadriceps when knee is stretched in valgus and external rotation

Clinical features

- Patella apprehension test (upon passive **lateral** translation)
  Risk factors for patellar dislocation (lateral)
- Young obese female
- High riding patella (patella alta)
- Wide Q angle, genu valgus
- Shallow patellofemoral groove
- Weak quadriceps
- Connective tissue disease
  X-ray features (AP, lateral, skyline view)
- **Lateral** displacement of patella^ (pulled towards lateral side as knee is slight valgus)
  Management
- Non-operative (MC): knee immobilisation, progressive weight bearing & quadriceps strengthening

[Radiograph of a knee joint, viewed from the side. A red arrow points towards the patella.]

Tibial plateau fracture
Mechanism of injury

- **High-energy trauma** (e.g. fall from height, RTA) → impaction of femoral condyle
- Usually varus-deforming force → **lateral** tibial plateau more commonly fractured
  Clinical features
- Sudden onset knee pain and unable to bear weight
- Significant swelling: lipohaemarthrosis
- Associated injuries: **popliteal artery** (Cx: compartment syndrome), **common peroneal nerve**
  Investigation: X-ray knee (AP, lateral) + CT
- Schatzker classification
  Management
- Uncomplicated lateral #: **hinged knee brace** x 8-12 weeks, physiotherapy, analgesics
- Complicated / Medial #: **ORIF** + post-op hinged knee brace x 8-12 weeks
- Open #: external fixation → delayed definitive surgery

[Radiograph of a knee, showing a tibial plateau fracture. The image is in black and white, showing the bones and soft tissue of the knee.]

Tibial shaft fracture
Clinical features

- Severe pain and unable to bear weight
- High risk of **open fracture**: lack of significant soft tissue protection (esp. anteromedial side)
- High risk of **compartment syndrome**: 6 Ps, pain exacerbated by passive dorsiflexion of great toe
  Investigation:
- X-ray tibia and fibula (AP, lateral)
- CT scan: indicated if suspected intraarticular extension, spiral fracture (rule out fracture of **posterior malleolus**)
  Acute management
- RICE, analgesics, **reduction + above knee backslab** (anatomical reduction not necessary)
- Monitor for compartment syndrome
  Subsequent management: usually surgical
- Uncomplicated fractures: closed reduction + **intramedullary nail** for early weightbearing
- Proximal / Distal fractures with possible intra-articular extension: **ORIF**
- Open fracture: external fixation before definitive surgery
  Complications: **compartment syndrome, limb ischaemia**, malunion/non-union

  7.4 OA knee
  See [Systemic diseases] for pathology and aetiology

- Pathology: genu varum in normal individuals → **medial** compartment most commonly affected
  Risk factors:
- Genetics
- Constitutional factors: increasing age, **female, obesity**, low bone density
- Local factors: **previous trauma**, occupation, muscle weakness

Clinical features

- **Knee pain:** worse on going downstairs (patella-femoral joint
  involvement)
- Stiffness, locking of joints, instability
- **Reduced ROM with crepitations** - Flexion deformity: extension lag (correctable on
  passive) VS fixed flexion contracture
  Radiological features
- 3 compartments: medial, lateral, patello-femoral
- Views: - **Weightbearing AP:** medial vs lateral compartment - Lateral: anteromedial vs posteromedial (e.g. posterior
  osteophytes) - **Skyline:** patello-femoral joint space - Valgus stress / Varus stress: assess medial / lateral joint space - **Standing scanogram** of bilateral LL: alignment - Tibiofemoral angle (TFA): valgus vs varus - Mechanical axis of LL: pass through medial or lateral side - +/- Schuss view (30° flexion): more sensitive for early OA
- 4 features of OA

Kellgren-Lawrence (KL) classification for OA knee
| Grade | Description |
| ----------- | ----------- |
| Grade 0 | No joint space narrowing (JSN) |
| Grade 1 | Possible osteophytes, doubtful JSN |
| Grade 2 | Definite osteophytes |
| Grade 3 | Definite JSN |
| Grade 4 | Bone-on-bone deformity |

[Image: A line drawing of a right leg from the hip to the foot, showing the bones and some major landmarks. A vertical line runs from the ASIS (anterior superior iliac spine) down the leg. There is an arrow pointing at the location where the tibiofemoral angle is measured, and labels for the "Midpoint of Patella" and "Midpoint Between Two Malleoli". A second image is an X-ray showing a knee joint with severe bone-on-bone arthritis. The joint space is severely narrowed, and there are bony spurs and irregularities visible.]

Management of OA knee:

- Conservative:
  - Lifestyle modifications: weight loss, regular exercise (e.g. bicycle), smoking cessation
  - Adequate pain control: **NSAIDs** have proven benefit
  - Physiotherapy: quadriceps muscle strengthening to slow disease progression and improve biomechanics
  - P&O to relieve medial compartment pressure (controversial): valgus unloading brace, lateral in-sole
- Surgical options - **Total knee replacement (TKR)** - Preferred in: posteromedial OA, lateral OA, PFJ OA, significant
  fixed flexion contracture (≥ 10°), arc of motion ≤110° - **Unicompartmental knee arthroplasty (UKA):** e.g. Oxford implant - High tibial osteotomy: if young (M < 70, F <60)

[Image: A table listing the Oxford partial knee replacement selection criteria, numbered 1 through 5. 1. Medial bone-on-bone, 2. Functionally intact ACL, 3. Functionally intact MCL, 4. Full thickness lateral cartilage, 5. Acceptable patellofemoral joint.]

8 Foot and ankle

8.1 Anatomy
Bones

- Hindfoot: talus, calcaneus
- Midfoot: navicular (insertion of TP), cuboid, cuneiforms
- Forefoot: metatarsals (5th MT = insertion of peroneus brevis), phalanges

[An illustration shows the bones of the ankle and foot. Different bones are colored differently and labelled. The bones are tibia, fibula, talus, calcaneus, navicular, cuboid, and cuneiforms.]

Leg muscles

| Muscles                                                                                              | Main action                                       | Nerve                |
| :--------------------------------------------------------------------------------------------------- | :------------------------------------------------ | :------------------- |
| Anterior TA: insert into medial cuneiform and 1st MT EDL, EHL                                        | Inversion & dorsiflexion Extension & dorsiflexion | Deep peroneal        |
| Lateral Peroneal longus: insert into medial cuneiform and 1st MT Peroneal brevis: insert into 5th MT | Eversion of foot                                  | Superficial peroneal |
| Posterior superficial Gastrocnemius Soleus Plantaris                                                 | Plantarflexion of foot                            | Tibial               |
| Posterior deep Popliteus TP: insert at navicular tuberosity and medial cuneiform FDL, FHL            | Pop: unlock knee TP: inversion FDL, FHL: flexion  | Tibial               |

Joints:

- Ankle joint: Talus articulating with mortise (medial malleolus + tibial plafond + lateral malleolus)
- Inversion and eversion mainly occur at:
  - Talocalcaneonavicular joint
  - Subtalar (talocalcaneal) joint
- Ankle ligaments
  - Lateral collateral ligaments: anterior talofibular ligament (ATFL), PTFL, calcaneofibular ligament (CFL)
  - Medial collateral ligament (deltoid): very strong
  - Syndesmosis: anterior inferior tibiofibular ligament (AITFL), PITFL, interosseous membrane
- Sinus tarsi: between talus and calcaneus on lateral side
- Gait cycle:
  - Swing phase
  - Stance phase: Heel strike, foot flat, heel off, toe off
- Physical examination of the ankle
  - Palpate ankle joint line: medial to TA tendon (Dorsiflex to palpate ant. talus, plantarflex to palpate post. talus)
  - Instability: drawer test, talar tilt test
  - Palpate ankle ligaments
  - Palpate Achilles tendon: musculotendinous junction, midshaft, insertion, retrocalcaneal bursa (ant. to tendon)

[An illustration of Talocalcaneonavicular Joint and lower leg structure.
The Talocalcaneonavicular Joint is labeled with Talus, Subtalar joint (posterior talocalcaneum joint), Sustentaculum tali, Navicular, Spring ligament, Calcaneus.
The lower leg structure labeled with Fibula, Tibia, Medial malleolus, Deltoid ligament, Subtalar joint.
The other view of the lower leg structure labeled with Fibula, Tibia, Posterior and anterior inferior tibiofibular ligaments, Anterior talofibular ligament, Calcaneofibular ligament, Subtalar joint.]

Forefoot: hallux valgus, bunion, lesser toes
Midfoot: foot arch
Hindfoot:
valgus (+pes planus) → **tip-toe test**
varus (+pes cavus) → **Coleman block test**
Ankle DF/PF: +/- **Silverskiold test** - Neutralise subtalar joint - Ankle DF ROM at knee flexion > extension (+ve = Gastrocnemius contracture)

261

8.2 F&A deformities
Hallux valgus

- Definition: deformity at 1st MTPJ with medial deviation of 1st metatarsal + lateral deviation of hallux (+/- rotation of hallux) with associated joint subluxation
- Pathophysiology: intrinsic instability of 1st metatarsal → extrinsic tendons become the deforming force once escaped the intrinsic anatomical control → metatarsal head drift medially → reactive exostosis (bunion)

[Image Description:
Two diagrams side by side illustrating the progression of Hallux Valgus. The first diagram on the left shows a foot with normal alignment, labeled with "Medial" and "Lateral" sides. Key anatomical points are marked: EHB at the top, AbH on the medial side, and FHBM and FHBL towards the bottom. An arrow points from left to right towards the second diagram, which depicts a foot with Hallux Valgus. This foot exhibits a visible deviation of the big toe towards the other toes. It also has similar anatomical points labeled as in the first diagram: EHB, AbH, AdH, FHBM and FHBL.]

- Risk factors
  - Female
  - Family history
  - Connective tissue disorders, hypermobility syndrome
  - Anatomical variants: flatfeet, long 1st metatarsal bone
- Clinical features: pain over
  - Bunion (MC)
  - 1st MTPJ (arthritic)
  - Bunionette (5th MTPJ)
  - 2nd & 3rd MTPJ (transfer metatarsalgia)
  - Plantar callosities with without pain
- Physical examination in both non-weightbearing and weightbearing positions
  - Skin over medial prominence: any inflammation / breakdown
  - Range of movement: dorsal & plantar both 5mm, no transverse movement
  - EHL contracture
- Plain AP weight-bearing XR
  [Image Description:
  A black and white medical illustration of a foot skeleton, with lines and labels indicating the angles measured in Hallux Valgus. The angle between the 1st metatarsal and the proximal phalanx is labeled "Hallux Valgus (<15°) Angle". Another angle between the 1st and 2nd metatarsal is labeled "1-2 Intermetatarsal (<9°) Angle".] - Hallux valgus angle (<15°): the angle between the line projected from 1st MT and 1st proximal phalanx on axial view of foot - Mild (15-20°), moderate (21-39°), severe (>40°) - Intermetatarsal angle (<9°): the angle between the 1st and 2nd MT shaft on axial view of foot - OA 1st MTPJ
- Management
  - Conservative:
    - Footwear: side & deep toe boxes (fig.), orthosis for flatfoot
    - Physiotherapy: intrinsic muscle strengthening
  - Surgery: only EBM recommendation
    - Arthritic joint:
      - Arthrodesis (e.g. Lapidus procedure - 1st TMT joint)
      - Keller's procedure (excision arthroplasty + hemiphalangectomy)
    - Non-arthritis joint:
      - Osteotomy (1st MT realignment) e.g. Chevron for mild, Scarf for moderate/severe
      - Soft tissue rebalancing (e.g. McBride)
      - Bunionectomy (e.g. Keller)
- Complications of hallux valgus:
  - Avascular necrosis
  - Non-union
  - Displacement
  - Reduced ROM

[Image Description:
A color photograph showing a pair of feet, each wearing a black brace designed to correct hallux valgus (bunions). The braces are positioned on the medial side of the feet, near the big toes, and appear to provide support and alignment.]

262

263

Pes planus (flat foot)
Definition: collapse of medial longitudinal arch
Aetiology

- Tibialis posterior tendon dysfunction (MC): degenerative, inflammatory, traumatic
- Bone: tarsal coalition
- Ligament: generalised ligament laxity
- Nerve: neuroarthropathy (Charcot's joint)
- Joint: arthritis
  Clinical features
- Associated with hindfoot valgus and forefoot hallux valgus
- Tip-toe test: rigid (bone deformities, e.g. tarsal coalition) if medial arch still not formed & hindfoot valgus still present
  - Windlass mechanism: accentuation of medial arch when MTPJ is hyperextended during tiptoe
- Jack's test: passive dorsiflexion of great toe (to tighten plantar fascia)
- Complications: tenosynovitis of calcaneonavicular ligament (cross PTT) → permanent elongation → rupture → arthritis
  Investigations: XR foot & ankle for **Meary's angle** (talo-1st metatarsal angle) > 4°
  [Image Description: An X-ray image of a foot, illustrating the measurement of Meary's angle. The X-ray highlights the bones of the foot with the Talus and 1st metatarsal bones clearly labeled. Blue and orange lines are superimposed on the X-ray, demonstrating how the angle is measured between these two bones to assess foot alignment.]

Management

- Identify and treat/ refer early
- **Insole**: medial heel wedge

Pes cavus (high-arched foot)
Definition: high arch of foot that does not flatten with weightbearing
Aetiology

- Neuromuscular disease, e.g. muscular dystrophy, CMT disease (weakening of tibialis anterior & peroneus brevis)
- Malunion of calcaneal/ talar fractures
- Residual clubfoot
  Clinical features
- Callosities under metatarsal heads
- Coleman block test (fig.): stand on a 1' wood block under lateral foot (try to offload the 1st MT of the tripod)
  - Corrected: pes cavus is driven by forefoot deformity
  - Uncorrected: both forefoot and hindfoot deformities
    Management
- Conservative: extra-depth shoes, PT
- Surgery: plantar fascia release

Club foot
Congenital fixed deformity (CAVE)

- Cavus
- Adduction of forefoot
- Varus
- Equinus (plantarflexed)
  Management
- Conservative: Ponsenti method (manipulation + casting)
- Operative (if refractory): surgical release
  Ruptured tibialis posterior:
- Flexible hindfoot valgus
- Pes planus
- Cannot stand on heels
- Weakened inversion
- Normal / weakened plantarflexion: partially compensated by Achilles tendon

  8.3 F&A trauma
  Ankle sprain & instability
  Definitions

- Sprain: any painful twisting of a joint causing **ligamentous injury**
- Strain: physical effect of tensile stress involving tearing of some fibres of ligament
- Rupture: complete tear of ligament
  Classification
- **High ankle sprains:** injuries to the syndesmosis
- **Low ankle sprains:** injuries to ATFL, CFL (PTFL very strong → fracture instead of rupture)
  ΜΟΙ
- Inversion injury: forced inversion of plantarflexion of foot
- Eversion injury: forced eversion of foot → Pott's fracture (deltoid ligament very strong)
  Clinical features
- Tenderness, swelling & pain distal to lateral malleolus over affected ligaments
- Difficulty walking & bruising
- Medial ankle joint pain: **osteochondral lesion** (interruption of normal lining of joint surface in which both
  cartilage and the directly underlying bone are affected; most commonly at medial talar dome)
- Signs: **anterior drawer test, talar tilt test**
  Investigations
- XR indicated if meet **Ottawa Ankle rules**:
  Any pain in malleolar region + any one of:
  1. Bone tenderness at distal 6cm of posterior edge of **tibia** / tip of **medial malleolus**
  2. Bone tenderness at distal 6cm of posterior edge of **fibula** / tip of **lateral malleolus**
  3. Inability to bear weight **immediately** + in A&E for **4 steps**
  - View: **AP, lateral, mortise view** (20°
    oblique to allow uniform joint space)
    Management
- Conservative:
  - Ankle sprain: RICE, then early mobilisation
  - Ankle instability: PT for peroneal muscles
    strengthening, braces to prevent recurrent
    sprains
- Surgery for ankle instability
  - Indications: pain & instability despite
    conservative management
  - **Arthroscopic debridement** of impinging
    lesions
  - Reconstruction of lateral ligaments
    (Brostrom-Gould procedure)

[X-ray images of an ankle joint in AP and Mortise views. The AP view shows the ankle from the front, and the Mortise view shows the ankle at a 20-degree oblique angle to allow uniform joint space. Anatomical structures such as the fibula, tibia, talus, and medial malleolus are visible. Red dotted lines indicate areas of concern]

Differential diagnosis of ankle sprain

- Ankle fracture
- Contusion of extensor digitorum brevis: tearing of muscle causes formation of haematoma, with swelling
  anteromedial to lateral malleolus

264

Ankle fracture
Definition: fracture of any malleolus (lateral, medial, posterior [posterior aspect of distal tibia]) **with or without disruption to the syndesmosis**
Pott's fracture: bimalleolar/trimalleolar fracture due to forced eversion of foot
Classification

- By injury pattern: isolated lateral malleolus, isolated medial malleolus, bimalleolar (medial + lateral), trimalleolar (medial + lateral + posterior)
- By level: **Weber classification** for lateral malleolus fracture (higher level = higher chance of ankle instability with syndesmosis diasthesis) - Type A: below syndesmosis - Type B: at level of syndesmosis - Type C: above syndesmosis
  Differential diagnosis: tibial pilon fracture (fracture of tibial plafond)
  Investigations
- Ankle series: **AP, lateral, mortise view** - ankle in full dorsiflexion (or else talus appear to move posteriorly) - Check joint space for uniformity. Ensure no **talar shift**.
  Management
- Non-operative:
  - Indications: non-displaced fracture, Weber A fracture, Weber B fracture without talar shift
  - **Closed reduction, below-knee back slab**, repeat neurovascular exam + XR
- Operative:
  - Indications: bimalleolar/trimalleolar fracture, Weber B fracture with talar shift, Weber C fracture, open #
  - **ORIF** +/- **syndesmotic screw** / **tightrope fixation**

[Illustration depicting ankle fractures labeled A, B, and C. Fracture A shows a fracture below the syndesmosis, labeled as "Type A: below syndesmosis". Fracture B shows a fracture at the level of the syndesmosis, labeled as "Type B: at level of syndesmosis". Fracture C shows a fracture above the syndesmosis, labeled as "Type C: above syndesmosis".]

Tibial pilon fracture (plafond fracture)
Mechanism of injury: high energy axial load (e.g. RTA, fall from height) → **talus punch up** onto tibial plafond
Clinical features:

- Severe ankle pain, inability to bear weight, obvious ankle deformity with significant swelling
- Assess peripheral pulses, nerves (e.g. superficial peroneal, deep peroneal, tibial) and compartment syndrome
  Classification: _Ruedi-Allgower classification_
  Investigations: Ankle series (**AP, lateral, mortise view**) +/- CT scan
  Management
- Non-operative:
  - **Closed reduction + below-knee back slab**, repeat neurovascular exam + XR
- Operative: mainstay - to reconstruct articular surface and restore alignment of ankle mortise
  - Staged approach: temporary external fixator → ORIF after 7-14 days +/- ankle fixation by hindfoot nail

[X-ray images showing severe comminuted fractures of the distal tibia and fibula, representing a tibial pilon fracture (plafond fracture).]

Calcaneal fracture
Most commonly fractured tarsal bone, usually due to **fall from height** (axial loading onto calcaneus)
Classification

- Intra-articular (75%): involve subtalar joint, further classified by Sanders classification
- Extra-articular (25%): usually avulsion fractures e.g. avulsion of calcaneal tuberosity by Achilles tendon
  Clinical features: similar to ankle fracture
- Shortened and widened heel with **varus** deformity
- Assess posterior heel skin integrity – may require emergency surgery
  Investigations: AP, lateral, oblique X-ray foot +/- CT
- **Calcaneal shortening** with **varus** deformity
- Decreased **Bohler's angle** (fig.)
  Management: usually operative (e.g. closed reduction with percutaneous pinning, **ORIF**)
  Complication: subtalar joint OA (if severe may require arthrodesis)

[X-ray image of the foot showing a calcaneal fracture. The Bohler's angle, is measured between two lines drawn on the lateral X-ray view. Line 1 extending from the superior aspect of the posterior calcaneal tuberosity to the superior aspect of the posterior articular facet and Line 2 extending from the superior aspect of the anterior process to the superior aspect of the posterior articular facet. The normal Bohler's angle is between 25 and 40 degrees. The Bohler's angle is labeled on the image.]

Talar fracture
2nd most commonly fractured tarsal bone (after calcaneus)
Pathophysiology:

- Mechanism of injury: ankle forced into **dorsiflexion** → talus press against tibial plafond
- Usually occur at talar neck (~50%)
- Talus is heavily relied on extraosseous arterial supply → High risk of AVN after fracture
  Investigation:
- Ankle series (AP + lateral + mortise) in both **dorsiflexion AND plantarflexion** to differentiate which type
  Classification of talar neck fractures: **Hawkins classification** (predict risk of AVN)
  | Type I | Undisplaced | 0-15% risk |
  | :------- | :------------------------------------------ | :------------- |
  | Type II | Subtalar dislocation | 20-50% risk |
  | Type III | Subtalar + tibiotalar dislocation | 90-100% risk |
  | Type IV | Subtalar + tibiotalar + talonavicular dislocation | 100% risk |

Management:

- Undisplaced (Type I): conservative
- Displaced (Type II-IV): closed reduction + cast in A&E → urgent ORIF

Lisfranc injury
Anatomy of “Lisfranc joint” (tarso-metatarsal joint)

- Base of 2nd MT fit into mortise created by medial and middle cuneiforms
- Supported by interosseous ligaments: e.g. **Lisfranc ligament** (from 2nd MT to medial cuneiform)
  Mechanism of injury:
- Severe torsional force onto **plantarflexed** foot (e.g. RTA, athletic injuries)
  Clinical features
- Swelling and tenderness over midfoot
- **Plantar bruising**
- Piano-key sign: pain on passive dorsiflexion and plantarflexion of toes

Radiological features: order **AP + lateral + oblique X-ray foot**

- Widened interval between base of 1st and 2nd MT
- Fleck sign: bony fragment between 1st and 2nd MT, indicating avulsion of Lisfranc ligament from 2nd MT base
- Dorsal displacement of proximal base of 1st and 2nd MT (on lateral view)
- Look for associated distal MT fractures (fig.)

Hardcastle and Myerson classification (fig.)

Management:

- Immediate: closed reduction (gentle traction to midfoot) + backslab in A&E
- Non-operative if not significantly displaced
  - Cast immobilization / air-cast boot + non-weight-bearing mobilization x 6-12 weeks
- Operative
  - Screw fixation: N-shaped (medial cuneiform to 2nd MT, medial cuneiform to 1st MT, middle cuneiform to 2nd NT) +/- small plates
  - Primary arthrodesis if severely comminuted or displaced

Complication: post-traumatic arthritis, midfoot compartment syndrome

[Illustration showing mechanism of Lisfranc injury. Medial view of the foot. On the left side is a red arrow pointing downwards to the foot representing normal position of the second metatarsal. On the right side, the arrow is curved towards the front of the foot, representing dislocation of the second metatarsal. ]

[Illustration comparing a healthy foot and a foot with Lisfranc injury. Top view with weight bearing. In the healthy foot, the Lisfranc ligament is intact and the space between the metatarsal bones is normal. In the foot with Lisfranc injury, the Lisfranc ligament is torn and the space between the metatarsal bones is widened.]

[X-ray image of foot with lisfranc injury. In the middle of the foot between the first and second metatarsal, there is a small bony fragment indicating Lisfranc injury.]

[X-ray image of foot showing fixation screws. The screws are inserted in the middle of the foot from the medial cuneiform to the second metatarsal.]

8.4 Soft tissue injury
Achilles tendinopathy & rupture
Pathophysiology

- Achilles tendon unites gastrocnemius, soleus & plantaris insert into calcaneus
- Repetitive action of tendon causes microtears, inflammation, fibrosis & potential rupture
  Risk factors
- Stop-and-go sports, e.g. basketball
- Poor footwear choice
- Obese male
- Recent fluoroquinolone use
  Clinical features
- Gradual onset of pain at posterior ankle, worse with movement
- Tenderness over tendon (worse 2-6cm above insertion site)
- Inability to stand / heel raise on single leg
- Tendon rupture: audible popping sound, sudden onset severe pain, Thompson test + (fig.)
- Active ankle plantarflexion still possible: e.g. tibialis posterior, peroneus longus & brevis
  Differential diagnosis: ankle fracture, ankle sprain
  Management
- Tendinopathy: avoid precipitating exercise, NSAID, physiotherapy
- Rupture:
  - Early presentation (< 2 weeks): plaster immobilisation in full equinus (foot plantarflexion + toe extension) x 2 weeks → semi-equinus x 4 weeks → neutral position x 4 weeks
  - Late presentation (> 2 weeks) / Relatively active patient:
    - End-to-end tendon repair +/- FHL graft (if no pre-existing tendinopathy)
    - Achilles tendon reconstruction (if tendinopathy)

Plantar fasciitis
Definition: inflammation of plantar fascia (thick fibrous band of connective tissue, origin at calcaneal tuberosity)

- MC cause of infracalcaneal pain (80%)
  Mechanism
- Repetitive strain injury causing microtears
  Risk factors:
- Anatomical factors: excessive pronation, pes cavus, leg length discrepancy
- Prolonged standing / Excessive running
- Unsupportive footwear
- DM, obesity
  Clinical features
- Dorsiflex great toe → Palpate for tenderness over plantar fascia up to calcaneal tuberosity
- Plantar heel pain with weightbearing, radiate down the arch
- Pain worsens with first few steps in morning (after inactivity) & toe dorsiflexion
  Differential diagnoses: achilles tendonitis, Morton's neuroma, calcaneal fracture
  Investigations: clinical diagnosis, XR to r/o fracture + plantar heel spur (fig.)
  Management:
- Non-operative: pain control, footwear adjustment, PT, shockwave, steroid injection
- Operative: surgical release (plantar fasciotomy)

[Image of Fig. 1.A. Squeezing calf produces plantar flexion of foot when heel cord is intact. and Fig. 1.B. Squeezing calf produces no motion of foot in injured leg. The image shows two simple line drawings depicting the thompson test. In both drawings, the lower leg and foot are visible in profile. In the first drawing, the calf is squeezed, and the foot plantarflexes, indicating a normal test. In the second drawing, the calf is squeezed, but the foot does not move, indicating a positive test for Achilles tendon rupture.]

[Image of an X-ray showing a right foot in profile. The bone spur on the calcaneus is easily identified. The cuneiform, talus, navicular, and calcaneus bones are labeled with arrows. The bone spur is located on the plantar aspect of the calcaneus. Bone spur and calcaneus are clearly visible. Additional parts of the foot visible in the xray include the talus, navicular and cuneiform.]

DDx of heel pain:

- Plantar fasciitis (MC)
- Achilles tendinopathy / rupture
- Retrocalcaneal bursitis
- Posterior ankle impingements (especially FHL)
- Arthritis of ankle joint / subtalar joint

# 8.5 Diabetic foot

## Diabetic foot ulcers

Pathophysiology: neuropathic + ischaemic (less important)
Brodsky classification: depth + degree of ischaemia

[Diagram of the foot showing classification by depth and ischemia. The depth classification starts at the top with a foot labeled 'Grade 0' with 'No break in skin'. The next foot is 'Grade 1' with 'Superficial ulcer'. The next is labeled 'Grade 2' with 'Exposed tendons, joints'. The final foot is 'Grade 3' with 'Exposed bone and/or abscess/osteomyelitis'. The Ischaemia classification begins below. First foot is 'Grade A' with 'No ischaemia'. The next foot is 'Grade B' with 'Ischaemia not gangrenous'. The next foot is 'Grade C' with 'Partial foot gangrene'. The last foot is 'Grade D' with 'Complete gangrene'.]

Investigations

- Transcutaneous O2 pressure (TcPO2): assess wound-healing potential (good if >30mmHg)
  - ABPI not useful in DM due to calcification of vessels
- XR foot & ankle

Management

- Neuropathic component: customised insole
- Vascular component: angioplasty
- Surgical: debridement, below knee amputation

**Charcot arthropathy (neuropathic arthropathy)**
Chronic progressive destructive arthropathy due to loss of pain or proprioception
Causes: classically DM & syphilis

- Peripheral: DM neuropathy, peripheral nerve injury, leprosy
- Central: cauda equina syndrome, syringomyelia, tabes dorsalis
  Clinical features: painless foot & ankle deformities with warmth, redness and oedema
  Investigations:
- Imaging: XR (degenerative changes, subluxation); MRI or bone scan if XR inconclusive
- Joint aspiration to rule out DDx
- Refer occu for proprioception testing
  Management:
- Walking aid to offload foot
- Surgical correction best avoided: high failure rate

268

# 9 Systemic diseases

## 9.1 Osteoarthritis

Definition

- Chronic wear & tear process involving a joint
- Degeneration only as one of the causes

Aetiology

- Primary (degenerative): more common in elderly > 70y as OA knee
- Secondary: may be seen in young < 50y - must ask about **previous trauma & chronic joint instability**
  - Defective load:
    - Force: obesity, occupational overuse
    - Area: joint dysplasia (e.g. DDH)
  - Defective cartilage:
    - Damage: trauma, haemophilia
    - Diseases: inflammatory (e.g. RA), metabolic (e.g. gout), infection
    - Unsupported: AVN

Clinical features

- Joints affected:
  - **Weight-bearing joints**, e.g. hip, knee, spine
  - UL joints spared, except **1st CMC joint** and IPJ
- Symptoms:
  - **Pain**: aggravated by exertion, relieved by rest - more in **knee**
  - **Morning stiffness**: < 30min after immobility - more in **hip**
  - Swelling: intermittent (effusion) or continuous (capsule thickening)
  - Deformity
  - Loss of function
- Signs:
  - Bony enlargement at affected joints, e.g. Heberden's node (DIPJ), Bouchard's node (PIPJ)
  - Limited ROM with crepitus
  - Small joints: grind test + (axial compression)
  - Joint deformities, e.g. genu varum

Radiological features (LOSS)

- **Loss of joint space** (earliest)
- **Osteophytes**
- **Subchondral cysts**
- **Subchondral sclerosis**

Classification of OA progression: WOMAC (Western Ontario and McMaster Universities Arthritis Index)

Degenerative arthritis vs inflammatory arthritis

|                            | Degenerative                                                                             | Inflammatory                    |
| -------------------------- | ---------------------------------------------------------------------------------------- | ------------------------------- |
| Joint involvement          | Weight-bearing joints: knee, hip, L spine, C spine Small hand joints: 1st CMC joint, IPJ | Any joint                       |
| Bone density               | Preserved                                                                                | Juxta-articular osteopenia (RA) |
| Periarticular bony erosion | No                                                                                       | Yes (RA)                        |
| Reactive bony changes      | Yes                                                                                      | No (RA)                         |

Management
Conservative

- Relief of weight-bearing: weight reduction, walking aids, muscle strengthening
- Pain relief: analgesics, intra-articular steroid
- Intra-articular hyaluronic acid / platelet-rich plasma (?evidence)
  Operative
- Indications:
  - Patient factor: age, functional status
  - Disease factor: severe impairment to ADL, pain despite conservative treatment
- Options:
  - Arthroplasty for big joints (e.g. hip, knee, shoulder, ankle)
  - Arthrodesis for small joints (e.g. MCP)
  - Realignment surgery e.g. osteotomy
  - Arthroscopic debridement e.g. remove osteophytes

|                                                             | Indications                                                                                | C/I                                                                  | Knee                                                                                                                                   | Hip                                                                        |
| ----------------------------------------------------------- | ------------------------------------------------------------------------------------------ | -------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------- |
| **Osteotomy:** correct deformity and relieve joint pressure | Young (<60y) with preservation of articular cartilage Pre-requisite: single compartment    | **Severe articular damage** Ligament laxity Severe varus deformities | High tibial osteotomy                                                                                                                  | Hip osteotomy                                                              |
| **Arthroplasty (replacement)**                              | Older with progressive joint destruction Old preferred: reduced chance of revision surgery |                                                                      | [X-ray of a knee with metal implants]TKR Unicompartmental knee arthroplasty (for medial compartment OA, higher revision rate c.f. TKR) | THR Hemiarthroplasty (quicker recovery, high risk of sciatic nerve damage) |

- Specific complications of total replacement
  - Immediate: bone fracture, vascular injury (femoral in THR, popliteal in TKR), nerve (sciatic nerve in THR, CPN in TKR)
  - Early: DVT/ PE, infection (difficult to detect and treat)
  - Late: LLD (must counsel patients beforehand), prosthesis infection, patellar instability
- Post-op:
  - Early mobilisation (1 day after operation)
  - Avoid contact sports, extreme ROM of hip (angle of bed < 45°)
  - Survival of replacement (not requiring revision surgery): 15-20 years
- No evidence: arthroscopic debridement, arthroscopic chondroplasty (drill holes)

# 9.2 Inflammatory arthritis

|              | RA                                                                                                                                                                                                                                                                                                                  | AS                                                                                                                                                                                                                                                  | PsA                                                                                                                                                                                                                  | Gouty arthritis                                                                                                                                                                                                           |
| ------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Definition   | Chronic, symmetric, **erosive synovitis** of peripheral joints                                                                                                                                                                                                                                                      | Repeated inflammation to enthesis and secondarily synovial joints                                                                                                                                                                                   | Arthritis associated with psoriasis (autoimmune disease characterised by patches of abnormal skin)                                                                                                                   | Inflammatory arthritis secondary to monosodium urate crystal deposition                                                                                                                                                   |
| M:F          | 1:3                                                                                                                                                                                                                                                                                                                 | 3:1                                                                                                                                                                                                                                                 | 3:1                                                                                                                                                                                                                  | More common in men                                                                                                                                                                                                        |
| MSK S/S      | Symmetric polyarthritis Joint deformities, e.g. Swan neck deformity LL: genu valgus, hammer/ mallet/ claw toe Spine: C1/2 subluxation                                                                                                                                                                               | Axial joints: reduced spine ROM, question mark deformity Peripheral joints: asymmetric large joint arthritis, enthesitis Extra-articular: 6A, e.g. atlanto-axial subluxation                                                                        | Arthritis: 5 general patterns - Asymmetric oligoarthritis (MC) - Symmetric polyarthritis (~ RA) - DIPJ arthritis + nail changes - Spondylitis - Arthritis mutilans (complete destruction of small joints) Dactylitis | Signs of inflammation (possible sites: 1st MTPJ, ear helix, olecranon bursa, Achilles tendon) Reduced ROM Chalk-like tophi                                                                                                |
| Lab          | RF, anti-CCP CRP, ESR                                                                                                                                                                                                                                                                                               | HLA-B27                                                                                                                                                                                                                                             | HLA-B27                                                                                                                                                                                                              | Joint aspirate: microscopy (negatively birefringent) Serum urate                                                                                                                                                          |
| XR           | - Periarticular soft tissue swelling (synovial thickening and joint effusion) - Periarticular bony erosion (pannus erodes adjacent bone) - Juxta-articular osteopenia (disuse osteopenia) - Narrowed joint space (cartilage destruction) - Knee: valgus (c.f. varus in OA), with concave tibial plateau (.'erosion) | SI joint: erosion (pseudo-widening) → sclerosis → fusion Spine: shiny corner sign (reactive sclerosis secondary to erosion at superior & inferior endplates) → vertebrae squaring → bamboo spine (syndesmophytes), ossification of spinal ligaments | DIPJ: pencil-in-cup deformity (simultaneous erosion at head of middle phalanx + new bone formation at base of distal phalanx) → resorption Small joint (MCPJ/PIPJ) erosion & fusion                                  | Joint effusion (earliest sign) "Punched out" erosion with overhanging sclerotic margin (inflamed synovium & pressure erosion by tophi) Preserved joint space until advanced disease Chondrocalcinosis: sign of pseudogout |
| Operative Mx | Soft tissue procedure, e.g. synovectomy Bone/ joint procedure, e.g. arthrodesis, arthroplasty                                                                                                                                                                                                                       | Spinal decompression Vertebral osteotomy                                                                                                                                                                                                            | Digit fusion Resection arthroplasty                                                                                                                                                                                  | Indicated if complicated tophaceous gout, e.g. active infection, nerve compression                                                                                                                                        |

Soft tissue swelling
[Image of an X-ray of a finger joint with an arrow pointing to the soft tissue swelling and labeled "Soft tissue swelling".]
Periarticular osteopenia
[Image of an X-ray of a finger joint with an arrow pointing to the periarticular osteopenia and labeled "Periarticular osteopenia".]
Joint space narrowing
[Image of an X-ray of a finger joint with an arrow pointing to the narrowing of the joint space and labeled "Joint space narrowing".]
Marginal erosion
[Image of an X-ray of a finger joint with an arrow pointing to the marginal erosion and labeled "Marginal erosion".]
Pseudo-widening of SI joint
[Image of an X-ray showing the pseudo-widening of the SI joint.]
Pencil-in-cup deformity
[Image showing an X-ray of a hand with pencil-in-cup deformity. There are multiple fingers and arrows pointing at deformities.]
Gout
[Image of the word Gout, bolded, followed by an x-ray of a finger with punched-out erosions and an arrow pointing to them, and the text "Punched-Out Erosions"]
Punched-Out Erosions
© Dr. Raj Carmona, 2014
[Image of a copyright sign, the name of a doctor, and the year 2014]
Gouty Tophi
[Image of the words "Gouty Tophi", followed by an x-ray of a finger with gouty tophi and arrows pointing to them.]
© Dr. Raj Carmona, 2014
[Image of a copyright sign, the name of a doctor, and the year 2014]
272

9.3 Infections

| Type of Infection                                                 | Appearance of Lesion                                                                                                                                                                                                                                                                                             | Description of Lesion                                                                                                                                                                                   | Layer of Skin Involved                                          | Common Pathogens                                                                                                                                                                  | Treatment                                                                                                             |
| ----------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------- |
| Impetigo                                                          | [Image of Impetigo on a child's face. The image shows a close-up of a child's face with yellowish, crusted sores around the mouth and nose. The crusts appear like dried honey, and the skin underneath looks red and inflamed. The child's expression is neutral.]                                              | Vesides with honey-colored crust, often on the face of a child                                                                                                                                          | Epidermis                                                       | Staphylococcus aureus, Streptococcus pyogenes                                                                                                                                     | Few lesions: topical antibiotics (e.g, mupirocin); numerous lesions: systemic therapy (e.g., cephalexin, clindamycin) |
| Erysipelas                                                        | [Image of Erysipelas on a woman's face. The image shows a woman's face with a large, sharply demarcated area of intense redness and swelling. The affected skin appears raised and inflamed, with a clear border separating it from the surrounding healthy skin. ]                                              | Erythematous, very painful lesion with sharply demarcated, raised, regular border                                                                                                                       | Superficial dermis                                              | S.pyogenes, Streptococcus agalactiae > S. aureus                                                                                                                                  | Systemic antibiotics (e.g, cephalexin or cefazolin)                                                                   |
| Cellulitis                                                        | [Image of Cellulitis on a patient's leg. The image shows a lower leg with diffuse redness and swelling. The skin appears smooth and shiny, and the border of the affected area is irregular and poorly defined. There are no distinct lesions or pustules visible.]                                              | Erythematous diffuse, flat lesion with irregular border                                                                                                                                                 | Deep dermis                                                     | Streptococcus pyogenes, Streptococcus agalactiae > Staphylococcus aureus                                                                                                          | Systemic antibiotics, eg cephalexin or cefazolin                                                                      |
| Folliculitis                                                      | [Image of Folliculitis on a man's face. The image shows a close-up of a man's face with multiple small, red bumps (papules) around hair follicles. Some of the papules contain pus, indicating an infection. The surrounding skin appears slightly inflamed.]                                                    | Localized, inflamed papules containing a small amount of pus                                                                                                                                            | Hair follicle                                                   | S. aureus, Pseudomonas aeruginosa (associated with hot tubs)                                                                                                                      | Antibiotics often not needed; warm, moist compresses are useful                                                       |
| Skin abscess (furuncle also known as a boil, furuncle, carbuncle) | [Image of Skin Abscess on a patient's skin. The image shows a raised, red, and tender nodule on the skin. The nodule has a central area of purulence (pus), indicating an infection. The surrounding skin is inflamed. ]                                                                                         | Raised, tender, inflamed nodule with central region of purulence; the area of pus initially is firm but then progresses to fluctuance (becomes movable)                                                 | Deep dermis                                                     | S. aureus                                                                                                                                                                         | Incision and drainage is main- stay of therapy; antibiotics directed against S. aureus in select cases                |
| Necrotizing soft tissue infections (necrotizing fasciitis)        | [Image of Necrotizing Soft Tissue Infections on a patient's body. The image shows an area of necrotic tissue with dark, purplish discoloration. There are also bullae (blisters) present. The surrounding skin appears inflamed, indicating a severe infection. A hand is shown, pointing to the affected area.] | Very painful area of inflammation with rapid progression to necrosis, bullae, purpura, anesthesia, and systemic toxicity Pain out of proportion to clinical findings Male perineum: Fournier's gangrene | Fascia and muscle; local blood vessels and nerves also involved | 1. Monomicrobial form: S. pyogenes, Clostridium perfringens, Vibrio vulnificus; 2. Polymicrobial form: enteric gram-negative rods plus anaerobes RF: DM, intra-abdo surgery, IVDA | Surgical débridement is critical in addition to broad-spectrum systemic antibiotics                                   |

| Pathogens             | Clinical features                                  | Investigations                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Management                                                                                                                                                     |
| --------------------- | -------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------- |
| Gas gangrene          | Clostridium perfringens                            | Recent trauma/ GI surgery Pain out of proportion to clinical findings (DDx NF)                                                                                                                                                                                                                                                                                                                                                                                                   | CBC: **no neutrophilia** (inflammatory response inhibited by C perfringes) XR: linear streak of gas                                                            | Resuscitation Urgent surgical debridement with fasciotomy IV antibiotics      |
| Osteomyelitis         | S aureus Group A Strep Salmonella (if sickle cell) | Limited ROM Draining sinus tract Signs of inflammation Types: **haematogenous, contiguous, direct inoculation** Pathology: Suppuration → ↑intraosseous pressure → bone surface via Volkmann canal → - **Sequestrum**: bone necrosis - **Involucrum**: new bone formation - **Cloacae**: periosteal openings Sites: - Infants < 1y: epiphysis (lack growth plate) → septic arthritis possible - Child: metaphysis (growth plate inhibits spread of infection) - Adults: vertebrae | XR: normal in acute, mimic CA in chronic (osteosclerotic lesion, wide zone of transition, periosteal reaction) MRI: best in diagnosis Blood for C/ST (50% +ve) | Analgesics IV cloxacillin x 4-6 weeks Surgical debridement                    |
| Septic arthritis      | S aureus STD: Neisseria gonorrhoea                 | Pain with movement Monoarthritis (DDx gout)                                                                                                                                                                                                                                                                                                                                                                                                                                      | Joint fluid for Gram stain, C/ST, AFB smear, microscopy (r/o gout) XR: joint space effusion, periarticular osteopenia                                          | IV cloxacillin x 4-6 weeks (NG: IV ceftriaxone x 1 week) Operative irrigation |
| Necrotizing fasciitis | S pyogenes V vulnificus Polymicrobial              | Pain out of proportion to clinical signs **Haemorrhagic bullae** Systemic toxicity Dirty "dishwater" discharge Risk factor: immunocompromised                                                                                                                                                                                                                                                                                                                                    | LRINEC score (fig.): >8 = high risk Finger probe test: +ve if minimal resistance to blunt dissection                                                           | **Aggressive debridement + IV broad- spectrum antibiotics**                   |

- Pyogenic osteomyelitis vs TB spine

|          | Pyogenic               | TB spine (Pott's disease)    |
| -------- | ---------------------- | ---------------------------- |
| Clinical | Acute                  | Insidious                    |
| X-ray    | Disc space narrowing   | Disc space relatively spared |
| Site     | Anywhere Spine: lumbar | Spine: thoracic (closest)    |

| Variable                              | Value    | Score |
| ------------------------------------- | -------- | ----- |
| C-reactive protein                    | 150 mg/l | 4     |
| Hemoglobin (gm/dl)                    | >13.5    | 0     |
|                                       | 11-13.5  | 1     |
|                                       | <11      | 2     |
| Total leucocyte count (thousand/cumm) | >15      | 0     |
|                                       | 15-25    | 1     |
|                                       | >25      | 2     |
| Serum sodium (mmol/L)                 | <135     | 2     |
| Serum creatinine (mmol/L)             | <1.4     | 0     |
|                                       | ≥1.4     | 2     |
| Blood glucose level                   | <100     | 0     |
|                                       | ≥100     | 1     |

A score of is considered positive for necrotizing fasciitis.

# 10 Malignancy

## 10.1 Overview

Overview of bone tumours

| Histology              | Benign                                               | Malignant                   |
| ---------------------- | ---------------------------------------------------- | --------------------------- |
| Osteogenic             | Osteoid osteoma Osteoblastoma                        | Osteosarcoma                |
| Chondrogenic           | Osteochondroma (exostosis) Chondroma Chondroblastoma | Chondrosarcoma              |
| Primitive neural cells |                                                      | Ewing's sarcoma             |
| Unknown                | Giant cell tumour                                    | Malignant giant cell tumour |
| Clinical features      |                                                      |                             |

|                            | Non-aggressive                                   | Aggressive                                                           |
| -------------------------- | ------------------------------------------------ | -------------------------------------------------------------------- |
| Age                        | 10-30                                            | Primary: 10-30 Secondary: > 60                                       |
| Onset                      | Slow                                             | Rapid                                                                |
| Symptoms                   | Painless mass                                    | Painful mass, night pain                                             |
| Physical findings          | Well defined, smooth Non-infiltrative Homogenous | Ill-defined Infiltrative (can be fungating) Heterogenous consistency |
| XR findings                | See below                                        | See below                                                            |
| Consistency                | Homogenous                                       | Heterogenous                                                         |
| Margin/ zone of transition | Better defined, narrow                           | More ill-defined, wide                                               |
| Periosteal reaction        | Solid                                            | Onion skin, sunburst or Codman's triangle                            |
| Cortical destruction       | No                                               | Yes                                                                  |
| Soft tissue extension      | Absent                                           | Present                                                              |

Other investigations

- Bloods: LFT (ALP)
- Bone biopsy (CT-guided)
- MRI: soft tissue involvement, neurovascular involvement
- CT thorax: lung metastasis
- Bone scan: skeletal metastasis

Biopsy: principles

- Provide representative sample
- No contamination
- Not compromise definitive Tx
- Excision of biopsy tract in definite Tx

Limb salvage surgery: prerequisites

- Oncological outcome equivalent to amputation
- Reconstructed limb is useful
- Morbidity is acceptable
- Reconstructed limb is durable

[Image Description: The image shows a page from a medical textbook, specifically chapter 10 titled "Malignancy." The page is divided into sections. The first section is titled "10.1 Overview" and provides a tabular comparison of benign and malignant bone tumors based on histology. The table lists different types of tumors under headings like Osteogenic, Chondrogenic, Primitive neural cells, and Unknown. The next table outlines the clinical features of non-aggressive and aggressive tumors, comparing aspects such as age, onset, symptoms, physical findings, XR findings, consistency, margin/zone of transition, periosteal reaction, cortical destruction, and soft tissue extension. Below the tables, there are bulleted lists detailing "Other investigations" which include blood tests, bone biopsies, MRI, CT scans, and bone scans. Another bulleted list titled "Biopsy: principles" outlines the guidelines for performing a biopsy. A final bulleted list titled "Limb salvage surgery: prerequisites" details the requirements for limb salvage surgery, which include oncological outcome, reconstructed limb usefulness, morbidity acceptability, and the reconstructed limb durability.]

Description of bone lesions in XR

- Age
- Site
- Location within bone: central, eccentric (along the cortex), within cortex, outside cortex
- Morphology (fig.): well-defined osteolytic (narrow zone of transition), ill-defined osteolytic (wide zone of
  transition), sclerotic
  [Radiographic images demonstrating three different bone lesion morphologies. The first image is labeled "Well-defined" and shows a bone with a clear, distinct boundary around the lesion. The second image is labeled "ill-defined" and shows a bone lesion with a blurred and indistinct boundary. The third image is labeled "Sclerotic" and shows increased bone density around the lesion.]
- Periosteal reaction (fig.)
  - Lamellated = onion skin appearance
  - Spiculated = sunburst appearance
    [A collage of four radiographic images displaying different types of periosteal reactions. Each image has bone tissue in shades of brown and shows reaction on bone tissue. The images are labeled from left to right as "Solid," "Lamellated," "Spiculated," and "Codman's," respectively. Below the images, corresponding aggressiveness levels are mentioned: "Benign" for Solid, "Aggressive" for Lamellated, and "Very Aggressive" for Spiculated and Codman's.]
- Cortical destruction
- Matrix: chondroid (popcorn), osteoid (cloud-like)
- DDx: chronic osteomyelitis, eosinophilic granuloma
  [Radiograph of a lower leg and ankle, showing bone with a dense, sunburst-like pattern of new bone formation radiating outwards.]
  [Radiograph showing the knee and lower femur with an arrow pointing at an area of elevation of the periosteum, forming a Codman's triangle.]
  [Radiograph of the upper leg, showing a bone lesion with multiple thin layers of new bone formation, resembling the layers of an onion, indicated by a horizontal white arrow.]

Sunburst appearance

Codman's triangle
L

copyright bonetumor.org
all rights reserved 6/24/1999
Onion skin appearance

276

# 10.2 Malignant bone tumour

Most common malignant bone tumour types by age

| Age   | Tumour                            |
| :---- | :-------------------------------- |
| <ly   | Neuroblastoma                     |
| 1-10  | Ewing's sarcoma                   |
| 10-30 | Osteosarcoma, Ewing's             |
| 30-40 | Malignant giant cell tumour       |
| >40   | Bone metastasis, multiple myeloma |

Common primary bone malignancy

|            | Osteosarcoma                                                                                                                                    | Ewing's sarcoma                                                       |
| :--------- | :---------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------- |
| Prevalence | Most common primary malignant bone tumour Most common in young adults (10-30y) Site: distal femur > proximal tibia > humerus Region: metaphyses | Most common in children (1-10y)                                       |
| Origin     | Osteoid cells                                                                                                                                   | Primitive neural cells Patho: pseudo-Rosettes, small blue round cells |
| S/S        | Progressive pain, night pain Decreased ROM ALP, LDH↑↑ (osteoblastic activity)                                                                   | Mimic infection: pain, fever                                          |
| XR         | Periosteal reaction: Codman's triangle, sunburst appearance                                                                                     | Onion skin appearance Moth-eaten appearance                           |
| Mx         | CT thorax (lung met), bone scan (skeletal met) Complete resection Neoadjuvant chemo +/- adjuvant chemo                                          | CT thorax, bone scan Complete resection Chemotherapy +/- adjuvant RT  |

[Illustration depicting the mechanism of action of available osteoporosis therapies. The illustration shows various cells, including osteoclasts and osteoblasts, and the interactions of different medications, such as Denosumab, bisphosphonates, and selective estrogen receptor modulators, with these cells. Arrows indicate the pathways and effects of these drugs in inhibiting osteoclast activity or promoting osteoblast function to manage osteoporosis.]

Chondrosarcoma

- 40-75 yo
- ChemoRT resistant
- Tx: surgery

Multiple myeloma

- XR: multiple punched-out lesions
- Histology: "clockface" round cells

Bone metastasis

- Most common form of bone malignancy
- Primary site:
  - Adult (paired organ): thyroid, breast, lung, kidney, prostate, MM
    - Osteosclerotic (prostate, SCLC), osteolytic (MM, thyroid, breast, RCC) or mixed
  - Children: neuroblastoma, Wilm's tumour, etc
- Management
  - Pain control
  - Bisphosphonates
  - Stabilisation of impending fracture if high risk (e.g. increasing size, osteolytic)

277

# 10.3 Benign bone tumour

Lytic

| Tumour               | Features                                           |
| -------------------- | -------------------------------------------------- |
| Simple bone cyst     | - <20yo                                            |
|                      | - Fracture: "fallen leaf sign"                     |
| Aneurysmal bone cyst | - MRI: multiple fluid layers                       |
| Giant cell tumor     | - Pathology: stromal cell, mononuclear, giant cell |
|                      | - Multi-nucleated giant cell, lung met?            |

Sclerotic

| Tumour                          | Features                                                              | Figures (if applicable)                                                                                                                                                                                             |
| ------------------------------- | --------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Osteoid osteoma / osteoblastoma | - 5-25yo                                                              | [Radiograph of a knee, the bones are grayscale with areas of white and black, an arrow points to an area labeled "Radiolucent Nidus with Mineralization and Surrounding Sclerosis," indicating a specific feature.] |
|                                 | - S/S: night pain                                                     |                                                                                                                                                                                                                     |
|                                 | - XR: radiolucent lesion (nidus) with sclerotic rim (Bull's eye)      |                                                                                                                                                                                                                     |
|                                 | - Mx: NSAID → RFA / surgical resection of nidus                       |                                                                                                                                                                                                                     |
| Osteochondroma = Exostosis      | - >5-30yo                                                             | [Radiograph of a right knee, the bones are grayscale with areas of white and black, showing an outgrowth near the knee joint.]                                                                                      |
|                                 | - Most common benign bone tumour                                      |                                                                                                                                                                                                                     |
|                                 | - S/S: bone exostosis, compression symptoms                           |                                                                                                                                                                                                                     |
|                                 | - XR: mushroom-shaped outgrowth from metaphysis, pedunculated/sessile |                                                                                                                                                                                                                     |
|                                 | - Cap >2cm: Trisk of chondrosarcoma                                   |                                                                                                                                                                                                                     |
|                                 | - Mx: observation, surgical excision                                  |                                                                                                                                                                                                                     |
| Enchondroma                     | - XR: "popcorn", rings & arcs calcifications                          |                                                                                                                                                                                                                     |
| Fibrous dysplasia               | - XR: ground glass                                                    |                                                                                                                                                                                                                     |
|                                 | - a/w: McCune-Albright syndrome                                       |                                                                                                                                                                                                                     |

# 11 Paediatric orthopaedics

## 11.1 Developmental dysplasia of hip

Definition
Abnormal development of hip resulting in a spectrum of disease:

- Dysplasia (shallow acetabulum)
- Subluxation (joint displacement with some contact remaining between articular surfaces)
- Dislocation

Risk factors

- Genetic factors: FHx, female (increased ligament laxity)
- Perinatal factors: firstborn, breech, oligohydramnios

Clinical features

- Neonatal screening: before soft tissue contracture forms
  - Barlow (dislocatable)
  - Ortolani (reducible)

[Image Description: This is a cartoon illustration depicting the Barlow and Ortolani maneuvers used for developmental dysplasia of the hip. The left side shows a doctor examining an infant with the Barlow maneuver, where the hip is being adducted. A small mouse character is explaining, "Examiner adducts the hip while injecting a posterior force on the knee to promote dislocation." Above the doctor and infant, another mouse is saying, "He did it now call Dr. O." The right side shows a different doctor examining another infant with the Ortolani maneuver, where the hip is being abducted. A bunny character is saying, "It's-a back in! Bravo!" Below the doctor and infant, another mouse is explaining, "Examiner abducts the hip while applying an anterior force on the femur to reduce the hip joint."]

- Age 3mo - 1yr: after soft tissue contracture forms
  - Limited hip abduction
  - LLD

- Age 1yr or beyond: after child starts walking
  - Trendelenburg's gait
  - Toe-walking (to compensate LLD)

Investigations

- USG hip: birth to 4 mo
  - Static or dynamic (USG-guided Barlow & Ortolani test)
- XR hip: at 4-6 mo (after femoral head begins to ossify) (fig.)

[Image Description: The image shows two X-ray diagrams side-by-side, illustrating the difference between a "Normal hip" and a "Dysplastic hip". The "Normal hip" diagram shows Perkin's line, Hilgenreiner's line, and Shenton's line which is normal. The Accetabular roof angle is shown to be normal, less than 30 degrees. The "Dysplastic hip" diagram shows Perkin's line, Hilgenreiner's line, and Shenton's line which is abnormal(broken). The Accetabular roof angle is shown to be abnormal, greater than 30 degrees. There are labels pointing to "Normal femoral head located medial to Perkin's line and inferior to Hilgenreiner's line" on the left and "Abnormal femoral head located lateral to Perkin's line and superior to Hilgenreiner's line" on the right.]

- Hip dysplasia: acetabular roof angle
- Hip dislocation:
  - Shenton's line
  - Hilgenreiner's line: horizontal line through triradiate cartilages
  - Perkin's line: vertical line through lateral margin of acetabulum

Management

- Pavlik harness
  [Illustration of a baby wearing a Pavlik harness. The harness consists of several straps: shoulder straps going over the baby's shoulders, a chest strap across the baby's chest, leg straps around the baby's legs, and abduction and flexion straps connecting the chest and leg straps. All these straps combined keeps the baby's legs in a frog like position. The baby is light skinned, bald, and lying on their back, viewed from above. The straps are white with red fasteners. ]
- Indications: < 6 mo
- Mechanism: maintain hip in abduction & flexion to provide early concentric reduction
- Administration: 3 months until stable clinically & in USG
- Complications:
  - AVN: impingement of MCFA; avoid extreme abduction (>60°)
  - Pavlik disease: erosion of pelvis superior to acetabulum due to prolonged positioning
  - Transient femoral nerve palsy
- Closed reduction with hip spica cast
  - Indications: 6-18 mo
  - Avoid extreme abduction (>60°): risk of AVN
- Operative:
  - Indications: >18mo
  - Methods:
    - Open reduction with spica cast
    - Open reduction with femoral osteotomy/ pelvic osteotomy

280

# 11.2 Scoliosis

Definitions

- 3D torsional deformities of spine affecting all 3 planes with intervertebral changes, defined as Cobb angle > 10°
  Classification
- Structural scoliosis: congenital (failure of vertebrae to form/ segment), **idiopathic**, neuromuscular, syndromic (e.g. NF)
- Non-structural scoliosis: postural scoliosis, LLD, etc
  **Adolescent idiopathic scoliosis**
  Clinical features
- Primary curve: most commonly right thoracic - shoulder tilt, pelvic tilt, trunk shift, prominent scapula
- Secondary curve (compensatory): kyphosis, lordosis
- Adam's forward bending test (FBT): rib hump, asymmetric shoulder height
- Forward bending sitting test: to eliminate LLD as the cause of scoliosis
- Disease course: - 90% do not progress (RF: low BMD - vit D intake) - 10% require treatment - 1% require surgical treatment
  Investigations
- XR (PA + lateral): SLAC (site, location, apical vertebral level, Cobb angle)
- Cobb angle: angle between the lines projected from the most tilted vertebrae at the top & bottom of the curve
  Management

| Cobb angle                | Child | Skeletal maturity         |
| ------------------------- | ----- | ------------------------- |
| Observation               | <25   | <40                       |
| Bracing                   | 25-45 | Progression between 25-40 |
| Operative (spinal fusion) | >45   | >50                       |

[Flowchart titled "School Scoliosis Screening-Hong Kong (1996-)" depicting a screening process. Starting at the top, there are rectangles that contain the words "Grades 5, 7, 9" and "Students screened biennially Grades 5 through 9". These rectangles lead to a diamond labeled "FBT & ATR". Two exits stem from the diamond. The left exit labeled "ATR 5-14" leads to a rectangle labeled "MT". The right exit labeled "ATR ≥ 15" goes to "Student Health Service Centre (SHSC) " which includes bulleted points: "Forward Bending Test (FBT)", "Angle of Trunk Rotation (ATR)". From the MT rectangle there is another diamond labeled "≥ 2 Moiré lines or Clinical signs" that leads to a rectangle labeled X-Ray. From the X-Ray rectangle, there is another diamond labeled "Cobb ≥ 20°" which leads to a rectangle labeled "Specialist Hospitals" which includes the bulleted points: "PWH" and "DKCH". Furthermore, an additional rectangle labeled Special Assessment Centre (SAC) lists the bulleted points: "Moiré Topography (MT)", "Clinical Signs of Scoliosis", and "X-Ray."]

11.3 Hip pain in paediatrics
Hip pain in paediatrics

- Age < 4y: transient synovitis, infection (osteomyelitis, septic arthritis), NAI
- Age 4-10: transient synovitis, Perthes disease, infection (osteomyelitis/ septic arthritis)
- Age 10-16: SCFE, avulsion fracture, infection (osteomyelitis/ septic arthritis), malignancy (osteosarcoma, Ewing's)

SCFE (slipped capital femoral epiphysis)
Definition

- Misnomer: anterolateral displacement of metaphysis relative to epiphysis (which remains in normal position in acetabulum)
- Left hip > right hip (unknown reason)
  Risk factors
- Obese boys aged 10-15y
  Clinical features
- Onset: acute following minor trauma or insidious onset
- Hip pain that may radiate to knee
- Antalgic gait
- Loss of internal rotation, abduction, flexion
- Complications: slipping at contralateral hip, AVN
  Investigations
- XR hip (fig.)
  Management
- Operative: percutaneous in situ fixation +/- prophylactic contralateral hip fixation - despite Salter-Harris type I injury

Perthes disease (Legg-Calve-Perthes disease)

- Definition: idiopathic AVN of proximal femoral epiphysis in children
- Risk factors: boys aged 5-10y
- Clinical features: hip pain, loss of internal rotation and abduction
- XR hip: medial joint space widening, crescent sign
- Management
  - Non-operative (for age < 8y - do not benefit from surgery): PT (ROM exercise), activity restriction (non- weightbearing)
  - Operative (for age > 8y): femoral/ pelvic osteotomy

[Image Description: Figure 28.13 shows an anteroposterior X-ray of the pelvis of a child with Perthes disease. The right femoral head is flattened and shows signs of sclerosis and fragmentation. A white arrow indicates the lateral aspect of the right femoral head. The left hip appears normal.]

[Image Description: Figure 28.14 shows a lateral radiograph of a child's right hip with a slipped capital femoral epiphysis (SCFE). A white arrow points to the posterior displacement of the femoral head relative to the neck.]

Figure 28.13 Perthes disease, showing flattening with sclerosis and fragmentation of the right femoral capital epiphysis; the left hip is normal. Figure 28.14 Slipped capital femoral epiphysis of the right hip.

# SUBSPECIALTY SURGERY

# 1 Anaesthesia and intensive care

1.1 Trauma
Advanced Trauma Life Support (ATLS)

Airway

- **Immobilize cervical spine** by rigid neck collar
- Signs of airway obstruction (may be absent if complete airway obstruction): cyanosis, stridor, abdominal breathing, accessory muscles, tracheal tug, tachypnea
- Simple airway maneuvers: **jaw thrust**, chin lift, **NO** head tilt (not yet r/o C-spine injury)
- Causes of delayed airway obstruction - obtain **definitive airway** (e.g. tracheal intubation, surgical airway) as soon as possible
  - Sedation
  - Inhalation burns
  - Maxillofacial injury

Breathing
Common problems: **pneumothorax, lung collapse, haemothorax**

Circulation
Check systemic perfusion: **BP/P**, consciousness, urine output

- Shock: **haemorrhagic shock** must be considered
  - Chest: intercostal / rib fracture
  - Abdomen: liver, spleen, mesenteric vessels
  - Pelvic fracture / retroperitoneal haematoma
  - Long bones: e.g. femoral shaft fracture (can cause 1L blood loss per side)

Fluid resuscitation:

- **Isotonic crystalloid** (NS / PlasmaLyte) **10mL/kg bolus** (e.g. IV NS 500mL bolus)
- Reassess BP/P → Give **another bolus**
- Reassess → Consider **blood replacement** / vasopressor / colloids

Disability Glasgow Coma Scale + pupils
(neurological) Table 2. The Glasgow coma scale

[Table Description: A table titled "Table 2. The Glasgow coma scale" displaying the scoring system for the Glasgow Coma Scale, with categories for Eye opening response, Best motor response, and Best verbal response. Each category lists different levels of response and their corresponding numerical scores. For Eye opening response, the options are spontaneously (4), to speech (3), to pain (2), and none (1). For Best motor response, the options are obeys commands (6), localization to painful stimuli (5), normal flexion to painful stimuli (4), abnormal flexion to painful stimuli (3), extension to painful stimuli (2), and none (1). For Best verbal response, the options are orientated (5), confused (4), inappropriate words (3), incomprehensible sounds (2), and none (1). A separate section lists verbal scores for intubated patients: patient appears able to converse (5), patient questionable to converse (3), and generally unresponsive (1).]

Events
AMPLE history

- Allergy
- Medications
- Past health
- Last meal
- Events related to injury

  1.2 Perioperative issues
  Preoperative assessment
  Goals of assessment

- Is this patient fit to proceed to surgery?
- What is the best timing to proceed?
- Are there any anticipated complications that will affect our anesthetic technique and preparation?
- What is the best choice of anesthetic and analgesic technique?
- Are there any investigations and
  treatment that may optimise this
  patient's physiological state prior
  to receiving anesthesia?
- Will the patient need escalation of
  care after surgery?

Fitness for
anaesthesia

- Cardiorespiratory reserve to tolerate anaesthetic drugs and surgical stress
  - Exercise tolerance (FOS)
  - Metabolic equivalents (MET): objective measure of physiological reserve - 1 MET = resting 02 consumption of a 40yo 70kg man = 3.5mL O2/min/kg BW - Role in non-emergency OT: - Low risk of MACE (<1%): proceed to surgery - High risk of MACE (≥1%): assess METS - ≥4 METs (clinically 2 FOS): fit for GA - <4 METs: pharmacologic stress testing (thallium or stress cardiac
    MRI); coronary revascularisation if abnormal
  - Cardiopulmonary exercise testing (CPET): real measure of functional capacity

Medical
history

- Past anesthetic history:
  - Allergy/Anaphylaxis: antibiotics/muscle relaxants / anaesthetic drugs
  - Difficult intubation
  - Poor dentition ("loose tooth alert")
  - Previous post-op n/v (PONV), awareness under GA (rare)
- Family history
  - Suxamethonium apnoea:
    - Pseudocholinesterase deficiency (prevalence: 1/2000) → prolonged paralysis (5-10min to several hours) → post-operative ventilation failure
    - Mx: mechanical ventilation until effect wears off 1-2h later
  - Malignant hyperpyrexia (MHP)
    - Uncontrolled release of intracellular Ca2+ due to defective ryanodine receptor
    - Trigger: suxamethonium, all inhalational agents except nitrous oxide
    - S/S: rigidity, tachycardia, tachpnoea, HT, diaphoresis, unexplained ↑ETCO2, hyperthermia (late), death (80% if untreated, 20% if treated)
    - Management:
      - Stop all trigger agents & change to IV propofol
      - Hyperventilate with 100% O2
      - IV dantrolene 2.5mg/kg Q5min (RyR antagonist)
      - Symptomatic: cooling, treat hyperK and acidosis (e.g. NaHCO3)
- Medical condition (e.g. OSA)
  - PMHx: any medications and S/E, control of chronic diseases, room for optimization
  - Physical examination & check vitals
  - Bloods: Hb, Plt, Na, K, Ur/Cr, clotting
  - CXR/ECG
- Surgical condition: e.g. multiple metastases, UGI tumor with malnutrition, perforated viscus causing sepsis
- Smoking, alcohol, drug Hx (e.g. steroids, antiplatelets, anticoagulants, OCP, HRT, psychiatric)

[Image of a physical exam detailing: Airway: MP3, receding chin +ve, TMD >6cm, removable denture x1, neck extension OK. BP 132/76 mmHg, HR 63/min BW: 52kg Ht: 150cm. CVS: HS dual, no murmur, AF. Chest: clear, no basal crepitations, no ankle edema. Investigations: Hb/Plt: 14.3/215 Na/K/Ur/Cr: 139/4.6/5.5/61. ECG: AF, RBBB. CXR: widened carina, clear lung fields.]

Quantifying American Society of Anaesthesiology classification (**ASA**): Gross predictor of overall outcome, but
anaesthetic not predict mortality
risk

- ASA1: healthy fit, no organic / biochemical / psychiatric disease
- ASA2: mild systemic disease, e.g. controlled T2DM, normal pregnancy, heavy smoker, HBV,
  obese (BMI 30-40)
- ASA3: severe systemic disease that limits normal activity, e.g. poorly controlled DM, CRF
  with regular CAPD, morbid obesity (BMI ≥ 40), stroke with dense hemiplegia
- ASA4: incapacitating disease that poses constant threat to life, e.g. unstable IHD, severe
  COPD requiring ventilation, end-stage cirrhosis
- ASA5: moribund, not expected to survive 24h with or without surgery, e.g. ruptured AAA
- ASA6: declared brain death whose organs are being removed for donation purposes
- Modifiers: Add **"E" for emergency surgery**, **"P" for pregnancy**
- Easy to use compared to other scores; Interobserver variability, cannot account for ≥2 systemic
  diseases of different severity, not take into account age, malignancy

Airway - Inspect jaw profile and oral cavity: e.g. receding chin, tongue fibrosis / tumor, poor dentition
assessment - 3-2-1 rule: difficult intubation if

- Thyromental distance < 3 FB
- Mouth opening < 2FB
- Anterior jaw subluxation < 1FB
- Neck mobility: atlanto-occipital joint (AOJ) extension (normal >35°)
- Mallampati classification (fig.): protrude tongue and say "ah", Class III or above: difficult

[Illustration of Mallampati classification with four classes. Each class depicts the view of the oral cavity when a person protrudes their tongue and says "ah". Class I shows the soft palate, uvula, and pillars being visible. Class II shows the soft palate and the uvula being visible. Class III depicts only the soft palate and the base of the uvula being visible. Class IV depicts only the hard palate being visible.]

- Class I - soft palate, uvula, and pillars are visible
- Class II - when the soft palate and the uvula are visible
- Class III when only the soft palate and base of the uvula are visible
- Class IV when only the hard palate is visible.
- Cormack and Lehane grading (laryngoscopy view): Grade III or above: difficult

[Illustration of Cormack and Lehane grading for laryngoscopy view, with four grades. Grade I shows a full view of the entire glottic aperture. Grade II shows a partial glottic view. Grade III shows a visualization of the epiglottis only. Grade IV shows inability to visualize even the epiglottis.]

- Grade I - full view of the entire glottic aperture
- Grade II - partial glottic view
- Grade III - visualization of the epiglottis only
- Grade IV - inability to visualize even the epiglottis

Aspiration - High risk of aspiration
risk - Unfasted patients: trauma, ruptured AAA

- High intra-abdominal pressure: morbid obesity, pregnancy
- GERD, hiatal hernia
- Delayed gastric emptying: DM with gastroparesis, GOO, IO
- Prevention
  - Pre-operative fasting
  - Antacid prophylaxis (e.g. sodium citrate, H2RA/PPI)
  - Cuffed ET tube
  - Rapid sequence induction with application of cricoid pressure

286

# Anaesthetic orders

Medications of anesthetic concern

| Drug class                                                                    | Considerations                                                                                              | Management                                                                                                                                                                                                              |
| ----------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Ongoing treatments: anticonvulsants, antihypertensives, bronchodilators       |                                                                                                             | Often continued + consult medical if change IV                                                                                                                                                                          |
| Antithrombotics: heparin, warfarin, NOAC, aspirin                             | Surgical bleeding Regional anesthetic (e.g. spinal anesthesia) Consequence of cessation of drugs (e.g. AMI) | Refer to [GEN SUR] DAPT: defer elective surgery, stop P2Y12i if emergency OT Warfarin: INR < 1.5 (vit K & FFP if emergency) + heparin bridging NOAC: withhold duration depends on RFT and bleeding risk, usually 2 days |
| Steroids                                                                      | Inadequate cortisol response for surgical stress → Addisonian crisis                                        | IV 100mg hydrocortisone tds (first dose given on induction of anesthesia) → taper to 50mg tds and 25mg tds                                                                                                              |
| Antidiabetic agents                                                           | Glucose fluctuation to fasting and surgical stress Metabolic complications e.g. DKA, HHS                    | Stop OHA / insulin 1 day before OT Dextrose-insulin-potassium (DKI): titrate insulin against H'stix Q6h, target 5-11                                                                                                    |
| Other drugs Bronchodilators for asthma / COPD Anxiolytic for anxious patients |                                                                                                             |                                                                                                                                                                                                                         |

Preoperative fasting - refer to [GEN SUR] for ERAS principles

- No clear fluid for 2h
- No solid food for 6h
- Adult: 2-6-8 rule (clear fluid prohibited within 2h of surgery, solid food/ milk within 6h, heavy meal within 8h)
- Child: 2-4-6-8 rule (clear fluid within 2h, breast milk within 4h, formula milk within 6h, solid food within 8h)

Routine investigations

- CBC, clotting, random glucose, RFT, CXR, ECG
- Blood transfusion:
  - No expected blood loss: omit pre-op T&S
  - Expect some blood loss: pre-op T&S
  - Expect moderate blood loss < 1L: 2 unit packed cells
  - Expect severe blood loss >2L: 4 units packed cells
  - Expect massive blood (> 1 blood volume): 8 units blood + FFP + platelets (stored blood lacks functional platelets and clotting factors)

Post-op destination

- Consider escalation to HDU / ICU: more invasive monitoring & organ support (e.g. mechanical ventilation, inotropes, continuous RRT), high nursing-to-patient ratio

\*Extra: Alternative scores for anesthetic risk

- Cardiovascular: Goldman-Lee score, Revised Cardiac Risk Index (RCRI), NSQIP
- Liver disease: Child-Pugh score
- Head injury: GCS
- Critical care: APACHE I-III, SOFA, RIFLE, Ranson Score

[Image Description: The text "The better known critical care scoring systems are:" is followed by descriptions of APACHE I-III, SOFA, RIFLE, and Ranson Score systems, detailing their purpose, application, and key features. The text is formatted in a paragraph style with some bolded text for emphasis.]

# 1.3 Airway management

Causes of airway obstruction
| | Causes | Management |
| :---------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :------------------------------------------------------------------------------------------------------------------------------ |
| Upper airway | Functional: - Reduced consciousness level - Neuromuscular abnormalities: bulbar palsy, MG - Recurrent laryngeal nerve problems / cord palsy | Refer to below: Non-definitive airways → Definitive airways |
| | Mechanical: - Inhaled foreign body - Soft tissue swelling: infection (e.g. tonsillitis, epiglottitis), neoplasms, anaphylaxis | Bypass by ETT / tracheostomy Manage underlying causes: drain abscesses, excise neoplasms, stents |
| Lower airway | - Extrinsic tracheal compression - Tracheal stenosis - Severe bronchospasm | |

Ventilation
Rate: 12-15/min
Volume: ~500mL (1/4 of adult resuscitation bag)
Observe chest movement and auscultate for air entry

Methods of supporting airway
Non-definitive airway

- Recovery position (tongue falls forward)
- Airway maneuvers: **head-tilt chin-lift / jaw thrust** (lift up tongue & epiglottis)
- Airway adjuncts:
  - Oropharyngeal airway: in unconscious patients, measure from corner of mouth to angle of mandible
  - Nasopharyngeal airway: in semi-conscious patients, measure from nostrils to angle of mandible, C/I if suspected skull-base fractures
  - Supraglottic devices e.g. laryngeal mask airway (LMA)

[Image of a laryngeal mask airway (LMA). The LMA consists of an oval mask with a cuff that is designed to create a seal around the entrance to the larynx. The mask is connected to an airway tube, which is used to ventilate the patient. The image also shows the different parts of the LMA, including the distal aperture, cuff, mask aperture bars, bowl, inflation line, proximal connector, pilot balloon, and valve. In the bottom right corner of the image, there are descriptions of the numbers shown in the image, that correspond to parts of the device. Number 1 refers to the inflatable cuff (25-30 ml air). Number 2 refers to the stalk with universal (15 mm) connector. Number 3 refers to the pilot balloon (with syringe). Number 4 refers to the fact that the device is disposable or reused.]

- Advantages over ETT: easier to insert (laryngoscopy not required), less traumatic, lower anaesthetic requirement (require only hypnosis + suppression of gag reflex)
- Role:
  - Alternative to intubation in short procedure (but avoid if high risk of aspiration)
  - Rescue device: cannot intubate (ETT), cannot ventilate (BMV)
- Second generation: additional channel for NG tube e.g. ProLeak

Definitive airway (protected)

- Endotracheal tube (ETT)

[Image of an endotracheal tube, labeled with "Murphy eye," "One-way valve," "Inflating tube," "15-mm adapter," "Pilot balloon," "Cap to one-way valve," "Inflated cuff," "Radiopaque line," and "Depth markings."]

- Markings: denote position of **vocal cords**
- Material: PVC (Portex), silicon-coated PVC (Shiley)
- Cuffed vs uncuffed:
  - Cuffed: high volume & low pressure usually
    preferred, aim pressure 20-30 cmH2O
  - Uncuffed: may be used in children to avoid injury
- Single vs double lumen: for one-lung ventilation
- **Fenestrated** vs non-fenestrated: allow phonation
- Inner tube: allow replacement
- Surgical airway: cricothyrotomy (emergency), tracheostomy

Tracheal intubation

- Pre-requisite
  - Suction of mouth and pharynx
  - Pre-oxygenation/denitrogenation: 100% O2 for 3-5 min
- Proper positioning:
  - Sniffing position: flexion of lower C spine + extension of
    upper C spine → oral axis, pharyngeal axis and laryngeal
    axis should be a straight line
  - C/I in suspected C-spine instability/fracture → manual in-
    line immobilisation of head & neck OR awake fiberoptic
    bronchoscopy
- Laryngoscopy
  - Stand at **head** end of patient and hold laryngoscope with
    **left** hand
  - Laryngoscope blade tip placed at **vallecula**
  - BURP maneuver (backward, upward, rightward pressure)
    to facilitate glottis visualization
- Tube insertion:
  - Tip of ETT at least 2cm above carina → ~21-23cm mark (M)/
    19-21cm mark (F) at right corner of mouth
  - _Stylet_ can be inserted through lumen to make it firmer
  - Confirmation of placement:
    - Direct vision + "misting" in endotracheal tube
    - Bilateral chest movement
    - **Auscultate both lungs** for equal breath sounds (to
      prevent transmission of sound over chest) +
      _epigastrium_ for absent breast sounds
    - ETCO2 measured by capnography: observe for 5
      expiratory peaks

[Image of a diagram illustrating the design of an endotracheal tube (ETT). The diagram shows a plastic tube labeled as "Clear, disposable & non-allergy". It includes a cuff with a pilot balloon (5-10 ml air), a seal to keep air in/vomit out, and a connector. The connector is specified as a "Universal size 15 mm". Markings such as size, length, and position are also indicated.]

[Image of a Resuscitation Bag. The bag shows oxygen supply connected here with label of 10L/min. The parts of the bag are labeled as follows: 1. Bag - self-inflating, 2. Valves - unidirectional, 3. Oxygen supply / reservoir, and 4. Face mask.]

[Image of a Macintosh Laryngoscope. The upper scope is in a ready position for use with light switched on, while the lower scope is in the off position. A blue arrow points to a feature on the laryngoscope.]

[Image of a person using a laryngoscope. The text reads "Laryngoscope held in LEFT hand, person intubating stands at head end of patient. Note (a) how the handle is grasped and (b) The orientation of blade in the mouth" Also, a note at the bottom reads: "Too much pressure on upper teeth" and an arrow indicates where the teeth are]

Complications

- Sedative-related
- Laryngoscopy-related: damage to lips, teeth, larynx
- Intubation-related:
  - Oesophageal intubation:
    - Delayed hypoxia for 3-5min (due to pre-oxygenation)
    - Abdominal distension → regurgitation → aspiration
  - Endobronchial intubation: one-lung ventilation → contralateral lung collapse
  - Accidental extubation

289

Modification: Nasal or oral RAE preformed tube (fig.): facilitate H&N surgery

Difficult airway

- Prevention: pre-op assessment (Mallampati score & TMD are most predictive; consider tracheostomy if burns/ maxillofacial trauma), pre-oxygenation
- Management modalities of unsuccessful intubation after induction
  - LMA manages to oxygenate:
    - Gum elastic Bougie (GEB, endotracheal tube introducer)
    - Video laryngoscopy (e.g. Pentex (fig.))
    - Awake fiberoptic bronchoscopy
  - LMA fails to oxygenate: emergency cricothyroidotomy
- Management of predicted unsuccessful intubation before induction
  - LMA (if short procedure)
  - Awake fiberoptic intubation (gold standard): no need of bag-mask ventilation to maintain oxygenation, but uncomfortable and difficult due to gag reflex
  - Awake tracheostomy
    EMERGENCY ACCESS TO TRACHEA

[Diagram showing Cricothyroidotomy and Formal Tracheostomy. On the left side, labeled "Anterior", is a diagram of Cricothyroidotomy. It's annotated with: "Quick, relatively easy stab through cricothyroid membrane. Insert any small round airway such as a biro casing. Anaesthetic not essential. Life saving." Below that is Formal Tracheostomy, with the annotation "Not usually an emergency. Needs full anaesthetic. Ideal for temporary or permanent intubation. Hole cut in 2nd & 3rd tracheal rings, usually after dividing thyroid isthmus. Inferior thyroid veins can be troublesome." On the right side, labeled "Lateral", is another view of the same anatomy.]

[Photograph of a difficult intubation trolley, which is a metal cart with shelves and drawers, holding various medical instruments and supplies. Some of the labeled items are: 1. Blind nasal, 2. Surgical airway* (Tracheostomy, Cricothyroidotomy), 3. Retrograde intubation, 4. Gum Elastic Bougie (GEB), 5. Novel laryngoscope blades (i.e. McCoy), 6. Light Wand, 7. Intubating LMA, 8. Fibre-optic laryngoscope, 9. Video laryngoscope.]

Operating table position
| Position | Features |
| ------------------------- | ------------------------------------------------------------ |
| Supine | Least likely to sustain injury |
| Lithotomy | Perineal surgery, e.g. anorectal, urologic, gynaecological |
| Lateral | Thoracic Intubation/ line when supine |
| Prone | Back: spine, adrenal Intubation/ line when supine |
| Trendelenburg (head down) | Pelvis (bowel moves proximally) |

1.4 General anaesthesia
Four stages of anaesthesia (ether): analgesia → excitement → surgical anaesthesia (unconscious & still) → respiratory
arrest & cardiovascular collapse

Balanced anaesthesia
Rationales

- Allow lower doses of combination → lower risk
- Improve surgical conditions
- More control on individual drugs
  Components
- Anaesthetics - see [Induction]
- Analgesia
- Neuromuscular blockers

[Illustration of a triangle with the title "Unconsciousness (1)" at the top, "Analgesia (2)" on the left, and "(3) Muscle relaxation" on the right.]

Neuromuscular blockers

[Diagram showing the mechanism of action of neuromuscular blockers. It depicts a synapse with a presynaptic neuron releasing Acetylcholine (ACh) which is then either broken down by Acetylcholinesterase (AChE) into Choline + Acetate, or binds to the Postsynaptic nicotinic ACh receptor. The diagram illustrates the Non-depolarising and Depolarising blocking agents, and their effects on the synapse.]

|            | Suxamethonium                                                                                                                                                                                                 | Rocuronium / Atracurium                                                                                 |
| ---------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------- |
| MOA        | **Depolarising**: rapid repeated activation → local accumulation of K+ → inactivation of Na+ channel                                                                                                          | **Non-depolarising** competitive antagonist at nicotinic AChR                                           |
| PK         | Rapid onset (45 sec) - initial fasciculations Short acting (9-10min): metabolized by succinylcholinesterase                                                                                                   | Delayed onset (R: 60-90 sec; A: 3 min) Long acting (up to 1hr)                                          |
| S/E        | Muscle pain Hyperkalaemia: K+ release from increased no. of receptors; higher risk in 3rd degree burns, spinal injury, neuromuscular diseases Increased ICP & IOP Malignant hyperthermia Suxamethonium apnoea | Atracurium: **non-organ elimination** Atracurium: rash, hypotension (histamine) Rocuronium: **minimal** |
| Monitoring | Peripheral nerve stimulation (ulnar nerve) - **train of four (TOF)**: 4 repeated stimuli at 0.5s intervals, usually aim 2 out of 4 twitches, some surgeries (e.g. retinal, CNS) require absolute immobility   |                                                                                                         |

- NMB Reversal
  - Neostigmine (cholinesterase inhibitor) + atropine (block muscarinic S/E of neostigmine)
  - Sugammadex: specific for reversing rocuronium / vecuronium

# Induction

**Equipment required**

- Ventilation: resuscitation bag / anesthetic circuit, face mask
- Airway obstruction: different airways (refer above)
- Intubation: laryngoscope, endotracheal tube (stylet, 10mL syringe), aqueous lubricating jelly
- Confirm tube position: stethoscope, ETCO2 monitor

**Types of induction**

|                      | Routine induction                                                                                                                                                                  | Rapid sequence induction (RSI)                                                                                                                                                                                             |
| :------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Indications          | Adequately fasted (no liquid x 2h, no solid food x 6h)                                                                                                                             | High risk of aspiration (refer to pre-op assessment)                                                                                                                                                                       |
| Pre-requisite        | Pre-oxygenation with high flow O2 for 3 min (aim to achieve expired O2 conc. >80%)                                                                                                 |                                                                                                                                                                                                                            |
|                      | (Rationale: FRC 2.5L, O2 consumption 250mL/min, CO2 production 200mL/min → pre-oxygenation can fill FRC with 100% O2 and keep the patient oxygenated for 10 min before intubation) |                                                                                                                                                                                                                            |
| Induction &paralysis | Induction anesthetic (**propofol**) + fast-acting opioid (**fentanyl**)                                                                                                            |                                                                                                                                                                                                                            |
|                      | Non-depolarising NMB (e.g. **atracuronium**) after onset of induction agent & ensuring patient is **fully unconscious** by checking eyelash reflex                                 | Depolarising NMB (**suxamethonium**) at the same time (shorter onset) → If C/I: rocuronium (fast onset, but long acting)→ stand-by Sugammadex if failed intubation                                                         |
| Post-induction       | Bag-mask ventilation (± oropharyngeal airway if difficult) x **3 minutes** to allow muscle relaxation                                                                              | Sellick's maneuver: cricoid pressure x **45sec** to allow muscle relaxation (10N before induction, 30N after induction) - only cricoid has a complete ring! Bag-mask ventilation **not done**: increase risk of aspiration |
|                      | Confirm position of ETT                                                                                                                                                            | Laryngoscopy & intubation (+ inflate cuff) Release cricoid pressure **after** ETT position confirmed and secured                                                                                                           |

[Image of a box with RSI: "7 P's" written on top, followed by a list with numbers. 1. P = Preparation 2. P = Preoxygenation 3. P = Pretreatment 4. P = Paralysis with induction 5. P = Protection 6. P = Placement of the tube 7. P = Post-Intubation management]

292
Induction agents
Intravenous agents: fast induction after 1 "arm-brain circulation time"
| | Propofol | Ketamine | Benzodiazepines |
| --- | --- | --- | --- |
| MOA | Positive modulation at GABAA receptors | NMDA antagonist | Positive modulation at GABA receptors (different site as propofol) |
| Role | Induction (~30sec) | Major trauma | Anxiolysis, sedation, anterograde amnesia |
| | Maintenance (require TCI) | (Not for head injury: increase ICP) | |
| | Total IV anaesthesia (TIVA): In/v | | |
| Caution | Sudden hypotension & bradycardia | Sympathomimetic: increase HR/BP | Respiratory depression |
| Remarks | Anti-emetic effects | Hallucinogenic Potent analgesic | Antagonist: flumazenil 0.2mg IV, repeat Q1min No analgesic effects |

\*Target-controlled infusion pump (TCI, fig.): input desired plasma concentration, and computer
will calculate and control infusion rate
[Image of Target-controlled infusion pump which shows an infusion pump, tubings, and an IV bag. The pump has a digital display showing infusion parameters. A gloved hand is adjusting the pump settings. The background is a sterile medical environment.]
Specific indications for TIVA

- Operation-related: tubeless ENT/ thoracic surgery, neurosurgery (minimise effect on ICP)
- Drug-related: history of severe PONV, long QT syndrome, risk of malignant hyperthermia

Inhalational agents

- Examples:
  - Halothane (less used now due to risk of autoimmune hepatitis)
  - Isoflurane (slower onset → for maintenance)
  - Sevoflurane (non-pungent banana-smelling → for induction)
  - Desflurane (fastest onset and offset, low potency, pungent → not for induction)
  - Xenon (under research)
- S/E:
  - PONV
  - Respiratory depression
  - CVS: hypotension, bradycardia
  - Increased ICP
  - Malignant hyperthermia
- Minimal alveolar concentration (MAC): concentration in inspired air at which 50% of patients have no response to a surgical incision

Depth of sedation
| | Minimal Sedation (Anxiolysis) | Moderate Sedation (Conscious Sedation) | Deep Sedation (Monitored Anaesthetic Care) | General Anesthesia |
| --- | --- | --- | --- | --- |
| Response | Normal response to verbal stimulation | Purposeful* response to verbal or tactile stimulation | Purposeful* response to repeated or painful stimulation | Unarousable, even with painful stimulus |
| Airway | Unaffected | No intervention required | Intervention may be required | Intervention often required |
| Spontaneous Ventilation | Unaffected | Adequate | May be inadequate | Frequently inadequate |
| Cardiovascular Function | Unaffected | Usually maintained | Usually maintained | May be impaired |

- Reflex withdrawal from a painful stimulus is NOT a purposeful response

Monitored Anaesthesia Care (MAC)

- Indicated for ambulatory diagnostic and therapeutic procedures with fast recovery
- Patient remains conscious, maintains own airway and gag reflexes, and responds purposefully
- Anaesthetist administers sedatives and analgesics, and continuously monitors and supports patients
  Contraindications to sedation
- Absolute: risk of aspiration, airway obstruction, respiratory distress, high ICP
- Relative: advanced COPD (T2RF), renal/hepatic dysfunction

Maintenance
Anaesthetic depth

- Clinical: SNS response (HT, tachycardia, sweating), patient movement, blink reflex when eyelashes lightly
  touched
- Machine:
  - Inhalational agents: end-tidal concentration of volatile agent, keep MAC > 0.7
  - Intravenous agents (TIVA): depth of anaesthesia monitoring, e.g. bispectral index (simplified EEG)

[Table with AGENT, MAC, POTENCY, Bispectral index system value and Depth of sedation. The AGENT column has the drugs Methoxy-flurane, Halothane, Isoflurane, Enflurane, Sevoflurane, Desflurane, Nitrous oxide. The MAC column has the values 0.16%, 0.74%, 1.17%, 1.7%, 2.05%, 6.0%, 104%. The POTENCY column contains text which includes Most potent and Least potent. The Bispectral index system value contains the values 0, 0-40, 40-60, 60-90 and 100. The Depth of sedation column contains the text Flat-line EEG, Deep hypnotic state; memory function lost; increasing burst suppression, Recommended range for general anesthesia, Recommended range for sedation, Awake; memory intact]

The lower the MAC- the more potent the agent!

EEG = electroencephalogram

Routine monitoring

- Airway/breathing: pulse oximetry, ETCO2, ventilator function
- Circulation: continuous ECG, non-invasive BP Q3-5min
- Body temperature

Additional monitoring

- Urine output: in all major operations, to prevent overfilling of bladder and post-op bladder dysfunction
- Arterial BP: in critically ill patients where acute changes in BP are possible
- CVP: in patients with poor CV function

Monitoring sedation by midazolam: Ramsay sedation score, Observer's Assessment of Alertness/Sedation (OAA/S)

[Table with Response, Speech, Facial expression, Eyes, Composite score, Sedation Level. The Response column consists of Responds readily to name spoken in normal tone, Lethargic response to name spoken in normal tone, Responds only after name is called loudly or repeatedly, Responds only after mild prodding or shaking, Does not respond to mild prodding or shaking, Does not respond to noxious stimulus. The Speech column consists of Normal, Mild slowing or thickening, Slurring or prominent slowing, Few recognizable words. The Facial expression column consists of Normal, Mild relaxation, Marked relaxation (slack jaw). The Eyes column consists of Clear, no ptosis, Glazed or mild ptosis (less than half the eye), Glazed and marked ptosis (half the eye or more). The Composite score consists of 5, 4, 3, 2, 1, 0. The Sedation Level column consists of Alert, Light, Moderate, Deep, Unconscious, Anaesthesia]

Emergence
General guidelines of extubation

- Suction secretions
- Ensure normal neuromuscular function: nerve stimulator of ulnar nerve (correspond well to respiratory
  muscles function)
- Ensure breathing spontaneously with adequate rate and tidal volume
- Bite block: prevent biting on ETT → might lead to negative pressure pulmonary edema
- Deflate ETT cuff and remove ETT on inspiration (vocal cords abducted)
- Ensure breathing adequately after extubation

Complications

- Early: aspiration, laryngospasm
- Late: transient vocal cord incompetence, oedema, pharyngitis

Aldrete's recovery room score: conscious, activity, respiration, circulation, SpO2

293

1.5 Local anaesthesia
Definitions & mechanism

- Drugs that block the generation and propagation of impulses in excitable tissues near the site of administration
- LA binds to receptors on cytosolic side of Na+ channel

Chemical classifications

- Amide: metabolized by liver
  |Lignocaine|Fast onset (<2min), short acting (~1.5h), max dose **3mg/kg (7mg/kg with adrenaline)**|
  |---|---|
  |Bupivacaine(Marcaine)|Slow onset, **long acting** (3-4h), **more potent, most cardiotoxic, least neurotoxic**, max dose **2mg/kg** (with or without adrenaline), often used for spinal / epidural blocks due to **long action**|
  |RopivacaineLevobupivacaine|Enantiomer of bupivacaine, less potent, **fewer S/E** but longer half life|
  |Prilocaine|Less cardiotoxic thus preferred in **IVLA**, risk of methemoglobinemia; N/A in HK|

- Ester (e.g. cocaine, procaine): metabolized by plasma cholinesterase (shorter halflife), possible metabolism to para-aminobenzoic acid (PABA) and cause HSR

Delivery techniques
Topical anaesthetic

- Must be able to penetrate skin or mucous membrane
- EMLA (eutectic mixture of LA): 2.5% lignocaine + 2.5% prilocaine for injection pain
- 10% lignocaine spray: laryngoscopy
- Cocaine: local vasoconstriction in ENT surgery
  Local infiltration

[Extent (Vol LA) x Duration (Conc LA) = Total Dose of LA image, there are mathematical expressions around it.]

- Direct injection of LA into tissues to anesthetize local terminal nerve endings
- Indications: **minor surgery** (e.g. wound suturing, tooth extraction, removal of sebaceous cyst / lipoma)

Risks of local anaesthesia

- Infection
- Injury to nearby vital structures
- Allergic reaction
- **Systemic toxicity**: caused by **overdose, rapid absorption, or accidental IV injection**
  - CNS: perioral numbness, dizziness, tinnitus, visual disturbance, convulsion, respiratory depression
  - CVS: hypotension, arrhythmia (VF), cardiorespiratory arrest
  - Management: resuscitation, diazepam (↑seizure threshold), intralipid 20% (bind LA in circulation), manage arrhythmia

Prevention of systemic toxicity

- Use within max dose
- Frequent aspiration & injection of **small increments** to make sure no blood
- Adrenaline
  - Causes vasoconstriction
    - Reduce bleeding of surgical site
    - Decrease systemic absorption of LA → Limit peak plasma conc. of LA and reduce LA toxicity
    - Increase neuronal uptake → Prolong duration of LA
  - S/E:
    - Local: tissue ischaemia - **avoid end arteries** (ears, nose, fingers/ toes, penis)
    - Systemic: HT, arrhythmia, MI - avoid if taking sympathomimetics (MAOI/TCA)
  - Usual conc.: 1:200,000 (5ug/mL)

[A pyramid-shaped chart showing plasma lidocaine concentration (µg/ml) on the Y-axis, ranging from 0 to 30. The X-axis is unlabeled. Horizontal lines mark the concentration levels, each corresponding to different physiological effects. At 30 µg/ml is labeled "Ventricular arrest". 25 µg/ml marks "Respiratory arrest" and "Cardiac arrhythmias". 20 µg/ml shows "Coma" and "Myocardial depression". 15 µg/ml indicates "Convulsions". 10 µg/ml notes "Unconsciousness", "Muscular twitches", and "Visual disturbance". Lastly, 5 µg/ml describes "Tinnitus", "Lightheadedness", "Numbness of the tongue", and "Circumoral paraesthesia". The chart visually depicts the correlation between lidocaine concentration and associated medical conditions.]

Toxicity: prilocaine < lidocaine < ropivacaine < levobupivacaine < bupivacaine

# 1.6 Regional & obstetrics anaesthesia

Peripheral nerve blocks

- Deposition of LA around target nerve or plexus (within perineural sheath)
- Usage: isolated to avoid GA, or combined with GA
- Examples
  - Distal radius fracture: brachial plexus block
  - Hip fracture: femoral nerve block
  - Hallux valgus: sciatic nerve block / saphenous nerve block
  - Breast surgery: thoracic paravertebral block
- Equipment: 30º short bevel, USG / peripheral nerve stimulator (stimulate nerve and watch for motor response)
- C/I: neurological disease (e.g. ALS, MS), local infection, coagulopathy

Brachial plexus block:
Approaches

- Interscalene (between scalenus anterior & medius)
- Supraclavicular
- Infraclavicular
- Axillary
  Complications (spreading of LA / direct trauma)
- Phrenic nerve block: caution if limited respiratory reserve
- Horner's syndrome (sympathetic trunk)
- Hoarseness (RLN)
- Pneumothorax
- Intravascular injection: subclavian vessels, vertebral a.

[Image of the brachial plexus. The image shows a diagram of the brachial plexus, which is a network of nerves that originates in the neck and shoulder and extends into the arm. The diagram shows the roots, trunks, divisions, cords, and branches of the brachial plexus, as well as the muscles and skin that are innervated by each nerve. Next to the diagram, there is a drawing of a side view of the bones and muscles in the neck and shoulder with the Brachial plexus.]

IV regional anaesthesia (Bier's block)

- Systemic injection of LA localized to upper/ lower limbs
- Indications: surgery below elbow / knee lasting within 1h
- C/I:
  - Procedures ≥ 1h (tourniquet pain)
  - Pre-existing AV shunt/ severe PVD
  - Sickle cell disease
- Components:
  - Double pneumatic tourniquets inflated to 100mmHg above SBP for at least 30min (to prevent systemic toxicity of LA)
  - Exsanguination: elevation + rubber Esmarch bandage
  - IV lignocaine / prilocaine WITHOUT adrenaline
  - After finishing operation: deflate then inflate again x 2 - to ensure no systemic toxicity of LA
- S/E:
  - Drug-related systemic toxicity
  - Equipment-related (tourniquet)
- Alternative: WALANT (wide-awake local anaesthesia no tourniquet) - lignocaine + adrenaline

[Image of a Bier's block procedure. The image shows a patient lying on a bed with a double cuff tourniquet applied to their arm. An IV is inserted into the patient's arm, and medication is being administered. The image also labels: Pressure source, Cotton padding, Esmarch bandage, and 0.5% Lidocaine.]

Paravertebral block

- Tuohy needle advanced into paravertebral space
- Advantages: avoid complications of thoracic epidural block, i.e. hypotension, spinal cord injury

Neuraxial blocks

|                   | Spinal                                                                                                                                                                                                                                                                                              | Epidural                                                                                                                                                                                                                                           |
| :---------------- | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Deposition site   | Subarachnoid space Endpoint: free-flow CSF Site: L3/4 (Tuffier's line)                                                                                                                                                                                                                              | Epidural space (potential space between ligamentum flavum & dura) Endpoint: loss of resistance (LOR) with saline/air Sites: depend on site of surgery: high/mid thoracic (thoracic surgery), low thoracic (abdominal surgery), lumbar (LL surgery) |
| Needle            | Pencil point 25-27G                                                                                                                                                                                                                                                                                 | Tuohy 16G                                                                                                                                                                                                                                          |
| Onset             | **Faster** (2-5min)                                                                                                                                                                                                                                                                                 | Slower (10-15min)                                                                                                                                                                                                                                  |
| Specific gravity  | Hyperbaric (higher specific gravity than CSF by mixing with D10) - position of patient important                                                                                                                                                                                                    | Not important                                                                                                                                                                                                                                      |
| Agent             | Bupivacaine^ + opioid (fentanyl / morphine)                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                    |
| Dosage            | Single dose → limited duration of operation Smaller dose required (< toxic IV dose): high conc., low volume                                                                                                                                                                                         | Continuous infusion via catheter → unlimited duration of operation Larger dose required (> toxic IV dose): low conc., high volume Give with adrenaline (transient tachycardia if misplaced IV)                                                     |
| Indications       | Surgical anaesthesia below the level of umbilicus for max 3h                                                                                                                                                                                                                                        | Surgical anesthesia Analgesia for labour/ post-op pain relief                                                                                                                                                                                      |
| Contraindications | Raised ICP Coagulopathy / Thrombocytopenia Local infection / sepsis Anatomical abnormality, e.g. severe scoliosis                                                                                                                                                                                   |                                                                                                                                                                                                                                                    |
| Complications     | Fixed cardiac output states (AS/ MS): risk of hypotension due to afterload reduction Demyelinating diseases Hypotension\*: r/o high block (T4-6 → pharmacological sympathectomy), pre-hydration, resuscitation prn Weakness/paraesthesia: neuro exam + MRI to rule out epidural haematoma/infection |                                                                                                                                                                                                                                                    |
|                   | Post-dural puncture headache (PDPH): - Onset 6h-3d after dural puncture - Postural: worse when sitting or straining - Prevention: pencil point / small gauge needle (25/27G) - Mx: o Conservative: bed rest, hydration o Epidural blood patch (10ml own blood injected into epidural space)         |                                                                                                                                                                                                                                                    |
|                   | Catheter site infections Nerve damage                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                    |

[Image of four different types of needles, namely Sprott, Whitacre, Quincke and Atraucan. Each needle has a distinct design and shape at its tip, indicating variations in their cutting or non-cutting mechanisms, which are critical in medical procedures to minimize tissue trauma and prevent post-dural puncture headache.]

^Bupivacaine is used in SA/ EA: not associated with any neurotoxicity & long-acting

- Mechanism of hypotension in high thoracic block

* Reduced TPR (arterial vasodilation), reduced CO (venodilation)
* Mx: Vasopressors used intra-op - Ephedrine (alpha + beta) - Phenylephrine (pure alpha) - Atropine (vagal block)
  Structures penetrated
* Skin
* Subcutaneous fat
* Supraspinous ligament
* Interspinous ligament
* Ligamentum flavum
* Dura + arachnoid (SA only)
  Epidural vs IV analgesia
* ↓Respiratory complications: deep breathing possible
* ↓CV complications: bradycardia → ↓stress to heart
* ↓Thromboembolism: vasodilation
  Obstetrics anaesthesia
* Choice of modality: regional anesthesia is safer (unless very urgent)
  - Spinal anesthesia (first line!)
  - Epidural anesthesia: usually for labour pain relief
  - Combined spinal epidural anaesthesia (CSE) (fig.)
    - Insert spinal needle through Tuohy needle for
      bolus SA, then insert EA catheter for additional
      analgesia prn
  - GA: RSI with propofol + suxamethonium +/- nitrous
    oxide inhalation
* Difficult intubation is 8 times more common than normal patients
  - Weight gain and oedema
  - Pre-existing obstetric disease e.g. pre-eclampsia
  - Increase oxygen demand by 20% & reduced oxygen reserve (FRC drop 20%): less apnea time allowed
  - Delayed gastric emptying and relaxed LES due to progesterone → risk of aspiration even with fasting
* Potential issues
  - Mendelson's syndrome (chemical pneumonitis caused by aspiration of acidic stomach contents during
    anesthesia in childbirth): reduced by RSI and antacids (30mL sodium citrate + H2RA/ PPI)
  - Aortocaval compression (supine hypotension syndrome): reduced by left lateral uterine displacement
    - Placenta bed has no autoregulation to compensate for drop in BP

[Image: A diagram of the intervertebral disc shows superficial tissues, ligamentum flavum, and intervertebral disc, with labels pointing to the supraspinous ligament, post. long. ligament, ant. long. ligament, and vertebral body. It is marked as Fig. 1. Additionally, there are two diagrams depicting a needle being inserted into the spinal column. The first diagram shows the needle passing through the Cauda Equina, Dura, and Ligamentum Flavum. The second diagram displays the Epidural Catheter being inserted through the Dura into the Epidural Space.]

# 1.7 Postoperative care

Pain management

[Diagram illustrating the recognition, assessment, and treatment (RAT) of pain in the brain. The diagram is divided into location of pain and emotional aspect of pain. Starting from the left at the top, an arrow comes from the somatosensory cortex, the level of the cortex. Below the cortex is the thalamus level. The thalamus has an arrow coming from the VPL. Below that is the midbrain with an arrow from the spinothalamic/spinoreticular tract. Below that is the pons. Below that is the medulla with an arrow from the anterolateral system. Below that is the dorsal horn. At the right, at the level of the cortex, there is the association cortex (insular, cingulate, prefrontal) for the emotional aspect of pain. Below that is centrolateral (intralaminar). Below that is the periaqueductal gray which leads to Opioids on the right edge. From the spinothalamic/spinoreticular tract, an arrow leads to the spino-mesencephalic tract, which feeds into the periaqueductal gray. Also Enkephalin comes from the periaqueductal gray and points to the locus coeruleus. The nucleus raphe magnus is below the locus coeruleus and from it comes 5-HT Enkephalin. An arrow comes from the anterolateral system and points to the nucleus raphe magnus. Underneath that there is a circular diagram. It has Lamina I/V (Substance P Glutamate) and substantia gelatinosa. A dotted line points from lamina I/V to the substantia gelatinosa. Next to that is a red box around NSAID. On the right are A delta and C fibers. At the very bottom right are mechanoreceptors. Finally in the bottom left is a polymodal section with Bradykinin, Adenosine, Histamine and PGs inside of it.]

Peripheral sensitization (inflammatory agents e.g. PG, histamine, substance P) vs central sensitization (NMDA receptor in SC)

Recognition

Definitions

- Nociception: detection & transmission of noxious stimuli
- Pain: perception of nociception; **unpleasant sensory & emotional** experience associated with actual or potential tissue damage (IASP 2020)

Factors affecting postoperative pain

- Surgical factors: site of incision (upper abdomen > thoracotomy > lower abdomen > limbs), complications
- Patient factors: genetics, history of substance abuse, history of chronic pain

Assessment

- Severity of pain
  - Subjective: numerical rating scale (NRS), visual analog scale (VAS)
    - Children: FLACC scale (for 2mo-2yo), faces pain scale (FPS)
    - Elderly: PAINAD scale (for advanced dementia), verbal descriptive scale
  - Objective: behaviour (shallow breathing), physiological (BP, HR, RR)
- Type of pain
  - Onset: Acute (<3mo) vs chronic (>3mo)
  - Etiology: Cancer (lower threshold to start opioids) vs non-cancer
  - Mechanism: can be mixed
    - Nociceptive (physiological): tissue injury, protective function
    - Neuropathic (pathological): no protective function
      - Characteristics: neuroanatomically associated deficits, allodynia, hyperalgesia, electric shock / shooting / burning / tingling sensation
    - Nociplastic (interaction of multiple factors → altered neural pathway)
- Other factors: psychological (e.g. anxiety), cultural, religious, personality, social

299

Treatment
Non-pharmacological treatment

- Physical: RICE, splinting & orthosis, physiotherapy, surgery, radiotherapy, acupuncture & massage
- Psychological: counselling, reassurance
- Placebo (no direct therapeutic value)

WHO analgesic ladder: **step up if chronic pain, step down if acute nociceptive pain, avoid strong opioids for chronic non-cancer pain**

- Paracetamol: mild pain, C/I in hepatectomy (liver impairment)
- NSAID:
  - Act at peripheral chemical mediators of pain
  - C/I in
    - Medical: extreme age, poor RFT, poorly controlled asthma, allergy, bleeding tendency, GIB, APO
    - Surgical: NS/ eye symptoms, difficult haemostasis
- Opioids (fig.): act at periaqueductal grey (midbrain) & dorsal horn (spinal cord)

[Image: A line graph showing the percent of peak effect at the site concentration of different opioids over time. The x-axis represents time in minutes since bolus injection, ranging from 0 to 20. The y-axis represents the percent of peak effect, ranging from 0 to 100. Several lines represent different opioids: Pethidine, Morphine, Fentanyl, Alfentanil, and Remifentanil. Each line has a different curvature, illustrating how quickly each opioid reaches its peak effect and how long it lasts. A key beside the graph shows that Pethidine and Morphine have low lipid solubility and a long half-life (T1/2), Fentanyl has high lipid solubility and a long half-life (T1/2), and Alfentanil and Remifentanil have high lipid solubility and a short half-life (T1/2).]

|                |                                                                                                                                                                          |
| :------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Mild opioids   | **Tramadol:** weak µ agonist, also act on 5-HT & NE, 1/5000 affinity of morphine                                                                                         |
|                | **Codeine:** 10% metabolized into morphine by CYP2D6 demethylation (8-10% lack this)                                                                                     |
| Strong opioids | **Morphine:** onset 5-15min, high efficacy, intermediate duration (~4h)                                                                                                  |
|                | - IV (1.5mg Q5min up to 5 doses post-op), IM (Q3h prn), epidural, PCA (see below)                                                                                        |
|                | - PO: only 1/3 can enter circulation                                                                                                                                     |
|                | **Pethidine:** long half life, no histamine effect, but antimuscarinic (tachycardia, dry mouth); neurotoxic metabolites can accumulate and cause generalized convulsions |
|                | **Fentanyl:** early onset (~3-5min), long half life, give with some lignocaine to reduce injection site pain                                                             |
|                | **Remifentanil:** early onset (~1min), **short half life** (give as infusion, often with TIVA)                                                                           |

- Side effects of opioids:
  - Respiratory depression: IV naloxone if RR < 8 or unconscious
  - N/V: IV metoclopramide (Maxolon) 10mg q8h / IV ondansetron 4mg q8h prn
  - Hypotension (histamine): reduce dose
  - Pruritus (histamine): r/o allergy, IV chlorpheniramine 10mg q6h prn
  - Urinary retention
  - Constipation
  - Dysphoria / hallucination
- Toxicity: muscle twitching, pinpoint pupil
- Opioid overdose:
  - S/S: drowsiness, respiratory depression, SaO2 drop (late)
  - Mx:
    - Maintain patent airway
    - Verbal stimulation (ask him to breathe) → pain stimulation (sternum rubbing)
    - High-flow O2 + pulse oximetry
    - Failed above or respiratory depression: IV naloxone 0.4mg (0.1mg if PCA) Q2min to desired reversal, closely monitor as S/S may recur as drug action passes

300

- Other adjuvants for neuropathic pain
  - Antidepressants: e.g. TCA, SNRI
  - Anticonvulsants: Ca channel blocker (e.g. gabapentin, pregabalin), Na channel blocker (e.g. carbamazepine)
  - Local anesthetics: e.g. lignocaine
  - Others: e.g. ketamine, Botox

# Methods of postoperative analgesia

| Routes                                |                                                                 |
| ------------------------------------- | --------------------------------------------------------------- |
| GI tract                              | PO, feeding tubes (e.g. NG tube), PR                            |
| Parenteral                            | IV (e.g. intermittent bolus PCA\*, continuous infusion), IM, SC |
| Neuroaxial                            | Epidural anesthesia (EA), paravertebral block (PVB)             |
| Peripheral nerve block / plexus block | Brachial plexus block (BPB), femoral block, popliteal block     |
| Topical                               | Transmucosal / transdermal (e.g. fentanyl patch)                |

Example regimens according to severity

- Severe pain (NRS ≥ 8): multimodal e.g. IV PCA, neuro-axial blocks (EA, PVB), plexus blocks
- Moderate pain (NRS 5-7): SC/PO morphine 5-10mg q4h prn, tramadol 50-100mg q8h prn
- Mild pain (NRS ≤ 4): paracetamol 500-1000mg q6h, Voltaran 100mg daily

\*Patient-controlled analgesia (PCA)

- Small injections of IV morphine on demand with measures preventing overdose
- Setting:
  - Bolus dose: morphine 1-2mg (adult), 20µg/kg (paediatric)
  - Lock out time: 5-10min
  - 4h max dose: 30mg
- Assessment: pain score (consider increase if >5/10), PCA usage (exceed 4h limit, consumption in 24h), vitals, S/E
- Advantages: better pain relief, less respiratory depression,

# Postoperative nausea and vomiting (PONV)

Risk factors

- Patient: Young female, non-smoker, early pregnancy, previous Hx of PONV / motion sickness, obesity
- Anesthetics: GA > RA, opioids, inhalational agents (→ try to use IV propofol)
- Surgery: Eye, ENT, laparoscopy (abdominal / pelvic)
- Post-op: pain, movement, hypotension

[Diagram illustrating the pathophysiology of vomiting. The diagram is broken up into 4 parts, starting from the left is the stimulus section, then the input section, then the integration section and finally the output section on the right.
Under Stimulus are listed: "Pain, repulsive sights and smells, emotional factors", "Inner ear" and "Motion sickness Labyrinth", "Endogenous toxins, drugs", "Stimuli from pharynx and stomach".
Under Input are listed: "Sensory afferents and CNS pathways" and "Vestibular nuclei (H1 and mACh receptors)" and "Visceral afferents (5-HT3 receptors?)".
Under Integration are listed: "Higher centres", "H1 receptor antagonists, muscarinic receptor antagonists", "Dopamine antagonists, aprepitant, 5-HT3 antagonists", and "CTZ (NK1, D2, and 5-HT3 receptors)" and "Nucleus of the solitary tract (mACh and H1 receptors)".
Under Output are listed: "Nerves to somatic and visceral receptors", "Vomiting centre (mACh receptors)", "Muscarinic receptor antagonists", and "5-HT3 antagonists" and "H1 receptor antagonists".]

| Antiemetics          |                                                                                      |
| -------------------- | ------------------------------------------------------------------------------------ |
| Antihistamine (H1RA) | Cinnarizine, cyclizine, diphenhydramine                                              |
| Antimuscarinic       | Scopolamine                                                                          |
| D2 antagonist        | Prochlorperazine, metoclopramide (cross BBB → EPSE, also encourage gastric emptying) |
|                      | Domperidone (not cross BBB)                                                          |
| 5HT3 antagonist      | Ondansetron (more effective than metoclopramide), topisetron                         |
| NK1 antagonist       | Aprepitant                                                                           |
| Corticosteroid       | Dexamethasone                                                                        |

# 1.8 Ventilator

Goals of mechanical ventilation

- Adequate oxygenation: FIO2
- Adequate CO2 removal
- Minimize adverse effects of mechanical ventilation

Basic structure

- Circuit: single-limb or dual-limb
  - Single-limb systems contain **expiratory valve**: dysfunction can cause rise in PaCO2 (CO2-rich gas passes down the circuit and is rebreathed)
- Heat-moisture exchanger (HME): placed between Y-piece and ETT
  - Heat and moisture deposited on device by expired gas, and picked up by cold dry inspired gas
  - Role: prevent airway mucosal damage and maintain mucociliary clearance

[Single limb circuit with active exhalation valve. The circuit goes from the Ventilator through a Pressurization line and ends at the Patient with an Active exhalation valve]

[Dual limb circuit: The circuit goes from the Ventilator to the Patient and back to the Ventilator. One line is the inspiration line and the other is the expiration line]

Ventilator settings

- Mode: Volume preset assist-control
  - Each breath is initiated by ventilator or by patient - exactly same tidal volume & duration

| Parameter                    | Usual setting | Remarks                                                                                     |
| ---------------------------- | ------------- | ------------------------------------------------------------------------------------------- |
| FIO2                         | 100%          | **Titrate down** and aim SpO2 >94%                                                          |
| PEEP                         | 5-10 cmH2O    | Prevent alveolar collapse during expiration                                                 |
|                              |               | Higher in pneumonia / pulmonary edema / atelectasis: reduce shunting to improve oxygenation |
| Tidal volume                 | 6-8 mL/kg     | Too high will damage the lungs                                                              |
| RR                           |               | Main determinant of CO2 removal (since tidal volume is quite fixed)                         |
|                              |               | Recommended initial settings (**memorize!**)                                                |
|                              |               | Normal metabolic rate, no cerebral injury                                                   |
|                              |               | 12-16                                                                                       |
|                              |               | Normal metabolic rate, **risk of brain injury**                                             |
|                              |               | 14-18                                                                                       |
|                              |               | High metabolic rate (e.g. severe sepsis)                                                    |
|                              |               | 20-25                                                                                       |
|                              |               | Severe **metabolic acidosis**                                                               |
|                              |               | 25-30                                                                                       |
|                              |               | **Expiratory flow restriction** (asthma, COPD)                                              |
|                              |               | 10-12                                                                                       |
| Inspiratory time (I:E ratio) |               | Inspiratory time = inspiratory flow time + inspiratory pause time                           |
|                              |               |                                                                                             |
|                              |               | I:E ratio                                                                                   |
|                              |               | Inspiratory pause time                                                                      |
|                              |               |                                                                                             |
| COPD / asthma                |               | ≥ 1:3                                                                                       |
|                              |               | 0                                                                                           |
| Other conditions             |               | 1:2                                                                                         |
|                              |               | 10%                                                                                         |
| PaCO2                        | 4-7 kPa       | Must be within range if respiratory acidosis (pH ≤7.2) or high ICP                          |
|                              |               | Not used for titration otherwise, allow hypercarbia if COPD/asthma                          |

- Mode: Pressure support
  - All breaths are triggered by patient, but positive pressure is provided to augment inspiration
  - Advantage: reduce work of breathing, relatively comfortable
  - Settings: similar to volume-control
    - Additional **pressure support** (initially set 6-10 cmH2O, then titrate to achieve TV 6-8mL/kg)
- Switching from volume-preset to pressure support
  - Keep FIO2
  - Original peak airway pressure = new PEEP + new PS

302
Troubleshooting

- High airway pressure alarm: usually set at 40 cmH2O (normal peak airway pressure ~30 cmH2O)
  - Causes: high resistance (e.g. sputum retention), low lung compliance (e.g. APO, ARDS, pleural effusion)
  - Also present as "low tidal volume" in pressure-support mode

[Flowchart describing actions to take in case of High Airway Pressure. First decision is to check that the chest wall is rising with inspiration. If not, consider Medical emergency, e.g. complete ETT obstruction - Ask for help. If yes, disconnect from ventilator and manually bag ventilate. If there is High Resistance, pass suction catheter through ETT. If Resistance is encountered, consider ETT: Blockage by secretions, blood, biting. If Patent, check Symmetrical Chest expansion. If No, consider Reduced Compliance unilaterally: Endobronchial intubation, Lung - pneumonia, collapse, Pleural - pneumothorax, pleural effusion. If Yes, consider Increased resistance: bronchospasm: Reduced lung Compliance: Lung - Hyperinflation (COPD/Asthma, Pneumonia, ARDS Pulmonary edema, Abdominal distension or ascites, Patient- ventilator dysnchrony, coughing. If there is Normal Resistance, consider Ventilator/Circuit problem: Check ventilator settings e.g. machine malfunction, inappropriate settings, Check the circuit for kinking, condensation.]

- Desaturation: Set FIO2 to 100%, rule out ventilator problems, and look for underlying cause

[Flowchart describing actions to take in case of Desaturation. Set FiO2=1.0. If Chest moving? is no, Manually ventilate. If Easy to ventilate? is yes, consider Ventilator problem: Check settings & function. If Easy to ventilate? is No, consider ETT/patient problem, see figure 1. If Chest moving? is Yes, Examine patient, In particular look for: Endobronchial intubation, Pneumothorax, Collapse, Pulmonary oedema, Bronchospasm. Treat cause and adjust ventilator settings.]

- Hypotension:
  - Causes:
    - Pharmacological effects: sedatives → vasodilation & myocardial depression
    - PPV: high intrathoracic pressure → obstruction of venous return to Rt heart
    - Hyperinflation of lungs (e.g. COPD, asthma) → obstruction of venous return to Rt heart
    - Tension pneumothorax
  - Management
    - Fluid resuscitation
    - Disconnect from ventilator to see if hyperinflation is the cause
    - Investigate for other causes

# 1.9 Anaesthetic monitoring

| Parameters measured      | Importance / Usefulness                                                | Normal range                                                                                                          | Limitations                     |
| ------------------------ | ---------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------- | ------------------------------- | ----------------------------------------------------------------------------------------------------------------------- |
| Electrocardiogram (ECG)  | Heart rate, rhythm, wave forms, ST/T changes                           | Monitor for arrhythmias, MI                                                                                           | 60-100 HR (adults) Sinus rhythm | Not full 12 lead during anesthesia, restricted analysis Limited ability to detect intra-op ischemia artifact            |
| Pulse oximeter           | Oxygen saturation (SpO2)                                               | Assess oxygenation and picks up any hypoxemia Desaturation: machine-to-patient check                                  | 100%                            | Inaccurate                                                                                                              |
| Sphygmomanometer         | Blood pressure (NIBP: at least Q5min)                                  | Assess hemodynamic stability for timely intervention                                                                  | 160/100 (90%-110% of baseline)  | Accuracy not as good if very low / high BP Not continuous                                                               |
| Arterial line            | Invasive BP monitoring                                                 | Continuous beat-to-beat monitoring Arterial waveform also provides information                                        | MAP ≥65 mmHg                    | Invasive                                                                                                                |
| Central venous line      | Central venous pressure                                                | Fluid management Vascular access Drug administration (inotropes)                                                      | 8-12 mmHg                       | Concomitant infusion of fluid renders CVP measurement inaccurate                                                        |
| Temperature              | Core temperature                                                       | Reflects temperature loss Detects malignant hyperthermia                                                              | 35.5 - 37°C                     |                                                                                                                         |
| Urine Output             | Hourly urine output                                                    | Detects any AKI, predicts morbidity Reflects hypovolemia                                                              | 0.5mL/kg/h (min)                | Not as reliable in predicting AKI intra-op as can be normal response to stress Foley can be uncomfortable → Paul's tube |
| End tidal gas monitoring | End tidal CO2 - capnometry (partial pressure of CO2 at end exhalation) | Indicates ventilatory compromise Elevated: hypoventilation, ... Decreased: low cardiac output → low perfusion to lung | 35-45 mmHg 4.0 - 5.7 kPa        | Difficult to interpret in mixed V/Q problem, metabolic problem (eg APO)                                                 |
| Bispectral index         | Single strip EEG over forehead                                         | Depth of anaesthesia                                                                                                  | 40-60: adequate (0 is flatline) | No added value to other parameters for patient management, although it helps confirm adequate depth                     |

[Image of a page number 303 in the top right corner of the page.]

1.10 Drugs and fluids in anaesthesia
Anaesthetic agents
| Drug | Indication/use | Mechanism(s) of action | Usual dosage (per kg of body weight) | Adverse effects | Antidote(s) |
|---|---|---|---|---|---|
| Midazolam | Induction & maintenance of GA Sedation Anxiolysis | Binds to BZR-R on GABA neurons to enhance the inhibitory effect | Non-premedicated: 0.3-0.35 mg/kg via slow IV Premedicated patient: 0.15-0.2 mg/kg via slow IV Sedation: IV 1 mg Q2min → max 0.1mg/kg | Respiratory depression Arrhythmia **Anterograde Amnesia** Vomiting Agitation Local irritation **No analgesic effect** | **Flumazenil** 0.2mg IV Q1min (max 1mg) |
| Ketamine | Induction & maintenance of GA | Non-competitive NMDA receptor antagonist | IV 1-4.5mg/kg over 60s 2mg/kg lasts 5-10min | Laryngospasm ↑BP, ↑HR | X |
| Propofol | **Induction &** maintenance of GA (TIVA) | Global CNS depression by positive modulation of GABA-A receptor | Induction: 20-40mg Q10s (usu. 1.5-2.5kg/kg) (titrate against response) Maintenance: 4-12mg/kg/hr | Local pain on induction **Myocardial depression** (bradycardia, hypotension) | X |
| Atropine | Reduce saliva before GA Reversal of muscle relaxant | Antimuscarinic | IV 300-600mcg before induction immediately IV 0.6-1.2mg | Drowsiness, blurred vision, dry mouth, mydriasis, palpitations, AROU, confusion | X |
| Fentanyl | Opioid analgesic IV opioid adjuvant agent | μ-opioid receptor | 0.5-1mcg/kg (before sedative/hypnotic) | Sedation, bradycardia, Pruritus, N/V **Respiratory depression** | **Naloxone** 0.4mg IV Q2min (max 2 mg) |
| Remifentanil | Opioid analgesic infusion in TIVA | μ-opioid receptor | 0.05-0.3 mcg/kg/hour infusion | Muscle & chest wall rigidity if rapid dose Dysphoria / Euphoria | |
| Morphine | Maintenance Emergence Post-op pain | μ-opioid receptor | 1-2mg IV bolus 1-2mg increments 1-2mg x 5min LO, 4h 30mg limit (PCA) | | |
| Neostigmine | Reversal of NM blockade for non-depolarising agents | Anticholinesterase | 0.05-0.07mg/kg by injection over 60s | N/V, increased salivation Diarrhea, cramps Hypersensitivity Neuromuscular dysfunction Respiratory failure | Atropine sulfate 1-2mg IV (antimuscarinic effect) |

Atracurium
Facilitate
intubation
Non-depolarising
Competitive
antagonism of
AChR
IV inj 0.3-0.6mg/kg
Maintenance: 0.3-0.6mg/kg/hr for long
surgeries
Intubation: 0.6mg/kg; 1mg/kg (RSI)
Mild & transient hypotension
Skin flushing
bronchospasm
Neostigmine

Rocuronium
Induce paralysis
in GA
Infusion 0.3-0.6mg/kg/hr
Pain/local reaction
Prolonged neuromuscular
block
Anaphylaxis
Tachyphylaxis
Sugammadex

Suxamethonium
Muscle relaxant
in GA (RSI)
Depolarizing
muscle relaxant
0.3-1.1mg/kg
2.5-4mg/min infusion
Malignant hyperthermia
Suxamethonium apnoea
Hyperkalemia
Muscle pain
X

Equipotent doses of opioids
Morphine IV | Morphine PO | Fentanyl IV (no PO!) | Codeine PO | Tramadol PO | Pethidine IM / IV | Methadone PO | Oxycodone PO
---|---|---|---|---|---|---|---
10mg | 30mg | 0.1mg | 200mg | 300mg | 20-30mg | 20mg | 20mg
[A table showing Equipotent doses of opioids. From left to right, the columns are: Morphine IV, Morphine PO, Fentanyl IV, Codeine PO, Tramadol PO, Pethidine IM / IV, Methadone PO, Oxycodone PO. The corresponding values are: 10mg, 30mg, 0.1mg, 200mg, 300mg, 20-30mg, 20mg, 20mg. ]

Fluids

Implications of fluid / electrolyte disturbances in anaesthesia:

- Hypovolemia → hemodynamic instability (hypotension, tachyarrhythmias) → **poor tolerance to anaesthetic induction**, exaggerated by PPV / surgical maneuvers
- Hypervolemia → tissue edema → respiratory (pulmonary edema), GI (ileus, anastomotic leak), dilutional coagulopathy, impaired wound healing
- Electrolyte disturbance → arrhythmia, choice of fluid therapy, interaction with anesthetic agents (e.g. suxamethonium-induced hyperK)

Maintenance fluid requirement: 4ml/kg/h x first 10kg + 2ml/kg/h x next 10kg + 1 ml/kg/h x additional weight

[A simple infusion set with a 15 µm in-line filter is depicted on the left. A blood infusion set with a 200 µm filter is depicted on the right.]

Goal-directed fluid management: assess physiological parameters (e.g. BP, CVP, Swan-Ganz catheter for PAWP, echo for IVC size) to guide fluid management

No benefits of using colloids over crystalloids in acute resuscitation

| Crystalloids                                   | Smaller molecules | Cheaper         | Faster redistribution to extravascular compartment (1:3) | Edema                                    |
| ---------------------------------------------- | ----------------- | --------------- | -------------------------------------------------------- | ---------------------------------------- | ---------------- | ------------------- | --------------------------------- | ------------------------------------------------------------------------------------------------------------------- |
| Colloids                                       | Bigger molecules  | More expensive  | Stay longer intravascular ("volume expander")            | Anaphylaxis, coagulopathy, renal failure |
| Fluid                                          | Type              | Sodium (mmol/L) | Chloride (mmol/L)                                        | Potassium (mmol/L)                       | Glucose (mmol/L) | Osmolality (mOsm/L) | Others                            | Remarks                                                                                                             |
| Normal saline                                  | Crystalloid       | 154             | 154                                                      | 0                                        | 0                | 308                 |                                   | S/E: HyperCl metabolic acidosis                                                                                     |
| Compound sodium lactate (Hartmann's solution)  | Crystalloid       | 131             | 111                                                      | 5                                        | 0                | 278                 | Lactate: 29 Ca: 2                 | Lactate metabolized into HCO3 by liver: avoid in liver failure Ca-containing: not compatible with blood transfusion |
| PlasmaLyte                                     | Crystalloid       | 140             | 98                                                       | 5                                        | 0                | N/A                 | Acetate: 27 Gluconate: 23 Mg: 1.5 | Preferred for **burns** (large volume) **Most physiological** Expensive                                             |
| 0.45% Saline, 2.5% Dextrose (1/2:1/2 solution) | Crystalloid       | 77              | 77                                                       | 0                                        | 139              | 293                 |                                   | Used for DM                                                                                                         |
| 5% Dextrose                                    | Crystalloid       | 0               | 0                                                        | 0                                        | 278 (50g)        | 278                 |                                   |                                                                                                                     |
| Gelofusine                                     | Colloid           | 154             | 120                                                      | 0                                        | 0                | 274                 | 20g succinated gelatin            |                                                                                                                     |
| Voluven                                        | Colloid           | 154             | 154                                                      | 0                                        | 0                | 308                 | Hydroxyethyl starch (HES)         | Risk of renal dysfunction and coagulopathy                                                                          |

2 Urology
2.1 Common urological complaints
Haematuria
Definitions

- Gross haematuria: red-coloured urine visible to naked eye
- Microscopic haematuria: ≥3 RBC/HPF in 2 out of 3 properly collected urine (freshly voided, clean-catch, mid-
  stream urine processed by centrifugation)
  Differential diagnosis
- Most common cause: UTI (60%)
- Most worrying: malignancy (until proven otherwise)
- Others: stone (10%), GN (5%), BPH, trauma, iatrogenic (e.g. post-TURP, post-FC)
  History taking - highlights
- Blood relative to urine stream: beginning (lower urinary tract), throughout (above bladder), terminal (prostate)
- Any blood clots: urological causes (urokinase in glomerular filtrate prevents formation of blood clots)
- Concomitant frothy urine (GN)
- Associated symptoms:
  - Urologic: irritative symptoms (UTI), obstructive symptoms (prostate), loin pain (colicky: stone, constant: infection), passage of stones
  - Autoimmune:
    - Rash: purpuric rash (HSP, GPA), malar rash (SLE)
    - Arthralgia, myalgia (SLE)
  - Respiratory:
    - Recent URTI (IgA nephropathy)
    - Epistaxis, rhinorrhoea (GPA)
    - Pleuritic chest pain, SOB (SLE)
    - Haemoptysis (pulmonary-renal syndrome)
    - Systemic: fever, weight loss, bleeding tendency
- Risk factors: smoking, occupation (hairdresser, rubber industry)
  Physical examination
- Abdomen: loin tenderness, ballotable kidneys, suprapubic masses
- Scrotum: varicocele (esp. left-sided: RCC obstructing left renal v.)
- DRE: prostate enlargement
  Investigations
  Pearls
- All Hb-positive dipstick should be
  accompanied by urine microscopy to
  differentiate haematuria vs pigmenturia
  - Glomerular disease: dysmorphic RBC
    / RBC casts
  - Urological disease: isomorphic RBC
- Antiplatelet/ anticoagulant use is not a
  satisfactory explanation for haematuria,
  except in warfarin OD
- Urine Ix: microscopy (RBC, WBC, casts),
  C/ST (r/o UTI), cytology x 3 (if malignant
  cells → cystoscopy!)

[A flowchart shows how to determine the cause of blood in the urine. The chart begins with a urine dipstick that tests positive for RBCs. From there, the flowchart splits based on whether the patient is treated for a UTI or receives repeat dipstick testing. If a repeat dipstick also shows RBCs, the patient undergoes urine microscopy and culture. If the urine microscopy reveals dysmorphic RBCs or RBC casts, indicating glomerular disease, the patient is referred for nephrology. However, if the urine microscopy reveals isomorphic RBCs, indicating a urologic disease, the patient undergoes a cystoscopy and CTU scan. If the initial dipstick test is positive for proteinuria or the patient has renal insufficiency, they are referred for nephrology. Finally, if a patient with isolated microscopic hematuria does not have an underlying condition or any abnormalities, they undergo periodic follow-up. If the initial urine dipstick is positive for RBCs but repeat dipstick testing is negative, it means the problem is resolved. The patient then undergoes an evaluation for hemoglobinuria or myoglobinuria. If there are risk factors for CA bladder, the patient undergoes a workup. Otherwise, the workup ends there. ]

308

- Upper tract imaging
  - Plain AXR / KUB: from upper pole of R kidney (T12) to pubic symphysis
  - USG: non-invasive, but cannot visualise the whole ureter
  - CT urogram (recommended): non-contrast phase (detect stones), renal parenchymal phase (detect tumors), excretory phase
  - IVU: not much role, except in trauma (5-minute) or pregnancy (reduced radiation)
- Lower tract imaging: cystoscopy
  - Flexible: performed under LA
  - Rigid: for persistent haematuria - allow washout
- If urological cancer is ruled out, treat as CKD, i.e. monitor RFT & urinalysis yearly

Urinary incontinence
Definition: involuntary leakage of urine
Aetiology

- Stress: intra-abdominal pressure > urethral pressure (e.g. constipation, post-partum, pelvic surgery)
- Urge: overactive bladder syndrome / detrusor hyperactivity causing increased intravesical pressure, e.g. infection, neurogenic, drugs (e.g. cholinesterase inhibitor)
- Overflow: chronic urinary retention, e.g. BPH
- Continuous: anatomical abnormalities (e.g. ectopic ureter), bladder fistula - consider in female
  Investigations
- Urine C/ST
- Bladder diary: urine output, voiding pattern, fluid intake pattern
- Urodynamic study to differentiate type if history not diagnostic
- Cystoscopy
  Management
- Lifestyle: weight loss, reduce caffeine intake, smoking cessation
- Stress UI: pelvic floor muscle training + biofeedback (repeated sets, repetition of contraction and relaxation), tension-free vaginal tape (TVT), fascia lata sling
- Urge UI: bladder training, anti-ACh (e.g. oxybutynin, solifenacin), ẞ3-agonist (mirabegron), Botox injection

Recurrent urinary tract infection (UTI)
Approach

- Check documented culture: urine C/ST if not available
  - Culture -ve: consider stones / TB tumor
  - Rule out treatment failure: resistant strain / incorrect antibiotics / poor compliance to Tx
- True recurrent UTI: check culture pattern

|           | Re-infection (different organism)                                                                | Relapsing (same organism)                              |
| :-------- | :----------------------------------------------------------------------------------------------- | :----------------------------------------------------- |
| Pathology | Failure of defence mechanism                                                                     | Structural causes: large RU, cannot eradicate bacteria |
|           | - Post-coital hygiene problem                                                                    | - Stones                                               |
|           | - Voiding dysfunction → large RU                                                                 | - Diverticulum                                         |
|           | - Diabetes                                                                                       | - Foreign body                                         |
| Workup    | Bladder scan: residual volume                                                                    | Imaging / cystoscopy / uroflowmetry                    |
|           | Rule out DM, check habit                                                                         |                                                        |
| Treatment | Treat underlying cause                                                                           |                                                        |
|           | If failed / no cause: Suppressive antibiotics (Septrin, nitrofurantoin), post-coital prophylaxis |                                                        |

Erectile dysfunction
Causes: psychological, systemic (e.g. hormonal, drug), local (vascular)

- Related to atherosclerosis: Increased risk of developing coronary artery disease in 10 years time
  Management:
- PDE5 inhibitors (Viagra): C/I if nitrate use / poor CV function, separate >6h if taking alpha blockers for HT
- Topical PGE2 analogues (Befar): transurethral / intracavernosal
- Surgery: vascular surgery, penile prosthesis
- Others: vacuum pump, low-energy shockwave therapy, stenting (?)

  2.2 Urological emergencies
  Acute scrotum
  Differential diagnosis

- Infection (bacterial / viral)
- **Testicular torsion**
- Torsion of testicular appendix
- Trauma
- Incarcerated inguinal hernia
  Management
- Doppler USG, surgical exploration if in doubt

Acute retention of urine (AROU)
Definition: sudden painful inability to void despite having a full bladder
Causes

- Mechanical
  - Extraluminal: BPH, CA prostate, constipation (fecal impaction), POP, pelvic/GI masses, pregnancy
  - Intramural: CA bladder neck, urethritis, urethral strictures
  - Intraluminal: stones, clots, foreign body
- Functional - Neurological: spinal cord compression (must r/o), peripheral neuropathy (GBS), stroke/Parki - Drug-induced: - Sympathomimetics: ephedrine, phenylephrine (cough mixture) - Anticholinergics: atropine - Post-operative / Prolonged immobility
  Physical examination
- Vitals
- Abdomen: bladder dull on percussion (>150mL) / palpable (>200mL)
- DRE: prostate size/tenderness, masses, anal tone
- - Neurological exam: sensory level
    Investigations
- CBC, RFT, urine dipstix & C/ST
- USG bladder (confirm diagnosis) + USG kidney/ureter (hydronephrosis/hydroureter)
  Immediate management: urethral catheterization (14Fr Foley) for bladder decompression
- Contraindication: urethral trauma (S/S: blood at urethral meatus, high riding prostate)
- Unable to pass into bladder:

| Situation                             | Likely causes      | Management                                                      |
| :------------------------------------ | :----------------- | :-------------------------------------------------------------- |
| Enlarged prostate                     | BPH                | Thicker catheter (20-22 Fr): stiffer and easier to pass through |
| Catheter stuck proximally, Hx of TURP | Urethral stricture | Thinner catheter (10-12 Fr)                                     |

- Still cannot pass Foley: - Tiemann catheter: curved tip designed for BPH - Cystoscopic-guided Foley insertion - Urethral dilators: for strictures - Suprapubic catheterization (~2 fingers above pubic symphysis): end hole (pass guidewire for changing) instead of side hole
  [Image of a foley catheter with a red balloon at the tip and the other end open with multiple ports]
  Subsequent management
- Treat reversible causes: stop offending drugs, treat constipation (e.g. fleet enema) & UTI
- Prescribe alpha blocker (Xatral) + trial wean-off catheter (TWOC) later:
  - Observe urine output and perform post-void bladder scan
  - Re-cath if BS >400mL → re-TWOC / long-term Foley / clean intermittent self-catheterization (CISC)
  - TWOC is C/I if obstructive uropathy (RFT improve after Foley insertion)
- Manage BPH: elective TURP 4-6 weeks after AROU (lower intra-op risk)
  Complications
- Post-obstructive diuresis (UO >200mL/h for ≥2h): closely monitor urine output and fluid/electrolyte status
- Haemorrhage ex-vacuo (transient haematuria due to mucosal disruption)

309

Foley insertion

- Check patient consent
- Check expiry date of foley set, open the set and open non-sterile covering
- Wash hand and wear sterile gloves
- Test patency of the foley balloon
- Use aqueous hibitane (blue/pink) to cleanse penis
- Set sterile zone
- Soak foley with xylocaine gel
- Insertion of foley (till foley fully inserted) (prevent damage to urethra) → observe for urine output
- inflate balloon by injection of water for injection WFI (10ml)
- Pull out foley catheter until resistance
- Connect foley to urine bag
- - Dispose needle of syringe to sharp box

[Image of a urinary drainage system, featuring three different bag types. On the left is a urinary leg bag, which is smaller and designed to be worn discreetly on the leg. In the middle is a standard urinary bag, which is a larger, more conventional drainage bag. On the right is a urine meter, which is a specialized bag with markings to accurately measure urine output. All three bags are transparent to allow for visual monitoring of the urine.]

Left: urinary leg bag Middle: standard urinary bag Right: urine meter
Hydronephrosis
Definition: imaging evidence of dilated renal pelvis and calyses
Types:

- Obstructive:
  - Unilateral: intraluminal (stone), luminal (stricture), extraluminal (tumour, LN)
  - Bilateral: bladder, prostate, urethra, external compression (e.g. CA cervix, uterine prolapse)
- Reflux, e.g. VUR
- Non-obstructive non-reflux, e.g. massive diuresis (e.g. DI), post-obstructive, severe sepsis
  Acute management
- Foley insertion
- Drainage:
  - Indications: symptomatic, sepsis, deranged RFT
  - Choice: PCN vs JJ

|              | Percutaneous nephrostomy (PCN)   | JJ stent                                    |
| :----------- | :------------------------------- | :------------------------------------------ |
| Size         | Larger calibre (8-10 Fr)         | Smaller calibre (6 Fr)                      |
| Preferred in | Tumor obstruction                | Acute stone obstruction                     |
|              | Infective: drain pus             | Less dilated system: difficult to put PCN   |
|              |                                  | Bleeding tendency                           |
| Advantages   | Quicker access and drainage      | More convenient: no need prone and sedation |
|              | Higher success rate              |                                             |
|              | Monitoring U/O possible          |                                             |
|              | Access for anterograde pyelogram |                                             |
|              | Symptom-free                     | Irritative LUTS                             |

- Drain the side that is: symptomatic, better function, easier to drain
- Monitor for post-obstructive diuresis: osmotic diuresis by accumulated substances, causing dehydration, electrolyte disturbance

Investigate for underlying cause:

- Obstructive cause: CT urogram, cystourethroscopy, MAG3/DTPA scans
- Reflux cause: MCUG

310

Acute loin pain with sepsis
Acute pyelonephritis
Clinical diagnosis
Rule out obstruction: history, KUB, USG
Antibiotics and reassess with USG in 48h
Acute pyelonephrosis
Antibiotics + Emergency drainage
Renal abscess
Antibiotics + Look for underlying cause (e.g. DM, immunosuppression)
Urological trauma
Kidney
Causes: blunt trauma (usually ESWL), penetrating injury
Mostly mild and managed conservatively: protected by ribs, renal capsule & Gerota's fascia for
tamponade effect
Ix: CT abdomen with contrast
Grading: Surgical exploration if AAST Grade 4/5
American Association for Surgery of Trauma Renal Injury Scale
| Grade | Type | Description |
| :---- | :---------- | :--------------------------------------------------------------------------------------------- |
| I | Contusion | Microscopic or gross haematuria. Urological studies normal. |
| | Haematoma | Subcapsular, non-expanding without parenchymal laceration. |
| II | Haematoma | Non-expanding peri-renal haematoma confined to renal retroperitoneum |
| | Laceration | <1.0cm parenchymal depth of renal cortex with no urinary extravasation |
| III | Laceration | >1.0cm parenchymal depth of renal cortex w/out collecting system rupture or urinary extravasation. |
| IV | Laceration | Parenchymal laceration extending through renal cortex, medulla & collecting system. |
| | Vascular | Main renal artery or vein injury with contained haemorrhage. |
| V | Laceration | Completely shattered kidney. |
| | Vascular | Avulsion of renal hilum that devascularises kidney. |
Ureter
Causes: iatrogenic (colon, AAA, hysterectomy)
Management: stenting, surgical repair
Bladder
Extraperitoneal: conservative Mx (Foley insertion for a few weeks + antibiotics)
Intraperitoneal (risk of peritonitis and SB herniation into bladder): surgical Mx - drain, repair
Urethra Parts of urethra: prostatic, membranous, bulbar, penile
Causes: direct trauma ("sit on something") (bulbar), pelvic fracture (membranous)
S/S: blood at urethral meatus, high-riding prostate, Hx of trauma, failure to void
Bruising pattern: penile bruising (no rupture of Buck's fascia), butterfly bruising from scrotum up to
clavicle (ruptured Buck's fascia)
Ix: retrograde urethrogram (catheter placed in urethral meatus)
Initial management: avoid catheterisation → suprapubic catheter
[Diagram of the male perineum, showing the layers of fascia and associated structures. The image depicts a cross-sectional view of the penis and surrounding tissues. The different layers, including Scarpa's fascia, Buck's fascia, and the tunica albuginea, are clearly labeled and color-coded for easy identification. The corpus cavernosum and corpus spongiosum are also visible. Colles' fascia and bulbospongiosus muscle are also labelled. Another diagram shows a cross section of the penis, with the following parts labelled: Superficial and deep dorsal vein, Dorsal artery, Fascicles of dorsal nerve, Skin, Superficial (dartos) fascia, Deep (Buck's) fascia]
311

2.3 Urinary stones (Urolithiasis)
Overview

- 10% population
- Recurrence rate: 10% / year

Pathophysiology:

- Formation of crystal: supersaturation
- Retain and aggregate to form stones: inflammation, Randall's plaque (calcium crystal in interstitial space of renal papilla - serve as nidus for stone formation)

Risk factors:

- Old age, male, urinary tract abnormalities (e.g. horseshoe kidney)
- Diet: high oxalate, high protein (acid-producing), high sodium (Na & Ca compete for renal reabsorption), high / low Ca (paradoxical: Ca binds to oxalate in GIT → prevent absorption of free oxalate into blood)
- Dehydration
- HyperPTH, milk-alkali syndrome

Types of urinary stone

|                       | Prevalence | Urine pH     | Mechanism                                                                                                                | XR features  | Prevention                                                                                                                                                                                                                             |
| --------------------- | ---------- | ------------ | ------------------------------------------------------------------------------------------------------------------------ | ------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Calcium (oxalate/PO4) | 85%        | Oxalate: any | Idiopathic (MC) 1° hyperparathyroidism RTA Medullary sponge kidney Ca oxalate: diet (e.g. spinach), IBD                  | Radio-opaque | Increase fluid intake Limit salt <2g/day Avoid animal protein Avoid oxalate-rich food (spinach, chocolate, coffee) **Normal Ca diet** (promote Ca oxalate binding in gut) **High citrous fruit** Treat underlying cause, e.g. hyperPTH |
| Uric acid             | 5%         | Acidic       | As hyperuricaemia: diet, drugs, ↑cell turnover                                                                           | Radiolucent  | Increase fluid intake Low purine diet Urine alkalinisation: NaHCO3, potassium citrate                                                                                                                                                  |
| Struvite / Staghorn   | 5%         | Alkaline     | Formation of MAP (magnesium ammonium phosphate) by urea-splitting organisms, e.g. Proteus vulgaris, Klebsiella, S aureus | Radio-opaque | Antibiotics x 6 weeks Staghorm stone: ≥ 2 calyces                                                                                                                                                                                      |
| Cystine               | 1%         | Acidic       | Cystinuria (AR)                                                                                                          | Radioopaque  | Increase fluid intake Urine alkalinisation Chelating agents, e.g. penicillamine                                                                                                                                                        |

Rare types: indinavir-induced, xanthine/pyruvate stones
_Hardness: struvite < uric acid < calcium phosphate < calcium oxalate < cysteine_

Anatomy of ureter

- Course in KUB: exit renal pelvis at L1/L2, along tip of transverse processes, in front of SIJ, laterally down pelvic wall towards ischial spine, then curve anteromedially into bladder
- 3 parts: upper 1/3, middle 1/3 (at SI joint), lower 1/3
- **3 common sites of obstruction:** Pelvi-ureteric junction (PUJ), pelvic brim (level of common iliac arteries), vesico-ureteric junction (VUJ)

Clinical features

- Pain: renal colic (colicky pain from loin to groin) +/- n/v (obstruction)
- Loin tenderness (obstruction or infection)
- Haematuria
- Irritative symptoms: FUN, dysuria

Complications

- Infection: pyelonephritis, urosepsis
- Obstruction: hydroureter + hydronephrosis (scarring around stone / post-obstructive effect)
- Acute kidney injury (obstructive nephropathy)

Investigations
Initial evaluation

- Imaging:
  - KUB: may miss radiolucent stones / hydronephrosis
  - Non-contrast CT (gold standard): detect urinary stone, urinary tract obstruction (dilated system, perinephric stranding), determine stone density (>1000 HU is considered hard)
  - Dual energy CT (differentiate stone composition)
  - USG (screening test, or C/I to radiation)
- Urine: pH, microscopy, MSU C/ST (r/o UTI before any definitive Tx)
- Bloods: CBC, clotting (before Tx), RFT, CaPO4, urate, PTH

| KUB vs AXR                 |
| -------------------------- |
| - Must see pubic symphysis |
| - Higher radiation dose    |

Before definitive treatment: CT urogram / IV urogram, ± DMSA / RFT (assess kidney function)
After treatment: stone analysis
High risk for recurrence (Young / bilateral / recurrent): full metabolic work-up with 24h urine collection - rule out hyperPTH, Type 1 RTA, etc.

Management

1. Acute management
2. Definitive management
3. Prevention depending on type of stone

Acute management

- Treat / Rule out urosepsis
- Analgesics: NSAID preferred (also reduce ureteric smooth muscle tone)
- Urgent decompression:
  - Indications: obstruction causing sepsis or obstructive uropathy (AKI)
  - Approach: PCN (1st line) vs JJ stent - refer to [hydronephrosis]
  - Monitor for post-obstructive diuresis: dehydration, electrolyte disturbance

Definitive management
Factors to consider

- Stone factor: site, size, composition, complications
- Patient factor: general medical condition, body build, social status
- Surgeon / institutional factor: availability of expertise and equipment

Conservative

- Increased fluid intake 2-3L/day (until urine is light in colour)
- Dietary modifications: normal Ca, low protein / oxalate / salt
  Medical therapy
- Indications: stone < 5mm without complications
- Medical expulsive therapy (MET): alpha blockers (tamsulosin)
  - Only useful for distal ureteric stones (with alpha receptors)
  - FU 4 weeks with KUB, NCCT
- Medical dissolution: potassium citrate / sodium bicarbonate
  - Useful for uric acid / cysteine stones (urine alkalinization)
    313

Surgical therapy

- Overview: Choice of treatment depends on size & location of stone
  - Kidney: ESWL if < 2cm, PCNL if > 2cm, RIRS as last resort
  - Ureter:
    - Upper ureter: ESWL if <2cm, ESWL (+ JJ stent) / URSL if >2cm
    - Middle / Lower ureter: URSL
  - Bladder: cystolithotripsy, treat outflow obstruction (e.g. BPH)
- Treatment options:

| Modality                                                                                           | Preferred in                                                                                                                                                       | Details                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| :------------------------------------------------------------------------------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| 1. Extracorporeal shockwave lithotripsy (ESWL) 體外衝擊波碎石術 → Lower efficacy, but non-invasive | Renal stone <2cm / Upper ureteric stone <1cm (Too large: Steinstrasse - multiple "streak of stones" causing blockage → Insert JJ stent before ESWL if large stone) | - Perform under IV sedation and fluoroscopy (or sometimes USG for radio-lucent stones) - Mechanism: high-energy shock wave - Renal stone: 1.5 Hz, 3000x, Level 6 - Ureteric stone: 1.5 Hz, 4000x, Level 7 - Position: supine (prone if obstructed by pelvic bone) - C/I: pregnancy, UTI, bleeding tendency (should withhold all antithrombotics), angiomyolipoma - Not preferred: obesity (large skin-to-stone distance), hard stones, unfavourable locations (lower pole of kidney, mid/lower ureter) - Complications: bleeding (perinephric haematoma), incomplete stone fragmentation, infection, hypertension, kidney parenchymal injury |
| 2. Percutaneous nephrolithotomy (PCNL) - nephroscope 經皮腎鏡取石術                                | Renal stone >2cm Hard / complex stones (e.g. cystine, Ca oxalate, staghorn) Unfavourable locations                                                                 | - Perform under GA, antibiotics on induction, prone position, insertion of nephroscope, lithotripsy by ultrasound, mechanical or laser - ± nephrostomy tube: post-op drainage, access for 2nd look PCNL - Complications: GA risks, bleeding, infection (flush bacteria into bloodstream), kidney rupture, bowel perforation                                                                                                                                                                                                                                                                                                                  |
| 3. Ureteroscopy with lithotripsy (URSL) - ureteroscope 輸尿管鏡碎石術                              | Middle / lower ureteric stone Coagulopathy (minimally invasive)                                                                                                    | - Perform under GA, semi-rigid ureteroscope, - Small stones extracted by baskets / forceps - Large stones fragmented by ultrasound / mechanical / laser lithotripsy before extraction - Complications: ureteral perforation, flush-back stone (esp. upper ureteric stone) - Flexible URSL                                                                                                                                                                                                                                                                                                                                                    |
| Retrograde intrarenal surgery (RIRS)                                                               | Last resort for renal stones (failed PCNL)                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 4. Laparoscopic / Robotic ureterolithotomy                                                         | Large ureteric stones (rarely done)                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 5. Open nephrolithotomy                                                                            | Rare                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

- Bilateral disease: consider - Obstruction side - Individual kidney function: nuclear scan (DMSA) - save better one first, non-functional kidney may be managed conservatively if asymptomatic - Symptomatic side

  2.4 **LUTS & BPH**
  Approach to lower urinary tract symptoms (LUTS)
  Traditional LUTS: "FUN" + "DISH"
  | Phase | Symptoms | Details | Causes |
  |--------------|----------------------------------------|---------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
  | Storage phase | **Irritative** | Frequency 尿频 | Local pathology: stone, UTI, tumor, post-RT, post-op |
  | | | Urgency 尿急 ± urge incontinence | Regional: detrusor overactivity |
  | | | Nocturia 夜尿 | Systemic: increased fluid intake / polyuria (DM, DI) |
  | Voiding phase | **Obstructive** | Dribbling 尿末滴漏 (weakened pelvic floor) | Outflow problem: **BPH, CA prostate**, urethral stricture |
  | | | Intermittent 尿流斷續(residual urine) | |
  | | | Incomplete emptying 尿意未盡 | |
  | | | Straining 谷 (higher bladder pressure needed) | |
  | | | Hesitancy 等尿 | Bladder problem: hypocontractility (nerve, detrusor muscle) |

Other symptoms: pain, haematuria, stone

Physical examination:

- General condition: any neurological cause
- Abdomen: distended bladder
- Genitalia: phimosis
- DRE: anal tone, prostate size

**Benign prostatic hyperplasia (BPH)**
**Overview**
Definition: proliferation of stromal component in transitional zone of prostate
Etiology: unknown

- Prostate starts increase in size at age **40** - usually become symptomatic at ~50 years old
  Pathophysiology
- Obstruction:
  - Static component: stromal hyperplasia mediated by dihydrotestosterone (DHT) via 5a-reductase - 5aRI
  - Dynamic component: **smooth muscle** hypertrophy & contraction by a1 receptors - a1 blockers
- Irritation: detrusor instability causing overactive bladder
- Complications: ↑residual urine, causing infection & stone
  Clinical features
- Typical age: **50-80**
- **LUTS**: both obstructive and irritative Sx (**obstructive** >> irritative)
- Complications:
  - Prostate level: bleeding (ruptured dilated bladder neck veins)
  - Bladder level: **AROU, recurrent UTI, bladder stone**, diverticulum, chronic ROU ± overflow incontinence
  - Upper tract: **Recurrent hydronephrosis**, obstructive uropathy, renal failure
- DRE: smooth enlarged > 3FB, non-tender, median sulcus present, anal tone intact

**Investigations**
Basic investigations:

- **International prostate symptom score (IPSS)**: quantify LUTS (obstructive + irritative + QoL)
- **Voiding diary** / Frequency-volume chart: **at least 3 days**, esp. if frequency / nocturia
- Urine: **urinalysis**, microscopy, C/ST (r/o UTI)
- **Uroflowmetry (fig.)**: to confirm obstruction
  - Volume voided > 150ml to be representative of usual voiding habit
  - Peak urine flow rate (Qmax): diagnostic (<15mL/sec), prognostic (<10mL/sec: better outcome after TURP)
  - Abnormal strain pattern (multiple peaks)
  - Post-void residual volume: <150mL

Other investigations:

- Bloods: RFT, PSA (r/o CA prostate)
- Upper tract imaging: if large residual volume / haematuria / Hx of stone
- TRUS: assess size of prostate (use of 5ARI, surgery planning)
- Cystoscopy / Urodynamic study

[Uroflowmetry graph. It contains 3 graphs: "a. Normal", "b. BPH" and "c. Urethral stricture". The X axis is labeled as Time (s), and the Y axis is labeled as Flow (mls/s). All three graphs show a curve starting from the origin. The graph in "a. Normal" reaches a peak around Time = 5s and then gradually decreases to 0 around Time = 15s. The graph in "b. BPH" reaches a peak lower than "a. Normal" around Time = 7s and then gradually decreases to 0 around Time = 15s. The graph in "c. Urethral stricture" reaches a peak much lower than "a. Normal" around Time = 10s and then gradually decreases to 0 around Time = 15s.]

# International Prostate Symptom Score (I-PSS)

| In the past month:                                                                                       | Not at All        | Less than 1 in 5 times | Less than Half the Time | About Half the Time | More than Half the Time | Almost Always | Your Score |
| -------------------------------------------------------------------------------------------------------- | ----------------- | ---------------------- | ----------------------- | ------------------- | ----------------------- | ------------- | ---------- |
| 1. Incomplete Emptying How often have you had the sensation of not emptying your bladder?                | 0                 | 1                      | 2                       | 3                   | 4                       | 5             |            |
| 2. Frequency How often have you had to urinate less than every two hours?                                | 0                 | 1                      | 2                       | 3                   | 4                       | 5             |            |
| 3. Intermittency How often have you found you stopped and started again several times when you urinated? | 0                 | 1                      | 2                       | 3                   | 4                       | 5             |            |
| 4. Urgency How often have you found it difficult to postpone urination?                                  | 0                 | 1                      | 2                       | 3                   | 4                       | 5             |            |
| 5. Weak Stream How often have you had a weak urinary stream?                                             | 0                 | 1                      | 2                       | 3                   | 4                       | 5             |            |
| 6. Straining How often have you had to strain to start urination?                                        | 0                 | 1                      | 2                       | 3                   | 4                       | 5             |            |
| 7. Nocturia How many times did you typically get up at night to urinate?                                 | None              | 1 time                 | 2 times                 | 3 times             | 4 times                 | 5 times       |            |
| **Total I-PSS Score**                                                                                    |                   |                        |                         |                     |                         |               |            |
| **Score: 1-7 Mild**                                                                                      | **8-19 Moderate** | **20-35 Severe**       |                         |                     |                         |               |

# Quality of Life Due to Urinary Symptoms

|                                                                                                                               | Delighted | Pleased | Mostly Satisfied | Mixed | Mostly Dissatisfied | Unhappy | Terrible |
| ----------------------------------------------------------------------------------------------------------------------------- | --------- | ------- | ---------------- | ----- | ------------------- | ------- | -------- |
| If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that? | 0         | 1       | 2                | 3     | 4                   | 5       | 6        |

316

Management
Indications for treatment:

- IPSS moderate or above (≥8)
- Complications (refer above)
  Conservative Indications: symptoms do not bother patient
  Lifestyle modifications: Avoid caffeine / tea, drinking water few hours before sleep, etc
  Medical α1 adrenergic blockers (MC): relax smooth muscles in prostate & bladder neck (NOT body)
- Non-selective: more orthostatic hypotension, nasal congestion, dizziness, tiredness
  - Prazosin (Minipress), terazosin (Hytrin), doxazosin (Cardura), alfuzosin (Xatral)
- Selective (α1A blockers): more retrograde ejaculation
  - Tamsulosin (Harnal), silodosin (Rapaflo)
- To reduce S/E: slow titration, subtype-selective (α1A), slow-release formulations

[Diagram of the lower urinary tract. It labels Muscarinic receptors (M3 subtype (selective)), a1-Adrenergic receptors, dynamic bladder outlet obstruction, prostate gland, a1-Reductase enzymes (Type 1, Type 2), and Phosphodiesterase enzymes (Type 5) in the inferior gland]

5α reductase inhibitors: reduce DHT → decrease size of prostate + decrease vascularity (less bleeding) + progression prevention

- Drugs: finasteride, dutasteride
- 2nd line / in combination with α1-blockers: slow onset (3-6 months for max effect)
- Preferred for larger glands ≥30-40ml (TRUS) / IPSS ≥ 12
- S/E: erectile dysfunction (10%), gynaecomastia
- 50% decrease in PSA: multiply PSA by 2 when screening for CA prostate

PDE5 inhibitor (tadalafil/ Cialis): avoid if using nitrate

Drugs for OAB: anticholinergics (C/I if RU >150mL due to risk of AROU), beta 3 agonist

Minimally invasive therapy
Thermotherapy: HIFU, TUMT (transurethral microwave therapy)
UroLift: implants to hold different parts of prostate away from prostatic urethra
Steam treatment (Rezum): induce coagulative necrosis
Prostatic artery embolisation (PAE): reduce part of blood supply to prostate

Transurethral
surgery
Others
317
Indications: failed medical therapy, recurrent complications
Modalities:

- Electrocautery: TURP (monopolar / bipolar), EVP (electrovarporization)
- Laser: Holium Laser prostatectomy (HoLRP), PVP (photo-selective vaporisation of prostate
  / Green Laser)
  Long term catheterization: Foley/SPC/CISC
  Metallic stent: temporary for very unfit patients

Transurethral resection of prostate (TURP)

- Procedures: spinal anesthesia, lithotomy position, cystoscopy (1.5% glycine), resection with electric knife
- 3-way Foley post-op to irrigate bladder with NS to avoid clot retention
- Specific complications:
  - Bleeding, infection
  - Perforation: can form fistula
  - TUR syndrome:
    - Patho: dilutional hypoNa + fluid overload + glycine toxicity
    - Risk factors: long OT time, e.g. massive prostate
    - S/S: nausea (1st), confusion, cerebral oedema, visual disturbance
    - Mx: manage as hypoNa (electrolytes, serum osmolality, volume status), hypertonic NS
    - Prevention: use bipolar (NS as irrigating fluid), limit volume < 1L & irrigation pressure <60 mmHg
  - Retrograde ejaculation (70-80% due to resection of bladder neck)
  - Urethral stricture (urethral instrumentation)
  - Incontinence (1%): urge (early) / stress (late)

Irritative LUTS
Approach

- Establish frequency (daytime symptoms +ve) but not pure nocturia
- Perform voiding diary / frequency-volume chart: assess urine output, voiding pattern, fluid intake pattern
  - High urine output: look for cause of polyuria
  - Low urine output: true frequency
    - Detrusor hypersensitivity: nerve problem, local causes, de novo
    - Capacity problem

Overactive bladder syndrome (OAB) if no other causes identified

- Exclude infection / stone / tumor
- Clinical Dx by bladder diary
  - Frequent voiding of small volumes
  - Normal prostate on DRE
  - Good flow rate on uroflowmetry
- Management:
  - Bladder training
  - Anticholinergics: oxybutynin / solifenacin
    - S/E: dry mouth, dry eye, constipation, cognitive impairment
  - Beta-3 agonist: mirabegron
    - S/E: elevated BP (>10%)

318

2.5 Urological neoplasm
Prostate cancer
Overview

- Adenocarcinoma arising in the peripheral zone of the gland
- 3rd MC cancer among males in HK, lifetime risk: 1/26, annual incidence: ~2300
- 1/3 is locally advanced / metastatic upon presentation
  Risk factors:
- Advanced age
- Smoking
- FHx (age & number of FDR)
- Genetics: TMPRSS2-ETS fusion gene (50%)
  Clinical features
- Incidental findings: abnormal DRE, elevated PSA
  - DRE (only 25% palpable): asymmetrically enlarged irregular prostate, hard nodule, midline sulcus lost
- Obstructive LUTS (late findings - cancer arises in peripheral zone)
- Haematuria / haemospermia, new-onset erectile dysfunction
- Metastasis: bone (vertebra: via Batson's venous plexus), liver, adrenal
  Investigations
- PSA (arbitrary cutoff at < 4 ng/mL)
  - Higher level = greater chance of CA prostate & higher risk of advanced disease
- Controversy of PSA
  - Organ-specific but not tumor-specific
  - Function of PSA: liquefy semen coagulum
  - Upper normal limit should be age-related
  - Factors affecting PSA level
    - ↑PSA: CA prostate, BPH, AROU, UTI, vigorous cycling, recent ejaculation <48h, DRE
    - ↓PSA: castration, 5α reductase inhibitors, prostate RT
  - PSA screening:
    - Not for age < 40 or >77 (with life-expectancy < 10 years)
    - May be considered for age 55-77
    - May be considered for age 40-55 with family history
- Prostate health index (PHI) if PSA 4-10 + normal DRE
  - Components: total PSA, free PSA, P2PSA (cancer-specific)
  - > 35: proceed to prostate biopsy
- Prostate biopsy:
  - Indications:
    - Elevated PSA > 10
    - Abnormal DRE
    - PHI > 35
    - Early CA prostate on active surveillance
    - Abnormal MRI prostate (PI-RADS 4-5)
  - Approach: transrectal (with TRUS or MRI), transperineal (TPUS or MRI)
    - "Fusion biopsy": combine MRI image with USG
  - Check MSU 1 week prior to procedure: treat UTI if +ve
  - Take 12-18 random systematic biopsies
  - Complications:
    - Bleeding: haematuria, PR bleed, haemospermia
    - Infection (<0.5% for transperineal, ~5% for transrectal: antibiotic prophylaxis with FQ required)
    - AROU (1-2%): pain and swelling of prostate

[Diagram showing Gleason's Pattern for prostate cancer. It illustrates different patterns based on the arrangement of glands and stroma in a prostate tissue sample, with each pattern corresponding to a grade. The diagram shows 5 different patterns from top to bottom: Pattern 1 shows small, uniform glands. Pattern 2 shows more stroma between the glands. Pattern 3 shows distinctly infiltrative margins. Pattern 4 shows irregular masses of neoplastic glands. Pattern 5 shows only occasional gland formation.]

| Grade group | Gleason score | Gleason pattern  |
| ----------- | ------------- | ---------------- |
| 1           | ≤6            | ≤3+3             |
| 2           | 7             | 3+4              |
| 3           | 7             | 4+3              |
| 4           | 8             | 4+4, 3+5, 5+3    |
| 5           | 9 or 10       | 4+5, 5+4, or 5+5 |

- Grading: Gleason score (1-5, sum of 2 most common histological patterns)
- Further classified into 5 groups for prognostication: higher group = more likely to have non-organ- confined disease
- Multiparametric MRI prostate
  - 3 sequences: T2-weighted, DWI with ADC (apparent diffusion coefficient), DCE (dynamic contrast-enhanced)
  - PI-RADS system: score from 1-5
  - Roles: determine need of biopsy in controversial cases (PI-RADS 4, 5 indicated); local staging

Staging
AJCC 8th edition staging system

- Combined use of TNM, serum PSA level & Gleason group
- T staging
  - T1: clinically undetectable (normal DRE)
  - T2: palpable on DRE but confined to prostate
  - T3: spread beyond prostatic capsule (e.g. T3b = seminal vesicle invasion)
  - T4: invade to pelvic side wall
    Staging workup: depend on risk stratification

| Definition | Low-risk                  | Intermediate-risk        | High-risk                                         |
| :--------- | :------------------------ | :----------------------- | :------------------------------------------------ |
|            | PSA < 10 ng/mL            | PSA 10-20 ng/mL          | PSA > 20 ng/mL                                    |
|            | and GS < 7 (ISUP grade 1) | or GS 7 (ISUP grade 2/3) | any PSA                                           |
|            | and cT1-2a                | or cT2b                  | or GS > 7 (ISUP grade 4/5) any GS (any ISUP grade |
|            | Localised                 |                          | or cT2c                                           |
|            |                           |                          | cT3-4 or cN+                                      |
|            |                           |                          | Locally advanced                                  |

GS = Gleason score; ISUP = International Society for Urological Pathology; PSA = prostate-specific antigen.

- Low risk: Multiparametric MRI prostate
- High risk (e.g. PSA > 20, GS ≥ 8): **PET-CT with PSMA** (prostate-specific membrane antigen), _c.f._ FDG
  - Superior to CT abdomen & pelvis + CXR + bone scan (Technetium-99 bone scintigraphy) - _HA practice_

Management of local disease
Patient factor: age, co-morbidities
Disease factors: PSA, DRE findings, Gleason score

|                                     | Procedures                                                                                                                                                                                                                                                           | Preferred in                       | Limitations                                                                                                                                                                                             |
| :---------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :--------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Active surveillance\*               | Regular FU with **serial DRE, PSA & biopsy for Gleason score** → Offer RP/ RT only if worsen - Avoid early Tx-related complications                                                                                                                                  | Low risk localised disease (T1/T2) | Disease progression Risk associated with repeated biopsy                                                                                                                                                |
| Radical prostatectomy (RP)          | - Robotic-assisted resection of prostate gland + seminal vesicles + ampulla of vas deferens - ± pelvic LN dissection in obturator & iliac regions (only for staging in **high risk**; no benefit in overall survival) - Anastomosis of bladder neck & urethral stump | Young <75y High risk disease       | Early: bleeding, UTI, rectal injury (1%), ureteric injury Late: stress urinary incontinence (10%), erectile dysfunction (50%), anastomotic stricture (urethra, bladder neck), residual tumor/recurrence |
|                                     | [Diagram of bladder and prostate area: The diagram shows the bladder with the connected urethra. The vas deferens connect to the seminal vesicles, which are located behind the prostate gland. A prostate tumor is visible inside the prostate gland.]              |                                    |
| Radiotherapy (EBRT / brachytherapy) | - Avoid risk of surgery & GA, but **equivalent oncological control**                                                                                                                                                                                                 | Older                              | ↓ Stress UI, similar ED c.f. RP ↑Irritative symptoms (FUN), radiation proctitis, radiation cystitis                                                                                                     |

\*Different from watchful waiting (palliative intent, for life expectancy < 10y)

Management of advanced / metastatic disease
Choice of treatment:

- Traditional approach: ADT monotherapy first → add others if CRPC
- New approach: upfront chemohormonal therapy to destroy potential CRPC clones

Options
Androgen
deprivation
therapy (ADT)
Modalities

- Surgical castration: bilateral simple orchidectomy (access via scrotal incision)
- Medical castration: traditionally use estrogens
  | | | |
  | :-------------- | :-------------------------------------------------------------------------------------------- | :----------------------------------- |
  | MoA | LHRH agonist (e.g. goserelin) + short-term antiandrogen cover (e.g. flutamide x 4/52) | LHRH antagonist (e.g. degarelix) |
  | | Downregulate gonadal axis (constant dose to mask normal LHRH pulsatility) | |
  | Dosing | Q3-6m (more convenient) | Q1m |
  | Pros | Cheaper ☺ | Faster onset |
  | | | ? Less CV risk |

S/E: osteoporosis, metabolic syndrome, thromboembolism, erectile dysfunction
Chemotherapy
Add if patient young & fit with good RFT; improve survival if high-volume metastases

- Docetaxel
- Cabazitaxel
  Androgen receptor
  targeted agents
  (ARTA)
  Others
- Abiraterone: CYP17 inhibitor, need maintenance steroids to prevent adrenal crisis
- Enzalutamide: potent multi-targeted AR antagonist
- Apalutamide
- Sipuleucel T: immunotherapy
- Radium 223: with bone-seeking element
- Lutetium-177 (177Lu)-PSMA

Castration-refractory prostate cancer (CRPC)

- Mechanisms:
  - Adrenal production of minor androgens
  - Tumor upregulation of androgen receptors
  - Tumor cells produce ectopic androgens

Bladder cancer
Overview
Types & risk factors (M:F = 3:1)
| Cell type | Prevalence | Risk factors |
| :------------------------------ | :--------- | :--------------------------------------------------------------------------------------------------------- |
| Transitional cell carcinoma (Urothelial carcinoma) | 98% | Smoking |
| | | Occupational chemical exposure (petrol / rubber / dye) |
| | | Cyclophosphamide |
| | | Concurrent upper tract TCC |
| | | Chronic cystitis (e.g. pelvic RT) |
| Squamous cell carcinoma | Rare | Chronic cystitis: Schistosoma haematobium (TOCC to Egypt), long-term indwelling catheter, bladder stones |
| Adenocarcinoma | Rare | |

Clinical features

- Painless gross haematuria throughout the stream (must rule out malignancy!)
- LUTS: irritative symptoms (in situ) → obstructive symptoms (tumor obstruct ureteric orifice / bladder neck)
- Metastasis: bone pain, RUQ pain / jaundice, SOB
- Constitutional symptoms

321

Investigations

- CBC, LRFT, urinalysis, MSU C/ST, urine cytology (low sensitivity, high specificity)
- Lower urinary tract workup: Flexible cystoscopy (gold standard) ± biopsy (NOT a must → direct TURBT)
- Upper urinary tract workup: CT urogram (delayed phase at 3-5 min to look for filling defects along urinary
  tract; arterial phase to look for LN involvement / metastasis), IV urogram
- Staging work-up: CXR, CT A+P, bone scan

Staging
Concept: Most important is whether it invades muscularis propria

- Non-muscle invasive bladder cancer (NMIBC): Tis / Ta / T1 disease
- Muscle invasive bladder cancer (MIBC): T2 disease or above

[An image showing a diagram of bladder cancer staging. The image shows different stages of bladder cancer, including Tis, Ta, T1, T2a, T2b, T3, and T4. Each stage shows how deeply the cancer has invaded into the layers of the bladder wall. The labels and annotations provide visual information about the disease progression.]

Management: non-muscle invasive bladder cancer
Approach: TURBT + post-op mitomycin C → pathological Dx & staging → non-muscle invasive (± 2nd TURBT /
intravesical BCG / FC surveillance) vs muscle invasive (radical cystectomy & urinary diversion / RT)

Transurethral resection of bladder tumour (TURBT)

- Roles:
  - Diagnostic: Ascertain diagnosis, obtain T-staging (non-muscle invasive vs muscle invasive)
  - Therapeutic: Potential cure if non-muscle-invasive
- Procedures:
  - Piecemeal → no histological proof on resection margins
  - Immediate post-op intravesical mitomycin C (not BCG: risk of infection)
    - Mitomycin C (cytotoxic alkylating agent): reduce recurrence but NOT progression rate (c.f. BCG)
    - Give only if confirmed non-muscle-invasive (reduce recurrence)
    - S/E: chemical cystitis, rash

Pathology confirmed non-muscle invasive cancer

- EAU guideline for risk stratification: - Low risk: Ta & low-grade & solitary & ≤ 3cm - High risk: Tis / T1, high-grade, multiple/recurrent, >3cm
  | 2nd TURBT | High risk Specimen not involving muscle | Detect residual disease in 20-30% cases who had 'complete resection' in 1st TURBT |
  |---|---|---|
  |Intravesical BCG | High risk Carcinoma-in-situ (1\* line Tx) | Reduce recurrence AND progression rate - Immunotherapy: Live-attenuated vaccine (Mycobacterium bovis) that triggers cytokine release against cancer cells Start 3 weeks post-op - PWH regimen: induction (weekly x 6) + maintenance (weekly x 3 at 3mo, x3 at 6mo, x3 at 12mo) - Compliance issues - Troublesome regimens: 15 doses for 1 year in total • S/E: irritative symptoms, infection (anti-TB drugs)|
  |Flexible cystoscopy surveillance | Low risk High risk | 3mo, 12mo, then Q1y x 5 Q3m for 2 years, then Q6m for 3 years, then Qly (can be lifelong) + Qly upper tract imaging (CTU) + cytology|

Management: muscle invasive bladder cancer

- **Radical cystectomy:** bladder + bilateral pelvic LN dissection (external iliac, internal iliac, obturator nodes) + adjacent organs (M: prostate, seminal vesicles, ± urethra; F: HBSO, part of vagina, ± urethra)
  - Pelvic LN dissection offers _survival benefit_ (c.f. CA prostate) because microscopic metastasis is common

[Diagram of Cystectomy in Male, showing the bladder, seminal vesicles (glands), prostate, and urethra with annotations describing that the prostate and seminal vesicles are often removed, and the urethra may also be removed.]

[Diagram of Cystectomy in Female, showing the fallopian tubes, uterus, ovaries, bladder, vagina, and urethra with annotations describing that the urethra, uterus, ovaries, fallopian tubes, and part of the vagina are often removed.]

- Surgical: open, laparoscopic, robotic-assisted laparoscopic
- Complications of cystectomy
  - Anastomotic leakage & stricture: bowel anastomosis, ureteric-enteral anastomosis
  - Lymphocele: pelvic LN dissection
  - **Erectile dysfunction:** consider nerve-sparing surgery if young + early stage low grade disease
  - **Urinary stress incontinence** (removal of prostate)
  - **Bowel injury**
  - Post-operative ileus
  - Residual tumor / recurrence

- Urinary diversion

[Diagram of Ileal conduit, showing the kidneys, ureters, stoma (outside the body), and conduit (inside the body).]

[Diagram of Neobladder (orthoptic bladder substitution), showing the kidneys, ureters, and neobladder.]

[Diagram of Continent pouch, showing the kidney, ureter, continence tunnel which is catheterized to empty urine, catheter, and new bladder or pouch.]

| Type                   | Non-continent                                                                             | Continent (ext. sphincter intact)                                                                                                                        | Continent (submucosal tunnel at oblique angle - act as valve)                                |
| ---------------------- | ----------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------- |
| Procedures             | Ureters attached to a segment of ileum (~15cm), then brought to surface as a stoma at RLQ | **Artificial bladder** constructed by a length of ileum (detubularized into sheet → reconfigured into reservoir to store urine)                          | Pouch created by appendix Submucosal tunnel for self- catheterization → Opening at umbilicus |
| Limitations            | Non-continent                                                                             | Require **good renal function** (eGFR ≥ 45): waste reabsorption Education: voiding by sphincter relaxation & **Valsalva maneuver**, self-catheterization |                                                                                              |
| Specific complications | Stoma complications (hernia, prolapse, retraction) Less NAGMA & UTI                       | NAGMA (reabsorption of NH4Cl in exchange for HCO3) **Urinary stasis** (SB muscle cannot contract voluntarily): recurrent UTI, AROU, stones               |                                                                                              |

Advantage of using ileum: abundant blood supply, long mesentery, low risk of metabolic Cx, ease of use
Disadvantage of using ileum: reabsorb waste from urine, cannot voluntarily control SB contraction

- Neoadjuvant chemotherapy: often considered for T2+/N+
  - Increase complete resection rate, reduce tumor load
  - Cisplatin/carboplatin-based
- Radiotherapy: for patients not fit for surgery
  - Inferior oncological outcome compared to surgery

Management: metastatic disease

- Chemotherapy: platinum-based
- Immunotherapy
- Palliative surgery: e.g. cystectomy (for symptomatic relief), percutaneous nephrostomy (decompression)

Renal cell carcinoma (RCC)
Overview

- Most common renal neoplasm (only 20% renal masses are benign: e.g. oncocytoma, angiomyolipoma)
- Prevalence of kidney cancers: RCC (MC) >> TCC renal pelvis > nephroblastoma (Wilm's tumor)
  Pathology
- Clear cell carcinoma (85%) - usually found in proximal tubule
- Others: papillary (10%), chromophobe, collecting duct (poor prognosis)
  Risk factors
- Smoking, HT, obesity
- Occupation (petroleum)
- Genetics: von-Hippel-Lindau (VHL), tuberous sclerosis, PKD
- Acquired cystic diseases (long-term HD/PD)
- Renal transplant on immunosuppressants

Clinical features: often asymptomatic until advanced disease

- Incidental finding on imaging (50-60%)
- Classical triad (10-20%): haematuria + flank pain + palpable renal mass
- Regional involvement: uniquely invade into renal vein, IVC, RA
  - Left 2º varicocele: invasion to left renal vein
  - LL edema, ascites, pulmonary embolism
- Metastasis: retroperitoneal LN, lung, bone
- Paraneoplastic syndrome (common, 6-10%)
  - Anemia of chronic disease
  - Endocrine: hypercalcaemia (vit D hydroxylation, PTHrP), polycythaemia (EPO), HT (renin)
  - Non-metastatic liver dysfunction (Stauffer syndrome): abnormal LFT, fever

Investigations

- Diagnostic: **CT abdomen with contrast → nephrectomy for pathology**
  - Classical appearance: renal parenchymal mass with thickened irregular walls and contrast enhancement
  - Role of USG: determine cystic vs solid (e.g. fat-filled - likely AML)
  - Renal mass biopsy is usually NOT indicated: risk of bleeding, tumor seedling, false negative results (20%)
    - Suspected lymphoma
    - Metastatic RCC in poor surgical candidate (guide Tx)
    - Suspected renal abscess
    - Strongly enhancing extrarenal primary lesion (e.g. lung, liver, colon, melanoma)
- Staging: CT T+A+P with contrast / PET-CT scan
- Prognostic: Fuhrman's grading (nuclear size)

TNM staging

- T1: ≤7cm (T1a: ≤4cm, T1b: 4-7cm), within kidney
- T2: > 7cm (T2a: 7-10cm, T2b: >10cm), within kidney
- T3: extend into perinephric tissues or major veins including IVC
- T4: extend beyond Gerota's fascia (fibrous tissue that encapsulates kidney and adrenal gland) and/or into ipsilateral adrenal gland

[Image Description: The image is composed of two sections. The left section shows "VHL" and "Inheritance: AD" with "Bilateral RCC" written below, accompanied by a simplified diagram of the human body highlighting areas with the presence of hemangioblastomas, including the cerebellum, spinal cord, retina, lungs, liver, pancreas, and epididymal cysts. The right section is an illustration of a kidney, with notations indicating "Gerota's fascia" on the upper right side, "Adrenal gland" and "Vein" slightly below it, "Artery" and "Ureter" further down, and sizes marked at "T1" with less than or equal to 7cm and "T2" with greater than 7cm. The renal capsule, cortex, and medulla are also labeled.]

Management
Resectable tumors: surgery
| | Partial nephrectomy | Radical nephrectomy |
| :-------------------- | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Preferred in | - T1 (<7cm) + **peripherally located** - Bilateral disease / multiple tumors - Solitary functional kidney / poor RFT on contralateral kidney | - Tumors >7cm/ Centrally located - Renal vein / IVC / adrenal gland involvement - LN involvement |
| Procedure | - Temporarily clamp renal vessels to remove tumor, and suture repair the kidney defect - Warm ischemia time <30min: barbed suture (e.g. Stratafix), early arterial unclamping after suturing inner layer, selective arterial clamping - c.f. Cold ischemia time 1-2h: ice pack, inject cold fluid into ureter - Resection margin: limited role, +ve does not necessarily predict recurrence | - Remove kidney with ligation of renal artery, vein and ureter (ligate artery first!) - Dissect external to Gerota's fascia - No need resect ipsil. ureter (c.f. TCC) - + Ipsilateral adrenalectomy (**not** routine, only if suspected invasion) - + retroperitoneal LN dissection - + IVC thrombectomy\* |
| Specific complications | Bleeding, urine leakage, recurrence in ipsilateral kidney | Injury to surrounding organs (R: D2, liver; L: spleen, tail of pancreas) |

Approaches: Open / laparoscopic / robotic-assisted laparoscopic

- Transperitoneal: more spacious operative field (allow triangulation of ports), but risk of post-op ileus
- Retroperitoneal: less manipulation of bowels, allow early ligation of arteries (enter from the back)

[Image of Transperitoneal and Retroperitoneal Surgical Approaches, showing the anatomical differences in accessing the kidney]

\*Grading of cavoatrial involvement
| Level 1: <2cm above renal vein | Simple thrombectomy |
| :----------------------------------------------------------- | :--------------------------------------- |
| Level 2: below intrahepatic IVC | |
| Level 3: involve intrahepatic IVC, below diaphragm | Consider cardiopulmonary bypass |
| Level 4: involve atrium | |

- adjuvant pembrolizumab (if high risk of locoregional recurrence)

* Unfit for surgery:
  - Radiofrequency ablation
  - Cryotherapy
  - Active surveillance for small asymptomatic lesions
* Metastatic disease:
  - RCC is traditionally resistant to chemoRT
  - Targeted therapy
    - TKI: e.g. **sunitinib**, sorafenib
    - Anti-VEGF: bevazicumab
    - mTOR inhibitors: temsirolimus, everolimus
  - Immunotherapy
    - IL-2 high dose
    - Checkpoint inhibitors: e.g. pembrolizumab

# Testicular tumour

## Overview

Most common solid CA in males 15-35 yo
Risk factors: cryptorchidism, Klinefelter syndrome, family
history, infertility

## Types

- Germ cell tumours (95%): malignant, divided into seminoma and NSGCT in 1:1 ratio
- Sex cord-stromal tumours (5%): benign, e.g. Sertoli cell tumor, Leydig cell tumor
- Others: e.g. lymphoma

## Clinical features

- Painless testicular mass, dull discomfort
- Secondary hydrocele
- Abdominal pain / distension: metastasis to **para-aortic LN** (can be very large)
- Gynaecomastia /hyperthyroidism (hCG)

## Investigations

- Tumour markers: **LDH, AFP, HCG** - for diagnosis of NSGCT and monitoring after treatment
- **USG scrotum**: seminoma (well-defined hypoechoic) vs NSGCT (indistinct margins, cystic areas / calcifications)
- Staging: CT **T + A + P** with contrast
- Pathological diagnosis by **radical orchiectomy**
- Do **NOT** do FNAC/biopsy (tumor seedling to scrotal skin → inguinal LN)

## Staging

AJCC TNM-S staging: note that

- T staging: scrotal invasion is cT4, otherwise determined by radical orchidectomy findings (pT staging)
- S staging: serum tumor marker levels
- Overall up to Stage IIIC only, Stage IV does not exist

## Management

- Scrotal exploration + **radical inguinal orchidectomy** (remove testis + spermatic cord) + **retroperitoneal LN dissection**
  - Allow histological diagnosis and staging
  - To prevent tumour seeding along testicular vein
    - **Inguinal** incision instead of scrotal incision (prevent spreading to scrotal skin)
    - Clamp cord before mobilizing testis
- Adjuvant: **RT** (seminoma), **chemotherapy** (both)
- Fertility preservation: e.g. cryopreservation of sperm

| Seminoma         | Non-seminoma GCT (NSGCT)        |
| ---------------- | ------------------------------- |
| 50%              | 50%                             |
| Age 30-40        | Age variable                    |
| Present early    | Present late                    |
| Lymphatic spread | Haematogenous spread            |
| No markers       | LDH, AFP (80-85%), HCG (80-85%) |
| Radiosensitive   | Radioresistant                  |
| 90% curable      | Prognosis varies with subtypes: |
|                  | - Choriocarcinoma               |
|                  | - Yolk sac tumour               |
|                  | - Teratoma                      |
|                  | - Embryonal carcinoma           |
|                  | - Mixed cell type (MC)          |

2.  6 Benign scrotal conditions
    Scrotal exam
    Exposure: groin and external genitalia
    Position: supine / standing

Inspection of penis, scrotum and groin

- Penis: Retract the foreskin to expose glans - look for phimosis, paraphimosis, urethral discharge
- Scrotum and perineum: inspect both anterior and posterior sides, look for surgical incisions along median
  raphe, swellings, pustular discharge
- Groin / spermatic cord: swelling, surgical scars, "bag of worm" appearance

Palpation of penis, scrotum and groin

- Scrotum: testis is anterior (size of testis, any hard nodules, lie of testis); epididymis is posterior
- Groin: LN, masses

If there is a mass, you need to determine:

- Relationship with testis (separable?)
- Consistency (soft / hard)
- Tenderness
- Any cough impulse
- Ability to get above: palpate the superficial inguinal ring 1cm above and lateral to pubic tubercle

Special tests

- Transillumination test for hydrocele
- Valsalva maneuver for varicocele
- Cough impulse for hernia

Acute scrotum

- Testis:
  - **Testicular torsion** (bimodal age: perinatal (_extravaginal_) vs young teens (_intravaginal_))
  - Torsion of testicular appendage (anytime, usually ~11yo)
  - Epididymitis / Epididymo-orchitis (typically 0-6mo)
  - Trauma
  - Testicular rupture (rare)
  - Idiopathic scrotal edema
  - Intra-testicular hematoma
  - Henoch-Schonlein purpura
- Groin: Incarcerated inguinal hernia

326

Common scrotal conditions [PSU]

#

| Features                            | Clinical exam findings                                                                                                                                                                                                           | Investigations                                                                                                                                                                | Management               |
| ----------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Undescended testis (cryptorchidism) | Palpable (80%) but cannot be manipulated into scrotum Non-palpable (20%) Bilateral in 10% Spontaneous descent likely occur by 6mo (Embryology: testicular descent begins at Week 5, at inguinal canal ~7mo, at scrotum at birth) | Absent testis                                                                                                                                                                 | Clinical                 | Orchidopexy between 12-18 months Palpable: **inguinal orchidopexy** (groin exploration to mobilize cord → scrotal incision to fix testis) Non-palpable: **EUA ± diagnostic laparoscopy** (locate the testis where testicular a. & vas deferens converge → decide **orchidopexy vs orchidectomy**) Too far from deep ring: may require 2-staged operation (Fowler-Stephens orchidopexy) Cx after 18mo: fertility, malignancy, frisk of testicular torsion Operation does not reduce risk of malignancy, but increase detection rate |
| Testicular torsion (emergency!)     | Bimodal age distribution (infants <1y, early adolescence) Risk factors: cryptorchidism, bell-clapper deformity (tunica vaginalis has abnormally high attachment to spermatic cord) TWIST score                                   | Excruciating pain High-riding testis Horizontal lie Absent cremasteric reflex Absent Prehn's sign (lifting testis NOT reduce pain c.f. epididymo-orchitis) Reactive hydrocele | Doppler USG (cannot r/o) | Urgent scrotal exploration **Detorsion** → assess testicular viability: wrap in warm gauze - observe if it gets redder, incise on tunica albuginea for fresh bleeding Viable: **bilateral orchidopexy** Non-viable: **orchidectomy** Antibiotics ± scrotal support Attempt manual detorsion if surgery N/A                                                                                                                                                                                                                         |

[Image of a table titled "Table 1. TWIST Scoring System" with two columns. The first column "Finding" includes "Hard testis", "Swelling", "Nausea/vomiting", "Absent cremasteric reflex", and "High-riding testis". The second column "Points" has the values "2", "2", "1", "1", and "1" corresponding to the rows respectively. Under the table it says "0-2 points: Low risk: 3-4 points: Intermediate risk: 5-7 points: Moderate risk"]

Torsion of testicular appendage | Emergency: viability decreases after 6h Common age group: pre-pubertal (~11yo) Pathology: Mullerian duct remnant Compared to torsion: prolonged period, less intensity pain, no n/v | Blue-dot sign Focal tenderness in upper pole of testis | | Scrotal exploration + **Excision of testicular appendage** Exploration of contralateral testis **not required**

Epididymo-orchitis Pathogens: E coli, mumps, STD (Chlamydia, Gonorrhea)
Risk factor: underlying BPH (ROU)
S/S: scrotal pain, fever
Swollen and tender scrotum
Positive Prehn's sign, cremasteric reflex present
Sexual Hx
Urine dipstick
Urethral swab for STD
USG scrotum (r/o abscess)
Empirical antibiotics x 2 weeks
DDx testicular torsion: scrotal exploration whenever in doubt

Epididymal mass
DDx:
Swelling over posterior aspect of scrotum (not from testis)
USG scrotum
Conversative
Surgical excision if large

Hydrocele
Varicocele
(10-15%)
Epididymal cyst
Post-inflammatory
Benign neoplasms
Pathology: fluid accumulation in tunica vaginalis (F: canal of Nuck)
Classification
Communicating: congenital (patent processus vaginalis) - a/w hernia
Non-communicating
Primary (idiopathic)
Secondary (reactive): URTI / GE, infection/inflammation of epididymis/testis, trauma, testicular torsion
Pathology: defective venous drainage → dilated pampiniform venous plexus
90% left sided
S/S: On-and-off dragging sensation after walking / strenuous exercise, resolved upon rest or lying supine
Causes: idiopathic, obstruction of Lt testicular vein (e.g. Lt RCC, nutcracker Sx)
Consequences: testicular atrophy, subfertility

USG Doppler Depend on etiology:
Testis NOT palpable Transillumination +ve
Communicating:
change in size upon crying / agitation
emptiable
Painless "bag of worms" at spermatic cord area
Enlarged on Valsalva maneuver (used for grading)
Communicating (i.e. hernia): laparoscopic ± open high ligation of PPV
Non-communicating idiopathic: age-specific
Ο Observe for spontaneous reduction
Indications for surgery: persist beyond 2-3yo (child), symptomatic (adults)
Options: Lord's plication, Jaboulay's operation (hydroceletomy + eversion of sac)
Non-communicating reactive: observe for spontaneous resolution, manage underlying causes

USG Doppler Indications of surgery

- CT abdomen (underlying cause)
  Intolerable symptoms: pain
  Abnormal semen analysis
  Testicular atrophy (10-20% difference in size)
  Options
  Conservative: analgesics, scrotal support
  Surgical approaches:
  Suprainguinal (MC): open/lap Palomo procedure (high ligation of testicular vein), Ivanessevich procedure (artery-sparing)
  Inguinal
  Subinguinal
  IR: transfemoral embolisation of testicular vein ± sclerotherapy
  Complications of surgery: post-op hydrocele

[Image of Hudson grading scale, which is a table with 4 rows and 2 columns. The first column contains the numbers 0, 1, 2 and 3. The second column contains the descriptions Only on USG Doppler, Palpable on Valsalva, Palpable upon standing and Visible on gross inspection respectively.]

3.1 Resuscitation
Paediatric assessment triangle

[Image: A triangle divided into three sections. The top left section is labeled "Appearance" and lists: Abnormal Tone, Interactiveness, Consolability, Abnormal Look/Gaze, Abnormal Speech/Cry. The top right section is labeled "Work of Breathing" and lists: Abnormal Sounds, Abnormal Position, Retractions, Flaring, Apnea/Gasping. The bottom section is labeled "Circulation to Skin" and lists: Pallor, Mottling, Cyanosis. Arrows indicate the direction of assessment.]

3 Paediatric surgery

[Image: A diagram titled "General Impression". It shows a green triangle representing the normal state (= STABLE). Two yellow triangles pointing downwards represent respiratory distress (= RESPIRATORY DISTRESS) and failure (= RESPIRATORY FAILURE) . Two orange triangles represent shock (= SHOCK) and metabolic issues (= CNS / METABOLIC = CARDIO-PULMONARY) ]

Fluids
Red flags of dehydration

- CR > 2 sec, tachycardia, hypotension
- Decreased urine output (normal: 1 mL/kg/h)
- Irritability / Reduced consciousness / Altered sensorium
- Sunken eyeball / fontanelles
- Dry mucous membranes

Fluid requirements

- Resuscitation: shock (20mL/kg NS or Hartmann), dehydration (10mL/kg NS or Hartmann)
- Maintenance (**must know!**) - Note neonates <D28 have different daily requirements

| First 10kg               | Next 10kg               | Subsequent kg           |
| ------------------------ | ----------------------- | ----------------------- |
| 100mL/kg/day or 4mL/kg/h | 50mL/kg/day or 2mL/kg/h | 20mL/kg/day or 1mL/kg/h |

- Replacement of ongoing losses: e.g. vomiting, diarrhoea, stoma / drain / fistula losses

[Image: Pediatric Basic Life Support Algorithm for Healthcare Providers-Single Rescuer. The algorithm uses flowcharts to guide medical personnel through the steps of assessing a patient and providing necessary interventions. The flowcharts include decisions about breathing, pulse, and responsiveness, and recommend actions such as rescue breathing, CPR, and activating emergency response systems. Specific medical interventions are also indicated, such as epinephrine administration. Shapes include: Rectangles for actions. Diamonds for questions. Start and end indicators. The algorithm is designed to be used by single rescuers in pediatric life support situations.]

329

3.2 Neonatal conditions
Abdominal distension / vomiting

|                |                                                                                                   |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
| :------------- | :------------------------------------------------------------------------------------------------ | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Malrotation    | Clinical features                                                                                 | Investigations                                                                                                                                                                                                                                                  | Management                                                                                                                                                                              |
| & volvulus     | Patho: failure of bowels to rotate around SMA → caecum fixed to right abdominal wall by Ladd band | AXR: dilated gastric shadow with no distal bowel gas                                                                                                                                                                                                            | NPO                                                                                                                                                                                     |
| 腸扭轉         | Onset: D3-7 (c.f. D1 in duodenal atresia)                                                         | [Image of the upper digestive tract showing a contrast meal test. The stomach and the duodenum are visible, with the contrast material highlighting their shape and structure.]                                                                                 | NG tube decompression                                                                                                                                                                   |
|                | **Repeated bilious vomiting**                                                                     | Contrast meal / follow-through: failure to delineate normal DJ junction                                                                                                                                                                                         |                                                                                                                                                                                         |
| Bilious        | **Flat abdomen** at beginning →Abd distension, PRB, peritonitis if bowel ischemia & gangrene      |                                                                                                                                                                                                                                                                 | Emergency Ladd procedure                                                                                                                                                                |
| vomiting in    |                                                                                                   |                                                                                                                                                                                                                                                                 | - Division of Ladd bands                                                                                                                                                                |
| neonate =      | Complications:                                                                                    |                                                                                                                                                                                                                                                                 | - Broaden mesentery                                                                                                                                                                     |
| surgical       | - Whole SB gangrene                                                                               |                                                                                                                                                                                                                                                                 | - Position the bowel into non-rotation                                                                                                                                                  |
| emergency!!    | - Short gut syndrome                                                                              |                                                                                                                                                                                                                                                                 | - + Bowel resection                                                                                                                                                                     |
|                | - Long-term TPN & cholestasis                                                                     |                                                                                                                                                                                                                                                                 | - Inverted appendectomy (to avoid diagnostic confusion as appendix would be placed in RUQ instead)                                                                                      |
| Duodenal       | Patho: failure of recanalization of 2nd part of duodenum                                          | AXR: **double bubble sign**                                                                                                                                                                                                                                     | NPO                                                                                                                                                                                     |
| atresia        | Associations:                                                                                     | [Image of an abdominal X-ray showing the "double bubble" sign. Two distinct air-filled spaces, representing the dilated stomach and proximal duodenum, are visible. The rest of the abdomen lacks air, indicating a blockage further down the digestive tract.] | Resuscitation                                                                                                                                                                           |
|                | - **Down's syndrome 30%**                                                                         |                                                                                                                                                                                                                                                                 | Workup for associated anomalies                                                                                                                                                         |
|                | - Congenital cardiac anomalies 30%                                                                |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
|                | - Malrotation 30%                                                                                 |                                                                                                                                                                                                                                                                 | Surgery: duodeno-duodenostomy                                                                                                                                                           |
|                | 3 types: Type 1 is MC                                                                             |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
|                | S/S:                                                                                              |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
|                | - Polyhydramnios                                                                                  |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
|                | - Bile-stained vomiting:                                                                          |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
|                | - Epigastric fullness                                                                             |                                                                                                                                                                                                                                                                 |                                                                                                                                                                                         |
|                |                                                                                                   | Contrast study: windstock anomaly                                                                                                                                                                                                                               |                                                                                                                                                                                         |
| Small bowel    | Patho: late intrauterine mesenteric vascular insult (e.g. intuss, volvulus)                       | AXR: dilated bowel loops, level of obstruction, calcification (if meconium peritonitis)                                                                                                                                                                         | NPO                                                                                                                                                                                     |
| atresia        | 4 types                                                                                           | Water-soluble contrast enema: microcolon                                                                                                                                                                                                                        | Resuscitation                                                                                                                                                                           |
|                | S/S:                                                                                              |                                                                                                                                                                                                                                                                 | Surgery:                                                                                                                                                                                |
|                | - Polyhydramnios                                                                                  |                                                                                                                                                                                                                                                                 | - Exclude multiple atresia                                                                                                                                                              |
|                | - Neonatal IO                                                                                     |                                                                                                                                                                                                                                                                 | - Excise both ends of atretic bowel and grossly dilated proximal end                                                                                                                    |
|                | - Perforation → Cystic meconium peritonitis                                                       |                                                                                                                                                                                                                                                                 | - Primary anastomosis / Defunctioning stoma                                                                                                                                             |
| Hypertrophic   | Present at 2-8 weeks (peak 5wk)                                                                   | HypoK, hypoCl metabolic alkalosis, hyper/hypo Na                                                                                                                                                                                                                | NPO                                                                                                                                                                                     |
| pyloric        | Hungry vomiter: **non-bilious projectile vomiting**, epigastric distention, ± visible peristalsis | Paradoxical aciduria                                                                                                                                                                                                                                            | IVF: NS bolus → maintenance with 1⁄2:1⁄2 + KCl supplement                                                                                                                               |
| stenosis 嬰兒  | UGIB, jaundice (2-5%)                                                                             | AXR: dilated stomach                                                                                                                                                                                                                                            | NG tube decompression                                                                                                                                                                   |
| 肥厚性幽門狹窄 |                                                                                                   | USG abdomen: criteria                                                                                                                                                                                                                                           | Lap. Ramstedt's pyloromyotomy: longitudinal splitting of pyloric muscle down to submucosa without suturing (Cx: GERD, perforation, incomplete myotomy - suspect if vomiting after POD3) |
|                | P/E: **olive-shaped mass** over epigastrium                                                       | - **Muscle thickness >4mm**                                                                                                                                                                                                                                     |                                                                                                                                                                                         |
|                | M:F=4:1                                                                                           | - **Channel length >16mm/diameter>14mm**                                                                                                                                                                                                                        |                                                                                                                                                                                         |
|                | Risk factor: macrolide                                                                            | - Failure of relaxation of pylorus                                                                                                                                                                                                                              |                                                                                                                                                                                         |

Necrotising
Risk factors: prematurity, low
enterocolitis
birth weight <1500g, enteral
壞死性腸炎
milk feeding, congenital heart
disease
Onset: 10-12 days (when
feeding starts)
S/S: Bilious vomiting, feeding
intolerance, vomiting
P/E: abdominal distension,
dusky skin, stool with fresh
blood & mucus, septic-looking
DDx: isolated perforation
(earlier onset at D0-2, postnatal
use of steroid, AXR shows
pneumoperitoneum only)
Hirschsprung Patho: absent enteric
disease
先天性巨結腸
(Congenital
intestinal
aganglionosis)
ganglions in distal bowel
Long segment disease (20%):
delayed passage of meconium

> 48h, enterocolitis, perforation
> Short segment disease, i.e.
> rectosigmoid (80%): chronic
> constipation
> 331

AXR (supine view, cross-table NPO, NG tube, TPN
lateral view)
Broad-spectrum antibiotics

- Dilated bowel loops
  PICU support: ventilation,
- Intramural gas
  inotropes
  (pneumatosis
  intestinalis)
  Indications of surgery
- Portal venous gas
- Bowel perforation
- Pneumoperitoneum:
- Bowel necrosis with
  Rigler sign, football
  impending perforation
  sign
- Clinical deterioration
  despite aggressive medical
  treatment
  AXR: absent rectal gas,
  NPO, warm IVF (avoid
  generalised dilated bowel
  ↑intraluminal pressure),
  antibiotics
  Suction rectal biopsy
  Decompression by daily rectal
  (diagnostic): absent ganglion washout (0.9% NS 20mL/kg,
  cells, hypertrophic nerve
  20mL each time, 16Fr(<1y)
  fibres (Ach stain)
  24Fr(>1y))→ Restart feeding if
  effective, stoma if ineffective
  ± Anorectal manometry
  Definitive surgery:
  ± Barium enema: transition
- One-stage laparoscopic
  zone and extent of
  pull-through operation:
  aganglionosis
  seromuscular biopsy
  (confirm ganglion cells),
  mobilize rectum to
  perineum
- Traditional 3-stage
  operation (defunctioning
  stoma + pull-through
  operation + closure of
  stoma) if perforation/
  sepsis
  Respiratory distress
  Esophageal
  Clinical features
  atresia
  50-70%: a/w VACTERL association
  (vertebral, anorectal, cardiac, TEF,
  renal, limb), T13/T18/T21, or
  CHARGE syndrome
  S/S:
- AN: polyhydramnios + absent
  stomach bubble
- Excessive salivation
- Choking when fed
- Cyanosis / resp distress
  5 types
- Type A: no fistula (10%)
- Type B: proximal TEF
- Type C: distal TEF (MC)
- Type D: proximal & distal
  fistula
- Type E: H-type fistula
  Investigations
  Pass catheter: note
  point of resistance
  CXR + AXR: OGT
  curled in pouch

[Esophageal atresia with tracheo-esophageal fistula: An X-ray shows a baby with esophageal atresia and tracheo-esophageal fistula. A catheter is inserted from the mouth and is curled in the esophagus, not reaching the stomach. The trachea is seen behind the esophagus and the lungs are clear.]

Management
NPO
Empty upper esophageal pouch by
continuous suction (Replogle tube)
Prop up patient 30 degree
Prophylactic antibiotics against
aspiration pneumonia
Treat associated anomalies
Surgery:

- Division and closure of TEF
- Primary anastomosis
  For long-gapped esophageal
  fistula: may require
- Gastrostomy: pre-op
  nutrition
- Delayed repair with
  esophageal replacement

332
Congenital
90% left posterolateral hernia
diaphragmatic **(Bochdalek hernia)**
hernia (CDH) S/S: Respiratory distress,
mediastinal shift, absent breath
sound on ipsilateral chest, scaphoid
abdomen
Cx: lung hypoplasia, pulmonary
HT, hearing defects
CXR: **bowel loops in
ipsilateral thorax,
mediastinal shift,
contralateral lung
collapse**
Resuscitation: mechanical
ventilation, NGT decompression
Correct pulmonary HT (HIFV, NO,
inotropes)
Manage associated anomalies

Antenatal: **FETO procedure** (foetal
endoscopic tracheal occlusion)
Surgery: **Direct repair with/**
without muscular flap

Hepatobiliary conditions
| | Clinical features | Investigations | Management |
| :------------------- | :-------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Biliary atresia | Patho: progressive fibrosis of extrahepatic +/- intrahepatic biliary duct | Conjugated bilirubin USG abdomen: **contracted GB, triangular cord sign** (fibrous duct remnant of extrahepatic duct) | Correct coagulopathy Nutritional support Diagnostic laparoscopy ± **operative cholangiogram** (gold standard to confirm diagnosis) + **liver biopsy** (to rule out DDx) **Kasai procedure** (open hepatic portoenterostomy) within 60 days of life Post-op: ursodeoxycholic acid, prophylactic antibiotics Post-op complications: lifelong FU for cholangitis, portal HT (→ cirrhosis → liver transplant) |
| | - **Prolonged NNJ** - Dark urine, pale stool - Hepatomegaly Aim early diagnosis before 8 weeks old 70-80% early biliary drainage rate 70-80% 5-year native survival rate (majority still cirrhosis / portal HT) | E-HIDA scan: **absence of isotope in intestine** - Pre-Tx with 5 days of phenobarbitone (liver enzyme inducer → ↑biliary secretion) | |
| Choledochal cyst | Patho: Congenital cystic or fusiform dilation of bile duct | Operative cholangiogram (gold standard) USG MRCP ERCP Operative cholangiogram | Complete excision of cyst & GB Reconstruction with Roux-en-Y hepaticojejunostomy |
| | S/S - **Prolonged NNJ** - Abdominal pain: mimic cholangitis, pancreatitis | | |

Cleft lip and cleft palate
Types: cleft lip & palate (45%), cleft lip only (20%), cleft palate only (35%)

- Unilateral vs bilateral
- Complete vs incomplete
- Syndromic vs non-syndromic

| Age               | Operation                                 |
| :---------------- | :---------------------------------------- |
| 2-3 m             | Repair of eleft lip + limited rhinoplasty |
| 1 year            | Repair of eleft palate                    |
| Any age           | Myringotomy & Grommet insertion           |
| 5-6 years         | Pharyngoplasty                            |
| 8-9 years         | Alveolar bone grafting                    |
| Any age           | Revisional procedures                     |
| Early adulthood   | Dental surgery                            |
| (Early adulthood) | Rhinoplasty                               |

Problems

- **Cosmetic concern** & psychosocial impact
- **Feeding** problem
- **Speech** problem
- **Hearing** problem: otitis media with effusion
- **Dental** problem: e.g. hypoplastic maxilla

# Abdominal wall defects

|                       | Omphalocele                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Gastroschisis                                                                                                                                 |
| --------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------- |
| Pathology             | Umbilical ring failed to close in EARLY gestation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Rupture of abdominal wall in LATE gestation                                                                                                   |
| Features              | Herniation of bowel with covering amniotic sac At umbilical cord insertion site Larger defect (>4cm) Other organs e.g. liver may be herniated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Herniation of bowel without covering sac Paraumbilical at location (always right side) Smaller defect (<4cm) Bowel looks edematous and matted |
| Diagnosis             | Usually antenatal USG (birth at term & preferable by Caesarean section)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                               |
| Associated conditions | Likely syndromal: Beckwith-Wiedemann, trisomy → overall poorer prognosis Better bowel condition                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Unlikely syndrome (usually isolated) → Overall better prognosis Poorer bowel status (chemical irritation)                                     |
| Management            | Resuscitation at birth: NPO, fluid resuscitation via UL (possible IVC compression), OGT decompression, Foley, DRE IV antibiotics Cover the bowel immediately with warm gauze and aseptic plastic wrap Gentle examination: avoid rupture of amniotic sac / tearing of intestinal mesentery Pre-op: ensure hemodynamically stable, exclude lifethreatening associated anomalies Options - Primary repair with umbilicoplasty - Staged closure (if large defect or increased intra-abdominal pressure during OT): suture with silastic silo (fig.) → daily bedside reduction 5-7d → secondary repair with umbilicoplasty - Paint membrane with antiseptic to allow epithelialization (if not fit for OT) Post-op: monitor for abdominal compartment syndrome - difficult ventilation, reduced VR (hypotension, reduced urine output, LL oedema), wound dehiscence |                                                                                                                                               |

# Other congenital anomalies

|                         | Clinical features                                                                                                                                                                                                                                                                                                                                                                  | Investigations                                                                                                                                                                                                                                          | Management                                                                                                                                                                                                                                                                |
| ----------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Imperforate anus        | Types of male malformation - Low type: anocutaneous fistula, anal membrane - High type: rectourethral / rectovesical fistula Types of female malformation - Low type: anterior ectopic anus, vestibular anus - High type: rectovaginal fistula - Cloacal anomaly (most serious) [Image of cloacal anomaly with caption saying "Single urogenital opening"] Associated with VACTERL | Cross table lateral X-ray with anal marker (taken 24h after birth: distend distal bowel) → Distance from distal bowel gas to anal marker - Low: <1cm - High: >1cm [Image of TABLE LT LAT X-ray] \*Distal loopogram + MCUG: delineate anatomy of fistula | Surgery - Low: anoplasty - High: colostomy → anorectoplasty* → closure of colostomy *Choice of anorectoplasty: depend on anatomy of fistula - Rectourethral fistula: Posterior sagittal anorectoplasty (PSARP) - Rectovesical fistula: Lapassisted anorectoplasty (LAARP) |
| Sacrococcygeal teratoma | Most common teratoma in neonates 4 types Risk of malignancy                                                                                                                                                                                                                                                                                                                        | [Image of Sacrococcygeal teratoma]                                                                                                                                                                                                                      | En-bloc removal of tumor with соссух Adjuvant therapy if malignant                                                                                                                                                                                                        |

| Skin conditions                                                                                                                                                                                                    | Rash                                     | Clinical features                                                                                                                                                                                               | Management                                                                                                                                                                                                                       |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ---------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Capillary malformation                                                                                                                                                                                             | Port-wine stain                          | Blanchable red patches, not regress                                                                                                                                                                             | Pulsed dye laser (PDL) MRI brain for Sturge-Weber syndrome (25%) if >1 trigeminal nerve region                                                                                                                                   |
| [Image of a baby's face with a large, flat, red birthmark covering most of the right side of the face, including the cheek and eye area. The birthmark is known as a Port-wine stain. The baby's eyes are closed.] |                                          |
| Nevus simplex (salmon patch)                                                                                                                                                                                       |                                          | Blanchable pink patches at eyelid or back of neck                                                                                                                                                               | Most resolve by 1y                                                                                                                                                                                                               |
| [Image of a baby's forehead and nose with a light pink, flat patch in the center of the forehead and upper nose. This type of birthmark is known as a Nevus simplex or salmon patch.]                              |                                          |                                                                                                                                                                                                                 |
| Vascular tumour                                                                                                                                                                                                    | Capillary haemangioma (strawberry naevi) | MC vascular tumour in infants Raised red nodule that may involute after 1 year of age (50% by 5, 90% by 9) Complications: - Ulceration: bleeding, infection Kasabach-Merritt syndrome: consumption coagulopathy | Active observation Prolonged compression to stop bleeding **Oral propranolol:** indicated if the lesion has the potential to impair function or cause permanent disfigurement 2nd line: systemic steroid, surgical excision, PDL |
| [Photograph of a raised, bright red, smooth-surfaced growth on a baby's skin. This is a capillary haemangioma, commonly known as a strawberry naevus.]                                                             |                                          |                                                                                                                                                                                                                 |
| Pyogenic granuloma                                                                                                                                                                                                 |                                          | Grow rapidly in days Erythematous papule that bleeds and ulcerates                                                                                                                                              | Surgical excision                                                                                                                                                                                                                |
| [Image shows a close-up of a baby's face with a small, raised, red, and somewhat crusty growth near the corner of the eye. This is a pyogenic granuloma. The baby has clear, bright blue eyes.]                    |                                          |                                                                                                                                                                                                                 |

3.3 Paediatric surgical abdomen
Acute abdominal pain
Differential diagnosis (selected)

- GI: IO, acute appendicitis, mesenteric adenitis, Meckel's diverticulitis, intussusception, pancreatitis, PPU, omental torsion
- GU: UTI / stone disease, testicular torsion (M), ectopic pregnancy / ovarian cyst torsion / PID (F)
- Vascular: HSP
- Medical: DKA, GE

General management

- Resuscitation: NS 20ml/kg FR
- NG decompression
- Correct electrolytes
- T&S for OT

|                                | Clinical features                                                                                                                                                                                      | Investigations                                                                                                                                                         | Management                                                                                                                                                                           |
| :----------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Acute appendicitis             | Similar to adults, but more likely complicated (delayed presentation to hospital)                                                                                                                      | Clinical diagnosis (Serial examination is important)                                                                                                                   | Laparoscopic appendicectomy ± open                                                                                                                                                   |
|                                | Complications - Abscess - Gangrene - Perforation                                                                                                                                                       | - Boys: usually no need imaging unless suspected delayed abscess / unclear diagnosis - Girls: ask LMP, order PT & USG abdomen, do not PV on your own (consult Gynae!!) | Non-operative management (NOM) can be considered in selected patients (no complications, no appendicoliths)                                                                          |
|                                | Differential diagnoses - Mesenteric adenitis: viral illness prodrome, USG detects lymphadenopathy - Meckel's diverticulitis: CT abdomen - Gynaecological causes                                        |                                                                                                                                                                        |                                                                                                                                                                                      |
| Henoch-Schonlein purpura (HSP) | IgA-mediated small vessel vasculitis - Palpable purpura (vasculitis + bleeding) - Abdominal pain: intestinal vasculitis vs intussusception - differentiated by USG - Arthritis - Renal involvement: GN | USG abdomen: look for intussusception                                                                                                                                  | - Paracetamol for abdominal pain - Steroid for reducing risk of persistent renal disease and severe abdominal pain - FU with BP & urine dipstick for 2 years (risk of developing GN) |

336
GI bleed
UGIB

- **Esophageal varices**: portal hypertension (e.g. Hx of umbilical vein catheterization, known biliary atresia)
- Peptic ulcer disease
- Mallory-Weiss tear
- Gastritis
- Esophagitis

LGIB

- Anal fissure: **painful** defecation, outlet type, Hx of constipation → Mx: treat underlying constipation
- Colonic polyp: **painless**, 90% juvenile polyps → Mx: bedside suture ligation, endoscopic polypectomy
- Meckel's diverticulum: **painless**, large amount, altered blood
- Intussusception: **painful**, small amount, mucus
- Intestinal duplication cyst
- Inflammatory bowel disease
- Small bowel ischemia e.g. volvulus

Meckel diverticulum

- Definition: **true** congenital diverticulum bulging at the **anti-mesenteric aspect** of small intestine, due to incomplete obliteration of **vitelline duct** (connect midgut to yolk sac in early weeks of gestation)
- Most common congenital anomaly of GI tract

Rule of 2s (**must know!**)

- 2% of the population, 2% symptomatic, often by age of 2
- 2:1 male-to-female ratio
- 2 inches in length, found within 2 feet of the ileocaecal valve
- 2 types of ectopic tissue: gastric (60%), pancreatic (6%) or both

Clinical features

- Haematochezia: **massive painless altered blood** (maroon-coloured stool, due to acid secretion by the ectopic gastric mucosa)
- Abdominal pain (midgut): due to IO or inflammation (mimic appendicitis)
- Intestinal obstruction: due to
  - Recurrent intussusception: Meckel's diverticulum as the lead point
  - Volvulus
  - Littre's hernia: hernia containing Meckel's diverticulum

Investigations

- **Meckel's scan**: Technetium-99m pertechnetate scan
  - Gastric mucosa actively secretes chloride into the intestinal lumen
  - Pertechnetate behaves like chloride ion → actively accumulated in the mucosa → secreted
  - Require pre-med with H2 blockers: inhibit excretion of isotope into bowel lumen
  - False +ve: intestinal duplications
  - False -ve: no/inadequate heterotopic gastric mucosa, rapid bleeding causing dilution of radiotracer

Management in children

- Acute Mx: Resuscitation, IV fluids, H2 blocker infusion
- Stable: Meckel's scan
- Unstable: diagnostic laparoscopy ± bowel resection
  - Narrow base: wedge resection (diverticulum excision and suture at the base)
  - Broad base / ulceration at margin / mesenteric border: segmental bowel resection + primary anastomosis

Duplication cyst
Usually diagnosed in first 2 years of life

Presentation: antenatal USG, abdominal pain / mass, IO, GI bleed (if heterotopic gastric mucosa), volvulus

USG: classical echogenic mucosal lining inside cyst

[Image of an ultrasound with a pink arrow pointing to a region labeled "Echogenic Mucosal lining". There is also a photograph of a resected portion of what appears to be intestinal tissue, laid alongside a ruler.]

# Intestinal obstruction

Surgical causes of SBO

- Incarcerated inguinal hernia (MC)
- Intussusception
- Adhesive IO (previous surgery)
- Pyloric stenosis
- Congenital: bands, duplication cyst, Meckel's diverticulum, malrotation & volvulus
- Foreign body ingestion, i.e. bezoar
- Intra-abdominal sepsis e.g. appendicitis, pancreatitis
  Medical causes: GE, neurological

18-22 Fr Foley:
337

|                              | Clinical features                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Investigations                                                                                 | Management                                                                                                                                                                                                                                                                                                                                                                                       |
| :--------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :--------------------------------------------------------------------------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Intussusception 腸套疊       | Pathology: invagination of bowel loop (intussusceptum) into distal segment (intussuscipien) MC: **ileocaecal intussusception** (85%) Typical age: 6 month - 2 years Causes: enlarged Peyer's patches (90%), Meckel's diverticulum, polyps, lymphoma, Rotavirus vaccine (within 1 week) Classical triad (<50%): intermittent **colicky abdominal pain** 陣痛, red currant jelly stool (late), sausage- shaped mass in RUQ Other S/S: **Bilious vomiting**, fever, abd distension | AXR: distended SB, absent LB gas USG abdomen **(diagnostic): target sign, pseudo-kidney sign** | **Fluoroscopic-guided pneumatic reduction** (75- 95% success rate): instill gas with 18-22 Fr foley → maintain pressure ~100- 120mmHg x 3min → observe for gush of air into terminal ileum Cx: bowel perforation, tension pneumoperitoneum, recurrence (5%) **Surgical reduction:** indicated if - Failed pneumatic reduction - **Peritonitis / necrosis** - Suspected pathological lead- points |
| Incarcerated inguinal hernia | Indirect hernia: due to **patent processus vaginalis (PPV)** Incarcerated hernia: erythema, pain & irritability, vomiting, cyanosis of mass                                                                                                                                                                                                                                                                                                                                     | Clinical diagnosis                                                                             | Open / Lap. herniotomy (c.f. mesh repair in adults)                                                                                                                                                                                                                                                                                                                                              |
| Adhesive IO                  | Previous abdominal surgery / scars                                                                                                                                                                                                                                                                                                                                                                                                                                              | Clinical diagnosis AXR: distended SB                                                           | **Drip & suck**: rehydration, NG tube decompression Failed: OT x **adhesiolysis**                                                                                                                                                                                                                                                                                                                |

Umbilical abnormalities

[Close-up photograph of a red umbilical granuloma on a newborn's abdomen. The granuloma is a small, raised bump that is located at the site where the umbilical cord was cut. The surrounding skin is slightly red and inflamed. Some serous fluid present at the base of the lesion.]
Umbilical granuloma

[Photograph of a large umbilical hernia in an infant. The hernia is a bulge in the belly button area. The infant is lying on their back, and the hernia is visible as a soft, round mass. The skin over the hernia is smooth and normal in color.]
Umbilical hernia

True granulation tissue with fibroblasts and abundant capillaries
Size: 1mm - 1cm
Treatment:

- **Cauterization with silver nitrate** until area epithelializes (liquid paraffin on skin to prevent irritation by secretions)
- No response: suspect umbilical polyp / sinus tract → order USG

Umbilicus is surrounded by dense fibromuscular ring (defect in linea alba) - supported by remnants of umbilical vessels, urachus and fascia → Weakened fascia results in hernia
More common in Down's syndrome, VP shunt, premature babies
**Rarely incarcerate <1%**

> 90% close by 3-4yo, but defects >2cm are less likely to close
> Surgical treatment: **Mayo operation** (indicated if >5yo)

3.4 Paediatric urology
Refer to [URO] for testicular / scrotal conditions
Imaging modalities
USG kidney
[Image of ultrasound of a kidney. The kidney appears dark with lighter gray areas within it, suggesting different tissue densities. The image shows a cross-sectional view of the kidney with internal structures visible. It is a medical diagnostic image.]
Can visualize

- Morphological abnormalities: **hydronephrosis**, **hydroureter**, **cortical thinning** (long-standing high-grade obstruction)
- Anatomical abnormalities: Duplex system, absent kidney, ectopic kidney
  Micturating cystourethrogram (MCUG)
  [Image of a micturating cystourethrogram (MCUG). The image shows the bladder filled with a contrast agent, visible as a bright white area. The urethra is also visible as a thin, bright line extending from the bladder. The surrounding tissue appears darker, providing contrast for the urinary tract. This is a diagnostic image used to assess the function and structure of the bladder and urethra.]
  Transurethral injection of contrast under fluoroscopic guidance
  Can visualize
- **Vesicoureteric reflux (VUR)** - gold standard
- Abnormal bladder / urethral contour
- Incomplete emptying
  Mercapto-acetyl-triglycine (MAG3) scan
  [Image of a series of scans illustrating kidney function over time. The scans show the uptake and excretion of a radioactive tracer in the kidneys. The images vary in intensity, reflecting the concentration of the tracer in different regions. Accompanying this set of images is a graph depicting the perfusion and uptake percentages, with specific numerical values (27.03, 30.94, 69.06) displayed. The graph also includes a "Diuretic T1/2" value of 51.99. This imaging technique assesses renal function and identifies any abnormalities.]
  Dynamic isotope scan: MAG3 is filtered & excreted
  Calculate the differential renal function between 2 kidneys during uptake phase
- Normal is 50%:50% - 45-55 regard as symmetrical
- Diuretic t½ > 20 min: indicate significant obstruction (more reliable for PUJO)
  Dimercaptosuccinic acid (DMSA) scan
  [Image of a DMSA scan showing both kidneys. The kidneys appear as bean-shaped structures, with variations in intensity indicating the distribution of the radiotracer. This static image helps assess the structure and function of the renal cortex.]
  Static isotope scan: DMSA is filtered & accumulates in renal cortex
  Gold standard for differential renal function (normal is 50:50, 45-55% still considered symmetrical) - causes:
- Cortical scarring: congenital / acquired (post-UTI)
- Chronic obstruction
- Congenital dysplasia
  Magnetic resonance urogram (MRU)
  [Image of a Magnetic Resonance Urogram (MRU) displaying the urinary tract system. High contrast visuals mark the kidneys, ureters, and bladder. The detailed image is captured through MRI technology, helping to diagnose abnormalities.]
  Good for anatomical details
- Atypical sites for ureteric obstruction
- Duplex system
- Horseshoe kidneys
  Require MAC or even GA for infants / toddlers
  Comparing DMSA vs MAG3 scan:
  | Similarities | MAG3 | DMSA |
  | ----------- | ----------- | ----------- |
  | | Functional assessment: report differential renal function between 2 kidneys | |
  | | Non-invasive but require sedation | |
  | | Low radiation (compared with MCUG and IVU) | |
  | Differences | Dynamic scan: renal tubular excretion | Static scan: cortical uptake |
  | | Detect obstruction | Detect scarring |
  | | Assess etiology of hydronephrosis | Assess complication of UTI |

Upper tract abnormalities

# Hydronephrosis ≠ Obstruction!

[Diagram illustrating Unilateral hydronephrosis, showing the Pelviureteric junction obstruction and Vesicoureteric junction obstruction.]

[Diagram illustrating Bilateral hydronephrosis, showing Bladder neck obstruction and Posterior urethral valves.]

General clinical features

- Antenatal ultrasound: **hydronephrosis**, oligohydramnios
- Infant: **UTI**, loin pain, continuous urinary dribbling after toilet training

Management of antenatal hydronephrosis

- Oral amoxicillin
- Bilateral: postnatal USG on D1-2 → MCUG if hydronephrosis persists
- Unilateral: postnatal USG after BW returns to birth weight (D5-14) → MCUG if hydronephrosis persists

Choice of radiological investigations (**need to know!**)

- Antenatal hydronephrosis: USG + MCUG (micturating cystourethrogram) + MAG3
- Recurrent / atypical UTI: USG + MCUG + DMSA

# Obstruction

|                                            | Clinical feature & management                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| ------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Pelvi-ureteric junction obstruction (PUJO) | **MC** cause of obstructive uropathy in children<br>Causes:<br>- Intrinsic obstruction (MC)<br>- Aberrant vessels to lower pole<br>- Horseshoe kidney<br>Investigations:<br>- USG: hydronephrosis, **no dilated ureter**, ± cortical thinning<br>- MAG3: isotope retention in **renal pelvis**, poor drainage despite Lasix (↑t1/2)<br>- + Antegrade pyelogram (if PCN is performed): no drainage to ureter, dilated system<br>Indications for surgical correction<br>- Symptomatic: recurrent loin pain / UTI<br>Initial investigations:<br> o USG: AP diameter > 30mm<br> o MAG3: **differential renal function < 40%**<br>- Follow up scans if not indicated for surgery<br> o Serial USG: progressive dilation<br> o Serial MAG3: persistent/deteriorating obstruction, progressive drop in differential renal function >5%<br>Surgical intervention: **dismembered pyeloplasty** (resection of stenosed PUJ)<br>- Open / Lap / Robotic-assisted lap<br>- Spatulation of ureter to create wider anastomosis<br>- JJ stent in early post-op period |

340
Vesico-ureteric
junction obstruction
(VUJO)

Also known as "obstructing megaureter"
Investigations:

- USG: **dilated ureter**
- MAG3: isotope retention in **distal ureter** (note: diuretic t1/2 is NOT reliable in VUJO)
- MRU: assess any duplex system, better delineate level of obstruction / ectopic ureteric insertion into bladder

Indications for surgical correction: similar to PUJO

Surgical intervention:

- Ureteroneocystostomy + reimplantation + extracorporal excisional tapering of megaureter
- Temporary ureterostomy for drainage if <1 yo

Bladder outlet
obstruction

Anatomical causes

- Congenital: **posterior urethral valve (PUV)** - boys only
- Acquired: large ureterocele, **urethral stricture** (e.g. hypospadias post-op)
  Functional cause: neurogenic bladder dysfunction

Investigations

- USG: **trabeculated bladder** + diverticulum (chronic obstruction)
- MCUG: dilated posterior urethra, **secondary VUR**

Management: **valve ablation**

Vesico-ureteric reflux (VUR)
Primary VUR (physiological bladder pressure): incomplete development of **submucosal tunnel** at VUJ

[Image Description: This is a diagram illustrating vesico-ureteric reflux (VUR). On the left, it shows a normal vesico-ureteric junction (VUJ) where the ureter smoothly enters the bladder. On the right, it depicts a ureter with VUR, indicating the backflow of urine from the bladder into the ureter. Labels indicate "Normal VUJ" and "Ureter with VUR", with arrows indicating the "Length of submucosal tunnel" in each case, with the length of the submucosal tunnel being longer in the Normal VUJ than in the Ureter with VUR.]

Secondary VUR (high bladder pressure):

- Bladder outlet obstruction e.g. **PUV**
- Neurogenic bladder dysfunction

Ix: USG renal system, MCUG (micturating cystourethrogram), DMSA^ (assess renal scarring as UTI common)

Management of primary VUR

- Mild VUR: observe for **spontaneous resolution**, treat UTI if occur
- Severe VUR (grade IV-V) / Renal scarring / Symptomatic: **antibiotic prophylaxis**, **endoscopic injection of Deflux** (bulking agent), ureteric reimplantation (not common)

Duplex system
Definition: abnormal anatomy with duplicated pyelourethral systems

- Incomplete duplex: usually uncomplicated → no need interventions
- Complete duplex can have complications (上塞下 flux)

|              |                                                                                                     |
| ------------ | --------------------------------------------------------------------------------------------------- |
| Upper moiety | Obstructing ureterocele                                                                             |
|              | Ectopic ureter insertion (fig. 1): infrasphincteric urethra / vagina → continuous urinary dribbling |
|              | Associated with dysplastic upper moiety (can perform heminephroureterectomy)                        |
| Lower moiety | VUR → hydronephrosis: drooping lily sign on MCUG (fig. 2)                                           |

[Image Description: This is an X-ray image depicting the urinary system. The contrast material highlights the kidneys, ureters, and bladder. There is clear visualization of a duplex collecting system, with two separate ureters draining into the bladder from one kidney. The bladder is also filled with contrast. The anatomical details provide visual information about the structure of the urinary tract.]

[Image Description: This is an X-ray image showing the urinary tract, particularly the bladder and ureters, filled with contrast. The bladder is centrally located and appears smooth in outline. There are abnormalities with one of the ureters, suggesting vesicoureteral reflux, where urine flows backward from the bladder into the ureter. There are also irregularities indicating potential duplex collecting system with duplicated ureters on one side of the bladder.]

Others

- Multicystic dysplastic kidney (MCDK): does not produce any urine

341
Genitalia conditions
Phimosis & Paraphimosis
Prepuce: protect the glans and urethral meatus, remain fused to glands for first 3-4 years (physiological phimosis)
| Phimosis | Paraphimosis |
|-----------------------------------------------------------------|--------------------------------------------------------------------|
| Clinical features Inability to retract foreskin (90% retract at 5yo) Cx: balanoposthitis (infection of glans & prepuce) | Entrapment of retracted foreskin behind coronal sulcus → edema of prepuce and glans |
| Management Medical: Retraction exercise, steroid cream (e.g. Betnovate) max 8 weeks Surgical: Circumcision (indicated if BXO / recurrent balanitis / recurrent UTI) Close wound: absorbable material / fall-off bell Post-op: yellow crusts are normal, advise to keep wound clean by regular water/NS irrigation for 2-3 weeks post-op | Manual reduction with analgesia Failed manual reduction: dorsal slit Formal circumcision after reduction |

[Image of scarred prepuce]
scarred prepuce

Balanitis xerotica obliterans (BXO)

- Pathological phimosis (a.k.a. lichen sclerosis et atrophicus)
- Scarred prepuce, often involving glans and meatus
- Management: circumcision (absolute indication!) ± meatoplasty
  Balanitis
  Clinical features: swollen red prepuce, difficulty in voiding, discharge
  Note: smegma (shed skin cells and sebum) is physiological (NOT infection)
  Management:
- Acute: analgesia, local irrigation + oral antibiotics (if severe)
- After acute episode: regular retraction + steroid cream, circumcision if recurrent attacks
  Hypospadias
  Pathology: Arrest in development of ventral structures of penis
  Clinical triad
- Ventrally and proximally located urethral meatus
- Ventral curvature (chordee)
- Dorsal hood: excessive prepuce over dorsal side, absent over ventral side
  Classification (fig.): distal, mid-shaft, proximal
- Defined by intra-op site of corpus spongiosum division: junction of normal urethra & hypoplastic urethra
  Surgical principles
- Functional: restore forward urinary stream
  ○ Correct penile curvature
  ○ Create distally located meatus
- Improve cosmesis
  ○ Correct dorsal skin hood
  ○ Reconstruct glans
  Surgical options
- Distal (less severe chordee): tubularised-incised plate (TIP) urethroplasty
- Proximal (more severe chordee ± scrotal deformities e.g. penoscrotal inversion, bifid scrotum): staged repair
  Complications after repair: higher rate for proximal hypospadias
- Early
  ○ Urethrocutaneous fistula / Neourethral dehiscence
  ○ Meatal stenosis / Neourethral stricture
- Late
  ○ Recurrent chordee

[Detailed anatomical illustration of hypospadias types. The illustration shows the ventral view of a penis with varying degrees of urethral meatus displacement, indicating the different types of hypospadias. Type I (1st degree) shows the meatus slightly displaced distally, labeled with anatomical references like glandular, coronal, and subcoronal. Type II (2nd degree) illustrates a more proximal displacement to the distal penile shaft. Type III (3rd degree) shows the meatus located further proximally near the penoscrotal junction. Each type is annotated with numbered points (n=1, n=3, n=7, n=2, n=4), presumably corresponding to specific anatomical locations. The diagram also indicates severity levels, with 'Mild' anteriorly, 'Moderate' in the middle, and 'Severe' posteriorly, aligning with the progressive displacement of the meatus. Anatomical regions like the scrotum, perineal area, and anus are also labeled.]

342

Buried penis
Definition: Penis partially or completely concealed within subcutaneous tissue of prepubic region

- E.g. Congenital megaprepuce (preputial bladder, fig.): small preputial opening → trapping of urine
- Excessive redundancy and ballooning of inner prepuce due to ill-defined penopubic & penoscrotal angle
  Anatomical factors
- Non-retractable tight prepuce
- Scarcity of shaft skin compared to penile shaft
- Obesity: Excessive prepubic fat
- Laxity of attachment between base of penile shaft and pubopenile angle
  Surgical principle: reconstruction of pubopenile angle & penoscrotal angle
- Penile shaft coverage by preputial flap e.g. Island flap, inner preputial flap

Disorders for sexual differentiation (DSD) - surgical options
Genitalia reconstruction

- Male
  - Repair of hypospadias and scrotal deformity
  - orchidopexy
- Female
  - reduction clitoroplasty
  - labioplasty
  - augmentation/reconstruction of vagina
    Gonadal management
- Gonadectomy for
  - non-functioning streak gonads
  - dysgenetic gonads not congruent with the assigned gender
- Gonadal biopsy+/-gonadecetomy
  - gonads with high risk of germ cell neoplasm

3.  5 Paediatric oncology
    Cancers are not common in children, but high mortality

- Leukaemia 30%
- Brain tumours 25%: MC medulloblastoma
- Lymphoma 15%

|                                                        | Clinical features                                                                                                                                                                |                                                                                                                              |
| :----------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :--------------------------------------------------------------------------------------------------------------------------- |
| Neuroblastoma (8%) → cross midline (esp. behind aorta) | MC extra-cranial solid tumor in childhood MC malignancy < 18 months Depends on primary location: abdominal (mass), thoracic (SVCO, Horner's) Poor prognosis: often detected late | [Abdominal computed tomography image showing a large mass in the abdomen. A photo of a surgical field with exposed vessels.] |
|                                                        | Mx: neoadjuvant chemo Tx before surgery                                                                                                                                          |                                                                                                                              |
| Wilm's tumour (6%) → not cross midline                 | Abdominal mass, HT, haematuria Good prognosis if early stage Mx: surgery + chemotherapy + RT                                                                                     | [Intraoperative photography showing a Wilms tumor.]                                                                          |
| Hepatoblastoma (1%)                                    | Associations: BWS, FAP Abdominal mass, ↑AFP (>90%) Good prognosis if early stage Mx: hepatectomy + chemotherapy + transplant                                                     | [Photo showing a liver with multiple white tumors.]                                                                          |

# 4 Plastic, Reconstructive & Aesthetic Surgery (PRAS)

## 4.1 Wound healing and reconstruction

"Plastikos" (Greek): to mould or to shape

**Wound healing**

Stages
| | |
|---|---|
| Inflammatory phase (~Day 1-4) | S/S: redness, heat, swelling, pain, loss of function Leucocyte migration and emigration, venodilation, neutrophil chemotaxis, etc. |
| Proliferative phase (~Day 4-42) | Fibroblasts synthesize collagen → gain tensile strength |
| Remodelling phase (after Wk 3) | Maturation by intermolecular cross-linking of collagen |

Types of wound healing
| | |
|---|---|
| Primary intention | Wound closure by direct approximation, pedicle flap or skin graft |
| Secondary intention | Wound left open to heal spontaneously by contraction and epithelialization |
| Tertiary intention | Delayed wound closure after a period of time |

Factors affecting wound healing
| Local factors | General factors |
|---|---|
| - Tissue trauma (kept minimum) - Hematoma - Blood supply - Temperature - Infection | - Steroids - Nutrition - Chemotherapy - Chronic illness |

Wound dressings

Protect the wound from trauma and provide environment for healing

- Antibacterial medications
  - Bacitracin and Neosporin: provide moist environment conducive to epithelialization
  - Silver sulfadiazine (Silvadene) and mafenide acetate (Sulfamylon): burn wounds and penetrate eschar
- Splinting and casting: immobilization to promote healing
- Negative pressure wound therapy: reduce exudate to promote healing

**Reconstruction ladder**

Spectrum of plastic reconstruction techniques that are of increasing complexity

[Illustration of reconstruction ladder: A diagram shows the reconstruction ladder with arrows indicating increasing complexity. The levels from top to bottom are: Free tissue transfer, Distant tissue transfer, Local tissue transfer, Tissue expansion, Skin grafting, Direct wound closure (including healing by primary intention and delayed primary closure), and Healing by secondary intention.]

Skin graft

- Definition: donor skin that is **without blood supply**
- Skin graft survival: graft "takes" by acquiring a blood supply from a healthy recipient bed
  - Plasmatic imbibition
  - Inosculation (~D3)
  - Revascularization (~D5)

[Diagram illustrating Plasmatic imbibition, Inosculation, Revascularization. Three diagrams (A,B,C) show skin graft integration.
Diagram A shows "Plasmatic imbibition" with the graft separated from the recipient area by fluid.
Diagram B shows "Inosculation" with blood vessels growing between graft and recipient area.
Diagram C shows "Revascularization" with established blood flow through the graft.]

- Donor site selection
  - Consider size, colour, hair pattern, texture, skin thickness
  - Avoid infected/necrotic tissues, irradiated tissues, exposed bone without periosteum, tendon without peritendon, cartilage without perichondrium
- Complications: graft failure due to
  - Haematoma/ seroma
  - Infection
  - Mechanical force, e.g. shearing, pressure
- Classification: **split-thickness skin graft (STSG) vs full thickness skin graft (FTSG)**

|            | STSG                                            | FTSG                                                        |
| :--------- | :---------------------------------------------- | :---------------------------------------------------------- |
| Definition | Epidermis + partial dermis                      | Epidermis + full dermis                                     |
| Donor site | More: remaining dermis for re-epithelialisation | Limited: nearby site of similar skin colour and consistency |
| Advantages | More area available: meshing, reharvesting      | Better cosmetics & function: used in face, hands            |
|            | Better survival than FTSG\*                     | Resist secondary contracture                                |

\*The small perforations in FTSG may not be sufficient to drain accumulating fluid → seroma/ haematoma → inhibit adhesion to recipient site

Skin flap

- Definition: donor skin with a **preserved blood supply** through a vascular pedicle → require **micro-anastomosis**
- Indications:
  - Situations where skin grafts will not take, e.g. infected tissue
  - Site of doubtful viability (vascularised donor skin promotes healing)
- Classification:
  - By blood supply to skin: random (unnamed), axial (named)
  - By donor site:
    - **Local**: adjacent to the defect, can be
      - **Rotational** (fig. 1)
      - **Advancement** (fig. 2)
      - **Transposition** (rotational + advancement)
      - Interpolated
    - **Regional**: based on known vascular pedicle
      - Example: _pedicled LD / TRAM flap_
    - **Distant**: non-contiguous anatomic site, can be
      - Pedicled
      - Free (unattached to blood supply, reattached to vessels at recipient site by microsurgical anastomosis): longer OT time, risk of complete flap loss (failure of microvascular anastomosis)

[Diagram of rotational flap. Illustration shows a triangular defect, a curved incision is made extending from one side of the defect, and the skin flap is rotated to cover the defect.]

[Diagram of pedicled flap. Illustration depicts a flap of skin and tissue raised on a vascular pedicle and tunneled under the skin to cover a defect.]

- Complications: **flap failure** due to
  - Haematoma/ seroma
  - Infection
  - Mechanical force
  - Vascular failure
  - Poor flap design

Clinical usage - examples

- Scalp reconstruction with ALT flap
- Mandible reconstruction with fibula flap
- Pharynx reconstruction with ALT flap rolled into tube
- Breast reconstruction: **pedicled TRAM flap / pedicled LD flap**

  4.2 Burns
  Overview
  Definition: wound caused by externally-induced **pathological change** in energy levels within a tissue leading to damage
  Assessment
  History taking

- Causative agents: thermal, chemical, electrical, radiation, cold
- Temperature of agent
- Contact time
- Circumstances of injury: enclosed space, jumping out of buildings
- Associated injury, e.g. fractures
- Any first aid: stop burning process, cooling

Pathophysiology - Jackson's zones

- Zone of hyperemia: reactive vasodilation, recover within 7 days → not included in TBSA measurement
- Zone of stasis: decreased perfusion → cell death in 48h without proper treatment → most salvageable zone
- Zone of coagulation: ischemia → irreversible cell damage

Severity of burns
Surface area (TBSA): Only 2° & 3° burns are counted

- Rule of palm: patient's (NOT your own) closed palm (including fingers) is 1% TBSA; for patchy burns
- Wallace's **Rule of 9s**: inaccurate in children
  - H&N 9%, each UL 9%, front of trunk 18%, back of trunk 18%, each LL 18%, perineum 1%
- Lund-Browder diagram: most accurate, used in burns unit, preferred in children

[Anterior view of a human body with the "Rules of 9" percentages marked on different body parts. The head and neck are marked with 4 1/2%. Each arm is marked with 4 1/2%. The front of the trunk is marked with 18%. Each leg is marked with 9%. The perineum is marked with 1%.]

[Posterior view of a human body with the "Rules of 9" percentages marked on different body parts. The head and neck are marked with 4 1/2%. Each arm is marked with 4 1/2%. The back of the trunk is marked with 18%. Each leg is marked with 9%. The perineum is marked with 1%.]

[Diagram showing the Lund-Browder diagram for estimating burn area in children, including the head, thigh, and leg area marked with percentages. The child has front and back views, with the body divided into area A, area B, and area C.]

Rules of 9

[Cross-sectional diagram of skin layers showing Zones of Thermal Injury. The diagram shows the skin surface, epidermis, dermis with nerves and vessels. Below the epidermis are three marked areas: Zone of hyperemia, Zone of stasis, and Zone of coagulation. Blood vessels and nerves are found in the dermis]

_Figure 16. Zones of thermal injury_

Lund-Browder diagram
Depth

- Factors: temperature of agent, contact time, thickness of skin (extremes of age, anatomical site)

|                    |            | Depth                               | Colour                   | Blister | CR  | Sensation         |
| :----------------- | :--------- | :---------------------------------- | :----------------------- | :------ | :-- | :---------------- |
| Superficial        | 1st degree | Epidermis                           | Pink                     | Nil     | <2s | Very painful      |
| Superficial dermal | 2nd degree | Into superficial dermis             | Pink, wet                | Small   | <2s | Extremely painful |
| Deep dermal        | 2nd degree | Into deep dermis                    | Pale with fixed staining | Big     | >2s | Reduced           |
| Full thickness     | 3rd degree | Complete loss of epidermis & dermis | White, unblanchable Hard | No      | No  | No                |

Management
Resuscitation
Fluid resuscitation (**must know!**)

- Indications: TBSA > **20% (adults)** or **10% (children)**, but no widely accepted limits
- Rationale: increased capillary permeability in burns → net fluid shift from intravascular compartment
- Modified Parkland's formula
  - 3-4ml x weight (kg) x %TBSA (greater than first degree)
  - 50% of fluid given in first **8h** (counted from the moment of injury), remaining 50% in next **16h**
  - Preferred fluid: **Hartmann's solution**
  - For paediatric patient, give additional daily maintenance fluid (100-50-25 per day or 4-2-1 per hr)
  - Monitoring: urine output: insert Foley catheter for all major burn patients
  - Target: **0.5ml/kg/h** in adults, **1ml/kg/h** in children
  - Give **extra fluid** whenever urine output is inadequate
  - Dark urine: consider myoglobinuria
- Additional fluid requirement for
  - Inhalational injury
  - Burns in children
  - Electrical burns: rhabdomyolysis
    Pharmacotherapy
- Analgesia
- Tetanus prophylaxis for burns > 10% TBSA (3 doses in total)

Specific considerations
| Inhalational injury & CO poisoning |
| ----------- |
| - Suspect if - History: fire in enclosed space, **unconscious**, long duration, type of combustible patients - Physical exam: **carbonaceous** sputum, **soot** in oral cavity/ oropharynx, burnt nasal hairs, **HOV/ stridor** (late signs) - S/S of **CO poisoning**: headache, nausea, dizziness, SOB, collapse, LOC - Management: - Airway: consider early intubation - Breathing: **100% O2** (compete with CO binding to Hb, take ~1hr), **hyperbaric O2** (take ~20min), carboxyHb (>5% in non-smokers, >10% in smokers), CXR - Circulation: higher requirement of fluid resuscitation - Diagnosis: fiberoptic bronchoscopy |
| Burns in children |
| - Thin skin → more severe injury - Large surface area-to-weight ratio → - Higher rate of water/ heat loss & metabolic requirement - Rules of 9 not applicable - More prone to hypothermia |
| Circumferential burns |
| - Unique in **full-thickness burn** - act as constricting eschar - Limbs: capillary leak of fluid → skin fails to expand due to loss of elasticity in burned tissues → **compartment syndrome** - Progressive loss of sensation/ power in limbs - Progressive loss of pulses in distal extremity by palpation or Doppler - Intracompartmental pressure (Stryker needle) > 30mmHg (fig.) - Chest: impaired ventilation → **respiratory distress** Management: escharotomy / fasciotomy |

[Image of a medical device, most likely used for measuring pressure. The device is rectangular and made of metal. It has a digital display showing numbers and a connected needle or probe. The image also contains a logo and text indicating it is associated with "EM:RAP".]

346

Types of burn - specific management

- Thermal injury
  - Remove clothing
  - Run effected area under **cold water** (NOT ice: vasoconstriction → less blood supply)
  - Cover with **cling film** (transparent, reduce irritation of skin)
- Electrical injury
  - Surface damage not representative of deeper tissue damage
  - **Arrhythmia**: cardiac monitor
  - **Rhabdomyolysis**:
    - Ix: myoglobinuria (dark urine), CK, RFT
    - Mx: forced diuresis (NS + frusemide +/- NaHCO3), target UO 1-2mL/kg/h
  - **Compartment syndrome**
- Chemical injury
  - Alkali (liquefaction necrosis) worse than acid (coagulation necrosis: eschar stops damage)
  - Exception: HF (liquefaction necrosis) → Mx: Ca gluconate
  - Severity determined by: pH, concentration, length of contact time involved TBSA%
  - Management
    - Remove clothing
    - **Copious irrigation with NS** until neutral pH
    - Document offending agent: test skin with Litmus paper if unknown

Wound care

- Achieve wound closure by **21 days** (↑scar formation afterwards)
  | | |
  | :--------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
  | Superficial | Analgesia |
  | | Wound dressing that aids skin healing, e.g. Tegaderm |
  | Superficial dermal | Analgesia |
  | | Wound dressing e.g. biological dressing (**amnion**) - accelerates healing |
  | | Prevent wound colonisation: topical antimicrobial agents, e.g. silver sulphadiazine (cannot penetrate eschar) |
  | Deep dermal | **Early wound debridement** |
  | | - Tangential excision up to bleeding tissue |
  | | - Fascial excision |
  | | [Image of a hand with meshed skin graft on it, and a close up of the meshed skin graft before it is placed on the wound. The meshed skin has small diamond shaped holes in it, and is pink in color. The hand with the graft on it shows a large wound with exposed tissue, and the meshed skin is covering the wound.] |
  | Full thickness | **+ Skin grafting**: harvest by skin graft knife at mid-dermis level |
  | | - **Autograft** |
  | | - **Meshed skin** (increase surface area to 1.5x to 6x, allow drainage holes for seroma/hematoma, but poorer cosmesis) |
  | | - **Skin substitutes**, e.g. **Integra** (dermo-matrix: collagen layer to promote neovascularization to create neodermis; silicone layer to protect → later removed and skin graft can be placed) |
  | | If skin grafting cannot be performed immediately: fine mesh gauze + topical antimicrobial agents (escharotomy before application) |

Rehabilitation: management of complications

- Cosmetics: burn scars
- Functional: contractures
- Psychosocial

Prognostic factors

- Age
- TBSA
- Inhalational injury

Criteria for referral to burns centre (reference)

- Requiring resuscitation
- Extremes of age
- Electrical / chemical burns
- Inhalation injury
- Concomitant trauma
- Circumferential burns
- Burns at face / hands / feet / perineum / joints

347

# 4.3 Scars

|                        | Hypertrophic scar: confined to site of injury                                                                                                               | Keloid scar: extend beyond site of injury                                                                                         |
| :--------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------------------------------------- |
|                        | [Image of a hypertrophic scar, which is a raised scar confined to the site of the original injury. The scar is linear and red. The skin around it is pale.] | [Image of a keloid scar on the ear, which extends beyond the original site of injury. There are multiple round scars on the ear.] |
| Incidence              | More common                                                                                                                                                 | Less common                                                                                                                       |
| Race association       | No                                                                                                                                                          | Yes, increasing racially determined pigmentation                                                                                  |
| Preceded by injury     | Always                                                                                                                                                      | Not always                                                                                                                        |
| Anatomical association | No                                                                                                                                                          | Anywhere, esp. earlobes, deltoid, presternal                                                                                      |
| Onset                  | Within 6-8 weeks                                                                                                                                            | May take months                                                                                                                   |
| Resolve                | Most eventually resolves                                                                                                                                    | No                                                                                                                                |
| Recur after surgery    | No                                                                                                                                                          | YES!                                                                                                                              |
| Contracture            | YES                                                                                                                                                         | No                                                                                                                                |
| Cell biology           | Fibre parallel to epidermis Myofibroblasts present Increased density of blood vessels                                                                       | Fibres random to epidermis Myofibroblasts absent Decreased density of blood vessels                                               |

Management
Non-surgical: multi-modal therapy

- Massage and moisture
- Compression therapy
- Silicone sheet / gel
- Intralesional corticosteroid injection
- Laser
- Cryotherapy

# 4.4 Benign skin conditions

Fitzpatrick skin types
Estimate response to UV light

[Image of The Fitzpatrick Scale showing six skin types, ranging from very light (Type I) to very dark (Type VI). Each type is represented by a skin tone swatch with a corresponding description.]

Benign skin conditions
Seborrheic keratosis
[Image of a seborrheic keratosis, which is a raised, waxy lesion on the skin. The lesion is brown and has a rough surface.]

- Pathology: Benign proliferation of keratinocytes
- Occur in sun-exposed areas, head & trunk
- "Stuck-on" appearance
- NO malignant potential

Actinic keratosis
[Image of an actinic keratosis, which is a rough, scaly patch on the skin. The lesion is pink or red and has an irregular shape.]

- Pathology: Atypia of epidermis that does not involve full-thickness (full-thickness involvement = SCC in-situ)
- Pre-malignant: 20-25% develop into SCC

Bowen's disease
[Image of Bowen's disease, which appears as a red, scaly patch on the skin. The patch is well-defined and slightly raised.]

- Pre-malignant: SCC in-situ
- Very similar to actinic keratosis, but no scaling
- Predominantly in women

349
Keratoacanthoma
[Image Description: a close-up photograph shows a round, raised skin lesion with a central crater-like depression filled with keratinous material. The surrounding skin appears slightly inflamed and uneven.]

- Pathology: keratinizing squamous cells in pilosebaceous follicles
- Fast growing over a few weeks, but spontaneously regresses
- Usually have central keratin plug
- Difficult to differentiate from SCC: require biopsy

Congenital melanocytic naevi
[Image Description: a close-up photograph shows a large, darkly pigmented skin lesion covering a significant portion of an infant's body. The lesion is slightly raised and has an irregular border.]

- Large, hairy, pigmented, verrucous
- "Giant" naevi have ~5% risk of transforming into malignant melanoma (usually within first 5 years of life)
  - Definition: 2% TBSA / ≥20cm in largest diameter
  - Risk reduced but NOT eliminated with excision

Acquired melanocytic naevi
(moles)
Usually do not involve skin appendages
Subtypes: junctional, compound, intradermal

Sebaeceous naevi (of Jadassohn)
[Image Description: a close-up photograph shows a patch of skin with a yellowish-orange, slightly raised, and waxy appearance. The patch is located on the scalp or face.]

- Pathology: hamartoma of sebaceous glands with overlying epidermal hyperplasia
- Typically appears on scalp / face
- 10-15% risk of malignant transformation: BCC (classically), SCC, sebaceous/apocrine carcinomas

Lipoma
[Image Description: a close-up photograph shows a smooth, soft, and slightly raised mass beneath the skin. The skin overlying the mass appears normal.]

- Pathology: benign tumour arising from adipose tissues
- Clinical features: slip sign, soft and rubbery consistency, normal overlying skin
- Investigations (usually not needed): USG/MRI, FNAC
- Management: observation, surgical excision, liposuction

Sebaceous cysts / Epidermoid cysts

- Pathology: inclusion cysts lined by stratified squamous epithelium and filled with keratin - originate from proliferation of epidermal cells from infundibulum of hair follicle
- NOT of sebaceous origin
- Management: excision with inclusion of punctum

Vascular lesions
ISSVA classification: tumor (endothelial proliferation) vs malformation (defective embryonic vasculogenesis)

Haemangioma
[Image Description: a close-up photograph shows a bright red, raised, and well-defined vascular lesion on the skin. The lesion appears superficial and may have a slightly bumpy texture.]
Benign vascular neoplasm, 60% appear on the face
Growth: mostly appear in first few weeks after birth (30% present at birth) → early proliferation in first year → spontaneous involution (50% at 5yo, 90% at 9yo)
May impinge on vital structures

- Obscure visual axis
- Obstruct airway
  Treatment: oral propranolol, oral steroids

Vascular malformations
[Image Description: a photograph shows a skin marking. It is a large, irregularly shaped, purplish-red skin lesion affecting the face. The lesion appears flat and covers a portion of the cheek and around the eye. The eye is covered by a blue marking.]
Errors of vascular development (~8th week)

- High flow (risk of high-output HF): Arterial, AVM, AVF
- Low flow: capillary, venous, lymphatic
  Growth: tend to remain static, but may be associated with soft tissue / bone hypertrophy

Example: port wine stain (fig.) - skin capillary malformation

- Associated with Sturge-Weber syndrome
- Treatment: pulsed dye laser (PDL)

  4.5 Skin cancers
  Prevalence: BCC (75%) > SCC (20%) > melanoma (5%)
  Aggressiveness: melanoma > SCC > BCC

|                   | Basal cell carcinoma (BCC)                                                                                                                                                                                                                                                                                                                        | Squamous cell carcinoma (SCC)                                                                                                                                                                                                                        | Malignant melanoma                                                                                                                                                                                                                                                                                                                                                                              |    350 |
| :---------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -----: | --- |
|                   | [Image of a basal cell carcinoma, it is a dark brown to black tumor, round in shape and raised from the skin. It has a smooth, pearly surface, and some small blood vessels are visible on the surface. The lesion is located on the patient's face, near the nose.]                                                                              | [Image of a squamous cell carcinoma. It appears as a pink to red, irregularly shaped growth with a rough, scaly surface. The lesion has raised edges and a central ulceration. It is located on the patient's skin.]                                 | [Image of Malignant melanoma. The image is composed of four smaller images, representing different types of malignant melanoma: Superficial spreading melanoma (irregularly shaped, multicolored), Nodular melanoma (darkly pigmented, raised lesion), Lentigo maligna melanoma (flat, tan or brown lesion), and Acral lentiginous melanoma (darkly pigmented lesion on the sole of the foot).] |        |
| Risk factors      | - UV light - Ionizing radiation - Immunosuppression - Pre-malignant conditions e.g. sebaceous naevi - Genetics: Gorlin's\*, xeroderma pigmentosum^                                                                                                                                                                                                | - UV light - Ionizing radiation - Immunosuppression - Chronic wounds (Marjolin ulcer): osteomyelitis sinuses, hidradenitis suppurativa - Pre-malignant conditions: actinic keratosis, Bowen's disease, leukoplakia - Genetic: xeroderma pigmentosum^ | - UV light - Fitzpatrick Type I - Congenitc and dysplastic naevi - Immunosuppression - Male gender - FHx/Hx of melanoma - Genetic: xeroderma pigmentosum^                                                                                                                                                                                                                                       |        |
| Clinical features | - **Most common** - 80% is pigmented in HK - 85% in **head and neck** (sun-exposed areas) - Classical description (Caucasians): **Rolled pearly edges, telangiectasia, central ulcer** - Slow-growing - Very rarely metastasize - Histopathology: peripheral palisading - Subtypes: nodular, superficial, morpheaform, infiltrative, basisquamous | - Variable depend on level of differentiation - Keratin horn - Everted edges with crusts - Locations: scalp, face, dorsum of hand - LN metastasis 2-3% at presentation                                                                               | - ABCDE rule (_must know_) - Asymmetry - Border irregular - Color: variegated - Diameter > 6mm - Evolving Subtypes (_must know_) - Acral lentiginous (MC in HK - 52%) - subungal melanoma (Hutchinson's sign) - Superficial spreading (MC worldwide) - Nodular - Lentigo maligna - Amelanocytic                                                                                                 |        |
| Treatment         | Wide local excision - 3mm margin if <2cm - 4-6mm margin if >2cm or morpheic lesion - Mohs micrographic surgery (N/A in HK) Others for elderly / not fit - Radiotherapy - Cryotherapy - Currettage - Intralesional interferon                                                                                                                      | Wide local excision - 5mm margin if low risk - 1cm margin if high risk - + LN dissection if clinically apparent Radiotherapy (IMRT): for elderly - Adjuvant if perineural involvement/+ve margins - Palliative: inoperable / recurrent SCC           | Wide local excision (margin depends on T staging - _Breslow's thickness_)                                                                                                                                                                                                                                                                                                                       |        |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | Thickness                                                                                                                                                                                                                                                                                                                                                                                       | Margin |     |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | In situ                                                                                                                                                                                                                                                                                                                                                                                         |  0.5cm |     |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | <1mm (T1)                                                                                                                                                                                                                                                                                                                                                                                       |    1cm |     |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | 1-2mm (T2)                                                                                                                                                                                                                                                                                                                                                                                      |  1-2cm |     |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | 2-4mm (T3)                                                                                                                                                                                                                                                                                                                                                                                      |    2cm |     |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | >4mm (T4)                                                                                                                                                                                                                                                                                                                                                                                       |  2-3cm |     |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | Sentinal LN biopsy: if Breslow depth ≥0.8mm (T1b or above)                                                                                                                                                                                                                                                                                                                                      |        |
|                   |                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                      | Chemo if LN +ve                                                                                                                                                                                                                                                                                                                                                                                 |        |

Workup of malignant melanoma:

- Excisional biopsy (2mm margin): Breslow's thickness, histologic ulceration, peripheral & deep margin status, microsatellitosis
- Chest X-ray, staging CT/MRI, PET-CT

\*Gorlin's syndrome (AD): multiple BCC, palmar pits, odontogenic cysts, bifid ribs, calcification of falx cerebri, overdevelopment of supraorbital ridges, learning difficulties
^Xeroderma pigmentosum: deficiency in DNA-repairing enzymes of skin, 100% lifetime risk of skin cancers

# 4.6 Lymphaedema

Definition: obstruction of lymphatic drainage resulting in oedema with high protein content

Aetiology

- Primary:
  - Milroy's syndrome (congenital hereditary lymphedema)
  - Meige disease (lymphedema praecox) (puberty)
  - Lymphoedema tarda (>30yo)
- Secondary:
  - Filariasis (MC worldwide, Wuchereria bancrofti)
  - Malignancy (MC cause in developed countries): 25% after mastectomy, 40% after mastectomy + AD
  - Post-radiation

[Image of the top of a foot with severely thickened, warty, and bumpy skin, primarily affecting the toes. The skin appears rough and irregular, showing signs of significant swelling and deformation.]

Clinical features

- Pitting oedema initially -> **warty & thickened skin** (fig.)
- Stemmer sign: unable to lift skin of 2nd finger or 2nd toe (due to thickened skinfold)

Management

- Conservative: **complete decongestive therapy** - reduce 50% in 8 weeks, but **recur** if stop
  - MLD (manual lymphatic drainage)
  - External compression
  - Exercise
  - Skin / nail care
- Surgical management

| Debulking     | - **Charles procedure** (covered with graft)                                                               |
| :------------ | :--------------------------------------------------------------------------------------------------------- |
|               | - **Homans procedure** (MC performed, only cut the subcutaneous tissue)                                    |
|               | - **Liposuction + compression garments**: chronic lymphoedema associated with fatty infiltration of tissue |
| Physiological | - **Lymph-to-vein** anastomosis (LVA)                                                                      |
|               | - **LN transfer** (lymph nodes can produce VEGF to promote growth of new lymph vessels)                    |

5 Neurosurgery 5. 1 Traumatic brain injury (TBI)
Overview
Epidemiology

- Account for >50% of trauma deaths
- Triple peaks by age: infants to preschooler (0-4yo), teenager to young adults (15-24yo), elderly (≥65yo)
- Causes: falls (MC, esp. children & elderly), road traffic accidents
- Broadly classified into: closed / blunt head injury vs open / penetrating head injury

Assessment
Initial assessment

- ABC
- **Glasgow Coma Scale (GCS)**: determine severity of HI
  Table 2. The Glasgow coma scale
  | Eye opening response: | | Best verbal response | |
  | :------------------------ | :-: | :------------------------ | :-: |
  | spontaneously | 4 | orientated | 5 |
  | to speech | 3 | confused | 4 |
  | to pain | 2 | inappropriate words | 3 |
  | none | 1 | incomprehensible sounds | 2 |
  | | | none | 1 |
  | **Best motor response:** | | **In intubated patient, the verbal scores are:** | |
  | obeys commands | 6 | patient appears able to converse | 5 |
  | localization to painful stimuli | 5 | patient questionable to converse | 3 |
  | normal flexion to painful stimuli | 4 | generally unresponsive | 1 |
  | abnormal flexion to painful stimuli | 3 | | |
  | extension to painful stimuli | 2 | | |
  | none | 1 | | |
- Mild TBI (13-15): 30% become disabled
- Moderate TBI (9-12): 40% become disabled
- Severe TBI (≤8): variable; predictors: post-resuscitation GCS & age
- **Focal neurological signs**: pupil, cranial nerves, limbs, posturing, reflexes
- Other relevant signs: e.g. raccoon eyes, CSF rhinorrhoea, ruptured tympanic membrane
- Spinal cord injury: sensory level, motor deficits, anal tone

History taking - pearls

- Mechanism of injury: high-energy vs low-energy
- Precipitating factors: convulsion, syncope, stroke
- Events during HI: duration of LOC, post-traumatic amnesia, lucid interval, convulsions, resuscitations given
- Neurological S/S: headache, vomiting
- Pre-morbid functioning
  Radiological investigations
- Plain CT brain
- Plain CT cervical spine
- ± CTA Circle of Willis: e.g. skull base fracture involving foramen lacerum
- ± CTA vertebral: e.g. C spine injury involving vertebral foramen
- ± MRI for spinal injuries: e.g. spinal epidural hematoma, cord contusions

Prognosis
High risk patients

- High-energy injury: fall from height, road traffic accident
- Advanced age
- On anticoagulants / antiplatelets / alcohol
- S/S of increased ICP: headache, n/v
- S/S of herniation: anisocoria, sluggish pupillary response
- Lucid interval
  [A picture comprised of two images showing "Head injury prognosis" and "CRASH" logo. On the left, there is a clinical tool. The clinical tool is a form with questions that when answered, estimates mortality at 14 days and death and severe disability at six months in patients with traumatic brain injury(TBI). The form questions are listed as: Country, Age, Glasgow Coma Scale score, Pupils react to light, Major extra-cranial injury?, CT scan available?, Presence of petechial hemorrhages, Obliteration of the third ventricle or basal cisterns, Subarachnoid bleeding and Midline shift and Non-evacuated haematoma. The form provides selections to choose a value. The tool has a "Prediction" section that shows the values for Risk of 14 day mortality (95% CI) and Risk of unfavorable outcome at 6 months. On the right is the CRASH logo]

CRASH score (fig.): predict risk of 14-day mortality and unfavourable outcome at 6 months

# Primary brain injuries

- Mechanisms
  - Concussion: trauma-induced alteration in mental state, without CT abnormalities
  - Contusion: brain slide against bony structures
  - **Coup injury**: brain injury at direct impact site
  - **Contre-coup injury**: brain injury opposite to impact site, due to sudden linear velocity changes e.g. acceleration-deceleration
  - Intracranial haematoma (see below)
  - Skull fractures (see below)
  - **Diffuse axonal injury (DAI)**: rotational force, classified by CT findings

[A table showing the CT Density and MRI Appearance of Blood over time. The table has four columns: Time, CT, MRI T1, and MRI T2. The rows are: Acute (<72h) with values Hyper, Grey, Black; Subacute (<3wk) with values Iso, White, White; Chronic (>3 wk) with values Hypo, Black, Black. Below the table are two lines: MRI-T1: "George Washington Bridge" and MRI-T2: "Oreo" cookie-Black/White/Black.]

| DAI | Description                                      |
| --- | ------------------------------------------------ |
| 1   | Normal CT                                        |
| 2   | Midline shift ≤ 5 mm, no parenchymal lesion      |
| 3   | Midline shift > 5 mm, parenchymal lesion ≤ 25 ml |
| 4   | Midline shift > 5 mm, parenchymal lesion > 25 ml |

# Skull fracture

- By fracture lines: linear, comminuted
- By degree of displacement: undisplaced, depressed, open/ compound
- By anatomy: skull vault, skull base

| Linear fracture                                                                                                                  | Depressed fracture                                                                       | Compound/ open fracture                                                                         |
| -------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------- |
| Full-thickness fracture without bone displacement                                                                                | Broken skull displaces inward                                                            | - Fracture that involves skin laceration / extension to paranasal sinus / middle ear structures |
|                                                                                                                                  |                                                                                          | - Increased risk of infection                                                                   |
| [A black and white X-ray image showing a linear fracture of the skull. A thin, bright line is visible on the skull's left side.] | [A CT scan image showing a depressed fracture of the skull. The skull appears indented.] | [A CT scan image showing a compound/open fracture. The bone is broken.]                         |

# Basilar fractures

- Skull fracture at skull base (one of 5 bones, most commonly temporal bone)
- Complications: EDH, **meningitis**, **CSF leak** (halo test, beta-2 transferrin)
- S/S:
  - Anterior cranial fossa fracture: **CSF rhinorrhea**, **raccoon eyes** (periorbital bruise), epistaxis, anosmia (CN I injury)
  - Petrous temporal fracture: **Battle sign** (retroauricular bruise), **CSF otorrhea**, **hemotympanum**, bleeding from ear, CN VII/VIII injury
- CT features: air fluid level in sphenoid sinus / mastoid air cells, fracture lines may not be seen

[A black and white X-ray image showing a basilar skull fracture. The image shows a fracture near the base of the skull.]

Intracranial haematoma

|                                | Patho                                                                     | S/S                                                                                               | Radiological features                                                                                                                                                                                                                                                                                      | Specific management                                                     |
| ------------------------------ | ------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------- |
| Epidural haematoma             | Ruptured **middle meningeal artery** (95%) Dural sinus (5%)               | **Lucid interval**, then rapid deterioration Associated with skull fractures                      | [Image of a brain scan showing a lens-shaped hyperdense mass on the right side of the skull. The mass appears bright on the scan, indicating it is denser than the surrounding brain tissue. The lesion abuts the inner table of the skull but is limited by suture lines and it also crosses the midline] | Craniotomy Good outcome if timely evacuation                            |
| Acute subdural haematoma (SDH) | Ruptured subarachnoid bridging veins                                      | Uncal herniation: blown pupil, ipsilateral hemiparesis, LOC Tonsillar herniation: Cushing's triad | [Image of a brain scan showing a crescent-shaped hyperdense mass on the left side of the skull. The mass is bright, suggesting a higher density than the surrounding brain tissue. It follows the contour of the skull and crosses suture lines and it does not cross the midline]                         | Craniotomy Poor outcome: associated with significant parenchymal injury |
| Chronic SDH                    | Ruptured subarachnoid bridging veins                                      | Mild headache Confusion                                                                           | [Image of a brain scan showing a hypodense area in the brain with flattened gyri and thin shallow sulci, indicating brain atrophy.]                                                                                                                                                                        | Burr hole to drain Craniotomy if recur Good outcome with drainage       |
| Diffuse axonal injury          | Multiple focal **white matter lesions** due to shearing /rotational force | Prolonged coma Multiple neurological deficits                                                     | CT can be normal; haemorrhagic lesions in _corpus callosum / dorsal brainstem_ MRI IHC: retraction balls                                                                                                                                                                                                   | Supportive: cerebral oedema, hypoxia etc                                |

Secondary brain injuries

| Extracranial                                                                                                                                                                                                                                                                 | Intracranial                                                                                                                                                                                                                                                                                                                                                                                                       |
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| - Hypoxaemia & hypercapnia: trauma to chest, blood loss - Hypotension - HypoNa: SIADH → may aggravate cerebral edema and cause seizure - Hyper/hypoglycemia - Hyperthermia - Extracranial infections (esp. MRSA): e.g. ventilator-associated pneumonia, aspiration pneumonia | - Delayed haemorrhages: SDH, EDH, SAH, ICH, IVH - **Cerebral edema:** cytotoxic oedema (ischaemia) + vasogenic oedema (BBB disruption) - **Hydrocephalus** - Intracranial infections: e.g. meningitis, brain abscess - Epileptic seizure: early (within 1 week after TBI) vs late - Cerebral diaschisis (reduced cerebral metabolic rate) → reduced cerebral blood flow without autoregulation → prone to ischemia |

- Pathophysiology: Monro-Kellie doctrine
  - (1) Rigidity of skull vault
  - (2) Incompressibility of intracranial constituents: blood, brain parenchyma, CSF
  - → Change in one component (**brain tissue / CSF / blood**) require compensatory change in another component to maintain constant ICP
- CPP = MAP – ICP
- End result of head injury is ↑ICP → may lead to ischemia (drop in CPP) & herniation

[Image of a flowchart illustrating the Monro-Kellie doctrine and its effects on brain physiology after a head injury. The flowchart starts with Intracranial haematoma, Mass effect, and Focal damage. It proceeds to Brain oedema and an upward arrow pointing to Intracranial pressure (ICP). Cerebral Perfusion Pressure (CPP) is indicated as having two paths down, one to Cerebral blood flow (CBF) and then Cerebral ischemia, and the other path to Brain shift, Brain herniation, and Brainstem compression.]

355
Management of head injury

- ABC
- Scalp wound: **MUST suture** to stop bleeding!
- Skull base fractures: nasal packing, antibiotics, discuss for embolization
- Open fracture: wound debridement and closure, antibiotics, ± Keppra
- **IV Transamine 1g:** within 3 hours if mild-moderate TBI + reactive pupils [CRASH-3 trial]
- CSF fistula: usually heal spontaneously, may require surgical repair if persistent / delayed
- Decide stability for transfer

Management of severe TBI (GCS ≤ 8)

- Treatment targets
  - ICP < 22mmHg, CPP 60-70mmHg
  - SpO2 > 97%, PaO2 > 9 kPa, PCO2 4.5-5kPa, temp <37, avoid hypoglycemia, serum Na >140
- **Endotracheal intubation** for airway protection (± early tracheostomy: better bronchial toileting)
- **Invasive ICP monitoring** with antimicrobial-impregnated EVD catheter
  - Head elevation 30° and loosen any constraints around neck
  - Consider sedation & paralysis
- Nutrition: feeding at least by Day 5
- DVT prophylaxis: graded compression stockings
- Seizure prophylaxis (for 1 week only): decrease incidence of post-traumatic seizure, NO need if sedated
- Antibiotics if open / skull base fractures
- Role of steroids: high-dose MP is contra-indicated [CRASH trial]

ICP management

- Indications for invasive ICP monitoring
  - Severe head injury (GCS ≤ 8)
  - Abnormal CT scan: evidence of mass effect (e.g. hematoma, contusion)
- Types of ICP monitoring
  - Intraventricular (gold standard): burr hole + external ventricular drainage (EVD), telemetric
    ventricular pressure monitoring device
  - Parenchymal: microsensor catheter
  - Subdural / Epidural
  - Non-invasive: optic nerve USG, transcranial Doppler USG
- S/S of impending herniation (**important!**)
  - Fixed and dilated pupils (unilateral/bilateral)
  - Decorticate / decerebrate posturing
  - Cushing triad: hypertension, bradycardia, irregular respiration
- If targets not met, first consider repeat CT brain / recalibrate probes / check catheter position
- Pharmacological approaches
  | Reduce cerebral blood volume | - Head elevation 30° and loosen any constraints around neck |
  | :-------------------------- | :------------------------------------------------------------------- |
  | | - Hyperventilation (PaCO2~30mmHg): cerebral vasoconstriction |
  | | - Sedation & paralysis: reduce metabolic demand of brain |
  | Reduce CSF volume | - Intermittent CSF drainage via EVD |
  | | - Frusemide: might reduce CSF formation |
  | Reduce brain volume | - IV Mannitol 0.25-1g/kg (note: C/I if hypotension) |
  | | - Immediate: improve cerebral blood flow and oxygenation |
  | | - 30min: osmotic effect |
  | | - Hypertonic saline (150mL 3% saline) if hypovolemia |
  | | - Require central line & dilution |

- Surgical approaches
  - Burr hole + external ventricular drainage for ICP monitoring and intermittent CSF drainage
  - Clot evacuation / Contusionectomy
  - Decompressive craniectomy + lobectomy: _NOT recommended for early [DECRA trial], but favourable for late
    [RescueICP trial]_
- Refractory: Barbiturate coma / thiopentone coma with EEG monitoring

# 5.2 Cerebrovascular disease

Refer to [MED] for more details about stroke management
Subarachnoid haemorrhage (SAH)
Aetiology
Overall MC: traumatic
Among spontaneous non-traumatic SAH,

- Cerebral aneurysm (85%)
- Other vascular lesions (5%): e.g. AVM, Moyamoya disease
- Non-aneurysmal peri-mesencephalic SAH (10%): no lesion seen on angiography, thought to be venous/capillary in nature, good prognosis

Clinical features

- Headache: sudden onset, severe "thunderclap" / worst headache ever had
- Brief LOC
- Meningism: neck stiffness, photophobia, n/v

Grading:
World Federation of Neurosurgical Societies (WFNS) grading (more common), Hunt and Hess grading
| WFNS Grade | GCS Score | Motor Deficit |
| ----------- | ----------- | ----------- |
| I | 15 | absent |
| II | 14-13 | absent |
| III | 14-13 | present |
| IV | 12-7 | present or absent |
| V | 6-3 | present or absent |

[Image Description: A gray scale CT scan of a human head, axial view, showing the brain inside the skull. The scan shows the cerebral hemispheres, ventricles, and other brain structures. There are varying shades of gray, representing different densities of brain tissue.]

Investigations

- Urgent NCCT brain: hyperdensity in basal cisterns around circle of Willis (65%) or Sylvian fissure (30%)
- LP (2nd line if CTB normal): bloody CSF, xanthochromia (12h to 12d), persistent ↑RBC > 100000, ↑protein
- Non-invasive vascular imaging for cerebral aneurysms: CTA/MRA → DSA

Management

- Resuscitation (ABC)
- Watch out for cervical spine injury and other associated injury: neck collar, CXR, C-spine X ray + CT C spine
- Bed rest, NPOEM, IV fluids, monitor vitals + neuro-obs
- Correct hypoglycemia, temperature / fluid / electrolyte abnormalities
- Symptomatic: analgesics, anticonvulsant, stool softener prn
- Antihypertensive: Nimodipine 60mg Q4h PO/IV (prevent vasospasm, risk of delayed cerebral infarction)
  - Closely monitor BP: target SBP < 160 (note risk of rebleeding vs maintenance of CPP)
- Tranexamic acid: for < 72h or until surgical treatment (risk of thrombosis)
- Early aneurysm occlusion to reduce risk of rebleeding - Endovascular (1st line): DSA + coil embolization of aneurysm; Cx contrast allergy, embolism - New modality: flow diverter (~ EVAR) - Surgical: craniotomy + microsurgical clipping
  Complications (9H)
- Early: haematoma, intracranial HT, systemic HT (compensate ↑ ICP), HF/arrhythmia / neurogenic pulmonary edema
- Late: haemorrhage (re-bleed), hypoperfusion (delayed cerebral ischemia), hydrocephalus, hypovolaemia (CSW), hypoNa (SIADH)

Decreased GC after SAH:

- Hydrocephalus
- Re-bleeding
- Acute ischemic stroke
- Non-convulsive seizure

Delayed cerebral ischemia

- Definition: Focal neurological deficit / decreased GCS x 2 points for at least 1 hour
- Ix: CT perfusion scan + CT angiogram for vasospasm
- Mx: haemodynamic augmentation (increase BP), IA vasodilators (e.g. CCB), angioplasty + stenting

# Intracerebral haemorrhage (ICH)

Aetiology (in order of prevalence)

- **Hypertensive arteriopathy** (rupture of capillary microaneurysms): deep ICH - more central
  - Common sites: **pons, cerebellum, putamen, thalamus**
- **Cerebral amyloid angiopathy (CAA)**: lobar ICH - more peripheral
- Others: **coagulopathy**, structural vascular lesions (e.g. Berry aneurysms, AVM), drugs (e.g. cocaine)

Investigations

- **Urgent NCCT brain**: size and location of haematoma, any IVH/hydrocephalus, any mass effect
- Indications for vascular imaging: suspected _non-hypertensive_ etiology
  - No HT
  - Age <40-45
  - Atypical location
  - CT abnormality: mass, calcifications

Management

- Resuscitation (ABC)
- Watch out for **cervical spine injury** and other associated injury: neck collar, CXR, C-spine X ray + CT C spine
- Bed rest, NPOEM, IV fluids, monitor vitals + **neuro-obs**
- Antihypertensive: **IV labetalol** (for adequate cerebral perfusion and reduce risk of bleeding)
  - Treat if SBP > 150 (unless evidence of increased ICP)
  - Target SBP <140, but avoid rapid BP reduction (renal complications)
- Reversal of anticoagulation
- Acute hydrocephalus: **burr hole + EVD**

Large territory infarct
Role of neurosurgery: prophylactic decompressive craniectomy and
duroplasty (add synthetic material to dural opening)

- Shown in RCT to reduce disability and mortality in:
  - Malignant MCA syndrome
  - Massive cerebellar infarct

Cerebral venous thrombosis
Epidemiology: F > M - pregnancy, use of COC

- 1% of stroke

Clinical features (require high index of suspicion)

- S/S depends on site:
  - Cerebral venous sinus thrombosis (90%): ↑↑ ICP (headache, papilledema, ↓GCS), seizure, focal neurological deficit
  - Cavernous sinus thrombosis: proptosis, painful ophthalmoplegia, CN 3, 4, 6, V1 involvement
  - Deep cerebral venous thrombosis (10%)

Investigations:

- CT brain: can be normal
- MRI brain + MR venogram for filling defect
  - Empty delta sign: superior sagittal sinus involvement (fig.)

Management:

- Anticoagulation: LMWH (acute) → warfarin or dabigatran for 3 months (chronic)
- Endovascular thrombolysis in selected patients
- ICP management
- Treat seizures

[A medical illustration depicts a surgical procedure called decompressive craniectomy and duroplasty. The drawing shows the outline of a human head and neck from a side view. A large, dashed rectangular area is marked on the skull to indicate the region where the bone flap will be removed. Inside this area, the word "Duraplasty" is written, referring to the surgical repair or reconstruction of the dura mater. Several small circles connected by lines are drawn along the edges of the dashed rectangle, suggesting points of attachment or sutures.
Below the medical illustration is a axial CT scan of the brain. A white arrow points to a bright white area in the midline at the back of the skull near the sagittal sinus, indicating a blood clot or thrombus. The ventricles appear normal in size and shape, without any obvious displacement. The sulci are well-defined and prominent, suggesting normal brain anatomy.]

```markdown
5.3 Hydrocephalus
Normal physiology of CSF flow

- Average volume of CSF: 150mL
  - 20% in ventricular system
  - 80% in subarachnoid and cisternal spaces
- Production rate: 480mL/day (i.e. renewed 3x/day)
- Active production:
  - Choroid plexus (75%)
  - Others (25%) e.g. ependymal wall, brain
    parenchyma, interstitial fluid
    [Anatomical drawing of the ventricular system. The ventricles are highlighted in blue. Arrows indicate the flow of cerebrospinal fluid from the lateral ventricles through the interventricular foramen to the third ventricle, then through the cerebral aqueduct to the fourth ventricle, and finally out into the subarachnoid space. The drawing includes labels for: "Lateral ventricles," "Interventricular foramen," "Third Ventricle," "Cerebral aqueduct," "Fourth ventricle", "Central canal" and includes lateral and anterior views.]
- Circulation: lateral ventricles → interventricular foramen (of Monroe) → 3rd ventricle → Sylvian aqueduct →
  4th ventricle → lateral foramina (of Luschka) & medial foramen (of Magendie) → subarachnoid
- Passive absorption: depend on CSF pressure gradient
  - Arachnoid granulations (80%) → Superior sagittal sinus
  - Extracranial lymphatics (20%): via subarachnoid space of exiting CNs, or perivascular (Virchow-Robin) spaces
    Overview
    Definition: accumulation of excess CSF within the cranium
    Etiology: subdivided into

|            | Obstructive: at ventricular system/ aqueduct - ventricular enlargement proximal to block (4th ventricle normal)                                                                                                                                                                | Communicating: at arachnoid villi - all ventricles dilated (4th ventricle enlarged)                                                              |
| ---------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------ |
| Acquired   | - Tumors: CPA tumors (vestibular schwannoma / meningioma), **brain metastasis**, gliomas, craniopharyngioma / pituitary macroadenoma- Vascular: cerebellar infarct, ICH, IVH- Infections: ventriculitis, post-infective aqueductal stenosis, brain abscess, neurocysticercosis | - Tumors: leptomeningeal carcinomatosis- Vascular: SAH, IVH- Infections: basal meningitis (e.g. TB, Cryptococcal)- Normal pressure hydrocephalus |
| Congenital | - Dandy-Walker malformation, Type II Chiari malformation, congenital aqueductal stenosis                                                                                                                                                                                       |                                                                                                                                                  |
|            | - Overproduction of CSF (rare): choroid plexus papilloma                                                                                                                                                                                                                       |                                                                                                                                                  |

Clinical features

- Acute hydrocephalus:, S/S of raised ICP (headache, n/v), sunsetting eyes / Parinaud syndrome, CN 6 palsy, UMN long tract signs
- Chronic hydrocephalus (i.e. NPH): **Adam's triad**
  Investigations
- CT/ MRI:
  - Ventriculomegaly: need to account for physiological increase in ventricular volume with aging ± cerebral atrophy (i.e. "hydrocephalus ex-cavuo")
    - First ventricle to dilate: temporal horn of lateral ventricles
  - Periventricular lucencies: due to transependymal edema
  - Sulci and fissure effacement
  - Midline shift / herniation
- ICP monitoring: LP or external ventricular drain (EVD)
```

Management

- Acute management: burr hole + external ventricular drainage (EVD), diuretics (acetazolamide + frusemide)
- Treat offending cause
- CSF diversion procedures
  - Permanent CSF shunts: ventriculo-peritoneal (VP) shunt, ventriculo-atrial (VA) shunt, lumboperitoneal (LP) shunt
    - Components: ventricular catheter, valve & reservoir, distal catheter
  - Endoscopic third ventriculostomy (ETV): for obstructive hydrocephalus only

Complications of CSF shunt
Ventricular catheter

- Mechanical failure: Shunt blockage (MC), migration, fracture
  - Site: 80% proximal block, 10% valve, 10% distal block
  - Causes: choroid plexus, brain parenchyma, protein, tumor cells
  - Investigations: urgent CT brain, shunt series (plain XR of entire shunt: skull XR, C spine XR, CXR, AXR)
  - Management: consult NS for shunt revision
- Shunt infection (most serious):
  - Pathogens: S. epidermidis, S. aureus
  - S/S: fever, lethargy, meningism, S/S of raised ICP
  - Investigation: contrast CT brain, inspect entire course of shunt for cutaneous erythema
  - Management: antibiotics, consult NS for shunt revision/removal + temporary EVD
- Overshunting:
  - S/S postural headache (worsened with standing/sitting, relieved when lying down)
  - Can lead to subdural hematoma (stretching of bridging veins)
- Distal catheter
  - Inguinal hernia
  - Perforated abdominal viscus / peritonitis
  - Intraperitoneal CSF-filled pseudocyst
  - Tumor seeding

5.  4 Skull base tumours
    Pathology

- Benign: meningioma, schwannoma, pituitary adenoma
- Benign but aggressive growth: chondroma, craniopharyngioma
- Malignant: carcinoma, sarcoma

General management: microscopic / endoscopic skull base surgeries + adjuvant RT / radiosurgery

|                         | Clinical presentation                                                                                                                                                                                                    | Common pathologies                                             |
| :---------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------- |
| Anterior cranial fossa  | - Can be asymptomatic- Raised ICP: headache, n/v- Seizure- Anosmia- Visual complaints- Foster-Kennedy syndrome: ipsilateral optic atrophy + contralateral papilledema; classically a/w large olfactory groove meningioma | - Meningioma- Olfactory groove neuroblastoma                   |
| Middle cranial fossa    | - Visual disturbance: optic nerve / chiasm compression- CN palsy: III, IV, V, VI- Hormonal disturbances                                                                                                                  | - Meningioma- Schwannoma- Pituitary adenoma- Craniopharyngioma |
| Posterior cranial fossa | - CN palsy: facial palsy, hearing loss, dysphagia, HoV, tongue atrophy- Obstructive hydrocephalus- Brainstem compression: hemiplegia, sensory loss                                                                       | - Meningioma- Vestibular schwannoma                            |

5.5 Brain tumours
Epidemiology

- 1-2% of all malignancies, 13% of all malignancy-related deaths
  Risk factors
- High-dose ionizing radiation → meningioma & gliomas (the only proven environmental factor!)
- EBV, immunosuppression → primary CNS lymphoma
- Familial syndromes e.g. NF1, NF2, VHL, TSC, MEN1, Turcot syndrome, Li-Fraumeni syndrome
  Classifications
  Distinguish "benign" vs "malignant" ( metastasize outside CNS) is less important for brain tumors
- Histological features: mitosis, invasiveness, vascular proliferation, necrosis
- Anatomical location: risk of fatal / severe neurological consequences
- Possibility of surgical removal: risk of recurrence
  Pathology: Secondary tumors are 6-10x more common

| PRIMARY INTRA-AXIAL                    | PRIMARY EXTRA-AXIAL         | METASTATIC      |
| -------------------------------------- | --------------------------- | --------------- |
| GLIOBLASTOMA (WHO IV) (47%)            | MENINGIOMA (80%)            | LUNG (37-49%)   |
| ANAPLASTIC ASTROCYTOMA (WHO III) (24%) | VESTIBULAR SCHWANNOMA (10%) | BREAST (16-19%) |
| ASTROCYTOMA (WHO II) (15%)             | PITUITARY ADENOMA (7%)      | MELANOMA (16%)  |
| OLIGODENDROGLIOMA (WHO II) (5%)        | OTHER (3%)                  | COLORECTUM (9%) |
| LYMPHOMA (3%)                          |                             | KIDNEY (8%)     |
|                                        |                             | OTHER (11%)     |
| OTHER (7%)                             |                             |                 |

Tumor locations & types: depend on age

- Adults: 70% supra-tentorial - metastatic brain tumours, meningioma, gliomas (e.g. GBM)
- Children 2-12yo: 70% infra-tentorial - medulloblastoma, astrocyotoma, ependymoma, germ cell tumours
- <2yo/ 12-18yo: 50% supra- & infra-tentorial
  [Detailed anatomical drawing of an adult human brain showing the distribution of intracranial tumors. Tumors in the Cerebral hemisphere are shown as: Astrocytoma, anaplastic astrocytoma, glioblastoma multiforme, Meningioma, Metastatic carcinoma, Vascular malformation, Oligodendroglioma, Ependymoma, and Sarcoma. Pineal region tumor: Germ cell neoplasm. Cerebellum tumors: Hemangioblastoma, Metastatic carcinoma, Astrocytoma, and Medulloblastoma. Tumors in the Fourth ventricle are: Ependymoma, Choroid plexus papilloma, Meningioma. Tumors in the Region of the foramen magnum: Meningioma, Schwannoma, Neurofibroma. Tumors in the Cerebellopontine angle: Acoustic schwannoma, Meningioma, Epidermoid cyst, Choroid plexus papilloma, Glomus jugulare tumor. Tumors in the Corpus callosum: Astrocytoma, anaplastic astrocytoma, glioblastoma multiforme, Oligodendroglioma, Lipoma. Tumors in the Region about the third ventricle: Astrocytoma, anaplastic astrocytoma, glioblastoma multiforme, Oligodendroglioma, Ependymoma, Pilocytic astrocytoma. Tumors in the Lateral ventricle: Ependymoma, Meningioma, Subependymoma, Choroid plexus papilloma. Tumors in the Third ventricle: Colloid cyst, Ependymoma. Optic chiasm and nerve tumors: Meningioma, Astrocytoma. Pituitary region tumors: Pituitary adenoma, Craniopharyngioma, Meningioma, Germ cell neoplasm. Brain stem tumors: Astrocytoma, anaplastic astrocytoma, glioblastoma multiforme.]

Pathophysiology and clinical features

- Increased ICP due to
  - Tumour mass effect
  - Vasogenic edema (most apparent on FLAIR MRI): disrupted BBB, tumor-secreting VEGF
  - Hydrocephalus: obstructive / communicating (leptomeningeal carcinomatosis)
  - Obstruction of cerebral venous drainage (e.g. superior sagittal sinus thrombosis)

- Seizures - 50% present as status epilepticus / post-ictal Todd's paralysis
  - Usually associated with **slow-growing** tumours that involve **cortex** e.g. meningioma, low grade glioma

- Focal neurological deficits depending on tumor location
  - Frontal lobe
    - **Motor** disturbances: convulsions, hemiparesis, aphasia
    - **Cognitive impairment** (esp. corpus callosum gliomas)
    - Impaired initiation and spontaneity
    - **Personality changes**: apathy (dorsolateral PFC), disinhibition (orbitofrontal cortex)
    - Urinary incontinence
    - **Anosmia**: esp. olfactory groove meningioma
  - Temporal lobe
    - **Receptive dysphasia**
    - Contralateral superior homonymous quadrantanopia
    - Complex partial seizures
    - Impaired working memory
  - Parietal lobe
    - **Sensory** disturbances: seizures, impaired two-point discrimination / stereognosis
    - Contralateral **inferior** homonymous quadrantanopia
    - **Gerstmann's syndrome** (agraphia, acalculia, finger agnosia) - **dominant side**
    - **Apraxia**, contralateral hemineglect - **non-dominant side**
  - Occipital lobe
    - Contralateral hemianopia (macular-sparing)
    - Visual hallucinations
    - Cortical blindness - if bilateral
  - Cerebellum
    - **Projective vomiting** (area postrema)
    - **Obstructive hydrocephalus**: S/S of raised ICP, CN 6 palsy
    - **Cerebellar signs**: nystagmus, ataxia
    - CN 7 palsy

- Hyperactive function depends on tumor producing other substances
  - Functional pituitary adenomas: Cushing's disease, acromegaly, TSH-secreting (rare)
  - Choroid plexus papillomas (rare): CSF-producing → hydrocephalus

Investigations

- **Gadolinium contrast-enhanced MRI**
- Other MRI imaging: FLAIR, GE/SWI, DWI / DTI, spectroscopy (MRS), perfusion (pMRI)
  - DWI: differentiate cystic intra-axial tumor (facilitated diffusion) vs brain abscess (restricted diffusion)
- Stereotactic biopsy

Management

- Medical: **steroids** to reduce cytotoxic oedema and improve functional outcome
- Surgical treatment: debulking and/or complete excision
- Adjuvant therapy: chemoRT / chemotherapy

361

362

5.  6 Spine diseases
    Anatomy
    Spine: Cervical spine (C1-C7), thoracic spine (T1-T12), lumbar spine (L1-L5), sacral spine (S1-S5), coccygeal spine

Nerve roots:

- C8 exits between C7 and T1 (there is no C8 vertebra)
- Above C8: exit on same level of vertebra (e.g. C4 exits between C3/4)
- Below C8: exit on next level of vertebra (e.g. L4 exits between L4/5)

Assessment
Physical examination

- UL:
  - Myelopathy: hyperreflexia, myelopathic hand signs e.g. Hoffmann sign, finger escape sign
  - Radiculopathy: hyporeflexia, dermatomal numbness, Spurling sign
- Trunk: sensory level (T4: nipple; T10: umbilicus)
- LL:
  - Clonus, hyperreflexia, upgoing plantar reflex
  - Straight leg raise test
  - Gait

Investigations

- X-ray spine: dynamic (flexion/extension), sagittal plane to look for any imbalance
- CT spine: bony lesions
- MRI spine: tumours
- Neurophysiological studies: nerve conduction study (NCS), somatosensory
  evoked potential (SSEP)
  Common spinal tumours
  | | | |
  | :------------------- | :-------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
  | Intradural extramedullary (IDEM) | Schwannoma | Common at **cervical & lumbar** spine 95% arise from **sensory** nerve root → present as pain Usually sporadic - if multiple, think about NF2 **T1 contrast-enhancing** Mx: surgery (nerve usually can be preserved - separate the diseased rootlet from other rootlets) |
  | | Neurofibroma | Usually **multiple** and associated with **NF1** **Cannot** be separated from nerve fibers within a nerve (c.f. Schwannoma) |
  | | Meningioma | Common at **thoracic** level (80%) Located **lateral** to spinal cord (70%), except at cervical spine (anterior) Well circumscribed with homogenous enhancement and **dural tail sign** Mx: surgery (<10% recurrence) |
  | | Metastasis | |
  | Intradural intramedullary: a/w syringomyelia | Ependymoma | More common **Discrete** from normal cord → Mx by **surgery** Example: myxopapillary ependymoma (WHO Grade 1, at filum terminale) |
  | | Astrocytoma | **Indistinct** from normal cord → Mx by biopsy and **debulking ± adjuvants** |
  | | Hemangioblastoma | |
  | Bony | Hemangioma | |
  | | Metastasis | |

[A medical illustration showing two spinal cords with masses. The first spinal cord has a mass on the outside that indents the cord. The words "Intradural Extramedullary" are written below. The second spinal cord has a mass growing from the inside. The words "Intramedullary" are written below.]

[A black and white medical image of the upper torso showing a large mass in the middle of the chest and upper back region.]

[A black and white medical image of the lower back showing a mass in the spinal canal. There is also enhancement along the dura.]

5.7 Deep brain stimulation
Patient selection criteria

- Advanced PD patient >5 years
- Idiopathic PD
- Previous good response to L-DOPA
- Severity: UPDRS motor score >30/108 at off state, Hoehn-and-Yahr grade ≥ 3
- Age ≤ 75
- MMSE ≥ 24/30 with no significant comorbidity, psychiatric problem and dementia
- No structural lesion, severe cerebral atrophy or extensive white matter change

Operative techniques

- Awake / Sedation: can facilitate intra-operative neurological testing (cf. GA)
- Target sites:
  | Parkinson's disease | Subthalamic nucleus (STN) <br> Globus pallidus interna (GPi) |
  | ----------------------------- | ------------------------------------------------------------ |
  | Essential tremor | Ventral intermediate nucleus of thalamus (VIM) |
  | Medical-refractory epilepsy | Anterior nucleus of thalamus |
  | Tourette's syndrome | Globus pallidus interna (GPi) |

- Pre-op:
  - Measure frame size: fixate at bilateral EAM
  - Assessment by neurologists: withhold anti-Parkinsonism medications to render patient in "off" state
  - Stereotactic CT brain with head frame just before OT → navigation planning (fusion with pre-op MRI)
- Intra-op - Awake technique: facilitate intra-operative neurological testing (cf. GA), but require good pain control, meticulous positioning, thermal control, avoid Foley catheter - Confirm coordinates of frame with intra-op fluoroscopy - Confirm site of implantation: EMG, BIS (bispectral index EEG), micro-electrode recording (MER) - Subcutaneous tunneling under GA

  5.8 Radiology of brain
  Pathology

- Description: size (small, large) + extent (focal, diffuse) + density (hyperdense, isodense, hypodense)
- Localisation: Intraaxial, extraaxial, ventricular, arterial, bone
  Density
- Hypodense: oedema, infarct, old clot/blood\*, abscess (ring-enhancing)
- Hyperdense: new clot/haemorrhage\*, contrast-enhanced blood, calcification, tumour (slightly hyperdense with surrounding hypodense oedema)
- Isodense: choroid plexus
  Mass effect
- Midline shift/ shift of structure
  Cerebral ring-enhancing lesion - MAGIC DR
- M: metastasis
- A: abscess
- G: glioblastoma
- I: infarct (subacute phase)
- C: contusion
- D: demyelinating disease
- R: radiation necrosis or resolving haematoma

[Axial CT scan of the brain, with labels pointing to the basal cistern (suprasellar), L frontal lobe, L temporal lobe, pons, cerebellum, and cerebellar vermis.]

[Axial CT scan of the brain with labels pointing to caudate nucleus (head), putamen, internal capsule, thalamus, lateral ventricles (anterior horns), pineal gland, lateral ventricles (posterior horns), and hippocampus.]

[Axial CT scan of the brain with labels pointing to L lateral ventricle (frontal horn), third ventricle, and basal cistern (quadrigeminal).]

[Axial CT scan of the brain with labels pointing to corona radiata (white matter), L lateral ventricle (occipital horn), L occipital lobe, and R parieto-occipital fissure.]

[Arterial circle of Willis on a brain angiogram with labels pointing to MCA, ACOM, PCA, PCOM, and Basilar artery.]

[Sagittal view of the Circle of Willis, showcasing the Corpus callosum, Thalamus, Midbrain, Pons, Medulla, Gyrus rectus, Sphenoid sinus, Clives, and pituitary gland highlighted by red circles and the label "P".]

[Axial view of the skull base with labels pointing to Petrosquamosal Fissure, Petro-occipital Fissure, Occipitomastoid Suture, Sphenosquamous Suture, Occipital condyle, Foramen Ovale. The legend shows Temporal (red), Occipital (purple), Sphenoid (green), Greater Wing of Sphenoid (light green), and Petrous Temporal (yellow).]

[Axial CT scan of the brain showing ventricles.]

364
